<SEC-DOCUMENT>0000950170-21-003448.txt : 20211108
<SEC-HEADER>0000950170-21-003448.hdr.sgml : 20211108
<ACCEPTANCE-DATETIME>20211108160400
ACCESSION NUMBER:		0000950170-21-003448
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		64
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211108
DATE AS OF CHANGE:		20211108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eliem Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001768446
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				832273741
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40708
		FILM NUMBER:		211387868

	BUSINESS ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL ROAD
		STREET 2:		SUITE B221 #125
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98053
		BUSINESS PHONE:		425-276-2300

	MAIL ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL ROAD
		STREET 2:		SUITE B221 #125
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98053
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>elym-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2021-11-08T15:43:54.4743+00:00 --><!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:elym="http://eliemtx.com/20210930" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonFraction id="F_cad6912b-f4dc-44a2-b287-0fa48d3726a3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_54b7083d-4cd2-4ee7-b111-7a31a0b56b00" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_f161b092-35d8-4378-b101-d067bf0d0c7b" name="dei:CurrentFiscalYearEndDate" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">--12-31</ix:nonNumeric><ix:nonFraction id="F_2455f9e5-7001-4416-b693-e07b21507683" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_9a126cdb-371c-4e20-aaf9-f06be6c3406a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_952dab32-e751-422e-a571-f065e2503d1d" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_4a372294-5c08-4856-8ab5-1e655a909612" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0caf0953-2fe3-4856-a0d2-4263052be7e7" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_cea26e02-7880-4f1c-83d4-65fc62248c5f" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_85f6ec00-71a2-4fee-a7e6-4e208f9bedb2" name="dei:DocumentFiscalPeriodFocus" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">Q3</ix:nonNumeric><ix:nonFraction id="F_18b1fff5-aa6f-4693-afe4-8fed26a3316f" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_5789f58a-2e10-4100-9e66-25c8a9b30a0d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_bdf1698b-4c4f-4e4e-86e5-5c9d69711ce1" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_f0adb4f9-e15c-4b6b-8040-c551c670f74b" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_6cba2cd1-feca-4dac-af1b-4c2e02d95093" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_536e3532-29ed-4c37-90c2-0ddc3fddf513" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0004fd8e-d21f-4b53-971f-f43d8e0443dd" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_4a8d8b13-384d-41d2-8000-99caf630a9b4" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_91b8529f-2f92-40c3-aca7-45631fc73d32" name="dei:AmendmentFlag" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">false</ix:nonNumeric><ix:nonNumeric id="F_48b04b20-61bc-4a16-8826-6dea6acb138e" name="us-gaap:PreferredStockRedemptionDate" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">2026-10-31</ix:nonNumeric><ix:nonFraction id="F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_6c88688a-cb57-432a-9574-d7f050357c95" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_bb574e2b-e549-41d5-a114-d1eae627d3de" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_438167c9-390f-440b-bc81-485d4089e8fa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_1f36fdf3-3b2c-43f0-b0ad-cd794e2c3a23" name="dei:EntityCentralIndexKey" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">0001768446</ix:nonNumeric><ix:nonFraction id="F_4ee89191-586d-4bd2-97cb-383860193695" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_573f20af-85b7-4cca-9a77-16dd39a823ea" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_caca09e3-072e-4355-8e2b-6979c157fdd0" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_48c9728b-916c-42b6-8e04-80f3aed9bdaa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_34f12efc-296e-4e51-8096-c241fee45935" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_b192cd7e-2aa4-4bde-a1f3-86421ba91240" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_8774bdeb-cb3d-48e2-a101-98fadcdf44be" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_34d11ddd-adb9-490d-935d-6318e8747598" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_237ebc67-be1b-4813-8e0c-2b9924f70c1a" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_fcf7810e-cac0-4293-8256-a2a97feb91f8" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="elym-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_68f7e8b4-274f-4fe8-b269-524e2cacfad2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:EsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9f66eae-8887-4a36-997b-b20ccec6a003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6b57452-47f5-4388-a412-3f3ba1283020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_240f8cde-e329-49df-8877-bf46eeb51205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_471f6e68-ef76-445c-b86e-f172ff3b5785"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_340d9bd0-d7ea-4047-a232-5b317397c002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68582859-0096-46e8-8bb0-1a00b93cbdf0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13f227b3-c2ea-418b-951c-f0a483067432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a8d8b13-384d-41d2-8000-99caf630a9b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f661c20-6f08-4391-8bc7-a8daecf3219b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b3c644e-edca-435e-b343-309e123a2ea3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_531646ff-7d69-4062-a71d-4de0f8f78fed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a08166e1-5c98-4297-81ec-f148b463fbeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_593e17e9-ffd0-4218-9443-cc138e4c41d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b78178eb-00d0-406e-baa2-53b8b434c787"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_347b031c-725b-474a-9a52-13972c241f68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f44875f-fa81-4c6f-a4d8-7bccd495c678"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ad6f985b-b398-416c-a97e-19ed5c2ba56c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d855745-343a-4c58-aacc-25642060cf47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a876d31-7de7-495b-a7b5-bba7c9a4a7d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c86051eb-0d3e-4119-82d7-626225e4cc0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e50b5ef4-1e50-483c-b6d3-4444344701f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_844e6091-3490-47b1-ba64-9d928eb8531d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d7d035a-64cf-46ac-a997-043054a67440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49b12a98-c4f0-494b-bb47-7d43ab89b59f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4ed1c900-e113-443f-a67b-a7be04e9fecf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3c1f890e-2a01-4903-afa6-61704660b423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_55e83e5b-e1f0-4f60-8528-da2a67b8a332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0e75eaf-c8c0-4041-b14e-3d776b96ecb0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_308a931a-0338-4cef-80b1-90d2080e2ef4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1335aefe-f684-4dfb-84f4-21a81a7b3905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f1a829c-ed84-4c89-b645-95747568e8c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_93109258-498b-4c14-93fc-9952e94ea8f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71ae99b8-6442-4275-bd07-b38f55d947bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa7a0150-db25-4f6d-8b6e-4487da4738f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02ca6dff-2485-430e-84db-9a99d6227383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1ac6833-38fa-4679-a86b-de27670a06dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50f80129-d404-4d29-a58a-3d06114b7d2a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_37af721e-0687-4647-a911-6481229378d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54207afe-8ac8-4d70-9d88-5a5cc0805155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3316dedf-bc1e-41a0-9dd7-e5ff0ba3463b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c979a217-c5e3-4cc3-a4c8-2ea6f9acc46d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e16d4b2c-90c7-4cf7-89fb-de39e5cd2c7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72d3a4a0-a7dd-4cce-b4cd-5ceeab4550af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_34d11ddd-adb9-490d-935d-6318e8747598"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7a07cf1a-9b36-4553-a382-4b7030b2b6fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8793bdfe-da79-41be-90e0-59ecbd5154a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ad1bea71-dec8-49f4-8388-dcc31f1a917a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0950534c-0e42-47f2-9fff-61cb3af705cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bae15c67-f4c8-4995-984c-a35ab4ed4694"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2019ec91-516c-4bf3-ac1b-fa77f62f2f90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a65d3f7-d7e5-4d07-9686-97499e60085d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5789f58a-2e10-4100-9e66-25c8a9b30a0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f078b167-0dbc-4247-867c-2c3caced4b04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b74eebe-7367-44f3-89a2-41a2ae3c4f6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81c02b73-1cfc-43ff-81c8-ad3d786216a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">elym:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66d4dd4a-39ec-4e58-a0db-4d2f02dce3b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:EsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ace5a9e-cd32-4d91-b90b-5a3b7e9a6f23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e8bd169-1cd0-4494-b634-7a499711cee0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_95fcdeb7-8d75-4866-b9b3-f9a0ef7464a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1f934220-7227-455a-a222-d949fb36f763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d1271c8-61fb-4654-8d3a-3c7dc98c3046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4dd18ba3-1af3-403a-a4dd-75dd15b5568f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_969acfbd-1a24-44dd-a3fe-5aa7b81c5654"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90f3cb70-fc4d-4dc8-b871-9fbf79d9d423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a126cdb-371c-4e20-aaf9-f06be6c3406a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_438167c9-390f-440b-bc81-485d4089e8fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61c4932e-fb1e-472e-b741-e5bb1f637f14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ead6c6d-1e36-4252-80e7-a03d15dab206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d57b29e1-52ee-4b19-9fdc-0dcbcf61ce63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8865c8f2-5fc8-47cb-be44-ea1ba848844c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a372294-5c08-4856-8ab5-1e655a909612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31b8ed67-f03c-4547-8524-ec693e5089df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_049452a9-fc43-43c7-8a1c-3587620997bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cea26e02-7880-4f1c-83d4-65fc62248c5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea28cdf2-fea4-428a-98b1-56bb6cc26c9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4227218-0fbb-4ded-b156-157f89ae7254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9af81434-0b8f-4b94-835b-f7c9145d2966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21615b53-9670-4e5e-9edd-186adb41d615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b3f43bab-a6cb-4d81-a307-cb587d9e5ead"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03e5d18b-f2bb-400c-bc23-acf4b46aceb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ed3a81a-7827-4cef-8afe-082b91627928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0791263e-f277-474d-b34a-5bf44a42eeb0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aec7af12-734e-49d6-876e-4f51ec91a65e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_481e58e9-cf0c-4dd5-a802-7bc69141a9ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d491de55-e878-46da-a26f-9d31bf0a5efa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ec6ede2-f478-478a-b73b-15c197d0267f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46ca06ae-f957-4d6e-af82-97b092ac535d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_83a11aaf-7840-457e-9202-2ea0f69ba41f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ab82fd0-f468-46f6-9578-f2c09bf493a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d49ac965-16d2-49f6-8496-6b6bd4de9295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_64c92ae1-3adc-4f1d-b3af-072fddc18c73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2aa7983d-2e71-4d10-bac5-a6414b081d2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9991e520-51cf-427f-89de-e1753fed04a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75286094-929a-4cd3-b751-e628bfe63388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e199be2-33a5-477c-a0da-56b294f88cd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ddf6340c-4eb3-4c81-96c0-c3840a43b061"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2392a1b8-059d-420a-a61d-e8a43d080997"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f03dc908-cddc-420d-9f23-e55b22233be8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e4be4acd-0552-45c9-9ae0-524e93aee408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_86547cb0-3862-4a95-981d-e7e9f18fd071"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_398fad3d-4870-4949-9d7c-6dfc42616d57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0d329b9-6c79-4719-a2f5-874661472d87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cce22c4e-7230-4435-ad69-db554d6a00a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b84124c-9c47-43b4-84c4-b441d84b7611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3a75adc8-6494-436d-8e73-ab1898a3f4a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcf7810e-cac0-4293-8256-a2a97feb91f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dba68e91-f80f-4784-96e6-c91207909a6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a46cf12-25cf-4536-bbb3-735a35b5967e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79e4fccb-c419-40b4-9864-4b8eeee9746d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58902cc5-c0a4-4b35-962a-3a2dc5e8d973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0baa77a4-0ccf-4e25-9f89-25825a5dd5de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a9e7f57-d4e5-4367-8742-49198b69b770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c88688a-cb57-432a-9574-d7f050357c95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48b80c70-8600-4f46-a177-2157d5d486f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e66b3150-0c6b-4578-9500-22dc6c115867"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">elym:StockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f32fa3fe-04ff-4f37-9cda-74b7fa643680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c81c2950-d46e-4287-a0f4-4964fefc37bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_861dbad3-d53a-4204-a645-525cd720e7a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_921214ea-f1eb-402a-b0d4-e85238b44c06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6cba2cd1-feca-4dac-af1b-4c2e02d95093"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73fac32b-1946-4425-9058-8304c2ddbf20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35048792-ecdc-4ad5-96d7-88fe71e99d94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e5d32c4-3b28-4cb4-944a-cb5fad009173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b30f421-7970-424e-addd-c4971489194f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed02f132-4271-4596-83d9-8aea2fbffae7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba7c150f-8562-403b-bdbc-e0b6db0cec39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48c9728b-916c-42b6-8e04-80f3aed9bdaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_87892d72-2788-4288-9f97-01316b8174e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9966861e-a257-4483-a647-6780eab777a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b3e80fb2-f161-4a38-a1e3-c8d52f228cee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_573f20af-85b7-4cca-9a77-16dd39a823ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31769d99-77c6-4ee7-9d41-eb3e0d4c18c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ceab66a-25cf-4427-b629-b07de4d324b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e23dbd6-7d37-4dc5-857b-7212c0ea9084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_467945a5-3ec2-4005-a9d6-1240297ff054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12bd7c9a-9686-44a2-803f-a81d4cdeccf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_91e85f77-84b1-41c9-939d-ce1d423da25a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f6cd6f8-2b85-43a3-8604-dcd98e7b76d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_26dc1ae5-daf7-4353-af46-9f523316d9d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ac126da1-96bb-4ee7-9242-49c11ef12bd4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_USDollarShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="border-top:2.250pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">WASHINGTON, DC 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:5.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8af660b6-f65c-4046-b7c8-c16bce3ae9eb" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">10-Q</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:5.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Mark One)</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fbafd745-a682-41a3-9cd4-7e3ad106437c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">For the quarterly period ended </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d7ac858-7673-46cc-9db2-2c34a96fbb1b" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_356c6a53-1721-4364-9043-390a0670a767" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">OR</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fdb55e41-d165-4e6d-ba34-8ccafba92fe6" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">For the transition period from  to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Commission File Number: </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9ecbe7fa-f40e-4af9-8d92-ea449140a922" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-40708</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:5.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cae572d-dd5b-4433-b4eb-4df86881558d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:Times New Roman;">ELIEM THERAPEUTICS, INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Exact Name of Registrant as Specified in its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7353715-2f60-4746-93d4-4ad0b22212bc" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_161ef73f-3b05-4d7b-b1e0-0770771b7ddd" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">82-2273741</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(I.R.S. Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_54daa2fd-1a62-4e4b-af49-1e8209dfb4fa" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">23515 NE Novelty Hill Road</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6dc4911b-f70f-48d0-9208-9c6657c85e5c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Suite B221 #125</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7ef6e600-aad9-4a99-afee-33faf8745637" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Redmond</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ee008c7d-9842-40ae-89a1-183683127aab" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">WA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_064de2cd-0128-4dd0-8b4f-522bf7c94830" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">98053</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2efcf921-45af-4794-a7af-013fc8ea6cad" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">425</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">) </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af9b1a65-9f20-4f70-9cdd-020d8274a774" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">276-2300</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aabe3c28-63f1-49e4-b166-ad47d6e81a70" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dac1e5f9-2d98-426e-addf-3d38e554020b" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ELYM</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_57c1ac5f-b584-4931-a251-9637eeff5799" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(The Nasdaq Global Market)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41b3b642-083b-4c8f-8a41-bfde9d30a696" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> &#9746;    No  &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a6d0b0d-a897-4f9d-816f-dbeaa59ccb07" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  &#9746;    No  &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.37%;"></td>
    <td style="width:0.537%;"></td>
    <td style="width:56.491%;"></td>
    <td style="width:0.824%;"></td>
    <td style="width:20.398%;"></td>
    <td style="width:0.537%;"></td>
    <td style="width:1.843%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c436557d-37d0-4fcc-8e8b-cfa0b38c908d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_151309dd-93b3-4c57-acc5-667e75c7dcea" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0d040d2e-302b-4a0d-9335-d73d67795daf" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9131f262-e5d9-4fec-99c9-10df724c3541" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_365481ed-f40e-4993-9d0c-f45880d4eb48" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">    No  &#9746;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.     Yes  &#9746;    No  &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">As of November 5, 2021, the registrant had</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e378259f-4c8c-4608-9df4-1b3ea91daf20" contextRef="C_2019ec91-516c-4bf3-ac1b-fa77f62f2f90" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">26,554,316</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">shares of common stock, $0.0001 par value per share, outstanding.</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.0%;"></td>
    <td style="width:83.0%;"></td>
    <td style="width:7.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Page</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART I.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#financial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">FINANCIAL INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Financial Statements (unaudited)</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:14.4pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:24.5pt;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:31.7pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:31.7pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:14.4pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_of_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:24.5pt;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:31.7pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:31.7pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:14.4pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:14.4pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_stock_and_stockholder_deficit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:24.5pt;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:31.7pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:31.7pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:14.4pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_of_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:24.5pt;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:31.7pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:31.7pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:14.4pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Discussion and Analysis of Financial Results and Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item3_quantitative_and_qualitative"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item4_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART II.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">OTHER INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item1a"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item3"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Defaults Upon Senior Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item4"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item5"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#ii_item6"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Signatures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="financial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART I - FINANCIAL INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. Condensed Consolidated Financial Statements (unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolid</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ated Balance Sheets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:96.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.605%;"></td>
    <td style="width:1.72%;"></td>
    <td style="width:1.662%;"></td>
    <td style="width:17.306%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:1.72%;"></td>
    <td style="width:1.662%;"></td>
    <td style="width:17.296%;"></td>
    <td style="width:1.015%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current assets:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dae021a7-a44f-4c1a-b95a-2598f788a7dd" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,819</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa53f4bf-2f72-4dae-8e51-a1a4a81ce1b3" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2c16731a-1fc5-4600-8464-3157a16c31b3" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,199</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3a723eaf-97a4-4d5a-bc85-0b55153a5e89" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d26b063-3a06-4286-8970-4b312d260958" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,614</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e2df3de-7ad7-494a-b374-d860d496ebab" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4eab7d42-14e7-438b-a366-a6d9d13c1637" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158,632</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55c19dd3-8ee7-4bb6-a9af-2e93f940c33f" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,998</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f6e64e4-60cb-43fa-8b6f-1d7e2f3a53e3" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,619</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8a55e454-2b3f-4ae3-8d4b-4958c4f09735" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other long-term assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8efa8076-82b2-4669-a7d1-bbe9f7e36787" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ba55fd0-1bf5-47b0-ac0d-858a5729bea8" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,633</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_52a317dd-14d0-4dcd-9725-d0cd876b036e" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">182,251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_62136ecc-2e4b-4de5-b721-59d2ce2f1fe1" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities, Redeemable Convertible Preferred Stock, and<br />&#160;&#160;&#160;Stockholders&#x2019; Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_615e07d2-753e-4ef9-a349-a52c26dbd604" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,579</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2197cb6a-d396-4d4f-8da4-23ab41a9b185" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,086</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable, related party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8b895d2-5d90-401b-ace2-0d8c16d79e93" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1ad18dd-222d-4c06-9d7e-fcfe25afea14" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">207</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_913f4aca-a230-4c30-a3d9-780bd465f27a" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,979</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0d7c083-cda9-4513-9563-2147b6673bd3" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,219</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses, related party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_caf6c7f3-4af7-4119-95ef-83918c8fd9ba" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e2d1c6f-157a-4506-88f0-5eea8a7fdc83" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock tranche liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_166e0603-a048-4999-ba59-0f8d9f2f0072" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:RedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_98c6346b-b1f3-4839-a917-7a0b924db5cd" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:RedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a070d7a0-6702-4682-a48a-cdb5fb91f849" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,590</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b7a166a-3ef8-41ea-a100-3ec091d2bb18" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,063</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c0a11a4-ddc1-443d-9454-760f9cb89a99" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,590</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b465d92-25b2-49de-8ac1-ef7a48db5872" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,063</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bdf1698b-4c4f-4e4e-86e5-5c9d69711ce1;"><span style="-sec-ix-hidden:F_34f12efc-296e-4e51-8096-c241fee45935;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Commitments</span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and contingencies (Note 6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3663ea36-2eb8-4fd3-82ea-e79c03645c76" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_USDollarShare" scale="0" decimals="4"><ix:nonFraction id="F_4d2e6215-cc1c-40f1-89bb-4a0aceb13864" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_USDollarShare" scale="0" decimals="4">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value,<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_63463708-15ea-465d-afdb-181869fb33fb" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b17ee0fd-0de8-4356-a145-e06ccd89838a" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,909,389</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86cf786b-7d24-4949-b5b0-3eab08e1fd05" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_3f60985d-e15f-4385-8360-444314d31d9b" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89999fb9-14c6-4bb9-ba32-375b4d526a20" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_7c91c613-50fd-4913-bc94-b098958eeb93" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,140,157</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding with aggregate<br />&#160;&#160;&#160;liquidation preference of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d4671cc6-4602-43cd-bcd8-606cd6b11f05" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e1fefb5-7812-4aae-a7d2-bda8e8cd6b4d" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,891</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;at September 30,<br />&#160;&#160;&#160;2021 and December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf4be240-a051-43f9-adea-9b69f40f22c6" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_de650fb0-e03c-4f1a-b87f-be967f9eb96e" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stockholders&#x2019; equity (deficit):</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb4d4505-fd5f-452a-99d2-6aa0405c6374" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" scale="0" decimals="4"><ix:nonFraction id="F_657bcf5b-4c36-4e74-ac13-ae5d61a6fe86" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" scale="0" decimals="4">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value per share, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7027728a-c77f-46f6-bf69-2c6f5a2c9143" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">250,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b234835b-fffd-405e-80e5-8f902f36d53b" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">40,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6132c1db-bfae-4ec4-aaaf-eaf068ee2b99" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_17b97c44-eedb-4f11-8353-570e404c4cbe" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">26,199,262</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df3c512b-964a-4689-a70e-4ca3dc4bc19d" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_cfce7194-71f5-4237-a18c-0f15a63c74fa" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,418,751</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br />&#160;&#160;&#160;shares issued and outstanding at September 30, 2021 and<br />&#160;&#160;&#160;December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5766b0b4-258f-40d8-8bff-21b2794a82cf" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2356fd64-ad9d-4d20-8ae2-5d933e7ade8d" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bef672de-198b-4dc0-9238-2656d3b6ebea" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">241,747</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_72e9da31-5ad3-457a-affa-764eda0d5ae3" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,152</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated other comprehensive income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b01ae11-03b6-44af-a8fb-6000b14ecff4" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b87c502-4f9b-4707-9def-e1449db3937e" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be8fa30d-7801-49e7-9e8b-00db1196fc9b" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">65,071</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0565cb9-1503-4af2-a134-d96a0747800d" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">28,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dbf50086-a905-459c-9d1e-0e34d2a04f0a" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176,661</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f3c382a8-cc5d-4986-8e3e-e7885a7e4717" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">24,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities, redeemable convertible preferred stock,<br />&#160;&#160;&#160;and stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d6cdf81-875a-4761-a54f-c730cc2fe141" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">182,251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_462fbc64-3693-4c60-a3ec-0f8353a18b68" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_of_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated St</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">atements of Operations and Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.283%;"></td>
    <td style="width:1.224%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:9.071%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.855%;"></td>
    <td style="width:1.595%;"></td>
    <td style="width:9.015%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.855%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:9.015%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.855%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:9.015%;"></td>
    <td style="width:0.927%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb73b728-df1f-4478-8a37-afeaf050c441" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,704</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_268e989e-095b-4cb3-8457-6f50bee913bb" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,930</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89ab67d4-f132-4dd7-85a3-5256c7c9df4c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,455</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40697878-1f5b-4165-86da-a4ad432cb136" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,644</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development, related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c01ae15-bcae-49f1-a355-7ddedb142f07" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="elym:ResearchAndDevelopmentExpenseRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">285</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8bfca85a-178e-4eec-9d53-fca7fd5e83d8" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="elym:ResearchAndDevelopmentExpenseRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_98af3a13-e6d6-4980-a756-04023c16f7ee" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ResearchAndDevelopmentExpenseRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">988</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_72366703-30a0-428a-b6a4-6e8e416a131b" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:ResearchAndDevelopmentExpenseRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_817241fa-b496-472a-b5c2-16cde7b8a58e" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,394</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a15fac6b-3fbc-48d8-bbb6-ebc26c84e2cb" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">312</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_749fa255-5192-43bc-94c5-f31052690f86" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a7bf4f1b-86a5-4616-9f7c-c7cd3939f1d8" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">888</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89bcc640-0d17-4aa9-90fe-01fafc4274ca" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,383</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9f24eded-d203-46bb-bf68-8179d651fbd4" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b5e110a-9d69-4dfd-8816-28c80ee5bdb7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,969</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc333a01-2732-4fd0-895c-bcf38681da65" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,818</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_054f2109-e7b0-4380-b640-c6fa646ce2d0" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,383</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_58ca2e72-d1b6-42e7-b693-f7f0317e94df" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e2354fe1-43b3-4c58-b0f1-230c3456235f" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">24,969</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d045293-026a-4184-8ca9-0cae99b79ef7" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,818</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income (expense):</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value of redeemable convertible preferred stock tranche liability</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b32a9be3-05e9-4e7a-a00e-18e27b0c06f9" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1343524e-1809-4bd0-be32-49f2b0f95ffc" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b2768036-4b04-48e6-91fc-fe2ff565ce1f" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,718</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_77ff43a5-5234-4a5a-8581-e924aa1b85fd" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency gain (loss)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70224af5-b951-4f00-b887-a8793dcd0cb4" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">252</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_98a844b7-55e0-4f9c-a3ea-d77cec91396f" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1435eaf8-db75-4f2f-8ff4-959cde163afb" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">268</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_661dcf38-a793-469e-be8a-02def9459804" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd5b367d-a5e3-42fd-8d03-7ca9506e2c0d" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c93a9cb1-61a8-44a0-be74-06ab6bbaa727" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ec1c8603-aab6-493f-aaae-89413643c99c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0f56a96-4bc8-4f51-9b3f-47e0f990adb7" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total other income (expense)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73b8d965-0b1a-4431-b936-0ada48f0a5af" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">232</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7747478f-0ec5-4be8-b6d4-ff783bcbe61c" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d749f19-7723-40b8-862e-94e90933b546" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">11,966</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d50649e-7edd-48da-9f5e-4cf59254ed98" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6730250b-17b4-49f9-9770-ea0bbc12f09a" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,615</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed9eb14b-797f-4216-8aa8-169a65070791" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f00e5d61-223a-4763-8980-dd532104e404" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,935</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc78b34f-7c46-4c8c-9415-1ce05349bb64" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,805</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd36e077-5b14-4b8f-bfec-32e1954b0738" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,322</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d74468d-0c99-46af-9648-d548aaedc87b" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1fe7b3a-000b-497d-a237-d26c224781b1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,548</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_527e1007-b924-445d-a2dd-f07433b5abcb" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,352</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46c6dc90-2ffd-4cac-b7f9-7f1b8a60c0a3" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">10,937</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be57334e-df62-4fe2-a69d-8c1957c7e6d9" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e814ba58-c513-4c85-b10e-31337d620b48" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">41,483</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73ca978c-ccbf-407c-be96-49cec9515dab" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7,157</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d27a5ca6-b287-4956-b56b-215293d44897" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">0.70</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0bf3094c-761e-4421-90d9-8b308c92ec65" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">1.46</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a1ed7d4-ee0b-4890-aabb-bcca4e0b8ab2" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">5.49</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_983d2492-3a21-47d6-9084-f3d2feaeb820" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">3.85</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7bc21c95-1bd2-4df7-a912-b529fc7a2f37" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,585,611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8944854-d547-4fc1-94ae-d5dea583a720" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,863,860</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6308d4c0-fb19-47d4-8cad-78afab034e6f" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,554,300</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8fa0a573-1ce8-4b20-9be9-e694a46587a1" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,859,713</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84baf45c-b9b1-43f6-875a-e37132840f86" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,615</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76cf9a98-e99d-448a-bb0e-9d25452f5212" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d64bf5e-378d-4be2-ad0b-d46fae04be22" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,935</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b12ce037-d561-4906-9ee8-6151f2b5bfe3" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,805</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unrealized loss on investments, net of tax of $0</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89b86afa-47d8-4e14-9a50-24aa9767f627" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4a83641-156f-4ab0-94d5-7d23bfb9df9f" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4e1170a7-da4f-4e4f-b723-c92f9afec674" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ec7d6c5-9ceb-4148-855a-92c2e9a2eb7f" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45d3922f-65df-423d-9238-8e93fff3e06c" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,633</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0beafbc8-347f-4593-8169-b4599940859e" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_020ed3ff-2ece-4140-b4bd-0be81b4ac606" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,953</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae1ca670-d0ca-4bb6-932c-87794d2aea9a" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,805</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_stock_and_stockholder_deficit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Redeema</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ble Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(In thousands, except share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:15.767%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:8.256%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.797%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:8.381%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.894%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.901%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.88%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.463%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.88%;"></td>
    <td style="width:0.584%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional Paid-in Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated Other Comprehensive Loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total Stockholders' Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1ed930e-e64f-4064-8703-7f6a5ef62861" contextRef="C_83a11aaf-7840-457e-9202-2ea0f69ba41f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,140,157</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c11858e-cb94-4382-ac94-b7724910eb09" contextRef="C_83a11aaf-7840-457e-9202-2ea0f69ba41f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_472f1814-4ae6-47e8-b7a4-872e5a86006e" contextRef="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,418,751</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2a7cdd4d-85fa-4523-bc6c-83408054820f" contextRef="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bab8c789-55a4-4969-8a9f-fe10a5904d26" contextRef="C_fa7a0150-db25-4f6d-8b6e-4487da4738f3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,152</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1a62508-0fec-4abe-9343-085c10db798c" contextRef="C_5ab82fd0-f468-46f6-9578-f2c09bf493a4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">28,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71d34bb5-0988-4b65-b8e5-7e3e0994c6ec" contextRef="C_9af81434-0b8f-4b94-835b-f7c9145d2966" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f2cf233-fb1f-427b-a3e0-61f709e66758" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">24,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-1 Preferred Stock Issuance (net of issuance costs of $</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_585d275d-4c78-4916-a832-08ea52afeb05" contextRef="C_921214ea-f1eb-402a-b0d4-e85238b44c06" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45d64305-0714-44ad-9910-7a8cdd65a512" contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5" name="elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,358,972</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_519305b4-5a2c-4bf8-b305-6a7acb40dfee" contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,978</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Reclassification of redeemable convertible preferred stock tranche liability upon settlement</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4debfd41-7ad2-49bc-bf73-b666cc348479" contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5" name="elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,269</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Exercise of stock options and release of restricted stock awards</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7222176-3180-48b7-b142-f951a24d7b4b" contextRef="C_03e5d18b-f2bb-400c-bc23-acf4b46aceb7" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">64,047</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_de0ca3f4-ac55-4c9a-9b57-c251ac17ffd8" contextRef="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a830d764-0ffe-4d2d-89e4-4d9308658e95" contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd20b005-66a1-4822-937e-bcc514863d74" contextRef="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">297</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b739564d-43e3-4a1a-a18d-35046642d5e6" contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">297</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8876a94-24e5-47e7-9262-51dffdabe1db" contextRef="C_75286094-929a-4cd3-b751-e628bfe63388" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18,601</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_173e9f2b-df0c-4952-be3d-f18f5fb28130" contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18,601</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of March 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_accb6df7-64e9-4e29-a4e6-1b28d776b90b" contextRef="C_35048792-ecdc-4ad5-96d7-88fe71e99d94" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">11,499,129</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d4259240-714e-46e7-bed0-c196347d5dba" contextRef="C_35048792-ecdc-4ad5-96d7-88fe71e99d94" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">92,798</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1d176c33-1662-4da8-91b3-cf0ff18dba62" contextRef="C_c1ac6833-38fa-4679-a86b-de27670a06dd" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,482,798</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_01c5a4e6-19d1-4f39-a970-65a4ca9ca51a" contextRef="C_c1ac6833-38fa-4679-a86b-de27670a06dd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e761520c-d75d-4a00-896d-d61b69eac2eb" contextRef="C_347b031c-725b-474a-9a52-13972c241f68" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,554</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55d48b8e-f187-47ca-851e-cbb0051d6856" contextRef="C_3a9e7f57-d4e5-4367-8742-49198b69b770" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">46,737</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ce123a77-a5cc-41ec-a098-c39f0d757d27" contextRef="C_844e6091-3490-47b1-ba64-9d928eb8531d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_42b374fd-100c-431e-9a1e-8d4af2e768a5" contextRef="C_2aa7983d-2e71-4d10-bac5-a6414b081d2c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,182</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series B Preferred Stock Issuance (net of issuance costs of $</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_78f4dd84-8f4f-4fc4-a230-fea863514593" contextRef="C_55e83e5b-e1f0-4f60-8528-da2a67b8a332" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb069e1d-0257-4914-b4ba-7b1a55c579d0" contextRef="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e" name="elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,846,150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_66de4a8b-2844-4ee7-9c61-833b3fd1cce9" contextRef="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,961</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Exercise of stock options and release of restricted stock awards</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d2af29f-3131-4087-83a6-11369c40c05f" contextRef="C_e16d4b2c-90c7-4cf7-89fb-de39e5cd2c7c" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d03603f0-4e37-4848-884c-27e090fc0a0d" contextRef="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_54b7083d-4cd2-4ee7-b111-7a31a0b56b00;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bec18e16-9bca-4ba7-b3ba-a1c09f102349" contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432" name="elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a8cea1ca-2ede-4724-abb5-f6c126b8f59b" contextRef="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b192cd7e-2aa4-4bde-a1f3-86421ba91240;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df18bb81-7273-4010-b521-1776f91dd217" contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c10edba3-291c-4874-9642-d4243803f840" contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be0d2950-f25f-42bd-b8d1-63b95d087f28" contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of June 30, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d46f1883-ff41-49de-908c-1ecc91fcf662" contextRef="C_c9f66eae-8887-4a36-997b-b20ccec6a003" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_921d60d2-faca-417a-958f-447c50a98cda" contextRef="C_c9f66eae-8887-4a36-997b-b20ccec6a003" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0eff54bb-0368-4d68-9194-cfeb0e3e26b3" contextRef="C_73fac32b-1946-4425-9058-8304c2ddbf20" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,489,956</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c53cb4c2-02fb-4454-9f3b-9f1cfbb00486" contextRef="C_73fac32b-1946-4425-9058-8304c2ddbf20" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0c64ae0-bef7-42bd-ad7d-7635799850da" contextRef="C_37af721e-0687-4647-a911-6481229378d2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,610</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b1fa709b-1949-4dd9-9f0c-91c5a21acda6" contextRef="C_861dbad3-d53a-4204-a645-525cd720e7a8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">55,456</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57b9e1fa-c0ae-418b-9ce3-acc976447961" contextRef="C_b3e80fb2-f161-4a38-a1e3-c8d52f228cee" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d5d8ad00-a2e7-46b3-9b79-08179f3e95bd" contextRef="C_dba68e91-f80f-4784-96e6-c91207909a6b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">50,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Proceeds from issuance of common stock in initial public offering (net of issuance costs of $</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb1cd009-d972-4c5e-b92c-89b80aca2f59" contextRef="C_26dc1ae5-daf7-4353-af46-9f523316d9d9" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,856</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e9b0e173-9616-4ef3-bfad-9516443663a2" contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,360,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3e4b9242-639d-43ed-95ba-a736f4d4eef8" contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_470a9ae4-77cd-425d-88a9-040f16fe0e34" contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,143</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_18b1fff5-aa6f-4693-afe4-8fed26a3316f;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_054f8225-7331-48c3-aa38-23a588c1b60e" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4d538b42-512a-4e1f-9d5c-1afcaf6cc93b" contextRef="C_b6b57452-47f5-4388-a412-3f3ba1283020" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7f78601-2905-4055-8fb8-d869eb501991" contextRef="C_b6b57452-47f5-4388-a412-3f3ba1283020" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">152,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07a4ff9d-ed2d-41d0-8cc3-fca7a6a04a07" contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_831f4172-16f5-4e67-9836-c703500d807b" contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_10f4170c-12bd-4c59-bfc6-73359b839308" contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,758</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cad6912b-f4dc-44a2-b287-0fa48d3726a3;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dfef0c35-a03d-4261-ac74-4ff7f52b2cc3" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Release of restricted stock awards</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aca553be-409b-459f-961d-ea32f8a97cee" contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,027</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b1f5bd35-5c48-40ed-9b37-50865ca790ad" contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,236</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_536e3532-29ed-4c37-90c2-0ddc3fddf513;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_056a98a0-7520-4fa7-a693-df2b34a079cd" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,236</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19b5b083-3377-42b1-904c-4539dd2a5238" contextRef="C_ad1bea71-dec8-49f4-8388-dcc31f1a917a" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b38f3351-2ab0-468f-b1fa-cfd3ce001a72" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_632c56b1-e7ba-458a-95df-156fc6e9c9c4" contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,615</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1afc5f6d-26dd-4071-945f-0317eea3b074" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,615</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of September 30, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_60dcca79-04e2-4075-a71d-4ead571942fb" contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87a8e4be-56fb-4779-b613-fa1764ec6d96" contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee7009ee-6027-482a-978d-8718f7b62fde" contextRef="C_e4be4acd-0552-45c9-9ae0-524e93aee408" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">26,199,262</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0019dc60-618b-4eae-a149-a16203f5f11a" contextRef="C_e4be4acd-0552-45c9-9ae0-524e93aee408" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_37252ea2-a738-47e3-aa8e-35a3a1d8714a" contextRef="C_95fcdeb7-8d75-4866-b9b3-f9a0ef7464a7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">241,747</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa042bbc-b43f-4962-b076-95dd7b30fbd9" contextRef="C_ed02f132-4271-4596-83d9-8aea2fbffae7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">65,071</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d024aa46-9a88-4ba4-9d89-648c80540672" contextRef="C_4ed1c900-e113-443f-a67b-a7be04e9fecf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71f546b1-1678-47aa-946b-fce31d6ec97d" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176,661</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(In thousands, except share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:15.761%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:8.374%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.895%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:8.374%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.895%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.797%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.881%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.568%;"></td>
    <td style="width:0.48%;"></td>
    <td style="width:1.092%;"></td>
    <td style="width:0.939%;"></td>
    <td style="width:7.881%;"></td>
    <td style="width:0.584%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional Paid-in Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated Other Comprehensive Income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total Stockholders' Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of December 31, 2019</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f453f6c-199e-41e4-a8c7-1d3fe94e7168" contextRef="C_79e4fccb-c419-40b4-9864-4b8eeee9746d" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,999,133</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1b612ad-aa06-46db-a785-66335837c9c2" contextRef="C_79e4fccb-c419-40b4-9864-4b8eeee9746d" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ff5908b-fd38-4f5c-940f-db8071fd011c" contextRef="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,852,797</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0d494e7-b563-4664-adb9-2e1c18e465ab" contextRef="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_059a1a5b-0953-4617-949c-b722be7ad591" contextRef="C_471f6e68-ef76-445c-b86e-f172ff3b5785" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,905</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e195a7c-58cc-4854-bfd3-70e9147f4a10" contextRef="C_3316dedf-bc1e-41a0-9dd7-e5ff0ba3463b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7,468</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf2c5514-25b3-4b1c-b498-2a097876a78e" contextRef="C_8f44875f-fa81-4c6f-a4d8-7bccd495c678" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_632cdc1b-b9e0-4a10-a614-8127495543cc" contextRef="C_1335aefe-f684-4dfb-84f4-21a81a7b3905" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,562</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Accretion of Series A and A-1 Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a2ac5b8e-c93f-4755-b332-58591c17db04" contextRef="C_ad6f985b-b398-416c-a97e-19ed5c2ba56c" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">439</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c158145e-d079-4405-8445-1f6026f2ad7d" contextRef="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">439</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d508e75e-cd97-40fe-bf2b-31981fb0c135" contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">439</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Release of restricted stock awards</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73943ac7-2953-4023-84e3-e914ca1ad58b" contextRef="C_aec7af12-734e-49d6-876e-4f51ec91a65e" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,170</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d678e60a-d00c-45cd-bd8b-5564b5f335fa" contextRef="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6004d698-5307-4fe5-a87c-ee7f62e187d1" contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fc7d827a-ad09-4206-8276-9a496183dcef" contextRef="C_8b74eebe-7367-44f3-89a2-41a2ae3c4f6a" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,916</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3a7a68e-7197-4d67-9043-cbc509616b01" contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,916</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of March 31, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c48ff24-1acf-43e3-9f49-d4aa74698524" contextRef="C_b4227218-0fbb-4ded-b156-157f89ae7254" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,999,133</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0f860ff-fc6d-4405-a130-e622e7d94c48" contextRef="C_b4227218-0fbb-4ded-b156-157f89ae7254" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,613</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3521032-0bbe-493b-b88a-89f784a56321" contextRef="C_3b30f421-7970-424e-addd-c4971489194f" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,856,967</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_391f51b0-825a-413d-83c3-dd1bb1d9dead" contextRef="C_3b30f421-7970-424e-addd-c4971489194f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57aa8005-26ed-49ba-93b6-cb3bbf3040ed" contextRef="C_240f8cde-e329-49df-8877-bf46eeb51205" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,600</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb691e91-d3f7-46cd-8dec-42eccf21a1b2" contextRef="C_f03dc908-cddc-420d-9f23-e55b22233be8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,384</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e4f388c-2bd3-4789-8dd6-901541f9e2ed" contextRef="C_12bd7c9a-9686-44a2-803f-a81d4cdeccf3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c32d5f63-50a9-4bcb-be81-6f2829d0578d" contextRef="C_7a07cf1a-9b36-4553-a382-4b7030b2b6fb" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7,783</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Accretion of Series A and A-1 Preferred Stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e292481c-856d-4748-af10-c6b0c7031c34" contextRef="C_9e23dbd6-7d37-4dc5-857b-7212c0ea9084" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">452</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40e31ad2-3340-4bef-ba57-3272d7994006" contextRef="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">452</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7d0bf2c-3ef3-49e9-8196-03c8bb2fbe7e" contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">452</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Release of restricted stock awards</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ba1e591f-2d4e-424a-bd98-21da4c5c0c4d" contextRef="C_58902cc5-c0a4-4b35-962a-3a2dc5e8d973" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f5e85256-aec5-43fd-a280-ceaafac4f136" contextRef="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9afb7c15-3e90-47a1-8183-775ea9a99170" contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_334fade6-8b72-42e1-903e-e092cc4dc2f3" contextRef="C_a0e75eaf-c8c0-4041-b14e-3d776b96ecb0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8a9ee90a-4161-4b06-b073-b5063ea3c8a3" contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of June 30, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4328d145-321a-414a-909c-0c0a04b16578" contextRef="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,999,133</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31b025cc-6d5a-406c-96d0-e6dfbb84c075" contextRef="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,065</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b83bb95a-1d03-4e5b-ba5c-76ff83af6706" contextRef="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,861,141</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_12727ca0-d44b-49ed-bf14-e3e4e11d90eb" contextRef="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1993bf86-ea8f-42ec-8882-49888984f1cf" contextRef="C_3a75adc8-6494-436d-8e73-ab1898a3f4a0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,199</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_96e37903-0348-4a66-bcd9-ba6c5e550711" contextRef="C_3e8bd169-1cd0-4494-b634-7a499711cee0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">11,015</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eae86503-666d-4eee-ac32-a77963e216b8" contextRef="C_ba7c150f-8562-403b-bdbc-e0b6db0cec39" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_133cd6c2-4db9-4e4b-9646-e7f71d072f0b" contextRef="C_0baa77a4-0ccf-4e25-9f89-25825a5dd5de" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,815</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Accretion of Series A and A-1 Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0f4f10c-40c2-4c3d-bf8d-c7e330728c62" contextRef="C_5b84124c-9c47-43b4-84c4-b441d84b7611" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0231dc5-16f8-4909-a8c1-2178eaaa7ccb" contextRef="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3086f857-2b5b-46a8-a43f-1e5614436d80" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Release of restricted stock awards</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43439bae-35b2-43d1-b431-8afe9485ac6a" contextRef="C_f32fa3fe-04ff-4f37-9cda-74b7fa643680" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,175</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa1aa9f9-e3a1-4ea7-ac15-a5984ce9c799" contextRef="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff45a56c-85c9-4df9-a551-9e310bdfdf61" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ca300f30-83d4-4120-a650-3743056afc13" contextRef="C_969acfbd-1a24-44dd-a3fe-5aa7b81c5654" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b030af62-cfc0-4723-adcc-803e521f1ecc" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balance as of September 30, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25dad995-2d74-452d-af31-241892f258f6" contextRef="C_0791263e-f277-474d-b34a-5bf44a42eeb0" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,999,133</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83645935-b520-4d15-8c8a-702b9ffdb3d2" contextRef="C_0791263e-f277-474d-b34a-5bf44a42eeb0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f7374677-1331-4c62-911b-a39479e411d0" contextRef="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,865,316</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e8de6d4-9131-4bdc-93cc-985c02b803bd" contextRef="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_63730ace-6b25-4f2f-9c0e-3cb0d206b0bf" contextRef="C_02ca6dff-2485-430e-84db-9a99d6227383" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">787</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3fdf359b-722f-4c2b-8b87-7e2e200d0140" contextRef="C_71ae99b8-6442-4275-bd07-b38f55d947bb" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">13,273</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b221799d-97c3-4ea7-aa2b-3b5d99d860f3" contextRef="C_8793bdfe-da79-41be-90e0-59ecbd5154a0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f5981060-6681-4cb8-b666-16bdd7a43174" contextRef="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">12,485</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_of_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Statements of Cash Flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(In thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:86.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:65.156%;"></td>
    <td style="width:1.694%;"></td>
    <td style="width:2.039%;"></td>
    <td style="width:12.615%;"></td>
    <td style="width:1.263%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:2.039%;"></td>
    <td style="width:12.55%;"></td>
    <td style="width:1.263%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d799ef09-b6f0-46a2-b388-da02c46f2c87" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,935</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d45b6608-4704-4803-9909-2a3fed7122e2" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,805</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f0ecf08-644b-4985-a468-ddb4646adfbc" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,583</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_49054650-cebc-4ff7-9488-1d4a783d6a4c" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">234</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value of redeemable convertible preferred stock<br />&#160;&#160;&#160;tranche liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e29e8cc2-e232-4a1e-ba5d-1214ba0c03e1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,718</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44da2829-56f0-4295-9c5a-ce151de9c10e" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization of premiums and accretion of discounts on investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_27ce27a3-20ce-456a-8a6c-b55987b0b8a7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">83</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ab2c2421-feb3-46d5-8110-3bfa17a681db" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency gain from remeasurement</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d074ebe-85d9-460e-8ec9-cf2068614c4c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">245</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_03991848-8878-4db8-b76f-4820b63895c5" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_af572de0-4054-4fd2-88e2-f6f96d924269" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">11,103</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a5cba05-0316-4266-b197-4ecf5ff5cf3b" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88d5088f-007f-4c1f-b8ca-1a9dfe7882a4" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:IncreaseDecreaseInNonCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,633</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_573643af-5ecb-41a6-8060-659061a98339" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:IncreaseDecreaseInNonCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,361</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ccb2b06d-ae56-4980-a4e7-a17c136db3b9" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,494</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3697c292-aba8-487f-89c0-1763e0931b14" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">82</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b18ab015-328b-4a6d-8cc4-8e4d88e2b6a0" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8fbffc80-640b-4af0-a35a-545037e68ca1" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable and accrued liabilities, related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b68d4462-fff2-43de-aa36-b2e6f447e998" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">176</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed408615-5d3a-4a0e-9549-5ef50d897245" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fdef9457-64ee-45c1-9079-910a9514e138" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">28,188</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a55aabe7-9b77-4df2-8e81-b6edb8f3bf5d" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,474</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flow from investing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchase of marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ff1f8e4-b119-4427-98ef-d89e34dae13d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">106,919</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2378196b-2172-4304-8230-69fc8755efaf" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_65cb912b-5665-473e-9037-1f6036a3210b" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">106,919</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3507728f-bba1-4211-95ff-a34ed0b3f892" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from issuance of common stock sold in initial public offering, net issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26eb5d61-6a23-40e9-84bb-5f7987d2851e" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e778c4a5-e0de-4599-b522-75c60d605836" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dbbe0bce-02ed-44a5-bfe3-c5d123cfac29" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93,939</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83bd210d-7a6b-4c9b-9539-7808c254c5ac" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from the exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_64ca2aea-21b6-4c0c-883d-bdf579129288" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">111</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d67f5394-3960-45b3-ac71-9d5f060bfc62" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d103fcf-9e5e-402e-9dfa-6c3da65367f7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177,194</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17160c6f-fc22-4a0b-ab0f-40b35d6e710c" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effect of exchange rate changes on cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6945243e-6099-4313-aa04-6724e37745b5" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">245</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae93c51d-52e4-4922-9639-cd3d749d217f" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net change in cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6b4779dd-ae8e-4a87-b0d0-b1fdc3b1e35c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,332</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73932ff9-c00d-4357-8baf-34d6025bf98d" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,533</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents at beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_053ef5d6-2d56-4a16-b208-6ea65eed4d87" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be1d636c-5cf2-4349-897e-3dac8e8ddc34" contextRef="C_1335aefe-f684-4dfb-84f4-21a81a7b3905" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,223</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents at end of period</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e86c91ed-a8fb-4b0d-9800-9cc95ac8ffa0" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,819</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0547441a-45cf-4556-b876-c3e94638de1f" contextRef="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,690</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Conversion of redeemable convertible preferred stock to common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9dddffa9-7c8b-4710-a955-0799bdd247f8" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f20ae5bd-74dd-4c8f-9463-73e44f7d7f39" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock accretion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f31013db-4243-4de4-85ea-99b9ee181ff1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_78db5932-60dd-4420-9067-b1db50d8e8da" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:TemporaryEquityAccretionReductionToRedemptionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,352</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Condensed Conso</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">lidated Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(unaudited)</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c50b406f-3e5b-4917-b9cf-d140449afd6c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1.    Description of Organization and Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8c2c3cd5-5dda-47d3-911c-94dde0014d5e" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NatureOfOperations" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc. (the Company) is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Headquartered in Redmond, Washington, the Company was incorporated on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_51861616-7030-4a62-af1c-134d871fdba6" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="dei:EntityIncorporationDateOfIncorporation" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">October 18, 2018</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Delaware corporation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_23ab2df8-a0b4-4913-aec8-cb2de9fc62b4" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ConsolidationPolicyTextBlock" escape="true" continuedAt="F_23ab2df8-a0b4-4913-aec8-cb2de9fc62b4_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying interim condensed consolidated financial statements of the Company and its wholly owned subsidiaries have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany transactions and balances have been eliminated in consolidation.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_23ab2df8-a0b4-4913-aec8-cb2de9fc62b4_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated balance sheet as of September 30, 2021, and condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of cash flows, and condensed consolidated statements of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) for the three and nine months ended September 30, 2021 and 2020, are unaudited. The consolidated balance sheet as of December 31, 2020 was derived from the audited financial statements as of and for the year ended December 31, 2020, but does not include all disclosures required by U.S. GAAP. The unaudited interim condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair statement of the Company&#x2019;s financial position as of September 30, 2021, the condensed results of its operations as of the three and nine months ended September 30, 2021 and 2020, and its cash flows for the nine months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2021 and 2020 are also unaudited. The condensed results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other period. These interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited financial statements included in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c433d299-e5f7-45f1-a038-8ab7b81e6af0" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ReserveStockSplitPolicyPolicyTextBlock" continuedAt="F_c433d299-e5f7-45f1-a038-8ab7b81e6af0_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reverse Stock Split</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_c433d299-e5f7-45f1-a038-8ab7b81e6af0_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2021, the Company's board of directors approved an amendment to the Company's certificate of incorporation to effect a reverse split of shares of the Company's common stock on a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d86db185-8ae9-4d32-a309-c4dc84783477" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1-for-2</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> basis, which was effected on July 29, 2021 (the Reverse Stock Split). The number of authorized shares and the par values of the common stock were not adjusted as a result of the Reverse Stock Split. In connection with the Reverse Stock Split, the number of authorized shares, outstanding shares, and the conversion ratio for the Company's redeemable convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. All references to common stock and options to purchase common stock share data, per share data, and related information contained in the condensed consolidated financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split for all periods presented.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40a42246-d7aa-4ce5-bf43-b4f02f32ce10" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:InitialPublicOfferingPolicyTextBlock" escape="true" continuedAt="F_40a42246-d7aa-4ce5-bf43-b4f02f32ce10_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_40a42246-d7aa-4ce5-bf43-b4f02f32ce10_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On August 12, 2021, the Company completed its initial public offering (IPO) of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb6de910-8135-43d1-aca3-1fbda3ee8dc6" contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,360,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, including the underwriters' full exercise of their over-allotment option at the IPO price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f3175582-393b-4bf1-bb0a-53866206bc2d" contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_USDollarShare" scale="0" decimals="2">12.50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. Gross proceeds from the IPO were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8154f19c-921f-4df1-b6e0-de0fa373df78" contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">92.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, and the net proceeds were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd002069-5217-48b9-ae66-aa15fbc22afc" contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928" name="elym:ProceedsFromIssuanceInitialPublicOfferingNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">83.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, after deducting underwriting discounts of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f346235c-ebd2-4179-9dc7-b7008914a835" contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928" name="elym:UnderwritingDiscount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35ce06d8-7563-4247-9f2c-a4d76c88d69a" contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of offering costs payable by the Company. At the closing of the IPO, all of the Company's then outstanding redeemable convertible preferred stock was automatically converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb5ad079-d156-427f-8cc4-883e6133851d" contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. The related carrying value of the redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_787b1f16-3cf5-4289-bc99-ddd8de301493" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" scale="6" decimals="-5" format="ixt:numdotdecimal">152.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million was reclassified to common stock and additional paid-in capital.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_928f8844-6538-4df6-a467-26af4889cddf" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:LiquidityPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07f224ee-4d3d-4a5c-bd5d-b31de2111a26" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:numdotdecimal">65.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million as of September 30, 2021 and expects to incur additional losses from operations in the future. The Company estimates the available cash, cash equivalents, and marketable securities as of September 30, 2021 will be sufficient to meet its projected operating requirements for at least the next twelve months from the filing date of these unaudited condensed consolidated financial statements. Therefore, based on management's updated evaluation of the Company's ability to continue as a going concern, management has concluded the factors that previously raised substantial doubt about the Company's ability to continue as a going concern no longer exist as of the issuance date of these unaudited condensed consolidated financial statements. The Company will need to obtain substantial additional funding to develop and commercialize the Company's clinical programs as currently contemplated. The Company expects to finance future cash needs through equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, but there are no assurances that the Company will be able to raise sufficient amounts of funding in the future on acceptable terms, or at all.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6dc57576-c27d-4889-8159-522e5f9cfc7c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to the valuation of assets acquired, accrual of research and development expenses, the valuation of stock-based awards, the valuation of common stock and redeemable convertible preferred stock, and the valuation of redeemable convertible preferred stock tranche liabilities. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4c1cc554-fefd-4849-ab73-9d0666207245" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ConcentrationRiskCreditRisk" escape="true" continuedAt="F_4c1cc554-fefd-4849-ab73-9d0666207245_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_4c1cc554-fefd-4849-ab73-9d0666207245_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and marketable securities. The Company&#x2019;s cash is held by two financial institutions in the United States (U.S.) and two financial institutions in the United Kingdom (U.K.). The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company&#x2019;s deposits held in the U.S. and U.K. may exceed the Federal Depository Insurance Corporation and Financial Services Compensation Scheme, respectively, insured limits. The Company has investments in money market funds, U.S. government debt securities, commercial paper, and corporate bonds with high-quality accredited financial institutions.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_24ef9726-6d02-48fd-915e-c7b53568c22d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:RisksAndUncertaintiesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company&#x2019;s products and processes and clinical efficacy and safety of the Company&#x2019;s products under development, compliance with government regulations and the need to obtain additional financing to fund operations. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical studies, clinical trials, and regulatory approval, prior to commercialization. These efforts will require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be obtained or maintained, that any products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s product development efforts are successful, it is uncertain when, if ever, the Company will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees, consultants and other third parties.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, the current COVID-19 pandemic, which is impacting worldwide economic activity, poses risk that the Company or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time which may delay the start-up and conduct of the Company&#x2019;s clinical trials, and negatively impact manufacturing and testing activities performed by third parties. Any significant delays may impact the use and sufficiency of the Company&#x2019;s existing cash reserves, and the Company may be required to raise additional capital earlier than it had previously planned. The Company may be unable to raise additional capital if and when needed, which may result in delays or suspension of its development plans. The extent to which the pandemic will impact the Company&#x2019;s business will depend on future developments that are highly uncertain and cannot be predicted at this time.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58fbf6b7-0407-4345-a333-b58dcd8c95a7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the CODM). The Company&#x2019;s CODM is its chief executive officer who reviews financial information together with certain operating metrics principally to make decisions about how to allocate resources and to measure the Company&#x2019;s performance. Management has determined that the Company operates as a single operating and reportable segment. The Company&#x2019;s CODM evaluates financial information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is found in the interim condensed consolidated financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28034bc4-7407-41d6-a14c-c5dad45ed6e8" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true" continuedAt="F_28034bc4-7407-41d6-a14c-c5dad45ed6e8_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company measures fair value based on a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In determining fair value, the Company utilizes quoted market prices, or valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_82a4a4fb-1226-419c-bc8e-9683cade0871" contextRef="C_d49ac965-16d2-49f6-8496-6b6bd4de9295" name="elym:FairValueLevel1Level2AndLevel3TransferAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers into or out of Level 3 for any of the periods presented.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_732f07bf-a2a8-4601-a079-2d39f91b592d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s fair value measurements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021 and December 31, 2020 was as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:35.72%;"></td>
          <td style="width:1.651%;"></td>
          <td style="width:1.53%;"></td>
          <td style="width:12.138%;"></td>
          <td style="width:0.751%;"></td>
          <td style="width:1.651%;"></td>
          <td style="width:1.53%;"></td>
          <td style="width:12.157%;"></td>
          <td style="width:0.751%;"></td>
          <td style="width:1.651%;"></td>
          <td style="width:1.53%;"></td>
          <td style="width:12.101%;"></td>
          <td style="width:0.751%;"></td>
          <td style="width:1.651%;"></td>
          <td style="width:1.53%;"></td>
          <td style="width:12.157%;"></td>
          <td style="width:0.751%;"></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets:</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48489c7f-76f0-47cb-9e1a-bfe11f7e975e" contextRef="C_9966861e-a257-4483-a647-6780eab777a6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,412</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3e75d8b-ad0e-4d0a-9f03-67723966c9b5" contextRef="C_308a931a-0338-4cef-80b1-90d2080e2ef4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,412</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20665e38-f91c-446f-b245-25f77c03ebf4" contextRef="C_481e58e9-cf0c-4dd5-a802-7bc69141a9ed" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,995</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2333b35c-ee5a-46eb-b029-a7643e90e6e8" contextRef="C_50f80129-d404-4d29-a58a-3d06114b7d2a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">102,823</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_61963b1e-d4fc-4296-98b0-dad16ef6742e" contextRef="C_54207afe-8ac8-4d70-9d88-5a5cc0805155" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">102,823</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5802c818-f8d9-435f-94d0-58d1c4877e4e" contextRef="C_c979a217-c5e3-4cc3-a4c8-2ea6f9acc46d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,407</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45d32ba1-13af-4a1e-acf5-39758863b6b1" contextRef="C_3c1f890e-2a01-4903-afa6-61704660b423" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">102,823</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9afe1ddb-21a6-47b1-b5f9-3802c35e5777" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">145,230</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liabilities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock<br />&#160;&#160;&#160;tranche liability</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f451a23f-0eb2-431b-895b-40e4470ec377" contextRef="C_9991e520-51cf-427f-89de-e1753fed04a5" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95ead2ef-a58b-412f-a929-b0c15b7966d7" contextRef="C_467945a5-3ec2-4005-a9d6-1240297ff054" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_369393c1-aa71-44c9-8f66-aeac0e8d4895" contextRef="C_d57b29e1-52ee-4b19-9fdc-0dcbcf61ce63" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd1dfe02-2545-431d-930e-b6974c8cf2ab" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_28034bc4-7407-41d6-a14c-c5dad45ed6e8_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The redeemable convertible preferred stock tranche liability was settled on March 9, 2021.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_933f940f-2e0e-49f2-a718-f28ea9bf75e2" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. As of September 30, 2021, the Company's cash equivalents consisted of money market funds. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ceb0945-4456-4511-bd5e-3facd9483858" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cash equivalents as of December 31, 2020.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a3bf8671-c5c4-4ae4-9a1d-c360179c2c46" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:DeferredChargesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs that were directly related to the Company&#x2019;s IPO were deferred for expense recognition and capitalized and recorded within prepaid and other current assets on the accompanying condensed consolidated balance sheet. These costs consist of legal fees, accounting fees, and other applicable professional services. These deferred offering costs were reclassified to additional paid in capital upon the closing of the IPO. As of September 30, 2021, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cea92f45-3c18-4602-bf75-88a3a2c2a722" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> deferred offering costs capitalized.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d8c605b-308e-48d0-8eef-cd2d3ae9a574" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments in Marketable Securities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities are classified as available-for-sale, primarily consisting of U.S. government debt securities, commercial paper, and corporate bonds, and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of stockholders' equity (deficit) in accumulated other comprehensive loss until realized. Realized gains and losses on the sale of these securities are recognized in other income, net. The cost of marketable securities sold is based on the specific identification method.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company periodically reviews its available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security rating or sector credit ratings, and other relevant market data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been no other significant changes in the Company&#x2019;s accounting policies during the three and nine months ended September 30, 2021.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aaeffccc-5133-4b99-88d2-82417ab730d6" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of consolidated financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The effective date of this update for nonpublic companies is for fiscal years beginning after December 15, 2021 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today&#x2019;s &#x201c;incurred loss&#x201d; approach with an &#x201c;expected loss&#x201d; model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard&#x2019;s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The effective date of this update for non-public companies is for fiscal years beginning after December 15, 2022 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_61806b46-f8da-42b6-be2f-ee1cb2e8e45b" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:InvestmentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2.   Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_d91e99b7-943a-4ef4-970e-1127862d4416" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments consists of available-for-sale securities as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.532%;"></td>
        <td style="width:1.856%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:11.746%;"></td>
        <td style="width:0.733%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:11.626%;"></td>
        <td style="width:0.733%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:11.755%;"></td>
        <td style="width:0.937%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.512%;"></td>
        <td style="width:11.737%;"></td>
        <td style="width:0.733%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_42a72ecf-c361-44f5-bbb3-0cacbe7bb6f2" contextRef="C_0950534c-0e42-47f2-9fff-61cb3af705cc" name="us-gaap:AvailableForSaleSecuritiesAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,208</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9edcfb88-78c4-43d5-bbcc-8dfa349dad60" contextRef="C_87892d72-2788-4288-9f97-01316b8174e3" name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89f73fdf-a83f-41a2-9b6c-7f20c1f4dd95" contextRef="C_0950534c-0e42-47f2-9fff-61cb3af705cc" name="us-gaap:AvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,199</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4ca931c-ec7d-4dcd-a7d2-b7af056f04f5" contextRef="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8" name="us-gaap:AvailableForSaleSecuritiesAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,208</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_782fa5c1-524d-4077-af70-c617d7209245" contextRef="C_5b3c644e-edca-435e-b343-309e123a2ea3" name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_016fe8bf-34de-48a5-8a29-9751471f3ed9" contextRef="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8" name="us-gaap:AvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,199</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1fabd9aa-d2f0-428e-ba74-45a4c881a113" contextRef="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc" name="us-gaap:AvailableForSaleSecuritiesAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,995</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99b1eee1-b8d7-4e8d-96c3-71502f2ddcb0" contextRef="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc" name="us-gaap:AvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,995</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c71c671-e53e-4de1-926b-7bd09a51b948" contextRef="C_340d9bd0-d7ea-4047-a232-5b317397c002" name="us-gaap:AvailableForSaleSecuritiesAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,633</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4c3bdbd2-c70c-4ff7-8cb7-1207a8ffe67d" contextRef="C_0d1271c8-61fb-4654-8d3a-3c7dc98c3046" name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_82a656d2-d966-4546-87a9-2e1de077a84f" contextRef="C_340d9bd0-d7ea-4047-a232-5b317397c002" name="us-gaap:AvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,624</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total long-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0fc3d966-bbff-4c47-8fc8-70038926d007" contextRef="C_86547cb0-3862-4a95-981d-e7e9f18fd071" name="us-gaap:AvailableForSaleSecuritiesAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,628</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f099496-24e6-4bac-a37b-4aa1f46c994d" contextRef="C_2ead6c6d-1e36-4252-80e7-a03d15dab206" name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fe7b6361-dba8-464f-9849-e4ca2d882eb7" contextRef="C_86547cb0-3862-4a95-981d-e7e9f18fd071" name="us-gaap:AvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,619</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All the commercial paper, U.S. government debt securities, and corporate bonds designated as short-term marketable securities have a  contractual maturity date that is equal to or less than one year from the respective balance sheet date. Those that are designated as long-term marketable securities have a contractual maturity date that is more than one year from the respective balance sheet date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued interest receivable is excluded from the amortized cost and estimated fair value of the Company's marketable securities. Accrued interest receivable of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6593856c-4c5a-4eba-afc9-5a7757dd9110" contextRef="C_ddf6340c-4eb3-4c81-96c0-c3840a43b061" name="us-gaap:InterestReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million is presented separately within the prepaid expenses and other current assets line items in the Company's unaudited condensed consolidated balance sheet as of September 30, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, there were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_67923007-6722-4c15-bb50-f97369c1293b" contextRef="C_b3f43bab-a6cb-4d81-a307-cb587d9e5ead" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">45.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of corporate bonds in a continual unrealized loss position for less than 12 months. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_58fe0e7e-b916-40d0-a7cd-ded52c0d0640" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> investments in a continual unrealized loss position for greater than twelve months.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, the Company did not intend, nor was the Company more likely than not to be required, to sell its available-for-sale investments before the recovery of the amortized cost basis, which may be maturity. Based on the Company's assessment, it concluded that none of the available-for-sale investments held as of September 30, 2021 were considered to be impaired, as such, no impairment loss was recorded for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9636a912-4fcf-48c7-93d9-0481598e09f6" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3.    Certain Balance Sheet Accounts</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prepaid Expenses and Other Current Assets</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68beea9e-c7c7-42e7-aaf3-d7ec6c813f9d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"></td>
        <td style="width:1.716%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.458%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.716%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.449%;"></td>
        <td style="width:0.993%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recoverable research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_810d4d20-ac3b-421d-99d5-e38b04d24ffa" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:RecoverableResearchAndDevelopmentTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,943</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ae0975a-524d-44e1-b15c-87d05938ae89" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:RecoverableResearchAndDevelopmentTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3db90650-7b05-46da-9892-9eaaa107e7f1" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:PrepaidResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,661</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7f38e564-d7b4-4124-8287-b9bc683ec8cb" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:PrepaidResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a47e161a-ad71-49d4-9965-4144ebd74f68" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,960</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e39dbb23-3bf4-48bb-a0c2-2e8a600fa3d4" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21cbcc28-d21f-4cc7-b87d-0237ae7810e8" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:OtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0b12c11-61e4-4500-83fa-49493e5fcfbb" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:OtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb02e764-8013-4b3a-9822-70db95971aa2" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,614</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7033503-9cae-4ddf-93df-f8a02114b885" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,511</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Expenses</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f024ba1a-6d02-4ab4-af36-dd3c7a5bc9e1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"></td>
        <td style="width:1.716%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.458%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.716%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.449%;"></td>
        <td style="width:0.993%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued payroll</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_15b16272-8d80-4879-b1fe-7a11a9c0b4b1" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:AccruedPayrollTaxesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,443</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db61ffd6-183a-4383-a080-8f0b07372d33" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:AccruedPayrollTaxesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">592</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f23d3198-aa9d-425b-8d71-8e3d2eb0254a" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:AccruedResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,278</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da4f6258-5583-4781-a917-a12935d5cfcb" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:AccruedResearchAndDevelopmentExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">627</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c902e6e6-65e7-4a10-8853-f8da9344f864" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">290</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db40dff2-0c20-448c-9a0a-1057e107f519" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7414acdd-dc57-4479-8b6d-7550b4d17bc0" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fc72fc89-83d3-420f-afc3-d123bd3e9e86" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4</span><span><ix:nonNumeric id="F_c9b9b1e3-a989-40c8-956a-391acb95c398" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:TemporaryEquityDisclosureTextBlock" escape="true" continuedAt="F_c9b9b1e3-a989-40c8-956a-391acb95c398_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.    Redeemable Convertible Preferred Stock </span></ix:nonNumeric></span><span style=""></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_c9b9b1e3-a989-40c8-956a-391acb95c398_1"><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1247c153-9074-4001-805f-d1c409e9cc14" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:TemporaryEquityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the Company&#x2019;s redeemable convertible preferred stock consisted of the following balance (in thousands, except share and per share amounts):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:28.541%;"></td>
        <td style="width:1.707%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:7.151%;"></td>
        <td style="width:0.742%;"></td>
        <td style="width:1.707%;"></td>
        <td style="width:0.751%;"></td>
        <td style="width:11.594%;"></td>
        <td style="width:0.742%;"></td>
        <td style="width:1.707%;"></td>
        <td style="width:0.751%;"></td>
        <td style="width:13.45%;"></td>
        <td style="width:0.742%;"></td>
        <td style="width:1.707%;"></td>
        <td style="width:1.53%;"></td>
        <td style="width:9.062%;"></td>
        <td style="width:0.742%;"></td>
        <td style="width:1.707%;"></td>
        <td style="width:1.53%;"></td>
        <td style="width:11.873%;"></td>
        <td style="width:0.742%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Issue<br />Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares <br />Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares Issued and Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Carrying<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br />Liquidation<br />Preference</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a21ddd1-92d3-4356-8b08-234d82b8c96a" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="elym:TemporaryEquityIssuePrice" unitRef="U_USDollarShare" decimals="INF">6.00</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3945cbd5-f61c-499a-b7e7-a90a82acb53c" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,717,084</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_166d012e-8144-4bc6-bb2c-0ebcb1ee8bcb" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_133588bb-9cd9-4d78-b2a9-ee8791391cfa" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,717,082</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_65c455b8-56bc-40ab-a796-d2e284c26a6d" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,074</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1faaa75-6212-454c-96d8-a42990d8d715" contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,569</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A  (Athenen Acquisition)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7399ae2a-3c89-4ebd-b2a0-2236b1acb995" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="elym:TemporaryEquityIssuePrice" unitRef="U_USDollarShare" decimals="INF">5.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa6fb93d-0757-4acd-ac10-3fe5dc8ac1e6" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,500,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_730456b9-d551-4a71-ae8f-cb117061c43c" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_db150609-ec19-454d-9b04-7b6330e65f04" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,500,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_42288466-da81-4aaf-9279-e58b35bcfac6" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f305a833-c957-4843-add9-098dc5880032" contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,253</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3eb044d5-9a9b-4a0f-9337-bf3d584e0e9f" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="elym:TemporaryEquityIssuePrice" unitRef="U_USDollarShare" decimals="INF">7.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_10a48ed4-d490-451b-ac74-e7919fd25641" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,692,305</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c2dedb4-65bf-47bf-a6c3-3e59a8424d48" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_5cabd6e1-6522-4d7e-953b-926a759510c2" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,923,075</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0bc38816-bcba-458f-acc3-64c9df6ec9c5" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,977</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_788f5044-c386-4b64-9eba-f8ea30901a04" contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,069</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ending balance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25989da9-e6f5-48ce-b5ea-f39c0826d768" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,909,389</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3444ca1f-5f45-43c7-b6dd-68eb4eaf4249" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_3721d358-6190-4604-9caa-c9c628a7e7b2" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,140,157</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f92c29c-6760-4da8-b880-577ab6d92947" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb3b4443-085e-4587-8590-db0b48d838e6" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,891</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, Series A-1 preferred stockholders exercised their tranche rights in connection with milestone achievements related to Phase 1 clinical trial results of ETX-155. As a result, the Company issued an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6083e9e2-c187-485c-8359-637e6ee0de25" contextRef="C_9f661c20-6f08-4391-8bc7-a8daecf3219b" name="elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,358,972</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-1 redeemable convertible preferred shares for gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75768dce-5c7e-4ad4-8815-0bddaf77d392" contextRef="C_9f661c20-6f08-4391-8bc7-a8daecf3219b" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">34.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. Upon exercise of the tranche rights, the Company reclassified the $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70bbe2c6-61d6-4437-8f0e-bfb4885ea278" contextRef="C_531646ff-7d69-4062-a71d-4de0f8f78fed" name="elym:RedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">12.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million in preferred stock tranche liability to Series A-1 redeemable convertible preferred stock on the consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2021, the Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e6c0a7e-6d9c-4a2c-af1f-bdfc99fda172" contextRef="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57" name="elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,846,150</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock for gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad09d509-61df-4186-af20-0a6837d71dc2" contextRef="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">60.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon completion of the IPO on August 12, 2021, all of the Company&#x2019;s then outstanding redeemable convertible preferred stock was converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_abd83a27-5a52-40a4-9c4c-f4f4757518b3" contextRef="C_5f6cd6f8-2b85-43a3-8604-dcd98e7b76d3" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. As of September 30, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_577c26f9-92f5-4f09-b86a-baf81e7713ac" contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> redeemable convertible preferred stock outstanding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to conversion, the holders of the Series A, Series A-1, and Series B redeemable convertible preferred stock had various rights, preferences, privileges, and restrictions, with respect to voting, dividends, liquidation, and conversion.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of any liquidation event, either voluntarily or involuntary, the holders of the Series B redeemable convertible preferred stock were entitled to receive, out of the assets of the Company before any payment shall be made or any assets distributed to the holders of Series A and A-1 redeemable convertible preferred stock, the Series B redeemable convertible preferred stock liquidation preference of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f4cd689-1b53-40a5-9e84-b440c7eb61a6" contextRef="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_USDollarShare" scale="0" decimals="2">15.60</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series B redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the Series B redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the payment to the holders of the Series B redeemable convertible preferred stock of the full preferential amount, the holders of the Series A and Series A-1 redeemable convertible preferred stock were entitled to receive, out of the assets of the Company, the applicable liquidation preference specified for each series of redeemable convertible preferred stock before any payment was made or any assets distributed to the holders of common stock. Liquidation preference was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35670ab0-f442-4710-a2ee-59aa8e7898a5" contextRef="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_USDollarShare" scale="0" decimals="2">6.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for Series A and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_121eb461-9772-4c3b-93bd-19c10f6ce956" contextRef="C_531646ff-7d69-4062-a71d-4de0f8f78fed" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_USDollarShare" scale="0" decimals="2">7.80</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for Series A-1, each adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series A and A-1 redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the payment to the holders of the redeemable convertible preferred stock of the full preferential amount specified above, any remaining assets of the Company would have been distributed pro rata among all holders of the preferred and common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A liquidation event required approval by the holders of at least a majority of the outstanding shares of redeemable convertible preferred stock and at least </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad074abd-615a-40cf-a005-0dd6b22eb91b" contextRef="C_4dd18ba3-1af3-403a-a4dd-75dd15b5568f" name="elym:PercentageOfTemporaryEquitySharesOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">70</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then outstanding shares of Series B redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Optional Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of redeemable convertible preferred stock was convertible into common stock at the stockholder&#x2019;s option. The converted shares would have been determined by dividing the original issue price for each series by the applicable conversion price for such series in effect at the date of conversion. The conversion price for each share of redeemable convertible preferred stock was initially equal to the original issuance price applicable to such share, with the exception of the Series A redeemable convertible preferred stock issued related to the Athenen Acquisition, which were convertible at any time after the date of issuance into common stock at the original issue price of the original Series A of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef93ac20-9d0a-471d-8d40-e83c93317ded" contextRef="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_USDollarShare" scale="0" decimals="2">6.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The conversion ratio was subject to appropriate adjustments for anti-dilution provisions, including stock splits, stock dividends, subdivisions, combinations, recapitalization events or similar events. Specific to the Series B convertible redeemable preferred stock, the conversion ratio was subject to specific anti-dilution provisions adjustments if there was common stock issued for consideration below the Series B issue price.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Automatic Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of redeemable convertible preferred stock was convertible into common stock at initial conversion rates described under the Optional Conversion heading above, subject to adjustments based on certain antidilution provisions, including stock splits, stock dividends, subdivision, combinations, recapitalization or similar events, as provided by the Company&#x2019;s certificate of incorporation. Further, all shares of redeemable convertible preferred stock automatically would have converted into common stock upon the vote or written consent of the holders of a majority of the shares of redeemable convertible preferred stock or upon the closing of a firm-commitment underwritten public offering of the Company&#x2019;s common stock at a stock price of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d936cc9-bb86-46a3-8cd8-92ed82afbe99" contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4" name="elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" unitRef="U_USDollarShare" scale="0" decimals="2">17.16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share and with gross aggregate proceeds to the Company of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_182eb8ac-03d8-4e5f-a62b-c9066311d2a6" contextRef="C_46ca06ae-f957-4d6e-af82-97b092ac535d" name="elym:TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">80.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon completion of the IPO, the Company's redeemable convertible preferred stock was converted into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53a99917-f1de-4ce4-b1de-82a1ddb880d5" contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,345,279</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of Series A, Series A-1, and Series B redeemable convertible preferred stock were entitled to receive cumulative dividends of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ff2cec3-cabc-41d0-9527-77d4cc31032e" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:CumulativeDividendsReceive" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% per annum of the original issuance price on each share of redeemable convertible preferred stock. The dividends were payable in cash, out of the assets at the time legally available thereof, when, as and if declared by the Board of Directors, on an equal basis according to the number of shares of redeemable convertible preferred stock held by such holders, prior and in preference to the common stock. As of December 31, 2020, the Company had total dividends in arrears for the Series A redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c3f8f00-be06-4ef2-9a4d-34ed384982f9" contextRef="C_91e85f77-84b1-41c9-939d-ce1d423da25a" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_38ce9951-7b80-4639-900c-82d7dbc1e5cb" contextRef="C_1a65d3f7-d7e5-4d07-9686-97499e60085d" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, or $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6b79f22-8efc-42ba-8c89-6a9f6d1c0d69" contextRef="C_91e85f77-84b1-41c9-939d-ce1d423da25a" name="us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears" unitRef="U_USDollarShare" scale="0" decimals="2">0.72</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be75b664-b6c4-42bb-aa42-c7190d77a4ce" contextRef="C_1a65d3f7-d7e5-4d07-9686-97499e60085d" name="us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears" unitRef="U_USDollarShare" scale="0" decimals="2">0.48</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, respectively, and for Series A-1 redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b9300c2-e4a5-4d5c-b0ee-b05a7e24c00a" contextRef="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59d02ef7-3662-4b1e-998d-06b7104a3a4a" contextRef="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, or $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d93c679-2717-406c-bd34-e22abea428fb" contextRef="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc" name="us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears" unitRef="U_USDollarShare" scale="0" decimals="2">0.40</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d924cd5c-d051-4d12-ae32-4ed5509d2ec8" contextRef="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215" name="us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears" unitRef="U_USDollarShare" scale="0" decimals="2">0.56</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. As of September 30, 2021, the Company had no dividends in arrears as all shares of redeemable convertible preferred stock converted to common stock upon the completion of the IPO.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Redemption</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under certain circumstances, subsequent to the occurrence of a deemed liquidation event, defined as (1) a majority of the holders of the then outstanding redeemable convertible preferred stock and (2) at least 70% of the then outstanding shares of the Series B redeemable convertible preferred stock could have required the Company to redeem their shares at a price per share equal to the liquidation amount, to the extent that sufficient funds were available. Additionally, holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock initially had the option to redeem their shares beginning in October 2026. As a result, these shares were considered probable of becoming redeemable since redemption is solely dependent on the passage of time. As such, the Company adjusted the carrying value of the redeemable convertible preferred stock by accreting changes in the redemption value over the period from the date of issuance to the earliest redemption date of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_48b04b20-61bc-4a16-8826-6dea6acb138e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">October 2026</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In October 2020, the Company amended the terms of their Certificate of Incorporation to remove the redemption option of their Series A and Series A-1 redeemable convertible preferred stock, as a result the Company ceased recording adjustments to the carrying value of its outstanding redeemable convertible preferred stock for accretion to redemption value. There was no change in value as a result of this modification. There was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d87d311c-061d-4207-a254-b337ecb95742" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accretion to redemption value recorded for the nine months ended September 30, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of the Company&#x2019;s Series B redeemable convertible preferred stock, voting together as a class, were entitled to elect one (1) member of the Board of Directors (the Series B director). The holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock, voting together as a class, were entitled to elect two (2) members of the Board of Directors (the Series A directors). The holders of the shares of common stock and of any other class or series of voting stock (including the preferred stock), voting together as a class, were entitled to elect the balance of the Company&#x2019;s directors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stockholder Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of the Company&#x2019;s redeemable convertible preferred stock had protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the redeemable convertible preferred stock, changes in the authorized number of shares, declaration or payment of dividends, repurchase of shares, changes in the size of the Board of directors, creation of a new class or series of stock, or taking any action that would cause a liquidation event.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the holders of the Company's Series B redeemable convertible preferred stock had additional protective provisions that required Series B preferred stockholders representing 70% of the outstanding shares of the Series B redeemable convertible preferred stock to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series B redeemable convertible preferred stock, changes in the authorized number of shares of Series B redeemable convertible preferred stock, declaration or payment of dividends or distributions shares of capital stock other than the Series A, Series A-1, and Series B redeemable convertible preferred stock, sell shares of Common Stock to the public at price below $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c437832-e0df-49bd-9e89-1e08a910a0d7" contextRef="C_81c02b73-1cfc-43ff-81c8-ad3d786216a0" name="elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" unitRef="U_USDollarShare" scale="0" decimals="2">17.16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in a firm-commitment underwritten public offering, or taking any action that would cause a liquidation event that would results in proceeds of less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aed479a9-1b2b-466a-9576-9f56decf6860" contextRef="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d" name="elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" unitRef="U_USDollarShare" scale="0" decimals="2">17.16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share of the Series B redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock had additional protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series A and Series A-1 redeemable convertible preferred stock and changes or reclassifications of any existing security of the Company that is pari passu with the Series A and/or Series A-1 redeemable convertible preferred stock.</span></p></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5</span><span><ix:nonNumeric id="F_d4da6288-b284-4398-9b13-3deff1b2ab91" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" escape="true" continuedAt="F_d4da6288-b284-4398-9b13-3deff1b2ab91_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Redeemable Convertible Preferred Stock Tranche Liability </span></ix:nonNumeric></span><span style=""></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_d4da6288-b284-4398-9b13-3deff1b2ab91_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purchasers of Series A-1 redeemable convertible preferred stock also received tranche rights, which provided them the right to purchase additional shares of Series A-1 redeemable convertible preferred stock in an additional future tranche. This tranche was for the purchase of Series A-1 and was valued based upon the Company achieving certain future milestones and utilized a valuation model that reflected both potential outcomes of success or failure to meet the milestone.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon issuance in October 2020, the Series A-1 redeemable convertible preferred tranche liability was valued at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4ab2fd4-db9f-4aa4-bcee-03871a966a4a" contextRef="C_3d855745-343a-4c58-aacc-25642060cf47" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF">0.86</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. There was no change in value from the date of issuance and December 31, 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company estimated the fair value of the Series A-1 Tranche Rights using a probability-weighted present value model that considered the probability of triggering the Series A-1 Tranche Rights through achievement of the clinical development milestones specified in the Series A-1 Purchase Agreement. These estimates were based, in part, on subjective assumptions. Changes to these assumptions could have had a significant impact on the reported fair value of the Series A-1 Tranche Rights.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_847674c6-26af-4357-a444-abbc52f68a25" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following reflects the significant quantitative inputs used in the valuation of the redeemable convertible preferred stock tranche liability:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.341%;"></td>
        <td style="width:2.087%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:14.768%;"></td>
        <td style="width:2.273%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Series A-1<br />Tranche<br />Call Option</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Estimated fair value of redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d3071b1-7cb2-4fff-b8e3-ea5e6c4026fe" contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f" name="elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" unitRef="U_USDollarShare" decimals="INF">6.94</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7d9f140-5c22-4ff9-9c67-0d2d60efd8e0" contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231" name="elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" unitRef="U_USDollarShare" decimals="INF">11.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b8483321-2db0-4407-a1e1-4a01acbd23cf" contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87" name="elym:TemporaryEquityDiscountRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">0.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1f26620-aa1f-4963-b4bc-9ffb48e72305" contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87" name="elym:TemporaryEquityDividendYield" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ba53466-0460-4e57-b72d-1365d036e2a4" contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f" name="elym:TemporaryEquityExpectedTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.25</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dcf091cb-3c82-4dd6-b658-107529cb6615" contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231" name="elym:TemporaryEquityExpectedTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.45</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">N/A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Probability of milestone achievement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1068024-5d7d-42d1-bd0d-b61b89ea54ea" contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f" name="elym:TemporaryEquityProbabilityOfMilestoneAchievement" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">80</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_997c8782-f7f4-4d94-ba9a-5fe657969c93" contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231" name="elym:TemporaryEquityProbabilityOfMilestoneAchievement" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Strike price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0de3d9f5-4b9a-4629-878a-289181eb8344" contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87" name="elym:TemporaryEquityStrikePrice" unitRef="U_USDollarShare" decimals="INF">7.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of each tranche feature</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c72bbd6c-8a1c-4d9d-baae-aeb78c31b09d" contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f" name="elym:TemporaryEquityFairValueOfEachTrancheFeature" unitRef="U_USDollarShare" decimals="INF">0.86</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e13db31d-0d42-4b68-8ced-9557a9f6f4e0" contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231" name="elym:TemporaryEquityFairValueOfEachTrancheFeature" unitRef="U_USDollarShare" decimals="INF">3.32</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Series A-1 redeemable convertible preferred tranche liability was settled on March 9, 2021 with the achievement of milestones set forth in the Series A-1 stock purchase agreement. The fair value of the liability was remeasured prior to settlement, resulting in the Company recognizing a loss in the consolidated statement of operations and comprehensive loss of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0072e6e8-5135-4109-93da-f0f6c794de38" contextRef="C_ac126da1-96bb-4ee7-9242-49c11ef12bd4" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">11.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Immediately thereafter, the balance of the redeemable convertible preferred stock tranche liability of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_85b64c88-6608-4765-af31-cbcbcc6d1894" contextRef="C_e50b5ef4-1e50-483c-b6d3-4444344701f9" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">12.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million was reclassified to Series A-1 redeemable convertible preferred stock.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9734d469-dbd4-4fe1-afdf-759cc1301443" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A rollforward of the redeemable convertible preferred stock tranche liability is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.602%;"></td>
        <td style="width:2.091%;"></td>
        <td style="width:1.529%;"></td>
        <td style="width:15.782%;"></td>
        <td style="width:0.995%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f1a09f0-2728-48e0-b979-71f53b6cac71" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="elym:RedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b932264-68b6-4e75-a74b-9decdb75babe" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,718</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Settlement upon issuance of Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2c56e34d-3598-4925-87f2-18f95ecfe527" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">12,269</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_325359d3-ada9-4339-a599-313299e3048d" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:RedeemableConvertiblePreferredStockTrancheLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6</span><span><ix:nonNumeric id="F_190cb0cc-2f3f-42bb-a7d5-6f309e4956b3" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_190cb0cc-2f3f-42bb-a7d5-6f309e4956b3_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Commitments and Contingencies</span></ix:nonNumeric></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_190cb0cc-2f3f-42bb-a7d5-6f309e4956b3_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company leases office space in the United Kingdom under non-cancelable operating leases. Total rent expense for the three months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a48f3eb9-4e7b-4463-8635-bb94e557328a" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ecf23442-b5bb-4b93-8edc-87c6242e9d28" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">13,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. Total rent expense for the nine months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d3c17df6-5af6-4a1a-bb2e-e84061c4ed03" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d9e4390-1b0a-4b08-b6b9-419fecac3928" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">38,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. As of September 30, 2021, future minimum lease payments under non-cancelable operating leases were </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dd2f2c0b-f1ff-43f2-9f6c-79af9c28eeb2" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the terms of which expire on various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ec47661-dca4-4511-afb2-b57f26f37db7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:LeaseExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">June 30, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Proceedings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Indemnification</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless, and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company intends to enter into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#x2019; and officers&#x2019; insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is immaterial.</span></p></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7</span><span><ix:nonNumeric id="F_e46c4580-be1c-4995-9890-a4aee560aec7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_e46c4580-be1c-4995-9890-a4aee560aec7_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Stock-Based Compensation</span></ix:nonNumeric></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_e46c4580-be1c-4995-9890-a4aee560aec7_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2019 Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2019, the Company adopted the 2019 Equity Incentive Plan (the 2019 Plan). The 2019 Plan provides for the Company to grant qualified stock options, non-qualified stock options, and restricted stock awards to employees, non-employee directors and consultants of the Company under terms and provisions established by the board of directors. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_623fd3d8-0390-4664-9810-a43827d23920" contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company&#x2019;s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7cfe926c-d353-483b-a3ac-39bd10dacd23" contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">110</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair value of the Company&#x2019;s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6a797a8b-d13b-453f-937d-590c2b3671e8" contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> terms measured from the option grant date. While</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> no s</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2021 Plan and ESPP</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_846b8296-bd8d-4042-994e-95df34a32b6d" contextRef="C_8865c8f2-5fc8-47cb-be44-ea1ba848844c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The compensation committee of the Company's board of directors adopted and the Company's stockholders approved the 2021 Equity Incentive Plan (2021 Plan) and the 2021 Employee Stock Purchase Plan (the ESPP ), which became effective immediately prior to the effectiveness of the Company's IPO. The 2021 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. The Company's employees, officers, directors and consultants are eligible to receive awards under the 2021 Plan. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021, the total number of shares authorized for issuance under the 2021 Plan was</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9eddc988-acf4-4c8c-98b6-6135eb32eb62" contextRef="C_31769d99-77c6-4ee7-9d41-eb3e0d4c18c0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,558,790</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_742db9b4-165b-4535-8007-13826b6ec831" contextRef="C_68f7e8b4-274f-4fe8-b269-524e2cacfad2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ESPP allows employees, including executive officers, to contribute up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0b4fb47d-da2d-4083-82e2-c83d1e0eaba1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:ExecutiveOfficerEarningContribution" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e53100c3-f35e-4acb-8ad8-ed0d79c7a8da" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:FairMarketValueCommonStockPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair market value of a share of common stock on the first day of the offering period, or (b) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_14329ebc-1f8e-49a6-ad87-4f47f1dace4e" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="elym:FairMarketValueCommonStockPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair market value of a share of common stock on the last day of the offering period. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48c1ffa7-04ee-40e1-add3-b63f89797c34" contextRef="C_66d4dd4a-39ec-4e58-a0db-4d2f02dce3b8" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">255,879</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock reserved for future issuance under our ESPP plan and no shares purchased as of September 30, 2021.</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awards with vesting conditions under both plans typically include vesting </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_842084b9-af53-4324-9c01-b7928da328d2" contextRef="C_e66b3150-0c6b-4578-9500-22dc6c115867" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% on the first anniversary of the grant date with the remainder vesting monthly over the following three years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e7136ebf-e8c3-465e-a1d7-9886a0420b03" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.145%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:10.121%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:10.046%;"></td>
        <td style="width:0.983%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:12.904%;"></td>
        <td style="width:0.983%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:12.857%;"></td>
        <td style="width:0.983%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Options <br />Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br />Average <br />Exercise <br />Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted <br />Average <br />Remaining <br />Contract Terms<br />(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br />Intrinsic <br />Values <br />(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50abde7e-9a0b-4b1a-8de7-d329d9c2ec1c" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">435,342</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6278b7b2-5a90-426e-b081-70f7df72679c" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">0.52</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5d1fa068-715d-447c-af5c-5286ec187ee1" contextRef="C_c86051eb-0d3e-4119-82d7-626225e4cc0b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.19</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_33196d6b-cb7d-41f2-a0bb-22417985284c" contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9eb86d3f-3fca-48dd-9601-78c57d8dc9bb" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,386,990</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0846cb41-4f9d-42e2-974c-def1431ef9f7" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">3.11</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fec9888b-96f1-42f3-aa5f-48fe9fe72ed3" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_491817d8-e74a-4b9f-a7f1-de8746516251" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">1.86</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercised</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8718d58a-1ce9-4d09-82c8-0daa084563e2" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">59,466</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43645783-d4c5-4f10-a100-1ed30c807771" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">1.86</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7ca971c4-f32d-424e-b1f5-a462cb232178" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">150</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_127c5bf3-b728-43f7-881b-ff35cd921af6" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,737,315</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1049221-d439-4f2f-bba4-0dea2e909a61" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">2.74</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_320c4237-cd19-4c2c-b9b5-b497c02a2c33" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6a36b12-e4fd-4699-b419-5f552e732209" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,727</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and expected to vest, September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46a2b5ca-bf71-47ed-867b-702f7d8f77eb" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,737,315</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d23ea602-4296-4b11-9340-20e29592eb03" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">2.74</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f70baa2f-b2c8-4bb9-926f-724243ec08c1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_130f7e75-2e53-4974-95de-390e95b8991c" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,727</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercisable as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5cd0f20e-fd02-42cf-b817-f172d6ded0b0" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">206,339</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_28ccde28-2245-455b-85fc-3b9b8172bdcd" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">0.31</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a754aa92-faba-4b5c-bdb8-c14af6d3113b" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.39</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a71dd9c-659d-4fbc-af60-68ba49885b90" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,646</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The aggregate intrinsic value disclosed in the above table is based on the difference between the exercise price of the stock option and the estimated fair value of the Company&#x2019;s common stock as of the respective period-end dates. The weighted-average grant date fair value of stock options granted during the nine months ended September 30, 2021, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_725fb74b-b675-4bfa-aa7f-6f470b9f5d2f" contextRef="C_e66b3150-0c6b-4578-9500-22dc6c115867" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">6.71</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Black-Scholes option pricing model for employee and nonemployee stock options incorporates the following assumptions:</span></p><div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value of Common Stock </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014; Prior to the completion of the Company's IPO, the fair value of the Company's common stock was determined by using straight-line interpolation between the value of common stock derived from valuations performed by independent third party specialists, further described in Note 2 to the consolidated financial statements </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies &#x2013; Fair Value of Common Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. After the completion of the Company's IPO, the fair value of each share of common stock is based on the closing price of the Company's common stock on the date of grant as reported on the Nasdaq Global Market. </span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Volatility </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014; The expected stock price volatilities are estimated based on the historical and implied volatilities of comparable publicly traded companies as the Company does not have sufficient history of trading its common stock.</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk-free Interest Rate </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014; The risk-free interest rates are based on US Treasury yields in effect at the grant date for notes with comparable terms as the awards.</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Term </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014; The expected term represents the period that the Company&#x2019;s stock options are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term).</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Yield </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014; The expected dividend yield assumption is based on the Company&#x2019;s current expectations about its anticipated dividend policy. </span></div></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_faddb653-9e72-409f-9ff9-a9d6f23db76e" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the Company&#x2019;s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.865%;"></td>
        <td style="width:2.083%;"></td>
        <td style="width:21.052%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_52656cc5-4cfa-4a72-a61d-be674e32c2ed" contextRef="C_1f934220-7227-455a-a222-d949fb36f763" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.80 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_24ce7552-1a80-4571-93ec-8cbd8737b36b" contextRef="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.08</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44b0c136-ba29-4b51-a268-0d27f14eb6af" contextRef="C_1f934220-7227-455a-a222-d949fb36f763" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">78.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b36a4f41-6b33-4889-8db4-ef7c393a3edf" contextRef="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">79.57</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_784db583-c8c4-498a-9e68-84f705835848" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.94</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_61cecf61-f91a-49c7-8707-4face6eef3b1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.13</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8ffb1b99-4bec-47aa-bf3d-b2d125fb3a1d" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has restricted stock awards with service and performance conditions. Awards with a service condition vest </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_afbf309c-c1b4-4a5a-bca2-10dedd91afdf" contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% on the first anniversary of the grant date and monthly thereafter. Awards with a performance condition will vest upon the Company&#x2019;s initiation of a registrational clinical trial to study the efficacy of ETX-810. The probability of achieving performance conditions is assessed each reporting period. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021, this performance condition was assessed and deemed not probable, and the Company has recognized no stock-based compensation expense relating to these performance awards. The Company also granted restricted stock awards to employees and non-employees with service conditions that are subject to repurchase by the Company at the original purchase price in the event that the award recipient&#x2019;s employment or relationship is terminated prior to the shares vesting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0789c9c0-efa8-4426-a7a6-a487e3a41827" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The activity for restricted stock awards is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.939%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:17.551%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:1.735%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.523%;"></td>
        <td style="width:0.993%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted-Average <br />Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ca3a35ef-a845-423b-806e-1680fbe58312" contextRef="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">66,681</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_206c9caf-3e3a-45eb-92b8-22ac58b33b2d" contextRef="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">1.00</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_325f5bc1-1c75-4316-b838-41eef3bbdeb4" contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">297,724</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b58c8079-9780-4e89-8377-daef67a468eb" contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">8.55</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dff68bf3-5f47-4d50-823e-cecbc804de2c" contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,766</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_489cd2fa-aa4f-42d0-a53e-99381cf17f7f" contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">1.42</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee753bd7-ca86-4051-bce4-f70049f368c8" contextRef="C_1a46cf12-25cf-4536-bbb3-735a35b5967e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">348,639</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be39a320-6d9b-4e7e-a4a5-82fd3e91a4ed" contextRef="C_1a46cf12-25cf-4536-bbb3-735a35b5967e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">7.03</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Includes </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_738e3f6d-a597-4cc1-b578-dc46e3ec241a" contextRef="C_4d7d035a-64cf-46ac-a997-043054a67440" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">21,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> restricted stock awards granted in 2018 and still outstanding for the period ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to only performance conditions.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e1e24c30-132c-4d88-8a28-e23154065a6f" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company&#x2019;s consolidated statements of operations and comprehensive loss (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.935%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:9.046%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:9.009%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:9.046%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.522%;"></td>
        <td style="width:9.009%;"></td>
        <td style="width:0.974%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ab4052c-0afb-4b13-b2c8-931a4f837329" contextRef="C_90f3cb70-fc4d-4dc8-b871-9fbf79d9d423" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">297</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f57dbeaa-a4d2-4095-acc2-67ad566b4807" contextRef="C_4a876d31-7de7-495b-a7b5-bba7c9a4a7d1" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6cf81ba3-a01c-4d28-8893-c55f2c3dd120" contextRef="C_5ace5a9e-cd32-4d91-b90b-5a3b7e9a6f23" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">626</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0f45842-3bc4-4ff8-8522-8154f03f34a7" contextRef="C_64c92ae1-3adc-4f1d-b3af-072fddc18c73" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">220</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_32345555-ee17-45bc-8b36-b4f9b778a158" contextRef="C_ea28cdf2-fea4-428a-98b1-56bb6cc26c9a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">939</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87d09a7c-0ee3-49b8-9e46-24fec84b5238" contextRef="C_0f1a829c-ed84-4c89-b645-95747568e8c8" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a613a50f-a6c5-4c02-b29b-45ad503025be" contextRef="C_49b12a98-c4f0-494b-bb47-7d43ab89b59f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,957</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7f0a193e-fbd7-444e-85ad-e8a84e9d3f32" contextRef="C_d491de55-e878-46da-a26f-9d31bf0a5efa" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b2b88bd-d225-4f1e-a6be-81c9c248f4cb" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,236</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74c622ad-0a3c-417d-a654-bed6b1b21b61" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6e07b5c-7a40-4117-a037-c1e535b812b2" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,583</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9c3c6f1f-a2ed-400c-8b9d-0afe0bed923e" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">234</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.44%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, there was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50e4b996-e42b-4df8-9afd-928059f3e2f7" contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="3" decimals="-2" format="ixt:numdotdecimal">13.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of total unrecognized compensation cost related to unvested stock options and unvested restricted stock awards granted, which is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d8b1609c-eaa5-4a8f-8f10-4e9fd86ab6be" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years.</span></p></ix:continuation></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_de4c04c1-29d0-4a89-8554-c07f8b162a6c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Net Loss Per Share Attributable to Common Stockholders</span></p><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_8d278068-baee-4e35-bad4-e69f8ed6ba4e" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.679%;"></td>
        <td style="width:1.265%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:9.185%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:0.975%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:9.138%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.265%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:9.007%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.265%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:9.138%;"></td>
        <td style="width:0.993%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2fb04a2a-a01e-40b8-9440-112590187eb9" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,615</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a8f333d3-b156-41a2-ab47-401d2224151c" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,258</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e9208b1a-6394-49d5-84fa-129392487132" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,935</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_60f66c9b-1a61-447e-8a45-2b453ad5542a" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,805</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8294a2c4-6be5-4b91-95d8-e1eede643ea7" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,322</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1389b62-5770-4fb6-bdd9-c615dc3b0894" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">461</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c103787b-2030-49c2-80bc-fc8bc6b6480f" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,548</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1abae1d-6945-4949-b21c-654f2bc6fa57" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,352</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_33a1dae7-693d-42ca-82d6-4f809c10802f" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">10,937</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aafbbd0d-3700-4a26-89ef-7a7620b20bb0" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,719</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9e3f3c8d-9678-4b2d-b774-93ca7d8f32ac" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">41,483</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ea8a822-b378-4df7-8bb2-7ff8371890a9" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7,157</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average common shares used in computed net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebbdbef8-e22d-47bd-b090-17e5c30681be" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">15,585,611</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebdfbfb9-b372-4fad-adc8-ccf0e976b815" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,863,860</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75f0f9ed-1fe2-4fa7-8a97-fe87a5616b1a" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,554,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_82858687-23fe-419f-92d8-ba2f5ccc7b6c" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,859,713</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76e457ef-d43f-4f99-b444-737c8a10099e" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">0.70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_15649890-402e-419b-84a0-c89bbfbe4207" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">1.46</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d825fe4-8e7e-4686-8874-d335deae8000" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">5.49</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f191110-a742-4c2d-9f32-454f48b56528" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-">3.85</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All outstanding shares of redeemable convertible preferred stock were converted on a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c9f28a47-051f-42d9-b600-212fdae2dd25" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:PreferredStockConversionBasis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1-for-1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> basis to shares of common stock on August 12, 2021, the date of the Company's IPO (see Note 1). </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The cumulative preferred stock dividend was therefore eliminated upon conversion of the redeemable convertible preferred stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_6f8c5a36-4023-4265-8d35-a5f65e6cd6c0" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following outstanding shares of potentially dilutive securities were excluded from the computation of the diluted net loss per share attributable to common stockholders for the periods presented because their effect would have been anti-dilutive:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.812%;"></td>
        <td style="width:1.224%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:13.366%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:1.224%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:13.366%;"></td>
        <td style="width:1.002%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three and Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1f1f2dec-f688-4178-9db4-3f7bd2396569" contextRef="C_72d3a4a0-a7dd-4cce-b4cd-5ceeab4550af" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_a342d02d-db0a-44f2-b33b-3374aa20e22c" contextRef="C_398fad3d-4870-4949-9d7c-6dfc42616d57" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,737,315</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f3f9216-a514-456a-9b6c-21ccc2e4e3e3" contextRef="C_049452a9-fc43-43c7-8a1c-3587620997bc" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_50f02997-8902-497d-b5fa-000dc8d62e37" contextRef="C_bae15c67-f4c8-4995-984c-a35ab4ed4694" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">366,501</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock awards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3387638f-6261-4d1f-92fc-cc71b29f6929" contextRef="C_3e5d32c4-3b28-4cb4-944a-cb5fad009173" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_071c8ba6-3e09-4a8e-b574-326a273678bc" contextRef="C_a08166e1-5c98-4297-81ec-f148b463fbeb" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">348,639</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c5409ecc-244c-417d-b2e4-6bafe91e4d20" contextRef="C_f078b167-0dbc-4247-867c-2c3caced4b04" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_d849e403-2733-448b-b90b-690218a519d4" contextRef="C_5ceab66a-25cf-4427-b629-b07de4d324b5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">117,556</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06176804-6fec-4439-85e9-e7c9e34692e9" contextRef="C_593e17e9-ffd0-4218-9443-cc138e4c41d3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:zerodash"><ix:nonFraction id="F_fc22df61-85c5-4b6f-a11e-96d7b760b9fe" contextRef="C_61c4932e-fb1e-472e-b741-e5bb1f637f14" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:zerodash">&#x2014;</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebf79400-53b0-48f7-93be-256e14811a4a" contextRef="C_cce22c4e-7230-4435-ad69-db554d6a00a1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1970432c-e649-4908-9bf6-8f23e3cc5069" contextRef="C_c81c2950-d46e-4287-a0f4-4964fefc37bd" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,999,133</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total potentially dilutive shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d4d6251-11e8-492a-af09-455ac1564b39" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4a848a18-b3ef-4278-81b0-aeb132f4c0a1" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,085,954</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71fcc4d3-5c53-4078-a1d6-3b13a9119c07" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_f1df89b6-4820-4cea-9358-96a066d3d4db" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,483,190</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9</span><span><ix:nonNumeric id="F_cbea8402-e9cf-438b-8935-45f128724e0c" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_cbea8402-e9cf-438b-8935-45f128724e0c_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Related Party Transactions</span></ix:nonNumeric></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_cbea8402-e9cf-438b-8935-45f128724e0c_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Services Provided by Related Parties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has a services agreement with Carnot, LLC. Carnot, LLC was subsequently dissolved and the services agreement transitioned to its successor Carnot Pharma, LLC. The Company reimburses Carnot Pharma, LLC for research and development expenses incurred on its behalf. RA Capital Management, L.P. is the manager of the members of Carnot, LLC and Andrew Levin, a member of the Company's board of directors and former CEO, is the President of Carnot Pharma, LLC. Adam Rosenberg, a member of the Company's board of directors, is a Venture Partner at Carnot Pharma, LLC dba RA Ventures.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts invoiced and reimbursed for the three months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9f12d996-ec24-45fd-a010-3edfcb26ea4f" contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9550d910-731c-4c1b-a1fe-1bae52349072" contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">17,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. Amounts invoiced and reimbursed for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ce170ed-e823-4329-84a3-47b5a659484a" contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f471f41-82c1-4378-88a1-8997eb7d173e" contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, respectively.</span></p></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. Management&#x2019;s Discussion and An</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">alysis of Financial Results and Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto as of and for the year ended December 31, 2020 and the related Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in our final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission (SEC) on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, or the Securities Act, for our initial public offering, or IPO. Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to Eliem Therapeutics, Inc. and its wholly owned subsidiaries.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Forward-Looking Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following discussion of our financial condition and results of operations contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on our management&#x2019;s beliefs and assumptions and on information currently available to our management. All statements other than statements of historical facts are &#x201c;forward-looking statements&#x201d; for purposes of these provisions, including those relating to future events or our future financial performance and financial guidance. In some cases, you can identify forward-looking statements by terminology such as &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;intend&#x201d; or &#x201c;continue,&#x201d; the negative of terms like these or other comparable terminology, and other words or terms of similar meaning in connection with any discussion of future operating or financial performance. These statements are only predictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. Any or all of our forward-looking statements in this document may turn out to be wrong. Actual events or results may differ materially. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks, uncertainties and other factors, including, among other things, impacts on our business due to health pandemics or other contagious outbreaks, such as the current COVID-19 pandemic. In evaluating these statements, you should specifically consider various factors, including the risks outlined under the caption &#x201c;Risk Factors&#x201d; set forth in Item 1A of Part II of this Quarterly Report on Form 10-Q, as well as those contained from time to time in our other filings with the SEC. We caution investors that our business and financial performance are subject to substantial risks and uncertainties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and our focus is on restoring homeostasis. We are developing a pipeline of clinically differentiated product candidates focused on validated mechanisms of action with broad therapeutic potential to deliver improved therapeutics for patients with these disorders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our two lead clinical-stage candidates are ETX-810 and ETX-155. ETX-810 is a novel palmitoylethanolamide (PEA) prodrug initially being developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and pain associated with lumbosacral radiculopathy (lumbosacral radicular pain (LSRP) commonly referred to as sciatica). ETX-810 is being evaluated in two Phase 2a clinical trials that are expected to report topline data in the first half of 2022. ETX-155 is a neurosteroid GAB</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">A</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A receptor positive allosteric modulator (PAM) initially being developed for the treatment of major depressive disorder (MDD), perimenopausal depression (PMD) and focal onset seizures (FOS), the most common type of seizure in people with epilepsy. In our single-arm proof-of-concept Phase 1b clinical trial in subjects with photosensitive epilepsy (PSE), we have commenced subject screening and anticipate dosing the first subject by the end of 2021, with expected topline data by the first half of 2022. In addition, we advanced start-up activities on two Phase 2a clinical trials for ETX-155 in subjects with MDD and PMD in the third quarter of 2021. We anticipate the first subjects will be dosed in each of these trials in early 2022, assuming regulatory approval of our Investigational New Drug (IND) application.  The topline data for the MDD and PMD trials are expected in the first half of 2023.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Below is a summary of our wholly owned pipeline:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img155835445_0.jpg" alt="img155835445_0.jpg" style="width:720px;height:269px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We were incorporated in October 2018. In February 2019, we acquired 100% of the share capital of NeoKera, LLC, and we separately acquired in-process research and development (IPR&amp;D) related to the ETX-810 program. In October 2020, we acquired 100% of the share capital of Athenen Therapeutics, Inc. (the Athenen Acquisition), which included IPR&amp;D related to the ETX-155 program. We have incurred significant operating losses since inception, as we have devoted substantially all of our resources to organizing and staffing our company, identifying potential product candidates, business planning, raising capital, undertaking research, executing preclinical studies and clinical development trials, and providing general and administrative support for business activities. We incurred net losses of $9.6 million and $2.3 million for the three months ended September 30, 2021 and 2020, respectively, and $36.9 million and $5.8 million for the nine months ended September 30, 2021 and 2020, respectively. We had an accumulated deficit of $65.1 million and $28.1 million as of September 30, 2021 and December 31, 2020, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception, we have funded our operations with an aggregate of $208.3 million in net proceeds from the sale and issuance of shares of our redeemable convertible preferred stock and our initial public offering of our common stock. We had cash, cash equivalents, and marketable securities of $169.6 million and $20.5 million as of September 30, 2021 and December 31, 2020, respectively. Based on our current operating plan, we estimate that our cash, cash equivalents and marketable securities will be sufficient to fund our operating expenses and capital expenditure requirements into late 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate that our expenses and operating losses will increase substantially over the foreseeable future. The expected increase in expenses will be largely driven by our ongoing activities as we:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to develop and conduct clinical trials, including for ETX-810 and ETX-155 for our initial and any potential additional indication;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate and continue research and development, including preclinical, clinical and discovery efforts for any future product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek regulatory approvals for ETX-810 and ETX-155, or any other product candidates that successfully complete clinical development;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add operational, financial and management information systems and personnel, including personnel to support our product candidate development and help us comply with our obligations as a public company;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire and retain additional personnel, such as clinical, manufacturing, quality control, scientific, commercial and administrative personnel;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand and protect our intellectual property portfolio;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish sales, marketing, distribution, manufacturing, supply chain and other commercial infrastructure in the future to commercialize various products for which we may obtain regulatory approval;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add equipment and physical infrastructure to support our research and development and growing staff;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license other product candidates and technologies; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">incur increased costs as a result of operating as a public company.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have any products approved for sale and have not generated any revenue from product sales since our inception. Our ability to generate product revenue will depend on the successful development, regulatory approval and eventual commercialization of one or more of our product candidates, if approved. We cannot assure you that we will ever be profitable or generate positive cash flow from operating activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will require substantial additional funding to support our continuing operations and further the development of our product candidates. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which could include income from collaborations, strategic partnerships or other strategic arrangements. Adequate funding may not be available when needed or on terms acceptable to us, or at all. If we are unable to raise additional capital as needed, we may have to significantly delay, scale back or discontinue development of our product candidates. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing pandemic and otherwise. If we fail to obtain necessary capital when needed on acceptable terms, or at all, it could force us to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations. Insufficient liquidity may also require us to relinquish rights to product candidates at an earlier stage of development or on less favorable terms than we would otherwise choose.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Developments</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We recently completed a 14-day repeat dose Phase 1 clinical trial in healthy subjects for ETX-155. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Phase 1 study evaluated the pharmacokinetic profile and safety of ETX-155 in 20 healthy human subjects, evaluating 60 mg ETX-155 (n=15) or placebo (n=5) dosed daily in the evening for 14 days. The results demonstrated that ETX-155 reached steady state concentration at Day 8 and had an approximate 40-hour half-life, confirming ETX-155&#x2019;s desirable profile for a once-daily dosing regimen. The study also confirmed that ETX-155 was generally well tolerated with no severe or serious adverse events, or discontinuations. All treatment emergent adverse events (TEAEs), including central nervous system (CNS) adverse events, were mild/moderate and transient. In particular, all somnolence adverse events were mild and the incidence was comparable in the ETX-155 and placebo groups.&#x202f; Notably, somnolence events were sporadic, and no subject who reported somnolence in either the ETX-155 or placebo arms reported it more than one time during the dosing or follow-up&#x202f;period. In addition, there was no clinically meaningful difference compared to placebo in sleep quality or next morning state of arousal, as measured by the Leeds Sleep Evaluation Questionnaire. The tolerability and safety findings of this study were consistent with those of the previous 7-day repeat dose Phase 1 study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Impact of the COVID-19 Pandemic on Our Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic and recommended containment and mitigation measures. Since then, extraordinary actions have been taken by international, federal, state, and local public health and governmental authorities to contain and combat the outbreak and spread of COVID-19 in regions throughout the world, including the United Kingdom (U.K.) and the State of Washington, where most of our operations are conducted. These actions substantially restricted daily activities for individuals and caused many businesses to curtail or cease normal operations. We have been carefully monitoring the COVID-19 pandemic as it continues to progress and its potential impact on our business. As a result of COVID-19, we have taken precautionary measures in order to minimize the risk of the virus to our employees, including the suspension of all non-essential business travel. In addition, the majority of our workforce now works remotely. To date, we have been able to continue our key business activities and advance our clinical programs. However, in the future, it is possible that it will become more difficult to enroll participants in our clinical trials, which could delay our clinical development timelines. While the broader implications of the COVID-19 pandemic on our results of operations and overall financial performance remain uncertain, it has, to date, not had a material adverse impact on our results of operations or our ability to raise funds to sustain operations. The economic effects of the pandemic and resulting societal changes are currently not predictable, and the future financial impacts could vary from those foreseen.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Components of Operating Results</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operating expenses consist of (i) research and development expenses, including expenses incurred with related parties, and (ii) general and administrative expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our research and development expenses consist primarily of direct and indirect costs incurred in connection with our discovery efforts, preclinical studies, and clinical trial activities related to our pipeline, including our lead product candidates, ETX-810 and ETX-155.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our direct research and development costs include:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expenses incurred in connection with research, laboratory consumables and preclinical and clinical trial activities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost to manufacture drug products for use in our preclinical and trials; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">consulting fees, including services provided by a related party.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our indirect research and development costs include:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">personnel-related expenses, such as salaries, bonuses, benefits, and stock-based compensation expense, for our scientific personnel performing research and development activities; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">facility rent.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total direct costs and indirect costs are as follows (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.064%;"></td>
    <td style="width:1.93%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.636%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.93%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.246%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.93%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.283%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.698%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.265%;"></td>
    <td style="width:0.983%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Direct costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,448</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,267</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,816</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,452</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Indirect costs</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,295</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">301</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,232</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">838</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1,754</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(621</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4,605</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1,360</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total research and development<br />&#160;&#160;&#160;expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,989</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,947</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,443</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,930</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expense research and development costs as incurred. Non-refundable advance payments for goods and services that will be used over time for research and development are capitalized and recognized as goods are delivered or as the related services are performed. Costs to acquire technologies used in research and development that have not yet received regulatory approval and that are not expected to have an alternative future use are expensed when incurred. We categorize costs by stage of development clinical or preclinical. Given our stage of development and the utilization of our resources across our various programs, we have not historically tracked our research and development costs by program. Research and development expenses are presented net of refundable research and development tax credits from the U.K. government.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development costs by stage of development are as follows (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.318%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.541%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:1.66%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.615%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:1.66%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.782%;"></td>
    <td style="width:0.992%;"></td>
    <td style="width:1.66%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.772%;"></td>
    <td style="width:0.992%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,631</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,686</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,080</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,086</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Preclinical</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,112</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">882</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,968</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,204</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1,754</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(621</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4,605</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1,360</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total research and development<br />&#160;&#160;&#160;expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,989</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,947</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,443</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,930</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development activities are central to our business model. We expect our research and development expenses to increase substantially for the foreseeable future as we continue to ramp up our clinical development activities and incur expenses associated with hiring additional personnel to support our research and development efforts. Our research and development expenses may vary significantly based on factors such as:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and scope of clinical studies needed for regulatory approval;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and scope of preclinical and investigational new drug (IND)-enabling studies;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the phases of development of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress and results of our research and development activities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the length of time required to enroll eligible subjects and initiate clinical trials;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of subjects that participate in the clinical trials;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential additional safety monitoring requested by regulatory agencies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the duration of subject participation in the trials and follow-up;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost and timing of manufacturing of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing, receipt and terms of any marketing approvals from applicable regulatory authorities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the hiring and retention of research and development personnel;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the degree to which we obtain, maintain, defend and enforce our intellectual property rights; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we establish collaborations, strategic partnerships or other strategic arrangements and the performance of any related third parties.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A change in the outcome of any of these variables with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of that product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses, related party included expense reimbursements paid to Carnot, LLC, a related party, of $0.3 million and $17,000 for the three months ended September 30, 2021 and 2020, respectively, and $1.0 million and $0.3 million for the nine months ended September 30, 2021 and 2020, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our general and administrative expenses consist primarily of personnel-related expenses, such as salaries, bonuses, benefits, and stock-based compensation, for our personnel in executive, finance and accounting, human resources, business development and other administrative functions. Other significant general and administrative expenses include legal fees relating to intellectual property and corporate matters, professional fees for accounting, tax and consulting services, insurance costs, and travel expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our general and administrative expenses will substantially increase for the foreseeable future as we continue to increase our general and administrative headcount to support our continued research and development activities and, if any product candidates receive marketing approval, commercialization activities, as well as to support our operations generally. We have also incurred and expect to incur increased expenses associated with operating as a public company, including costs related to accounting, audit, legal, regulatory, and tax-related services associated with maintaining compliance with exchange listing, and SEC requirements, director and officer insurance costs, and investor and public relations costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income (Expense)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Change in Fair Value of Redeemable Convertible Preferred Tranche Liability</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our redeemable convertible preferred stock tranche liability is accounted for at fair value at inception, with changes in the fair value recorded in earnings at each reporting period through settlement. Refer to Note 5 of the interim condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Gain (Loss)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our foreign currency gain (loss) primarily consists of foreign exchange gains and losses resulting from remeasurement and foreign currency transactions between the British Pound and the U.S. Dollar.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income, net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our other income consists of interest</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> income, accretion and amortization related to our investments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth our results of operations (dollars in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36.073%;"></td>
    <td style="width:2.097%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:11.412%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:2.097%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:11.412%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:2.097%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:11.431%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:2.097%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:11.412%;"></td>
    <td style="width:0.937%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,704</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,930</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,455</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,644</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development,<br />&#160;&#160;&#160;related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">285</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">988</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">286</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,394</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">312</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,526</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">888</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,383</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,259</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,969</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,818</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(9,383</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2,259</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(24,969</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5,818</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income (expense):</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value of<br />&#160;&#160;&#160;redeemable convertible<br />&#160;&#160;&#160;preferred stock tranche<br />&#160;&#160;&#160;liability</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(11,718</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign current gain (loss)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(252</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(268</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total other income (expense)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(232</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(11,966</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(9,615</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2,258</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(36,935</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5,805</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Comparison of the Three Months Ended September 30, 2021 and September 30, 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth our operating expenses (dollars in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.2%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.687%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.687%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.687%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:12.019%;"></td>
    <td style="width:2.263%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,704</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,930</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,774</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">195.5</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development, related<br />&#160;&#160;&#160;party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">285</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">268</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;*%</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,394</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">312</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,082</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">987.8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* - Not meaningful</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development and Research and Development, related party</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses increased 195.5% from $1.9 million for the three months ended September 30, 2020 to $5.7 million for the three months ended September 30, 2021. Research and development expenses, related party increased to $0.3 million for the three months ended September 30, 2021. In total, research and development expenses increased 207.6% from $1.9 million for the three months ended September 30, 2020 to $6.0 million for the three months ended September 30, 2021. This increase was primarily driven by a $1.0 million increase in clinical expenses associated with Phase 1 and Phase 2 clinical trials of ETX-155 and ETX-810, respectively, a $2.2 million increase in preclinical expenses associated with ETX-155, ETX-810 and our preclinical programs, and a $1.9 million increase in personnel related expenses from increased headcount and stock-based compensation. Clinical and preclinical costs have increased and are expected to continue to increase due to the further advancement of our programs into later stages of clinical development where clinical studies may have increased numbers of subjects, longer duration and more substantial data collection and analysis. The increase was partially offset by a $1.1 million increase in the refundable research and development tax credits from the U.K. driven by increased research and development activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses increased 987.8% from $0.3 million for the three months ended September 30, 2020 to $3.4 million for the three months ended September 30, 2021. The increase in general and administrative expenses is primarily due to an increase of $1.8 million in personnel related expenses from increased headcount and stock-based compensation and a $0.8 million increase in consulting and legal expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income (Expense)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth our other income (expense) (dollars in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.176%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.521%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.669%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.521%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:1.716%;"></td>
    <td style="width:0.751%;"></td>
    <td style="width:12.02%;"></td>
    <td style="width:2.263%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency gain (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(252</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(253</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;(*)%</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100.0</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* - Not meaningful</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Gain (Loss)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency loss decreased from a $1,000 gain for the three months ended September 30, 2020 to a $0.3 million loss for the three months ended September 30, 2021. The decrease was due to an unfavorable foreign currency exchange rates between the British Pound and the U.S. Dollar.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income, net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net increased to $20,000 for the three months ended September 30, 2021. The increase was due to the interest income, partially offset by amortization of premiums and accretion of discounts recognized on our investments recognized during the quarter. For the three months ended September 30, 2020, we held no investments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Comparison of the Nine Months Ended September 30, 2021 and September 30, 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth our operating expenses (dollars in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.077%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.652%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.624%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:12.652%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:10.862%;"></td>
    <td style="width:2.81%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,455</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,644</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,811</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">232.8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development, related<br />&#160;&#160;&#160;party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">988</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">286</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">702</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">245.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,526</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">888</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,638</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">860.1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development and Research and Development, related party</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses increased 232.8% from $4.6 million for the nine months ended September 30, 2020 to $15.5 million for the nine months ended September 30, 2021. Research and development expenses, related party increased 245.5% from $0.3 million for the nine months ended September 30, 2020 to $1.0 million for the nine months ended September 30, 2021. In total, research and development expenses increased 233.5% from $4.9 million for the nine months ended September 30, 2020 to $16.4 million the nine months ended September 30, 2021. This increase was primarily driven by a $7.7 million increase in clinical expenses associated with Phase 1 and Phase 2 clinical trials of ETX-155 and ETX-810, a $4.8 million increase in preclinical expenses associated with ETX-155, ETX-810, and our preclinical programs, and a $2.3 million increase in personnel related expenses from increased headcount and stock-based compensation. Clinical and preclinical costs have increased and are expected to continue to increase due to the further advancement of our programs into later stages of clinical development where clinical studies may have increased numbers of subjects, longer duration and more substantial data collection and analysis. The increase was partially offset by a $3.2 million increase in the refundable research and development tax credits from the U.K. driven by increased research and development activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses increased 860.1% from $0.9 million for the nine months ended September 30, 2020 to $8.5 million for the nine months ended September 30, 2021. The increase in general and administrative expenses is primarily due to an increase of $4.3 million in personnel related expenses from increased headcount and stock-based compensation and a $2.7 million increase in consulting and legal expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income (Expense)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth our other income (expense) (dollars in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.098%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.522%;"></td>
    <td style="width:12.545%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.522%;"></td>
    <td style="width:12.638%;"></td>
    <td style="width:0.742%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.522%;"></td>
    <td style="width:12.545%;"></td>
    <td style="width:0.937%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:0.742%;"></td>
    <td style="width:11.218%;"></td>
    <td style="width:3.201%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value of redeemable<br />&#160;&#160;&#160;convertible preferred stock tranche<br />&#160;&#160;&#160;liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(11,718</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(11,718</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(100.0</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency gain (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(268</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(281</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;(*)%</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100.0</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* - Not meaningful</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Change in fair value of redeemable convertible preferred stock tranche liability</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the nine months ended September 30, 2021, we recognized an $11.7 million charge from the settlement of our Series A-1 preferred stock tranche liability and in connection with significant valuation changes in our Series A-1 redeemable convertible preferred stock. The valuation changes were driven primarily by the Phase 1 results of ETX-155, as well as an increased likelihood of future financing events.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Gain (Loss)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign currency gain (loss) decreased from a $13,000 gain for the nine months ended September 30, 2020 to a $0.3 million loss for the nine months ended September 30, 2021. The loss was due to unfavorable foreign currency exchange rates between the British Pound and the U.S. Dollar.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income, net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income, net increased to $20,000 for the nine months ended September 30, 2021. The increase was due to the interest income, partially offset by amortization of premiums and accretion of discounts recognized on our investments during the quarter. For the nine-months ending September 30, 2020, we held no investments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liquidity and Capital Resources</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sources of Liquidity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We primarily generate cash and cash equivalents from the sale of our equity securities, including common stock and redeemable convertible preferred stock, and to a lesser extent from cash received pursuant to refundable research and development tax credits. From our inception to September 30, 2021, we raised aggregate proceeds of $208.3 million from the issuance of shares of our redeemable convertible preferred stock and from our initial public offering of our common stock. We have not generated any revenue from product sales or otherwise. We have incurred net losses from operations since our inception and anticipate we will continue to incur net losses for the foreseeable future. As of September 30, 2021 and December 31, 2020, we had cash, cash equivalents, and marketable securities of $169.6 million and $20.5 million and an accumulated deficit of $65.1 million and $28.1 million, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Funding Requirements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have experienced recurring net losses since inception. Our transition to profitability is dependent upon the successful development, approval and commercialization of our product candidates and achieving a level of revenue adequate to support our cost structure. We do not expect to achieve such revenue and expect to continue to incur losses for the foreseeable future. We believe our cash, cash equivalents, and marketable securities of $169.6 million as of September 30, 2021 will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our research and development and general and administrative expenses will continue to increase for the foreseeable future. As a result, we will need significant additional capital to fund our operations, which we may obtain through one or more equity offerings, debt financings or other third-party funding, including potential strategic alliances and licensing or collaboration arrangements. Because of the numerous risks and uncertainties associated with the development and commercialization of our product candidates, we are unable to estimate the amount of increased capital we will need to raise to support our operations and the outlays and operating expenditures necessary to complete the development of our product candidates and build additional manufacturing capacity, and we may use our available capital resources sooner than we currently expect.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our future capital requirements will depend on many factors, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress of our current and future product candidates through preclinical and clinical development;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential delays in our preclinical studies and clinical trials, whether current or planned, due to the COVID-19 pandemic, or other factors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continuing our research and discovery activities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiating and conducting additional preclinical, clinical, or other studies for our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changing or adding additional contract manufacturers or suppliers;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seeking regulatory approvals and marketing authorizations for our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishing sales, marketing, and distribution infrastructure to commercialize any products for which we obtain approval;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquiring or in-licensing product candidates, intellectual property and technologies;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">making milestone, royalty, or other payments due under any current or future collaboration or license agreements;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining, maintaining, expanding, protecting, and enforcing our intellectual property portfolio;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">attracting, hiring and retaining qualified personnel;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential delays or other issues related to our operations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">meeting the requirements and demands of being a public company;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">defending against any product liability claims or other lawsuits related to our products; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of the COVID-19 pandemic, which may exacerbate the magnitude of the factors discussed above.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that our existing cash, cash equivalents and marketable securities will enable us to fund our operating expenses and capital expenditure requirements through late 2023. We have based our estimates as to how long we expect we will be able to fund our operations on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect, in which case, we would be required to obtain additional financing sooner than currently projected, which may not be available to us on acceptable terms, or at all. Our failure to raise capital as and when needed would have a negative impact on our financial condition and our ability to pursue our business strategy.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will need substantial additional funding to support our continuing operations and pursue our development strategy. Until such time as we can generate significant revenue from sales of our product candidates, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, including potential collaborations with other companies or other strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. If we are unable to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back, or discontinue the development and commercialization of our product candidates or delay our efforts to expand our product pipeline. We may also be required to sell or license to other parties&#x2019; rights to develop or commercialize our product candidates that we would prefer to retain.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our cash flows (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.197%;"></td>
    <td style="width:1.725%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:12.709%;"></td>
    <td style="width:0.946%;"></td>
    <td style="width:1.725%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:12.69%;"></td>
    <td style="width:0.946%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(28,188</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(8,474</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(106,919</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">177,194</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the nine months ended September 30, 2021, net cash used in operating activities was $28.2 million. This consisted primarily of net loss of $36.9 million and an increase in our operating assets and liabilities of $5.4 million, primarily related to research and development activities, which was partially offset by the non-cash charges for changes in the fair value of the redeemable convertible preferred stock tranche liability of $11.7 million and stock-based compensation of $2.6 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the nine months ended September 30, 2020, net cash used in operating activities was $8.5 million. This consisted primarily of a net loss of $5.8 million and an increase in our operating assets and liabilities of $3.0 million, which was partially offset by the non-cash charge for stock-based compensation of $0.2 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investing activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the nine months ended September 30, 2021, net cash used in investing activities was $106.9 million. This consisted primarily of investments in United States government debt securities, commercial paper, and corporate bonds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financing activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the nine months ended September 30, 2021, net cash provided by financing activities was $177.2 million, primarily attributable to the proceeds from the issuance of our Series A-1 and Series B redeemable convertible preferred stock, net of issuance costs, and the proceeds from the issuance of our common stock in our initial public offering, net of issuance costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contractual Commitments and Obligations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the normal course of business, we enter into contracts with contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and other third parties for preclinical studies and clinical trials, research and development supplies, and other testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and generally provide us the option to cancel, reschedule and adjust our requirements based on our business needs, prior to the delivery of goods or performance of services. However, it is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We lease various operating spaces in the United Kingdom under non-cancelable operating lease arrangements that expire on various dates through June 30, 2023. As of September 30, 2021 and December 31, 2020, our future minimum lease payments under non-cancelable lease agreements were $0.6 million and $47,000, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Off Balance Sheet Arrangements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not have any off-balance sheet arrangements as of September 30, 2021 and December 31, 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Critical Accounting Policies and Estimates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This management&#x2019;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and notes to the condensed consolidated financial statements. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions and conditions. A summary of our critical accounting policies is presented in our audited financial statements and notes thereto as of and for the year ended December 31, 2020 included in our final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended for our IPO. There were no material changes to our critical accounting policies during the nine months ended September 30, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">See Note 1 in our interim condensed consolidated financial statements included herein and see Note 2 to our annual consolidated financial statements included in our final prospectus dated August 9, 2021 and filed with the SEC on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Emerging Growth Company Status</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act (JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years audited consolidated financial statements in a registration statement for an IPO, an exemption from the requirement to provide an auditor&#x2019;s report on internal controls over financial reporting pursuant to the Sarbanes-Oxley Act, an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i) we are no longer an emerging growth company or (ii) we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a result, our consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. We will remain an emerging growth company under the JOBS Act until the earliest of (i) the last day of our first fiscal year in which we have total annual gross revenue of $1.07 billion or more, (ii) the date on which we have issued more than $1.0 billion of non-convertible debt instruments during the previous three fiscal years, (iii) the date on which we are deemed a &#x201c;large accelerated filer&#x201d; under the rules of the SEC with at least $700.0 million of outstanding equity securities held by non-affiliates, or (iv) the last day of the fiscal year following the fifth anniversary of completion of our IPO.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item3_quantitative_and_qualitative"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Exchange Risk</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some of our employees and operations are located in the U.K., and a portion of our expenses and payment obligations are denominated in and have been satisfied with the British Pound. There was no material foreign currency risk for the three and nine months ended September 30, 2021 and 2020. However, we have and will continue to enter into contracts with vendors outside of the U.S. for research and development services. In the future, some of these contracts may continue to be denominated in foreign currencies and to the extent they are, we will be subject to foreign currency transaction gains or losses. We incurred an immaterial foreign currency transaction loss and an immaterial foreign currency transaction gain for the three and nine months ended September 30, 2021 and 2020. We have not had a formal hedging program with respect to foreign currency. We believe a hypothetical 100 basis point increase or decrease in exchange rates during any of the periods presented would not have a material effect on our interim condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest Rate Risk</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to market risk for changes in interest rates related primarily to our cash and cash equivalents and marketable securities. As of September 30, 2021, we had cash and cash equivalents of $62.8 million held primarily in cash deposits and money market funds. As of September 30, 2021, we had short-term and long-term marketable securities of $106.8 million, held in U.S. government debt securities and corporate bonds. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of interest rates in the United States. As of September 30, 2021, a hypothetical 100 basis point increase in interest rates would not have resulted in a material decline of the fair value of our available-for-sale securities. This estimate is based on a sensitivity model that measures market value changes when changes in interest rates occur. Such losses would only be realized if we sold the investments prior to maturity. We do not enter into investments for trading purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item4_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. Controls and Procedures</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#x2019;s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on our evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that the Company&#x2019;s disclosure controls and procedures (as such term is defined in Rule(s) 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were not effective as of September 30, 2021 because of the material weaknesses in our internal control over financial reporting described below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Material Weaknesses in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Management identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the financial statements would not be prevented or detected on a timely basis. The material weaknesses are as follows:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design or maintain an effective control environment. Specifically, we lacked a sufficient number of professionals with an appropriate level of accounting knowledge, training and experience to appropriately analyze, record and disclose accounting matters commensurate with accounting and reporting requirements. The lack of personnel contributed to additional material weaknesses.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design and maintain formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and controls over the preparation and review of journal entries, account reconciliations and consolidation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These material weaknesses did not result in a misstatement to the financial statements. However, these material weaknesses could result in a misstatement of our account balances or disclosures that would result in a material misstatement of our annual or interim financial statements that would not be prevented or detected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design and maintain effective controls over information technology (IT) general controls for information systems that are relevant to the preparation of our financial statements. Specifically, we did not design and maintain (a) program change management controls to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately, (b) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate Company personnel, (c) computer operations controls to ensure that critical batch jobs are monitored, and data backups are authorized and monitored, and (d) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These IT deficiencies did not result in a misstatement to the financial statements. However, the IT deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined the IT deficiencies in the aggregate constitute a material weakness.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Management has concluded that these material weaknesses in internal control over financial reporting were due to the fact that we were recently a private company with limited resources and did not have the necessary business processes and related internal controls formally designed and implemented, coupled with the appropriate resources with the appropriate level of experience and technical expertise, to oversee our business processes and controls.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding the above identified material weaknesses, management believes the condensed consolidated financial statements as included in Part I of this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company's financial condition, results of operations and cash flows as of and for the periods presented in accordance with generally accepted accounting principles in the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Remediation Efforts to Address Material Weaknesses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are in the process of implementing remediation efforts, including the hiring of additional financial employees and consultants with the appropriate public company and technical accounting expertise, and other actions described below. As such remediation efforts are still ongoing, we have concluded that the material weaknesses have not been remediated. Remediation efforts to date include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We engaged external consultants with public company and technical accounting experience to facilitate accurate and timely accounting closes and to accurately prepare and review the financial statements and related footnote disclosures. </span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We hired experienced accounting personnel to strengthen our compliance and accounting functions and to assist in our risk assessment process and the design and implementation of controls. Further, we have implemented policies and procedures to improve segregation of duties over the preparation of account reconciliations and consolidation.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have begun implementing new financial systems to improve segregation of duties and controls over the preparation and review of journal entries and reliability of system generated data. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The actions that have been taken are subject to continued review, implementation and testing by management, as well as oversight by the audit committee of our board of directors. While we have implemented a variety of steps to remediate these weaknesses, we cannot assure you that we will be able to fully remediate them, which could impair our ability to accurately and timely meet our public company reporting requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other than in connection with the implementation of the remedial measures described above, there have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter to which this Report relates that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART II&#x2014;O</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">THER INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. Le</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">gal Proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, in the ordinary course of business, we may be involved in various claims, lawsuits and other proceedings. As of the date of filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item1a"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1A</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Risk Factors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RISK FACTORS</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following information sets forth risk factors that could cause our actual results to differ materially from those contained in forward-looking statements we have made in this Quarterly Report on Form 10-Q and those we may make from time to time. You should carefully consider the risks described below, in addition to the other information contained in this Quarterly Report on Form 10-Q and our other public filings. Our business, financial condition or results of operations could be harmed by any of these risks. The risks and uncertainties described below are not the only ones we face. Additional risks not presently known to us or other factors not perceived by us to present significant risks to our business at this time also may impair our business operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risk Factor Summary</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to numerous risks and uncertainties, including those risks discussed in further detail below.  These risks include, among others, the following:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred significant losses since our inception, anticipate that we will incur substantial losses for the foreseeable future, and may never achieve or maintain profitability. As of September 30, 2021, we had an accumulated deficit of $65.1 million.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will need additional funding to conduct our future clinical trials and to complete development and commercialization of our product candidates. If we are unable to raise capital when needed, we would be forced to delay, reduce or eliminate our clinical development programs or commercialization efforts.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never generated any revenue from product sales, and we may never generate revenue or be profitable.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business substantially depends upon the successful development, regulatory approval and commercialization of ETX-810 and ETX-155.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical development involves a lengthy, complex and expensive process, with an uncertain outcome. The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and the results of our clinical trials may not satisfy the requirements of the FDA or comparable foreign regulatory authorities.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never commercialized a product candidate and we may lack the necessary expertise, personnel and resources to successfully commercialize any of our products that receive regulatory approval on our own or together with collaborators.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face significant competition from other pharmaceutical and biotechnology companies and other research organizations and our operating results will suffer if we fail to compete effectively.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Public health crises such as pandemics or similar outbreaks could materially and adversely affect our preclinical and clinical trials, business, financial condition and results of operations.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely, and expect to continue to rely, on third parties to conduct, supervise and monitor our preclinical studies and clinical trials, and those third parties may not perform satisfactorily, including by failing to meet deadlines for the completion of such trials or failing to comply with regulatory requirements.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely, and expect to continue to rely, on third parties to manufacture our clinical and ultimately commercial product supply. Those third parties may not perform satisfactorily, including by failing to meet product specifications, required demand or cost-efficient scale levels.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to obtain, maintain and protect sufficient patent and other intellectual property rights for our product candidates and technology, or if the scope of patent and other intellectual property rights obtained is not sufficiently broad, we may not be able to compete effectively in our market.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have identified material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify additional material weaknesses in the future or otherwise fail to maintain effective internal control over financial reporting, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Financial Position and Need for Additional Capital</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have incurred significant losses since our inception, anticipate that we will incur substantial losses for the foreseeable future and may never achieve or maintain profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage biotechnology company with a limited operating history. For the last several years, we have focused our efforts primarily on developing our product candidates, including our two lead clinical-stage candidates, ETX-810 and ETX-155, with the goal of a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">chieving regulatory approval and commercialization. Since inception, we have incurred significant operating losses. Our net losses were $20.7 million, $5.8 million and $36.9 million for the year ended December 31, 2020 and the nine months ended September 30, 2020 and September 30, 2021, respectively. As of September 30, 2021, we had an accumulated deficit of $65.1 million.</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> To date, we have not received regulatory approvals for any of our product candidates or generated any revenue from the sale of products, and we do not expect to generate any revenue in the foreseeable future. We expect to continue to incur substantial expenses and operating losses over the next several years as we continue to develop our current and future product candidates. In addition, we expect to incur significant sales, marketing and manufacturing expenses related to the commercialization of our current and future product candidates, if they are approved by the U.S. Food and Drug Administration (FDA). As a result, we expect to continue to incur significant losses for the foreseeable future. We anticipate that our expenses will increase substantially as we:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to develop and conduct clinical trials, including for ETX-810 and ETX-155 for our initial and any potential additional indications;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate and continue research and development, including preclinical, clinical and discovery efforts for any future product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek regulatory approvals for ETX-810 and ETX-155, or any other product candidates that successfully complete clinical development;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add operational, financial and management information systems and personnel, including personnel to support our product candidate development and help us comply with our obligations as a public company;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire and retain additional personnel, such as clinical, manufacturing, quality control, scientific, commercial and administrative personnel;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand and protect our intellectual property portfolio;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish sales, marketing, distribution, manufacturing, supply chain and other commercial infrastructure in the future to commercialize various products for which we may obtain regulatory approval;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add equipment and physical infrastructure to support our research and development and growing staff;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license other product candidates and technologies; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">incur increased costs as a result of operating as a public company.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will need additional funding to conduct our future clinical trials and to complete development and commercialization of our product candidates. If we are unable to raise capital when needed, we would be forced to delay, reduce or eliminate our product development programs or commercialization efforts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We had cash, cash equivalents, and marketable securities of $20.5 million and $169.6 million at December 31, 2020 and September 30, 2021, respectively. Our independent registered public accounting firm included an explanatory paragraph in its report on our financial statements as of, and for the year ended, December 31, 2020, describing the existence of substantial doubt about our ability to continue as a going concern at May 12, 2021, the date of their report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based upon our current operating plan and assumptions, we believe that our existing cash, cash equivalents and marketable securities will be sufficient to fund our operations through late 2023. However, we will need additional capital to complete the clinical development of our product candidates and to commercialize any approved products. Our estimates of the sufficiency of our cash, cash equivalents and marketable securities are based on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we expect. Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Conducting clinical trials, pursuing regulatory approvals, establishing outsourced manufacturing relationships and successfully manufacturing and commercializing our product candidates is, and will be, very time-consuming, expensive and an uncertain process that takes years to complete. Our future need for additional funding depends on many factors, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope, progress, results and costs of researching and developing ETX-810 and ETX-155 for our initial and potential additional indications, as well as our preclinical product candidates and other future product candidates we may develop;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and uncertainty of, and the costs involved in, obtaining marketing approvals for ETX-810 and ETX-155 for our initial and potential additional indications and our preclinical product candidates and other future product candidates we may develop and pursue;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of future product candidates that we may pursue and their development requirements;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of jurisdictions in which we plan to seek regulatory approvals;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">if approved, the costs of commercialization activities for ETX-810 and ETX-155 for any approved indications or any other product candidate that receives regulatory approval to the extent such costs are not the responsibility of any future collaborators, including the costs and timing of establishing product sales, marketing, distribution and manufacturing capabilities;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subject to receipt of regulatory approval, revenue, if any, received from commercial sales of ETX-810 and ETX-155 for any approved indications or any other product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we in-license or acquire rights to other products, product candidates or technologies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our headcount growth and associated costs as we expand our research and development, establish or increase our office space and establish a commercial infrastructure;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights, including enforcing and defending intellectual property related claims;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any product liability lawsuits related to our products;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ongoing costs of operating as a public company; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of the COVID-19 pandemic, which may exacerbate the magnitude of the factors discussed above.</span></div></div>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot be certain that additional funding will be available on acceptable terms, or at all. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions resulting from the ongoing COVID-19 pandemic and any disruptions to, or volatility in, the credit and financial markets in the United States and worldwide that arise from the pandemic. We have no committed source of additional capital and if we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our product candidates or other research and development initiatives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are in the early stages of clinical drug development and have a very limited operating history and no products approved for commercial sale, which may make it difficult to evaluate our current business and predict our future success and viability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage, U.S.-headquartered biotechnology company with a very limited operating history and with international operations in the United Kingdom. We commenced operations in 2018, have no products approved for commercial sale and have not generated any revenue from product sales. Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We are conducting multiple Phase 2a clinical trials for our ETX-810 clinical program and plan to initiate Phase 2a and other clinical trials for our ETX-155 clinical program, and have not initiated clinical trials for any of our other current research programs. To date, we have not initiated or completed a pivotal clinical trial, obtained marketing approval for any product candidates, manufactured a commercial scale product or arranged for a third party to do so on our behalf, or conducted sales and marketing activities necessary for successful product commercialization. Our short operating history as a company makes any assessment of our future success and viability subject to significant uncertainty. We will encounter risks and difficulties frequently experienced by early-stage biotechnology companies in rapidly evolving fields, and we have not yet demonstrated an ability to successfully overcome such risks and difficulties. If we do not address these risks and difficulties successfully, our business may be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have never generated any revenue from product sales and we may never generate revenue or be profitable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have no products approved for commercial sale. To obtain revenues from the sales of our product candidates that are significant or large enough to achieve profitability, we must succeed, either alone or with third parties, in developing, obtaining regulatory approval for, manufacturing and marketing therapies with significant commercial success. Our ability to generate revenue and achieve profitability depends on many factors, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">successfully completing preclinical and clinical development of our product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">identifying, assessing and/or developing new product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing a sustainable and scalable manufacturing process for our product candidates, as well as establishing and maintaining commercially viable supply relationships with third parties that can provide adequate products and services to support clinical activities and commercial demand for our product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining regulatory approvals and marketing authorizations for product candidates for which we successfully complete clinical development;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">launching and successfully commercializing product candidates for which we obtain regulatory and marketing approval, either by establishing a sales, marketing and distribution infrastructure or collaborating with a partner;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negotiating and maintaining an adequate price for our product candidates, both in the United States and in foreign countries where our products are commercialized;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">satisfying any post-marketing requirements and obtaining reimbursement for its products from private insurance or government payors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining market acceptance of our product candidates as viable treatment options;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">building out new facilities or expanding existing facilities to support our ongoing development activity;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">addressing any competing technological and market developments;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintaining, protecting, expanding and enforcing our portfolio of intellectual property rights, including patents, trade secrets and know-how; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">attracting, hiring and retaining qualified personnel.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the numerous risks and uncertainties associated with drug development, we are unable to predict the timing or amount of our expenses, or when we will be able to generate any meaningful revenue or achieve or maintain profitability, if ever. In addition, our expenses could increase beyond our current expectations if we are required by the FDA, or foreign regulatory agencies, to perform studies or clinical trials in addition to those that we currently anticipate, or if there are any delays in any of our or our future collaborators&#x2019; clinical trials or the development of any of our product candidates. Even if one or more of our product candidates is approved for commercial sale, absent our entering into a collaboration or partnership agreement, we anticipate incurring significant costs associated with commercializing any approved product candidate and ongoing compliance efforts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Business and the Development of our Product Candidates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business substantially depends upon the successful development of ETX-810 and ETX-155. If we are unable to obtain regulatory approval for, and successfully commercialize, ETX-810 or ETX-155, our business will be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently have no products approved for sale and are investing the majority of our efforts and financial resources in the development of our lead product candidates, ETX-810 for the treatment of diabetic peripheral neuropathic pain and pain associated with lumbosacral radiculopathy, and ETX-155 for the treatment of major depressive disorder, perimenopausal depression and epilepsy. Successful continued development and potential regulatory approval of ETX-810 or ETX-155 for our initial and potential additional indications is critical to the future success of our business. We will need to raise sufficient funds for, and successfully enroll and complete, our clinical development programs of ETX-810 and ETX-155.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before we can generate any revenue from sales of ETX-810, ETX-155 or any of our other programs, we must undergo additional preclinical and clinical development, regulatory review and approval in one or more jurisdictions. In addition, if one or more of our product candidates are approved, we must ensure access to sufficient commercial manufacturing capacity and conduct significant marketing efforts in connection with any commercial launch. These efforts will require substantial investment, and we may not have the financial resources to continue development of our product candidates or commercialization of any products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may experience setbacks that could delay or prevent regulatory approval of our product candidates or our ability to commercialize any products, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negative or inconclusive results from our preclinical studies or clinical trials or the clinical trials of others for product candidates similar to ours, leading to a decision or requirement to conduct additional preclinical testing or clinical trials or abandon a program;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product-related side effects experienced by subjects in our clinical trials or by individuals using drugs or therapeutics similar to our product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in submitting investigational new drug applications (INDs) in the United States or comparable foreign applications or delays or failure in obtaining the necessary approvals from regulators or institutional review boards to commence a clinical trial, or a suspension or termination of a clinical trial once commenced;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">if the FDA or comparable foreign authorities do not accept the earlier preclinical and clinical trial work, then we may need to conduct additional preclinical studies or clinical trials beyond that which we currently have planned and significant preclinical study or clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our drug candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our drug candidates and may harm our business;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">conditions imposed by the FDA or comparable foreign authorities regarding the scope or design of our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in contracting with clinical sites or enrolling subjects in clinical trials, including due to the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays or interruptions in the supply of materials necessary for the conduct of our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulators or institutional review boards (IRBs) or ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or other comparable regulatory authorities may disagree with our clinical trial design, including with respect to dosing levels administered in our planned clinical trials, which may delay or prevent us from initiating our clinical trials with our originally intended trial design;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching, or failure to reach, agreement on acceptable terms with prospective trial sites and prospective contract research organizations (CROs) which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of subjects required for clinical trials of any product candidates may be larger than we anticipate or subjects may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our third-party contractors for preclinical studies or clinical trials may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, or may deviate from the clinical trial protocol or take actions that could cause clinical sites or clinical investigators to drop out of the trial, which may require that we add new clinical trial sites or investigators;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">due to the impact of the COVID-19 pandemic or other events beyond our control, we may experience some delays and interruptions to our preclinical studies and clinical trials, we may experience delays or interruptions to our manufacturing supply chain, or we could suffer delays in reaching, or we may fail to reach, agreement on acceptable terms with third-party service providers on whom we rely;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">greater than anticipated clinical trial costs, including as a result of delays or interruptions that could increase the overall costs to finish our clinical trials as our fixed costs are not substantially reduced during delays;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may elect to, or regulators, IRBs, Data Safety Monitoring Boards (DSMBs), or ethics committees may require that we or our investigators, suspend or terminate clinical research or trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not have the financial resources available to begin and complete the planned trials, or the cost of clinical trials of any product candidates may be greater than we anticipate;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate to initiate or complete a given clinical trial;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or other comparable foreign regulatory authorities may require us to submit additional data such as long-term toxicology studies, or impose other requirements before permitting us to initiate a clinical trial, including because the FDA has not reviewed our preclinical or clinical data, to date, having been developed outside the United States;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to compete with other therapies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">poor efficacy of our product candidates during clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unfavorable FDA or other regulatory agency inspection and review of clinical trial sites or manufacturing facilities;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unfavorable product labeling associated with any product approvals and any requirements for a Risk Evaluation and Mitigation Strategy (REMS) that may be required by the FDA or comparable requirements in other jurisdictions to ensure the benefits of an individual product outweigh its risks;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unfavorable acceptance of our clinical trial data by the patient or medical communities or third-party payors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet their contractual obligations in a timely manner, or at all;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays related to the impact or the spread of COVID-19 or other pandemics, including the impact of COVID-19 on the FDA&#x2019;s, or similar foreign regulatory agency&#x2019;s, ability to continue its normal operations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional regulatory oversight around clinical testing generally or with respect to our technology in particular; or</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">varying interpretations of data by the FDA and similar foreign regulatory agencies.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and our manufacturing, marketing, distribution and sales efforts or that of any future collaborator.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, of the large number of drugs in development in the biotechnology industry, only a small percentage result in the submission of a marketing application, such as a new drug application (NDA) to the FDA, and even fewer are approved for commercialization. Furthermore, even if we do receive regulatory approval for ETX-810, ETX-155 or any other potential product candidate we may develop for any indication, any such approval may be subject to limitations on the indications or uses or patient populations for which we may market the product. Accordingly, even if we are able to obtain the requisite financing to continue to fund our development programs, we cannot assure that we will successfully develop or commercialize ETX-810, ETX-155 or any other potential product candidate we may develop for any indication. If we or any of our future collaborators are unable to develop, or obtain regulatory approval for, or, if approved, successfully commercialize ETX-810 or ETX-155 for our initial or potential additional indications, or any other potential product candidate we may develop, we may not be able to generate sufficient revenue to continue our business. In addition, our failure to demonstrate positive results in our clinical trials in any indication for which we are developing ETX-810 and ETX-155 could adversely affect our development efforts for ETX-810 and ETX-155 in other indications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preclinical and clinical development involves a lengthy, complex and expensive process with an uncertain outcome. The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and the results of our clinical trials may not satisfy the requirements of the FDA or comparable foreign regulatory authorities.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To obtain the requisite regulatory approvals to commercialize any product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our product candidates are safe and effective in humans to the satisfaction of FDA. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. In particular, in the United States, the general approach for FDA approval of a new drug is dispositive data from two well-controlled, Phase 3 clinical trials of the relevant drug in the relevant patient population. Phase 3 clinical trials typically involve hundreds to thousands of patients, have significant costs and take years to complete. A product candidate can fail at any stage of testing, even after observing promising signs of activity in earlier preclinical studies or clinical trials. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. For example, preclinical models evaluating product candidates for pain are notoriously unreliable and, as such, the therapies face substantial translational risk. In addition, initial success in clinical trials may not be indicative of results obtained when such trials are completed. There is typically an extremely high rate of attrition from the failure of product candidates proceeding through clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biotechnology industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or emergence of unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that commence clinical trials are never approved and there can be no assurance that any of our future clinical trials will ultimately be successful or support further clinical development of ETX-810, ETX-155 or any of our other product candidates. The commencement and rate of completion of preclinical studies and clinical trials may be delayed by many factors, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to generate sufficient preclinical or other in vivo or in vitro data to support the initiation of clinical studies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">preclinical studies or clinical trials may show the product candidates to be less effective than expected (</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">e.g.</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, a clinical trial could fail to meet its primary endpoint(s)) or to have unacceptable side effects or toxicities;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to establish clinical endpoints that applicable regulatory authorities would consider clinically meaningful;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching agreement on acceptable terms with prospective CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in identifying, recruiting and training suitable clinical investigators;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">differences in trial design between early-stage clinical trials and later-stage clinical trials make it difficult to extrapolate the results of earlier clinical trials to later clinical trials (</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">e.g.</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, we are basing our therapeutic hypothesis for ETX-810 on studies conducted in the academic setting and the results from the academic studies may not be replicated in a clinical setting);</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in recruiting suitable patients to participate in our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in manufacturing, testing, releasing, validating or importing/exporting sufficient stable quantities of our product candidates for use in clinical trials or the inability to do any of the foregoing;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">insufficient or inadequate supply or quality of product candidates or other materials necessary for use in clinical trials, or delays in sufficiently developing, characterizing or controlling a manufacturing process suitable for clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">imposition of a temporary or permanent clinical hold by regulatory authorities;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developments on trials conducted by competitors for related technology that raises FDA or foreign regulatory authority concerns about risk to patients of the technology broadly, or if the FDA or a foreign regulatory authority finds that the investigational protocol or plan is clearly deficient to meet its stated objectives;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in recruiting, screening and enrolling patients and delays caused by patients withdrawing from clinical trials or failing to return for post-treatment follow-up;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulty collaborating with patient groups and investigators;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure by our CROs, other third parties or us to adhere to clinical trial protocols;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to perform in accordance with the FDA&#x2019;s or any other regulatory authority&#x2019;s good clinical practice requirements (GCPs) or applicable regulatory guidelines in other countries;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occurrence of adverse events associated with the product candidate that are viewed to outweigh its potential benefits, or occurrence of adverse events in trial of the same class of agents conducted by other companies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of clinical trials of our product candidates being greater than we anticipate;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinical trials of our product candidates producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development of such product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">transfer of manufacturing processes to larger-scale facilities operated by a third-party contract development and manufacturing organization (CDMO) and delays or failure by our CDMOs or us to make any necessary changes to such manufacturing process; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">third parties being unwilling or unable to satisfy their contractual obligations to us.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, disruptions caused by the COVID-19 pandemic may increase the likelihood that we encounter such difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing preclinical studies and clinical trials. Any inability to successfully initiate or complete preclinical studies or clinical trials could result in additional costs to us or impair our ability to generate revenue from product sales. In addition, if we make manufacturing or formulation changes to our product candidates, we may be required to or we may elect to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which our products have patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may seriously harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, our current and planned clinical trials do or will contain endpoints that require subjective assessments and subject us to a substantial risk of &#x201c;placebo effect&#x201d; which is a well-known risk in clinical trials evaluating therapeutics for pain as well as depression. While a product candidate may show clinical activity or therapeutic benefit, a high placebo effect in a clinical trial will make it difficult to ascertain that benefit or to show statistically significant effect of the product candidate as compared to the control arm and may ultimately cause a clinical trial to fail.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Delays in the completion of any preclinical studies or clinical trials of our product candidates will increase our costs, slow down our product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate product revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. Any delays to our preclinical studies or clinical trials that occur as a result could shorten any period during which we may have the exclusive right to commercialize our product candidates and our competitors may be able to bring products to market before we do, and the commercial viability of our product candidates could be significantly reduced. Any of these occurrences may harm our business, financial condition and prospects significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we seek to conduct clinical trials in foreign countries or pursue marketing approvals in foreign jurisdictions, we must comply with numerous foreign regulatory requirements governing, among other things, the conduct of clinical trials, manufacturing and marketing authorization, pricing and third-party reimbursement. The foreign regulatory approval process varies among countries and jurisdictions and may include all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of local regulations in foreign jurisdictions. Moreover, the time required to obtain approval may differ jurisdiction-to-jurisdiction from that required to obtain FDA approval. Approval by foreign regulatory authorities does not ensure approval by the FDA and, similarly, approval by the FDA does not ensure approval by regulatory authorities outside the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Successful completion of clinical trials is a prerequisite to submitting a marketing application to foreign regulatory authorities or the FDA, for each product candidate and, consequently, the ultimate approval and commercial marketing of any product candidates. We may experience negative or inconclusive results, or regulators may be unwilling to accept preclinical or clinical data obtained in foreign jurisdictions, which may result in our deciding, or our being required by regulators, to conduct additional clinical studies or trials or abandon some or all of our product development programs, which could harm our business.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cross-trial comparisons are not reliable predictors of the relative efficacy of our product candidates against comparators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not conducted head-to-head clinical trials to compare our product candidates with competing products. There are risks associated with comparing the results of our clinical trials with results from other independent studies and trials, as cross-trial comparisons may not be reliable predictors of the relative efficacy or other benefits of our product candidates compared to other product candidates that may be approved or that are in development. Moreover, unless we conduct head-to-head comparative studies, we will not be able to make any claims of superiority even if our products are approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, even though our product candidates are designed to address the same indications as existing therapies, we have not conducted head-to-head clinical trials comparing our product candidates with such existing drugs and therapies. Accordingly, you should consider our prospects in light of the costs, uncertainties, delays and difficulties frequently encountered by clinical and preclinical stage biotechnology companies such as ours.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Public health crises such as pandemics or similar outbreaks could materially and adversely affect our preclinical and clinical trials, business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared COVID-19 a global pandemic and the United States declared a national emergency with respect to COVID-19. In response to the COVID-19 pandemic, &#x201c;shelter in place&#x201d; orders and other public health guidance measures have been implemented across much of the United States and Europe, including in the locations of our offices, clinical trial sites, key vendors and partners. We expect that our clinical development program timelines will be negatively affected by COVID-19, which could materially and adversely affect our business, financial condition and results of operations. Further, due to &#x201c;shelter in place&#x201d; orders and other public health guidance measures, we have implemented a work-from-home policy for all staff members excluding those necessary to maintain minimum basic operations. Our increased reliance on personnel working from home may negatively impact productivity, or disrupt, delay or otherwise adversely impact our business. For example, with our personnel working from home, some of our research activities that require our personnel to be in our laboratories will be delayed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a result of the COVID-19 pandemic, or similar pandemics, and related &#x201c;shelter in place&#x201d; orders and other public health guidance measures, we have and may in the future experience disruptions that could materially and adversely impact our clinical trials, business, financial condition and results of operations. Potential disruptions include but are not limited to:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays or difficulties in enrolling patients in our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays or difficulties in initiating or expanding clinical trials, including delays or difficulties with clinical site initiation and recruiting clinical site investigators and clinical site staff;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">increased rates of patients withdrawing from our clinical trials following enrollment as a result of contracting COVID-19or other health conditions or being forced to quarantine;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption of key clinical trial activities, such as clinical trial site data monitoring and efficacy, safety and translational data collection, processing and analyses, due to limitations on travel imposed or recommended by federal, state or local governments, employers and others or interruption of clinical trial subject visits, which may impact the collection and integrity of subject data and clinical study endpoints;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays or disruptions in preclinical experiments and IND-enabling studies due to restrictions of on-site staff and unforeseen circumstances at CROs and vendors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption or delays in the operations of the FDA and comparable foreign regulatory agencies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in receiving approval from local regulatory authorities to initiate our planned clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limitations on employee or other resources that would otherwise be focused on the conduct of our clinical trials and pre-clinical work, including because of sickness of employees or their families, the desire of employees to avoid travel or contact with large groups of people, an increased reliance on working from home, school closures or mass transit disruptions;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in regulations as part of a response to the COVID-19 pandemic which may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or to discontinue the clinical trials altogether;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in necessary interactions with regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government or contractor personnel; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal of the FDA to accept data from clinical trials in affected geographies outside the United States.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These and other factors arising from the COVID-19 global pandemic could worsen in countries that are already afflicted with COVID-19, could continue to spread to additional countries or could return to countries where the pandemic has been partially contained, each of which could further adversely impact our ability to conduct clinical trials and our business generally, and could materially and adversely affect our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be required to develop and implement additional clinical trial policies and procedures designed to help protect subjects from the COVID-19 virus. For example, in March 2020, the FDA issued a guidance, which FDA subsequently revised, on conducting clinical trials during the pandemic, which describes a number of considerations for sponsors of clinical trials impacted by the pandemic.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 global pandemic continues to rapidly evolve. The extent to which the outbreak may affect our clinical trials, business, financial condition and results of operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions and actions to contain the outbreak or treat its impact, such as social distancing and quarantines or lock-downs in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease. Future developments in these and other areas present material uncertainty and risk with respect to our clinical trials, business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The trading prices for shares of other biopharmaceutical companies have been highly volatile as a result of the COVID-19 pandemic and, going forward, the trading prices for shares of our common stock could also experience high volatility. As a result, we may face difficulties raising capital through sales of our common stock or such sales may be on unfavorable terms. In addition, a recession, depression or other sustained adverse market event resulting from the spread of the COVID-19 could materially and adversely affect our business and the value of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ultimate impact of the COVID-19 pandemic on our business operations is highly uncertain and subject to change and will depend on future developments, which cannot be accurately predicted, including the duration of the pandemic, the ultimate geographic spread of the disease, additional or modified government actions, new information that will emerge concerning the severity and impact of COVID-19 and the actions taken to contain COVID-19 or address its impact in the short and long term, among others. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or the global economy. We will continue to monitor the situation closely.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our business could be materially adversely affected by other business disruptions to us or our third-party providers that could materially adversely affect our potential future revenue and financial condition and increase our costs and expenses. Our operations, and those of our CROs, CDMOs and other contractors, consultants and third parties could be subject to other global pandemics, earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured. The occurrence of any of these business disruptions could materially adversely affect our operations and financial condition and increase our costs and expenses. We rely on third-party manufacturers to produce and process our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster or other business interruption.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Disruptions at the FDA, the U.S. Securities and Exchange Commission (SEC) and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, in recent years, including in 2018 and 2019, the U.S. government shut down several times and certain regulatory agencies, such as the FDA and the SEC, and had to furlough critical employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Separately, in response to the COVID-19 pandemic, in March 2020 the FDA announced its intention to postpone most inspections of foreign and domestic manufacturing facilities. In July 2020, the FDA resumed certain on-site inspections subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission-critical inspections to resumption of all regulatory activities. Additionally, in April 2021, the FDA issued a guidance document describing its plans to conduct voluntary remote interactive evaluations of certain drug manufacturing facilities and clinical research sites. Remote interactive evaluations may be requested in situations where an in-person inspection would not be prioritized, deemed mission-critical, or where direct inspection is otherwise limited by travel restrictions, but where the FDA determines that remote evaluation would still be appropriate. Regulatory authorities outside the United States have adopted similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval, limit their commercial potential or result in significant negative consequences following regulatory approval, if obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Undesirable side effects caused by ETX-810, ETX-155 or any other current or future product candidate could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable foreign regulatory authorities. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. In addition, many compounds that have initially showed promise in clinical or earlier stage testing are later found to cause undesirable or unexpected side effects that prevented further development of the compound. For example, our lead preclinical program is a Kv7.2/3 potassium channel opener. This mechanism has been validated through regulatory approvals of multiple first generation Kv7.2/3 openers for the treatment of epilepsy and pain. These molecules showed efficacy but subsequently had to be withdrawn from the market due to significant safety issues. There is no assurance that, if we are able to move our preclinical program forward, we will be able to avoid similar safety problems. Additionally, the composition of our product candidates or learnings in preclinical studies or clinical trials may result in contraindications for any product candidates for which we may obtain regulatory approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If unacceptable side effects arise in the development of our product candidates, we may have difficulty recruiting patients to the clinical trials, patients may drop out of our trials, or we may be required to abandon the trials or our development efforts of that product candidate altogether. We, the FDA, other comparable regulatory authorities or IRBs, DSMBs or independent ethics committees at the institutions in which our trials are conducted could suspend or terminate our trials for various reasons, including a belief that subjects in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential therapeutics developed in the biotechnology industry that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product candidate from obtaining or maintaining marketing approval, undesirable side effects may inhibit market acceptance due to its tolerability versus other therapies. Any of these developments could materially adversely affect our business, financial condition and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Treatment-emergent side effects that are deemed to be drug-related could also result in potential product liability claims. Undesirable side effects in one of our clinical trials (or in a clinical trial of a competitor with a similar mechanism of action) for our product candidates in one indication could adversely affect enrollment in clinical trials, regulatory approval and commercialization of our product candidates in other indications. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. Any of these occurrences may harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, clinical trials of our product candidates are conducted in carefully defined sets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials, or those of any future collaborator, may indicate an apparent positive effect of a product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects. Clinical trials by their nature utilize a sample of the potential patient population. With a limited number of patients, rare and severe side effects of our product candidates may only be uncovered with a significantly larger number of patients exposed to the product candidate. If our product candidates receive marketing approval and we or others identify undesirable side effects caused by such product candidates (or any other similar products) after such approval, a number of potentially significant negative consequences could result, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may withdraw or limit their approval of such product candidates, or seek an injunction against its manufacture or distribution;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may require the addition of labeling statements, &#x201c;boxed&#x201d; warnings, or issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to change the way such product candidates are distributed or administered, or change the labeling of the product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA may require a REMS plan to mitigate risks, which could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools, and regulatory authorities in other jurisdictions may require comparable risk mitigation plans;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be subject to regulatory investigations and government enforcement actions;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or a comparable foreign regulatory authority may require us to conduct additional clinical trials or costly post-marketing testing and surveillance to monitor the safety and efficacy of the product;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we could be sued and held liable for injury caused to individuals exposed to or taking our product candidates; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our reputation may suffer.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product candidates and could substantially increase the costs of commercializing our product candidates, if approved, and significantly impact our ability to successfully commercialize our product candidates and generate revenues.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we encounter difficulties enrolling and/or retaining patients in our future clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be able to initiate or continue our planned clinical trials on a timely basis or at all for our product candidates if we are unable to recruit and enroll a sufficient number of eligible patients to participate in these trials through completion of such trials as required by the FDA or other comparable foreign regulatory authorities. Patient enrollment is a significant factor in the timing of clinical trials. Our ability to enroll eligible patients may be limited or may result in slower enrollment than we anticipate. There may be limited patient pools from which to draw for clinical studies. The eligibility criteria of our clinical studies will further limit the pool of available study participants as we will require that patients have specific characteristics that we can measure or to assure their disease is either severe enough or not too advanced to include them in a study. Patient enrollment for our current or any future clinical trials may be affected by other factors, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patient eligibility criteria defined in the protocol;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size of the patient population required for analysis of the trial&#x2019;s primary endpoints;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the proximity of patients to trial sites;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the design of the trial;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the availability and efficacy of approved drugs for the disease under investigation;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">perceived risks and benefits of the product candidate under study;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">competing clinical trials and clinicians&#x2019; and patients&#x2019; perceptions as to the potential advantages and risks of the product candidate being studied in relation to other available therapies, including any new drugs that may be approved for the indications that we are investigating;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinicians&#x2019; willingness to screen their patients for biomarkers to indicate which patients may be eligible for enrollment in our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in or temporary suspension of the enrollment of patients in our planned clinical trials due to the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impacts of the COVID-19 pandemic on clinical trial sites, personnel and patient travel;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain and maintain patient consents;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">patient referral practices of physicians;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability to monitor patients adequately during and after treatment;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">proximity and availability of clinical trial sites for prospective patients; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the risk that patients enrolled in clinical trials will drop out of the trials before completion, including as a result of contracting COVID-19 or other health conditions or being forced to quarantine.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our clinical trials may compete with other clinical trials for product candidates that are in the same therapeutic areas as our product candidates, and this competition would reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials in such clinical trial site.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or might require us to abandon one or more clinical trials altogether. Delays in patient enrollment may result in increased costs, affect the timing or outcome of the planned clinical trials, product candidate development and approval process and jeopardize our ability to seek and obtain the regulatory approval required to commence product sales and generate revenue, which could prevent completion of these trials, adversely affect our ability to advance the development of our product candidates, cause the value of our company to decline and limit our ability to obtain additional financing if needed. Furthermore, even if we are able to enroll a sufficient number of patients for our clinical trials, we may have difficulty maintaining participation in our clinical trials through the treatment and any follow-up periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also required to register certain clinical trials and post the results of completed clinical trials on a government-sponsored database, such as www.ClinicalTrials.gov in the United States, within certain time frames. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available, and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may publicly disclose preliminary or topline data from our preclinical studies and clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline and preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the topline or preliminary data we previously published. As a result, topline and preliminary data should be viewed with caution until the final data are available.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may also disclose interim data from our preclinical studies and clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments for their disease. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure. If the interim, topline or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Due to the significant resources required for the development of our pipeline, and depending on our ability to access capital, we must prioritize development of certain product candidates. Moreover, we may fail to expend our limited resources on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently have two lead clinical-stage candidates, ETX-810 and ETX-155. We seek to maintain a process of prioritization and resource allocation to maintain an optimal balance between aggressively advancing product candidates and ensuring replenishment of our portfolio.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Due to the significant resources required for the development of our product candidates, we must focus on specific diseases and disease pathways and decide which product candidates to pursue and advance and the amount of resources to allocate to each. Our decisions concerning the allocation of research, development, collaboration, management, and financial resources toward particular product candidates or therapeutic areas may not lead to the development of any viable commercial product and may divert resources away from better opportunities. If we make incorrect determinations regarding the viability or market potential of any of our product candidates or misread trends in the biotechnology industry, in particular for disorders of the peripheral and central nervous systems, our business may be harmed. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing, or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be successful in our efforts to continue to create a pipeline of product candidates or to develop commercially successful products. If we fail to successfully identify and develop additional product candidates, our commercial opportunity may be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">One of our strategies is to identify and pursue clinical development of additional product candidates. We currently have novel preclinical candidates in the research, discovery, screening and preclinical stages of development, with two programs currently in advanced discovery stage. Identifying, developing, obtaining regulatory approval and commercializing additional product candidates for the treatment of disorders of the peripheral and central nervous systems will require substantial additional funding and is prone to the risks of failure inherent in drug development. We cannot provide you any assurance that we will be able to successfully identify or acquire additional product candidates, advance any of these additional product candidates through the development process, successfully commercialize any such additional product candidates, if approved, or assemble sufficient resources to identify, acquire, develop or, if approved, commercialize additional product candidates. If we are unable to successfully identify, acquire, develop and commercialize additional product candidates, our commercial opportunity may be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">One of the core elements of our strategy is to develop our existing products in multiple indications, also referred to as label expansion. Even if we are successful in developing a product in one indication this does not guarantee that it will be successful in other indications or that we will be able to obtain approval in other patient populations or diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Label expansion is one of the core elements of our strategy. If our current and planned trials are successful, we intend to evaluate additional potential indications for both ETX-810 and ETX-155. For ETX-810, we will explore additional pain indications, which could enable a broad label in peripheral neuropathic pain and chronic pain. For ETX-155, we intend to explore a wide-range of compelling opportunities in both psychiatry and neurology, including potentially generalized anxiety disorder, and bipolar disorder. Even if we are successful in developing a product in one indication does not guarantee that it will be successful in other indications or that we will be able to obtain approval in other patient populations or diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We could be subject to product liability lawsuits based on the use of our product candidates in clinical testing or, if obtained, following our products&#x2019; marketing approval and commercialization. Product liability lawsuits brought against us or any of our future collaborators could divert our resources and attention, require us to cease clinical testing, cause us to incur substantial liabilities or limit commercialization of our product candidates.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of biotechnology products. Currently, we have no products that have been approved for commercial sale; however, the use of our product candidates by us and any collaborators in clinical trials may expose us to liability claims. We will face an even greater risk if product candidates are approved by regulatory authorities and introduced commercially. Product liability claims may be brought against us or our partners if any product candidate we develop allegedly causes injury or is found to be otherwise unsuitable for human use during product testing, manufacturing, marketing or sale. Any such product liability claim may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability and a breach of warranties. Claims could also be asserted under state consumer protection acts. Such claims could be made by participants enrolled in our clinical trials, patients, health care providers, biotechnology companies, our collaborators or others using, administering or selling any of our future approved products. If we cannot successfully defend ourselves against any such claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. Even successful defense would require significant financial and management resources.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Regardless of the merits or eventual outcome, product liability claims may result in:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">decreased demand for any of our future approved products;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injury to our reputation;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withdrawal of clinical trial participants;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">termination of clinical trial sites or entire trial programs;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant litigation costs;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">substantial monetary awards to, or costly settlements with, patients or other claimants;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product recalls or a change in the indications for which any approved drug products may be used;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss of revenue;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">diversion of management and scientific resources from our business operations; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability to commercialize our product candidates.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although the clinical trial process is designed to identify and assess potential side effects, clinical development does not always fully characterize the safety and efficacy profile of a new medicine, and it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If our product candidates were to cause adverse side effects during clinical trials or after approval, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates. If any of our product candidates are approved for commercial sale, we will be highly dependent upon consumer perceptions of us and the safety and quality of our products. We could be adversely affected if we are subject to negative publicity associated with illness or other adverse effects resulting from physicians&#x2019; or patients&#x2019; use or misuse of our products or any similar products distributed by other companies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we maintain product liability insurance coverage including clinical trial liability, this insurance may not fully cover potential liabilities that we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial. We will need to increase our insurance coverage if we commercialize any product that receives regulatory approval. In addition, insurance coverage is becoming increasingly expensive. If we are unable to maintain sufficient insurance coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit the development and commercial production and sale of our product candidates, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Legal and Regulatory Compliance</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval and commercialize our product candidates and may affect the prices we may charge for such product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The United States and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product for which we obtain marketing approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the Affordable Care Act (ACA), was enacted, which includes measures that have significantly changed the way health care is financed by both governmental and private insurers. There have been executive, judicial and congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#x2019;s decision, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace, which began on February 15, 2021 and remained open through August 15, 2021. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how the Supreme Court ruling, other such litigation, and the healthcare reform measures of the Biden administration will impact the ACA. We continue to evaluate the effect that the ACA and its possible repeal and replacement has on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. For example, in August 2011, the Budget Control Act of 2011 was signed into law, which, among other things, included aggregate reductions to Medicare payments to providers of, on average, 2% per fiscal year through 2030 with the exception of a temporary suspension from May 1, 2020 through December 31, 2021 due to the COVID-19 pandemic, unless Congress takes additional action. Recently, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. presidential executive orders, congressional inquiries and legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for drugs. At the federal level, the Biden administration used several means to propose or implement drug pricing reform, including through executive orders and policy initiatives. For example, in July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, U.S. Department of Health and Human Services (HHS) released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue to advance these principles. In addition, Congress is considering drug pricing as part of the budget reconciliation process. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control costs for pharmaceutical and biological products. It is also possible that additional governmental action will be taken in response to the COVID-19 pandemic.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that the healthcare reform measures that have been adopted and may be adopted in the future may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business operations and current and future relationships with investigators, health care professionals, consultants, third-party payors and customers will be subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws and other healthcare laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Healthcare providers and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Although we do not currently have any products on the market, our operations may be, directly or indirectly through our prescribers, customers and third-party payors, subject to various U.S. federal and state healthcare laws and regulations. These laws may impact, among other things, our current business operations, including our clinical research activities and proposed sales, marketing and education programs and constrain the business of financial arrangements and relationships with healthcare providers and other parties through which we may market, sell and distribute our products for which we obtain marketing approval. In addition, we may be subject to additional healthcare, statutory and regulatory requirements and enforcement by foreign regulatory authorities in jurisdictions in which we conduct our business. The laws that may affect our ability to operate include:</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal Anti-Kickback Statute, which makes it illegal for any person or entity, including a prescription drug manufacturer (or a party acting on its behalf), to knowingly and willfully solicit, receive, offer or pay any remuneration (including any kickback, bribe, or rebate), directly or indirectly,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual, or the purchase, lease, order, arrangement, or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal civil and criminal false claims laws, including the False Claims Act (FCA), which can be enforced through &#x201c;qui tam&#x201d; or &#x201c;whistleblower&#x201d; actions, and civil monetary penalty law, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid, or other federal health care programs that are false, fictitious or fraudulent; knowingly making, using, or causing to be made or used, a false record or statement material to a false, fictitious or fraudulent claim or an obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing or concealing such an obligation to pay money to the federal government. In addition, a claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim under the FCA;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which created additional federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false, fictitious or fraudulent statement or representation, or making or using any false writing or document knowing the same to contain any materially false fictitious or fraudulent statement or entry in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating HIPAA fraud provisions without actual knowledge of the statute or specific intent to violate it;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal Physician Payments Sunshine Act and its implementing regulations, which require certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program to report annually to the Centers for Medicare and Medicaid Services (CMS) an agency within the HHS under the Open Payments Program, information related to direct or indirect payments and other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by the physicians and their immediate family members. Effective January 1, 2022, these reporting obligations will extend to include payments and other transfers of value made during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists and certified nurse midwives;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. federal and state consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">analogous U.S. state laws and regulations, including state anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and other relevant compliance guidance promulgated by the federal government that otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; and state and local laws requiring the registration of pharmaceutical sales representatives; and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">          </span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">European and other foreign law equivalents of each of the laws, including reporting requirements detailing interactions with and payments to healthcare providers.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government funded healthcare programs, such as Medicare and Medicaid, or similar programs in other countries or jurisdictions, disgorgement, imprisonment, contractual damages, reputational harm, diminished profits, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the delay, reduction, termination or restructuring of our operations. Further, defending against any such actions can be costly and time-consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business is found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment. If any of the above occur, it could adversely affect our ability to operate our business and our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Actual or perceived failure to comply with current or future federal, state and foreign laws and regulations and industry standards relating to privacy and data protection laws could lead to government enforcement actions (which could include civil or criminal penalties), private litigation, and/or adverse publicity and could negatively affect our operating results and business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and our third-party providers may be subject to federal, state and foreign data privacy and security laws and regulations. In the United States, numerous federal and state laws and regulations, including federal health information privacy laws, data breach notification laws, health information privacy laws, including HIPAA (as amended by the Health Information Technology for Economic and Clinical Health Act of 2009), and federal and state consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our collaborators and third-party providers. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA. Depending on the facts and circumstances, we could be subject to significant civil and criminal penalties if we receive, use or disclose individually identifiable health information in a manner that is not authorized or permitted by HIPAA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In many jurisdictions, enforcement actions and consequences for noncompliance are rising. In the United States, these include enforcement actions in response to rules and regulations promulgated under the authority of federal agencies and state attorneys general and legislatures and consumer protection agencies. In addition, privacy advocates and industry groups have regularly proposed, and may propose in the future, self-regulatory standards that may legally or contractually apply to us. If we fail to follow these security standards, even if no customer information is compromised, we may incur significant fines or experience a significant increase in costs. Many state legislatures have adopted legislation that regulates how businesses operate online, including measures relating to privacy, data security and data breaches. Laws in all 50 states require businesses to provide notice to customers whose personally identifiable information has been disclosed as a result of a data breach. The laws are not consistent, and compliance in the event of a widespread data breach is costly. States are also constantly amending existing laws, requiring attention to frequently changing regulatory requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, California recently enacted the California Consumer Privacy Act (CCPA), which became effective on January 1, 2020. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Additionally, a new privacy law, the California Privacy Rights Act (CPRA) was approved by California voters on November 3, 2020. The CPRA, which will take effect in most material respects on January 1, 2023, modifies the CCPA significantly, including by expanding consumers&#x2019; rights with respect to certain sensitive personal information and creating a new state agency to oversee implementation and enforcement efforts, potentially resulting in further uncertainty and requiring us to incur additional costs and expenses in an effort to comply. At this time, we do not collect personal data on residents of California, but should we begin to do so, the CCPA and CPRA will impose new and burdensome privacy compliance obligations on our business and will raise new risks for potential fines and class actions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign data protection laws, including the EU General Data Protection Regulation (GDPR) may also apply to health-related and other personal data obtained outside of the United States. The GDPR, which came into effect on May 25, 2018, imposes strict requirements for processing the personal data of individuals within the European Economic Area (EEA). Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and for noncompliance of up to the greater of &#x20ac;20 million or 4% of annual global revenue. The regulation imposes numerous requirements regarding the collection, use and disclosure of personal information, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches and taking certain measures when engaging third-party processors Among other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States, and the efficacy and longevity of current transfer mechanisms between the EU and the United States remains uncertain. For example, in 2016, the EU and United States agreed to a transfer framework for data transferred from the EU to the United States, called the Privacy Shield, but the Privacy Shield was invalidated in July 2020 by the Court of Justice of the European Union.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the vote in the United Kingdom in favor of exiting the EU, referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. From January 1, 2021, companies have to comply with the GDPR and also the United Kingdom GDPR (U.K. GDPR), which, together with the amended U.K. Data Protection Act 2018, retains the GDPR in U.K. national law. The U.K. GDPR mirrors the fines under the GDPR, i.e., fines up to the greater of &#x20ac;20 million (&#163;17.5 million) or 4% of global turnover. The relationship between the United Kingdom and the European Union (EU), in relation to certain aspects of data protection law remains unclear, and it is unclear how United Kingdom data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the United Kingdom will be regulated in the long term. These changes will lead to additional costs and increase our overall risk exposure. Currently there is a four to six-month grace period agreed in the EU and United Kingdom Trade and Cooperation Agreement, ending June 30, 2021 at the latest, whilst the parties discuss an adequacy decision. The European Commission published a draft adequacy decision on February 19, 2021. If adopted, the decision will enable data transfers from EU member states to the United Kingdom for a four-year period, subject to subsequent extensions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we work to comply with applicable laws, regulations and standards, our contractual obligations and other legal obligations, these requirements are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Compliance with U.S. and foreign data protection laws and regulations could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure by us or our collaborators and third-party providers to comply with U.S. and foreign data protection laws and regulations could result in government enforcement actions (which could include civil or criminal penalties), private litigation and/or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects about whom we or our potential collaborators obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information. Claims that we have violated individuals&#x2019; privacy rights, failed to comply with data protection laws or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend, could result in adverse publicity and could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Commercialization of our Product Candidates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have never commercialized a product candidate and we may lack the necessary expertise, personnel and resources to successfully commercialize any of our products that receive regulatory approval on our own or together with collaborators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never commercialized a product candidate. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, and undertaking preclinical studies and clinical trials of our product candidates. We currently have no sales force, marketing, manufacturing or distribution capabilities. To achieve commercial success of our product candidates, if any are approved, we will have to develop our own sales, marketing, reimbursement and manufacturing capabilities or outsource these activities to a third party.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Factors that may affect our ability to commercialize our product candidates on our own include recruiting and retaining adequate numbers of effective sales and marketing personnel, persuading adequate numbers of physicians to prescribe our product candidates and other unforeseen costs associated with creating an independent sales and marketing organization. Developing a sales and marketing organization requires significant investment, is time-consuming and could delay the launch of our product candidates. We may not be able to build an effective sales and marketing organization in the United States, the European Union or other key global markets. If we are unable to build our own distribution and marketing capabilities or to find suitable partners for the commercialization of our product candidates, we may have difficulties generating revenue from them.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We face significant competition from other pharmaceutical and biotechnology companies and other research organizations, and our operating results will suffer if we fail to compete effectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The biotechnology industry is characterized by rapid technological advancement, significant competition and an emphasis on intellectual property. We face potential competition from many different sources, including major and specialty pharmaceutical, biopharmaceutical, and biotechnology companies, and public and private research institutions. Any product candidates that we successfully develop and commercialize will compete with current therapies and new therapies that may become available in the future. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective or more convenient or have fewer or less severe side effects than any products that we may develop. Our competitors also may obtain FDA, EMA or other regulatory approval for their products more rapidly than we do.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to face competition from existing products and products in development for each of our product candidates. In addition, there may be other earlier stage clinical programs that, if approved, would compete with our product candidates. Many of our competitors have substantially greater financial, technical, manufacturing, marketing, sales and supply resources or experience than we do. Additional mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated in our competitors. Competition may increase further as a result of advances made in the commercial applicability of technologies and greater availability of capital for investment in these fields.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Because ETX-810 is a prodrug of PEA, an endogenous bioactive lipid, which is already marketed by other companies in various formulations as medical foods, nutraceuticals and over-the-counter dietary supplements, we may be exposed to unique risk related to non-prescription competition and consumer substitution.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ETX-810 is a prodrug of PEA, an endogenous bioactive lipid. Various formulations of PEA are currently marketed by others as medical foods, nutraceuticals and over-the-counter dietary supplements. We believe that ETX-810, if approved, will have a superior therapeutic profile to dietary supplement PEA available over the counter. However, we cannot be sure physicians and patients will view ETX-810, if approved, as superior. To the extent the price of ETX-810, if approved, is significantly higher than the prices of over-the-counter PEA, physicians may recommend these commercial alternatives instead of writing prescriptions for ETX-810, or patients may elect on their own to take over-the-counter PEA products. Additionally, negative experiences with over-the-counter PEA may have an adverse impact on our ability to obtain regulatory approval, or if we obtain such approval, on demand for our products. Either of these outcomes may adversely impact our results of operations by limiting how we price our product. Additionally, any adverse effects experienced by the users of over-the-counter PEA could adversely impact the regulatory approval process for ETX-810 or physician or patient demand for ETX-810, even if we are successful in obtaining regulatory approval for and commercialization of such product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, because current formulations of PEA are only available as over-the-counter supplements, the precedent body of data regarding PEA is based exclusively on studies of PEA in its over-the-counter dietary supplement formulations. There can be no assurance that ETX-810 will achieve the same or similar results in clinical testing as observed in these studies of PEA in its dietary supplement formulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The successful commercialization of certain of our product candidates will depend in part on the extent to which governmental authorities and health insurers establish adequate coverage, reimbursement levels and pricing policies. Failure to obtain or maintain adequate coverage and reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to generate revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The availability and adequacy of coverage and reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers and other third-party payors are essential for most patients to be able to afford products such as our product candidates, if approved. Our ability to achieve acceptable levels of coverage and reimbursement for products by governmental authorities, private health insurers and other organizations will have an effect on our ability to successfully commercialize our product candidates and attract additional collaboration partners to invest in the development of our product candidates. Coverage under certain government programs, such as Medicare, Medicaid, the 340B drug pricing program and TRICARE, may not be available for certain of our product candidates. Assuming we obtain coverage for a given product by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. We cannot be sure that coverage and reimbursement in the United States, the European Union or elsewhere will be available for any product that we may develop, and any reimbursement that may become available may be decreased or eliminated in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party payors increasingly are challenging prices charged for pharmaceutical products and services, and many third-party payors may refuse to provide coverage and reimbursement for particular drugs when an equivalent generic drug, biosimilar or a less expensive therapy is available. It is possible that a third-party payor may consider our product candidates and other therapies as substitutable and only offer to reimburse patients for the less expensive product. Even if we show improved efficacy or improved convenience of administration with our product candidates, pricing of existing drugs may limit the amount we will be able to charge for our product candidates. These payors may deny or revoke the reimbursement status of a given product or establish prices for new or existing marketed products at levels that are too low to enable us to realize an appropriate return on our investment in product development. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our product candidates, and may not be able to obtain a satisfactory financial return on products that we may develop.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, third-party payors, including private and governmental payors, such as the Medicare and Medicaid programs, play an important role in determining the extent to which new drugs and biologics will be covered. The Medicare and Medicaid programs increasingly are used as models for how private payors and other governmental payors develop their coverage and reimbursement policies for drugs and biologics. Some third-party payors may require pre-approval of coverage for new or innovative devices or drug therapies before they will reimburse health care providers who use such therapies. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining and maintaining reimbursement status is time-consuming and costly. No uniform policy for coverage and reimbursement for products exists among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases at short notice, and we believe that changes in these rules and regulations are likely.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, increasing efforts by governmental and third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. The continuing efforts of the government, insurance companies, managed care organizations and other payors of health care services to contain or reduce costs of health care may adversely affect:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the demand for any products for which we may obtain regulatory approval;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to set a price that we believe is fair for our products;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain coverage and reimbursement approval for a product;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to generate revenues and achieve or maintain profitability; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the level of taxes that we are required to pay.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to establish or sustain coverage and adequate reimbursement for any product candidates from third-party payors, the adoption of those products and sales revenue will be adversely affected, which, in turn, could adversely affect the ability to market or sell those product candidates, if approved. Further, coverage policies and third-party payor reimbursement rates may change at any time. Therefore, even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we receive marketing approval for any of our product candidates, we may not achieve market acceptance, which would limit the revenue that we can generate from sales of any of our approved product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if the FDA or any comparable foreign regulatory authority approves the marketing of any product candidates that we develop, physicians, patients, third-party payors or the medical community may not accept or use them. Efforts to educate the medical community and third-party payors on the benefits of our product candidates may require significant resources and may not be successful. Market acceptance of ETX-810, ETX-155 and our other product candidates, if any are approved, will depend on a number of factors, including, among others:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability of ETX-810, ETX-155 and our other product candidates to treat neuronal excitability disorders, as compared with other available drugs, treatments or therapies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the prevalence and severity of any adverse side effects associated with ETX-810, ETX-155 and our other future product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limitations or warnings contained in the labeling approved for ETX-810, ETX-155 or our other future product candidates by the FDA or any comparable foreign regulatory authority;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">availability of alternative treatments;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size of the target patient population, and the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the strength of marketing and distribution support and timing of market introduction of competitive products;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">publicity for our product candidates and competing products and treatments;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pricing and cost effectiveness;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the effectiveness of our sales and marketing strategies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to increase awareness of our product candidates through marketing efforts;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain sufficient third-party coverage and adequate reimbursement; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the likelihood that the FDA or any comparable foreign regulatory authority may impose additional requirements that limit the promotion, advertising, distribution or sales of our product candidates.</span></div></div>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any one of our product candidates is approved but does not achieve an adequate level of acceptance by patients, physicians and third-party payors, we may not generate sufficient revenue to become or remain profitable and our business may be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If any of our product candidates are approved for marketing and commercialization and we are unable to establish sales, marketing and market access capabilities or enter into agreements with third parties to sell and market our product candidates, we will be unable to successfully commercialize our product candidates if and when they are approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently have no sales, marketing, reimbursement or distribution capabilities. To achieve commercial success for any approved product for which we retain sales, marketing and market access and reimbursement responsibilities, we must either develop these capabilities, which would be expensive and time consuming, or outsource these functions to other third parties, some or all of which may be occur in advance of any approval of the product candidate. In the future, we may choose to build a focused sales and marketing infrastructure to sell, or participate in sales activities with any future collaborators for, some of our product candidates if and when they are approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are risks involved with both establishing our own sales and marketing capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Factors that may inhibit our efforts to commercialize our product candidates on our own include:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our inability to recruit and retain adequate numbers of effective sales and marketing personnel;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability of sales personnel to obtain access to physicians or educate adequate numbers of physicians on the benefits of prescribing any future product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unforeseen costs and expenses associated with creating an independent sales and marketing organization.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenues or the profitability of these product revenues to us are likely to be lower than if we were to market and sell any products that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our product candidates or may be unable to do so on terms that are favorable to us. In entering into third-party marketing or distribution arrangements, any revenue we receive will depend upon the efforts of the third parties and we cannot assure you that such third parties will establish adequate sales and distribution capabilities or devote the necessary resources and attention to sell and market our product candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Dependence on Third Parties</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We rely, and expect to continue to rely, on third parties to conduct, supervise, and monitor our preclinical studies and clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on third-party CROs to conduct, supervise, and monitor our preclinical studies and certain clinical trials for our product candidates and do not currently plan to independently conduct preclinical studies or clinical trials of any other potential product candidates. We expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators to conduct our preclinical studies and clinical trials. While we have agreements governing their activities, we have limited influence over their actual performance and control only certain aspects of their activities. The failure of these third parties to successfully carry out their contractual duties or meet expected deadlines could substantially harm our business because we may not obtain marketing approval for or commercialize our product candidates in a timely manner or at all. Moreover, these agreements might terminate for a variety of reasons, including a failure to perform by the third parties. If we need to enter into alternative arrangements, that would delay our product development activities and harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our reliance on these third parties for development activities will reduce our control over these activities. Nevertheless, we are responsible for ensuring that each of our studies and clinical trials is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the CROs does not relieve us of our regulatory responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial and for ensuring that our preclinical trials are conducted in accordance with good laboratory practice, or GLP, as appropriate. Moreover, the FDA and comparable foreign regulatory authorities require us to comply with standards, commonly referred to as good clinical practices, or GCPs, for conducting, monitoring, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity, and confidentiality of trial participants are protected. As a clinical trial sponsor, we also have regulatory requirements that directly apply to us. Regulatory authorities enforce these requirements through periodic inspections of trial sponsors, clinical investigators, and trial sites. If we or any of our CROs fail to comply with applicable GCPs, we or our CROs may be subject to enforcement or other legal actions, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, once we have an approved product, we will be required to report certain financial interests of our third-party investigators if these relationships exceed certain financial thresholds or meet other criteria. The FDA and comparable foreign regulatory authorities may question the integrity of the data from those clinical trials conducted by investigators who previously served or currently serve as scientific advisors or consultants to us from time to time and receive cash compensation in connection with such services or otherwise receive compensation from us that could be deemed to impact study outcome, proprietary interests in a product candidate, certain company equity interests or significant payments of other sorts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with GCP regulations. In addition, our clinical trials must be conducted with product candidates that were produced under current Good Manufacturing Process (cGMP) regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. We also are required to register certain clinical trials and post the results of certain completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within specified time frames. Failure to do so can result in enforcement actions and adverse publicity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our CROs may also have relationships with other entities, some of which may be our competitors, for whom they may also be conducting clinical trials or other drug development activities that could harm our competitive position. In addition, our CROs are not our employees, and except for remedies available to us under our agreements with such CROs, we cannot control whether or not they devote sufficient time and resources to our ongoing clinical, non-clinical, and preclinical programs. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our preclinical studies or clinical trials in accordance with regulatory requirements or our stated protocols, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates, or we or they may be subject to regulatory enforcement actions. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenues could be delayed. To the extent we are unable to successfully identify and manage the performance of third-party service providers in the future, our business may be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of our relationships with these third-party CROs terminates, we may not be able to enter into arrangements with alternative CROs or to do so on commercially reasonable terms. Switching or adding additional CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays could occur, which could compromise our ability to meet our desired development timelines. Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If the manufacturers upon whom we rely fail to produce our product candidates in the volumes that we require on a timely basis, or to comply with stringent regulations applicable to pharmaceutical drug manufacturers, we may face delays in the development and commercialization of, or be unable to meet demand for, our products and may lose potential revenues.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not manufacture any of our product candidates, and we do not currently plan to develop any capacity to do so. We currently outsource all manufacturing of our product candidates to third-party CDMOs, typically without any guarantee that there will be sufficient supplies to fulfill our requirements or that we may obtain such supplies on acceptable terms. Any delays in obtaining adequate supplies with respect to our product candidates may delay the development or commercialization of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not succeed in our efforts to establish manufacturing relationships or other alternative arrangements for any of our existing or future product candidates and programs. Our product candidates may compete with other products and product candidates for access to manufacturing facilities. There are a limited number of CDMOs that operate under cGMP regulations and that are both capable of manufacturing for us and willing to do so. If our existing third-party manufacturers, or the third parties that we engage in the future to manufacture a product for commercial sale or for our clinical trials, should cease to continue to do so for any reason, we likely would experience delays in obtaining sufficient quantities of our product candidates for us to meet commercial demand or to advance our clinical trials while we identify and qualify replacement suppliers. If for any reason we are unable to obtain adequate supplies of our product candidates or the raw materials used to manufacture them, it will be more difficult for us to develop our product candidates and compete effectively. Further, even if we do establish such collaborations or arrangements, our third-party manufacturers may breach, terminate or not renew these agreements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have a limited number of contract manufacturers for our product candidates. At times we may have only one manufacturer for a product. In addition, we do not have any long-term commitments from our suppliers of clinical trial material or guaranteed prices for our product candidates. The manufacture of pharmaceutical products requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of pharmaceutical products often encounter difficulties in production, particularly in scaling up initial production. These problems include difficulties with production costs and yields; quality control, including stability of the product candidate and quality assurance testing; shortages of qualified personnel; and compliance with strictly enforced federal, state, and foreign regulations. Our manufacturers may not perform as agreed. If our manufacturers were to encounter any of these difficulties, our ability to provide product candidates to patients in our clinical trials and for commercial use, if approved, would be jeopardized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, all manufacturers of our product candidates must comply with cGMP requirements enforced by the FDA and comparable foreign regulatory authorities that are applicable to both finished drug products and active pharmaceutical ingredients used both for clinical and commercial supply, through its facilities inspection program. The FDA must verify our contract manufacturers&#x2019; compliance with cGMP requirements and comparable foreign regulatory authorities will similarly inspect our contract manufacturers&#x2019; facilities after we submit our marketing applications to the agency and comparable foreign regulatory authorities. The cGMP requirements include quality control, quality assurance, and the maintenance of records and documentation. Manufacturers of our product candidates may be unable to comply with our specifications, these cGMP requirements and with other FDA, state, and foreign regulatory requirements. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or other regulatory authorities, they will not be able to secure or maintain regulatory approval for their manufacturing facilities. While we are ultimately responsible for the manufacture of our product candidates, other than through our contractual arrangements, we have little control over our manufacturers&#x2019; compliance with these regulations and standards. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for, or market our product candidates, if approved. A failure to comply with these requirements may result in regulatory enforcement actions against our manufacturers or us, including fines and civil and criminal penalties, including imprisonment; suspension or restrictions of production; suspension, delay, or denial of product approval or supplements to approved products; clinical holds or termination of clinical studies; warning or untitled letters; regulatory authority communications warning the public about safety issues with the drug; refusal to permit the import or export of the products; product seizure, detention, or recall; civil suits under the FCA; corporate integrity agreements; consent decrees; or withdrawal of product approval. If the safety of any quantities supplied is compromised due to our manufacturers&#x2019; failure to adhere to applicable laws or for other reasons, we may not be able to obtain regulatory approval for or successfully commercialize our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any failure or refusal to supply our product candidates or components for our current or future product candidates that we may develop could delay, prevent, or impair our clinical development or commercialization efforts. Any change in our manufacturers could be costly because the commercial terms of any new arrangement could be less favorable and because the expenses relating to the transfer of necessary technology and processes could be significant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are not able to establish future collaborations, we may have to alter some of our future development and commercialization plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product development programs and the potential commercialization of our product candidates will require substantial additional capital to fund expenses. While currently we have no plans to do so, we may decide to collaborate for the future development and potential commercialization of our product candidates. Furthermore, we may find that our programs require the use of proprietary rights held by third parties, and the growth of our business may depend in part on our ability to acquire, in-license or use these proprietary rights. We will likely have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of any product candidates we may seek to develop with them. We cannot predict the success of any collaboration that we have entered into or will enter into.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face significant competition in seeking appropriate collaborators, and a number of more established companies may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, financial resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#x2019;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA, European Medicines Agency (EMA), the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) or similar foreign regulatory authorities, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be restricted under future license agreements from entering into agreements on certain terms with potential collaborators. Collaborations are complex and time consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be able to negotiate further collaborations on a timely basis, on acceptable terms, or at all. Even if we are able to obtain a license to intellectual property of interest, we may not be able to secure exclusive rights, in which case others could use the same rights and compete with us. Our existing collaboration partners may not prioritize our product candidates or otherwise not effectively pursue the development of our product candidates which may delay, reduce or terminate the development of such product candidate, reduce or delay its development program or delay its potential commercialization. Further if we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to delay, reduce or terminate the development of such product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. Doing so will likely harm our ability to execute our business plans. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain, maintain and protect sufficient patent and other intellectual property rights for our product candidates and technology, or if the scope of patent and other intellectual property rights obtained is not sufficiently broad, we may not be able to compete effectively in our market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends in significant part on our ability and the ability of future licensors, licensees or collaborators to obtain, maintain, enforce and defend patents and other intellectual property rights with respect to our product candidates and technology and to operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of others. In the last year, we have filed nine U.S. provisional applications covering methods of treatment and formulations of ETX-155. A U.S. provisional patent application is not eligible to become an issued patent until, among other things, we file non-provisional patent application within 12 months of filing of the provisional patent application. With regard to such U.S. provisional patent applications, if we do not timely file any non-provisional patent applications, we may lose our priority dates with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent applications will result in the issuance of patents that provide us with any competitive advantage.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent prosecution process is expensive and time-consuming. We and our future licensors, licensees or collaborators may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our future licensors will fail to identify patentable aspects of our research and development output in time to obtain patent protection or fail to file patent applications covering inventions made in the course of development and commercialization activities before a competitor or another third party files a patent application covering, or publishes information disclosing, a similar, independently-developed invention. Such competitor&#x2019;s or other third party&#x2019;s patent application may pose obstacles to our ability to obtain patent protection or limit the scope of the patent protection we may obtain.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, collaborators, CROs, CDMOs, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we or our future licensors were the first to make the inventions claimed in our owned or any future licensed patents or pending patent applications, or were the first to file for patent protection of such inventions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent position of biotechnology and pharmaceutical companies generally is uncertain, involves complex legal and factual questions and is the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#x2019; patent rights are uncertain. Our and our future licensors&#x2019; pending, and future patent applications may not result in patents being issued that protect our technology or product candidates, in whole or in part, or which effectively exclude others from commercializing competitive technologies and product candidates. The patent examination process may require us or our future licensors to narrow the scope of the claims of our pending and future patent applications, and therefore, even if such patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us or otherwise provide us with any competitive advantage. Our and our licensors&#x2019; patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications, and then only to the extent the issued claims cover such technology. Any patents that we hold or in-license in the future may be challenged, narrowed, circumvented or invalidated by third parties. Consequently, we do not know whether any of our product candidates will be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. Any of the foregoing could impair our competitive position and harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The patent protection we obtain for our product candidates and technologies may be challenged and rendered invalid and/or unenforceable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if our owned patent applications issue as patents, the issuance of any such patents is not conclusive as to their inventorship, scope, validity or enforceability, and such patents may be challenged, invalidated, narrowed or held to be unenforceable, including in the courts or patent offices in the United States and abroad, or circumvented. We may be subject to a third-party preissuance submission of prior art to the United States Patent and Trademark Office (USPTO), or equivalent foreign bodies, or become involved in opposition, derivation, revocation, re-examination, post-grant and inter partes review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Moreover, we may have to participate in interference or derivation proceedings declared by the USPTO to determine priority or ownership of invention or in post-grant challenge proceedings, such as oppositions in a foreign patent office, that challenge priority of invention or other features of patentability. Such proceedings and any other patent challenges may result in loss of patent rights, loss of exclusivity, loss of priority or in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability to stop others from using or commercializing similar or identical technology and products or limit the duration of the patent protection of our technology and product candidates. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us. Moreover, there could be public announcements of the results of hearings, motions or other developments related to any of the foregoing proceedings. If securities analysts or investors perceive those results to be negative, it could cause the price of shares of our common stock to decline. Any of the foregoing could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:16.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we rely on third parties to develop and manufacture our product candidates, we must, at times, share trade secrets with them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, collaborative research agreements, consulting agreements or other similar agreements with our collaborators, advisors, employees and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, such as trade secrets. Despite these contractual agreements with third parties, sharing trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#x2019;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets, although our agreements may contain certain limited publication rights. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our third-party collaborators. A competitor&#x2019;s discovery of our trade secrets would impair our competitive position and harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful, and issued patents covering our technology and product candidates could be found invalid or unenforceable if challenged.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Competitors and other third parties may infringe, misappropriate or otherwise violate our issued patents or other intellectual property. In addition, our patents may become involved in inventorship or priority disputes. Our pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. To counter infringement or other unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents or that our patents are invalid or unenforceable. In a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#x2019;s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated, held unenforceable or interpreted narrowly. We may find it impractical or undesirable to enforce our intellectual property against some third parties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, non-enablement or insufficient written description. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. Third parties may also raise similar claims before the USPTO or an equivalent foreign body, even outside the context of litigation. Potential proceedings include re-examination, post-grant review, inter partes review, interference proceedings, derivation proceedings and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in the revocation of, cancellation of, or amendment to our patents in such a way that they no longer cover our technology or any product candidates that we may develop. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on the applicable product candidates or technology covered by the patent rendered invalid or unenforceable. Such a loss of patent protection would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the ownership or priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Such licenses may not be available on commercially reasonable terms, or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture and commercialization of one or more of the product candidates we may develop. In addition, if we or any future licensors are unsuccessful in any inventorship disputes to which we or they are subject, we may lose valuable intellectual property rights, such as exclusive ownership of, or the exclusive right to use, our owned or any future in-licensed patents. The loss of exclusivity or the narrowing of such patent claims could limit our ability to stop others from using or commercializing similar or identical technology and products. Any of the foregoing could harm our business. Even if we are successful in any of the foregoing disputes, it could result in substantial costs and be a distraction to management and other employees. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or proceeding.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Most of our competitors are larger than we are and have substantially greater resources. They are, therefore, likely to be able to sustain the costs of complex patent litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing, misappropriating or otherwise violating our intellectual property. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims could result in substantial costs and diversion of management resources, which could harm our business. In addition, the uncertainties associated with litigation could compromise our ability to raise the funds necessary to continue our clinical trials, continue our internal research programs or in-license needed technology or other product candidates. There could also be public announcements of the results of the hearing, motions or other interim proceedings or developments. If securities analysts or investors perceive those results to be negative, it could cause the price of shares of our common stock to decline. Any of the foregoing events could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Filing, prosecuting, maintaining, defending and enforcing patents and other intellectual property rights on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection or other intellectual property rights to develop their own products and may export otherwise infringing, misappropriating or violating products to territories where we have patent or other intellectual property protection, but enforcement rights are not as strong as those in the United States. These products may compete with our product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of some countries do not favor the enforcement of patents and other intellectual property rights, which could make it difficult for us to stop the infringement, misappropriation or other violation of our intellectual property rights generally. Proceedings to enforce our intellectual property rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many countries, including European Union countries, India, Japan and China, have compulsory licensing laws under which a patent owner may be compelled under specified circumstances to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In those countries, we may have limited remedies if patents are infringed or if we are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent which might adversely affect our ability to develop and market our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending patent application in the United States and abroad that is relevant to or necessary for the commercialization of our product candidates in any jurisdiction. For example, U.S. patent applications filed before November 29, 2000 and certain U.S. patent applications filed after that date that will not be filed outside the United States remain confidential until patents issue. Patent applications in the United States and elsewhere are published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications covering our product candidates could have been filed by third parties without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our product candidates or the use of our product candidates. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#x2019;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our product candidates. We may incorrectly determine that our product candidates are not covered by a third-party patent or may incorrectly predict whether a third party&#x2019;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our product candidates. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail to identify and correctly interpret relevant patents or if we are unable to obtain licenses to relevant patents, we may be subject to infringement claims. We cannot guarantee that we will be able to successfully settle or otherwise resolve such infringement claims. If we fail in any such dispute, in addition to being forced to pay damages, which may be significant, we may be temporarily or permanently prohibited from commercializing any of our product candidates that are held to be infringing. We might, if possible, also be forced to redesign product candidates so that we no longer infringe the third-party intellectual property rights. Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business and could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain licenses from third parties on commercially reasonable terms or fail to comply with our obligations under such agreements, our business could be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. If we are unable to license such technology, or if we are forced to license such technology, on unfavorable terms, our business could be harmed. If we are unable to obtain a necessary license, we may be unable to develop or commercialize the affected product candidates, which could harm our business, and the third parties owning such intellectual property rights could seek either an injunction prohibiting our sales, or, with respect to our sales, an obligation on our part to pay royalties and/or other forms of compensation. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, some of our patents and patent applications in the future may be co-owned with third parties. If we are unable to obtain an exclusive license to any such co-owners&#x2019; interest in such patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, who could market competing products and technology. In addition, we may need the cooperation of any such co-owners in order to enforce such patents against third parties, and such cooperation may not be provided to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:13.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product candidate, we may be open to competition from competitive medications, including generic medications. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned and any future licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depending upon the timing, duration and conditions of any FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments, and one or more of our foreign patents may be eligible for patent term extension under similar legislation, for example, in the European Union. In the United States, the Hatch-Waxman Amendments permit a patent term extension of up to five years for a patent covering an approved product as compensation for effective patent term lost during product development and the FDA regulatory review process. However, there are no assurances that the FDA or any comparable foreign regulatory authority or national patent office will grant such extensions, in whole or in part. For example, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. Only one patent per approved product can be extended, the extension cannot extend the total patent term beyond 14 years from approval, and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. If we are unable to obtain patent term extension or the term of any such extension is less than we request, the period during which we can enforce our patent rights for the applicable product candidate will be shortened, and our competitors may obtain approval to market competing products sooner. As a result, our revenue from applicable products could be reduced.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, if this occurs, our competitors may take advantage of our investment in development and trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case, and our competitive position and business could be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:13.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in patent law could diminish the value of our patents, thereby impairing our ability to protect our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining and enforcing patents in the pharmaceutical industry is inherently uncertain, due in part to ongoing changes in the patent laws. Depending on decisions by Congress, the federal courts, and the USPTO and equivalent institutions in other jurisdictions, the laws and regulations governing patents, and interpretation thereof, could change in unpredictable ways that could weaken our ability to obtain new patents or to enforce existing or future patents. For example, the U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Therefore, there is increased uncertainty with regard to our ability to obtain patents in the future, as well as uncertainty with respect to the value of patents once obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. Assuming that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After March 2013, under the Leahy-Smith America Invents Act, or the Leahy-Smith Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. The Leahy-Smith Act also includes a number of significant changes that affect the way patent applications are prosecuted and may also affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO-administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. The USPTO recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, particularly the first inventor-to-file provisions. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated if we fail to comply with these requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on any issued patents and applications are required to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of a patent. In certain circumstances, we may rely on our future licensors to pay these fees. The USPTO and various foreign patent agencies also require compliance with a number of procedural, documentary, fee payment and other similar requirements during the patent application and prosecution process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Noncompliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official communications within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which non-compliance can result in irrevocable abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If we or any future licensors or collaborators fail to maintain the patents and patent applications covering our product candidates, our competitors might be able to enter the market with similar or identical products or technology, which would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could negatively impact the success of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property and other proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. We may become party to, or be threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our product candidates and technology, including re-examination, interference, post-grant review, inter partes review or derivation proceedings before the USPTO or an equivalent foreign body. Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist in the fields in which we are developing our product candidates. In the event that any of these patents were asserted against us, we believe that we would have defenses against any such action, including that such patents are not valid or that we would be able to replace such technology with alternative, non-infringing technology. However, if any such patents were to be asserted against us and our defenses to such assertion were unsuccessful and such alternative technology was not available or technologically or commercially practical, unless we obtain a license to such patents, we could be liable for damages, which could be significant and include treble damages and attorneys&#x2019; fees if we are found to willfully infringe such patents, and we could be precluded from commercializing any product candidates that were ultimately held to infringe such patents. Any potential future legal proceedings relating to these patents could cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. If we are unsuccessful in our challenges to these patents and become subject to litigation or are unable to obtain a license on commercially reasonable terms with respect to these patents, it could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future, regardless of their merit. Even if we believe third-party intellectual property claims are without merit, there is no assurance that a court would find in our favor on questions of infringement, validity, enforceability or priority. A court of competent jurisdiction could hold that third-party patents asserted against us are valid, enforceable and infringed, which could adversely affect our ability to commercialize any product candidates we may develop and any other product candidates or technologies covered by the asserted third- party patents. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. If we are found to infringe, misappropriate or otherwise violate a third party&#x2019;s intellectual property rights, and we are unsuccessful in demonstrating that such rights are invalid or unenforceable, we could be required to obtain a license from such a third party in order to continue developing and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty payments. We could be forced, including by court order, to cease commercializing the infringing technology or product candidates. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#x2019; fees for willful infringement, pay royalties and other fees, redesign our infringing drug or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business. Any of the foregoing events would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:14.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims by third parties asserting that we or our employees have infringed upon, misappropriated or otherwise violated their intellectual property rights, or claiming ownership of what we regard as our own intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our employees were previously employed at other biotechnology or pharmaceutical companies. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#x2019;s former employer. Litigation may be necessary to defend against these claims.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we or our future licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or any future in-licensed patents or other intellectual property as an inventor or co-inventor. While it is our policy to require our employees and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact conceives, develops or reduces to practice intellectual property that we regard as our own. Our and their assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs, delay development of our product candidates and be a distraction to management. Any of the foregoing events would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace, including compromising our ability to raise the funds necessary to continue our clinical trials, continue our research programs, license necessary technology from third parties or enter into development collaborations that would help us commercialize our product candidates, if approved. Any of the foregoing events would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information and to maintain our competitive position. Trade secrets and know-how can be difficult to protect. We seek to protect these trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. We cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or proprietary technology and processes. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position would be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect and enforce our trademarks and trade names, or build name recognition in our markets of interest thereby harming our competitive position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We intend to rely on both registered and common law rights for our trademarks. We plan to apply to register these trademarks with the USPTO and may in the future seek to register additional trademarks in the United States and other countries. Our trademark applications may not be allowed for registration in a timely fashion or at all, and our future registered trademarks may not be maintained or enforced. In addition, any registered or unregistered trademarks or trade names that we own or will own may be challenged, infringed, circumvented, declared generic, lapsed or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. In addition, third parties have filed, and may in the future file, for registration of trademarks similar or identical to our trademarks, thereby impeding our ability to build brand identity and possibly leading to market confusion. If they succeed in registering or developing common law rights in such trademarks, and if we are not successful in challenging such rights, we may not be able to use these trademarks to develop brand recognition of our technologies, products or services. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the trademark registration process, we may receive Office Actions from the USPTO or from comparable agencies in foreign jurisdictions objecting to the registration of our trademark. Although we would be given an opportunity to respond to those objections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and/or to seek the cancellation of registered trademarks. Opposition or cancellation proceedings may in the future be filed against our trademark applications or registrations, and our trademark applications or registrations may not survive such proceedings. In addition, third parties may file first for our trademarks in certain countries. If they succeed in registering such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to market our products in those countries. If we do not secure registrations for our trademarks, we may encounter more difficulty in enforcing them against third parties than we otherwise would. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property rights do not necessarily address all potential threats.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may be able to make products that are similar to any product candidates we may develop or utilize similar technology but that are not covered by the claims of the patents that we own now or own or license in the future;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our future licensors, might not have been the first to make the inventions covered by the issued patent or pending patent application that we own now or own or license in the future;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our future licensors, might not have been the first to file patent applications covering certain of our or their inventions;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our pending owned patent applications or those that we may own or license in the future will not lead to issued patents;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors might conduct research and development activities in the United States under FDA-related safe harbor patent infringement exemptions and/or in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not develop additional proprietary technologies that are patentable;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patents of others may harm our business; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Should any of these events occur, they could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Business Operations, Employee Matters and Managing Growth</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our future success depends on our ability to retain key employees, consultants and advisors and to attract, retain and motivate qualified personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are highly dependent on the management, research and development, clinical, financial and business development expertise of our executive officers, as well as the other members of our scientific and clinical teams. Although we have employment offer letters with each of our executive officers, each of them may terminate their employment with us at any time. We do not maintain &#x201c;key person&#x201d; insurance for any of our executives or employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recruiting and retaining qualified scientific and clinical personnel and, if we are successful in obtaining marketing approval for our product candidates, sales and marketing personnel, is critical to our success. The permanent or temporary loss of the services of our executive officers or other key employees for any reason could impede the achievement of our research, development and commercialization objectives, impair our operations and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval for and commercialize our product candidates. Competition to hire qualified personnel in our industry is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. Furthermore, to the extent we hire personnel from competitors, we may be subject to allegations that they have been improperly solicited or that they have divulged proprietary or other confidential information, or that their former employers own their research output. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited, and could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect to expand our development and regulatory capabilities and potentially implement sales, marketing and distribution capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our full-time and part-time employee base grew from nine employees as of December 31, 2020 to 28 employees as of September 30, 2021. As our clinical development progresses, we expect to experience growth in the number of our employees and the scope of our operations, particularly in the areas of research, clinical operations, regulatory affairs, general and administrative and, if any of our product candidates receives marketing approval, sales, marketing and distribution. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs and vendors may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs and vendors may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless or negligent conduct or unauthorized activities that violates (1) the laws and regulations of the FDA, the EMA, the MHRA and other similar regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such authorities, (2) manufacturing standards, (3) federal and state data privacy, security, fraud and abuse and other healthcare laws and regulations in the United States and abroad and (4) laws that require the true, complete and accurate reporting of financial information or data. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Misconduct by these parties could also involve the improper use of individually identifiable information, including information obtained in the course of clinical trials, creating fraudulent data in our preclinical studies or clinical trials or illegal misappropriation of product candidates, which could result in regulatory sanctions and harm our reputation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have adopted a code of business conduct and ethics, but it is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Additionally, we are subject to the risk that a person or government could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, including damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm and the delay, reduction, termination or restructuring of our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our international operations in the United Kingdom may expose us to business, regulatory, political, operational, financial, pricing and reimbursement risks associated with doing business outside of the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to risks associated with conducting business internationally. Some of our suppliers, industry partners and clinical study centers are located outside of the United States. Furthermore, our business strategy incorporates potential international expansion as we seek to obtain regulatory approval for, and commercialize, our product candidates in patient populations outside the United States. If approved, we may hire sales representatives and conduct physician and patient association outreach activities outside of the United States. Doing business internationally involves a number of risks, including but not limited to:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">multiple, conflicting and changing laws and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure by us to obtain and maintain regulatory approvals for the use of our products in various countries;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">rejection or qualification of foreign clinical trial data by the competent authorities of other countries;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays or interruptions in the supply of clinical trial materials resulting from any events affecting raw material supply or manufacturing capabilities abroad, including those that may result from the ongoing COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">additional potentially relevant third-party patent and other intellectual property rights;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complexities and difficulties in obtaining, maintaining, protecting and enforcing our intellectual property;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties in staffing and managing foreign operations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complexities associated with managing multiple payor reimbursement regimes, government payors or patient self-pay systems;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limits in our ability to penetrate international markets;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our product candidates and exposure to foreign currency exchange rate fluctuations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">currency exchange rate fluctuations and the resulting effect on our revenue and expenses and the cost and risk of entering into hedging transactions if we chose to do so in the future;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">natural disasters, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, including COVID-19 and related shelter-in-place orders, travel, social distancing and quarantine policies, boycotts, curtailment of trade and other business restrictions;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">certain expenses including, among others, expenses for travel and insurance; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory and compliance risks that relate to anti-corruption compliance and record-keeping that may fall within the purview of the U.S. Foreign Corrupt Practices Act, its accounting provisions or its anti- bribery provisions or provisions of anti-corruption or anti-bribery laws in other countries.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these factors could harm our future international expansion and operations and, consequently, our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to utilize a significant portion of our net operating loss carryforwards.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, we had net operating loss carryforwards of approximately $8.7 million for federal income tax purposes, $3.6 million for foreign income tax purposes and $2.1 million for state income tax purposes. These may be used to offset up to 100% of future taxable income. The federal net operating loss carryforward can be carried forward indefinitely while the state net operating loss carryforward will begin to expire in varying amounts in 2038. The net operating loss carryforwards subject to expiration could expire unused and be unavailable to offset future income tax liabilities. Under the Tax Cuts and Jobs Act (Tax Act), as modified by the Coronavirus Aid, Relief and Economic Security Act (CARES Act), federal net operating losses incurred in taxable years beginning after December 31, 2017 and in future taxable years may be carried forward indefinitely, but the deductibility of such federal net operating losses in taxable years beginning after December 31, 2020 is limited. There is variation in how states will respond to the Tax Act and CARES Act. In addition, for state income tax purposes, there may be periods during which the use of net operating losses (NOLs) is suspended or otherwise limited, such as recent California legislation limiting the usability of NOLs for tax years beginning in 2020 and before 2023.</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Separately, under Section 382 of the Internal Revenue Code of 1986, as amended, (Internal Revenue Code), and corresponding provisions of state law, if a corporation undergoes an &#x201c;ownership change,&#x201d; which is generally defined as a greater than 50 percentage point change, by value, in its equity ownership by certain stockholders over a rolling three-year period, the corporation&#x2019;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. The completion of our recent IPO, together with private placements and other transactions that have occurred since our inception, may trigger such an ownership change pursuant to Section 382 of the Internal Revenue Code. We have not completed a Section 382 analysis, and therefore, there can be no assurances that the NOLs carryforward are not already limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we may experience ownership changes as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. If an ownership change occurs and our ability to use our NOL carryforwards is materially limited, it could harm our future operating results by effectively increasing our future tax obligations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may seek to grow our business through acquisitions or investments in new or complementary businesses, products or technologies, through the licensing of products or technologies from third parties or other strategic alliances, and the failure to manage acquisitions, investments, licenses or other strategic alliances, or the failure to integrate them with our existing business, could have a material adverse effect on our operating results, dilute our stockholders&#x2019; ownership, increase our debt or cause us to incur significant expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends on our ability to continually enhance and broaden our product offerings in response to changing clinician and patients&#x2019; needs, competitive technologies and market pressures. Accordingly, from time to time we may consider opportunities to acquire, make investments in or license other technologies, products and businesses that may enhance our capabilities, complement our existing products and technologies or expand the breadth of our markets or customer base. Potential and completed acquisitions, strategic investments, licenses and other alliances involve numerous risks, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulty assimilating or integrating acquired or licensed technologies, products, employees or business operations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issues maintaining uniform standards, procedures, controls and policies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unanticipated costs associated with acquisitions or strategic alliances, including the assumption of unknown or contingent liabilities and the incurrence of debt or future write-offs of intangible assets or goodwill;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">diversion of management&#x2019;s attention from our core business and disruption of ongoing operations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse effects on existing business relationships with suppliers, sales agents, health care facilities, surgeons and other health care providers;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">risks associated with entering new markets in which we have limited or no experience;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential losses related to investments in other companies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential loss of key employees of acquired businesses; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">increased legal and accounting compliance costs.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not know if we will be able to identify acquisitions or strategic relationships we deem suitable, whether we will be able to successfully complete any such transactions on favorable terms, if at all, or whether we will be able to successfully integrate any acquired business, product or technology into our business or retain any key personnel, suppliers, sales agent, health care facilities, physicians or other health care providers. Our ability to successfully grow through strategic transactions depends upon our ability to identify, negotiate, complete and integrate suitable target businesses, technologies or products and to obtain any necessary financing. These efforts could be expensive and time-consuming and may disrupt our ongoing business and prevent management from focusing on our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we pursue any foreign acquisitions, they typically involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures, languages and legal and regulatory environments, currency risks and the particular economic, political and regulatory risks associated with specific countries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To finance any acquisitions, investments or strategic alliances, we may choose to issue shares of our common stock as consideration, which could dilute the ownership of our stockholders. If the price of our common stock is low or volatile, we may be unable to consummate any acquisitions, investments or strategic alliances using our common stock as consideration. Additional funds may not be available on terms that are favorable to us, or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Common Stock</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur due to a variety of factors, many of which are outside of our control and may be difficult to predict, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and cost of, and level of investment in, research, development and, if approved, commercialization activities relating to our product candidates, which may change from time to time;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and status of enrollment for our clinical trials;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of manufacturing our product candidates, as well as building out our supply chain, which may vary depending on the quantity of production and the terms of our agreements with manufacturers;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expenditures that we may incur to acquire, develop or commercialize additional product candidates and technologies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">timing and amount of any milestone, royalty or other payments due under any collaboration or license agreement;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">future accounting pronouncements or changes in our accounting policies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and success or failure of preclinical studies and clinical trials for our product candidates or competing product candidates, or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of receipt of approvals for our product candidates from regulatory authorities in the United States and internationally;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">exchange rate fluctuations;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">coverage and reimbursement policies with respect to our product candidates, if approved, and potential future drugs that compete with our products; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the level of demand for our product candidates, if approved, which may vary significantly over time.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if any forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated revenue or earnings guidance we may provide.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The trading price of the shares of our common stock may be volatile, and purchasers of our common stock could incur substantial losses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our stock price may be volatile. The stock market in general and the market for biotechnology companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, investors may not be able to sell their common stock at or above the price paid for the shares. The market price for our common stock may be influenced by many factors, including:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse regulatory decisions;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any delay in our regulatory filings for our product candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#x2019;s review of such filings, including without limitation the FDA&#x2019;s issuance of a &#x201c;refusal to file&#x201d; letter or a request for additional information;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the commencement, enrollment or results of any future clinical trials we may conduct, or changes in the development status of our product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse results from, delays in or termination of our clinical trials or those of our competitors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unanticipated serious safety concerns related to the use of our product candidates;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">lower than expected market acceptance of our product candidates following approval for commercialization;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in financial estimates by us or by any securities analysts who might cover our stock;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">conditions or trends in our industry;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the market valuations of similar companies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">stock market price and volume fluctuations of comparable companies and, in particular, those that operate in the pharmaceutical industry;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">publication of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">announcements by us or our competitors of significant acquisitions, strategic partnerships or divestitures;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">announcements of investigations or regulatory scrutiny of our operations or lawsuits filed against us;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">investors&#x2019; general perception of our company and our business;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">recruitment or departure of key personnel;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">overall performance of the equity markets;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trading volume of our common stock;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disputes or other developments relating to intellectual property rights, including patents, litigation matters and our ability to obtain, maintain, defend, protect and enforce patent and other intellectual property rights for our technologies;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant lawsuits, including patent or stockholder litigation;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">proposed changes to healthcare laws in the United States or foreign jurisdictions, or speculation regarding such changes;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">general political and economic conditions; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">other events or factors, many of which are beyond our control.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In recent years, the stock market in general, and the market for pharmaceutical and biotechnology companies in particular, has experienced significant price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Further, the stock market in general has been highly volatile due to the COVID-19 pandemic and political uncertainty in the United States. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our stock shortly following the IPO. In addition, in the past, stockholders have initiated class action lawsuits against pharmaceutical and biotechnology companies following periods of volatility in the market prices of these companies&#x2019; stock. Such litigation, if instituted against us, could cause us to incur substantial costs and divert management&#x2019;s attention and resources from our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our operating and financial performance in any given period does not meet any guidance that we provide to the public, the market price of our common stock may decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may, but are not obligated to, provide public guidance on our expected operating and financial results for future periods. Any such guidance will be comprised of forward-looking statements subject to the risks and uncertainties herein and in our other public filings and public statements. Our actual results may not always be in line with or exceed any guidance we have provided, especially in times of economic uncertainty. If, in the future, our operating or financial results for a particular period do not meet any guidance we provide or the expectations of investment analysts, or if we reduce our guidance for future periods, the market price of our common stock may decline. Even if we do issue public guidance, there can be no assurance that we will continue to do so in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">A significant portion of our common stock may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales of a substantial number of shares of our common stock in the public market could occur at any time, in particular upon expiration of the lock-up agreements with our stockholders entered into in connection with our IPO. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of our common stock in the public market, the market price of our common stock could decline significantly.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we filed a registration statement on Form S-8 registering the issuance of approximately 8.1 million shares of common stock subject to options or other equity awards issued or reserved for future issuance under our equity incentive plans. Shares registered under this registration statement on Form S-8 will be available for sale in the public market subject to vesting arrangements and exercise of options, outstanding lock-up agreements and, in the case of our affiliates, the restrictions of Rule 144.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the holders of an aggregate of 18.3 million shares of our common stock, or their transferees, have rights, subject to some conditions, to require us to file one or more registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. If we were to register the resale of these shares, they could be freely sold in the public market without limitation. If these additional shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:13.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws, as currently in effect, may have the effect of delaying or preventing a change of control or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide for a classified board of directors whose members serve staggered terms;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">authorize our board of directors to issue, without further action by the stockholders, shares of undesignated preferred stock with terms, rights and preferences determined by our board of directors that may be senior to our common stock;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">specify that special meetings of our stockholders can be called only by our board of directors, the chairperson of our board of directors or our chief executive officer;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">prohibit cumulative voting in the election of directors;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that our directors may be removed for cause only upon the vote of the holders of at least 66 2/3% of our outstanding shares of common stock;</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum; and</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Symbol;display:inline-block;font-size:7.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require the approval of our board of directors or the holders of at least 66 2/3% of our outstanding shares of common stock to amend our bylaws and certain provisions of our certificate of incorporation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (DGCL), which generally, subject to certain exceptions, prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any &#x201c;interested&#x201d; stockholder for a period of three years following the date on which the stockholder became an &#x201c;interested&#x201d; stockholder. Any delay or prevention of a change of control transaction or changes in our management could cause the market price of our common stock to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation and amended and restated bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as permitted by Section 145 of the DGCL, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#x2019;s conduct was unlawful.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of ownership of our common stock among our existing executive officers, directors and principal stockholders may prevent new investors from influencing significant corporate decisions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based upon our common stock outstanding as of September 30, 2021, our executive officers, directors and current beneficial owners of 5% or more of our common stock, in the aggregate, beneficially own approximately 89.2% of our outstanding common stock. These stockholders, acting together, are able to significantly influence all matters requiring stockholder approval, including the election and removal of directors and any merger or other significant corporate transactions. The interests of this group of stockholders may not coincide with the interests of other stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some of these persons or entities may have interests different than yours. For example, because many of these stockholders purchased their shares at prices substantially below the price at which shares were sold in the IPO and have held their shares for a longer period, they may be more interested in selling our company to an acquirer than other investors, or they may want us to pursue strategies that deviate from the interests of other stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Participation in the IPO by our existing stockholders and their affiliated entities reduces the public float for our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain of our existing stockholders purchased shares of our common stock in the IPO, including RA Capital Management. Such purchases reduced the non-affiliate public float of our shares, meaning the number of shares of our common stock that are not held by officers, directors and controlling stockholders. A reduction in the public float reduces the number of shares that are available to be traded at any given time, thereby adversely impacting the liquidity of our common stock and depressing the price at which you may be able to sell shares of common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:16.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have identified material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses, or if we identify additional material weaknesses in the future or otherwise fail to maintain effective internal control over financial reporting, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the completion of the IPO, we were a private company with limited accounting personnel to adequately execute our accounting processes and other supervisory resources with which to address our internal control over financial reporting. In connection with the preparation of our consolidated financial statements, we identified material weaknesses in our internal control over financial reporting as of December 31, 2020. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weaknesses are as follows:</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design or maintain an effective control environment. Specifically, we lacked a sufficient number of professionals with an appropriate level of accounting knowledge, training and experience to appropriately analyze, record and disclose accounting matters commensurate with accounting and reporting requirements. The lack of personnel contributed to additional material weaknesses.</span></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design and maintain formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and controls over the preparation and review of journal entries, account reconciliations and consolidation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These material weaknesses did not result in a misstatement to the financial statements. However, these material weaknesses could result in a misstatement of our account balances or disclosures that would result in a material misstatement of our annual or interim financial statements that would not be prevented or detected.</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.3402777777777778in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not design and maintain effective controls over information technology (IT) general controls for information systems that are relevant to the preparation of our financial statements. Specifically, we did not design and maintain (a) program change management controls to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately, (b) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate Company personnel, (c) computer operations controls to ensure that critical batch jobs are monitored, and data backups are authorized and monitored, and (d) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These IT deficiencies did not result in a misstatement to the financial statements. However, the IT deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined the IT deficiencies in the aggregate constitute a material weakness.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To address the material weaknesses, we have begun adding personnel, such as a Chief Financial Officer and Vice President of Accounting, and have implemented new financial processes. We intend to continue to take steps to remediate the material weaknesses through the hiring of additional experienced accounting and financial reporting personnel, formalizing documentation of policies and procedures and further evolving the accounting processes, including implementing appropriate segregation of duties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are committed to continuing to improve our internal control processes and will continue to review, optimize and enhance our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may take additional measures to address control deficiencies, or we may modify, or in appropriate circumstances not complete, certain of the remediation measures described above. These material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that the enhanced control is operating effectively. We cannot assure you that the measures we have taken to date, and are continuing to implement, will be sufficient to remediate the material weaknesses we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material weaknesses in a timely manner, we will be unable to conclude that we maintain effective internal controls over financial reporting. Accordingly, there could continue to be a reasonable possibility that these deficiencies or others could result in a misstatement of our accounts or disclosures that would result in a material misstatement of our financial statements that would not be prevented or detected on a timely basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">As a public company, we are subject to additional requirements and regulations with respect to our accounting procedures and internal controls, which make it more difficult and costly for us to produce timely and accurate financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following the closing of the IPO, we became subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (Exchange Act), the Sarbanes-Oxley Act and the rules and regulations of the Nasdaq Stock Market. Section 302 of the Sarbanes-Oxley Act requires, among other things, that we report on the effectiveness of our disclosure controls and procedures in our quarterly and annual reports and, beginning with our annual report for the year ending 2022, Section 404 of the Sarbanes-Oxley Act requires that we perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form 10-K filing for that year. This requires that we incur substantial additional professional fees and internal costs to expand our accounting and finance functions and that we expend significant management efforts. Prior to the IPO, we were not required to test our internal control within a specified period, and, as a result, we may experience difficulty in meeting these reporting requirements in a timely manner going forward. In addition, our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting in our first annual report required to be filed with the SEC following the date we are no longer an emerging growth company or a smaller reporting company with less than $100 million in revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our stock could decline and we could be subject to sanctions or investigations by the Nasdaq Stock Market, the SEC or other regulatory authorities. In addition, our common stock may not be able to remain listed on the Nasdaq Stock Market or any other securities exchange.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware and, to the extent enforceable, the federal district courts of the United States of America as the exclusive forums for substantially all disputes between us and our stockholders, which restricts our stockholders&#x2019; ability to choose the judicial forum for disputes with us or our directors, officers, or employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of claims or causes of action under Delaware statutory or common law: any derivative claims or causes of action brought on our behalf; any claims or causes of action asserting a breach of a fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. In addition, our amended and restated certificate of incorporation provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. These choice of forum provisions will not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Such provisions are intended to benefit and may be enforced by us, our officers and directors, employees and agents, including the underwriters for any offering giving rise to such complaint and any other professional or entity who has prepared or certified any part of the document underlying the offering and may result in increased costs for stockholders to bring a claim.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe these provisions may benefit us by providing increased consistency in the application of Delaware law and federal securities laws by chancellors and judges, as applicable, particularly experienced in resolving corporate disputes, efficient administration of cases on a more expedited schedule relative to other forums and protection against the burdens of multi-forum litigation. These choice of forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits with respect to such claims or make such lawsuits more costly for stockholders, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions, and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions. If a court were to find either choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">General Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect our expenses to increase in connection with our planned operations. Unless and until we can generate a substantial amount of revenue from our product candidates, we expect to finance our future cash needs through public or private equity offerings, debt financings, collaborations, licensing arrangements or other sources, or any combination of the foregoing. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that we raise additional capital through the sale of common stock, convertible securities or other equity securities, your ownership interest may be diluted, and the terms of these securities could include liquidation or other preferences and anti-dilution protections that could adversely affect your rights as a common stockholder. In addition, debt financing, if available, may result in fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures, creating liens, redeeming stock or declaring dividends, that could adversely impact our ability to conduct our business. In addition, securing financing could require a substantial amount of time and attention from our management and may divert a disproportionate amount of their attention away from day-to-day activities, which may adversely affect our management&#x2019;s ability to oversee the development of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we raise additional funds through collaborations or marketing, distribution, licensing and royalty arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:14.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The trading market for our common stock will be influenced by the research and reports that equity research analysts publish about us and our business. As a newly public company, we may have limited equity analyst coverage. Equity research analysts may elect not to provide research coverage of our common stock, and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We incur costs and demands upon our management as a result of complying with the laws and regulations affecting public companies in the United States, which may harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a public company listed in the United States, we incur significant additional legal, accounting and other expenses. In addition, changing laws, regulations and standards relating to corporate governance and public disclosure, including regulations implemented by the SEC and the Nasdaq Stock Market, may increase legal and financial compliance costs and make some activities more time consuming. These laws, regulations and standards are subject to varying interpretations and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#x2019;s time and attention from regular business activities to compliance activities. If, notwithstanding our efforts, we fail to comply with new laws, regulations and standards, regulatory authorities may initiate legal proceedings against us and our business may be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Failure to comply with these rules might also make it more difficult for us to obtain certain types of insurance, including director and officer liability insurance, and we might be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors or as members of senior management.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our internal computer systems, or those used by our CROs or other vendors, contractors or consultants, may fail or experience security breaches or other unauthorized or improper access.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We collect and maintain information in digital form that is necessary to conduct our business, and we are increasingly dependent on IT systems and infrastructure to operate our business. In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information of customers and our employees and contractors. It is critical that we do so in a secure manner to maintain the confidentiality and integrity of such confidential information. We have also outsourced elements of our IT infrastructure, and as a result a number of third-party vendors may or could have access to our confidential information. Despite the implementation of security measures, our internal computer systems, and those of our CROs, vendors, contractors, consultants and other third parties on which we rely, are vulnerable to privacy and information security incidents, such as data breaches, damage from computer viruses and unauthorized access, malware, supply chain attacks, natural disasters, fire, terrorism, war and telecommunication, electrical failures, cyber-attacks or cyber-intrusions over the Internet, attachments to emails, persons inside our organization or persons with access to systems inside our organization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The risk of a security breach or disruption, particularly through cyber-attacks or cyber-intrusions, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. As a result of the COVID-19 pandemic, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period. While we do not believe we have experienced any such material system failure or security breach to our knowledge to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also harm our business. These threats pose a risk to the security of our systems and networks, the confidentiality and the availability and integrity of our data, and these risks apply both to us, and to third parties on whose systems we rely for the conduct of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may need to expend significant resources and make significant capital investment to protect against security breaches or to mitigate the impact of any such breaches. Further, we cannot provide assurance that we or our third-party providers will be successful in preventing cyber-attacks or mitigating their effects. Unauthorized disclosure of sensitive or confidential data, including personally identifiable information, whether through a breach of computer systems, systems failure, employee negligence, fraud or misappropriation, or otherwise, or unauthorized access to or through our information systems and networks, whether by our employees or third parties, could result in negative publicity, legal liability and damage to our reputation. Such unauthorized disclosure could also expose us to sanctions for violations of data privacy laws and regulations around the world. To the extent that any disruption or security breach resulted in a loss of or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development of our product candidates could be delayed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are an &#x201c;emerging growth company&#x201d; and a &#x201c;smaller reporting company,&#x201d; and as a result of the reduced reporting requirements applicable to &#x201c;emerging growth companies&#x201d; and &#x201c;smaller reporting companies,&#x201d; our common stock may be less attractive to investors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an &#x201c;emerging growth company,&#x201d; as defined in the JOBS Act. For as long as we continue to be an &#x201c;emerging growth company,&#x201d; we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not &#x201c;emerging growth companies,&#x201d; including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may take advantage of these exemptions until we are no longer an &#x201c;emerging growth company.&#x201d; We could be an &#x201c;emerging growth company&#x201d; for up to five years, although circumstances could cause us to lose that status earlier, including if the aggregate market value of our common stock held by non-affiliates exceeds $700 million as of any June 30 (the end of our second fiscal quarter)before that time, in which case we would no longer be an &#x201c;emerging growth company&#x201d; as of the following December 31 (our fiscal year-end).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also a &#x201c;smaller reporting company,&#x201d; as defined in the Exchange Act. Even after we no longer qualify as an &#x201c;emerging growth company,&#x201d; we may still qualify as a &#x201c;smaller reporting company,&#x201d; which would allow us to continue to take advantage of many of the same exemptions from disclosure requirements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and the price of our common stock may be more volatile.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:15.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be unable to obtain adequate insurance coverage.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We presently have general liability, workers&#x2019; compensation, directors&#x2019; and officers&#x2019; and product liability insurance coverage. Although we believe we will be able to maintain such coverage for a reasonable cost and obtain any additional coverages that our business may require, no assurances can be made that we will be able to do so.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in tax laws or regulations that are applied adversely to us or our customers may seriously harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of any of our future domestic and foreign earnings. Any new taxes could adversely affect our domestic and international business operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Unregistered Sales of Equity Securities and Use of Proceeds.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:4.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following sets forth information regarding all unregistered securities sold for the three months ended September 30, 2021:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3.88%;"></td>
    <td style="width:4.843%;"></td>
    <td style="width:91.278%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From July 1, 2021 through August 12, 2021 (the date of filing our registration statement on Form S-8, File No. 333-258771), we granted to certain employees options to purchase an aggregate of 31,598 shares of our common stock under our 2019 Equity Incentive Plan at an exercise price of $10.06 per share.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From July 1, 2021 through August 12, 2021 (the date of filing our registration statement on Form S-8, File No. 333-258771), we granted to certain directors options to purchase an aggregate of 80,000 shares of our common stock under our 2021 Equity Incentive Plan at an exercise price of $12.50 per share.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. Unless otherwise specified above, we believe these transactions were exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act (and Regulation D promulgated thereunder), or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer not involving any public offering or under benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed on the share certificates issued in these transactions. All recipients had adequate access, through their relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Proceeds</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On August 9, 2021 our Registration Statement on Form S-1, as amended (File No. 333-257980), was declared effective in connection with our IPO, pursuant to which we sold an aggregate of 7,360,000 shares of our common stock, including the full exercise of the underwriters&#x2019; option to purchase additional shares, at a price to the public of $12.50 per share. Evercore L.L.C., Guggenheim Securities LLC, Stifel, Nicolaus &amp; Company, Incorporated, and SVB Leerink LLC, acted as lead manager for the offering.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The IPO closed on August 12, 2021. The aggregate net proceeds from our IPO, after underwriting discounts and commissions of $6.4 million and other estimated offering expenses of $2.5 million, were $83.1 million. In connection with our IPO, no payments were made by us to directors, officers or persons owning ten percent or more of our common stock or to their associates or to our affiliates. There has been no material change in the planned use of proceeds from our IPO as described in our prospectus filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC on August 11, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item3"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Defaults Upon Senior Securities.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item4"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Mine Safety Disclosures.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item5"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Other Information.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item6"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Exhibits.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.184%;"></td>
    <td style="width:63.265%;"></td>
    <td style="width:6.122%;"></td>
    <td style="width:6.122%;"></td>
    <td style="width:7.143%;"></td>
    <td style="width:8.163%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Incorporated by Reference</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Description of Exhibit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Form</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">File No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Filing Date</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Certificate of Incorporation of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.2*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="elym-ex3_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Bylaws of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Reference is made to Exhibits </span><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">3.1</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and </span><a href="elym-ex3_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">3.2</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of common stock certificate of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521217529/d105292dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Investors Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex109.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Effective Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2020, as amended.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.9</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.2+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex1010.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2020, as amended.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.10</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.3+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex104.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2021 Equity Incentive Plan.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.4+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001768446/000119312521232117/d105292dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2021 Employee Stock Purchase Plan.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-257980</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8/2/2021</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.1*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="elym-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.2*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="elym-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.1*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="elym-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.2*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="elym-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.INS</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Instance Document &#x2013; the instance document does not appear in the Interactive File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.SCH</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Scheme Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.CAL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.DEF</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.LAB</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.PRE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*   Filed herewith.</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">+   Indicates management contract or compensatory Plan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIG</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.454%;"></td>
    <td style="width:4.241%;"></td>
    <td style="width:3.843%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Azelby</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Azelby</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Executive Officer (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Executive Officer</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Erin M. Lavelle</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Erin M. Lavelle</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Vice President, Chief Operating Officer and Chief Financial Officer (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Financial Officer</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>elym-ex3_2.htm
<DESCRIPTION>EX-3.2
<TEXT>
<html>
 <head>
  <title>EX-3.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:36.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Exhibit 3.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">AMENDED AND RESTATED</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">BYLAWS<br><br>OF<br><br>ELIEM THERAPEUTICS, INC.<br>(A DELAWARE CORPORATION)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Effective: August 12, 2021</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">AMENDED AND RESTATED BYLAWS<br><br>OF<br><br>ELIEM THERAPEUTICS, INC.<br>(A DELAWARE CORPORATION)</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Offices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Registered Office</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The registered office of the corporation in the State of Delaware shall be as set forth in the Amended and Restated</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Certificate of Incorporation of the corporation, as the same may be amended or restated from time to time (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Certificate of Incorporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;).</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Other Offices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation may also have and maintain an office or principal place of business at such place as may be fixed by the Board of Directors of the corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Board of Directors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;), and may also have offices at such other places, both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the corporation may require. </font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Corporate Seal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Corporate Seal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors may adopt a corporate seal. If adopted, the corporate seal shall consist of a die bearing the name of the corporation and the inscription, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Corporate Seal-Delaware</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">.&#x201d; Said seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise. </font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Stockholders&#x2019; Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Place of Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Meetings of the stockholders of the corporation may be held at such place, if any, either within or without the State of Delaware, as may be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the General Corporation Law of the State of Delaware (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">DGCL</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;) and Section 14 below. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Annual Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as may properly come before it, shall be held on such date and at such time as may be designated from time to time by the Board of Directors.  The corporation may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled by the Board of Directors.  Nominations of persons for election to the Board of Directors and proposals of business to be considered by the stockholders may be made at an annual meeting of stockholders: (i) pursuant to the corporation&#x2019;s notice of meeting of stockholders; (ii) by or at the direction of the Board of Directors or a duly authorized committee thereof; or (iii) by any stockholder of the corporation who was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed or such </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">nomination or nominations are made, only if such beneficial owner was the beneficial owner of shares of the corporation) at the time of giving the stockholder&#x2019;s notice provided for in Section 5(b) below, who is entitled to vote at the meeting and who complied with the notice procedures set forth in this Section 5. For the avoidance of doubt, clause (iii) above shall be the exclusive means for a stockholder to make nominations and submit other business (other than matters properly included in the corporation&#x2019;s notice of meeting of stockholders and proxy statement under Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">1934 Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;)) before an annual meeting of stockholders.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">At an annual meeting of the stockholders, only such business shall be conducted as is a proper matter for stockholder action under Delaware law, the Certificate of Incorporation and these Amended and Restated Bylaws of the corporation, as the same may be amended or restated from time to time (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Bylaws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;), and only such nominations shall be made and such business shall be conducted as shall have been properly brought before the meeting in accordance with the procedures below. </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">For nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of Section 5(a), the stockholder must deliver written notice to the Secretary at the principal executive offices of the corporation on a timely basis as set forth in Section 5(b)(iii) and must update and supplement such written notice on a timely basis as set forth in Section 5(c). Such stockholder&#x2019;s notice shall set forth: (A) as to each nominee such stockholder proposes to nominate at the meeting: (1) the name, age, business address and residence address of such nominee, (2) the principal occupation or employment of such nominee, (3) the class or series and number of shares of each class or series of capital stock of the corporation that are owned of record and beneficially by such nominee, (4) the date or dates on which such shares were acquired and the investment intent of such acquisition, (5) all other information concerning such nominee as would be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved and whether or not proxies are being or will be solicited), or that is otherwise required to be disclosed pursuant to Section 14 of the 1934 Act and the rules and regulations promulgated thereunder (including such person&#x2019;s written consent to being named in the corporation&#x2019;s proxy statement and associated proxy card as a nominee of the stockholder and to serving as a director if elected); and (B) all of the information required by Section 5(b)(iv). The corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the corporation (as such term is used in any applicable stock exchange listing requirements or applicable law) or on any committee or sub-committee of the Board of Directors under any applicable stock exchange listing requirements or applicable law, or that could be material to a reasonable stockholder&#x2019;s understanding of the independence, or lack thereof, of such proposed nominee.</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Other than proposals sought to be included in the corporation&#x2019;s proxy materials pursuant to Rule 14a-8 under the 1934 Act, for business other than nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of Section 5(a), the stockholder must deliver written notice to the Secretary at the principal executive offices of the corporation on a timely basis as set forth in Section 5(b)(iii), and must update and supplement such written notice on a timely basis as set forth in Section 5(c). Such stockholder&#x2019;s notice shall set forth: (A) as to each matter such stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the Bylaws, the language of the proposed amendment), the reasons for conducting such business at the meeting, and any material interest (including any anticipated benefit of such business to any Proponent (as defined below) other than solely as a result of its ownership of the corporation&#x2019;s capital stock, that is material to </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">any Proponent individually, or to the Proponents in the aggregate) in such business of any Proponent; and (B) the information required by Section 5(b)(iv).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">To be timely, the written notice required by Section 5(b)(i) or 5(b)(ii) must be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the 90</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Times New Roman;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> day, nor earlier than the close of business on the 120</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Times New Roman;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> day, prior to the first anniversary of the immediately preceding year&#x2019;s annual meeting; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> that, subject to the last sentence of this Section 5(b)(iii), in the event that (A) the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 30 days after the anniversary of the preceding year&#x2019;s annual meeting, notice by the stockholder to be timely must be so received not earlier than the close of business on the 120</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Times New Roman;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> day prior to such annual meeting and not later than the close of business on the later of the 90</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Times New Roman;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such meeting is first made by the corporation or (B) the corporation did not have an annual meeting in the preceding year, notice by the stockholder to be timely must be so received not later than the tenth day following the day on which public announcement of the date of such meeting is first made. In no event shall an adjournment or postponement of an annual meeting for which notice has been given, or the public announcement thereof has been made, commence a new time period (or extend any time period) for the giving of a stockholder&#x2019;s notice as described above. </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The written notice required by Sections 5(b)(i) or 5(b)(ii) shall also set forth, as of the date of the notice and as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Proponent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; and collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Proponents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;): (A) the name and address of each Proponent, including, if applicable, such name and address as they appear on the corporation&#x2019;s books and records; (B) the class, series and number of shares of each class or series of the capital stock of the corporation that are, directly or indirectly, owned of record or beneficially (within the meaning of Rule 13d-3 under the 1934 Act) by each Proponent (provided, that for purposes of this Section 5(b)(iv), such Proponent shall in all events be deemed to beneficially own all shares of any class or series of capital stock of the corporation as to which such Proponent has a right to acquire beneficial ownership at any time in the future); (C) a description of any agreement, arrangement or understanding (whether oral or in writing) with respect to such nomination or proposal (and/or the voting of shares of any class or series of capital stock of the corporation) between or among any Proponent and any of its affiliates or associates, and any others (including their names) acting in concert, or otherwise under the agreement, arrangement or understanding, with any of the foregoing; (D) a representation that the Proponents are holders of record or beneficial owners, as the case may be, of shares of the corporation at the time of giving notice, will be entitled to vote at the meeting, and intend to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice (with respect to a notice under Section 5(b)(i)) or to propose the business that is specified in the notice (with respect to a notice under Section 5(b)(ii)); (E) a representation as to whether the Proponents intend to deliver a proxy statement and form of proxy to holders of a sufficient number of the corporation&#x2019;s voting shares to elect such nominee or nominees (with respect to a notice under Section 5(b)(i)) or to carry such proposal (with respect to a notice under Section 5(b)(ii)); (F) to the extent known by any Proponent, the name and address of any other stockholder supporting the proposal on the date of such stockholder&#x2019;s notice; and (G) a description of all Derivative Transactions (as defined below) by each Proponent during the previous 12-month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such Derivative Transactions.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">A stockholder providing the written notice required by Section 5(b)(i) or (ii) shall update and supplement such notice in writing, if necessary, so that the information provided or required to be provided in such notice is true and correct in all material respects as of (i) the record date for the determination of stockholders entitled to notice of the meeting and (ii) the date that is five Business Days </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">(as defined below) prior to the meeting and, in the event of any adjournment or postponement thereof, five Business Days prior to such adjourned or postponed meeting. In the case of an update and supplement pursuant to clause (i) of this Section 5(c), such update and supplement shall be received by the Secretary at the principal executive offices of the corporation not later than five Business Days after the later of the record date for the determination of stockholders entitled to notice of the meeting or the public announcement of such record date. In the case of an update and supplement pursuant to clause (ii) of this Section 5(c), such update and supplement shall be received by the Secretary at the principal executive offices of the corporation not later than two Business Days prior to the date for the meeting, and, in the event of any adjournment or postponement thereof, two Business Days prior to such adjourned or postponed meeting.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notwithstanding anything in Section 5(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">to the contrary, in the event that the number of directors in an Expiring Class (as defined below) to be elected to the Board of Directors at the next annual meeting is increased effective after the time period for which nominations would otherwise be due under Section 5(b)(iii) and there is no public announcement by the corporation naming all of the nominees for the Expiring Class or specifying the size of the increased Expiring Class at least 100 days before the first anniversary of the preceding year&#x2019;s annual meeting, a stockholder&#x2019;s notice required by this Section 5 and that complies with the requirements in Section 5(b)(i), other than the timing requirements in Section 5(b)(iii), shall also be considered timely, but only with respect to nominees for any new positions in such Expiring Class created by such increase, if it shall be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the tenth day following the day on which such public announcement is first made by the corporation. For purposes of this section, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Expiring Class</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall mean a class of directors whose term shall expire at the next annual meeting of stockholders.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">A person shall not be eligible for election or re-election as a director at an annual meeting, unless the person is nominated in accordance with either clause (ii) or (iii) of Section 5(a) and in accordance with the procedures set forth in Section 5(b), Section 5(c), and Section 5(d), as applicable. Only such business shall be conducted at any annual meeting of the stockholders of the corporation as shall have been brought before the meeting in accordance with clauses (i), (ii), or (iii) of Section 5(a) and in accordance with the procedures set forth in Section 5(b) and Section 5(c), as applicable. Except as otherwise required by applicable law, the chairperson of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures set forth in the Bylaws and, if any proposed nomination or business is not in compliance with the Bylaws, or the Proponent does not act in accordance with the representations in Sections 5(b)(iv)(D) and 5(b)(iv)(E), to declare that such proposal or nomination shall not be presented for stockholder action at the meeting and shall be disregarded, or that such business shall not be transacted, notwithstanding that proxies in respect of such nomination or such business may have been solicited or received.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notwithstanding the foregoing provisions of this Section 5, in order to include information with respect to a stockholder proposal in the proxy statement and form of proxy for a stockholders&#x2019; meeting, a stockholder must also comply with all applicable requirements of the 1934 Act and the rules and regulations thereunder. Nothing in the Bylaws shall be deemed to affect any rights of stockholders to request inclusion of proposals in the corporation&#x2019;s proxy statement pursuant to Rule 14a-8 under the 1934 Act; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">that any references in the Bylaws to the 1934 Act or the rules and regulations thereunder are not intended to and shall not limit the requirements applicable to proposals and/or nominations to be considered pursuant to Section 5(a)(iii). Nothing in the Bylaws shall be deemed to affect any rights of holders of any class or series of preferred stock to nominate and elect directors pursuant to and to the extent provided in any applicable provision of the Certificate of Incorporation. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">For purposes of Sections 5 and 6, </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">affiliates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; and &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">associates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall have the meanings set forth in Rule 405 under the Securities Act of 1933, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">1933 Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;); </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Business Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; means any day other than Saturday, Sunday or a day on which banks are closed in New York City, New York; </font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">close of business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; means 6:00 p.m. local time at the principal executive offices of the corporation on any calendar day, whether or not the day is a Business Day;</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Derivative Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proponent or any of its affiliates or associates, whether record or beneficial:</font></div></div>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">(A) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the corporation;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">(B) that otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the corporation;</font></p>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">(C) the effect or intent of which is to mitigate loss, manage risk or benefit from changes in value or price with respect to any securities of the corporation; or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:20.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">(D) that provides the right to vote or increase or decrease the voting power of, such Proponent, or any of its affiliates or associates, directly or indirectly, with respect to any securities of the corporation,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation or similar right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proponent in the securities of the corporation held by any general or limited partnership, or any limited liability company, of which such Proponent is, directly or indirectly, a general partner or managing member;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></p>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">public announcement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press, Business Wire, GlobeNewswire or comparable national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the 1934 Act or by such other means reasonably designed to inform the public or security holders in general of such information, including, without limitation, posting on the corporation&#x2019;s investor relations website. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Special Meetings TC .</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Special meetings of the stockholders of the corporation may be called, for any purpose as is a proper matter for stockholder action under Delaware law, by (i) the Chairperson of the Board of Directors, (ii) the Chief Executive Officer, or (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is presented to the Board of Directors </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">for adoption).  The corporation may postpone, reschedule or cancel any special meeting of stockholders previously scheduled by the Board of Directors.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors shall determine the time and place, if any, of such special meeting. Upon determination of the time and place, if any, of the meeting, the Secretary shall cause a notice of meeting to be given to the stockholders entitled to vote, in accordance with the provisions of Section 7. No business may be transacted at such special meeting otherwise than specified in the notice of meeting. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected (i) by or at the direction of the Board of Directors or a duly authorized committee thereof or (ii) by any stockholder of the corporation who is a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination or nominations are made, only if such beneficial owner was the beneficial owner of shares of the corporation) at the time of giving notice provided for in this paragraph, who is entitled to vote at the meeting and who delivers written notice to the Secretary of the corporation setting forth the information required by Sections 5(b)(i) and 5(b)(iv). In the event the corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder of record may nominate a person or persons (as the case may be), for election to such position(s) as specified in the corporation&#x2019;s notice of meeting, if written notice setting forth the information required by Sections 5(b)(i) and 5(b)(iv) shall be received by the Secretary at the principal executive offices of the corporation not earlier than 120 days prior to such special meeting and not later than the close of business on the later of the 90</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Times New Roman;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> day prior to such meeting or the tenth day following the day on which the corporation first makes a public announcement of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. The stockholder shall also update and supplement such information as required under Section 5(c). In no event shall an adjournment or a postponement of a special meeting for which notice has been given, or the public announcement thereof has been made, commence a new time period (or extend any time period) for the giving of a stockholder&#x2019;s notice as described above. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">A person shall not be eligible for election or re-election as a director at the special meeting unless the person is nominated either in accordance with clause (i) or clause (ii) of this Section 6(c). Except as otherwise required by applicable law, the chairperson of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the procedures set forth in the Bylaws and, if any proposed nomination or business is not in compliance with the Bylaws, or if the Proponent does not act in accordance with the representations in Sections 5(b)(iv)(D) and 5(b)(iv)(E), to declare that such nomination shall not be presented for stockholder action at the meeting and shall be disregarded, notwithstanding that proxies in respect of such nomination may have been solicited or received.</font></p>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notwithstanding the foregoing provisions of this Section 6, a stockholder must also comply with all applicable requirements of the 1934 Act and the rules and regulations thereunder with respect to matters set forth in this Section 6. Nothing in the Bylaws shall be deemed to affect any rights of stockholders to request inclusion of proposals in the corporation&#x2019;s proxy statement pursuant to Rule 14a-8 under the 1934 Act; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">that any references in the Bylaws to the 1934 Act or the rules and regulations thereunder are not intended to and shall not limit the requirements applicable to nominations for the election to the Board of Directors to be considered pursuant to Section 6(c).</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">d.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice of Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Except as otherwise provided by applicable law, notice, given in writing or by electronic transmission, of each meeting of stockholders shall be given not less than ten nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting. Such notice shall specify the place, if any, date and hour, in the case of special meetings, the purpose or purposes of the meeting, the record date for determining stockholders entitled to vote at the meeting, if such record </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">date is different from the record date for determining stockholders entitled to notice of the meeting, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at any such meeting. Such notice may be given by personal delivery, mail, or with the consent of the stockholder entitled to receive notice, by facsimile or electronic transmission. If mailed, notice is given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&#x2019;s address as it appears on the records of the corporation. If sent via electronic transmission, notice is given when directed to such stockholder&#x2019;s electronic mail address appearing in the records of the corporation. Notice of the time, place, if any, and purpose of any meeting of stockholders (to the extent required) may be waived in writing, signed by the person entitled to notice thereof, or by electronic transmission by such person, either before or after such meeting, and will be waived by any stockholder by his or her attendance thereat in person, by remote communication, if applicable, or by proxy, except when the stockholder attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder so waiving notice of such meeting shall be bound by the proceedings of any such meeting in all respects as if due notice thereof had been given.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">e.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Quorum and Vote Required</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">At all meetings of stockholders, except where otherwise provided by statute or by the Certificate of Incorporation, or by the Bylaws, the presence, in person, by remote communication, if applicable, or by proxy, of the holders of a majority of the voting power of the outstanding shares of stock entitled to vote at the meeting shall constitute a quorum for the transaction of business. In the absence of a quorum, any meeting of stockholders may be adjourned, from time to time, either by the chairperson of the meeting or by vote of the holders of a majority of the voting power of the shares represented thereat and entitled to vote thereon, but no other business shall be transacted at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Except as otherwise provided by statute or by applicable stock exchange rules, or by the Certificate of Incorporation or the Bylaws, in all matters other than the election of directors, the affirmative vote of the holders of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and voting affirmatively or negatively (excluding abstentions and broker non-votes) on such matter shall be the act of the stockholders. Except as otherwise provided by statute, the Certificate of Incorporation or the Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and entitled to vote generally on the election of directors. Where a separate vote by a class or classes or series is required, except where otherwise provided by statute or by the Certificate of Incorporation or the Bylaws or any applicable stock exchange rules, a majority of the voting power of the outstanding shares of such class or classes or series, present in person, by remote communication, if applicable, or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter. Except where otherwise provided by statute or by the Certificate of Incorporation or the Bylaws or any applicable stock exchange rules, the affirmative vote of the holders of a majority (plurality, in the case of the election of directors) of the voting power of the shares of such class or classes or series present in person, by remote communication, if applicable, or represented by proxy at the meeting and voting affirmatively or negatively (excluding abstention and broker non-votes) on such matter shall be the act of such class or classes or series.</font></p>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">f.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Adjournment and Notice of Adjourned Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any meeting of stockholders, whether annual or special, may be adjourned from time to time either by the chairperson of the meeting or by the vote of the holders of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and entitled to vote thereon. When a </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">meeting is adjourned to another time or place, if any, notice need not be given of the adjourned meeting if the time and place, if any, thereof and the means of remote communication, if any, by which stockholders and proxyholders may be deemed present in person and may vote at such meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the corporation may transact any business that might have been transacted at the original meeting. If the adjournment is for more than 30 days or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Board of Directors shall fix as the record date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall give notice of the adjourned meeting to each stockholder of record as of the record date so fixed for notice of such adjourned meeting.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">g.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Voting Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">For the purpose of determining those stockholders entitled to vote at any meeting of the stockholders or adjournment thereof, except as otherwise provided by applicable law, only persons in whose names shares stand on the stock records of the corporation on the record date shall be entitled to vote at any meeting of stockholders. Every person entitled to vote shall have the right to do so either in person, by remote communication, if applicable, or by an agent or agents authorized by a proxy granted in accordance with Delaware law. An agent so appointed need not be a stockholder. No proxy shall be voted after three years from its date of creation unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy that is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the corporation a revocation of the proxy or a new proxy bearing a later date. Voting at meetings of stockholders need not be by written ballot. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">h.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Joint Owners of Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">If shares or other securities having voting power stand of record in the names of two or more persons, whether fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two or more persons have the same fiduciary relationship respecting the same shares, unless the Secretary is given written notice to the contrary and is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their acts with respect to voting shall have the following effect: (a) if only one votes, his or her act binds all; (b) if more than one votes, the act of the majority so voting binds all; (c) if more than one votes, but the vote is evenly split on any particular matter, each faction may vote the securities in question proportionally, or may apply to the Delaware Court of Chancery for relief as provided in Section 217(b) of the DGCL. If the instrument filed with the Secretary shows that any such tenancy is held in unequal interests, a majority or even-split for the purpose of subsection (c) shall be a majority or even-split in interest. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">List of Stockholders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall prepare, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and the number and class of shares registered in the name of each stockholder; provided, however, if the record date for determining the stockholders entitled to vote is less than ten days before the meeting date, the list shall reflect all of the stockholders entitled to vote as of the tenth day before the meeting date. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (b) during ordinary business hours, at the principal place of business of the corporation. In the event that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation. The </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">list shall be open to examination of any stockholder during the time of the meeting as provided by applicable law.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">j.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Action without Meeting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">No action shall be taken by the stockholders of the corporation except at an annual or special meeting of stockholders duly called in accordance with the Bylaws, and no action shall be taken by the stockholders by written consent.</font></p>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">k.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Remote Communication. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">For the purposes of the Bylaws, if authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxyholders may, by means of remote communication:</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">participate in a meeting of stockholders; and</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely by means of remote communication, provided that (i) the corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder, (ii) the corporation shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (iii) if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the corporation. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">l.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Organization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">At every meeting of stockholders, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed, is absent or refuses to act, the Chief Executive Officer, or if no Chief Executive Officer is then serving or the Chief Executive Officer is absent or refuses to act, the President, or, if the President is absent or refuses to act, a chairperson of the meeting designated by the Board of Directors, or, if the Board of Directors does not designate such chairperson, a chairperson of the meeting chosen by a majority of the voting power of the stockholders entitled to vote, present in person or by proxy, shall act as chairperson of the meeting of stockholders. The Chairperson of the Board of Directors may appoint the Chief Executive Officer as chairperson of the meeting. The Secretary, or, in his or her absence, an Assistant Secretary or other officer or other person directed to do so by the chairperson of the meeting, shall act as secretary of the meeting.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairperson of the meeting shall have the right and authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairperson, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without limitation, establishing an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting to stockholders of record of the corporation and their duly authorized and constituted proxies and such other persons as the chairperson shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters that are to be voted on by ballot. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">be announced at the meeting. Unless and to the extent determined by the Board of Directors or the chairperson of the meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Directors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Number and Term of Office</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The authorized number of directors of the corporation shall be fixed in accordance with the Certificate of Incorporation. Directors need not be stockholders unless so required by the Certificate of Incorporation. If for any cause, the directors shall not have been elected at an annual meeting, they may be elected as soon thereafter as convenient at a special meeting of the stockholders called for that purpose in the manner provided in the Bylaws. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Powers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors, except as may be otherwise provided by the Certificate of Incorporation or the DGCL. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Classes of Directors. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The directors shall be divided into classes as and to the extent provided in the Certificate of Incorporation, except as otherwise required by applicable law.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">d.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Vacancies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Vacancies on the Board of Directors shall be filled as provided in the Certificate of Incorporation, except as otherwise required by applicable law.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">e.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Resignation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any director may resign at any time by delivering his or her notice in writing or by electronic transmission to the Board of Directors or the Secretary. Such resignation shall take effect at the time of delivery of the notice or at any later time specified therein. Acceptance of such resignation shall not be necessary to make it effective. When one or more directors shall resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office for the unexpired portion of the term of the director whose place shall be vacated and until his or her successor shall have been duly elected and qualified or until his or her earlier death, resignation or removal. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">f.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Removal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Subject to the rights of holders of any series of preferred stock to elect additional directors under specified circumstances, the Board of Directors or any individual director may be removed only in the manner specified in the Certificate of Incorporation, except as otherwise required by applicable law.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">g.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Regular Meetings. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of Directors may be held at any time or date and at any place within or without the State of Delaware that has been designated by the Board of Directors and publicized among all directors, either orally or in writing, by telephone, including a voice-messaging system or other system designed to record and communicate messages, or by electronic mail or other electronic means. No further notice shall be required for regular meetings of the Board of Directors.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Special Meetings. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of Directors may be held at any time and place within or without the State of </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Delaware as designated and called by the Chairperson of the Board of Directors, the Chief Executive Officer or the Board of Directors.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Meetings by Electronic Communications Equipment. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any member of the Board of Directors, or of any committee thereof, may participate in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting by such means shall constitute presence in person at such meeting. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice of Special Meetings. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notice of the time and place, if any, of all special meetings of the Board of Directors shall be transmitted orally or in writing, by telephone, including a voice messaging system or other system or technology designed to record and communicate messages, or by electronic mail or other electronic means, during normal business hours, at least 24 hours before the date and time of the meeting. If notice is sent by U.S. mail, it shall be sent by first class mail, postage prepaid, at least three days before the date of the meeting. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Waiver of Notice. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notice of any meeting of the Board of Directors may be waived in writing, or by electronic transmission, at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. The transaction of all business at any meeting of the Board of Directors, or any committee thereof, however called or noticed, or wherever held, shall be as valid as though it had been transacted at a meeting duly held after regular call and notice, if a quorum be present and if, either before or after the meeting, each of the directors not present who did not receive notice shall sign a written waiver of notice or shall waive notice by electronic transmission. All such waivers shall be filed with the corporate records or made a part of the minutes of the meeting.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">h.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Quorum and Voting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless the Certificate of Incorporation requires a greater number, and except with respect to questions related to indemnification arising under Section 46 for which a quorum shall be one-third of the exact number of directors fixed from time to time by the Board of Directors in accordance with the Certificate of Incorporation, a quorum of the Board of Directors shall consist of a majority of the total number of directors then serving on the Board of Directors or, if greater, one-third of the exact number of directors fixed from time to time by the Board of Directors in accordance with the Certificate of Incorporation. At any meeting whether a quorum be present or otherwise, a majority of the directors present may adjourn from time to time until the time fixed for the next regular meeting of the Board of Directors, without notice other than by announcement at the meeting.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">At each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the affirmative vote of a majority of the directors present, unless a different vote be required by applicable law, the Certificate of Incorporation or the Bylaws.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Action without Meeting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless otherwise restricted by the Certificate of Incorporation or the Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission. Such consent or consents shall be filed with the minutes of proceedings of the Board of Directors or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Fees and Compensation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> Directors shall be entitled to such compensation for their services as may be approved by the Board of Directors, or a committee thereof to which the Board of Directors has delegated such responsibility and authority, including, if so approved, by resolution of the Board of Directors or a committee thereof to which the Board of Directors has delegated such responsibility and authority, a fixed sum and reimbursement of expenses incurred, if any, for attendance at each regular or special meeting of the Board of Directors and at any meeting of a committee of the Board of Directors, as well as reimbursement for other reasonable expenses incurred with respect to duties as a member of the Board of Directors or any committee thereof. Nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity as an officer, agent, employee, or otherwise and receiving compensation therefor.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">j.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Committees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Executive Committee. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors may appoint an Executive Committee to consist of one or more members of the Board of Directors. The Executive Committee, to the extent permitted by applicable law and provided in the resolution of the Board of Directors shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers that may require it; but no such committee shall have the power or authority in reference to (i) approving or adopting, or recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopting, amending or repealing any Bylaw of the corporation.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Other Committees. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors may, from time to time, appoint such other committees as may be permitted by applicable law. Such other committees appointed by the Board of Directors shall consist of one or more members of the Board of Directors and shall have such powers and perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall any such committee have the powers denied to the Executive Committee in the Bylaws.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Term. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors, subject to any requirements of any outstanding series of preferred stock and the provisions of subsections (a) or (b) of this Section 25, may at any time increase or decrease the number of members of a committee or terminate the existence of a committee. The membership of a committee member shall terminate on the date of his or her death or voluntary resignation from the committee or from the Board of Directors. The Board of Directors may at any time for any reason remove any individual committee member and the Board of Directors may fill any committee vacancy created by death, resignation, removal or increase in the number of members of the committee. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee, and, in addition, in the absence or disqualification of any member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Meetings. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless the Board of Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee appointed pursuant to this Section 26 shall be held at such times and places, if any, as are determined by the Board of Directors, or by any such committee, and when notice thereof has been given to each member of such committee, no further notice of such regular meetings need be given thereafter. Special meetings of any such committee may be held at such place, if any, that has been determined from time to time by such committee, and may be called by any director</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">who is a member of such committee, upon notice to the members of such committee of the time and place, if any, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">of such special meeting given in the manner provided for the giving of notice to members of the Board of Directors of the time and place, if any, of special meetings of the Board of Directors. Notice of any meeting of any committee may be waived in writing or by electronic transmission at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends such meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Unless otherwise provided by the Board of Directors in the resolutions authorizing the creation of the committee, a majority of the authorized number of members of any such committee shall constitute a quorum for the transaction of business, and the act of a majority of those present at any meeting at which a quorum is present shall be the act of such committee.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">k.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Chairperson of the Board of Directors. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Chairperson of the Board of Directors, when present, shall preside at all meetings of the stockholders and the Board of Directors. The Chairperson of the Board of Directors shall perform such other duties customarily associated with the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">l.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Lead Independent Director</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Chairperson of the Board of Directors, or one of the independent directors, may be designated by the Board of Directors as lead independent director to serve until replaced by the Board of Directors (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Lead Independent Director</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;). The Lead Independent Director, if any, will preside over meetings of the independent directors and perform such other duties as may be established or delegated by the Board of Directors and perform such other duties as may be established or delegated by the Chairperson of the Board of Directors. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">m.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Organization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">At every meeting of the directors, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed or is absent, the Lead Independent Director, or if the Lead Independent Director has not been appointed or is absent, the Chief Executive Officer (if a director), or, if a Chief Executive Officer is absent, the President (if a director), or if the President is absent, the most senior Vice President (if a director), or, in the absence of any such person, a chairperson of the meeting chosen by a majority of the directors present, shall preside over the meeting. The Secretary, or in his or her absence, any Assistant Secretary or other officer, director or other person directed to do so by the person presiding over the meeting, shall act as secretary of the meeting.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Officers Designated</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The officers of the corporation shall include, if and when designated by the Board of Directors, the Chief Executive Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer and the Treasurer. The Board of Directors may also appoint one or more Assistant Secretaries and Assistant Treasurers and such other officers and agents with such powers and duties as it shall deem appropriate or necessary. The Board of Directors may assign such additional titles to one or more of the officers as it shall deem appropriate. Any one person may hold any number of offices of the corporation at any one time unless specifically prohibited therefrom by applicable law, the Certificate of Incorporation or the Bylaws. The salaries and other compensation of the officers of the corporation shall be fixed by or in the manner designated by the Board of Directors or by a committee thereof to which the Board of Directors has delegated such responsibility. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Tenure and Duties of Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">General. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been duly elected and qualified, unless sooner removed. If the office of any officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors or by a committee thereof to which the Board of Directors has delegated such responsibility or, if so authorized by the Board of Directors, by the Chief Executive Officer or another officer of the corporation.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Chief Executive Officer. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Chief Executive Officer shall preside at all meetings of the stockholders and, if a director, at all meetings of the Board of Directors, unless a Chairperson of the Board of Directors or Lead Independent Director has been appointed and is present. The Chief Executive Officer shall be the chief executive officer of the corporation and, subject to the supervision, direction and control of the Board of Directors, shall have the general powers and duties of supervision, direction, management and control of the business and officers of the corporation as are customarily associated with the position of Chief Executive Officer. To the extent that a Chief Executive Officer has been appointed and no President has been appointed, all references in the Bylaws to the President shall be deemed references to the Chief Executive Officer. The Chief Executive Officer shall perform other duties customarily associated with the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of President. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The President shall preside at all meetings of the stockholders and, if a director, at all meetings of the Board of Directors, unless a Chairperson of the Board of Directors, Lead Independent Director, or Chief Executive Officer has been appointed and is present. Unless another officer has been appointed Chief Executive Officer of the corporation, the President shall be the chief executive officer of the corporation and, subject to the supervision, direction and control of the Board of Directors, shall have the general powers and duties of supervision, direction, management and control of the business and officers of the corporation as are customarily associated with the position of President. The President shall perform other duties customarily associated with the office and shall also perform such other duties and have such other powers, as the Board of Directors (or the Chief Executive Officer, if the Chief Executive Officer and President are not the same person and the Board of Directors has delegated the designation of the President&#x2019;s duties to the Chief Executive Officer) shall designate from time to time.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Vice Presidents. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">A Vice President may assume and perform the duties of the President in the absence or disability of the President or whenever the office of President is vacant (unless the duties of the President are being filled by the Chief Executive Officer). A Vice President shall perform other duties customarily associated with the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or, if the Chief Executive Officer has not been appointed or is absent, the President shall designate from time to time.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Secretary and Assistant Secretary. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Secretary shall attend all meetings of the stockholders and of the Board of Directors and shall record all acts, votes and proceedings thereof in the minute books of the corporation. The Secretary shall give notice in conformity with the Bylaws of all meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary shall perform all other duties provided for in the Bylaws and other duties customarily associated with the office and shall also perform such other duties and have such other powers, as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. The Chief Executive Officer, or if no Chief Executive Officer is then serving, the President may direct any Assistant Secretary or other officer to assume and perform the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary shall perform other duties customarily associated with the office and shall also perform such other duties </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Chief Financial Officer. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors, the Chief Executive Officer, or the President. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Chief Financial Officer shall perform other duties customarily associated with the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. To the extent that a Chief Financial Officer has been appointed and no Treasurer has been appointed, all references in the Bylaws to the Treasurer shall be deemed references to the Chief Financial Officer. The President may direct the Treasurer, if any, or any Assistant Treasurer to assume and perform the duties of the Chief Financial Officer in the absence or disability of the Chief Financial Officer.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Duties of Treasurer and Assistant Treasurer. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless another officer has been appointed Chief Financial Officer of the corporation, the Treasurer shall be the chief financial officer of the corporation, shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors, the Chief Executive Officer or the President. Unless another officer has been appointed Chief Financial Officer of the corporation, the Treasurer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Treasurer shall perform other duties customarily associated with the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. The Chief Executive Officer, or if no Chief Executive Officer is then serving, the President may direct any Assistant Treasurer or other officer to assume and perform the duties of the Treasurer in the absence or disability of the Treasurer, and each Assistant Treasurer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time. </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Delegation of Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding any provision hereof.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">d.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Resignations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any officer may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors, the Chairperson of the Board of Directors, the Chief Executive Officer, the President or the Secretary. Any such resignation shall be effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance of any such resignation shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the corporation under any contract with the resigning officer.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">e.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Removal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any officer may be removed from office at any time, either with or without cause, by the Board of Directors, or by any committee thereof or any superior officer upon whom such power of removal may have been conferred by the Board of Directors.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">&#160;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;visibility:hidden;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Execution Of Corporate Instruments And Voting Of Securities Owned By The Corporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Execution of Corporate Instruments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The Board of Directors may, in its discretion, determine the method and designate the signatory officer or officers, or other person or persons, to execute, sign or endorse on behalf of the corporation any corporate instrument or document, or to sign on behalf of the corporation the corporate name without limitation, or to enter into contracts on behalf of the corporation, except where otherwise provided by applicable law or the Bylaws, and such execution or signature shall be binding upon the corporation.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">All checks and drafts drawn on banks or other depositaries on funds to the credit of the corporation or in special accounts of the corporation shall be signed by such person or persons as the Board of Directors shall from time to time authorize so to do.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless otherwise specifically determined by the Board of Directors or otherwise required by applicable law, the execution, signing or endorsement of any corporate instrument or document may be effected manually, by facsimile or (to the extent permitted by applicable law and subject to such policies and procedures as the corporation may have in effect from time to time) by electronic signature.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Unless authorized or ratified by the Board of Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</font></p>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Voting of Securities Owned by the Corporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">All stock and other securities of or interests in other corporations or entities owned or held by the corporation for itself, or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall be executed, by the person authorized so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the Chairperson of the Board of Directors, the Chief Executive Officer, the President, or any Vice President.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Shares Of Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Form and Execution of Certificates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The shares of the corporation shall be represented by certificates, or shall be uncertificated if so provided by resolution or resolutions of the Board of Directors. Certificates for the shares of stock, if any, shall be in such form</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">as is consistent with the Certificate of Incorporation and applicable law. Every holder of stock in the corporation represented by certificates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">shall be entitled to have a certificate signed by or in the name of the corporation by any two authorized officers of the corporation, certifying the number, and the class or series, of shares owned by such holder in the corporation. Any or all of the signatures on the certificate may be facsimiles. In case any officer, transfer agent, or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued with the same effect as if he were such officer, transfer agent, or registrar at the date of issue.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Lost Certificates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">A new certificate or certificates shall be issued in place of any certificate or certificates theretofore issued by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent to the issuance of a new certificate or certificates, the owner of such lost, stolen, or destroyed certificate or certificates, or the owner&#x2019;s legal representative, to agree to indemnify the corporation in such manner as it shall require or to give the corporation a surety bond in such form and amount as it may direct as indemnity against any claim that </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">may be made against the corporation with respect to the certificate alleged to have been lost, stolen, or destroyed.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Transfers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Transfers of record of shares of stock of the corporation shall be made only upon its books by the holders thereof, in person or by attorney duly authorized, and, in the case of stock represented by certificate, upon the surrender of a properly endorsed certificate or certificates for a like number of shares.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes or series of stock of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes or series owned by such stockholders in any manner not prohibited by the DGCL.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">d.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Fixing Record Dates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be more than 60 nor less than ten days before the date of such meeting. If the Board of Directors so fixes a record date for determining the stockholders entitled to notice of any meeting of stockholders, such date shall also be the record date for determining the stockholders entitled to vote at such meeting, unless the Board of Directors determines, at the time it fixes the record date for determining the stockholders entitled to notice of such meeting, that a later date on or before the date of the meeting shall be the record date for determining the stockholders entitled to vote at such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day immediately preceding the day on which notice is given, or if notice is waived, at the close of business on the day immediately preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> that the Board of Directors may fix a new record date for the adjourned meeting in accordance with the provisions of this Section 39(a).</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">e.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Registered Stockholders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">f.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Additional Powers of the Board. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">In addition to, and without limiting, the powers set forth in the Bylaws, the Board of Directors shall have power and authority to make all such rules and regulations as it shall deem expedient concerning the issue, transfer, and registration of certificates for shares of stock </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">of the corporation, including the use of uncertificated shares of stock, subject to the provisions of the DGCL, other applicable law, the Certificate of Incorporation and the Bylaws. The Board of Directors may appoint and remove transfer agents and registrars of transfers, and may require all stock certificates to bear the signature of any such transfer agent and/or any such registrar of transfers.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Other Securities Of The Corporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Execution of Other Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">All bonds, debentures and other corporate securities of the corporation, other than stock certificates (covered in Section 36), may be signed by the Chairperson of the Board of Directors, the Chief Executive Officer, the President or any Vice President, or such other person as may be authorized by the Board of Directors; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> that where any such bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature, of a trustee under an indenture pursuant to which such bond, debenture or other corporate security shall be issued, the signatures of the persons signing and attesting the corporate seal on such bond, debenture or other corporate security may be the imprinted facsimile of the signatures of such persons. Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the corporation or such other person as may be authorized by the Board of Directors, or bear imprinted thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture or other corporate security, or whose facsimile signature shall appear thereon or on any such interest coupon, shall have ceased to be such officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture or other corporate security nevertheless may be adopted by the corporation and issued and delivered as though the person who signed the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the corporation.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Dividends</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Declaration of Dividends</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation and applicable law, if any, may be declared by the Board of Directors. Dividends may be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation and applicable law.</font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Dividend Reserve</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, determines proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose or purposes as the Board of Directors shall determine to be conducive to the interests of the corporation, and the Board of Directors may modify or abolish any such reserve in the manner in which it was created.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Fiscal Year</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Fiscal Year</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The fiscal year of the corporation shall be fixed by resolution of the Board of Directors.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Indemnification of Directors, Executive Officers, Employees and Other Agents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Directors and Executive Officers</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall indemnify to the full extent permitted under and in any manner permitted under the DGCL or any other applicable law, any person who is made or threatened to be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (hereinafter, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Proceeding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;), by reason of the fact that such person is or was a director or executive officer (for the purposes of this Article XI, &#x201c;executive officers&#x201d; shall be those persons designated by the corporation as (a) executive officers for purposes of the disclosures required in the corporation&#x2019;s proxy and periodic reports or (b) officers for purposes of Section 16 of the 1934 Act) of the corporation, or while serving as a director or executive officer of the corporation, is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, including service with respect to an employee benefit plan (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Another Enterprise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;), against expenses (including attorneys&#x2019; fees), judgments, fines (including ERISA excise taxes or penalties) and amounts paid in settlement actually and reasonably incurred by him or her in connection with such Proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> that the corporation may modify the extent of such indemnification by individual contracts with its directors and executive officers; and, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, further,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> that the corporation shall not be required to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly required to be made by applicable law, (ii) the proceeding was authorized by the Board of Directors, (iii) such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested in the corporation under the DGCL or any other applicable law or (iv) such indemnification is required to be made under subsection (d) of this Section 46.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Other Officers,</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Employees and Other Agents. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall have power to indemnify (including the power to advance expenses in a manner consistent with subsection (c) of this Section 46) its other officers</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">employees and other agents as set forth in the DGCL or any other applicable law. The Board of Directors shall have the power to delegate the determination of whether indemnification shall be given to any such person except executive officers to such officers or other persons as the Board of Directors shall determine.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Expenses. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed Proceeding, by reason of the fact that such person is or was a director or executive officer</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> of the corporation, or is or was serving at the request of the corporation as a director or executive officer of Another Enterprise, prior to the final disposition of the Proceeding, promptly following request therefor, all expenses (including attorneys&#x2019; fees) incurred by any director or executive officer in connection with such Proceeding provided, however, that if the DGCL requires, an advancement of expenses incurred by a director or executive officer in his or her capacity as a director or executive officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the corporation of an undertaking (hereinafter an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">undertaking</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">final adjudication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d;) that such indemnitee is not entitled to be indemnified for such expenses under this Section 46 or otherwise.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Notwithstanding the foregoing, unless otherwise determined pursuant to paragraph (d) of this Section 46, no advance shall be made by the corporation to an executive officer of the corporation (except by reason of the fact that such executive officer is or was a director of the corporation in which event this paragraph shall not apply) in any Proceeding, if a determination is reasonably and promptly made (i) by a majority vote of directors who were not parties to the Proceeding, even if not a quorum, or (ii) by a committee of such directors designated by a majority vote of such directors, even though less than a quorum, or (iii) if there are no such directors, or such directors so direct, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation.</font></p>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Enforcement. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Without the necessity of entering into an express contract, all rights to indemnification and advances to directors and executive officers under this Section 46 shall be deemed to be contractual rights, shall vest when the person becomes a director or executive officer of the corporation, shall continue as vested contract rights even if such person ceases to be a director or executive officer of the corporation, and shall be effective to the same extent and as if provided for in a contract between the corporation and the director or executive officer. Any right to indemnification or advances granted by this Section 46 to a director or executive officer shall be enforceable by or on behalf of the person holding such right in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of such claim is made within 90 days of request therefor. To the fullest extent permitted by applicable law, the claimant in such enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting the claim. In connection with any claim for indemnification, the corporation shall be entitled to raise as a defense to any such action that the claimant has not met the standards of conduct that make it permissible under the DGCL or any other applicable law for the corporation to indemnify the claimant for the amount claimed. In connection with any claim by an executive officer of the corporation (except in any Proceeding, by reason of the fact that such executive officer is or was a director of the corporation) for advances, the corporation shall be entitled to raise a defense as to any such action clear and convincing evidence that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation, or with respect to any criminal action or proceeding that such person acted without reasonable cause to believe that his or her conduct was lawful</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> Neither the failure of the corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL or any other applicable law, nor an actual determination by the corporation (including its Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that claimant has not met the applicable standard of conduct. In any suit brought by a director or executive officer to enforce a right to indemnification or to an advancement of expenses hereunder, the burden of proving that the director or executive officer is not entitled to be indemnified, or to such advancement of expenses, under this Section 46 or otherwise shall be on the corporation.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Non-Exclusivity of Rights. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The rights conferred on any person by this Section 46 shall not be exclusive of any other right that such person may have or hereafter acquire under any applicable statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL, or by any other applicable law.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Survival of Rights. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The rights conferred on any person by this Bylaw shall continue as to a person who has ceased to be a director</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">or executive officer or officer, employee or other agent</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">and shall inure to the benefit of the heirs, executors and administrators of such a person. </font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Insurance. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">To the fullest extent permitted by the DGCL or any other applicable law, the corporation, upon approval by the Board of Directors, may purchase and maintain insurance on behalf of any person required or permitted to be indemnified pursuant to this Section 46.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">viii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Amendments. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any repeal or modification of this Section 46 shall only be prospective and shall not affect the rights under this Section 46 as in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any Proceeding against any agent of the corporation.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ix.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Saving Clause. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">If this Article XI or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the corporation shall nevertheless indemnify each director and executive officer to the full extent not prohibited by any applicable portion of this Article XI that shall not have been invalidated, or by any other applicable law. If this Article XI shall be invalid due to the application of the indemnification provisions of another jurisdiction, then the corporation shall indemnify each director and executive officer to the full extent under any other applicable law.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">x.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Certain Definitions and Construction of Terms. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">For the purposes of Article XI of the Bylaws, the following definitions and rules of construction shall apply:</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Proceeding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall be broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative.</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall be broadly construed and shall include, without limitation, court costs, attorneys&#x2019; fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in connection with any Proceeding.</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">The term the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">corporation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger that, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Section 46 with respect to the resulting or surviving corporation as he would have with respect to such constituent corporation if its separate existence had continued.</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">References to a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">director</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">executive officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">employee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">,&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; of the corporation shall include, without limitation, situations where such person is serving at the request of the corporation as, respectively, a director, executive officer, officer, employee, trustee or agent of another corporation, partnership, joint venture, trust or other enterprise.</font></div></div>
  <div style="text-indent:20.0%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.5in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">References to &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">Another Enterprise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#x201d; shall include employee benefit plans; references to &#x201c;fines&#x201d; shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to &#x201c;serving at the request of the corporation&#x201d; shall include any service as a director, officer, employee or agent of the corporation that imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants, or beneficiaries; and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.5in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#x201c;not opposed to the best interests of the corporation&#x201d; as referred to in this Section 46.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">i.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice to Stockholders.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> Notice to stockholders of stockholder meetings shall be given as provided in Section 7. Without limiting the manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder, and except as otherwise required by applicable law, written notice to stockholders for purposes other than stockholder meetings may be sent by U.S. mail or nationally recognized overnight courier, or by electronic mail or other electronic means.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">ii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice to Directors. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Any notice required to be given to any director may be given by the method stated in subsection (a), as otherwise provided in the Bylaws (including by any of the means specified in Section 22(d)), or by overnight delivery service. Any notice sent by overnight delivery service or U.S. mail shall be sent to such address as such director shall have filed in writing with the Secretary, or, in the absence of such filing, to the last known post office address of such director.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iii.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Affidavit of Mailing. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer agent appointed with respect to the class of stock affected, or other agent, specifying the name and address or the names and addresses of the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">iv.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Methods of Notice. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">It shall not be necessary that the same method of giving notice be employed in respect of all recipients of notice, but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of any other or others.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">v.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice to Person with Whom Communication is Unlawful. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Whenever notice is required to be given, under applicable law or any provision of the Certificate of Incorporation or Bylaws of the corporation, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting that shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom communication is unlawful.</font></div></div>
  <div style="text-indent:13.333%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-flex;width:0.0in;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-end;padding-right:1.0in;">vi.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Notice to Stockholders Sharing an Address. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Except as otherwise prohibited under the DGCL, any notice given under the provisions of the DGCL, the Certificate of Incorporation or the Bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have been given if such stockholder fails to object in writing to the corporation within 60 days of having </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:1.0in;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">been given notice by the corporation of its intention to send the single notice. Any consent shall be revocable by the stockholder by written notice to the corporation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Amendments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Amendments. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC Subject to the limitations set forth in Section 46(h) or the provisions of the Certificate of Incorporation, the Board of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the corporation. Any adoption, amendment or repeal of the Bylaws of the corporation by the Board of Directors shall require the approval of a majority of the authorized number of directors</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> The stockholders also shall have power to adopt, amend or repeal the Bylaws of the corporation; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;font-style:italic;">provided, however, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">that, in addition to any vote of the holders of any class or series of stock of the corporation required by applicable law or by the Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least 66-2/3%</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;">14.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"><br><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Loans To Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font></div></div>
  <div style="text-indent:6.667%;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;margin-bottom:12.0pt;min-width:0.5in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;display:inline-block;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.5in;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Loans to Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> TC </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">Except as otherwise prohibited by applicable law, the corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the corporation or of its subsidiaries, including any officer or employee who is a director of the corporation or its subsidiaries, whenever, in the judgment of the Board of Directors, such loan, guarantee or assistance may reasonably be expected to benefit the corporation. The loan, guarantee or other assistance may be with or without interest and may be unsecured, or secured in such manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the corporation. Nothing in the Bylaws shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the corporation at common law or under any statute.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Arial;">251822363 v2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>elym-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Robert Azelby, certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Quarterly Report on Form 10-Q of Eliem Therapeutics, Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Azelby</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Robert Azelby</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>elym-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Erin M. Lavelle, certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Quarterly Report on Form 10-Q of Eliem Therapeutics, Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Erin M. Lavelle</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Erin M. Lavelle</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive Vice President, Chief Operating Officer and Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>elym-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the Quarterly Report of Eliem Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Azelby</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Robert Azelby</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Eliem Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>elym-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the Quarterly Report of Eliem Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 8, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Erin M. Lavelle</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Erin M. Lavelle</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive Vice President, Chief Operating Officer and Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Eliem Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img155835445_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img155835445_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" K)'-$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#C?C_ /'_ ,)?LN?"35O'7CK5O[#\*Z'Y/VZ^^RS7/D>;-'!'^[A1
MY&S)*B_*IQNR< $U\U_\/^_V2/\ HK/_ ):^L_\ R)1_P7[_ .42/Q9_[@__
M *>;&OYK:]'"82%6'-*^Y]]PKPKA,SPDJ]>4DU)K1JUK)]4^Y_2E_P /^_V2
M/^BL_P#EKZS_ /(E'_#_ +_9(_Z*S_Y:^L__ ")7\UM%=7]FTN[_ *^1]-_Q
M#S+OYY_?'_Y$_I2_X?\ ?[)'_16?_+7UG_Y$H_X?]_LD?]%9_P#+7UG_ .1*
M_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\ EKZS_P#(E'_#
M_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'_?[)
M'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?S
MS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_
M-;11_9M+N_Z^0?\ $/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_
M '^R1_T5G_RU]9_^1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z
M*S_Y:^L__(E'_#_O]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?W
MQ_\ D3^E+_A_W^R1_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH
M_LVEW?\ 7R#_ (AYEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\ \B4?\/\
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M?6?_ )$H_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\ B'F7?SS^^/\
M\B?TI?\ #_O]DC_HK/\ Y:^L_P#R)1_P_P"_V2/^BL_^6OK/_P B5_-;11_9
MM+N_Z^0?\0\R[^>?WQ_^1/Z4O^'_ '^R1_T5G_RU]9_^1*/^'_?[)'_16?\
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M?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\
MO]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\
M$/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_ '^R1_T5G_RU]9_^
M1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z*S_Y:^L__(E'_#_O
M]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_W^R1
M_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH_LVEW?\ 7R#_ (AY
MEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\ \B4?\/\ O]DC_HK/_EKZS_\
M(E?S6T4?V;2[O^OD'_$/,N_GG]\?_D3^E+_A_P!_LD?]%9_\M?6?_D2C_A_W
M^R1_T5G_ ,M?6?\ Y$K^:VBC^S:7=_U\@_XAYEW\\_OC_P#(G]*7_#_O]DC_
M **S_P"6OK/_ ,B4?\/^_P!DC_HK/_EKZS_\B5_-;11_9M+N_P"OD'_$/,N_
MGG]\?_D3^E+_ (?]_LD?]%9_\M?6?_D2C_A_W^R1_P!%9_\ +7UG_P"1*_FM
MHH_LVEW?]?(/^(>9=_//[X__ ")_2E_P_P"_V2/^BL_^6OK/_P B4?\ #_O]
MDC_HK/\ Y:^L_P#R)7\UM%']FTN[_KY!_P 0\R[^>?WQ_P#D3^E+_A_W^R1_
MT5G_ ,M?6?\ Y$H_X?\ ?[)'_16?_+7UG_Y$K^:VBC^S:7=_U\@_XAYEW\\_
MOC_\B?TI?\/^_P!DC_HK/_EKZS_\B4?\/^_V2/\ HK/_ ):^L_\ R)7\UM%'
M]FTN[_KY!_Q#S+OYY_?'_P"1/Z4O^'_?[)'_ $5G_P M?6?_ )$H_P"'_?[)
M'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\ B'F7?SS^^/\ \B?TI?\ #_O]DC_H
MK/\ Y:^L_P#R)1_P_P"_V2/^BL_^6OK/_P B5_-;11_9M+N_Z^0?\0\R[^>?
MWQ_^1/Z4O^'_ '^R1_T5G_RU]9_^1*/^'_?[)'_16?\ RU]9_P#D2OYK:*/[
M-I=W_7R#_B'F7?SS^^/_ ,B?TI?\/^_V2/\ HK/_ ):^L_\ R)1_P_[_ &2/
M^BL_^6OK/_R)7\UM%']FTN[_ *^0?\0\R[^>?WQ_^1/Z4O\ A_W^R1_T5G_R
MU]9_^1*/^'_?[)'_ $5G_P M?6?_ )$K^:VBC^S:7=_U\@_XAYEW\\_OC_\
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ME_P_[_9(_P"BL_\ EKZS_P#(E'_#_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\
MKY!_Q#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]
M9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\
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M'_$/,N_GG]\?_D3^E+_A_P!_LD?]%9_\M?6?_D2C_A_W^R1_T5G_ ,M?6?\
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M_P#+7UG_ .1*_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\
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M[)'_ $5G_P M?6?_ )$H_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\
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MH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\ EKZS_P#(E'_#_O\
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M:^L__(E'_#_O]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?WQ_\
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M_P"OD'_$/,N_GG]\?_D3^E+_ (?]_LD?]%9_\M?6?_D2C_A_W^R1_P!%9_\
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M_P#D2OYK:*/[-I=W_7R#_B'F7?SS^^/_ ,B?TI?\/^_V2/\ HK/_ ):^L_\
MR)1_P_[_ &2/^BL_^6OK/_R)7\UM%']FTN[_ *^0?\0\R[^>?WQ_^1/Z4O\
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M'_#_ +_9(_Z*S_Y:^L__ ")7\UM%']FTN[_KY!_Q#S+OYY_?'_Y$_I2_X?\
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M?_+7UG_Y$K^:VBC^S:7=_P!?(/\ B'F7?SS^^/\ \B?TI?\ #_O]DC_HK/\
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MQ#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]9_\
MD2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\ (E'_
M  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\ $/,N_GG]\?\ Y$_I2_X?
M]_LD?]%9_P#+7UG_ .1*/^'_ '^R1_T5G_RU]9_^1*_FMHH_LVEW?]?(/^(>
M9=_//[X__(G]*7_#_O\ 9(_Z*S_Y:^L__(E'_#_O]DC_ **S_P"6OK/_ ,B5
M_-;11_9M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_W^R1_P!%9_\ +7UG_P"1*/\
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MM%']FTN[_KY!_P 0\R[^>?WQ_P#D3^E+_A_W^R1_T5G_ ,M?6?\ Y$H_X?\
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M=W_7R#_B'F7?SS^^/_R)_2E_P_[_ &2/^BL_^6OK/_R)1_P_[_9(_P"BL_\
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M^1*_FMHH_LVEW?\ 7R#_ (AYEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\
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M)'_16?\ RU]9_P#D2OYK:*/[-I=W_7R#_B'F7?SS^^/_ ,B?TI?\/^_V2/\
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M+_A_W^R1_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH_LVEW?\
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MXAYEW\\_OC_\B?TI?\/^_P!DC_HK/_EKZS_\B4?\/^_V2/\ HK/_ ):^L_\
MR)7\UM%']FTN[_KY!_Q#S+OYY_?'_P"1/Z4O^'_?[)'_ $5G_P M?6?_ )$H
M_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\ B'F7?SS^^/\ \B?TI?\
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M?V;2[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\
M16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/
M_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\ $/,N_GG]
M\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_ '^R1_T5G_RU]9_^1*_FMHH_
MLVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z*S_Y:^L__(E'_#_O]DC_ **S
M_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_W^R1_P!%9_\
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M]?(/^(>9=_//[X__ ")_2E_P_P"_V2/^BL_^6OK/_P B4?\ #_O]DC_HK/\
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M_P#(E?S6T4?V;2[O^OD'_$/,N_GG]\?_ )$_I2_X?]_LD?\ 16?_ "U]9_\
MD2C_ (?]_LD?]%9_\M?6?_D2OYK:*/[-I=W_ %\@_P"(>9=_//[X_P#R)_2E
M_P /^_V2/^BL_P#EKZS_ /(E'_#_ +_9(_Z*S_Y:^L__ ")7\UM%']FTN[_K
MY!_Q#S+OYY_?'_Y$_I2_X?\ ?[)'_16?_+7UG_Y$H_X?]_LD?]%9_P#+7UG_
M .1*_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\ EKZS_P#(
ME'_#_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'
M_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'
MF7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\
M\B5_-;11_9M+N_Z^0?\ $/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*
M/^'_ '^R1_T5G_RU]9_^1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\
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MBC^S:7=_U\@_XAYEW\\_OC_\B?TI?\/^_P!DC_HK/_EKZS_\B4?\/^_V2/\
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M_P#EKZS_ /(E?S6T4?V;2[O^OD'_ !#S+OYY_?'_ .1/Z4O^'_?[)'_16?\
MRU]9_P#D2C_A_P!_LD?]%9_\M?6?_D2OYK:*/[-I=W_7R#_B'F7?SS^^/_R)
M_2E_P_[_ &2/^BL_^6OK/_R)1_P_[_9(_P"BL_\ EKZS_P#(E?S6T4?V;2[O
M^OD'_$/,N_GG]\?_ )$_I2_X?]_LD?\ 16?_ "U]9_\ D2C_ (?]_LD?]%9_
M\M?6?_D2OYK:*/[-I=W_ %\@_P"(>9=_//[X_P#R)_2E_P /^_V2/^BL_P#E
MKZS_ /(E'_#_ +_9(_Z*S_Y:^L__ ")7\UM%']FTN[_KY!_Q#S+OYY_?'_Y$
M_I2_X?\ ?[)'_16?_+7UG_Y$H_X?]_LD?]%9_P#+7UG_ .1*_FMHH_LVEW?]
M?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\ EKZS_P#(E'_#_O\ 9(_Z*S_Y
M:^L__(E?S6T4?V;2[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y
M$H_X?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?
M\/\ O]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^
M0?\ $/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_ '^R1_T5G_RU
M]9_^1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z*S_Y:^L__(E'
M_#_O]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_
MW^R1_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH_LVEW?\ 7R#_
M (AYEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\ \B4?\/\ O]DC_HK/_EKZ
MS_\ (E?S6T4?V;2[O^OD'_$/,N_GG]\?_D3^E+_A_P!_LD?]%9_\M?6?_D2C
M_A_W^R1_T5G_ ,M?6?\ Y$K^:VBC^S:7=_U\@_XAYEW\\_OC_P#(G]*7_#_O
M]DC_ **S_P"6OK/_ ,B4?\/^_P!DC_HK/_EKZS_\B5_-;11_9M+N_P"OD'_$
M/,N_GG]\?_D3^E+_ (?]_LD?]%9_\M?6?_D2C_A_W^R1_P!%9_\ +7UG_P"1
M*_FMHH_LVEW?]?(/^(>9=_//[X__ ")_2E_P_P"_V2/^BL_^6OK/_P B4?\
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M_+7UG_Y$H_X?]_LD?]%9_P#+7UG_ .1*_FMHH_LVEW?]?(/^(>9=_//[X_\
MR)_2E_P_[_9(_P"BL_\ EKZS_P#(E'_#_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2
M[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_
M "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZ
MS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\ $/,N_GG]\?\
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M_P#R)7\UM%']FTN[_KY!_P 0\R[^>?WQ_P#D3^E+_A_W^R1_T5G_ ,M?6?\
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M_P"BL_\ EKZS_P#(E?S6T4?V;2[O^OD'_$/,N_GG]\?_ )$_I2_X?]_LD?\
M16?_ "U]9_\ D2C_ (?]_LD?]%9_\M?6?_D2OYK:*/[-I=W_ %\@_P"(>9=_
M//[X_P#R)_2E_P /^_V2/^BL_P#EKZS_ /(E'_#_ +_9(_Z*S_Y:^L__ ")7
M\UM%']FTN[_KY!_Q#S+OYY_?'_Y$_I2_X?\ ?[)'_16?_+7UG_Y$H_X?]_LD
M?]%9_P#+7UG_ .1*_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"B
ML_\ EKZS_P#(E'_#_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\ KY!_Q#S+OYY_
M?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]9_\ D2OYK:*/
M[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\ (E'_  _[_9(_
MZ*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\ $/,N_GG]\?\ Y$_I2_X?]_LD?]%9
M_P#+7UG_ .1*/^'_ '^R1_T5G_RU]9_^1*_FMHH_LVEW?]?(/^(>9=_//[X_
M_(G]*7_#_O\ 9(_Z*S_Y:^L__(E'_#_O]DC_ **S_P"6OK/_ ,B5_-;11_9M
M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_W^R1_P!%9_\ +7UG_P"1*/\ A_W^R1_T
M5G_RU]9_^1*_FMHH_LVEW?\ 7R#_ (AYEW\\_OC_ /(G]*7_  _[_9(_Z*S_
M .6OK/\ \B4?\/\ O]DC_HK/_EKZS_\ (E?S6T4?V;2[O^OD'_$/,N_GG]\?
M_D3^E+_A_P!_LD?]%9_\M?6?_D2C_A_W^R1_T5G_ ,M?6?\ Y$K^:VBC^S:7
M=_U\@_XAYEW\\_OC_P#(G]*7_#_O]DC_ **S_P"6OK/_ ,B4?\/^_P!DC_HK
M/_EKZS_\B5_-;11_9M+N_P"OD'_$/,N_GG]\?_D3^E+_ (?]_LD?]%9_\M?6
M?_D2C_A_W^R1_P!%9_\ +7UG_P"1*_FMHH_LVEW?]?(/^(>9=_//[X__ ")_
M2E_P_P"_V2/^BL_^6OK/_P B4?\ #_O]DC_HK/\ Y:^L_P#R)7\UM%']FTN[
M_KY!_P 0\R[^>?WQ_P#D3^E+_A_W^R1_T5G_ ,M?6?\ Y$H_X?\ ?[)'_16?
M_+7UG_Y$K^:VBC^S:7=_U\@_XAYEW\\_OC_\B?TI?\/^_P!DC_HK/_EKZS_\
MB4?\/^_V2/\ HK/_ ):^L_\ R)7\UM%']FTN[_KY!_Q#S+OYY_?'_P"1/Z4O
M^'_?[)'_ $5G_P M?6?_ )$H_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?
M(/\ B'F7?SS^^/\ \B?TI?\ #_O]DC_HK/\ Y:^L_P#R)1_P_P"_V2/^BL_^
M6OK/_P B5_-;11_9M+N_Z^0?\0\R[^>?WQ_^1/Z4O^'_ '^R1_T5G_RU]9_^
M1*/^'_?[)'_16?\ RU]9_P#D2OYK:*/[-I=W_7R#_B'F7?SS^^/_ ,B?TI?\
M/^_V2/\ HK/_ ):^L_\ R)1_P_[_ &2/^BL_^6OK/_R)7\UM%']FTN[_ *^0
M?\0\R[^>?WQ_^1/Z4O\ A_W^R1_T5G_RU]9_^1*/^'_?[)'_ $5G_P M?6?_
M )$K^:VBC^S:7=_U\@_XAYEW\\_OC_\ (G]*7_#_ +_9(_Z*S_Y:^L__ ")1
M_P /^_V2/^BL_P#EKZS_ /(E?S6T4?V;2[O^OD'_ !#S+OYY_?'_ .1/Z4O^
M'_?[)'_16?\ RU]9_P#D2C_A_P!_LD?]%9_\M?6?_D2OYK:*/[-I=W_7R#_B
M'F7?SS^^/_R)_2E_P_[_ &2/^BL_^6OK/_R)1_P_[_9(_P"BL_\ EKZS_P#(
ME?S6T4?V;2[O^OD'_$/,N_GG]\?_ )$_I2_X?]_LD?\ 16?_ "U]9_\ D2C_
M (?]_LD?]%9_\M?6?_D2OYK:*/[-I=W_ %\@_P"(>9=_//[X_P#R)_2E_P /
M^_V2/^BL_P#EKZS_ /(E'_#_ +_9(_Z*S_Y:^L__ ")7\UM%']FTN[_KY!_Q
M#S+OYY_?'_Y$_I2_X?\ ?[)'_16?_+7UG_Y$H_X?]_LD?]%9_P#+7UG_ .1*
M_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\ EKZS_P#(E'_#
M_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\ KY!_Q#S+OYY_?'_Y$_I2_P"'_?[)
M'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?S
MS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_
M-;11_9M+N_Z^0?\ $/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_
M '^R1_T5G_RU]9_^1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z
M*S_Y:^L__(E'_#_O]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?W
MQ_\ D3^E+_A_W^R1_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH
M_LVEW?\ 7R#_ (AYEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\ \B4?\/\
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M?6?_ )$H_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\ B'F7?SS^^/\
M\B?TI?\ #_O]DC_HK/\ Y:^L_P#R)1_P_P"_V2/^BL_^6OK/_P B5_-;11_9
MM+N_Z^0?\0\R[^>?WQ_^1/Z4O^'_ '^R1_T5G_RU]9_^1*/^'_?[)'_16?\
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M?]_LD?\ 16?_ "U]9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\
MO]DC_HK/_EKZS_\ (E'_  _[_9(_Z*S_ .6OK/\ \B5_-;11_9M+N_Z^0?\
M$/,N_GG]\?\ Y$_I2_X?]_LD?]%9_P#+7UG_ .1*/^'_ '^R1_T5G_RU]9_^
M1*_FMHH_LVEW?]?(/^(>9=_//[X__(G]*7_#_O\ 9(_Z*S_Y:^L__(E'_#_O
M]DC_ **S_P"6OK/_ ,B5_-;11_9M+N_Z^0?\0\R[^>?WQ_\ D3^E+_A_W^R1
M_P!%9_\ +7UG_P"1*/\ A_W^R1_T5G_RU]9_^1*_FMHH_LVEW?\ 7R#_ (AY
MEW\\_OC_ /(G]*7_  _[_9(_Z*S_ .6OK/\ \B4?\/\ O]DC_HK/_EKZS_\
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MU]9_^1*/^'_?[)'_ $5G_P M?6?_ )$K^:VBC^S:7=_U\@_XAYEW\\_OC_\
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ME_P_[_9(_P"BL_\ EKZS_P#(E'_#_O\ 9(_Z*S_Y:^L__(E?S6T4?V;2[O\
MKY!_Q#S+OYY_?'_Y$_I2_P"'_?[)'_16?_+7UG_Y$H_X?]_LD?\ 16?_ "U]
M9_\ D2OYK:*/[-I=W_7R#_B'F7?SS^^/_P B?TI?\/\ O]DC_HK/_EKZS_\
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M'_$/,N_GG]\?_D3^E+_A_P!_LD?]%9_\M?6?_D2C_A_W^R1_T5G_ ,M?6?\
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M_P#+7UG_ .1*_FMHH_LVEW?]?(/^(>9=_//[X_\ R)_2E_P_[_9(_P"BL_\
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M[)'_ $5G_P M?6?_ )$H_P"'_?[)'_16?_+7UG_Y$K^:VBC^S:7=_P!?(/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?^GF^KSLR_A+U_S/@_$/_D70_P :_P#29'V-1117B'XV%%%% !1110 4444
M%%%% 'QS_P %^_\ E$C\6?\ N#_^GFQK^:VOZ4O^"_?_ "B1^+/_ '!__3S8
MU_-;7MY;_"?K_D?LGAY_R+I_XW_Z3$****]$^\"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK^E+_@@)_P HD?A-_P!QC_T\WU?S6U_2E_P0$_Y1(_";_N,?^GF^KSLR_A+U
M_P SX/Q#_P"1=#_&O_29'V-1117B'XV%%%% !1110 4444 %%%% 'QS_ ,%^
M_P#E$C\6?^X/_P"GFQK^:VOZ4O\ @OW_ ,HD?BS_ -P?_P!/-C7\UM>WEO\
M"?K_ )'[)X>?\BZ?^-_^DQ"BBBO1/O HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ^AOV#?\ @F7\2?\ @HN?%/\ PKU_#J?\(?\ 9/[0.JWK6W_'
MSY_E[-J/N_X]Y,],<=<U]+P?\&O7[1$TRJWB#X41 GEVUB]POUQ9D_I7M_\
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MIP-]O,AVLI()!''# D$$$$@@UAUZE[ZH_3(RC**E%W3"BBBF4%%%% !1110
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MXDL]&T+2]1UK5]0D$-K8V%L]S<W+GHJ1H"S'V -=G^RS^RWXR_;(^-FD> ?
MNF_VAK>K/EGD)2VL( 1YES.X!V0H#DG!)R%4,S*I_I"_X)T_\$P?AY_P3J^&
M\%EH-I%K'C"[A"ZSXGNH +S4'."RH,GR8 1\L2GH 6+MESR8G%1I*V[/F.(N
M)J.5P44N:H]H_J_+\_Q/R!_9V_X-L?V@/C#:VE]XG;PU\-].G.9(]5NS<Z@J
M8.&6" ,N<X^622,C//I7O]G_ ,&FDSP W'QZBCD[K'X++J/Q-\O\J_9&O/?B
M+^UK\*OA!J26?BWXF?#[PO>2;MD&K^(K.RD?;C=A99%)QD9],CUKRWCJ\GH_
MP/S67&><UJG[J=K]%%/\TV?DEXX_X-1/%MAILS>&_C%X<U:\53Y,6IZ%-I\<
MA[!GCEG*CU(5L>AKXV_:V_X([_'W]C33+G5?$O@R75O#=HI>;7- D_M&R@15
M+,\NT"6%  <O+&B].>:_I4\ ?&+PC\6+);GPMXI\.>);=T$BRZ5J4-XC*0"&
M!C9A@@@Y]ZYW]K;]H[1/V2?V</%WQ#\0%3I_AG3WN! 6"F\F/R0VZYXW22LB
M#W:JIX^LG9ZF^!XVS:%50J6J7=K-)/T5DOU/Y+:*U_'WC.[^(_CO6O$-^EM'
M?:]?SZC<I;1"&%9)I&D8(@X5<L<*.@P*R*]Q>9^T1;<4Y*S"BBBF4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !75? SX577QV^-O@[P/8W-O97OC+7+
M+0[>XG!,5O)=3I KOC)V@N"<<X%<K7L?_!.S_E('\"_^RA:!_P"G*WJ9.T6T
M<^*G*%"<X[I/\C]4_@I_P:J>"]'1)?B%\3_$>O2[PYM]"L8M-B &,H7E\]FS
MSR AP?QKX?\ ^"[?[&?@#]AG]K+POX0^'.E7.E:->>#+75+E;B]FNY)[E[V^
MB:0M(QQE(8QM7"_+G&2<_P!(5?@A_P '2_\ RD#\'_\ 9/;+_P!.6IUY&#KU
M)U?>9^6\)9UCL9FB6)JN2L]-E]RLOP/S6K]#_P!@3_@W<\?_ +8WPCT_QUXD
M\6V'PX\.Z];I=Z,KZ:VIWU]"V2LS0B6)8XV&TH3(68'.T#!/YX5_7Y\,O$>B
M>+_AQH&J^&9K6X\.ZCIUO<Z7+;,##):O&K1%".-NPKC%=6.Q$Z:7)U/H^-,\
MQ67TZ4<*[.=];7M:VFNFM_P/YX?^"E7_  0V\?\ _!//P5_PF4.NV'COP'')
M';W>J6UHUE<Z=)(VQ/.MR[A8V8HH=9&^9@"%R,_$-?U,_P#!5/Q'HGAC_@G#
M\:Y_$$UK!93^$-1M(3<, K7<T#16JC/\1N'B"]]Q%?RS56"KRJ0;F='!V<XG
M,,+.6*UE%VO:U]/+0****[3Z\**** .J^!GPJNOCM\;?!W@>QN;>RO?&6N66
MAV]Q."8K>2ZG2!7?&3M!<$XYP*_8SX*?\&JG@O1T27XA?$_Q'KTN\.;?0K&+
M38@!C*%Y?/9L\\@(<'\:_*S_ ()V?\I _@7_ -E"T#_TY6]?U:UY>/K3@THN
MQ^<<<YQC<)5ITL-4<5).]K=^^Y_-[_P7;_8S\ ?L,_M9>%_"'PYTJYTK1KSP
M9:ZI<K<7LUW)/<O>WT32%I&.,I#&-JX7Y<XR3GXIK]*?^#I?_E('X/\ ^R>V
M7_IRU.OS6KMPS;I1;/K>':LZN6T:E1MMK5O5A1116Y[04444 %%%% !17J?[
M'_[&OCW]N?XM_P#"%_#S3;;4=8BLWU&Y:YNTMH+.U1XXVF=F/W0\L8PH9CO&
M >:_5+]EK_@UCT/25M=0^,7CZ[U>X4QR/H_AA/LUJ"I):-[J93)(C<#Y(XF
MW8;)!'/5Q-.GI)ZGAYIQ%@,O?)B)^]V6K_X'SL?BU17I/[97P^TGX2?M?_%;
MPIH%L;+0O#/C'5])TZW,KRF"V@O9HHDWN2S81%&6))QDDFO-JW3NKGL4JBJ0
M52.S5_O"BBBF:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7]*7_! 3_E$C\)O^XQ_P"GF^K^:VOZ4O\ @@)_
MRB1^$W_<8_\ 3S?5YV9?PEZ_YGP?B'_R+H?XU_Z3(^QJ***\0_&PHHHH ***
M* "BBB@ HHHH ^.?^"_?_*)'XL_]P?\ ]/-C7\UM?TI?\%^_^42/Q9_[@_\
MZ>;&OYK:]O+?X3]?\C]D\//^1=/_ !O_ -)B%%%%>B?>!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!^QG_!IC_S7[_N7?_<I7[&5^.?_  :8_P#-
M?O\ N7?_ '*5^QE?/8[^/+Y?D?@_&?\ R.:W_;O_ *1$_E0_X*07\^I?\%"?
MCG)<32SR+X^UR(-(Y8A$OYT1<GLJJJ@=@ !P*Q_AA^VW\8?@OJ5M=>%_B=XZ
MT9K5@T<4&M7'D''&&B+&-UZ<,I''2M+_ (*)_P#*0/XZ?]E"U_\ ].5Q7CE>
MY&,7!)KH?L^'PU&KA:<:L%)<JW2?1'[H_P#!%#_@N/KG[6?Q @^$WQ;^PR>,
M;J!Y=#U^VA6V76#&F]X)XEPBS[5=U:,*K!2NU6 +_J/7\LO_  2MT_5M3_X*
M0?!*/179+Q?&&GRR%>IMDF5[D=#P8%E!]CVZU_4U7BXZE&G4]WJ?C_&F64,%
MCDL.K*4;V[:M?<[?F?@__P '1/P L_A_^USX/\>64<,'_"P=$:&]1(PK37=B
MZQF9FSR3#-;)R.!#U.<#\QZ_8?\ X.R[Q'O?@+;@_O(TU^1AZ!CIH'_H)K\S
M_P!@_P .Z?XP_;B^#.DZM8V>J:5JGCK1+2]LKN!9[>[ADU"!)(I(V!5T925*
ML"""017J823]@FS](X6Q$EDE.K/6RE]R;M^"/***_JU_X=V_L_?]$+^#G_A%
MZ;_\9KYC^/W_  0.^&/[1'[:VE^+;K1/#_A#X6Z+X9MK-O#7A:QCTDZUJ0NK
MMY9)C J!$$3VZEE_>/@#<@C&[".90>Z/)H>(.#FW[2$HI*_1_)>I_/-17]<?
MP=_9P\ _L]^'H-*\$>#O#GA:QMQA4TZPC@+'^\S ;G8]V8DGN:U_B-IOANX\
M(ZC=>*[31[C1+&UDN+UM2@CEMXH$4M(SAP1M"@DY[ UG_:G]W\?^ >>_$A7]
MW#Z?X_\ [4_D%HKT;]KCXF^&_C'^TMXT\2^#O#>F^$?"FJ:G(^D:386RVT%I
M:KA(L1K\J,RJ'8+P&=L#%3?LE?LB^.?VV_C-9^!OA_I:ZCK%PGVBXDFE$5MI
MUL'1)+F=S]V)#(N<!F.0%5F(4^GSKEYI:'Z*L5&.'6(K^XK7=^GD_0\SHK^B
MK]BS_@WV^!O[,NAVUUXMTB#XJ^+2@-S>:[")-.C8@;EALCF+9D<&42/R?F .
M!]M^&O!FC^"[%+71]*TW2;:)=B0V=JD"(OH%4  >U>?/,XIVBKGP>+\1,/"?
M+AZ3FN[?+]VC_&Q_'U17]?OC;X:^'/B7I$^G^(] T3Q!8749AGMM2L8KN&9"
M""K)(I!!!(P1CFOAK]N'_@WD^#/[2/AV[O?A_8VWPI\9</!<:;"3I4Y!Y26S
M#!%4C(W0["IP2' VDAF46[25BL'XAX:I-1Q-)P7=/F^_1/[KG\\]%>A?M0?L
MO>-/V//C-JG@3QYI+Z5KFF,&!!W6]]"Q.RX@DP!)$^#AAW!5@K*RCSVO2335
MT?H%*K"K!5*;NGJF@HJ?2]+N=;U.WLK*WGN[R[E6"""",R2SR,0JHJCEF)(
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M\Q+FTM4>[N(B/1XH'3VW9P<8J9248N3Z&&)KQH49UY[13;^2N?M]_P $&_\
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M>A*\6%%%%6=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(\1?LI_$./XN_%J*TL_%EM;20Z!H4,ZSMI1E0I)<3NF4\TQLR*BLP42,2=V
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M"8.'(IS5VSZ'A;A/"+"0Q6+@ISFDU?9)ZK39W6KOZ=[_ '_\)/\ @Y._:3\
M7MN=?OO"?CJU24-.FIZ-':RRQYY57M/)53C@$JV."0W(/LG_  4$_P"#AW1O
MVH?V")?!_@K1=:\+>./&S/I7B6"XV2P:?I_EH9A#./\ 6K<;S$,HK!5GW*F8
MV?\ )RBNEX2ES*5CWY\*Y9*M&NJ23B[Z:)^JVM_6QZ7^R#^U-X@_8K_:)\/?
M$SPM9Z/?Z]X:^T_98-5BDEM)//MI;9]ZQR1N<),Q&''S 9R,@_NK_P $/O\
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ME8W-G#G\IB./6OSJK])/^#7"[6V_X*$>*4;.;CP!>QK@=_[0TYN?P4US8O\
M@R/!XG_Y%5?_  G[Z5_/+_P<I^/5\7_\%,;O3UD1SX5\-:;I;*K9,9827>".
MQQ= X]&![U_0U7\WW_!PMX7NM _X*M_$&[GV>5K=II-[;;<Y,:Z;;0'/'7?
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MRO#8+$P^K1Y5):KIH?@A_P '2_\ RD#\'_\ 9/;+_P!.6IU^:U?I3_P=+_\
M*0/P?_V3VR_].6IU^:U>KA?X,3],X8_Y%5#_  GZ6?LX_P#!Q/KO[*?["G@C
MX:^'_!L/B'QGX:MKBRDUG6[@BP@@$[M:HD$1#S;86"'+Q8\M?OY)KS3QO_P<
M2_M4^*]3$]AXTT7PS$,_Z-IOARQDB/XW,<S\?[W>H_\ @GY_P0B^+?[<FA6W
MB:^:#X=>!+V)9K/6-5MS+/J:-G#VUJ&5W3&#O=HT8,"C/SC]*?A%_P &R_[/
M/@.(OXCNO&_CBX=5#+?:H+.W0@G)1+9(W&>AW2-TXQ7).>%IR=U=_?\ \ ^7
MQN*X9P->?/352=VVDN;5]-7RZ7V6UNY\6_LP_P#!SK\7? ?BC3H/BAH^@^._
M#GR17L]E:+IVJ@9 :9"A$#,!N/EF- QP T8YK]Q?A7\3M%^-/PTT#Q=X<N_M
M^@>)K"'4]/N-C(9H)4#H2K ,IP1E6 (.00"*^4F_X-^_V2VL_*_X5=*'VX\X
M>)]7WY]?^/K;G\,>U?2?[-W[/GA_]E;X*Z)X!\*G4O\ A'O#PF2Q6_NFNIHH
MY)I)O+\QN2JF0JH/154=JX,1.C+6DK'Q.?8O*<1RSRZG*$NMTDFODWK]Q^8/
M_!U'^S1;W?@GX=?%VS@C2]L;Q_"VJ.D.7N(I4>XMF9QT6-HK@<CDW Y&,'\@
M_@Q\4]0^!GQA\*>-M)AL[C5?!^LV>N645VC/;RS6TZ31K(JLK%"R $*RG&<$
M=:_H;_X.%]!35_\ @E)\0+AE#'2[S2;I"?X2=1MX<C\)2/QK^;^O3R]\U&S/
MT7@6LZ^5.E4U49./RLG^K/WB_P"",/\ P6?^*/\ P46_:BU[P3XVT'P#I>E:
M7X6N-<BET.RNX+AIH[NSA56::YE79MN') 4'(7GJ#^FU?@A_P:T?\I _&'_9
M/;W_ -.6F5^]]>;C81A5M%:'Y]QA@Z&%S%TL/'EC9:(_$[]JS_@Y$^./P,_:
MB^)/@G2?"OPIN-*\'^*=3T.REN],U![B6&VNY88VD9;U5+E4!)55&<X Z5XY
M\9_^#D3XX_'/X/>*_!.K>%?A3;Z5XPT:\T.]EM-,U!+B*&Y@>&1HV:]90X5R
M065AG&0>E?+W_!1/_E('\=/^RA:__P"G*XKQRO7IX:ERI\I^J8'AW+?94ZGL
M5>R=_.P5^O?_  ;7_P#!-VP\5"X_:!\86*W:6%U)I_A"UG16B\U.)[_!SED;
M,4?HPE.,A"/R$K^LC]BGX*0_LY?LC_#CP1$(MWASP]9VEP\2;%FN/*5IY0,G
M&^5I'ZG[U8YC5<8<JZGD<>YE/#X..'INSJ-W]%O^:^1Z7?7T.F64US<2QP6]
MNC2RRR,%2-5&2Q)X  &<U^+7[=/_  <V^*'^(5_H7P+TG1['P]ITTMO_ ,)#
MK%L;JYU0JVT2P1;A'%$<,1Y@=F5E)$9RM?HM_P %;/ 'Q0^+W["GB_P=\(M'
MFUKQ9XM$.E211WMK:&.QD<&Z)>XD1,/$K1$ [L3<#C(_$'_AP)^UO_T2;_RZ
M-&_^2ZXL'3I.\JK7H?(\)9?E=2,L1F-2.CLHRDETWW5]]/1G3_"S_@XV_:?\
M!Z[]IUKQ+X?\;6A9"UGJN@VMN@4$[@K6B0,"P/4EL8&!US^S7_!,_P#X*4>$
M_P#@I+\&I]=T:W;1?$>AO';Z_H<LPEDT^5U)1T; WPR;7V/@$[&! *FOP^_X
M<"?M;_\ 1)O_ "Z-&_\ DNOLK_@AK_P3E_:3_89_;-?6/&_@*ZT/P1XAT6YT
MO4[A/$&F7443C;-!(\,-TSL=\6P,J,5\X]%+$;XJGAW!R@U?R/;XFP&1U<+*
MM@YTXU(ZI1E'7RLG^2O<_5+]HS]GWPS^U-\%O$'@/Q?81ZAH7B&U:WF1E!:%
MNJ31G^&2-PKJW9E%?RL?M.? +5_V6OV@O%_P]USY]2\):G+8/,$V+=(IS'.J
MY.%DC*2 9R XS7];M?SY?\',W@.S\'_\%(X;^V@CBF\4^$M/U2[91S-*LMS:
M!C[[+6-?HHK++:C4W#HSS?#_ !U2&,EA?LR5_FNOW;_+L?GI1117MG[ %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_2E_P0$_Y1(_";_N
M,?\ IYOJ_FMK^E+_ (("?\HD?A-_W&/_ $\WU>=F7\)>O^9\'XA_\BZ'^-?^
MDR/L:BBBO$/QL**** "BBB@ HHHH **** /CG_@OW_RB1^+/_<'_ /3S8U_-
M;7]*7_!?O_E$C\6?^X/_ .GFQK^:VO;RW^$_7_(_9/#S_D73_P ;_P#28A11
M17HGW@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?L9_P:8_\U^_[
MEW_W*5^QE?CG_P &F/\ S7[_ +EW_P!RE?L97SV._CR^7Y'X/QG_ ,CFM_V[
M_P"D1/Q)_:D_X./?CG\!OVI/B9X*TOPW\+;W2O"/BO5-%L9+[2[YIS!;7<L,
M9=DO$4L509(49.< =*\UU[_@Y]_:*U>!EM]&^%NELRX#VNC73,I]1YMTXS]1
MVKY*_P""B?\ RD#^.G_90M?_ /3E<5XY7K0PM)Q3<3]2PG#65RH0E*C&[2_(
M^A_VC/\ @JW^T%^U3I%WI?C#XF:[-HM[O2;3-.$>F6<T;@@Q21VZH)8]IQMD
MW9[Y/-?/%%%=,81BK15CWL-A*&'CR4(**\E;\@KV/_@G9_RD#^!?_90M _\
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M#\'_ /9/;+_TY:G7[WU^"'_!TO\ \I _!_\ V3VR_P#3EJ=>)E_\8_'N!/\
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MMRIKCRQZR7H?*>&\TI8B'5\OX<W^9B4445ZY^IA1110 5]I_\&_?Q:7X5_\
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MPPB<3U:^-JX7A>G.B[-I*_:[U/TQBB6")4151$ 5548"@= !7RM^W7_P6/\
M@O\ L"ZTVA>)-4OO$'C!%5I/#^@QI<WEH&564SEG2.'*NK!78.58,%((-?5=
M?R*?'KXBZ[\7/C;XL\3^)ENH_$&NZO<WNH17);S;>9Y6+1$-\PV'Y #C 4#
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M\3_9^_Z+I\'/_"TTW_X]7\I52V=G-J-Y%;V\4D\\[B.**-2SR,3@*H'))/
MKJ_LR'\Q]*_#K#)7=:7W(_JP_P"'B?[/W_1=/@Y_X6FF_P#QZOPT_P"#AO\
M:,\*_M(?M_Q7G@[Q#I'BC1_#WA>QT?\ M#2[I+NSED\RXN6$<T9*28^T@$JQ
MPP92<J0/AW5M*NM!U2YL;ZVN+.]LY6@N+>>,QRP2*2K(ZG!5@0001D$57K>A
M@HTI<Z=SU\DX0H9?B/K5.HY.S73J%%%%=I]@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445=\
M/^'=0\6ZS;Z=I5C>:GJ%VVR"UM(6FFF;KA44%B>#T%(3DHKFEL4J*]G\4_\
M!/#XW> _@?JWQ'\0?#3Q/X=\&Z)Y7VR_U>W&GM'YL\<$9$,Q65PTDJ+E4/WL
M] 37C%*,E+X694<32K)RHR4DG9V:>O;3J%%%%4;!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !17N?P7_X)G?'[]H)U_X17X3>-+R"10Z7
M5U8'3[20'IMGN/+B/X-7AE2IQ>B9ST<51JR<:4U)K>S3M?:_:X44451T!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_&.K?\)I_97V'^P;2VG\K[+]M\SS/.GBQG[2FW;NSALXP,_>_P#Q%+_L_?\
M0G_&/_P4Z;_\GUXF+P]259RBM/\ @'X[Q3D688C-*M:A2<HOEL_^W4C\<_\
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MRW"K#T]7NWW?]:+R/V"_X-L/^"DNG>'+.;]GWQC?1V?VBYDU#P?=SNB1.\C
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MD8Y())Q@Y'[+_P#P=*>"_$6DV=E\7?!.L>'-7PL<^I>'P+W3I"%&9#%(RS1
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MSWO]Q^1E%%%>V?L1^QG_  :8_P#-?O\ N7?_ '*5^QE?SO\ _!#[_@J9\/\
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MG?\ OVQUV^4H.0-PYQ\C_L#_ /!POXZ^%G[3?B76?C)<WGBOP;X]N4FO8K-
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MS*WF,JC<COEV,=A93?M(!QIPW7Q4UC<(N9VLUU\FOR:_X)]L_P#!2#_@AO\
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MM-/O"BBBMSV0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<1?L">$?V.?C]X2\2>!=/L]!\._$>UNW;1K2+R[>QN[1H1,T2@X2-UN(2$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZE_\ !M-^RE\-
MOVG#\:#\0O!/AWQC_8?]A_V?_:MFMQ]D\W^T?,V;NF[RH\^NP>E?EI7[&?\
M!IC_ ,U^_P"Y=_\ <I7)C6U1;7]:GS/&$Y0RBM*#L_=_]*B?H[!_P31_9WMI
ME=?@=\*"5.0&\+63#\08R#5S_AW;^S]_T0OX.?\ A%Z;_P#&:]CK\JOVEO\
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M?L97D8[^/+Y?D?EG&?\ R.:W_;O_ *1$_CGHHHKZ$_> HHHH **** "BBB@
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M+X 2^\+_  ]UE[#5[G0;6XU5)H=/G9+@W;QF4S!P&\S=D, 1C K^;BOZM?\
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M_!7C/2+;7/#?B"W-M>6DZ\,.JNIZI(C!61U(9&564@@&OY9?VVOV9;S]C?\
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M7E@*L<-\?*[6W^7GV/Z9_#OPS\.>$/!$/AG2M T;3O#MO +:+2[:RCBLXX@
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MB.U\ Z)%;3W.NWEHUK9NEQ,D,+0O)M\_<\B#]UOP'!. <UYM7]*/_!?H;?\
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MU>I=:-+)D!4:XPC1,V>-\>P8(+Y(S<L)6I^];[CIQ'#&;X%.NH.RZQ?^3O\
M@? ?_!;C_@DUX$_X)TOX<U[P7XRO;BS\87LL%OX9U0++>6BQ@O)-'.NW? FZ
M&/:Z;P77+ODX_/VOJ7_@L+^V\W[='[;'B'7;"Z:?PAX>)T/PXH;,;VL+-NG
MR1^^D+R9X.UHP?NU\M5[6'Y_9KGW/V#((XJ. I_7)<TVKN^^NR^2W\S]X/\
M@UK\*Z7)^P_XOUAM-L#JP\>7=L+XVZ?:1$NGZ<PC\S&[:"[D#.,LWJ:^U?\
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MTU34;S6_#%I>7\D]TGVEUEDFB:0E3*5"L?E"A1@* /QV_P""YW[*NE_LF?\
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M"VF>*?\ @H!XG&IZ=8ZB++P)>7-N+JW2;R)1J&G*)$W [6"NPW#G#$=S7[^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG!,F.217[1?&W_@H1\$?V<M5GT_QI\4?!NAZI:C,VGOJ*2WL0/3=!'NE&?\
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MM'.2,&OH+X(_M(> ?VD] FU/P#XQ\.^+[&V<1SR:5?1W'V9R,A9%4[D;'.&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OV,_P"#3'_FOW_<N_\ N4K\<Z_8S_@TQ_YK]_W+O_N4KDQW\"7R
M_,^7XS_Y$U;_ +=_]+B?L97\I7_!1/\ Y2!_'3_LH6O_ /IRN*_JUK^4K_@H
MG_RD#^.G_90M?_\ 3E<5PY9\;/C?#K_>:W^%?F>.5]??\$.OVIM8_9J_X*'>
M!;2TO9X]#^(&HP>%]7L@6,5V+E_*MV*CC='.\;!L9 +CHS9^0:^Q_P#@A+^S
M+JG[1'_!1GP1>PZ?)<:#X!NAXEU:Z*?NK3R 6M@3TWM<B(*O7 =APA(]+$6]
ME+FVL?H>?^R_LVO[?X>5_EI\[VMYG]*-?C-_P=C:%!;^(O@9J:J/M-W;:Y:R
M-CDI$U@RC\#,_P"=?LS7XD?\'6GQ+LM7^-GPD\(12EK_ $#1;[5KA,?+&EY-
M%''STR39/D=< >HKQ<#_ !U_70_'^"TWG%)KIS?^DL_,/X,?"S4/CG\8?"G@
MG29K.WU7QCK-GH=E+=NR6\4US.D,;2,JLP0,X)*JQQG /2OT$_XA:/V@?^AP
M^#G_ (-=2_\ D"OCG_@G9_RD#^!?_90M _\ 3E;U_5K7H8W$SI22B?<\8<0X
MS+JU.&&:M)-NZOU/YAOVA?\ @D3\8_@#^U/H7P<AT_3/'?C;Q#HL>O6L/A>6
M:X@CMFGF@W2R3Q0B/:T#;F8! &3YLG ^N/@[_P &J_C[Q/X>@N?&_P 3_#GA
M*^F&YK+3M+DU@P#T9S+ N[UV[AZ,:_:^#P=I5MXON?$$>G6::Y>V<.GSWXB'
MVB6VA>62*%GZE%>>9@O0&1CWKP'X[_\ !77]G']FOQE)X?\ %WQ4T6UUF!WC
MGM+"VNM5>U=<;DE^R12B)QD?*Y!Z\<&N3Z]6G:,-SYB7&6;XOEHX->\EKRQY
MF^^EG9?+YGYX^)O^#3O5[6P=M'^.&FWUT%)2.]\*O:1LW8%UNI2![[3]*_+[
M]I3X!ZM^RW\=/$OP^UZ]T;4=9\*W?V*\GTJY-Q:-(%5B$<JI.W=M(*@AE8$9
M%?T<?M/_ /!5KX7_  T_8E\9?%3P1XT\+^,9-*MQ9Z9!87R3L^I3#;;Q2Q@[
MTY.]E8 ^6CGM7\S?B3Q'?>,/$5_JVJ74U]J6J7,EW=W,S;I+B:1B[NQ[EF))
M/J:Z\%4K3;=1Z'U/!V8YIC95*F-E>$=-8I/FWZ);+>_=%*O?OV-?^"9'QF_;
MMN_,\!^$YWT-',<VO:BWV/2H2,Y F8?O&!&"L0=ER,@ YKZ5_P""'O\ P1W'
M[;6OCXD_$&WGA^%^A7GE6]DRM&WB:Y3!:,-Q_HZ' =E^\V4!R'*_OIX1\(:5
MX \,6&B:'IMCH^CZ7 MM9V-E L%O:Q*,*B(H"JH'0 4L3CN1\D-R.(^-%@ZC
MPN#5YK=O9>7F_P %YGXT>!O^#4'Q)J.C6\GB7XSZ)I&H-&#/!IOAV7488W[A
M9))X"PZ\E%^E3>+/^#3W7+.P=M#^-NDZC=!<I'?^&)+*-FYX+I<RD#ISM/4\
M<<_I3^T%_P %/?@%^RWK=UI?C?XH^&]+U:Q94NM.MVDU"]M6.T@206RR2(<,
MIPRC@YZ<U9_9U_X*3_ K]J_4X+#P%\3/#FM:I=;C#ITCO8W\VTX.VWN%CE/3
M/"].>G-<?UK$VYNGI_P#Y!\3<0^S]OS/D[\D;??RG\^'[97_  2*^.?[#=C-
MJ?BWPL-2\,PD!O$&A2F^TY,_\]#M62$9XS+&@)( )S7S-7]B=]8PZG9RV]S#
M%<6\Z&.6*5 Z2*1@J0>"".QK\(_^"\?_  1UL/V4[F3XP?#"Q%G\/M4NEBUK
M1H_N>'KJ5L))#Z6LK$+L_P"63L%7Y'5(^O"X[G?)4W/K.&^-/K=587&I*3^%
MK9OL^S[=]O7\R***^P?^"0/_  2TU3_@H[\9II-4^W:5\-/"[))KNJ1 *;J0
MD%+&!C_RU=<LS $1H,G!:,-Z%2I&$>:6Q]OCL;1P="6(KNT8_P!67FSP7]FW
M]D;XE?M?^+)M%^&W@_5_%E]:JK7)M45(+,-D*9IG*Q1!MK8WL,[3CH:^_P#X
M1?\ !K%\5/$UCYWC/X@^#?";/@K!8P3ZM*O'1\^2@.?[K,/>OVD^!WP)\(_L
MV?#+3/!W@?0;'P[X=TB(16UI:J<>[NQ):21CRSN2S$DDDG-5_C=^TEX _9LT
M"/4_'WC'P[X0LIV*02:I?1VYN6 )*QJQW2-@$X4$\5X]3,*DG:GH?D^/X[Q]
M>IR8)<BZ:<TGZWNODE\V?E-)_P &F<@@)7X]H9<<*?!)"D^F?M_]*\6_:)_X
M-D?CA\+M/GO_  1K'A?XDVL"*1:P2G3-2D.[#;8ICY) 7!_U^X\@*3C/ZD:-
M_P %Q_V5-=\2OI,/Q?TE+J-V0O<:9?V]L2IP<3R0+$1GH0^".02.:^C/A9\8
MO"?QQ\*QZYX-\2Z%XJT>4E5O=)OH[N L."I:,D!@000>01S4?6\1!WE^*.=\
M59_AI*6(O;M*"2?W)/\ $_DE^(7PZU[X2^--0\.>)]&U+P_KVE2>5>:?J%NU
MO<6S$!@&1@",J01Z@@C@BL6ON#_@O7^W18_ME?MG3Z;H LIO"GPV270]/OH4
M&_4IMP-U,7P"4\U=B#)7;'O7_6&OA^O:I2E*"E)69^N97B:V(PE.O7ARRDKM
M?UW6MNFQ_8Q7XY_\'9W_ #0'_N8O_<77[&5^.?\ P=G?\T!_[F+_ -Q=>%@?
MX\?G^1^+<&?\CFC_ -O?^D2/R8^#'PLU#XY_&'PIX)TF:SM]5\8ZS9Z'92W;
MLEO%-<SI#&TC*K,$#."2JL<9P#TK]!/^(6C]H'_H</@Y_P"#74O_ ) KXM_8
M/\1Z?X/_ &XO@SJVK7UGI>E:7XZT2[O;V[F6"WM(8]0@>2621B%1%4%BS$
M$DU_3OX _;.^#WQ8\76F@>%OBO\ #7Q+KU_O^RZ;I7B>RO+NYV(TC[(HY6=M
MJ(S' X523P#7HXRO4IM<A]]Q;G>88"I!81>ZTV]+GXM?\0M'[0/_ $.'P<_\
M&NI?_(%?$/[7W[+/B#]BK]HGQ#\,_%-YH]_KWAK[-]JGTJ626TD\^VBN4V-)
M'&YPDR@Y0?,#C(P3_6;7\UO_  7[_P"4MWQ9_P"X/_Z9K&HP>*J59N,NQR<(
M\2XW,,9*CB6K*+>BMK=+]3XYK]!/@Q_P;=_''XY_![PIXVTGQ5\*;?2O&.C6
M>N645WJ>H)<10W,"31K(JV3*'"N 0K,,YP3UK\^Z_JU_X)V?\H_/@7_V3W0/
M_3;;UKC:\Z23B>KQAG6)RZC3GAFKR;3NK]#^;_\ :B_X)T?$_P#92_:BM/A#
MJVDQ>(?%^J6\%UI2>'_-O8M7BF#8: %$D(#QRHVY%(,+G[N&/U[^SW_P:_?&
M#XC:+'?^._%7ACX=B>-72R5&U:^B)SE95C9(5QQ]V5^IZ8Y_<ZZ\ :)>^.;3
MQ--I.GR^(;"SET^VU)X%-S;V\K(\D2OC(1FC0D#J5%>5_M'_ /!1OX'_ +)%
MZ]G\0?B1X>T+4H@K/IR.][?HK'"L;:W628 ^I3'!/0&N)X^K)*,%J?&5.-\T
MQ,84<+&T[:M+F;?DM5\K,_-F]_X--)X[<FV^/44LO99/!9C4_B+YC^E?*7[9
M_P#P01^.W[(FCW6NVNG6?Q$\*VH:2:_\.;Y;BTC!4!IK5E$HZDDQB15"L691
M7[D?L_?\%-_@'^U'K-GIG@CXH^&=5U;469+339Y'L+ZZ9=V52WN%CE8X5C@+
MT&>G->[U"QM>$O?_ ".:'&.=86M;$N_>,HI?DDS^.>BOU4_X../^"9FE?!'7
M['XW^!=,AT[0O$U]]A\3:?:0[8;.^=2T=VBJNU$FVN),X'F[#RTIQ^5=>S1J
MJI#G1^LY1FE+,,+'$TM+[KL^J_KH?I3_ ,0M'[0/_0X?!S_P:ZE_\@4?\0M'
M[0/_ $.'P<_\&NI?_(%?LQX=_;P^!WC#Q!8Z3I/QF^%.J:KJEQ':65E:>+=/
MGN+N:1@D<4<:REG=F(4*H))( %>KUX[QU=;_ )'Y14XUSFF[5++UC8_E7_;Y
M_8&\8?\ !.GXPZ;X)\;:EX:U35=4T:+7(I=#N)Y[=89)YX55FFBB;?NMW) 4
MC!7GJ!X?7Z4_\'2__*0/P?\ ]D]LO_3EJ=?FM7KT)N=-29^JY)BZF*P-+$5?
MBDKL*]F_9+_X)^?%W]M[4Y(OAQX-U#6K*VN%MKO5)"MMIUDYVDB2XD*IN"L&
M**2^",*<C/U)_P $2/\ @CFO[=FMW'CWXB6M];?"K19_L\$".T#^)[D9WQ(Z
MD.L,?&^1<99MB-E7*?OUX+\%:/\ #CPI8:%H&EV&BZ-I4*VUG8V4"P6]M&HP
MJ(B@  #TKDQ..5-\D-SY?B/C2."J/"X1<U1;M[+R\W]UO/5'XI?#'_@U2^(.
MMZ6DOB_XI>$O#UTW)@TO3I]5"#W9VM^<>@(]Z["[_P"#329+<F#X]1R2]ED\
M%%%/XB^/\J_4?X]?MB_"S]EU8/\ A8/C[POX3FNE,D%O?WR)<W"@@%DAR9&
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M7RMLSR#X-?!GQ/\ M"?$S2O!W@W1[G7O$NMN\=E80%5><HC2-RQ"@!$9B20
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M%##$A=Y78X554<DDD  =<U]W_LJ?\&Z_Q]_:(TNRU?Q!;:5\,M$N\.#K[/\
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MOBK^WEXQ_M3XA>))[NSA</9:+:%K?2=.QN ,5ODKOP[ R-ND(."Y  '[S_\
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M5[_Z;=,KAS#^"?&\=_\ (J?^*)^E-?QSU_8Q7\<]<^5_:^7ZG@^&_P#S$?\
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M*P8LR%W[<+C?:/DGN?9<,\8+'3^JXM*-3HUM+_)_@_+8^&Z***]$^\"BBB@
MKK_@;\>O&'[-7Q(L?%W@77[_ ,->(M.SY-Y:L,[3]Y'5@4D0]T<%3CD&N0HI
M-)JS(J4X5(N%173W3U3/2OVM/VL/&7[:OQOU+Q]XYO8[O6M12.!8H R6ME#&
MH5(8(V9O+C'+;0>6=V.2Q)\UHHH225D31I0I05*FK16B1]!_\$H=%U?7_P#@
MI+\%(-$E\F\3Q;97,C9(S;12"6Y7@'K;I*/QZCJ/ZE:_#_\ X-A/V,;OQ=\:
MO$'QMU>RVZ)X3MI-&T*66(?Z1J$Z@3R1MG(\FW)1N.?M8P?E85^X%>%F$U*K
M9=#\9X\QD*V9<E/7DBD_6[=OE?Y.Y^-7_!V3J$$FK? BU4C[3##KTL@[A'.G
M!?U1Z_'ROM+_ (+V?M96_P"U/_P4(\01:5<M<>'_ (?PKX6LG#MY<TL#NUU(
MJD #_2'D3<,AUA0@D$8^+:]7"1<:,4S]+X6PT\/E5&G4WLW][;_4****Z3Z
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M:/?Z]X:^S?:I]*EDEM)//MHKE-C21QN<),H.4'S XR,$_P!9M?S6_P#!?O\
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MXG^S]_T73X.?^%IIO_QZL*&(JPC:&QXV39YF>"H.E@XWBW?X;ZV7^2/YW_\
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M6W_@UT_8YM?%/C3Q?\;]6MXIQX:<^&] W -Y-W)$LEW,,KE76"2*-2&^[<S
MCI7[5U\G?\$/_A(OP>_X)@?"RU.&N-;L9=>G<1[-YO)I)TR/]F)XESWV9[XK
MV[]K;XRO^SQ^R[\0_'442SW'A+P[?:I;Q,VU9IHH'>-"<' 9PHS@]>AKYO$3
M=2JS^?>(,7/'9G4DM?>Y8^B=E]^_S/Q1_P"#AK_@I7J/[0'QZOO@YX6U,IX
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M*LC*>58$$$'D$5ZF%Q*K1\T?I7#?$,,THMM<LX[K\FO(^L_V!O\ @C#\4?\
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M7//\5I%* ..N<5TWP&_X*A?L_P#[3&K66G>#?BIX7U'5-2<QVFGW,CZ?>W+
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M^\QW^[5/\+_(_JUK\$/^#I?_ )2!^#_^R>V7_IRU.OWOK\$/^#I?_E('X/\
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M9((*B0D'(K^G/PIX3TOP)X9L-%T33K+2-(TJW2ULK*S@6&WM(4 5(XT4!54
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_!-[X,?MN>)=+U?XG^#Y/$]_HMLUG9.=9U"S6WB9B[ );SQH26/+$$G &<
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M:VOZ4O\ @OW_ ,HD?BS_ -P?_P!/-C7\UM&6_P )^O\ D/P\_P"1=/\ QO\
M])B%%%%>B?>!1110!^QG_!IC_P U^_[EW_W*5^QE?CG_ ,&F/_-?O^Y=_P#<
MI7[&5\]COX\OE^1^#\9_\CFM_P!N_P#I$3^.>O8_^"=G_*0/X%_]E"T#_P!.
M5O7CE>Q_\$[/^4@?P+_[*%H'_IRMZ]Z?PL_;L=_NU3_"_P C^K6OQ9_X.?\
M]K?Q[X:^-/A?X1:5KMUI/@B_\+Q:[J-I9.T+ZK/+=7<&RX8']Y"J6ZE8_N[F
M8L&(3;^TU?@A_P '2_\ RD#\'_\ 9/;+_P!.6IUX> 2=;4_%N":,*F:1517L
MF]>Y^:U=]^S#^T=XE_9,^.GAWQ]X4O);35O#]VD^U7VI>19_>6\G7,<B95AC
MH<]0*X&BO>:35F?MU:E"K!TJBO%Z-']@W@[Q/;^-O".EZS9Y-IJ]G#>P$]2D
MB!U_1A7Y??\ !U7\,[+4OV:?AEXR:#_B9:-XFDT:.8$C$5W:R3.I&<'YK)",
MCC!QC)S]X?\ !.S_ )1^? O_ +)[H'_IMMZ^.?\ @Z7_ .4?G@__ +*%9?\
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M"KZ"OHG_ ()6?\$O/$?_  4G^,4EHD\VA> O#S))XBUM4!>-6R5MK<'AKB0
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M3^JU8].9?D?V ^ /&FG?$CP+HOB'2+B&[TK7;&#4+*>%P\<T,L:R(RL.""K
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M  0X_;EU7]N+]B>TO?$]P]WXQ\&7K:!J]TX ;4-B))!<G!/+1.JL3C=)'(<
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M'_H9_94_8F^&/[%?@>/0OAUX4T_0X@/](O"OG7]\QY+37#YD<YZ G:O10H
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M+_?K^NAP\%R:SBDEUYO_ $EGX[5^QG_!IC_S7[_N7?\ W*5^.=?L9_P:8_\
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M\:_])D>Q_P#!1/\ Y1^?'3_LGNO_ /IMN*_E*K^K7_@HG_RC\^.G_9/=?_\
M3;<5_*54Y9\#.7PZ_P!VK?XE^04445Z9^C!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P =PI/J6X[GTBS^]#9#^ZPR'EQU<A<L(U-<N*Q'LH7Z]#YSB;/(Y9A.>/\
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MC_!/_P!)9_2E7\UO_!?O_E+=\6?^X/\ ^F:QK^E*OYK?^"_?_*6[XL_]P?\
M],UC7DY;_%?I_D?E_AY_R,9_X'_Z5$\=_P""?/[-*_M@?MG_  \^'4S%;'Q%
MJ@^WE6*M]CA1[BY"D8(;R(I,'UQ7]56B:+:>&]&M-.L+:&SL+"%+:VMX5"QP
M1(H5$4#@    >@K\"_\ @U_T&+6/^"B>MW$BJ7TKP/?W41(Y5C=V,.1[[96_
M,U^_U&8S;J<O87B!B9SS"-%[1BOO>K?Y+Y'P%_P7N_X*8ZI^P[\$-+\*>";L
MV7Q ^("RK!?1G]YHUC'@2W"^DK,P2,]OG8'*#/\ /9JVK76O:I<WU]<W%Y>W
MDK3W%Q/(9)9Y&)9G=CDLQ))))R2:^Y?^#CGXAOXU_P""HGB/36$F/".BZ7I*
M;AP0]N+WY>>F;L^G.>.Y^$J]#!4E"DGU9]UP=EE/"Y="JE[]1<S?KLO2W^85
MV=I^T3XZL?@G>_#>+Q9KJ^ ]0O8=0GT+[6YLFGB+E6$9.%^:0LRK@.RQLP9H
MT*\9176TGN?43IPG;G5[:_/N%>Q_\$[/^4@?P+_[*%H'_IRMZ\<KV/\ X)V?
M\I _@7_V4+0/_3E;U,_A9ACO]VJ?X7^1_5K7X(?\'2__ "D#\'_]D]LO_3EJ
M=?O?7X(?\'2__*0/P?\ ]D]LO_3EJ=>)E_\ &/QO@3_D:K_#(_-:OZM?^"=G
M_*/SX%_]D]T#_P!-MO7\I5?U:_\ !.S_ )1^? O_ +)[H'_IMMZZLS^&)]1X
MB_[M1_Q/\CY(_P"#GOQ7JGAC_@GKH$6FZE?Z?'J_CBSL;Y+:X>);VW-AJ#F&
M4*1OC+QQMM;(RBG&0*_ &OWO_P"#I?\ Y1^>#_\ LH5E_P"FW4Z_!"M<O_A'
MI\!I+*TU_,S1\)>+]6\ ^)+/6="U34=%U?3Y!-:WUA<O;7-LXZ,DB$,I]P17
M],?_  1X_;>NOV\OV(M"\4:S*)O%NASOH'B*01A!<7D"(WGX"JO[V*2&0A %
M#2,H^[@?S%U^TW_!J!XUGO\ X=_&GPZRG[-I6HZ5J4;;^KW,5U&PQCC M4YS
MSGMCE9A33I\W5&7'N!A4R_ZQ;WH-:^3=K>EVOZN?J'\?_@]IW[0?P/\ %O@?
M5E#:?XLTFYTN8GK&)8V0./1E)# ]BH-?R1^(_#UYX2\0W^E:C ;;4-,N)+2Z
MA8@F*6-BCJ2"0<,".#CBO["Z_E!_;ZTQ-%_;L^-5G%@1VGCS7(4VKM&%U"<#
M [=*Y\LD[RB>%X<UI>TK4NED_GK_ )_D>6Z3JUUH.J6U]8W-Q9WMG*L]O<02
M&.6"12&5T88*L" 00<@BMSPOX,\7?'CQO/!HND^(_&?B347>[GCLK6;4;ZZ9
MFR\K! SL2S<L<Y+<G)K[)_X(V_\ !'/4/^"A/B:7Q;XNDO-%^$^A7'DSS0'9
M=:_<K@FV@)^XB@@R2X.,A%^8LT?[Z? 3]F[P+^R]X"M?#/@#POI/A?1[1%01
M6<.'FP,;Y9#F25SW>1F8]R:Z<1C8TWRQ5V>]GW&.'P%5T:$>>HM^R\K]7Y?C
M?0_G&\$_\$3/VIO'^EV]Y8_![7H(KI!(BZE=V>F2J",_-'<S1NA]F ([BOJS
M_@E7^PA^UO\ \$\/VS?">N:K\/->L? OB2]BT;Q1!8ZMI]_!+:RDQI/-'#.Y
M MY'67> &55<9VLRM^XE%<$\?4G%Q:5F?%8SCC&XFC/#U:<.62:V?_R6ZZ>8
M5_.7_P '$GPIA^&?_!3SQ/>6XVQ>,-+L-=V;<!':+[.^/7<]LS'W8U_1I7X&
M_P#!TG D/_!0;PFRJ 9?A_9,Y_O'^T=2&?R _*C+OXWR#@.36:676+_0_-FO
MZ4O^" G_ "B1^$W_ '&/_3S?5_-;7]*7_! 3_E$C\)O^XQ_Z>;ZNW,OX2]?\
MS[#Q#_Y%T/\ &O\ TF0?\%^_^42/Q9_[@_\ Z>;&OYK:_I2_X+]_\HD?BS_W
M!_\ T\V-?S6T9;_"?K_D'AY_R+I_XW_Z3$*]D_X)\_LTK^V!^V?\//AU,Q6Q
M\1:H/MY5BK?8X4>XN0I&"&\B*3!]<5XW7Z,_\&P/A^'6O^"BFM7,J(SZ3X(O
M[N$L,E'-W8PDCT.V5A]":Z\1-QIRDCZ?/,3/#Y?6K4]U%V\GM?Y;G[ZZ)HMI
MX;T:TTZPMH;.PL(4MK:WA4+'!$BA410.    !Z"ORP_X.4?^"B.K?!WPOHOP
M2\':E=:9JOBRS_M7Q'>6LSPS1:?YC)#;*ZXXF>.4N P.R,*05E-?JS7SK^T?
M_P $GO@#^UQ\4)_&?Q#\"2>(O$ES!%;/=MKVIVP\N-=J*(X;A(U 'HHR22<D
MDU\_0E",U*:T/PK),3A</C(U\9%RC'6RMOTW:]3^7&MGX??$+7/A1XUTWQ'X
M;U6]T37='G6YLKZSE,<UO(.ZL/Q!'0@D'(-?T<_\.!/V2/\ HDW_ )=&L_\
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M_'9(V/0XKN?^"57BJ'QE_P $WO@G=P2^<D/A#3[$MG.'MX1;LOX-$1^%5_\
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MNDG8.<7MQ#9'N.,7!S[9X/2O+J-U*S\V?FF/E4Q^:3OO.=EUZV2^2LC\)_\
M@J1_P4M\4_\ !1#XZ7]Y+>WMG\/](NG3PWH?F$0P1+E5N)$Z&XD4DLQR5#;
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MS]KRT_;B_9NMOB!91""WOM8U2TABP0R00WTT=ON!Z.UN(&8>K&O(_P#@N_\
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M]&I??H_R1CU_8Q7\<]?V,4LT^S\_T,O$C_F'_P"W_P#VT_'/_@[._P": _\
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MW78_1<[Q,\/D,JD-^2*_\"LOU/V<K\0_^#D__@HCJWB;XO+\!?"^I75EX?\
M#44-UXH-O,\?]IWDL8DCMI,8#PQ1/&Y&2IDDY&Z(5^WE?+GQ=_X(O_LU?'GX
MF:UXQ\6_#F36/$GB&Z:\U"\?Q'JT1GE;J=B72HHX "JH     %>/AJD(3YIH
M_).'L;@\)C%B,9%R26B5M_.[72_SL?S%5W/[.'[1WB[]E#XP:1XX\$:K-I.N
MZ/*'1E)\JZCR"T$R CS(GQAE/4>A (_H9_X<"?LD?]$F_P#+HUG_ .2Z/^'
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M$1)>WDXXR2C;@%=CD#Y0KUH3C-<T-C].P6+P^)I*MA9*47V^_7L^]]3]*?\
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MN1N&#7\N_P#P5J_9EM?V2O\ @H%\1/"6F6@LM!>^&JZ1"B*D45K=(LZQQJH
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M[_P1?_9J^//Q,UKQCXM^',FL>)/$-TUYJ%X_B/5HC/*W4[$NE11P %50
M *\S#5(0GS31^;\/8W!X3&+$8R+DDM$K;^=VNE_G8_F*KN?V</VCO%W[*'Q@
MTCQQX(U6;2==T>4.C*3Y5U'D%H)D!'F1/C#*>H]" 1_0S_PX$_9(_P"B3?\
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M_";_ +C'_IYOJ_FMK^E+_@@)_P HD?A-_P!QC_T\WU>=F7\)>O\ F?!^(?\
MR+H?XU_Z3(^QJ***\0_&PHHHH **** "BBB@ HHHH ^.?^"_?_*)'XL_]P?_
M -/-C7\UM?TI?\%^_P#E$C\6?^X/_P"GFQK^:VO;RW^$_7_(_9/#S_D73_QO
M_P!)B%%%%>B?>!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6.TD0;EPPPY^5AG!R!\A?M)? '7?V6?CKXF^'OB5K*37/"MZUE=26<C/;RD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFM_V[_Z1$_CGKV/_ ()V?\I _@7_ -E"T#_TY6]>.5['_P $[/\ E('\"_\
MLH6@?^G*WKWI_"S]NQW^[5/\+_(_JUK\$/\ @Z7_ .4@?@__ +)[9?\ IRU.
MOWOK\$/^#I?_ )2!^#_^R>V7_IRU.O$R_P#C'XWP)_R-5_AD?FM1117O'[<?
MU:_\$[/^4?GP+_[)[H'_ *;;>OCG_@Z7_P"4?G@__LH5E_Z;=3K[&_X)V?\
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M,T5T/C;X2>*_AIXB32/$?AGQ#X?U:1]B66I:=-:7#MP,".10Q/(XQW%?;?\
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M***[3ZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.?GL$[5XW/PC@^:CG%%R\_QBT?BG7V-_P0$_Y2W?";_N,?\ IFOJ^.:^QO\
M@@)_REN^$W_<8_\ 3-?5[E?^%+T9^SYW_P B[$?X)_\ I+/Z4J_FM_X+]_\
M*6[XL_\ <'_],UC7]*5?S6_\%^_^4MWQ9_[@_P#Z9K&O)RW^*_3_ "/R_P /
M/^1C/_ __2HGQS7]6O\ P3L_Y1^? O\ [)[H'_IMMZ_E*K^K7_@G9_RC\^!?
M_9/= _\ 3;;UT9G\,3WO$7_=J/\ B?Y'QS_P=+_\H_/!_P#V4*R_]-NIU^"%
M?O?_ ,'2_P#RC\\'_P#90K+_ --NIU^"%;9?_!/4X$_Y%2_Q2"OWO_X-:/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K^K7_@G9_RC\^!?_9/= _]-MO7\I5?U:_\$[/^
M4?GP+_[)[H'_ *;;>O+S/X8GYSXB_P"[4?\ $_R/'/\ @OW_ ,HD?BS_ -P?
M_P!/-C7\UM?TI?\ !?O_ )1(_%G_ +@__IYL:_FMJ\M_A/U_R.KP\_Y%T_\
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MC\0Z+KOAS7!X8L[V1=)UYK9I++4;0N1#)YZJ(]Y4KN3@JQP0.*Y<OC!S?/\
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MS_@V)\40Z!_P4:U.UD=5?6_!=_90@_QLMS9SX'_ 8&/X5^R7_!3;Q#:>&/\
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M5E'86-NI+%(T&,LQY9V.69CRS,2>37,?MA^+/B1X._9W\1W7PD\*KXP^(<L
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MFT@$TD6Z[D!=$)8#8V=N,<UI+!5[:_F=]?@_.Y0;J>\EK;FO]WF?N77\QO\
MP66_9-'['W_!0+QIH5G!Y&@>(91XET51@*MK=L[&-0  %CF6>)1_=B')ZU_3
M?;W"7<"2Q.DD4BAT=#E7!Y!![BOS._X.<?V33\4_V5-"^*&FV^_5/AK?>3?D
M9R^G7;)&QP <E)Q 1G "O*<U&!J\E779G+P;F7U3,8QE\,_=?SV_'\S\&Z_L
M8K^.>O[&*ZLT^S\_T/I/$C_F'_[?_P#;3\<_^#L[_F@/_<Q?^XNOQSK]C/\
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M@G_Z2S^E*OYK?^"_?_*6[XL_]P?_ -,UC7]*5?S6_P#!?O\ Y2W?%G_N#_\
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MD0SU;RKB5E4$%F11GG!\VG:51<^US\_P'LZV-@\7+W7)<S?KK?\ 5_,_!?\
M:!_X*+_&W]IOQ)>ZAXM^)/BNYCO6/_$NM=0DM-.A4DD(EM$5C &<9VDG R2>
M:9_P3BLYK_\ X*$? Q((I)G'C_0I"L:EB%74(&9L#L%!)/8 GM7F?B;X9>)/
M!7BU= UCP_K>DZZ[K&NFWMA+!=LS-M51$RA\EN ,<GBOTY_X(%?\$G/B$G[3
M.D_&+XA>&=5\)>&/"$<MQH]OJD)MKO5[YT:)"('7S%AC5G?>P7+^5LWC?M]Z
MK*G3IMJQ^VYGB<#E^7U)4^6-XM)*RN[.UK;_ /#G[AU^"'_!TO\ \I _!_\
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MP_\ ^"4?[27Q+U%K73O@G\0[:1"H+:KI$FDQ_-G&'NA$IZ'.#QQG&17Z'?\
M!.O_ (-I+OPYXRT_Q;\?[[2KRUL'$T'A#393/'<N-I7[9<<*4!W9BC#!_ES)
MMW(V]3%4X+5GKYAQ)E^#@W.HFUT3N_PV^=C\;J*_6C_@Y;_X)ZQ>!?$FD?'7
MPGIB0:3JYBT7Q/!:PXCM;A4VVMUM5<*CHGE,20 R0CEI*_)>JH554ASHZLGS
M2GF&$CBJ:M?==GV_KH?O?_P:T?\ */SQA_V4*]_]-NF5]C?\%$_^4?GQT_[)
M[K__ *;;BOCG_@UH_P"4?GC#_LH5[_Z;=,K[F_:Z^'US\6OV4/B?X5LV*7?B
M;PEJNDP,$WE7GLY8E.W(SRXXR,^HKQ,0[8AM]S\8SV:AGE2<ME-?H?R54445
M]"?O9_5K_P $[/\ E'Y\"_\ LGN@?^FVWKXY_P"#I?\ Y1^>#_\ LH5E_P"F
MW4Z^QO\ @G9_RC\^!?\ V3W0/_3;;U\<_P#!TO\ \H_/!_\ V4*R_P#3;J=?
M.T/]X7J?@^3?\CZ'^-_J?@A7[&?\&F/_ #7[_N7?_<I7XYU^QG_!IC_S7[_N
M7?\ W*5Z^._@2^7YGZAQG_R)JW_;O_I<3]C*_CGK^QBOXYZY,K^U\OU/E_#?
M_F(_[<_]N"OL;_@@)_REN^$W_<8_],U]7QS7V-_P0$_Y2W?";_N,?^F:^KT*
M_P#"EZ,^\SO_ )%V(_P3_P#26?TI5_-;_P %^_\ E+=\6?\ N#_^F:QK^E*O
MYK?^"_?_ "EN^+/_ '!__3-8UY.6_P 5^G^1^7^'G_(QG_@?_I43XYK^E+_@
M@)_RB1^$W_<8_P#3S?5_-;7]*7_! 3_E$C\)O^XQ_P"GF^KKS+^$O7_,^H\0
M_P#D70_QK_TF0?\ !?O_ )1(_%G_ +@__IYL:_FMK^E+_@OW_P HD?BS_P!P
M?_T\V-?S6T9;_"?K_D'AY_R+I_XW_P"DQ/ZG_P#@EQXK@\9?\$Y/@C=VTB2Q
MP^#-,L2R] ]O;I;N.IY#1,#[@]*R_P#@KG\*)?C3_P $U_C#H4%M+>7 T!]3
MA@B#%Y9+.1+Q H7DG= , =3Q@YQ7R%_P;$?MCV7CK]GO6_@QJ-Q%%KO@:YEU
M728B0IN].N9"\FT;B6,5R[[S@ "YBZG-?J/<6Z7<#Q2HDD4BE'1URK@\$$=Q
M7EU4Z=5^3/S7,Z57 9I-/>,KK[[IG\=5%?I/_P %2O\ @@-X_P#@?\2=9\7?
M!W0;WQI\/-2F>\32].C\[4] +$LT @7YYH5S\C1AF"\.,KO?\[?&/@76_AYK
M!T[Q!H^JZ'J 7>;74+22VF"Y(SL< XRI'3J#Z5]!2K0J*\6?N>79OA<=34\/
M--OIU7JC*HKZ>_9 _P""0GQU_;$\7VMKI?@G6/#6@-(GVOQ!K]I)86%M&V3O
M3S &N#\N-L(<@LN[:#NJ7_@K%_P3CG_X)M?M!:?X:M]1O=<\-Z[I4.H:7J=S
M$L;SN ([F-@O *R@D#LDD>23DE>W@Y\B>HEG.#EBE@XU$YM-V6NWZVUMV/IW
M_@UP^ .F^/OVI?&_CZ_@2XG^'^CPV^GAXPWV>XOFD3SE/9A#!,G':9J_=BOQ
MB_X-.O$MM:^*_CCH[.@O+ZTT6\B0M\S1PO?(Y ] 9X\_4>M?L[7B8YOV[_KH
M?CO&LY2SBJF]N5+_ ,!3_-L_$C_@N)_P6?\ B/I'[1?B+X0?"[7[CP?X>\*%
M;'5M4TUO*U+4;W:3,B7 ;=%$FY4P@5]\;DL00H_+GQO\2?$7Q-U,7OB37]:\
M07@SB?4KZ6[E&>OS2,3V'Y5]A?\ !:O_ ()\>/\ ]G[]M#XA^,%\.:YJ?@7Q
MGJ]UXEM-<@MFGM8C<N9YXI71=L31RO(H#X)15.3R:^9?@!^R;\2OVI_$,6F?
M#WP3XA\57$LWD&2RM6-K ^,_O9VQ%$,$<R.HY'/->MAE2C34E;U/T[A^GEN'
MR^G6I..RO+1.]M;OIUTOH?MA_P &M]G-:_\ !/?Q4\D4D:7'C^]DB9E($J_V
M?IR[E/<;E89'=2.U?87_  43_P"4?GQT_P"R>Z__ .FVXK._X)M_L?C]A;]C
M?P?\.IKF&]U;3H'NM7N86W137T[F6?RR54F-6;8A*@E(U)&<UU?[97@J?XD_
ML@_%7P[;,4N=?\':OIL3!-^UYK*:-3C(SRPXR*\6I44JSGTN?D6/QU.MFLL4
MOA<[_)/?[C^3"O8_^"=G_*0/X%_]E"T#_P!.5O7CE>Q_\$[/^4@?P+_[*%H'
M_IRMZ^BG\+/WO'?[M4_PO\C^K6OP0_X.E_\ E('X/_[)[9?^G+4Z_>^OPP_X
M.J?A]<Z;^U?\-O%3,?LFL^$FTF)=G >TO)I7.[/.1>IQ@8QU.>/#R]_OD?C'
M TU'-HI]5+\K_H?EM1117OG[B%%%% &OX!\%WOQ(\=:+X=TT1G4=>OX-.M1(
M2$,LTBQID@$@;F&>#7]>/A3PY;^#O"VFZ1:*%M=+M8K.%0,82- BC'T K^97
M_@C/\)$^-'_!3;X1Z7-;R7%MI^L_VW-M!VH+&)[M2Q_N^9"@YX)8#OBOZ>J\
M;,Y7FHGY)XBXGFQ-*A_+%O\ \"?_ -J?DY_P=8_%J'3O@I\*O @WM/K.MW.O
M/C&V-;2#R%SSG+&\;''\#=.,_G__ ,$0_P!IH?LO?\%&_ U]=7 MM&\62-X6
MU-BN08KLJL63V"W*V[$]@AKV'_@YL^+W_"=?\%!;'PW#=K+:^"/#5I:20*01
M!<SO)<N3W#-%);\>BKZ\_G;;74EE<QS0R/%-$P='1BK(P.001R"#77AJ5\/R
MOJ?4\/98JF0+#3_Y>*7_ )->S^ZQ_8I530="L_"VAV>F:=:P6.GZ= EK:VT"
M!(K>)%"HBJ. JJ  !T KR/\ X)Y_M,+^U_\ L6_#SX@M+#+J&N:3&NJ>4C(B
MW\),%V K<A?/CDVY)^4J02""?3/B5\0=,^$WP[U[Q3K=PMIH_AS3Y]3OIFZ1
M00QM([?@JFO"::?*S\6JT9TZCI37O)V?JM#\-/\ @YR_:J'Q1_:TT+X8Z?<E
M]-^&NGB6_12P4ZC>*DK C[K;+<6^",X,LBYSD5S'_!M%\:%^'/\ P41;PW/<
MO';^/O#UYIT4.W*RW,&V[0D]B(X)P">/GQU(KXC^/WQDU/\ :'^-_BSQUK+.
M=2\6:M<:I,K2F7R?-D9Q$K'G8BD(HXPJ@  #%=?^P%\:A^SM^VO\+O&4MQ#:
M6>B>([-[Z:8X2.T>017))R,?N7DY[5[_ +"V']GY?B?N4LE5/(I8!+7D?_@7
MQ?\ I1_5U7\RO_!;OX0?\*9_X*>?%.SCM/LMEK=_'KUL0N%G%Y"D\KK_ -MW
MF!]U-?TU5^&__!U/\)4\/_M*?#/QM'N'_"3^'KC2I%_A+V4X?=]2MZ@//1!^
M/FY?*U:W<_.^ \3[/-%3_GBU_P"W?H?E?7]C%?QSU_8Q71FGV?G^A[OB1_S#
M_P#;_P#[:?CG_P '9W_- ?\ N8O_ '%U^.=?L9_P=G?\T!_[F+_W%U^.==>!
M_@1^?YGU'!G_ ")J/_;W_I<C]*?^#6C_ )2!^,/^R>WO_IRTROWOK\$/^#6C
M_E('XP_[)[>_^G+3*_>^O+S#^,?G/'?_ "-7_AB?RE?\%$_^4@?QT_[*%K__
M *<KBOT4_P"#3WQ1#:>-_C;HI=1<7]CH]ZB=V6"2\1C^!N%[=Q7P7_P5>^'U
MS\,_^"DOQKTZZ8O)<^+;W5E)3;\E[(;Q!C)Z).HSWQG S@=+_P $:/VP[3]B
MK]O?PKXBU>:.V\,Z^K^'-<G=@JVUK<LF)F9F 5(IT@D<G/R1O@9Q7IU8N>&M
M'LC]$S7#RQN0N%'6\(M>=K2_&Q_3A7XV_MZ_\' ?Q\_8_P#VQ/B!\-[7PM\*
M;JP\,:HT-A->:5J!N)+215FMS(5O54N89(\E54$Y(50<#]D5<.H((((R".]?
MG-_P7 _X(U:A^W+]F^(_PW%FGQ(T>S^R7FG3RB%/$-LF3&JNQV)<)DJI?:K*
MP#,NQ:\C"NFIVJ['Y3PU6P,,9RYA%.$E;79/H_T^=SXJ_P"(I?\ :!_Z$_X.
M?^"G4O\ Y/H_XBE_V@?^A/\ @Y_X*=2_^3Z^#?C%^S7\0?V>]3DM/''@KQ1X
M4ECN&MMVJ:;+;QRR#/"2,H20$ D%"00,@D<U/\'_ -ECXE?M WMM!X)\!>+O
M%)NY%BCETW2IIX 2VW+RA=B*"#EF8*N"20 :]CZOA[7LK'ZU_8>1\GM?9PY>
M]]/ON?=?_$4O^T#_ -"?\'/_  4ZE_\ )]<)^TW_ ,'#'QO_ &I_@-XE^'NL
M:'\-]&TGQ5:BRO+K2--O([Q8=ZLZ(TMU(@WJI1LH3M=L8.&%S]HW_@@GX^_9
M>_X)[W7Q:\1WL;^,=+O(+C5O#EH1.FE:9)F-F:1 PDG25XB^P^6D8D.YMN:^
M!:5*EAY^]!;&>6Y;D>*O6PE.+Y96OYK^OF%6=(UB[\/ZM:W]A=7%C?6,R7%M
M<V\ACEMY$(971E(*LI ((.00*986$^JWT-K:PRW-S<R+%##$A=Y78X554<DD
MD  =<U]R?M-?\&]_Q\^ ?@G2M?T72H_B':7&FPW6I6NAH6U#2K@QAI8/LY.^
M94;*J\6XMC)1,XKHG5A%I2>Y[>+S+"8:<:6)FHN>U^OZ?>;O[&?_  <8_&K]
MG5;'2?'!M_BKX9M]L;?VI(8M8BC "@)>*"9#QDF=)&8D_,.W[1?L,?\ !07X
M;_\ !0CX;3^(/ &IS//IC1Q:OI%['Y.H:1(ZED65,D%6PVV1"R,4<!MR,%_E
MQ\;_  V\1?#+4Q9>)- UKP_>'.(-2L9;24XZ_+(H/<?G7ZW_ /!L5^RO\3OA
MM\4?'OCKQ!HFN>&?!6I:(FEV\.I6;VO]KW?GQRI-$K@,R11K*I8#:3<8!)4@
M>=C,/24/:1T9\'Q;D661PDL=0M"?2STEJD]/\OF?KG\1_AUHOQ<\!:OX8\2:
M=;:MH.O6DEE?6<Z[H[B)QAE/IUX(Y! (P17\JO[;?[-TO[(7[6/CSX<23O=1
M^%M5DM[2=VW23VK 2V[N0JC>T+QEL #<3CBOZQ:_F>_X+L>(;3Q/_P %7OB[
M<V4B2PQW6GVC,AR!)!IEI#(/J'C8'W!K++9/G<?(\OP[KS6-J44_=<;_ #32
M7YL]R_X-:/\ E('XP_[)[>_^G+3*_>^OP _X-@O$EOH?_!136;::2-)-8\$7
M]G;AFP9'%W93D+ZG9"YQZ GM7[_UEF'\8X.._P#D:O\ PQ/Y2O\ @HG_ ,I
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M ,R[%KS,*Z:G:KL?G?#5; PQG+F$4X25M=D^C_3YW/BK_B*7_:!_Z$_X.?\
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MO(8Y;>1"&5T92"K*0""#D$"F6%A/JM]#:VL,MS<W,BQ0PQ(7>5V.%55')))
M '7-?<G[37_!O?\ 'SX!^"=*U_1=*C^(=I<:;#=:E:Z&A;4-*N#&&E@^SD[Y
ME1LJKQ;BV,E$SBNB=6$6E)[GMXO,L)AIQI8F:BY[7Z_I]YN_L9_\'&/QJ_9U
M6QTGQP;?XJ^&;?;&W]J2&+6(HP H"7B@F0\9)G21F)/S#M^T7[#'_!07X;_\
M%"/AM/X@\ :G,\^F-'%J^D7L?DZAI$CJ6194R05;#;9$+(Q1P&W(P7^7'QO\
M-O$7PRU,67B30-:\/WASB#4K&6TE..ORR*#W'YU^M_\ P;%?LK_$[X;?%'Q[
MXZ\0:)KGAGP5J6B)I=O#J5F]K_:]WY\<J31*X#,D4:RJ6 VDW& 25('G8S#T
ME#VD=&?!\6Y%ED<)+'4+0GTL]):I/3_+YGZY_$?X=:+\7/ 6K^&/$FG6VK:#
MKUI)97UG.NZ.XB<893Z=>".00",$5_*K^VW^S=+^R%^UCX\^'$D[W4?A;59+
M>TG=MTD]JP$MN[D*HWM"\9;  W$XXK^L6OYGO^"['B&T\3_\%7OB[<V4B2PQ
MW6GVC,AR!)!IEI#(/J'C8'W!K++9/G<?(\OP[KS6-J44_=<;_--)?FSY(HHH
MKVC]?"BBB@ HHHH **** "BBB@ HHHH **** "OZ4O\ @@)_RB1^$W_<8_\
M3S?5_-;7]*7_  0$_P"42/PF_P"XQ_Z>;ZO.S+^$O7_,^#\0_P#D70_QK_TF
M1]C4445XA^-A1110 4444 %%%% !1110!\<_\%^_^42/Q9_[@_\ Z>;&OYK:
M_I2_X+]_\HD?BS_W!_\ T\V-?S6U[>6_PGZ_Y'[)X>?\BZ?^-_\ I,0HHHKT
M3[P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ]3DIN1]EG..^IX*KB>L5IZO1?C8_>SPGX8LO!'A;3=&TV%;?3M(M(K*UB4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP= [L%S(@&5;) VD5]XU_'7;74EE<QS0R/%-$P='1BK(P.001R"#7TO\+O\
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MS*J-*T<,BJ7*HBEB,X11G@48FBZL.1!Q#E,\QP;PT)<KNG=^1_3O_P %$_\
ME'Y\=/\ LGNO_P#IMN*_E*KU?Q%^WA\<?&'A^^TG5OC-\5M4TK5+>2TO;*[\
M6ZA/;W<,BE)(I(VE*NC*2I5@002"*\HJ,)AW1339Q\,9#4RNE.G4DI<SOH?U
M$?\ !*2?X6Z/^Q%X&\-?"OQ=H'B_2_#NF0Q7]WISA)'O9%$T\D\!/F02/)(S
M^7( RA@.U?2%?R!?#_XE^(_A-XDCUCPKK^M^&=7B4HE]I5]+9W**<9 DC96
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?L9_P:8_\U^_[EW_ -RE?CG7
M9?"7]HGX@_ /[?\ \(+XZ\8^"_[6\O[=_8.M7.G?;/+W^7YGDNN_;YC[=V<;
MVQU-8XBFZE-P1Y&>Y=+'X&>$@[.5M?1I_H?US5_*5_P43_Y2!_'3_LH6O_\
MIRN*/^'B?[0/_1=/C'_X6FI?_'J\I\1>(]0\8>(+[5M6OKS5-5U2XDN[V]NY
MFGN+N:1B\DLDC$L[LQ+%F)))))KGPF$=%MMGA\,<,5<KJSJ5)J7,K:%*BBBN
MX^S"BBB@#V/_ ()V?\I _@7_ -E"T#_TY6]?U:U_'IX=\1ZAX/\ $%CJVDWU
MYI>JZ7<1W=E>VDS07%I-&P>.6.12&1U8!@RD$$ @UZM_P\3_ &@?^BZ?&/\
M\+34O_CU<.+PKK--,^,XGX8JYI5A4IS4>56U/L;_ (.E_P#E('X/_P"R>V7_
M *<M3K\UJZ7XI_&?QA\<_$$.K>-O%?B7QAJMO;K:17NN:G/J%Q%"K,ZQ+),S
M,$#.[!0<9=CCDUS5=-&#A!1?0^BRG!2P>#IX:3NXJUPHHHK4]$^Z/^".O_!8
MK4_^">?B>7PKXJBO-=^%.NW EN+>$[KG0IS@&YMP3AE88\R+C=@,I# A_P!^
MO@'^T;X'_:A^'MIXI\ ^)M+\3Z)>(&6:TER\)(!V2QG#Q2#/*2*K#N!7\CM;
MWPZ^*7B;X/\ B1=8\)>(M=\+ZNJ&-;[2+^6RN0A()421,K8RH.,]AZ5P8C Q
MJ/FCHSXK/N#*&/J/$4)<DWOIH_\ )^?X7U/Z^J*_F=\/?\%U/VKO#%HL-M\7
M=1D1%" W>CZ;=OCW:6W9B?<G-2ZM_P %X?VL=:AV3?%R[08QF#0M+MS^<=LI
MKB_LVKW7]?(^0_XAYF/\\/OE_P#(G]*/B#Q%I_A+1;G4M5OK/3-.LHS+<75W
M,L,," 9+.[$*H ZDFOYE?^"QOBGX5>/?V_/&7B'X0ZS!K?A[7G6\U":UMFBM
M$U,EDNO(8@>:CN@E\T95VF<J2N"?&OC5^U-\2?VC[I9/'GCOQ7XNV2>='%JF
MIRW$,#XVYCB9MB'!(^4#J?6N"KMPN#=)\S>I]=PSPG/+*KQ%6I>35K+;\=7Y
M:(*^G?\ @F!_P4V\5?\ !-WXR'4K%)-9\%ZX\<?B'0B^!=QKG$T)/"3H"=IZ
M,,JW!!'S%179.$9QY9;'UF,P='%494*\;Q9_5U^R1^W7\+OVW_!:ZQ\._%6G
MZNZ1J]YICN(M2TTDD8GMV^=.58!L;&VDJS#FO7J_CW\*^+-5\"^(+;5M$U+4
M-'U6R8O;WEC</;W$#$$921"&4X)'![FOI7P'_P %KOVI?AQI4%GIWQA\03PV
MZA4.IVMIJDI &/FDNH9';ZL3ZUY4\LE?W']Y^98WP[K*=\'53C_>NFOFD[_<
MC^G.H;^_@TNREN;F:*WMX%+R2RN$2-1R22> !ZFOYKKW_@O?^UI?P>6_Q:E5
M<YS'X<TB-OS6U!KQ/X\_MR?&#]IZ%H?'OQ'\6^);)]N;&YOW6QRIW _9TVQ9
M!P<[,\#G@5"RRI?5HYJ7AWCG*U6I!+RNW]UE^9]1_P#!PI\5O@S\</VO].\3
M?"OQ)8>)-9FTT67BJXTQ ^GRSP[1;RI< ;9W,+>6S(S*%@C&<@BO@>BBO7I0
MY(*"Z'ZEEN"6#PT,-&3DHJUWO_7;R/ZS/V.?VB-(_:L_9B\%>/M&N4N+;Q#I
M<,TRB02-;7(4+/ Y!/SQRAT;W6H/VS?V3O"W[;/[.VO_  \\7>=#I>K(LD=Y
M 0LVG7$9WQ7$9/&58<@\,I93PQK^9K]ES]OOXP_L7"^3X9^.M5\,6VI2"6YM
M%CANK2:0 #S#!.CQ;\ #=MW8 &<"NI^/W_!63]HG]IWP;/X>\9?%+7;[1+L%
M;JRLH;?2X;Q"I4QS+:QQ>;&03E'RIX)&0#7E_P!G34[Q>A^:O@#&0Q7/AZL5
M%.Z>O,NVEK77K]QY-\?_ (=:-\(_C/XC\,^'_%NF>.]'T2]:TMM?TZ)HK74P
MN 7C#$Y7=D;@65MN59E*L?I;_@@)_P I;OA-_P!QC_TS7U?'-;/@#XB^(/A/
MXNM-?\+:[K/AK7K#?]EU+2KV2SN[;>C1OLEC977<CLIP>58@\$UZDX.4'#R/
MTG%X2=;!3PW-=RBXW?=JUW;[]#^O^OYK?^"_?_*6[XL_]P?_ -,UC7CG_#Q/
M]H'_ *+I\8__  M-2_\ CU>:^/\ XB^(/BQXNN]?\4Z[K/B77K_9]JU+5;V2
M\N[G8BQIOED9G;:B*HR>%4 < 5QX7!RI3YFSY;AKA2KEF*EB*E123BUHGW3_
M $,:OZM?^"=G_*/SX%_]D]T#_P!-MO7\I5>K^'?V\/CCX/\ #]CI.D_&;XK:
M7I6EV\=I965IXMU""WM(8U"1Q1QK*%1%4!0J@    5KB\.ZR23/0XGR&IFE*
M%.G)1Y7?4_9C_@Z7_P"4?G@__LH5E_Z;=3K\$*[[XI_M6?%'XY^'X=)\;?$C
MQ]XPTJWN%NXK+7/$%WJ%O%,JLBRK'-(RAPKNH8#.'89Y-<#5X:BZ4.1G9P]E
M,\NP:PTY<SNW=>85^]__  :T?\H_/&'_ &4*]_\ 3;IE?@A7??"S]JSXH_ S
MP_-I/@GXD>/O!^E7%PUW+9:'X@N]/MY9F54:5HX9%4N51%+$9PBC/ HQ-%U8
M<B#B'*9YC@WAH2Y7=.[\C^G?_@HG_P H_/CI_P!D]U__ --MQ7\I5>K^(OV\
M/CCXP\/WVDZM\9OBMJFE:I;R6E[97?BW4)[>[AD4I)%)&TI5T925*L"""017
ME%1A,.Z*:;./AC(:F5TITZDE+F=]#V/_ ()V?\I _@7_ -E"T#_TY6]?U:U_
M'IX=\1ZAX/\ $%CJVDWUYI>JZ7<1W=E>VDS07%I-&P>.6.12&1U8!@RD$$ @
MUZM_P\3_ &@?^BZ?&/\ \+34O_CU1B\*ZS33.3B?ABKFE6%2G-1Y5;4^QO\
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M.JDEORW=UV=TE;^E9ZG+4445ZA^DA1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<M3T\HRGZKET<!6:DK23[--M_DS^K+]B3]N[X?\ [>OPCL_%'@K5(7N#$O\
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M^]=/\$S^EZN;^*WQ>\*_ [P7=>(?&?B'1O#&A6@ FOM4NTMH%). NYR 6)(
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M &3W0/\ TVV]?RE5_5K_ ,$[/^4?GP+_ .R>Z!_Z;;>HS/X8G/XB_P"[4?\
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M,>:2/Q+_ &6?^"@7QC_8JBOXOAEXZU/PS::G()KJS$,%W:2R !?,\B=)(P^
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M[&=H9[=\$95E(/()!'0@D'()%?4%S_P7?_:PN])^Q-\7+P0[=NY-#TM)<?\
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MWNTC[(HY51=SNS' Y9B3R36^*H.K#E3/6XER6>9X6.'IR46I)Z^C7ZG] _\
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M3_QO_P!)B%%%%>B?>!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA7O_ *;=,KKQ[:I71]/QO4G#*W*#L^9;'7?\%-O^"&7@;]K'X<^&+;X5^&O
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M/EA\RC2^S4T?YK\?S/Q4HHHKWS]Q"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M117HGW@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYX9\1Z/'#H,ZSAXS;Z1.((?+ &"DPNKFXSGC>>N>/U$K^8/_ ((V?&,? _\
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M_P""A-LEE^WS\<(8QMCB^(&O(@SG &HW %?U<5_*5_P43_Y2!_'3_LH6O_\
MIRN*\_+/C9\+X=?[S6_PK\SQROT5_83_ .#<OXI?M+Z+:>(_B%>_\*K\-7+1
MR0VUW:_:-8OH3ABPM]RB $$@&8AP1GRR,9[_ /X-M/\ @G-H_P :/%FJ_&[Q
MEIT.I:9X.U!;#PS:7"[HGU)%662Z92,-Y*O%Y?4>8[-@-$IK]Q*TQ>-<9<E,
M[^*N,*N'K/!X'1KXI;Z]ET]6_EM<_/[X7?\ !M7^S9X%TXQZU;>,O&MP[;C-
MJ>M-;A.,;46T6'"YY^;<>>N.*[/4O^#??]DV^L'BB^&5Q9R,,">'Q-JQD3W
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M<\[AR,HYQ1C/=2U/P0K][_\ @UH_Y1^>,/\ LH5[_P"FW3*_!"OWO_X-:/\
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M[WU^"'_!TO\ \I _!_\ V3VR_P#3EJ=>-E_\8_(^!/\ D:K_  R/S6K]+?\
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M_@X!N4@_X)*_%16.&F;2$08^\?[8LF_DI_*OF:'\6/JC^=LD_P"1CA_\</\
MTI'\V-%%%?3G]&!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?TI?\ ! 3_
M )1(_";_ +C'_IYOJ_FMK^E+_@@)_P HD?A-_P!QC_T\WU>=F7\)>O\ F?!^
M(?\ R+H?XU_Z3(^QJ***\0_&PHHHH **** "BBB@ HHHH ^.?^"_?_*)'XL_
M]P?_ -/-C7\UM?TI?\%^_P#E$C\6?^X/_P"GFQK^:VO;RW^$_7_(_9/#S_D7
M3_QO_P!)B%%%%>B?>!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCICGLO@9_P &NGP>\#:I9WGCCQ?XO\>&VP9;*()I-C=G;@AUC+SA<\@),I&
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M )1^>,/^RA7O_IMTRO7S#^"?JO'?_(J?^*)]C?\ !1/_ )1^?'3_ +)[K_\
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M=?O?7X(?\'2__*0/P?\ ]D]LO_3EJ=<&7_QCXC@3_D:K_#(_-:OTI_X-:/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#]DSXPZ3XY\#:M+I&O:1)E''S17,9QOAF3H\3@893[$8(!'[-_LK_P#!S_\
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M^T3X&^%+_2+FZC>$>)/$*Q&:U)R-\%HA="V.5:5R!WC-?D!11#+Z47=ZBPO
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MN 0K,,YP3UK@:*RHX:%)W@>;E/#V#RZ<IX9.\M'=W"OTU_X(P_\ !9_X7?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *]S_P""?W[?7C/_ ()X_'>V\8^%7%[8SA;?6]$GE*6NMVN<F-R,
M[)%R3'* 2C=F4NC^&45,HJ2Y9;&.(P].O3=&LKQ>Z/ZG?A?\5_@__P %;?V/
MKMK5;;Q1X)\6VOV+5])N\)=Z9.-K&"=%),-Q$X5U=3U5)(V(*.?Y8J]5_9&_
M;2^(O[#WQ-3Q3\.]>ETF[<HE[:2+YMEJL*MN\FXB/#J>1D8==Q*,IYKRJN;#
M8=TG)7T>Q\[P]D,\KJUXQE>G*SCW6][].VO6P4445UGU 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?3O_!&SX*^&?VA?^"E?PO\*>,=*@US
MP[>W-[=75A<<PW36VGW-U$LB]'3S84W(?E9058$$BOVW_P""LG_!6OPQ_P $
MX?AM_9^G_8?$'Q3UNW)T70B^8[-#D"\O I#) ISM7(:9@54@"22/^>;]FO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K^E+_@@)_P HD?A-_P!QC_T\WU?S6U_2E_P0$_Y1(_";_N,?^GF^
MKSLR_A+U_P SX/Q#_P"1=#_&O_29'V-1117B'XV%%%% !1110 4444 %%%%
M&-\0/^11N_\ @'_H:UYI7I?Q _Y%&[_X!_Z&M>:4%(****"@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#OOA7_P B]-_U\-_Z"M=-7,_"O_D7IO\ KX;_ -!6NFH(>X4444""BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH QOB!_R*-W_ , _]#6O-*]+^('_ "*-W_P#_P!#
M6O-*"D%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7
MPW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11N_P#@'_H:
MUYI7I?Q _P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%?\ R+TW
M_7PW_H*UTU<S\*_^1>F_Z^&_]!6NFH(>X4444""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\Q_A1_PMWQ+_ -!B[_,?X5SE%'LX=@^MU_YW][.C_P"%N^)?^@Q=_F/\*/\
MA;OB7_H,7?YC_"N<HH]G#L'UNO\ SO[V='_PMWQ+_P!!B[_,?X4?\+=\2_\
M08N_S'^%<Y11[.'8/K=?^=_>SH_^%N^)?^@Q=_F/\*/^%N^)?^@Q=_F/\*YR
MBCV<.P?6Z_\ ._O9T?\ PMWQ+_T&+O\ ,?X4?\+=\2_]!B[_ #'^%<Y11[.'
M8/K=?^=_>SH_^%N^)?\ H,7?YC_"C_A;OB7_ *#%W^8_PKG**/9P[!];K_SO
M[V='_P +=\2_]!B[_,?X4?\ "W?$O_08N_S'^%<Y11[.'8/K=?\ G?WLZ/\
MX6[XE_Z#%W^8_P */^%N^)?^@Q=_F/\ "N<HH]G#L'UNO_._O9T?_"W?$O\
MT&+O\Q_A1_PMWQ+_ -!B[_,?X5SE%'LX=@^MU_YW][.C_P"%N^)?^@Q=_F/\
M*/\ A;OB7_H,7?YC_"N<HH]G#L'UNO\ SO[V='_PMWQ+_P!!B[_,?X4?\+=\
M2_\ 08N_S'^%<Y11[.'8/K=?^=_>SH_^%N^)?^@Q=_F/\*/^%N^)?^@Q=_F/
M\*YRBCV<.P?6Z_\ ._O9T?\ PMWQ+_T&+O\ ,?X4?\+=\2_]!B[_ #'^%<Y1
M1[.'8/K=?^=_>SH_^%N^)?\ H,7?YC_"C_A;OB7_ *#%W^8_PKG**/9P[!];
MK_SO[V='_P +=\2_]!B[_,?X4?\ "W?$O_08N_S'^%<Y11[.'8/K=?\ G?WL
MZ/\ X6[XE_Z#%W^8_P */^%N^)?^@Q=_F/\ "N<HH]G#L'UNO_._O9T?_"W?
M$O\ T&+O\Q_A1_PMWQ+_ -!B[_,?X5SE%'LX=@^MU_YW][.C_P"%N^)?^@Q=
M_F/\*/\ A;OB7_H,7?YC_"N<HH]G#L'UNO\ SO[V='_PMWQ+_P!!B[_,?X4?
M\+=\2_\ 08N_S'^%<Y11[.'8/K=?^=_>SH_^%N^)?^@Q=_F/\*/^%N^)?^@Q
M=_F/\*YRBCV<.P?6Z_\ ._O9T?\ PMWQ+_T&+O\ ,?X4?\+=\2_]!B[_ #'^
M%<Y11[.'8/K=?^=_>SH_^%N^)?\ H,7?YC_"C_A;OB7_ *#%W^8_PKG**/9P
M[!];K_SO[V='_P +=\2_]!B[_,?X4?\ "W?$O_08N_S'^%<Y11[.'8/K=?\
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M?^@Q=_F/\*/^%N^)?^@Q=_F/\*YRBCV<.P?6Z_\ ._O9T?\ PMWQ+_T&+O\
M,?X4?\+=\2_]!B[_ #'^%<Y11[.'8/K=?^=_>SH_^%N^)?\ H,7?YC_"C_A;
MOB7_ *#%W^8_PKG**/9P[!];K_SO[V='_P +=\2_]!B[_,?X4?\ "W?$O_08
MN_S'^%<Y11[.'8/K=?\ G?WLZ/\ X6[XE_Z#%W^8_P */^%N^)?^@Q=_F/\
M"N<HH]G#L'UNO_._O9T?_"W?$O\ T&+O\Q_A1_PMWQ+_ -!B[_,?X5SE%'LX
M=@^MU_YW][.C_P"%N^)?^@Q=_F/\*/\ A;OB7_H,7?YC_"N<HH]G#L'UNO\
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MYC_"C_A;OB7_ *#%W^8_PKG**/9P[!];K_SO[V='_P +=\2_]!B[_,?X4?\
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M;]5V'4445D=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% &-\0/^11N_^ ?^AK7FE>E_$#_D4;O_ (!_Z&M>:4%(****"@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#OOA7_R+TW_ %\-_P"@K735S/PK_P"1>F_Z^&_]!6NFH(>X4444
M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KYL^-7_)4-7_ZZ+_Z M?2=?-GQJ_Y*AJ__71?_0%KLP7QOT/GN(_]WCZ_
MHSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KT7X,_&9O"<J:9J;L^F.<1R'DVI/_LOMVKSJBHG
M!37+(Z,-B:E"HJE-ZGUU%*L\2NC*Z. RLIR&!Z$&G5X1\&?C,WA.5-,U-V?3
M'.(Y#R;4G_V7V[5[K%*L\2NC*Z. RLIR&!Z$&O'JTG3=F??X''4\53YX;]5V
M'4445D=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WQ
M _Y%&[_X!_Z&M>:5Z7\0/^11N_\ @'_H:UYI04@HHHH*"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.^^%?_(O3?\ 7PW_ *"M=-7,_"O_ )%Z;_KX;_T%:Z:@A[A1110(**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?
M\E0U?_KHO_H"U])U\V?&K_DJ&K_]=%_] 6NS!?&_0^>XC_W>/K^C.6HHHKU#
MXP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KT7X,_&9O"<J:9J;L^F.<1R'DVI/_LOMVKSJBHG!37+
M(Z,-B:E"HJE-ZGUU%*L\2NC*Z. RLIR&!Z$&G5X1\&?C,WA.5-,U-V?3'.(Y
M#R;4G_V7V[5[K%*L\2NC*Z. RLIR&!Z$&O'JTG3=F??X''4\53YX;]5V'444
M5D=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O_@'
M_H:UYI7I?Q _Y%&[_P" ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\B]-
M_P!?#?\ H*UTU<S\*_\ D7IO^OAO_05KIJ"'N%%%% @HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;/C5_R5#5_^NB_
M^@+7TG7S9\:O^2H:O_UT7_T!:[,%\;]#Y[B/_=X^OZ,Y:BBBO4/C HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KT7X,_&9O"<J:9J;L^F.<1R'DVI/_LOMVKSJBHG!37+(Z,-
MB:E"HJE-ZGUU%*L\2NC*Z. RLIR&!Z$&G5X1\&?C,WA.5-,U-V?3'.(Y#R;4
MG_V7V[5[K%*L\2NC*Z. RLIR&!Z$&O'JTG3=F??X''4\53YX;]5V'4445D=H
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NF
MKF?A7_R+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?-GQJ_P"2H:O_ -=%_P#0%KZ3KYL^
M-7_)4-7_ .NB_P#H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3_TZW-?V0U_&]_P4^_Y25_M#?]E,\2?^G6YIH:/Z//\ @VT_Y0L?!C_N.?\
MI]U&ON6OAK_@VT_Y0L?!C_N.?^GW4:^Y:0@HHK"^*/Q+T7X+_#/Q%XQ\2WO]
MF^'/">F7.LZK=^3)-]EM+>)III-D:L[[8T8[44L<8 )XH W:*_FD_P""F_\
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M ,HU/ __ &4RP_\ 35JU?JQ7Y3_\'?\ _P HU/ __93+#_TU:M2$?#?_  :
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MP/\ ]DSL/_3KJU?JM_P;9G/_  17^#'_ ''/_3[J-?E3_P '?_\ RDK\#_\
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M]6U#Q3\0?'GBJZM[&.>\N)]6U?6+@A+>WA#,7FFD($<2+R<!% X J_\ &O\
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M?;L\S226M\[JT\F^96V7C2 K D,;VZG>I8+']-5%<G\#/CGX1_:7^$>@^._
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\BC=_\
M /\ T-:\TKTOX@?\BC=_\ _]#6O-*"D%%%%!04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!WWPK_Y%
MZ;_KX;_T%:Z:N9^%?_(O3?\ 7PW_ *"M=-00]PHHHH$%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O_P!=
M%_\ 0%KZ3KYL^-7_ "5#5_\ KHO_ * M=F"^-^A\]Q'_ +O'U_1G+4445ZA\
M8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5Z+\&?C,WA.5-,U-V?3'.(Y#R;4G
M_P!E]NU>=45$X*:Y9'1AL34H5%4IO4^NHI5GB5T971P&5E.0P/0@TZO"/@S\
M9F\)RIIFINSZ8YQ'(>3:D_\ LOMVKW6*59XE=&5T<!E93D,#T(->/5I.F[,^
M_P #CJ>*I\\-^J[#J***R.T**** "BBB@ HHHH **** "BBB@ HHHH ****
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M$WQ#GO;"WO=.O3:F">RTZWCFENTA:V@C\V&0,TTJ! A9BJ_-7Z6_&K_@N/\
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M]F[3?V/OV6/A_P###2382VW@C0K72I+JST]+"/4KB.,?:+PPJ6"27$WF3/\
M,Q+RN2S$EC^!G_!W_P#\I*_ _P#V3.P_].NK5_1Y7\X?_!W_ /\ *2OP/_V3
M.P_].NK4D)%S_@VI_P"",GA/]MW4K_XW?$U['7?!'@;7#I&G>$WC+IK&IQ0P
M7!DO@1M:TC2XA(A!;SW+"3$4;1W']$/A;PMIG@;PQIVBZ+IUCH^C:/:Q6-A8
M6-NEO:V-O$@2.&*- %2-$5555     P*_+;_ (- /^4:GCC_ +*9?_\ IJTF
MOU8H>X/<_);_ (.H?^"='@?Q_P#L>ZI^T#86]CX<\=?#VZM6U*XLM+MUD\70
M7MS8Z<J7DP59GDMQY!A=G<(BRQ[/WBO'^.'_  1@^+^I_ __ (*L_ /6M)@L
M+B[O/&-EX?=;Q'>-;?4V.FW# *RGS%@NY60YP'"$JP!4_P!0O_!3[_E&I^T-
M_P!DS\2?^FJYK^5'_@F#_P I*_V>?^RF>&__ $ZVU-;#6Q_9#7QK_P %2/\
M@B;\-?\ @JQXV\ :[XOU?7?"]_X-%U9WEWH,%HE[K-A+&S1VSSRQ.5\FY"2Q
MDAT59;M1'NG$L?V57S[_ ,%$_P#@IG\+?^"8?PELO%7Q*O[^236+H6FD:'I,
M4=QJ^LN"OFF")Y(U\N%'#R2.Z(N47<9)(D>23TC]G;]F7X?_ +)/PTM?!_PU
M\(:'X,\.VNQOLFF6PB^TRK%'#Y\[_?GG:.*,--*SR/L!9F/-=7XI\+:9XY\,
M:CHNM:=8ZQHVL6LMC?V%];I<6M];RH4DAEC<%7C=&965@002",&OY>?VT?\
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M71;5_&GAJ9B\D>GP&:&WOK4L\I$:&:>VFBCBB WRWKNV74']OJ_G"_X- /\
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M)6EWMK>>'M&TT65E;W6FM;*;J-$;RD\Z*\@0QQ11J&MFD.]YG(^1?@[^V/\
MMF?M!^)Y]#\ ?%7]IWQSK-K:M?36&@>)]=U.ZAMU=$:9HX9781AY(U+$8!=1
MG)%>;_M#?M/_ !N^*#W7@SXK_$7XK>(CX=U-Q<Z#XM\0:A=_V9?P^9"^^VN9
M#Y4\>Z6,Y4.NYUXR132&D?IW_P &>/[1'B;3_P!IKXF_"?[5YW@W5_##>+3;
M2R2M]BO[6[M+7? F_P I/.BN\2G87?[+;?,!'@_T"U_.'_P: ?\ *2OQQ_V3
M._\ _3KI-?T>4GN)[A1112$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 8WQ _Y%&[_P" ?^AK7FE>E_$#
M_D4;O_@'_H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX/\ #?Q:_LWP[X4\<ZWH^E6G_"+Z--]EM+>_GAACWR6C.VV-%&YV+'&22>:
M/Z6:*\I_81^)6M?&;]A_X->,/$E[_:7B+Q7X&T36-5N_)CA^U7=Q80332;(U
M5%W2.QVHH49P !Q7JU !1110 4444 %%%% !1110 4444 %%%% !1110 45^
M+WQP_P"#QKPGX-^+&O:5X$^"]]XX\):?<F#3=?O/%!T:35T4 &<6IL96BC9]
MVP.^\IL9TC8M&GZL_LA_M5^$OVW?V;_"OQ3\#2W\OACQ=;//:K?6QM[FW>.5
MX9H)4.0)(IHI8V*LR$H2CNA5B >D4444 %%%% !1110 4444 %%%% !1110
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MX(!XH W:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7
M_)4-7_ZZ+_Z M?2=?-GQJ_Y*AJ__ %T7_P! 6NS!?&_0^>XC_P!WCZ_HSEJ*
M**]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O1?@S\9F\)RIIFINS
MZ8YQ'(>3:D_^R^W:O.J*B<%-<LCHPV)J4*BJ4WJ?744JSQ*Z,KHX#*RG(8'H
M0:=7A'P9^,S>$Y4TS4W9],<XCD/)M2?_ &7V[5[K%*L\2NC*Z. RLIR&!Z$&
MO'JTG3=F??X''4\53YX;]5V'4445D=H4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\/-#TCP_IKVZ.LD]O):)J3-,68AI/.U"=05"C8L8QD,S?OI_P4\_X*>> /\
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M:'I'A_37MT=9)[>2T34F:8LQ#2>=J$Z@J%&Q8QMR&9OWF_X*9?\ !6+X6_\
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M%/P-+?2^&/%UL\]JM];&WN;=XY7AF@E0Y >*:*6-BK,A*$H[H58^D4 %%%%
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M*O>*?%.F>!O#&HZWK>HV&CZ-H]K+?7]_?7"6]K8V\2%Y)I9'(5(T169F8@
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M7/!/B9-=\3:Q;S@V6E7<-M=6PTU< ^=./M+M,00L+1K&=\AE6"42CRO_ (-
M/^4E?CC_ +)G?_\ IUTFOZ/*_FE_X-+OB7HG@3_@J7?Z7JM[]EOO&G@;4M&T
M:+R9'^V7:7%G?-'E5(3%M97+[G*K^[VYW,JG^EJF]QO<****0@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#&^('_(HW?_  #_ -#6O-*]+^('_(HW?_ /_0UKS2@I!11104%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 =]\*_^1>F_Z^&_]!6NFKF?A7_R+TW_ %\-_P"@K734$/<****!!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^&O\ P>??\VW?]S/_ .X>OW*K\-?^#S[_ )MN
M_P"YG_\ </36XUN?EK_P3B_X)P>.?^"H'QOU7P#\/]4\)Z3K.D:'-X@FF\0W
M5Q;VK6\=Q;P,JM!!,QDW7,9 *@8#?," #^COB/\ X,VO'5K\(H[W2/C?X3OO
M'IM;=Y-'O-!N+72%N&*?:(QJ"RR3&- 9-C_8P9"B I%N)3SK_@T _P"4E?CC
M_LF=_P#^G72:_H\IMC;/Y:_VL?\ @V@_:F_96\$PZ_!X>T/XI6//VN+P'<W&
MIWMA^\BC3=:2P0W$V\RY'V>.78L4C2>6H!/Q3\#_ (W^+/V;_BUH'COP+KM]
MX:\6^&;H7FF:E9L/,MWP5(((*O&Z,R/&X9)$=T=65F4_VU5^&7_!T5_P1[\,
M^#O!FH_M0?#K3O[(O9-4@C\?Z9;"*.QN#<R>4FKJK.I2=KEX8IDB5_.:X68J
MC)/)*)@F?>G_  1E_P""SGA+_@JI\)VM+I;'PS\7_#-JLGB3PVDA$<\>53^T
M+'<2SVC.RAE)9[=W6.0L&AFF^V:_CJ_X)A?MT:G_ ,$Z?VV/!?Q/M&OY='TZ
MY^Q^(["U+EM4TB?"74/EB6)99%3]["LK^6+B"!V!"5_8K28F?$__  7S_P""
M=WB[_@I/^P<?"7@2\L8_%OA778?%6G:?=D1IKKP6UU ;(3,P6"1UNF9'?Y"\
M:HYC5VEC_*C_ ()<?\&Y/[3'@_\ ;Q^&OBWXD^&+'X<^$O .NV7BNYU"XUC3
M]4>^>QN8IX[*&&TN)&\R9E"EWVI&@D?+,J12?:__ !%__LU?]"/\<O\ P3:5
M_P#+&O5OV(_^#C_X'_M[?M/^&?A/X/\ "OQ6TWQ%XK^U?9+G6-,L(;*/[/:3
M73^8T5[(XS' X&$/S%<X&2#4-3] J**^?/VZO^"HWP1_X)T>&GNOB;XTL;'6
MI+4W5AX:L?\ 3-=U0%)S'Y5JAW+'(]O+$L\QCMQ( K2H32$?0=%?BA\2/^#R
M_P .:9XVO8/"'P#UO7/#B>7]COM9\5Q:5?3YC4OYEM%:W*1XD+J,3ON558[2
MQ1<-O^#S\@<?LVC\?B%_][*=F.S/W+HKX8_X)W_\'!OP _;]&EZ&VM_\*U^(
MU]Y,'_",^)ID@%Y<O]GC\NQN^(;K?/<>5%'F.YE\MF^SJM?<](05_&]_P4^_
MY25_M#?]E,\2?^G6YK^R&OXWO^"GW_*2O]H;_LIGB3_TZW--#1_5=_P3!_Y1
MJ?L\_P#9,_#?_IJMJ]SK\>M%_P"#DWX)_L&_\$^O@CX-\/VU]\6?B5H?P]\/
M6-_I&E3?8]-TJXCTVP\R&ZU!T=1($DE&VWCN"LMN\4ODMR/.?^(SXX_Y-M_\
MR#_][*+,+,_<NBOS"_8O_P"#JWX ?M&:KI&A?$'3]=^#7B+4LQO<:HZ7_AZ.
M9KE8H8A?QA73=&ZR-+<6\$,024-+A59_T]I""BBB@ HK\_/^"@/_  <B_ #]
MA;QMKO@NV;7?B7X_T+[7:7>F>'XD6QTR_BC0I;7=[*RHNZ1_+<VZW+0M%,LD
M8=!&WQN/^#S[C_DVW_S(/_WLIV8[,_<NBOQ[_9O_ .#PKX7>._$QL?B?\+?%
M7P[M;BZM;>UU'2=2C\0VT*2.RSSW2F*VECCB&QL0QW#N"^$!55?]2OV=?VG/
MA]^UM\-+;QA\-?%^A>,_#MSL4W>F7(E^S2M%'-Y$Z??@G6.6,M#*J2)O 95/
M%(1W5?!?_!Q5^WE\2/\ @GS^P?I/BGX6:G8Z'XG\0^,++P^=3GL(KV2QMVMK
MNZ=H8Y@T.]C:+&3(C@)))@!]KI]Z5_.C_P %W_\ @N_\(O\ @J#^R)X<\ ^
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MKS;]JO\ :]^&_P"Q#\))?'/Q3\56/A'PQ%=0V*W4\4L\EQ<2DA(88(5>:9R
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M ";;_P"9!_\ O92LQ69^Y=%?F_\ \$Y/^#F/X-_MV?$SPW\/M=T+7?A;X_\
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M'+3?%_;>IZZ- ^V2K+(N^"W^S7#F!HUC='E,4G[PJT*%>2P6/V2HK\0O#/\
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M**H>*/%.F>!_#.HZUK6HV.CZ-H]K+>W]_>W"6]M96\2%Y)I9'(5(T12S,Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM)TW9GW^!QU/%4^>&_5=AU%%%9':%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\H7_!1;_@
MG3^T'XW_ ."@WQVUK1?@3\9-7T?5_B'K][87]EX*U*XMKV"34KAXYHI$A*O&
MZL&5E)!!!!P:_J]HH0(^-O\ @W]^&'B7X,_\$C?A+X;\8>'M<\*>(M-_MC[7
MI6L6$MC>VN_6;^1/,AE577=&Z.,@95E(X(K[)HHH *Y/XY_ SPC^TO\ "/7O
M GCO0;'Q-X2\36QM-1TZ[4^7.F0RD,I#)(CJKI(A5XW1'1E958=910!_,/\
M\%./^#;GXS?L8^-I-3^&NCZ[\8_AUK&J26VD'0=/GU'Q!I<?EB2-=0M8(O\
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M8YUC?=M(4I)&[_;/_!G]\3_$G_#<'CCP8/$.N?\ "''P-?ZW_80OY?[,-_\
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M4LS,0  23@5_5[13N.X5^&?_  <%?\&^OC;XD?&O6_CQ\!]$_P"$F'B;??\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\BC=_P#
M/_0UKS2O2_B!_P BC=_\ _\ 0UKS2@I!11104%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_\
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MXD:U\9/B3XA\7^);W^TO$?BO4[G6=5O/)CA^UW=Q*TTTNR-51-TCL=J*%&<
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M<[%CC))/-;M%(04444 %?SA_\'?_ /RDK\#_ /9,[#_TZZM7]'E?SA_\'?\
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MJMW*S2S3S32-_P!=)99I6"JJR22,%5F'[(_LV?\ !G Q;1;_ .,'QE4#]_\
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M%%?V5_ _AG3M%T7XZ_L_:/HVCVL5C86%CXTTBWMK*WB0)'#%&DP5(T15554
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M-H99(3+;(D4K*"]RKE94BDB;[UK^4#_@X0_:JG_:L_X*M?$R<2W[:/X NO\
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MO,_M4MNWC;Y&-K;\K]6_\'?_ /RC4\#_ /93+#_TU:M2ZBZGX,?L7_L7^/\
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MD-K"[/&7MK5$&;J[6%S+Y6Y$ ""26'SHB_ZD_P#$'!\-_P#A2?V#_A<WC?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '??"O_ )%Z;_KX;_T%:Z:N9^%?
M_(O3?]?#?^@K734$/<****!!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^&O_!Y]_S;
M=_W,_P#[AZ_<JOPU_P"#S[_FV[_N9_\ W#TUN-;GAO\ P: ?\I*_''_9,[__
M -.NDU_1Y7\X?_!H!_RDK\<?]DSO_P#TZZ37]'E#W![A7R'_ ,%WOVD-,_9F
M_P""4GQCU"_%C<77BO0YO!VG65QJ"6<EY/J:FS;R=P8RR0PRSW)B499+63E
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M%'_!Y]_S;=_W,_\ [AZ/^#,'_FY'_N6/_<Q3Z#Z'[E5_&]_P4^_Y25_M#?\
M93/$G_IUN:_LAK^-[_@I]_RDK_:&_P"RF>)/_3K<TD)']5W_  3!_P"4:G[/
M/_9,_#?_ *:K:O<Z\,_X)@_\HU/V>?\ LF?AO_TU6U>YTA&#\4O^$9_X5EXB
M_P"$U_L+_A#?[+N?[>_MORO[,^P>4WVG[5YO[KR/*W^9YGR;-V[C-?Q$U_6Q
M_P %X/VC]-_9G_X)1?&/4+Y;"YNO%>AS>#M.LKC4$LY+R?4U-FQAW*QEDAAE
MGN3$HRR6LG* ,Z_R:^&O#.I>-/$>GZ-HNG7^L:QJUS'96%A8V[W%U?7$C!(X
M8HT!9Y'=E554$L2  2:I%(_J@Z_\&T__ ';-_P"ZM7\J-?V7>*?V---N_P#@
MGIJ/[/>B:U?:?H\GP[E^'=AJ]]$EY<VT!TTZ?'<RHGE++(J[795\L,00-@/'
M\;_B;PSJ7@KQ)J&C:UIU_H^L:3<R65_87UN]O=6,\;%)(98W 9)$92K*P!4@
M@@$4($?IWX6_X-*?V@O'/AC3M;T3XD_L_:QHVL6L5]87]CXAU*XM;ZWE0/'-
M%(FGE7C=&5E920000<&K_P#Q" ?M*_\ 0\? W_P<ZK_\KJ_7'_@@3^UCHO[6
M7_!++X83:5#]COOAYID'@/6+3=))]FNM-MX85;>T:!O.MC;7&$W*GVGR][-&
MQK[+I78KL_G#_P"(0#]I7_H>/@;_ .#G5?\ Y74?\0@'[2O_ $/'P-_\'.J_
M_*ZOZ/**+L+L^;_^"1_['_B;]@G_ ()[?#_X3^,+[0M2\1^%/[1^UW.C32S6
M4GVC4KN[3RVECB<XCG0'*#Y@V,C!/QO_ ,'?_P#RC4\#_P#93+#_ --6K5^K
M%?E/_P '?_\ RC4\#_\ 93+#_P!-6K4NHNI\-_\ !H!_RDK\<?\ 9,[_ /\
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M^V?*@$+L?VPH;!L_G#_XA /VE?\ H>/@;_X.=5_^5U'_ !" ?M*_]#Q\#?\
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MS0R;)%5TW1NIVNH89P0#Q6[2NQ79_.'_ ,0@'[2O_0\? W_P<ZK_ /*ZD/\
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MV<8&?SB_X.__ /E)7X'_ .R9V'_IUU:OZ/*_G"_X._S_ ,;+/!'_ &3*P_\
M3KJU-;C6Y]R_\&@'_*-3QQ_V4R__ /35I-?JQ7X]_P#!G1\8M,UO]D;XM?#^
M*"_76/#/B^'Q#=3.B"UDM]0LH[>%4;=N,BMIDY<%0 'BPS$L%_82D]Q/<*_A
MKK^VCXY_'/PC^S1\)->\=^.]>L?#/A+PS;&[U'4;MB(X$R%4!0"SR.[*B1H&
M>1W1$5F95/\ $O3B.)_<I7X:_P#!Y]_S;=_W,_\ [AZ_<JOPU_X//O\ FV[_
M +F?_P!P]);B6X?\&8/_ #<C_P!RQ_[F*_<JOPU_X,P?^;D?^Y8_]S%?N50]
MP>X5_.'_ ,'?_P#RDL\$?]DSL/\ TZZM7]'E?@1_P>+?LWZGIGQU^$WQ>B:_
MNM&UK09?!]RJ:>_V73+BTN);N'?<[BOF7"7L^R(JIQ8RL"XW!! B_P#\&:/_
M  C/_"S?CU]J_L+_ (3+^R]&_LOS?*_M/[!YMY]M\C/[WR/-^P>;M^3?]FW\
M^77[T5_,1_P:T?M#^&?@)_P5-MK+Q+=?8?\ A8_AF\\(:5<R2116\=_+<6EW
M"DKR.N/-^QM#&$#.\TT*!?GR/Z=Z'N#W"OP7_P"#R[_A&?\ A9OP%^R_V%_P
MF7]EZS_:GE>5_:?V#S;/[%Y^/WOD>;]O\K=\F_[3LY\ROWHK^6O_ (.7OVL=
M$_:J_P""IOB&'0(?]!^%NF1> I;S=)_I]U:7%S-=ML>-#'Y5S<S6^!O5_LWF
M*Y60 "W!;GK'_!H!_P I+/&__9,[_P#].NDU]R?\'?\ _P HU/ __93+#_TU
M:M7S!_P9T_LWZGJ?QU^+/Q>E:_M=&T708O!]LKZ>_P!EU.XN[B*[FV7.X+YE
MNEE!OB"L<7T3$H-H?Z?_ .#O_P#Y1J>!_P#LIEA_Z:M6HZAU/AO_ (- /^4E
M?CC_ +)G?_\ IUTFOZ/*_G#_ .#0#_E)7XX_[)G?_P#IUTFOZ/*'N#W"OP7_
M .#R[_A&?^%F_ 7[+_87_"9?V7K/]J>5Y7]I_8/-L_L7GX_>^1YOV_RMWR;_
M +3LY\ROWHK^6O\ X.7_ -K'1/VJ?^"IGB&#0(?]!^%NF1> Y;S=)_I]U:7%
MS-=-L>-#'Y5S<S6^!O5_LWF*Y60 "W!;GK'_  : ?\I+/&__ &3._P#_ $ZZ
M37[ ?\%F_P#@JCIO_!*G]EI/$T&GV/B#QYXINFTKPKHUS=)'').(V>2\G0.L
MSVEN-GF>4,EYK>,M%YPE3\Q/^#.G]F_4]3^.OQ9^+TIOK71M%T&+P?;*^GO]
MFU.XN[B*[FV7.0OF6Z64&^(*QQ?1,2@VA^'_ .#P;Q-J=W_P4(^'NC2ZC?RZ
M/8?#RWO;6P>X<VMM/-J6H)-,D>=JR2+;P*[  L((@20BX?4?4_/W5?$_QL_X
M*B_M2:7:7VH^*_BS\3_&%TUEIT-Q<>=( TDMP885)$5K:1F2:0JOEV\">8V(
MT4D?IU^R?_P9[^+_ !AX9T36?C'\4;#P9=374%Q?^&M TT:I=)9E(GD@:^:5
M(8;L$S1$I%<PH45U>8':.Z_X,Z/V58(?#OQ:^-][#8RW-Q<P^!M'E2YF^TVJ
M1K%>Z@KQ8$)CE,FFE'RS@V\H&P$^9^WM#8-GX2_M_P#_  :@>"?@5\$?'GQ)
M\ ?%[Q59Z+X \'ZAX@FT7Q!H\&J76I7%G;SW+*MW"]JL,<B)&@!@D*D,VY@P
M1?RX_P""8/\ RDK_ &>?^RF>&_\ TZVU?U7?\%/O^4:G[0W_ &3/Q)_Z:KFO
MY4?^"8/_ "DK_9Y_[*9X;_\ 3K;4T-']D->&?\%/O^4:G[0W_9,_$G_IJN:]
MSKPS_@I]_P HU/VAO^R9^)/_ $U7-00?RH_\$P?^4E?[//\ V4SPW_Z=;:O[
M(:_BR_8[^,6F?L[_ +7'PL^(&M07]UHW@;Q?I/B&_AL41[J:WM+V&XD6)795
M,A2,A0S*"2,L!S7]IM5(J05X9_P4^_Y1J?M#?]DS\2?^FJYKW.O#/^"GW_*-
M3]H;_LF?B3_TU7-22?RH_P#!,'_E)7^SS_V4SPW_ .G6VK^R&OXWO^"8/_*2
MO]GG_LIGAO\ ].MM7]D-5(J05_.'_P '?_\ RDK\#_\ 9,[#_P!.NK5_1Y7\
MX?\ P=__ /*2OP/_ -DSL/\ TZZM20D?<G_!H!_RC4\<?]E,O_\ TU:37ZL5
M^4__  : ?\HU/''_ &4R_P#_ $U:37ZL4/<'N?SA_P#!W_\ \I*_ _\ V3.P
M_P#3KJU?<G_!H!_RC4\<?]E,O_\ TU:37PW_ ,'?_P#RDK\#_P#9,[#_ -.N
MK5]R?\&@'_*-3QQ_V4R__P#35I-/H/H'_!W_ /\ *-3P/_V4VP_]-6K5^/G_
M  0<\.>$?%/_  5W^!EMXWDL8M&BUY[RV:\OC9QG4X+6>;30'#KF0W\=J$CS
MB5RD95P^T_N3_P '0W[-^I_M ?\ !*;6M2TDWTMS\,=>LO&$EE::>]Y)?6\:
MS6<^=K Q1PPWLER\N&"I:OD $NG\VO[,GQF_X9Q_:3^'GQ#_ +,_MK_A O$V
MF^(QI_VC[-]O^QW<5QY/F[7\O?Y>W?L;;G.TXQ0M@6Q_:Y16%\+OB7HOQG^&
M?AWQAX:O?[2\.>+-,MM9TJ[\F2'[5:7$2S0R;)%5TW1NIVNH89P0#Q6[4DA1
M110 4444 %?E/_P=_P#_ "C4\#_]E,L/_35JU?JQ7Y3_ /!W_P#\HU/ _P#V
M4RP_]-6K4 ?#?_!H!_RDK\<?]DSO_P#TZZ37]'E?SA_\&@'_ "DK\<?]DSO_
M /TZZ37]'E-[C>X5^"__  >7?\(S_P +-^ OV7^PO^$R_LO6?[4\KRO[3^P>
M;9_8O/Q^]\CS?M_E;ODW_:=G/F5^]%?RU_\ !R_^UCHG[5/_  5,\0P:!#_H
M/PMTR+P'+>;I/]/NK2XN9KIMCQH8_*N;F:WP-ZO]F\Q7*R  6X+<]8_X- /^
M4EGC?_LF=_\ ^G72:_8#_@LW_P %4=-_X)4_LM)XF@T^Q\0>//%-TVE>%=&N
M;I(XY)Q&SR7DZ!UF>TMQL\SRADO-;QEHO.$J?F)_P9T_LWZGJ?QU^+/Q>E-]
M:Z-HN@Q>#[97T]_LVIW%W<17<VRYR%\RW2R@WQ!6.+Z)B4&T/P__  >#>)M3
MN_\ @H1\/=&EU&_ET>P^'EO>VM@]PYM;:>;4M02:9(\[5DD6W@5V !801 DA
M%P^H^I^?NJ^)_C9_P5%_:DTNTOM1\5_%GXG^,+IK+3H;BX\Z0!I);@PPJ2(K
M6TC,DTA5?+MX$\QL1HI(_3K]D_\ X,]_%_C#PSHFL_&/XHV'@RZFNH+B_P##
M6@::-4NDLRD3R0-?-*D,-V"9HB4BN84**ZO,#M'=?\&='[*L$/AWXM?&^]AL
M9;FXN8? VCRI<S?:;5(UBO=05XL"$QRF332CY9P;>4#8"?,_;VAL&S\)?V__
M /@U \$_ KX(^//B3X ^+WBJST7P!X/U#Q!-HOB#1X-4NM2N+.WGN65;N%[5
M88Y$2- #!(5(9MS!@B_EQ_P3!_Y25_L\_P#93/#?_IUMJ_JN_P""GW_*-3]H
M;_LF?B3_ --5S7\J/_!,'_E)7^SS_P!E,\-_^G6VIH:/[(:***@@_AKK^Y2O
MX:Z_N4JI%2/RG_X._P#_ )1J>!_^RF6'_IJU:OAO_@T _P"4E?CC_LF=_P#^
MG72:^Y/^#O\ _P"4:G@?_LIEA_Z:M6KX;_X- /\ E)7XX_[)G?\ _IUTFET%
MT/Z/****0C^-[_@I]_RDK_:&_P"RF>)/_3K<U_5=_P $P?\ E&I^SS_V3/PW
M_P"FJVK^5'_@I]_RDK_:&_[*9XD_].MS7]5W_!,'_E&I^SS_ -DS\-_^FJVI
ML;/<Z***0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *^;/C5_R5#5_^NB_^@+7TG7S9
M\:O^2H:O_P!=%_\ 0%KLP7QOT/GN(_\ =X^OZ,Y:BBBO4/C HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 8WQ _Y%&[_X!_Z&M>:5Z7\0/^11N_\ @'_H:UYI04@HHHH*"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAB"0B [07071^WM?QO?\%/O^4E?[0W_93/$G_IUN:_LAK\IKG_@UO\->,/\
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M !Q\5>)=&:U9(;7P]X?M]#NH[C>A61IYY;Q&C""0%!$I)93O 4JWZ6_L??\
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MR;@KM%(%)!*.!M/WG^Q=_P $$/V9/V']6TC6] \"_P#"5>,=%RUOXD\67/\
M:EZDHN5N8ITA(6T@GB9(UCF@MXY56/[Q+.7- T/LJOPU_P"#S[_FV[_N9_\
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M?WNN^(=5\:ZG<+<>(+Z$B+4+N&. RP1N%$0\B*:U'DQX6&*2!0J(8Q7ZK_\
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M,ZCHNM:=8ZQHVL6LMC?V%];I<6U[;RH4DAEC<%7C=&965@002",&I)/Y;/\
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MLWQ'X5U*VUC2;SR8YOLEW;RK-#+LD5D?;(BG:ZE3C!!'%?UE_L"?\$6_V?\
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M']0LK>V:".XN)U9EFM)F,FZYD!(8# 7C()/JW_!-_P#X)P>!_P#@E]\#]5\
M^ =5\5ZOH^KZ[-X@FF\07-O<7*SR6]O RJT,,*B/;;1D J3DMS@@!WT'?0]R
M\4>%],\<>&=1T76M.L=8T;6+66RO["]MTN+:]MY4*20RQN"KQNC%65@002",
M&OY0?^"Q_P#P2)\2_P#!+3]H&XL;4:[XE^%NL>5<>'_%$VFRK#'YQGV:==W
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M=CNJ***0@K\I_P#@[_\ ^4:G@?\ [*98?^FK5J_5BORG_P"#O_\ Y1J>!_\
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MJ2([(<.CJ_[LQR_KGJ__  =?_LIZ;\(]+\20GXDZAK.H736\_A2W\/H-7TQ
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MJOBO2-'TC78?$$,WA^YM[>Y:>.WN(%5FFAF4Q[;F0D!0<A>< @^4_P#!-_\
MX(0?"+_@E]\<-5\?> ?$?Q'U?6-7T*;P_-#X@U"RN+98)+BWG9E6&TA82;K:
M, EB,%N,D$'0.A]KT444A'\;W_!3[_E)7^T-_P!E,\2?^G6YK^J[_@F#_P H
MU/V>?^R9^&__ $U6U?(OQW_X-8/V?/VA?CAXR\?:UXQ^,EMK'CC7;WQ!?PV6
MK::EM%/=W#SR+$KV#,(PTA"AF8@ 9)/-?H%\"/@_IO[/7P/\&^ =%GOKG1_
M^A67A^PFO75[F6"TMT@C:5D55,A6,%BJJ"2< #BFQLZNBBBD(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "OFSXU?\E0U?\ ZZ+_ .@+7TG7S9\:O^2H:O\ ]=%_] 6N
MS!?&_0^>XC_W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT_QG_P"X'_Z8M.K]RO\ @VT_Y0L?!C_N.?\ I]U&OPU_X.2_^4T_QG_[@?\
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M7%I]H\B>.XB_>P/'*N)88V^5QG;@Y!(/Y3?L_?\ !HWX,^''[95WJ?CKQ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH QOB!_P BC=_\ _\ 0UKS2O2_B!_R*-W_ , _
M]#6O-*"D%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!WWPK_Y%Z;_ *^&_P#05KIJYGX5_P#(
MO3?]?#?^@K734$/<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?SA_P#!W_\ \I*_
M _\ V3.P_P#3KJU?T>5^3/\ P7?_ ."$'Q=_X*@_M=^'/'W@'Q'\.-(T?2/!
M]MX?FA\0:A>V]RT\=[?3LRK#:3*8]MS& 2P.0W& "6AHO?\ !H!_RC4\<?\
M93+_ /\ 35I-?JQ7Q1_P0@_X)P>./^"7W[(GB/P#X^U7PIJ^L:OXPN?$$,WA
M^YN+BV6"2RL8%5FFAA82;K:0D!2,%><D@?:]#!A1112$%%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ K\>_^"S__  <R0?LW>)=2^%O[/GV'5_'6E75_I/BC
MQ%JVF3?9O#-S"\UJUO:PRA!/=QS)YGFNLEJ B +<>:WE>R?\'*G_  4YUO\
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M_9L_9#^$=IHNJ?#OPG\4_$T]K"FM>(O%^CPZF^I7"&1C)!;7'FPV<>964)"
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M:L[[8T8[44L<8 )XH _%'_@\?_:4S)\&O@_8:UT%YXQUS2/L?TM--N?/9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .^^%?\ R+TW_7PW_H*UTU<S\*_^1>F_Z^&_
M]!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYL^-7_)4-7_ .NB_P#H"U])U\V?&K_DJ&K_ /71?_0%
MKLP7QOT/GN(_]WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX*/?M:>&_A7X:N/[+_M7S+K5-8DLI;JWT*PA7?-<RK&/]V.,.R(\TT,9D3S
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MQ_69X6\+:9X&\,:=HNBZ=8Z/HVCVL5C86%C;I;VMC;Q($CABC0!4C1%5550
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7PW_H*UTU!#W"BBB@04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ
M_P"2H:O_ -=%_P#0%KZ3KYL^-7_)4-7_ .NB_P#H"UV8+XWZ'SW$?^[Q]?T9
MRU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[J/R/O<NRZ&%A9:R>[_KH%%%%8'HA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(_!FIS:7>A8Y4BN-A^2XA\U$=H)HRDL3E%WQ2QN!AA7]0G_! O\ X*(>+_\
M@I/^P</%OCRSL$\6^%==G\*ZCJ%F!''KKP6UK.MZ80H6"1UNE5T3*%XW=!&K
MB*,8,]D_X*@-L_X)I?M#GT^&7B0_^4JYK^/OX9_$G6_@U\2/#_B_PS>_V;XD
M\*ZE;:QI-YY,<WV2[MY5FADV2*R/MD13M=2IQ@@CBO[>*_E._P""W_\ P1^\
M2_\ !,C]H"]U;3=.^U?!CQGJ<\GA34[42O%I6\O*ND7+2.[K<0Q@A'=V^T1Q
M&13N6:.$0(_J4^%_Q*T7XS_#/P[XP\-7O]I>'/%>F6VLZ5=^3)#]JM+B)9H9
M-DBJZ;HW4[74,,X(!XK=K^,[]E;_ (*"_&O]B/4H9OA9\2_%?A"VBNI;YM+M
M[PS:1<W$L(@>::PEWVLTAC" -)$Q'EQD$%$(]Q_80_X*#_&WXS_\%;_V?_%7
MB[XF>*_%&LR?$2TLHFU:[^V6UA;ZQ=Q6FHPVMM(#!:QS6\KQ[8$0( FP(8T*
ME@L?>O\ P>?'YOV;?7_BI_\ W#UYO_P9TZMX1A_:_P#BQ8WFE7\OCRX\'13Z
M/J2.?LMIIL=[$M_ Z^8 9)9I--9#Y;$"WEPZ9*R?KI_P5]_X)VP?\%.?V)-<
M^',-Y8:5XGMKJ'7/"^HWQF^RV.I0;E7S1$P)CEAEN(&8K((Q<&01N\:+7\MN
MJ^&?C9_P2Z_:ETNZO].\5_";XH>#[IK[3IKBW\F0A9);<S0L08KJTD,<T99?
M,MYT\Q<R(Q!%JK M58_LQKRC]M/]M/X?_L!?L_:M\2/B1JW]FZ'IN(;>WA D
MO=8NV#&*SM(B1YL\FUL#(555W=DCC=U_G0TG_@Z+_:]TWX1ZIX;F\7>%K_6=
M0NEN(/%<_AFT&KZ8@,1,$,<:K9&,^6X)EM9'Q/)AP1&4X;P3\(/VQ_\ @OS\
M6K?5+B;Q7\1;>PNC:R:_J\BZ=X6\-$BSBN/+VJEK"XC-K++!:1FXE5?,\J1@
M32L*Q\55_<+X6\4Z9XY\,:=K6BZC8ZQHVL6L5]87]C<)<6M];RH'CFBD0E7C
M=&5E920000<&OXZ_^"C'["?B7_@G!^UMXD^%7B6Y_M1M*\J[TO6([*6UM]=L
M)EW0W42R#_>CD",Z)-#-&)'\LL?W8_X-9/\ @H?XN_:\_9:\1?#3Q=9V$K?
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MK_P>??\ -MW_ ',__N'H6X+<\-_X- /^4E?CC_LF=_\ ^G72:_H\K^</_@T
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MEAL1/G<_.U/8I['T%1114DA1110 4444 %%%% !1110 4444 %%%% !1110
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MS^QO#6C?V?\ 8[/[3+<>3YNGVTS_ #RL[G,DCGECC.!@ "OZ,J_GX_X+=_\
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M7IWA23R3\2- &C2SI*;>739E<B*^BEC F$T,,UVL>R1 LEPLC;_*5#XPJB-
M   !@ =A54,$H57-[=#IR;A".$S&>)GK!?!\^_ILOO.R_9]^ WB/]I_XT>'_
M  !X1BLI?$7B:X:WM!>7 M[>,)&\LLDCX)"1Q1R2-M5G*H0JNQ"G^E;X#?!7
M0_V<O@UX;\#>&X?)T7PQ81V-N6CC26X*CYYY?+1$::5RTDC!1NDD=L9-?''_
M  0=_85MOV?OV=H/BAJR^=XM^*6GPW4"R16[#2]*+-);K#*A9S]I0Q7$GSJ.
M+=&C5X6+?>E<6.Q'M)\JV1\=QCGGUW%>PI/]W3_%]7^B^_J%%%%<)\<%%%%
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M/EQ729C52DHW!'D$;Q,_F#\L/^"/7_!1/2_V!OC-K,'B;3O.\&^/A9VNKZC
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M 1'EYD^=T81]^,:5!\Q]KQ75C3RBHJSU:2]7=;?F?J_1117SQ^%'Y??MM_\
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MI++9R(L4K3EI95,@FC,7V62,HQ)K\B;J<6MM)(>D:EC^ S7]3_P^\!Z5\+/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+
MTW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?-GQJ_P"2H:O_ -=%_P#0%KZ3KYL^-7_)4-7_
M .NB_P#H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 50\4^%M,\<
M^&-1T36].L-8T;6+66QO["^MTN+6^MY4*20RQN"KQNC,K*P(()!&#5^B@#PQ
M?^"8'[-*CC]GCX&#Z> ]*_\ C%=S\%OV7OAG^S:=2_X5W\._ O@+^VO*_M#_
M (1S0;72OM_E;_*\WR(T\S9YDFW=G;YC8QN-=U10 4444 %<+\:?V7_AI^TB
M=,_X6)\._ OCW^Q?-_L__A(]!M=4^P>;L\WRO/C?R]_EQ[MN-WEKG.T5W5%
M'A;_ /!+[]FB0?-^SO\  L_7P%I7_P 8KW2BB@#A/C3^R[\,_P!I(Z8?B+\.
MO OCXZ+YO]G'Q'H%KJOV#S=GF^5Y\;^7O\N/=MQN\M<YVBM#X/\ P(\#_L]>
M&9]%\ ^#?"G@?1[FZ:]FL/#^D6^F6TL[(B-,T<**ID*QQJ6(R0BC. *ZNB@
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MTJ./V>/@8/IX#TK_ .,5[G10!PGP6_9=^&?[-IU/_A7?P[\"^ ?[:\K^T/\
MA'- M=*^W^5O\KS?(C3S-GF2;=V=OF-C&XUW=%% !1110 4444 %%%% !111
M0 4444 %%%% !7Y]_P#!RM^VE:?LI_\ !,OQ/X>M-7^P^,?B[_Q2FDV\0MI9
M9;20J=3D>*4[O(^Q^; TL:,T<EY;XV%U=?T$K^:3_@J!X@^,O_!<G_@LMK/P
M@\%Z!MC^&>IZCX/TNS-].^F:3:65Z\-[K5ZY!2'S9 A=HXPQ1+2W43RK&96A
MH\W_ .#?'_@F;/\ \%"_VVM/U/6M/L+[X7_"NZM=:\61W4L+"^9O->QL/L\D
M<@GCN)K=A,C($-O%< R([1!_ZHZ\+_X)Q?L'>&O^";O[)/ASX6>&[G^U3I?F
M7>JZS)916MQKM_,V^:YD6,?[L<8=G=(888S))Y>X^Z4,&%%%%(04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3O\ N%?^FFRKT,M_BOT_R/NO#[_D8S_P/_TJ)ZO_ ,&WG_)\7BK_ +$6[_\
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MT^S\_P!#Z7Q&_P"8?_M__P!M"BBBO)/S(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#OOA7_P B]-_U\-_Z"M=-7,_"
MO_D7IO\ KX;_ -!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KYL^-7_ "5#5_\ KHO_ * M?2=?-GQJ
M_P"2H:O_ -=%_P#0%KLP7QOT/GN(_P#=X^OZ,Y:BBBO4/C HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *H>*?"VF>.?#&HZ)K>G6&L:-K%K+8W]A?6Z7%K?6\J%)(98W!5XW1
MF5E8$$$@C!J_10!RGP3^!OA+]G'X=6WA'P-H-CX9\,65U=W=KIEDI6VM'NKJ
M6[F$2$D1QF:>0K&N$0,%15154=7110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %<+\'/V9/A_^S[J_B?4?!GA#0O#VJ^-M3GUCQ!J-K; 7NMW4
MUS<73R7,YS+-B6ZG**[%8ED*1A$ 4=U10 4444 %%%% !1110 4444 %%%%
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M<B,!AA7]0'AWP]I_A#P_8Z3I-C9Z7I>EV\=I9V=I"L-O:0QJ$CBCC4!415
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%?_
M "+TW_7PW_H*UTU<S\*_^1>F_P"OAO\ T%:Z:@A[A1110(**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?\ )4-7
M_P"NB_\ H"U])U\Z_&31;RY^)>JO':7,B-(N&6)B#\B]\5V8+XWZ'S_$2;P\
M;=_T9QM%7/\ A'M0_P"?&\_[\M_A1_PCVH?\^-Y_WY;_  KT[H^.Y)=BG15S
M_A'M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X
M4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\
M?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+H.278IT5
M<_X1[4/^?&\_[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW
M^%'_  CVH?\ /C>?]^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_"/:A_SXWG_
M 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=
M%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\ ?EO\*+H.278IT5<_X1[4/^?&\_[\
MM_A1_P (]J'_ #XWG_?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_PCVH?\^-Y
M_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_  CVH?\ /C>?]^6_PHN@Y)=B
MG15S_A'M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^
M_+?X4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C
M>?\ ?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+H.27
M8IT5<_X1[4/^?&\_[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S
M_ORW^%'_  CVH?\ /C>?]^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_"/:A_S
MXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\ "/:A_P ^-Y_WY;_"BZ#D
MEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\ ?EO\*+H.278IT5<_X1[4/^?&
M\_[\M_A1_P (]J'_ #XWG_?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_PCVH?
M\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_  CVH?\ /C>?]^6_PHN@
MY)=BG15S_A'M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_G
MQO/^_+?X4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J
M'_/C>?\ ?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+
MH.278IT5<_X1[4/^?&\_[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_
MY\;S_ORW^%'_  CVH?\ /C>?]^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_"/
M:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\ "/:A_P ^-Y_WY;_"
MBZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\ ?EO\*+H.278IT5<_X1[4
M/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P
MCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_  CVH?\ /C>?]^6_
MPHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>
MU#_GQO/^_+?X4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?
M\(]J'_/C>?\ ?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XWG_?E
MO\*+H.278IT5<_X1[4/^?&\_[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A
M'M0_Y\;S_ORW^%'_  CVH?\ /C>?]^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%
M'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\ "/:A_P ^-Y_W
MY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\ ?EO\*+H.278IT5<_
MX1[4/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+H.278IT5<_X1[4/^?&\_[\M_
MA1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_  CVH?\ /C>?
M]^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7
M/^$>U#_GQO/^_+?X4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+
M?X4?\(]J'_/C>?\ ?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XW
MG_?EO\*+H.278IT5<_X1[4/^?&\_[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG1
M5S_A'M0_Y\;S_ORW^%'_  CVH?\ /C>?]^6_PHN@Y)=BG15S_A'M0_Y\;S_O
MRW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\ "/:A_P ^
M-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\ ?EO\*+H.278I
MT5<_X1[4/^?&\_[\M_A1_P (]J'_ #XWG_?EO\*+H.278IT5<_X1[4/^?&\_
M[\M_A1_PCVH?\^-Y_P!^6_PHN@Y)=BG15S_A'M0_Y\;S_ORW^%'_  CVH?\
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M0_Y\;S_ORW^%'_"/:A_SXWG_ 'Y;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\
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M4?\ "/:A_P ^-Y_WY;_"BZ#DEV*=%7/^$>U#_GQO/^_+?X4?\(]J'_/C>?\
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MFB_X8/\ CC_T1GXK?^$EJ'_QJC_A@_XX_P#1&?BM_P"$EJ'_ ,:K^EVBNO\
MM.7\I]-_Q$3$_P#/F/WL_FB_X8/^./\ T1GXK?\ A):A_P#&J/\ A@_XX_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11
MN_\ @'_H:UYI7I?Q _Y%&[_X!_Z&M>:4%(****"@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#OOA7
M_P B]-_U\-_Z"M=-7,_"O_D7IO\ KX;_ -!6NFH(>X4444""BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH QOB!_R*-W_ , _]#6O-*]+^('_ "*-W_P#_P!#6O-*"D%%
M%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7PW_H*UTU
M!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11N_P#@'_H:UYI7I?Q
M_P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%?\ R+TW_7PW_H*U
MTU<S\*_^1>F_Z^&_]!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT7_Y#IV _IDHK^9O_B(+_:\_Z*Y_Y:VB_P#R'1_Q$%_M>?\ 17/_ "UM%_\
MD.BP'],E%?S-_P#$07^UY_T5S_RUM%_^0Z_IDHM8 HHHI %%?S^G_@N5J8_X
M+._\+)_X3+QI_P *#_X2/^S_ .PO[?U#^R/[+^R?V=_:7V+R_P#N(?9_L^_S
M/DSO_>5_0%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_^1>F_P"O
MAO\ T%:Z:N9^%?\ R+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2G^-?*M%'U%=P_UEJ?R+[SZJ_P"$QTC_ *"FG?\ @2G^-'_"8Z1_T%-._P#
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M?*M%'U%=P_UEJ?R+[SZJ_P"$QTC_ *"FG?\ @2G^-'_"8Z1_T%-._P# E/\
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MT%-._P# E/\ &C_A,=(_Z"FG?^!*?XU\JT4?45W#_66I_(OO/JK_ (3'2/\
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M *"FG?\ @2G^-?*M%'U%=P_UEJ?R+[SZJ_X3'2/^@IIW_@2G^-'_  F.D?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPCL9/(QM7>:K= ?T 4445(!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+
MTW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?-GQJ_P"2H:O_ -=%_P#0%KZ3KYL^-7_)4-7_
M .NB_P#H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!N_#_X@7GP^UD7
M-L=\+X$\!/RS+_0^A[?F*^C?"?BRS\9Z-'?6,F^-^&4_>C;NK#L:^5:W?A_\
M0+SX?:R+FV.^%\"> GY9E_H?0]OS%<N(PZFKK<]K*LUEAI>SJ:P?X'T_16;X
M3\66?C/1H[ZQDWQOPRG[T;=U8=C6E7E--.S/N(R4HJ4=4PHHHI%!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O\ X!_Z&M>:
M5Z7\0/\ D4;O_@'_ *&M>:4%(****"@HHHH **** "OP_P#^#L[XJZ=K/QJ^
M#?@B."]75_#FB:CKES,R+]G>"_GA@B5&W;BX;39BP*@ /'@L2P7]P*_ '_@Z
MK'_&POP=_P!D[LO_ $Y:I36X#?\ @U5;'_!1#Q@/7X=7Q_\ *GI=?T 5^+7_
M  :1^&M.NO$?QWUB6PLI-6L;;0[.VOF@4W-O!,VH/-$DF-RI(T$#,H.&,,9(
M)1<?M+0]P/&?^"C?_*/3X\?]D[\0?^FVXK^8']BSXA:1\(_VQ_A-XK\0W?\
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M&ZM<6[6<M[H>J3Z=<2P,RNT320LK%"R(Q4G!**<<"OW7_P"#JO\ Y1Z>#O\
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MYKQ[Y;E7 D0(7@@M0ZAD-?TL5_&<B[$ ]!BA ?MY_P &V7_!,;PN/@HGQ_\
M&FF^&/%>J>*+G'A""ZLC<OX:6QO98Y+H&3]VMT]S I1D0O$ENI67,\B+^NM>
M>_LD_"C4O@/^RI\,O ^L365SJ_@SPGI6A7TUF[/;2SVMG%!(T;,JL4+(2I95
M)!&0#Q7H5(#\6?\ @Y8_X)B^%_A[H"?M#>!],O=.U#6=:CL?&.GV%D7L)'G6
M5EU9RO%L[2HD4I(V32W,3?+*SF?Y^_X-MOVP9OV>/V]8O ][=65OX7^,%O\
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M2\UZY4$!F )\N!-SB* ,5C5F)+R/++)[I/X;TZZ\16NKR6%E)JUC;36=M>M
MIN+>"9HGFB23&Y4D:"!F4'#&&,D$HN+M%2!^9O\ P=5_\H]/!W_91++_ --N
MIU\9_P#!JI_RD+\8_P#9.[W_ -.6F5]F?\'5?_*/3P=_V42R_P#3;J=?&?\
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M_#7QQK$%[<Z3X+\5Z7KU[#9HKW$L%K>13R+&K,JERL9"AF49QD@<U_3_ /\
M!3KPUIWBO_@G-\=+75+"RU*VB\":S>)#=0+,B3P64L\$H5@0'CFCCD1NJNBL
M"" :_E"(R*I ?V84445(!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!WWPK_Y%Z;_ *^&_P#05KIJYGX5_P#(
MO3?]?#?^@K734$/<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5\V?&K_DJ&K_]=%_] 6OI.OFSXU?\E0U?_KHO
M_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ;OP_\ B!>?#[61
M<VQWPO@3P$_+,O\ 0^A[?F*^C?"?BRS\9Z-'?6,F^-^&4_>C;NK#L:^5:W?A
M_P#$"\^'VLBYMCOA? G@)^69?Z'T/;\Q7+B,.IJZW/:RK-98:7LZFL'^!]/T
M5F^$_%EGXST:.^L9-\;\,I^]&W=6'8UI5Y333LS[B,E**E'5,****104444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6\TRRURS\$Z>;C1IYH'CCNH]J(V^)F#KM=3E!AEZA70'X9_\&^W[2T'[-_\
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M]RO^&DOAW_PI[_A8?_">^"_^$ _Z&;^V[;^Q_P#7_9_^/O?Y/^O_ '7WOO\
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M0>/?!>A>$]?\G^S-:U'6[:UT[4?.B,T7DW#N(Y-\2LZ[6.Y5+#(&:D#\-?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 =]\*_\ D7IO^OAO_05KIJYGX5_\B]-_
MU\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#K
MHO\ Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%C\,/A9XK^(=I;W5U;W6HZMJ4?AVVF2-U6">U417,LD<HWMB>.W= $RA9F5
M#]A:*_#0_P#!Y]QQ^S;_ .9!_P#O97TY^P9_P=%_ C]K3Q+IGAGQQ9WWP4\3
M7MK<W$MSX@U&V?PTCQ.2D"ZD6B(D>$;P9X(4W*T8=G,?FNS'9GZ7T444A!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!C?$#_ )%&[_X!_P"AK7FE>E_$#_D4
M;O\ X!_Z&M>:4%(****"@HHHH **** "OF3_ (+#_LN?\-<_\$ZOB3X:M;'[
M=K^FZ<?$&A+%I7]I7AO;+_2%AM8QAQ/<(DMJ&C^8+=. '!*-]-T4 ?RY_P#!
M%'XJZ=\&_P#@J?\ !?6-4AO;BVNM;?0XUM$5W$^HVTVG0,0S*-BRW4;.<Y"!
MB Q 4_U&5_-]_P %Y/\ @F%-^PS^TC<>*?#&F7I^%7Q$N);VQFCLH8;'0;^6
M262724$.%1$4>9 "D>8F*+YAMY7K]S/^";G[:.G_ +?/['?A'XBV[64>KWEO
M]B\0V5L5 TW58<)<Q>6)96B1FQ+$LC^88)H&8 O3?<#M?VL?A5J'QV_98^)?
M@?2)K.WU;QEX5U30[*6\=DMXI[JTE@C:1E5F"!G!8JK$#. >E?D#^R=_P;4_
M'3X$_M3_  T\<:OXK^$UQI/@WQ7I>N7L5GJ>H/<2P6MW%/(L:M9*I<JA"AF4
M$XR1UK]OJ*5P"BBB@ HHHH ^0/\ @M7_ ,$__&7_  4>_98T#P/X'U+PSI6K
M:5XKM]<EEURXG@MV@CM+R!E5H896W[KA" 5 P&YX /Y@?\0JG[0O_0X_!G_P
M;:E_\@5^_P!13N!^ /\ Q"J?M"_]#C\&?_!MJ7_R!1_Q"J?M"_\ 0X_!G_P;
M:E_\@5^_U%%V!^ /_$*I^T+_ -#C\&?_  ;:E_\ (%?<G_!<#_@E1\9/^"FW
MQ&\!'P9K'PRTGPIX(TVZ$?\ ;5W?0:C+>W<J?:,^5;S1F$1VUKL^ZP8S9R"N
M/T:HHN!^4O\ P1]_X()>//V%?VQ8OB5\2M3^'^O6NC:+>0Z(-#U._DN;+49_
M+A\YDDMX49/LKWD9#%L&52%R R_JU112 **** /QF_X*$?\ !MY\3?VC/VT/
MB#X\^'.L_#+0O"?B_4AJT-GJVK:C]L6YFBC>\DD M957S+LW$@59"H5U "@!
M%^O_ /@B+_P3]^*?_!.#X.^-/!'Q U+X?ZII.K:U'KND2^'KB\GN5GD@6"Z6
MX:>&)=FVWM3&$4G)FW'!4#[:HIW ****0!7XS_\ !W'_ ,V^_P#<Q_\ N*K]
MF*_&?_@[C_YM]_[F/_W%4UN!\,_\$T/^"3?B+_@I[X0^)DWA3Q;HOA[7O /]
ME_9;+5K:7['JGVQ[@/ON(]SP>6EL[#$,N]F53L&6K97_ (-]OVO6'_)(B/8^
M*=%_^3*^S?\ @T<_YN"_[ES_ -RM?LQ3; _G-^ __!MG^TQ\3?B);:;XMT#1
M_AMH'RRW>LZCK%GJ 6/S8U=(8+.:5Y)]C.ZJ_E1MY9#2H2N?V*_X)I?\$C_A
MM_P3.T"^G\//>^)?&VNVT5OJWB;4TC%PZ*J%[>V11BVM6F0R^7N=R2@DEE\J
M+9]444K@%?F!_P %J_\ @BI\4_\ @H]^U/H'CCP/K_@#2M)TKPK;Z'+%KE]=
MP7#3QW=Y.S*L-M*NS;<( 2P.0W' )_3^BD!\@?\ !%3_ ()_^,O^"</[+&O^
M!_'&I>&=5U;5?%=QKD4NAW$\]NL$EI9P*K--#$V_=;N2 I&"O/) ^OZ** "O
M,?VO?V0_ W[<7P,U3X?_ ! TO^T-&U#$L$\)"7FDW2AA'=VLA!\N9-S8."K*
MSHZO&[HWIU% '\__ .UU_P &Q?QJ^&7C#5+OX3RZ-\2/"<VI"+2K235(K#7;
M>U9&??="<0VI\MAY1:*8M(2CB) S)'XW_P 0^O[7F/\ DD?_ )=.B_\ R97]
M,E%.[ _"7]B?_@UU^(7CSQ#IVJ?'35[/P/X6DMKAKG1M#U&.[\0K.K&.%#((
MI;.-&_UQ=9)CM"H45G9HOVS^#'P9\+?L\?"W1/!7@K1+/P[X7\.VXM;"PM0=
MD*9+$DDEG=F+.\CDN[NSLS,Q)Z>BE< KX+_X*W?\$-?#'_!16_7QKX8U.R\#
M?%.UMVBGOWM#)9>)42$K;Q7@0AD=6$:"Z4.ZQ91HY@L(B^]** /YI_$/_!O%
M^UMHOB*_LK;X9VFKVUG<R00ZA:>)]*6WOD5BJS1"6XCE". &421H^"-RJ<@7
M/A__ ,&YW[6'C+QA9Z9J'@71_"=G<[_,U;5O$MA)9VFU&8>8MI+/.=Q4(-D3
M?,ZYVKEA_2913N!^&?QG_P"#47XAZ9J>D0_#SXC>#-:LTT__ (FMYXC:YTN2
M:]-Q.?W%O!!<!(1;_9A\\SLT@E;Y5*JOZ&_\$5/^"?\ XR_X)P_LL:_X'\<:
MEX9U75M5\5W&N12Z'<3SVZP26EG JLTT,3;]UNY("D8*\\D#Z_HHN!\__P#!
M4?\ 94\0_MM_L)^.?AAX5O-&T_7_ !-]@^RW&K2RQ6<?D:A;7+[VCCD<92%@
M,(?F(S@9(^ /^"7'_!O_ /&3]B3]NSP-\3_%7B7X9ZAH'AG[?]JM])U&^EO)
M//T^YMDV+):1H</,I.7'R@XR< _K_12 **** *7B3PWIWC/P[?Z/K%A9:KI.
MJVTEG>V5Y L]O>02*4DBDC8%71E)5E8$$$@C!K\3/^"@?_!L%XI\.^(=6\3?
ML^ZA9^(=$NKEIX?!NIW(M=0TU':%5AMKN9_*N44O.V;AX72.)%W7$A+']P**
M /YFS_P;Z_M>X_Y)'_Y=.B__ "97VM_P3P_X-@8=+O;'Q1^T9J%GJ<3VS,/!
M&CW4RJCR0Q[#=W\3HV^)FF#16V4+QQ,+ATW1M^QU%.[ _$']K'_@VI^.GQV_
M:G^)?CC2/%?PFM])\9>*]4URRBO-3U!+B*"ZNY9XUD5;)E#A7 8*S '.">M?
MK]^R=\*M0^!/[+'PT\#ZO-9W&K>#?"NEZ'>RV;L]O+/:VD4$C1LRJQ0LA*EE
M4D8R!TKT"BD!^;'_  5V_P"" </[>'Q2O?BC\//$]EX7^(.I6\$.JV.LB:32
M];>(0P13>:F^2T=+9"I"12)(8H?EB8R2O\4'_@U4_:&Q_P CC\&?_!OJ7_R!
M7OO_  5S_P"#@/QA^S1^VC:>"/@U)HUW9?#K[1:^*O[3B@U#3/$-]-%'MMQY
M3">+[$=P8I/$QG,L<B;8?WGN?['O_!R=\"/V@[*ULO'CWOP@\47%S%:K;:IO
MOM*G>6:1$,=_%&%1%41-+)=1VZ)YO#.J,XK4#Y!\&?\ !IS\1;[X=ZM<^(?B
MQX+TOQ9#YW]F:;IVG7-_IUYB(&'SKM_)DAW2[E;;;2[% 8;R=@^ /VZ_V%?'
M'_!/+XY_\(#X].BS:G-IT&K6EWI-V;FSOK64N@D0LJ2+B6*:,B2-&W1,0"A1
MV_HQ^+W_  65_9>^")T[^V?C3X-O?[4\SR?[ ED\0;/+V;O-^P)/Y.=XV^9M
MWX;;G:V/PT_X+1_\%2;;_@IM\<O#UYX<T[6M%\ ^#-.:VTBRU9+=;R6ZG*O=
MW+B+=LW[((A'YLBA;97&QI74"N!^DO\ P:^?M@^*/CK^S;XS^'7B:ZO=6C^%
M-Q8+HVH75R)'BT^[CG6*P V!MD#6DA1F=_DG6-0B0H*_4"OR9_X-0_@1XA\&
M_ _XI_$'4;?[+X?\<ZCI^G:/YD<J2W?]GBZ\^==R!'A+W8B5T9OWEO<*0I3G
M]9J3W _*7_@["^*NG:3^RY\+? \L%ZVK>(/%<NO6TRHIMHX+"SD@F5VW;@[-
MJ4)4!2"$DR5(4-X;_P &J?[+O_"6_';Q]\7-1L=]EX/TU-!T>2YTKS(GOKL[
MYY;>Z;B.>"WA$;J@+&/4ADJK8D^??^"L7QKU?_@J]_P55N=&^%NC_P#"5_8/
M+\#^%5TP([:U%:R3R2W1E69X6A:>6ZE6?<D8M1&[A-KM7[S?L _L4>'O^"?G
M[+N@?#7P_<?VF=.,EUJ>K/9Q6T^M7TK;I;B14'^[&@9G9(8H8R[[-Q>R ]HH
MHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#OOA7_R+TW_ %\-_P"@K735S/PK_P"1>F_Z^&_]!6NFH(>X
M4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KYL^-7_)4-7_ZZ+_Z M?2=?-GQJ_Y*AJ__71?_0%KLP7QOT/GN(_]
MWCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#=^'_P 0+SX?:R+FV.^%
M\"> GY9E_H?0]OS%?1OA/Q99^,]&COK&3?&_#*?O1MW5AV-?*M;OP_\ B!>?
M#[61<VQWPO@3P$_+,O\ 0^A[?F*Y<1AU-76Y[659K+#2]G4U@_P/I^BLWPGX
MLL_&>C1WUC)OC?AE/WHV[JP[&M*O*::=F?<1DI14HZIA1112*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#E&IX'_P"RF6'_ *:M6K]6*_*?_@[_ /\ E&IX'_[*98?^FK5J /AO_@T
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MKX\"U@U#Q=KWPVU2^U1-,MK'Q;HTD/F;_+"7#W-J;BT@@+2%2\\\>SRW9PJ
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ME6:7RCM^]** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\S?\ @XK_ ."?7Q>_;M_X4]_PJKPC_P )3_PBW]M?VI_Q-+*Q^R_:
M/[/\G_CYFCW;O(E^[G&WG&1G],J* /S-_P"#=3_@GU\7OV$O^%P_\+5\(_\
M"+?\)3_8O]E_\32ROOM7V?\ M#SO^/::3;M\^+[V,[N,X./TRHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#\\?^"B'_  ;L?#?]MCXI7WCSPQXDO?A=XNURY2XUDVNFQZAI>IOB
M3S;@VN^%H[J5FC+R++L;RV9HFDE>4_F=\5?^#;K]JGX>>(H;+2?"_AGQW;2V
MRSOJ&A>(K6*VA<LRF%A?-;2[P%#$K&4PZX8G<%_H_HIW _F:;_@WU_:] _Y)
M$3]/%.B__)E?6/[#7_!K=XDN_&&B^(?CUXBT6R\/P?9;Z?PIH4\MQ>W^Y':6
MSNKL!$MMC^4KM;&?S%,H26,A)3^VE%%V!2\-^&]/\&^';#2-(L++2M)TJVCL
M[*RLX%@M[."-0D<4<:@*B*H"JJ@    8%<9^UEH/BCQ5^RO\2],\#O>Q^--1
M\*:I:^'WL[P6=PFH/:2K;&.<L@B?S2FV0LNTX.X8S7H%%(#X*_X(O?\ !%^+
M_@FM9ZQXN\7:Q9>(?BGXAMI-+EETN>;^RM*T[SDD$$(=8VFDE:&*2261!MVI
M&BJ%>2;[UHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#OOA7_P B]-_U\-_Z"M=-7,_"O_D7IO\
MKX;_ -!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KYL^-7_ "5#5_\ KHO_ * M?2=?-GQJ_P"2H:O_
M -=%_P#0%KLP7QOT/GN(_P#=X^OZ,Y:BBBO4/C HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!C_N.?\ I]U&ON6OAK_@VT_Y0L?!C_N.?^GW4:^Y:0@KYO\ ^"K?_!0K1?\
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M@R2UUZPOK;PS;ZIJ5EK,7E7UA?WY:_O+>2/8AC\JYN9HPC+O1456+,"QW?\
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M^UVOP6_X/ /V+;7PQXY^'7QZT32/('B82>%/%5W$;:*&6[A3SM.D9 !/+/)
MMY&TK%U$=C;I^[PH<3!,_4K_ ()!?\%$H/\ @IS^Q)H?Q&FL[#2O%%M=3:'X
MHTZQ$WV6QU*#:S>495!,<L,MO.JAI!&+@1F1WC9J^GZ_G>_X,\?B1K>E_MR_
M$WPA!>^7X<UWP*VL7]GY,9\^[L]0M(;:3>5WKLCO[L;58*WG98$JA7^B&I9+
M"BBB@ HHHH *_DR_X+T_MHVG[<7_  4T\=^(=$U?^VO!WACRO"GANX46S1-:
M68(E>&6 LL\$MX]Y/%*SLS1W"?= ")^UG_!R+_P5+_X89_9+?P+X'\5?V/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 8WQ _Y%&[_P" ?^AK7FE>E_$#_D4;O_@'_H:UYI04@HHH
MH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5\V?&K_DJ&K_]=%_] 6OI.OFS
MXU?\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% &[\/_ (@7GP^UD7-L=\+X$\!/RS+_ $/H>WYBOHWP
MGXLL_&>C1WUC)OC?AE/WHV[JP[&OE6MWX?\ Q O/A]K(N;8[X7P)X"?EF7^A
M]#V_,5RXC#J:NMSVLJS66&E[.IK!_@?3]%9OA/Q99^,]&COK&3?&_#*?O1MW
M5AV-:5>4TT[,^XC)2BI1U3"BBBD4%%%% !1110 4444 %%%% !1110 4444
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MA_Z==6H0(^Y/^#0#_E&IXX_[*9?_ /IJTFOU8K\I_P#@T _Y1J>./^RF7_\
MZ:M)K]6*'N#W/X:Z_N4K^&NO[E*<AR"OPU_X//O^;;O^YG_]P]?N57X:_P#!
MY]_S;=_W,_\ [AZ2W$MP_P"#,'_FY'_N6/\ W,5[E_P=_C/_  34\#_]E-L/
M_35JU>&_\&8/_-R/_<L?^YBOIO\ X.O_ (0:G\2O^"4S:U8SV$-I\/?&.E^(
M-26X=UDGMY%N--580%(:3S]0@8ABHV+(=V0JL=0ZG\ZG[-G[-GC7]KSXU:+\
M._AWHO\ PD/C'Q#Y_P#9^G_:X+3[1Y,$EQ+^]G=(EQ%%(WS,,[<#)(!^J_\
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MDPV*D5Q_/=I'A?XV?\%1?VI=4N[#3O%?Q8^*'C&Z6]U*:WM_.D :2*W6:9E
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ML/\ TU:M2N*Y\-_\&@'_ "DK\<?]DSO_ /TZZ37]'E?SA_\ !H!_RDK\<?\
M9,[_ /\ 3KI-?T>4/<'N%%%%(04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O_ (!_Z&M>:5Z7
M\0/^11N_^ ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=:UK4;[5]8U?X>:!>W]_>SO<7-[/)IMN\DTLCDL\CLQ9F8DDDDG)KV2O#/\
M@F#_ ,HU/V>?^R9^&_\ TU6U>YU)(4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7PU_P<E_\H6/C/\ ]P/_ -/NG5]RU\-?\')?_*%CXS_]P/\
M]/NG4 ?AK_P;:?\ *:?X,?\ <<_],6HU_5?7\J'_  ;:?\II_@Q_W'/_ $Q:
MC7]5]-C84444A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5^&O_  >??\VW?]S/_P"X
M>OW*K\-?^#S[_FV[_N9__</36XUN'_!F#_S<C_W+'_N8K]RJ_#7_ (,P?^;D
M?^Y8_P#<Q7[E4/<'N%%%%(04444 %%%% !1110 4444 %%%% !1110 4444
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M:#8191/%#$D<!D02,%0-(^TNSB*(1_5M(04444 %%%% !1110 4444 %%%%
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ML(WEGN6_L36BK16DL$*!T/VJ1H;:4E%)_P!&=I52W*M_2W0P84444A!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5\V?&K_DJ&K_ /71?_0%KZ3KYL^-7_)4-7_ZZ+_Z
M M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ;OP_^(%Y\/M9%S;'?"^!/ 3\LR_T/H>WYBOHWPGXLL_&>C1WU
MC)OC?AE/WHV[JP[&OE6MWX?_ ! O/A]K(N;8[X7P)X"?EF7^A]#V_,5RXC#J
M:NMSVLJS66&E[.IK!_@?3]%9OA/Q99^,]&COK&3?&_#*?O1MW5AV-:5>4TT[
M,^XC)2BI1U3"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML/ L4EK;):>#O$*75YIZW"N$GD74C)+<Q1M%^\"/#.?-##>D;J(>\_X(/_\
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M5+"ZO;[4K2YN;<.1')+"EE*L4C)M+(LL@4D@.X&X]5^SO_P9X_$W4/B;:_\
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MO_OE1_Q!@_\ 5R7_ )C[_P"^5&@:!_Q&??\ 5MW_ )D'_P"]M?LC^S!\:/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% &-\0/^11N_\ @'_H:UYI7I?Q _Y%&[_X!_Z&M>:4%(**
M**"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVN=2\-OX4T>RTB+79Q'G^S;M%\F%TG*(B2R,#;N5<-L\Z*4N@NCXY_X)2_\
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M_M=?\'17QU^,?P?\.^"? .H_\(2(_#.GV/B?Q4EI"GB#7M3-B8M2EA9/W-E
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M])7A;PMIG@;PSIVBZ+IUCH^C:/:Q6-A86-NEO;6-O$@2.&*- %2-$5555
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M^$/@7P_JOAWS_P"S]:.F)=ZW;^?Y@E_XF,^^[;<LTB?-*<1ML&$ 47OVJ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH W?A_\0+S
MX?:R+FV.^%\"> GY9E_H?0]OS%?1OA/Q99^,]&COK&3?&_#*?O1MW5AV-?*M
M;OP_^(%Y\/M9%S;'?"^!/ 3\LR_T/H>WYBN7$8=35UN>UE6:RPTO9U-8/\#Z
M?HJMH^IKK.E6]VD<L2W$8D"2KM=<C."*LUY)]RFFKH****!A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?AK_P>??\VW?]S/\ ^X>OW*K\I_\
M@YO_ .";7QJ_X*%?\*2_X4_X,_X2[_A$?[=_M;_B;V%A]D^T_P!F^3_Q]31;
M]WV>7[F[&SG&1EK<:W/#?^#,'_FY'_N6/_<Q7[E5^4__  ;(?\$VOC5_P3U_
MX7;_ ,+@\&?\(C_PEW]A?V3_ ,3>PO\ [7]F_M+SO^/6:79M^T1??VYW\9P<
M?JQ0]P>X4444A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!C?$#_ )%&[_X!_P"AK7FE>E_$#_D4;O\
MX!_Z&M>:4%(****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#OOA7_R+TW_7PW_H*UTU<S\*_P#D
M7IO^OAO_ $%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OX:Z_N4K^&N
MJB5$_LA_X)@_\HU/V>?^R9^&_P#TU6U>YUX9_P $P?\ E&I^SS_V3/PW_P"F
MJVKW.I)"BBB@#\-?^#S[_FV[_N9__</1_P &8/\ S<C_ -RQ_P"YBC_@\^_Y
MMN_[F?\ ]P]'_!F#_P W(_\ <L?^YBJZ%=#]RJ***DD_C>_X*??\I*_VAO\
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ME>S6'A_2+?3+:6=M2U-&F:.!%4R%8XU+$9(11G %"!'Z(?\ !H!_RC4\<?\
M93+_ /\ 35I-;G_!VI\2=;\#?\$MM.TO2KW[+8>,O'6FZ/K,7DQO]LM$M[R^
M6/+*2F+FSMGW(5;]UMSM9E.'_P &@'_*-3QQ_P!E,O\ _P!-6DT?\'@#8_X)
MJ>!_?XFV'_IJU:EU%U/PE_X)Z_ Z#]I7]NSX/^!+[0;_ ,3:-XG\8:79ZSIM
MFLWF3Z8;J,WQ+0D2)&EJ)G>12IC1'?<H7</[,J_D6_X(??&K_A0?_!6CX$:Y
M_9G]K?;O$\7ASR/M'D>7_:L<FE^=NVMGROMGF[<?/Y>W<N[</ZZ:<AR"BBBI
M)"OPU_X//O\ FV[_ +F?_P!P]?N57X:_\'GW_-MW_<S_ /N'IK<:W.3_ .#-
MGX.Z9K?QS^-_Q EGOUUCPSH6F^'K6%'06LEOJ%Q-<3,Z[=QD5M,@"$,  \N5
M8E2O[[5^&O\ P9@_\W(_]RQ_[F*_<JA[@]PHHK\>O^#L+_@I%J7P1^$_ASX
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MTV.[N& WS&&UCBA$CD;G94!D=G=BSLS'^R__ (9<^&?_  I/_A6G_"NO O\
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MNO$MZUNLPCTQ[*TFGL[J9XB-D:7ZV8!<A'=XXV#"3:W]7]?S$?\ !JY\:O\
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M)7^T-_V4SQ)_Z=;FOZKO^"8/_*-3]GG_ +)GX;_]-5M38V?#7_!W_P#\HU/
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M !'H7CD:-8WGG2#R+2]L+J:YCV!MC;Y+"T.YE++Y6%(#.&_76ORG_P"#O_\
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MSH5CX;M_M=A;^,?$%O+<WVH[HT2*^M+,F..UV2><Z+=+<>8IA,D41#PGY_\
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MX \&>%/ VC7/P\LKV:P\/Z1;Z9;2SMJ6IHTS1P(JF0K'&I8C)"*,X K]$/\
M@T _Y1J>./\ LIE__P"FK2:'L#V/U8HHHJ23^:7_ (.T/AIHG@3_ (*EV&J:
M59?9;_QIX&TW6=9E\Z1_MEVEQ>6*R89B$Q;65LFU J_N]V-S,QW?^#0%?^-E
MOC<_]4ROQ_Y5=)K"_P"#M#XF:)X[_P""I=AI>E7OVJ_\%^!M-T;68O)D3['=
MO<7E\L>64!\VU[;/N0LO[S;G<K*-W_@T!/\ QLM\;C_JF5__ .G72:KH5T/Z
M/:***DD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?\E0U?_KHO_H"U])U\V?&K
M_DJ&K_\ 71?_ $!:[,%\;]#Y[B/_ '>/K^C.6HHHKU#XP**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KU[X*?!3_5:QK$7H]M;./R=Q_(?B
M:/@I\%/]5K&L1>CVULX_)W'\A^)KUZO/Q.)^Q ^JR?)]J]=>B_5A1117GGU0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 8WQ _Y%&[_X!_Z&M>:5Z7\0/^11N_\ @'_H:UYI04@H
MHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .^^%?_(O3?\ 7PW_ *"M=-7,_"O_ )%Z;_KX;_T%
M:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "OX:Z_N4K^&NJB5$_LA_P""
M8/\ RC4_9Y_[)GX;_P#35;5[G7\-=%'*'*?W*45_#77W+_P;:?\ *:?X,?\
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MU_<I52*D%?SA_P#!W_\ \I*_ _\ V3.P_P#3KJU?T>5_.'_P=_\ _*2OP/\
M]DSL/_3KJU)"1]R?\&@'_*-3QQ_V4R__ /35I->Y_P#!R7_RA8^,_P#W _\
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M&\,:CK>MZC8:/HVCVLM]?W]]<);VMC;Q(7DFED<A4C1%9F9B  "2<"OY3O\
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MM:U&QT?1M'^(>@7U_?WUPEO:V-O%J5N\DTLCD*D:(K,S,0  23@5]&_LR_\
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M7]'E#W![A1112$%%%% !7\;W_!3[_E)7^T-_V4SQ)_Z=;FO[(:_C>_X*??\
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M[O$*F%ED#VDD_F*BS0L_X;?L0?LGZW^W-^UGX$^$^@2_9;_QIJ:VDEWMC?\
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M_9#7\;W_  3!_P"4E?[//_93/#?_ *=;:O[(:J14C^-W_@IX<_\ !2K]H?\
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M %T7_P! 6NS!?&_0^>XC_P!WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KU[X*?!3_5:QK$7H]M;./R=Q_(?B:/@I\%/]5K&L
M1>CVULX_)W'\A^)KUZO/Q.)^Q ^JR?)]J]=>B_5A1117GGU04444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYN+6UN+73M*TZ3Q#=0O(C-/!='S+:&.2([%S#)<(Y+X<!59_C7_@H]_P1/\
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MXD^@J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_(HW?_ /_0UKS2O2
M_B!_R*-W_P  _P#0UKS2@I!11104%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<U+X9^%_M>E:S817]E=>7IUI(GF0RJR/MD1'&0<,BD<@5N_\.P/V:<?\F\?
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M_&7QO>^)O%_P9^%'BOQ)J?E_;-6UCPCI]]?7?EQK$GF32Q,[[8T1!DG"HH'
M%>D>%_"^F^"/#6G:+HNG6.D:/I%K'96%A96ZV]M901J$CABC0!4C15"JJ@
M  8%7Z* "N3^,7P&\#?M#^&H-%\?^#/"?CG1[6Z6^@L/$.D6^IVT-PJ.BS+'
M.C*) DDBA@,@.PS@FNLHH \,/_!,']FD_P#-O'P,_P#"#TK_ .,5Z/\ !WX"
M^!OV=_#,^B_#_P &>$_ VC75TU]-8>'M(M],MIKAD1&F:.!%4R%(XU+$9(11
MG %=910 4444 %%%% !7E'Q)_8.^!WQE\;WOB;Q?\&?A1XK\1ZEY?VS5=8\(
MZ??7UWY<:Q)YDTL3.^V-$09)PJ*!P!7J]% 'AC?\$O\ ]FENO[/'P,/U\!Z5
M_P#&*]D\+>%M,\#>&-.T71=.L='T;1[6*QL+"QMTM[6QMXD"1PQ1H J1HBJJ
MJH    &!5^B@ HHHH \,'_!,#]FE1Q^SQ\#!_P!R'I7_ ,8KN/@M^R[\,_V;
M3J9^'7PZ\"^ 3K7E?VC_ ,(YH%KI7V_RM_E>;Y$:>9L\R3;NSM\QL8W&N[HH
M *\9\*_\$YOV>_ GB33M9T3X$?!K1M7TBYBO;"^L?!6FV]S93Q,'CEBD2$,C
MHRAE92"" 0<BO9J* "OF[_@K;^VE:?L$_P#!/[XB^/O[7_LCQ&-,ETGPJ\8M
MI+B36KE&BLS%#<$)-Y3G[1(F'/DVTS;'"%3](U_/9_P<C?'_ .*7[>G_  4O
MT+]E'P+X9OM1C\#W5L--TO3KN1Y/$NI7VGV]VUW.C,L$:6UO*R*[C$*?;)7F
M$<K+&T-'P7_P2J_X)[:W_P %+_VR?#WPYTT_9]$@VZQXJO5O8[6;3M%BGA2Z
MEA+I)NG/G)'$HC<>;+&7 C$CK_7QX6\+:9X&\,:=HFB:=8:/HVCVL5C86%C;
MI;VMC;Q($CABC0!4C1%5550    ,"OE+_@C)_P $KM-_X)4_LM/X9GU"Q\0>
M//%-TNK>*M9MK5(XY)Q&J1V=NY19GM+<;_+\TY+S7$@6+SO*3Z\H8,****0@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^;/C5_R5#5_P#KHO\ Z M?2=?-GQJ_Y*AJ
M_P#UT7_T!:[,%\;]#Y[B/_=X^OZ,Y:BBBO4/C HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KU[X*?!3_5:QK$7H]M;./R=Q_(?B:/@I\%/]5K&L1>CVUL
MX_)W'\A^)KUZO/Q.)^Q ^JR?)]J]=>B_5A1117GGU04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-&CCY%U7]DCXCZ%^RWI?QJO?"M]9_"_6]=;PWIVNSR11QW]\L<LC)#$6$TB
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M=)\2WNF:7I/VN)?MMA=6HDO;CR2/-?R9;2P3>I")]JPX)DCQ^<7_  ;:C/\
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M#4_VA?V0OA5X_P!;@L;76?''@_2/$%_#8HZ6L-Q=V4,\BQ*[.PC#R,%#,Q
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M&\,_$/\ X)*?':P\6:S_ &%I=OX:?4X+G[7%:^;?VDL=W86^^4%3Y]Y#;0[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#OOA7_ ,B]-_U\-_Z"M=-7,_"O_D7IO^OAO_05KIJ"'N%%%% @HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KXV^)_\ P;^_LC?&;XE^(?&'B3X2_P!I>(O%>IW.L:K=
M_P#"4:S#]JN[B5III-D=VJ+ND=CM10HS@ #BOLFB@#"^&'PVT7X,_#3P]X/\
M-V7]F^'?"FF6VCZ5:>=)-]EM+>)888]\C,[;8T4;G8L<9))YK=HHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA?C'^S
M)\/_ -H+5_#&H^,_"&A>(=5\$ZG!K'A_4;JV!O=$NH;FWNDDMIQB6',MK 75
M&"RK&$D#H2I[JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X7
MPE^S)\/_  +\:_$_Q)TOPAH5K\0/&6Q=8\1_9@^IWD206MNL'GMET@"65M^Y
M0K'OBW[=[,Q[JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7_)
M4-7_ .NB_P#H"U])U\V?&K_DJ&K_ /71?_0%KLP7QOT/GN(_]WCZ_HSEJ***
M]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSJ%A<^ _A;=17>L/#%#*U]XB\J5) +A)'/EVL,Y@,>(F6X:[617\N(I^J_\
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M-A86-NEO;65O$@2.&*- %2-$5555     P*OU)(4444 ?QU?\%6O#&I^$?\
M@IQ^T':ZOIU_I=U+\1-=O8X;RW>"1[>XOYI[>8*P!,<L,D<B-T=)$8$A@:_8
M+_@S?^-']N?LV_&;X=_V9Y7_  B_B:R\2?VC]HW?:O[2M3;^3Y6T;?+_ +*W
M;MYW>?C:NS+?G'_P<E_\II_C/_W _P#TQ:=7W+_P9@_\W)?]RQ_[F*KH5T/W
M*HHHJ20HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_ "*-W_P#_P!#6O-*]+^(
M'_(HW?\ P#_T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_D7IO\ KX;_ -!6
MNFKF?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O_UT7_T!:^DZ^;/C
M5_R5#5_^NB_^@+79@OC?H?/<1_[O'U_1G+4445ZA\8%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7KWP4^"G^JUC6(O1[:V<?D[C^0_$T?!3X*?ZK6-8B]'MK9Q^3N/Y
M#\37KU>?B<3]B!]5D^3[5ZZ]%^K"BBBO//J@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH _E=_P"#E_PSJ>@_\%F?BK=7^G7]E:ZU
M;:+>Z;-<6[QQZA;C2+. S0LP DC$T,T99<C?#(N<HP'V/_P9L?'&"U\5_'#X
M;7NO7YNKZTTSQ-H^B.TSVJI"\]MJ%T@P88Y"9]-1^0\@6/ 81'9ZO_P=A?\
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MT#H?T)UX9_P4^_Y1J?M#?]DS\2?^FJYKJ=7_ &S/@_X?^$>E_$"_^*WPVLO
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MI\[ *6&QHSNR65:>Q3V/TNHHHJ20HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('
M_(HW?_ /_0UKS2O2_B!_R*-W_P  _P#0UKS2@I!11104%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M=]\*_P#D7IO^OAO_ $%:Z:N9^%?_ "+TW_7PW_H*UTU!#W"BBB@04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_
MY*AJ_P#UT7_T!:^DZ^;/C5_R5#5_^NB_^@+79@OC?H?/<1_[O'U_1G+4445Z
MA\8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=E?LL7'P>_X*)Z;\2((;]M'^,&A0W+W-Q<PO&=2T]([*X@AC7$B1I:KISDR
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M.I]_])LM1O9X4'^_;Q+(_P#S\NT7_'O+7[F4V-A1112$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 8WQ _P"11N_^ ?\ H:UYI7I?Q _Y%&[_ . ?^AK7FE!2"BBB
M@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH [[X5_\B]-_U\-_Z"M=-7,_"O\ Y%Z;_KX;_P!!6NFH
M(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KYL^-7_)4-7_ZZ+_Z M?2=?-GQJ_Y*AJ__ %T7_P! 6NS!?&_0
M^>XC_P!WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *]>^"GP4_U6L:Q%Z/;6SC\G
M<?R'XFCX*?!3_5:QK$7H]M;./R=Q_(?B:]>KS\3B?L0/JLGR?:O77HOU8444
M5YY]4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7YH?\%Y/^"#FF_P#!0WPU=_$WX96ECI/QRTBU EB+
M);VWC>WB0*EM<.<*EVB*%AN&(! 6&4B,1RVWZ7T4 ?*7_!$7X;>/_@S_ ,$P
M?AEX/^*%EKNF^-O"G]JZ-?6FKS--<6L=OJU[#;1JY9@T"VR0B%D8QF$1&,F/
M8:^K:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\,OAK_P &
M_?Q _;V_X*P_&'XI_'V#7=*^#G_"<ZO=:='?:@?[5\9VL.HW%O:6D7SF>UL5
M@@B'F-L9K?R%MOED$\/[FT4 4/"WA?3/ _AG3M%T73K'1]&T>UBL;"PL;=+>
MVLK>) D<,4: *D:(JJJJ    !@5?HHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,;X@?\ (HW?_ /_ $-:\TKTOX@?\BC=_P# /_0UKS2@I!11104%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 =]\*_^1>F_P"OAO\ T%:Z:N9^%?\ R+TW_7PW_H*UTU!#W"BB
MB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?-GQJ_Y*AJ__71?_0%KZ3KYL^-7_)4-7_ZZ+_Z M=F"^-^A\]Q'_N\?
M7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %>O?!3X*?ZK6-8B]'MK9Q^3N/Y#\31\%/@I_JM
M8UB+T>VMG'Y.X_D/Q->O5Y^)Q/V('U63Y/M7KKT7ZL****\\^J"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QOB!_R*-W_P#_T-
M:\TKTOX@?\BC=_\  /\ T-:\TH*04444%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O\ Y%Z;
M_KX;_P!!6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CWQ&^!>M>*O&M_J%
MLUD(+EU9-\I#<*!R,>U>PT5I3JR@[Q.3%X.GB8*%79:G@?\ PS7XB_OZ=_W^
M;_XFC_AFOQ%_?T[_ +_-_P#$U[Y16WURH>?_ *OX3S^\\#_X9K\1?W]._P"_
MS?\ Q-'_  S7XB_OZ=_W^;_XFO?**/KE0/\ 5_">?WG@?_#-?B+^_IW_ '^;
M_P")H_X9K\1?W]._[_-_\37OE%'URH'^K^$\_O/ _P#AFOQ%_?T[_O\ -_\
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M_P#$U[Y11]<J!_J_A//[SP/_ (9K\1?W]._[_-_\31_PS7XB_OZ=_P!_F_\
MB:]\HH^N5 _U?PGG]YX'_P ,U^(O[^G?]_F_^)H_X9K\1?W]._[_ #?_ !->
M^44?7*@?ZOX3S^\\#_X9K\1?W]._[_-_\31_PS7XB_OZ=_W^;_XFO?**/KE0
M/]7\)Y_>>!_\,U^(O[^G?]_F_P#B:/\ AFOQ%_?T[_O\W_Q->^44?7*@?ZOX
M3S^\\#_X9K\1?W]._P"_S?\ Q-'_  S7XB_OZ=_W^;_XFO?**/KE0/\ 5_">
M?WG@?_#-?B+^_IW_ '^;_P")H_X9K\1?W]._[_-_\37OE%'URH'^K^$\_O/
M_P#AFOQ%_?T[_O\ -_\ $T?\,U^(O[^G?]_F_P#B:]\HH^N5 _U?PGG]YX'_
M ,,U^(O[^G?]_F_^)H_X9K\1?W]._P"_S?\ Q->^44?7*@?ZOX3S^\\#_P"&
M:_$7]_3O^_S?_$T?\,U^(O[^G?\ ?YO_ (FO?**/KE0/]7\)Y_>>!_\ #-?B
M+^_IW_?YO_B:/^&:_$7]_3O^_P W_P 37OE%'URH'^K^$\_O/ _^&:_$7]_3
MO^_S?_$T?\,U^(O[^G?]_F_^)KWRBCZY4#_5_">?WG@?_#-?B+^_IW_?YO\
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M '^;_P")KWRBCZY4#_5_">?WG@?_  S7XB_OZ=_W^;_XFC_AFOQ%_?T[_O\
M-_\ $U[Y11]<J!_J_A//[SP/_AFOQ%_?T[_O\W_Q-'_#-?B+^_IW_?YO_B:]
M\HH^N5 _U?PGG]YX'_PS7XB_OZ=_W^;_ .)H_P"&:_$7]_3O^_S?_$U[Y11]
M<J!_J_A//[SP/_AFOQ%_?T[_ +_-_P#$T?\ #-?B+^_IW_?YO_B:]\HH^N5
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M_P")H_X9K\1?W]._[_-_\37OE%'URH'^K^$\_O/ _P#AFOQ%_?T[_O\ -_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_ "*-W_P#_P!#6O-*]+^(
M'_(HW?\ P#_T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_D7IO\ KX;_ -!6
MNFKF?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!A
M?$J[BL?!-[+-)'#$NS<[L%4?O%')->4?\);I7_02T_\ \"$_QKO?VC? R_$G
MX-:QHKW#6BWOD9E5-Y3;/&_3(_NX_&OEK_AART_Z&*X_\!!_\504KGM'_"6Z
M5_T$M/\ _ A/\:/^$MTK_H):?_X$)_C7B_\ PPY:?]#%<?\ @(/_ (JC_AAR
MT_Z&*X_\!!_\50/4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
M@_\ BJ U/:/^$MTK_H):?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H
M8KC_ ,!!_P#%4?\ ##EI_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PE
MNE?]!+3_ /P(3_&O%_\ AART_P"ABN/_  $'_P 51_PPY:?]#%<?^ @_^*H#
M4]H_X2W2O^@EI_\ X$)_C1_PENE?]!+3_P#P(3_&O%_^&'+3_H8KC_P$'_Q5
M'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\ @0G^-'_"6Z5_T$M/_P#
MA/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P" @_\ BJ U/:/^$MTK_H):
M?_X$)_C1_P );I7_ $$M/_\  A/\:\7_ .&'+3_H8KC_ ,!!_P#%4?\ ##EI
M_P!#%<?^ @_^*H#4]H_X2W2O^@EI_P#X$)_C1_PENE?]!+3_ /P(3_&O%_\
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MO%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_X"#_ .*H#4]H_P"$MTK_ *"6G_\
M@0G^-'_"6Z5_T$M/_P# A/\ &O%_^&'+3_H8KC_P$'_Q5'_##EI_T,5Q_P"
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M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<
MO_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]
M#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!<O_QRC_AV'8_]#A=_^"Y?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.Q_Z'"[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>
MO_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X
M&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K
M2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]
M#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/^$_T+_H-:3_X&1_XU\W_ /#L
M.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE 'TA_PG^A?]!K2?\ P,C_ ,:/
M^$_T+_H-:3_X&1_XU\W_ /#L.P_Z&^[_ /!>O_QRC_AV'8?]#?=_^"]?_CE
M'TA_PG^A?]!K2?\ P,C_ ,:T;'4(-4M5GMIHKB!\[9(G#JV#@X(XZ@U\O?\
M#L.P_P"AON__  7K_P#'*]]^"GPP3X-?#+3?#<5X]^FF^;B=H_+,F^5Y/NY.
M,;\=>U '54444 %%%% !1110 4444 %%%% &-\0/^11N_P#@'_H:UYI7I?Q
M_P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%?\ R+TW_7PW_H*U
MTU<S\*_^1>F_Z^&_]!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QOB
M!_R*-W_P#_T-:\TKTOX@?\BC=_\  /\ T-:\TH*04444%!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '??"O\ Y%Z;_KX;_P!!6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_AJ'2/\ H'ZC_P".?_%4?5ZG8/[6PG\Z/3:*\R_X:ATC_H'ZC_XY_P#%4?\
M#4.D?] _4?\ QS_XJCZO4[!_:V$_G1Z;17F7_#4.D?\ 0/U'_P <_P#BJ/\
MAJ'2/^@?J/\ XY_\51]7J=@_M;"?SH]-HKS+_AJ'2/\ H'ZC_P".?_%4?\-0
MZ1_T#]1_\<_^*H^KU.P?VMA/YT>FT5YE_P -0Z1_T#]1_P#'/_BJ/^&H=(_Z
M!^H_^.?_ !5'U>IV#^UL)_.CTVBO,O\ AJ'2/^@?J/\ XY_\51_PU#I'_0/U
M'_QS_P"*H^KU.P?VMA/YT>FT5YE_PU#I'_0/U'_QS_XJC_AJ'2/^@?J/_CG_
M ,51]7J=@_M;"?SH]-HKS+_AJ'2/^@?J/_CG_P 51_PU#I'_ $#]1_\ '/\
MXJCZO4[!_:V$_G1Z;17F7_#4.D?] _4?_'/_ (JC_AJ'2/\ H'ZC_P".?_%4
M?5ZG8/[6PG\Z/3:*\R_X:ATC_H'ZC_XY_P#%4?\ #4.D?] _4?\ QS_XJCZO
M4[!_:V$_G1Z;17F7_#4.D?\ 0/U'_P <_P#BJ/\ AJ'2/^@?J/\ XY_\51]7
MJ=@_M;"?SH]-HKS+_AJ'2/\ H'ZC_P".?_%4?\-0Z1_T#]1_\<_^*H^KU.P?
MVMA/YT>FT5YE_P -0Z1_T#]1_P#'/_BJ/^&H=(_Z!^H_^.?_ !5'U>IV#^UL
M)_.CTVBO,O\ AJ'2/^@?J/\ XY_\51_PU#I'_0/U'_QS_P"*H^KU.P?VMA/Y
MT>FT5YE_PU#I'_0/U'_QS_XJC_AJ'2/^@?J/_CG_ ,51]7J=@_M;"?SH]-HK
MS+_AJ'2/^@?J/_CG_P 51_PU#I'_ $#]1_\ '/\ XJCZO4[!_:V$_G1Z;17F
M7_#4.D?] _4?_'/_ (JC_AJ'2/\ H'ZC_P".?_%4?5ZG8/[6PG\Z/3:*\R_X
M:ATC_H'ZC_XY_P#%4?\ #4.D?] _4?\ QS_XJCZO4[!_:V$_G1Z;17F7_#4.
MD?\ 0/U'_P <_P#BJ/\ AJ'2/^@?J/\ XY_\51]7J=@_M;"?SH]-HKS+_AJ'
M2/\ H'ZC_P".?_%4?\-0Z1_T#]1_\<_^*H^KU.P?VMA/YT>FT5YE_P -0Z1_
MT#]1_P#'/_BJ/^&H=(_Z!^H_^.?_ !5'U>IV#^UL)_.CTVBO,O\ AJ'2/^@?
MJ/\ XY_\51_PU#I'_0/U'_QS_P"*H^KU.P?VMA/YT>FT5YE_PU#I'_0/U'_Q
MS_XJC_AJ'2/^@?J/_CG_ ,51]7J=@_M;"?SH]-HKS+_AJ'2/^@?J/_CG_P 5
M1_PU#I'_ $#]1_\ '/\ XJCZO4[!_:V$_G1Z;17F7_#4.D?] _4?_'/_ (JC
M_AJ'2/\ H'ZC_P".?_%4?5ZG8/[6PG\Z/3:*\R_X:ATC_H'ZC_XY_P#%4?\
M#4.D?] _4?\ QS_XJCZO4[!_:V$_G1Z;17F7_#4.D?\ 0/U'_P <_P#BJ/\
MAJ'2/^@?J/\ XY_\51]7J=@_M;"?SH]-HKS+_AJ'2/\ H'ZC_P".?_%4?\-0
MZ1_T#]1_\<_^*H^KU.P?VMA/YT>FT5YE_P -0Z1_T#]1_P#'/_BJ/^&H=(_Z
M!^H_^.?_ !5'U>IV#^UL)_.CTVBO,O\ AJ'2/^@?J/\ XY_\51_PU#I'_0/U
M'_QS_P"*H^KU.P?VMA/YT>FT5YE_PU#I'_0/U'_QS_XJC_AJ'2/^@?J/_CG_
M ,51]7J=@_M;"?SH]-HKS+_AJ'2/^@?J/_CG_P 51_PU#I'_ $#]1_\ '/\
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M_AJ'2/\ H'ZC_P".?_%4?5ZG8/[6PG\Z/3:*\R_X:ATC_H'ZC_XY_P#%4?\
M#4.D?] _4?\ QS_XJCZO4[!_:V$_G1Z;17F7_#4.D?\ 0/U'_P <_P#BJ/\
MAJ'2/^@?J/\ XY_\51]7J=@_M;"?SH]-HKS+_AJ'2/\ H'ZC_P".?_%4?\-0
MZ1_T#]1_\<_^*H^KU.P?VMA/YT>FT5YE_P -0Z1_T#]1_P#'/_BJ/^&H=(_Z
M!^H_^.?_ !5'U>IV#^UL)_.CTVBO,O\ AJ'2/^@?J/\ XY_\51_PU#I'_0/U
M'_QS_P"*H^KU.P?VMA/YT>FT5YE_PU#I'_0/U'_QS_XJC_AJ'2/^@?J/_CG_
M ,51]7J=@_M;"?SH]-HKS+_AJ'2/^@?J/_CG_P 51_PU#I'_ $#]1_\ '/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,;X@?\BC=_\  /\ T-:\TKTOX@?\BC=_\ _]#6O-*"D%
M%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!WWPK_Y%Z;_KX;_T%:Z:N9^%?_(O3?\ 7PW_ *"M
M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7S9\:O^2H:O_P!=%_\ 0%KZ3KYL^-7_ "5#5_\ KHO_ * M
M=F"^-^A\]Q'_ +O'U_1G+4445ZA\8%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7:_"/XMS> ;T6UR7FTJ9OG3J83_>7^H[UQ5%3.*DN61M0
MKSHS52F[-'UMI^H0ZK91W%O(DT$RAT=#D,#4U?/'PC^+<W@&]%M<EYM*F;YT
MZF$_WE_J.]?0.GZA#JME'<6\B303*'1T.0P->/6HNF_(^^R_,(8J%UI);K^N
MA-1116)Z 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 8WQ _Y%&[_ . ?^AK7FE>E_$#_ )%&[_X!_P"A
MK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH [[X5_P#(O3?]?#?^@K735S/PK_Y%Z;_K
MX;_T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OFSXU?\E0U?\ ZZ+_ .@+7TG7S9\:O^2H:O\ ]=%_
M] 6NS!?&_0^>XC_W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KM?A'\6YO -Z+:Y+S:5,WSIU,)_O+_ %'>N*HJ
M9Q4ERR-J%>=&:J4W9H^MM/U"'5;*.XMY$F@F4.CH<A@:FKYX^$?Q;F\ WHMK
MDO-I4S?.G4PG^\O]1WKZ!T_4(=5LH[BWD2:"90Z.AR&!KQZU%TWY'WV7YA#%
M0NM)+=?UT)J***Q/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** ,;X@?\ (HW?_ /_ $-:\TKTOX@?\BC=_P#
M/_0UKS2@I!11104%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 =]\*_^1>F_P"OAO\ T%:Z:N9^%?\
MR+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %?-GQJ_Y*AJ__71?_0%KZ3KYL^-7_)4-7_ZZ
M+_Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5VOPC^+<W@&]%M<EYM*F;YTZF$_WE_J
M.]<514SBI+ED;4*\Z,U4INS1];:?J$.JV4=Q;R)-!,H='0Y# U-7SQ\(_BW-
MX!O1;7)>;2IF^=.IA/\ >7^H[U] Z?J$.JV4=Q;R)-!,H='0Y# UX]:BZ;\C
M[[+\PABH76DENOZZ$U%%%8GH!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 8WQ _Y%&[_P" ?^AK7FE>E_$#_D4;O_@'
M_H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .^^%?_ "+TW_7PW_H*UTU<S\*_^1>F
M_P"OAO\ T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "OFSXU?\ )4-7_P"NB_\ H"U])U\V?&K_ )*A
MJ_\ UT7_ - 6NS!?&_0^>XC_ -WCZ_HSEJ***]0^,"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM-#1^&O_ !$E_MI_]%G_ /+1T+_Y"H_XB2_VT_\ HL__ ):.A?\ R%7[E?\
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M4B2:3)WN[O+(Q?;Y<<7UW2$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M,R>3<QS1>8$59/+WK\K U^#7_!W_ /\ *2OP/_V3.P_].NK4D)'W)_P: ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#O
MOA7_ ,B]-_U\-_Z"M=-7,_"O_D7IO^OAO_05KIJ"'N%%%% @HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;/C5_R5#5
M_P#KHO\ Z M?2=?-GQJ_Y*AJ_P#UT7_T!:[,%\;]#Y[B/_=X^OZ,Y:BBBO4/
MC HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "NU^$?Q;F\ WHMKDO-I4S?.G4PG^\O\ 4=ZXJBIG%27+(VH5YT9J
MI3=FCZVT_4(=5LH[BWD2:"90Z.AR&!J:OGCX1_%N;P#>BVN2\VE3-\Z=3"?[
MR_U'>OH'3]0AU6RCN+>1)H)E#HZ'(8&O'K473?D??9?F$,5"ZTDMU_70FHHH
MK$] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\6V=UI<'A#0/"L5WI4>HI(;DW\]W=W$ETL20I';[ J%W>8*$*EY(?D7XD?\
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M_P#3%IU?U7U_*A_P<E_\II_C/_W _P#TQ:=30T?JO_P: ?\ *-3QQ_V4R_\
M_35I-?JQ7Y3_ /!H!_RC4\<?]E,O_P#TU:37ZL4/<'N%?Q1_M.>!_#/PQ_:3
M^(7AKP7K/_"1>#O#WB74M,T'5OM<5W_:EA#=21VUQYT0$4OF1*C[XP$;=E0
M17])/_!8+_@OM\+?V)?A)XR\(> O&%CXJ^.<EK/I>G6.B-'>1^%[QC/ UU>3
M,DELDEI+$Q:S?=,SB)7B2.1I4_E]X1?0 ?E30T?U7_\ !MGQ_P $5_@Q_P!Q
MS_T^ZC7Y4_\ !W__ ,I*_ __ &3.P_\ 3KJU?MU_P2I_95N/V*/^"=WPF^&M
M_#?VNLZ%H:7&LVUY<PW,EGJ5V[WM[ )(1Y;1QW5Q,B%2PV(GSN?G;\1?^#O_
M /Y25^!_^R9V'_IUU:A;@MS<_P"".7_!:+P!_P $H/\ @D_XDCU"Q_X3;XC>
M(?B9>3:5X1M;\6DK6G]G:4LEY<S;)/L\ VNJ$QLTLBE44JDTD7AGQ(_X.=OV
MQ?'/C:]U73/B#H?@VQNO+\K1M&\+:=+8V>V-4/EM>0W%P=S*7/F3/\SMMVKM
M4<G_ ,$:/^"-'B[_ (*J?%TSW!OO#/PA\-7*IXE\2I& \SX#_P!GV.X%9+MU
M*DL0R6Z.LD@8M##/^^OP6_X-_P#]DKX*?#/4_#4/PAT7Q+_;NEQ:9J>J^(Y9
M=3U.YV1/&UQ%-(W^@SOYCNSV(M_GVE0OEQ[#0-#\1/A#_P '1O[7WPT\2SW^
ML>+?"GQ"MI;5K=--\0^&+2&U@<NC"=3IZVDQD 4J TA3$C90G:R_OK_P3%_X
M*=_#_P#X*C?L_P ?B_PA)_9FO:9Y=OXF\,W$XDO?#MVP)"L0!YL$FUS#.%"R
MJK A)(Y8H_Q\_P"#@O\ X(!^$_V+OA-%\9_@;IU]I_@C3KI;?Q=HM]K9NDT1
M)3:VUG-9B=3/)&]PT@F$D\KA[F(H@B5_+^4_^#?#]JB?]E3_ (*M_#*X,M\N
MC^/[K_A!M5@L[:&:2[CU%DBME)EQLC2_6QF=XV#A(& W@F-S=!NC^K^OS0_X
M*^?\''?A3_@G3\1M=^%G@_PE?>-_BQI5K"UT]\39Z%HCW-J\T)E<?OKJ10]I
M(T,01'CG(%RDB,@_2^OR7_X+X?\ ! WQ=_P4._:1\#_$3X0+X3TO7M5M9-%\
M93ZO=BQM=L$3265^XAMWFF<@-:.^9' %@JQB..61$A(_-/XD?\'.W[8OCGQM
M>ZKIGQ!T3P;8W7E^5HVC>%M.EL;/;&J'RVO(;BX.YE+GS)G^9VV[5VJ,-O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 8WQ _Y%&[_P" ?^AK7FE>E_$#_D4;O_@'_H:UYI04@HHHH*"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .^^%?_ "+TW_7PW_H*UTU<S\*_^1>F_P"OAO\ T%:Z:@A[
MA1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OFSXU?\ )4-7_P"NB_\ H"U])U\V?&K_ )*AJ_\ UT7_ - 6NS!?
M&_0^>XC_ -WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OXWO^"GW_ "DK_:&_[*9XD_\ 3K<U_9#7\;W_
M  4^_P"4E?[0W_93/$G_ *=;FFAH_H\_X-M/^4+'P8_[CG_I]U&ON6OAK_@V
MT_Y0L?!C_N.?^GW4:^Y:0@K^6O\ X.=OB1K?CG_@L5\0=,U6]^U6/@W3=&T;
M1HO)C3[':/IT%\T>54%\W-Y<ON<LW[W;G:JJ/ZE*_E0_X.2CG_@M1\9_;^P_
M_3%IU-#1]J?\&;'P.@NO%?QP^)5[H-^+JQM-,\,Z/K;K,EJR3//<ZA:H<B&2
M0&#37?(+QAH\%1*=_P"[=?CW_P &='QCTS6_V1_BU\/XH+]=9\,^+X?$-U,Z
M(+62WU&RCMX51MVXR*^EW!<%0 'BPS$L%_82A[@]PK^4[_@X\^&/_"LO^"Q7
MQ9\CP[_PCNE>(#INM6/EZ?\ 9+?4_/TZV-S=Q84++YEZMWYDJYW3+-N)</7]
M6-?S+_\ !UU\8M,^)O\ P5;ET6P@OX;KX=^$-+\/:D]PB+'/<2&?4@T)#$M'
MY.H0J2P4[UD&W 5F$"/KG_@S0^).MZI\-_CYX0GO=_AS0]2T76+&S\F,>1=W
MD5[#<R;PN]M\=A:#:S%5\K*@%G+8G_!Y]_S;=_W,_P#[AZ3_ (,P3S^TD/\
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M ,HU/ __ &4RP_\ 35JU'4.I\-_\&@'_ "DK\<?]DSO_ /TZZ37]'E?SA_\
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MJQ$0DVJ6VBOW9_XA /V:O^AX^.7_ (.=*_\ E=3=NHW;J'_$7_\ LU?]"/\
M'+_P3:5_\L:Y/X]?\'3O[*_[0_P-\9_#_6O!_P"T#:Z/XYT*^\/7\]CI.D)=
M0V]W;O;R-$SW[*) LA*EE8 @94CBNL_XA /V:O\ H>/CE_X.=*_^5U'_ !"
M?LU?]#Q\<O\ P<Z5_P#*ZEH+0_G#8;E(]>*_N4K\IS_P9_\ [-1'_(\?'/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXXN='L] U*=0D>KO8G45NC""=S)&]Q&ADQL+^8@8M%(J?M#2$%%%% !1110
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M7^Q9_P!%G_\ +1UW_P"0J_E0KZJ^"G_!#_\ :S^/O]I_V%\"/'=C_9/E>?\
M\));)X:W^9OV^5_:+V_G8\MMWE;MF5W;=ZYJR*LC^A+PS_P<6?L9^+?$VG:3
M:_&JRBNM4NHK.&2]\.ZO96R/(X13+<36B0PQ@D;I)'5$&69@ 2/JSX._'KP-
M^T1X:GUKX?\ C/PGXYT>UNFL9[_P]J]OJ=M#<*B.T+20.RB0))&Q4G(#J<8(
MK^0CXG?\$S/VB?@T?$3^)/@;\5]-L?"?VEM5U,^%KR73+6.VW>=/]L2-K=X%
M",WG)(8B@W!BO-<-^SQ^TOX__9-^)=KXP^&WB[7/!GB.UV+]LTRY,7VB)98Y
MO(G3[D\#211EX95>)]@#*PXHL%C^URBOS0_X(-_\%XM-_P""AOAFT^&7Q-N[
M'2?CEI%J3'*%2WMO&\$2%GN;=!A4NT12TUNH (#31 1B2.W_ $OJ23RC]L']
MM[X8?L$?#2Q\8?%GQ-_PBGAW4M3CT:VN_P"S;N_\R[>*698]EM%*XS'!*=Q4
M+\N,Y(!^</\ B)-_8K/_ #6<_P#A(:[_ /(5>&_\'?\ _P HU/ __93+#_TU
M:M7\[_PX^&7B7XR>,[/PWX0\.Z[XK\1:CO\ LFE:-I\M_>W6R-I'\N&)6=]J
M([G .%5B> ::0TC^I/\ XB2_V+/^BS_^6CKO_P A5U/P?_X+U?LA?'#Q-/I.
MC?'/PK8W5O:M>/)XA@N_#MJ45T0A;C4(8(6DRZXC5RY 9@I",1_/!X=_X(.?
MM=^*/A%)XWMO@9XLCT:*UN+QK:[EM;/5RD!<.!IDTJWQD/EMLC$!>7*&-7#K
MGPSXO?L>?%S]GSPS!K7C[X5_$CP-H]U=+8PW_B'PS>Z7;37#([K"LD\2*9"D
M<C!0<D(QQ@&G9#LC^S_PMXITSQSX8T[6]$U&PUC1M8M8KZPO[&X2XM;ZWE0/
M'-%(A*O&Z,K*RD@@@@X-7Z_CJ_89_P""G_QM_P""=?B5;OX8>-;[3M(ENA=7
M_AR]_P!,T/5"7@,GFVKG:KR);Q1-/%Y=P(P525 :_J%_X)B_\%.OA_\ \%1O
MV?X_%_A"3^S-=TSR[;Q-X9N9Q)>^';M@2%8@#S8)-KF&<*%D56!"21RQ1IH3
M1](5YM^TU^U[\-_V-?#.@:U\3O%5CX.T;Q+KMOX;L+^]CE-L;Z=9'C261%98
M(]L,C--,4B0(2[J*])KY2_X+2_L"G_@HS_P3^\7>"-.M_/\ &6D;?$?A$;]N
M[5;5)/+A^::*+_2(I)[7=,QCC^U>:5)C6D(^K:*_ C_@W-_X+RZEX#\2>$OV
M;_BY=7VL>'-9NK?1/ 6O[7N+G1IY76*WTNXQEGM'9D2&3DVY*HW^CE3:_OO0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#KHO\ Z M=F"^-^A\]
MQ'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %=K\(_BW-X!O1;7)>;2IF^=.
MIA/]Y?ZCO7%45,XJ2Y9&U"O.C-5*;LT?6VGZA#JME'<6\B303*'1T.0P-35\
M\?"/XMS> ;T6UR7FTJ9OG3J83_>7^H[U] Z?J$.JV4=Q;R)-!,H='0Y# UX]
M:BZ;\C[[+\PABH76DENOZZ$U%%%8GH!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#8?!.J7^L:,^B2SW$]XA62/4I+N>34H #''^[AOWNHD.T@I$A#R ^8WY,_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^VED09D@E&TL&^7.,$$U8JQ_8G\'_COX'_:%\-3ZUX!\9>%/'&CVUTUE-?\
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M_P#;?\%3>)?AE\*->U_P['CR]4N;BUTFROLR2Q'[-->2PQW.R2"1'\EG\ME
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M7-(_9^^-VOW_ (KA\5W4J>$_%^M:F)+^SO'#RC3[N>=]UQ'.X*6[%FF6:2.
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M &/2M'\6V%]>W>R-I7\N&*5G?;&CN< X5&)X!KU>OXP/V(?VL=;_ &&?VLO
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MU5XYHI$)5XW1E964D$$$'!K[S_X- /\ E&IXX_[*9?\ _IJTFOYT?$WA;4?
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M\,Z%8Z3?Z_>AQ<ZY<06Z127DN]Y&WS.C2-N=SESEF/)3$SK*X7]HK]IOX?\
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M-$#(9([G^FJI)/-_C!^V/\(OV>O$L&B^/OBI\./ ^L7-JM[#8>(/$MEIES+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7:_"/XMS> ;T6UR7FTJ9OG3J83_ 'E_
MJ.]<514SBI+ED;4*\Z,U4INS1];:?J$.JV4=Q;R)-!,H='0Y# U-7SQ\(_BW
M-X!O1;7)>;2IF^=.IA/]Y?ZCO7T#I^H0ZK91W%O(DT$RAT=#D,#7CUJ+IOR/
MOLOS"&*A=:26Z_KH34445B>@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M['/PB_:%\2P:UX^^%?PX\<:Q;6JV4-_X@\,V6IW,4"L[K"LDT;,(PTDC!0<
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MV,_%OB74=6NO@I9176J74MW-'9>(=7LK9'D<NPB@ANTBAC!)VQQHJ(,*J@
M=5^SO_P0]_95_97^)MKXQ\&?!W1+;Q'8;&L[O4[^^UK[!(DL<T<\$=[/-'#.
MDD2%)HU65,$*P#,#]744 4/%/A;3/'/AC4=$UO3K#6-&UBUEL;^POK=+BUOK
M>5"DD,L;@J\;HS*RL"""01@U\;>)?^#=+]C/Q9XFU'5KKX*645UJEU+>31V7
MB+5[*U1Y'+L(K>&[2&&,$G;'$BH@PJJH  ^V** "OE_]H_\ X(N_LM_M8^)Q
MK7C7X,>%9]9:ZNKZXO\ 2#/H5SJ-Q<NKS374EA) UU(SKNW3ER"SD$%WW?4%
M% 'PS_Q#9_L68_Y(Q_Y=VN__ ";7N7['O_!-#X$_L#F^D^$WPWT/PK?ZEYBW
M.IEYK_4Y(Y/)WP?;+EY;@0$P1-Y(D$6]=VW<23[I10 4444 4/%/A?3/''AG
M4=%UK3K'6-&UBUEL;^POK=+BVO;>5"DD,L;@J\;HS*RL"""01@U\;>)O^#=+
M]C/Q9XFU'5KKX*645UJEU+>31V7B+5[*U1Y'+L(K>&[2&&,$G;'$BH@PJJH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?E?V9JU^YN)_WI0-+YEFNEMP[QKC VOYHK;_ ."?W_!/;6]=_P"#:S]J;QS
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MUEB(L[V\E5MD?D/"MJ)'CW2?;;>,R 10H?@#_C97_P!7R_\ ETUA_$GX8?\
M!0;XS>"KWPWXP\/?MD>*_#NI;/M>E:Q8>)+ZRNMDBR)YD,JLC;9$1QD'#*I'
M(%%@L>J?\&M?[0_B;X4?\%5O#O@S2[K/ASXI:9J&F:Y9RR2^4PM;*XO[>X2-
M75#/');F-7=7VQ7-PJ@&3</V2_X.2_\ E"Q\9_\ N!_^GW3J_(O_ (-_OV$O
MCA\&?^"N?PD\2>,/@U\5O"GAW3O[8^UZKK'A*_L;*UWZ+?QIYDTL2HFZ1T09
M(RSJ!R0*_73_ (.2_P#E"Q\9_P#N!_\ I]TZA[@]S\)_^#=;POIGC#_@LO\
M!2TU;3K'5+6*ZU.^CAN[=)XTN+?2+VXMY@K @21311R(W5'C1@05!K^KVOY4
M/^#;3_E-/\&/^XY_Z8M1K^J^DQ,*_F'_ .#EW_@G)X9_8._;,T36?A]X;_X1
MKX?_ !1TN74X+2&>+[%::K#.RWUO:0+\\$"I+92A"/+5KIUB(1!%%_3Q7X]_
M\'B_P=TS6_V1_A+\0)9[]=9\,^+YO#UK"CH+62WU&RDN)F==NXR*^EVX0A@
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MVEBR:O:R/I&I7%J;B3P]J8C=;;4(55XVWPL^2JR()$,D3'RY'!_FV_XV5_\
M5\O_ )=-'_&RO_J^7_RZ:FQ-CXV!\2_!3XC_ /,=\(>,/"6I?]-=/U/1+^VE
M_P" RP3Q2I_LNCIV(K^E?_@K%X[\3?M9?\&U&J^-9='^U>(_&?@7PIXMU.ST
M:TE>&VWW6F7]X\<>7=8(4$TA+,VR*-F9L*6K\#?%'_!.G]JCQOXEU'6M:^!/
M[0.KZQJ]U)>W]_>^"M7N+F]GD8O)-+(\)9Y'9BS,Q)))).37]3_["/POW_\
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M\97-GK&@:Y=FWLKG6[@.EG_9+W$DJM/)OFA>TMHXV.9;]LY8 _I!_P %FO\
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M^#O_ /Y1J>!_^RF6'_IJU:D(^&_^#0#_ )25^./^R9W_ /Z==)K^CROYP_\
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M2Z-X6M4\7:^+>ZAGD_M.<30VL$R!/,MY(;4R2@>8/-34XV*82-C^^]?RH?\
M!R4,?\%J/C1[_P!A_P#IBTZDMQ+<]%_X-FO^"9OA']OC]J?Q/XH^(>GV.O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5['^S1;ZTEO.[';H;9V+(#EI.YC]O7M^.<<Q\'O@])XXN5OKU7BTF)
MOH;DC^%?;U/X#GI[Y:VL=C;)#"BQ11*%1%& H'0 5P8NNK<B/ILCRZIS+$ST
M73S_ . 24445YQ]<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5\I_\%-_^"0'PU_X*N?\ "$_\+$USQSHW_"!?
M;_[/_P"$<O+6W\[[9]F\WS?/MYLX^RQ[=NW&6SG(Q]644 ?*?_!,C_@D!\-?
M^"4?_";?\*[USQSK/_">_8/[0_X2.\M;CR?L?VGRO*\BWAQG[5)NW;LX7&,'
M/U9110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[WQC>^($>S=WC6WU-O[2MU)95/F+#=Q*XQ@.K@,P 8_T0?\ !N]\<KCXZ_\
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M:#3)I=4U.+SHFE3S["V22[ML*I#^=$GEOA'VN0I^"_VR/^#OKPIX4\2Z-8_
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MQ\(=6UFP\17?@ZZA1=2LXGACO8)[:*ZMY#&V3'(89XMZ;F"/N4/( ';]K?\
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M'?\ _P I*_ __9,[#_TZZM7W)_P: ?\ *-3QQ_V4R_\ _35I-?C=_P %CO\
M@I0?^"I?[95S\0;7P^/#7AW1],C\.^'K25MU[)80SSS)-=D,R>?))<2L5C^2
M-2D8:0H99/V1_P"#0#_E&IXX_P"RF7__ *:M)JGL4]C]6*_G#_X._P#_ )25
M^!_^R9V'_IUU:OZ/*_G#_P"#O_\ Y25^!_\ LF=A_P"G75J2$C[D_P"#0#_E
M&IXX_P"RF7__ *:M)K]6*_*?_@T _P"4:GCC_LIE_P#^FK2:^Y/^"E_[8/\
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M-Q)K.I+'\C/"LD;?9(7>-[B3>@5&"AO-DB1_S2_:4_X/'V)UJP^#_P &@/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_Y*AJ_
M_71?_0%KZ3KYL^-7_)4-7_ZZ+_Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7>?![X/2>.+E;Z]5XM)B;Z&Y(_A7V]3^ YZ'P>^#
MTGCBY6^O5>+28F^AN2/X5]O4_@.>GOEK:QV-LD,*+%%$H5$48"@= !7%B<3R
M^Y#<^BRC*/:VK5E[O1=_^!^86MK'8VR0PHL442A411@*!T %2445YA]EMH@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME2X^S+))+;AF18F$:R&,/(5\YOV$H ***_.'_@X'_P""P'Q+_P""4G_"I/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_\ D7IO^OAO
M_05KIJYGX5_\B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% '\X,?_!G[^TK&@7_A-_@;P,?\AG5?
M_E=7[Z_L:_!_5/V>?V0?A5X UN>QNM:\#^#](\/W\UB[O;37%I90P2-$SJK&
M,O&Q4LJD@C*@\5Z310 5^6G_  <L?\$D_'O_  4&\.?#/Q?\(?#-CXB\=^%;
MFYT?4[)#8V-U?Z;.HFCE>\N9H@8[::%U2#YLG49'7;A]_P"I=% 'C/\ P3P_
M94@_8A_8A^&7PLCAL(KOPCH4,&JFQN9KFUN-3DS/?SQ/,!(8Y;R6XD4%5 #@
M!$ "#V:BB@#\W_\ @X'_ ."/_P 3/^"KC_"/_A7>N>!M&'@(:S_:'_"1WMU;
M^=]L^P>5Y7D6TV<?99-V[;C<N,Y..&_X(,?\$1OCA_P2S_:8\6^)?'/C3P-J
M7@[Q-X8?3)-*\.:OJ$WGWZW5O);W$L,UK#$WEQ+=HKY+K]H8*,.]?JS10!^=
MO_!9G_@W\\)_\%-]17QYX3U6P^'_ ,7K6V:&XU%[,RV'BI(X66VAO@A#)(C+
M$@NT$CI#N1HI@D(B_'#Q-_P;/_MF:#XEU&QM?A79:U:V5U+;PZC9>*](6VU!
M$<JL\0FN8Y1&X 91)&CX8;D4Y4?U0T4[CN?S$?L[_P#!K7^U7\5_B;:Z7XS\
M.Z)\+?#@V2WFN:GK=CJ6V/S8UD2"WLII9))_+=W1)/*B;RBK31DKG]'/%O\
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M.[?DUXF_X-H/VS-!\3:C86OPJLM:M;*ZEMX=2LO%FD+:Z@B.56>(374<PC<
M,HEC1\,-R*<J/ZHJ*=QW/Y3V_P"#;;]M11_R18GZ>+M!_P#DVOM;]E?_ (,Y
M]4N+^*\^-WQ:L+6UBNIDETCP-;-/)=V_DCRI%O[R-!#()B2R&SE!2/ <&3,?
M[M447879A?"[X:Z+\&/AGX=\'^&K+^S?#GA/3+;1M*M/.DF^RVEO$L,,>^1F
M=]L:*-SL6.,DD\UNT44A!1110 5^4W_!8/\ X-GM&_;@^)FH_$_X/:YH7P^\
M?ZQF;6])U"VD71?$5VTJ;KPR0AGM)S&9FD*0RK/((R5C=III/U9HH _E/3_@
MVV_;48?\D6*^Q\7:#_\ )M=7\(?^#7+]K[XE^)9[#6/"7A3X>VT5JUPFI>(?
M$]I-:SN'11 HT]KN82$,6!:,)B-LN#M5OZA:*=QW/P)_:6_X,]_'-GXET&+X
M._$3PKJ&CQZ';KK=UXSO9[.YN-6#2"X>VAM;*58K1E\DHCRR2*2X+N &/Z/_
M /!"#_@G!XX_X)??LB>(_ /C[5?"FKZQJ_C"Y\00S>'[FXN+98)+*Q@56::&
M%A)NMI"0%(P5YR2!]KT47"X5^3/_  7?_P""$'Q=_P""H/[7?ASQ]X!\1_#C
M2-'TCP?;>'YH?$&H7MO<M/'>WT[,JPVDRF/;<Q@$L#D-Q@ G]9J*0CXH_P""
M$'_!.#QQ_P $OOV1/$?@'Q]JOA35]8U?QA<^((9O#]S<7%LL$EE8P*K--#"P
MDW6TA("D8*\Y) [C_@K9_P $S=-_X*K_ ++5M\.K[Q7>^"[O2M=MO$.FZI!8
MK?1Q7$4<T#+- 7C,B-#<S@!98R'\MLL%:-_I^B@#^7GXO?\ !KG^U]\-/$T%
MAH_A'PK\0K:6U6X?4O#WB>TAM8'+NI@8:@UI,9 %5B5C*8D7#D[E7EC_ ,&V
MO[:@'_)&,_\ <W:%_P#)M?U7T4[L=V?@1_P3<_X--/%_B;Q+H_BO]I/4K'PU
MH%I=+/-X'TJ[%WJ6J(CS*T%U>P/Y-K&Q2!\V[SN\4KKNMI0&7]Z/"_A?3/ _
MAG3M%T73K'2-&TBUBLK"PLK=+>VLK>) D<,4: *D:(H554    # J_12$4/%
M'A?3/''AG4=%UK3K'5]&U>UELK^PO;=+BVO;>5"DD,L;@J\;HQ5E8$$$@C!K
M\,_^"B__  :2ZI%XEN/$7[,^MV,NC-:WE[=>$_%.J,MU#<!VD@M=.N?**21N
MC"%5O)$*&)6DN)!(QB_=NB@#^5!?^#;7]M0C_DB^/KXNT+_Y-KN/V>/^#6O]
MJOXK_$VUTOQGX=T/X6^'/DEO-<U/6[+4@L?FQK(D%O932R23^6[NB2>5$WE%
M6FC)7/\ 3O13NQW9\A_\$KO^",GPM_X)4^&[^?PR]]XI\>>(+6&VUGQ5JT<8
MN9$5(R]M:QH,6MHTR&7RMSN24$DLOE1;/KRBBD(_)G_@N_\ \$(/B[_P5!_:
M[\.>/O /B/X<:1H^D>#[;P_-#X@U"]M[EIX[V^G9E6&TF4Q[;F, E@<AN, $
M_1__  0@_P""<'CC_@E]^R)XC\ ^/M5\*:OK&K^,+GQ!#-X?N;BXME@DLK&!
M59IH86$FZVD) 4C!7G)('VO11<+A1110 5^*'_!5K_@U5/Q'\:^(?B)^S;?:
M'HDNH;KZ?X>WJ?8[/SA',\HTVY!*0^;((5CM952&-I)")XHE2)/VOHH _E07
M_@VU_;4(_P"2+X^OB[0O_DVO1OV<?^#53]J3XN^)3%XUL?"GPGT>UNK5+BZU
M?68-3N;BWD=A-):PV#3+))$BY\N>6W#ET ?&]D_IIHIW8[L_G[_:1_X,_P#X
MECXTZU_PJ#QQX'/PZ_<?V3_PF.LW7]M_ZB/SO/\ LNG>3_K_ #=FS_EGLS\V
M:_77_@DA^Q_XE_8)_P"">_P_^$_C"^T/4O$7A3^T?M=SH\TLUE)]HU*ZND\M
MI8XW.(YT!R@^8-C(P3]'T4KBN%?!7_!5O_@W]^%O_!3SQ/\ \)HFJWWPX^)X
MM8[237]-LX[JUU9$>((;^T)0SR1PH\4<B2Q. Z!VE2&.-?O6B@#^6OXD?\&Q
M/[8O@;QM>Z5IGP^T3QE8VOE^5K.C>*=.BL;S=&KGRUO)K>X&TL4/F0I\R-MW
M+M8X;?\ !MK^VH!_R1<GZ>+M"_\ DVOZL**=V.[/Y^OV2/\ @S_^(/C,6&J?
M&CXBZ%X)L9/L-U+HGAV$ZMJ;Q/EKNTEN'\NWMIT&U%DB^V1%V9L,J#S/V\_9
M"_94\)?L0_LW>%/A9X&BOX_#/A&U:"U:^N3<75P\DKS33RO@ R2S2RR,$54!
MD(1$0*@])HI7%<^</^"M_P"Q_P")?V]O^">_Q ^$_@^^T/3?$7BO^SOLESK$
MTL-E']GU*UNG\QHHY'&8X' PA^8KG R1^<'_  20_P"#<#XX?L$_\%"/A_\
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MQ3VL>DT445)(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?-GQJ_Y*AJ_P#UT7_T!:^DZ^;/C5_R5#5_^NB_^@+79@OC?H?/
M<1_[O'U_1G+4445ZA\8%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7>?![X/2>.+E;Z]5XM)B;Z&
MY(_A7V]3^ YZ'P>^#TGCBY6^O5>+28F^AN2/X5]O4_@.>GOEK:QV-LD,*+%%
M$H5$48"@= !7%B<3R^Y#<^BRC*/:VK5E[O1=_P#@?F%K:QV-LD,*+%%$H5$4
M8"@= !4E%%>8?9;:(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBOD3_@JC_P %F_A;_P $J?#5A!XF2^\4^//$%K-<
M:-X5TJ2,7,B*D@2YNI'.+6T:9!%YNUW)+F.*7RI0@!]=T5_.AXF_X/!OVA+O
MQ-J,NC_#WX-6&CRW4KV%K>V&I7=S;6Y<F..69;V)99%3:&=8HPQ!(1 =HO?#
M?_@\.^.6E^-K*?Q?\,OA1KOAR/S/MEAHZ:AI-[/F-@GEW,MQ<I'B0HQS ^Y5
M91M+!U=F.S/G'_@Y+_Y33_&?_N!_^F+3J_<K_@VT_P"4+'P8_P"XY_Z?=1K^
M=_\ X*V_M@^&OV]_^"@_Q ^+/A"PUW3/#OBO^SOLEMK,,4-[']GTVUM'\Q8I
M)4&7@<C#GY2N<'(']$'_  ;:?\H6/@Q_W'/_ $^ZC3>PWL?<M%>;?M5_M>_#
M?]B'X22^.?BGXJL?"/AB*ZAL5NIXY9Y+BXE)"0PP0J\TSD!W*QHQ5(Y'("([
M#\;?VJ?^#Q?5;B_EL_@A\);"TM8KJ%XM7\<W+W$EW;^0?-C:PLY$$,@F(VN+
MR4%(R2@,F(Y)/W;HK^<+_B+_ /VEL?\ (D? S_P3:K_\L:]4_9-_X/#_ !1:
M^-IH/CI\,=!O?#EQCRKWP&DMK?:=MCE)W6UY<2)<[Y/(4?O[?RU$C?O250.S
M'9G[TT5YM^RI^U[\-_VW?A)%XY^%GBNQ\7>&9;J:Q:Z@CE@DM[B(@/#-#,J3
M0N 4<+(BDI)&X!1T8^DTA'E/[=WQ)UKX,_L/?&7QAX;O?[-\1>%/ VMZQI5W
MY,<WV6[M[">:&39(K(VV1%.UU*G&"".*_E/_ &"?B9XD^,?_  5@^ WB7Q?X
MAUSQ7XCU+XF>%_MFJZS?RW]]=^7J-I$GF32LSOMC1$&XG"HH' %?KK_P7$_X
M.!_^%"^/OCO^RY_PJ3^U?MWAF3PY_P )-_PE/D;/[5T:-_.^R?9&SY7VS&WS
MOG\O[R[N/PV_9@^-'_#-_P"TM\//B)_9O]L_\(%XFTWQ'_9_VC[/]N^QW45Q
MY/F[7\O?Y>W=M;;G.TXQ5(I']K5%?AK_ ,1GW_5MW_F0?_O;7W+_ ,$8/^"S
M_P#P]X_X63_Q;;_A7O\ PKW^S/\ F8/[6^W_ &W[9_T[0>7L^R?[6[S.VWE6
M%8^Y:*Y/XY_'/PC^S1\(]>\>>.]>L?#/A+PS:F[U'4;LG9 F0J@*H+/([LJ)
M&@9Y'=$169E4_CW^VC_P> Z/X<U;5]$^ OPY'B+[/B*S\5>+)I+:RED2Y97=
M-.BVS2P20*K1O)<6\H:;YX1Y95T(_;"BOYPA_P '?_[2V/\ D2/@9_X)M5_^
M6-=Q^SQ_P>'?$W3_ (FVO_"V/AEX$U?P;-LBN1X22[T[4[+,L>^X3[3<3Q3[
M(O-Q ?)WN4_?1@'+LQV9_0+17A?[!W_!1WX2?\%(OAK<^)/A9XC_ +4.E?9X
M]9TJ[@:UU/0IIHA(L5Q"W_ T$L9>%WAF$<C^6V/=*0@HHHH **** /-OVO?V
MJ_"7[$7[-WBKXI^.9;^+PQX1MDGNEL;8W%S</)*D$,$2# +RS2Q1J694!<%W
M1 SC^8CX(:1\5/\ @X/_ ."J^@P>/-4OKZ;Q)="?7+C3TDAL_"?AZV8R30V@
M\N=;6-48Q0&565[JYB,KM),\C?9/_!WQ^VQ<>*OB_P"!?@#I5W82Z-X6M4\7
M:^+>ZAGD.ISB:&U@F0)YEO)!:F24#S,2IJ<;,F$C8]7_ ,&<'[-F9?C+\8+_
M $7H+/P=H>K_ &SZWFI6WD*__8)?S)(_:-O]:*K9%;(_;WPMX6TSP-X9T[1=
M%TZQT?1M'M8K&PL+&W2WMK&WB0)'#%&@"I&B*JJJ@    8%7Z**DD\+_ &\?
M^"COPE_X)O?#6V\2?%/Q'_9?]J_:(]&TJT@:ZU/79H8C(T5O"O\ P!#+(4A1
MYHA)(GF+G^9?_@J;_P %EOBG_P %5O$NGQ>*5L/#'@;P_=37.C>%=)>0VL3L
M\@2XNI'.;J[6%Q%YNU$ #F.*'SI0_E/P?^"GQK_X*>_M'SZ5X<MO%?Q:^)6L
M6K7UY=:CJ?VBZ>WMXDC\ZZO+N0*B(BQ1*TT@&3#&IW,BGZ[_ ."FG_!!<_\
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MEV8,4KPVV]OGN)O*1W6"&,/+*X1MD4<CD84U_3K^Q9_P;Q?LR_LD^"](35/
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M "*-W_P#_P!#6O-*]+^('_(HW?\ P#_T-:\TH*04444%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'??"O_D7IO\ KX;_ -!6NFKF?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\H_;3_8L^'_[?O[/VK?#?XD:3_:6AZEB:WN(2([W1[M0PBO+24@^5/'N
M;!P596='5XY'1O5Z* /Q[_X(7_\ !*7XW?\ !+'_ (*>?$C1?%(OM3^%.O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\I?\
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M^SO>WVC1W4J6%U>^-UM+JYMPY$<DL*6,JQ2,FTLBRR!22 [@;CX9_P %"/\
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M_;6]Q<K/)>V,ZLRS30J(]MM("0Q.2O&"2/UE_P"(O_\ 9J_Z$?XY?^";2O\
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M]HHHJ20HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_ "*-W_P#_P!#6O-*]+^(
M'_(HW?\ P#_T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_D7IO\ KX;_ -!6
MNFKF?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O_UT7_T!:^DZ^;/C
M5_R5#5_^NB_^@+79@OC?H?/<1_[O'U_1G+4445ZA\8%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5WGP>^#TGCB
MY6^O5>+28F^AN2/X5]O4_@.>A\'O@])XXN5OKU7BTF)OH;DC^%?;U/X#GI[Y
M:VL=C;)#"BQ11*%1%& H'0 5Q8G$\ON0W/HLHRCVMJU9>[T7?_@?F%K:QV-L
MD,*+%%$H5$48"@= !4E%%>8?9;:(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E0_X.2O^4T_QG_[@?\
MZ8M.K]*_^#.CQ'X1NOV2/BUI-E'8CQ[9>+X;S6)$L2ETVF364::>'N-@$D8F
M@U+9'O)C+2L57S07^&O^#JO]F_4_A#_P5'OO&LIOKK1_BQH=AJUK</I[PVUO
M/:0)ITUFDQ)6>1%M8)WQM*"]B!7&UWW/^#4_]NC3?V:/VWM9^&6OM8V>C?&^
MUMK&UOYBD;0:O9^>]E$9'E15CG6>ZA"A)))+B2T10 6S70KH?TFT445))_*A
M_P ')?\ RFG^,_\ W __ $Q:=7[E?\&VG_*%CX,?]QS_ -/NHU^&O_!R7_RF
MG^,__<#_ /3%IU?N5_P;:?\ *%CX,?\ <<_]/NHU3V*>QG_\' 7_  5;U/\
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M^SS_ -E,\-_^G6VK^R&G(<CPS_@I]_RC4_:&_P"R9^)/_35<U_*C_P $P?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH QOB!_R*-W_P  _P#0UKS2O2_B!_R*-W_P#_T-:\TH*044
M44%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '??"O_D7IO^OAO_05KIJYGX5_\B]-_P!?#?\ H*UT
MU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?-GQJ_Y*AJ__ %T7_P! 6OI.OFSXU?\ )4-7_P"NB_\ H"UV
M8+XWZ'SW$?\ N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %=Y\'O@])XXN5OKU7BTF)OH;DC^%?;U
M/X#GH?![X/2>.+E;Z]5XM)B;Z&Y(_A7V]3^ YZ>^6MK'8VR0PHL442A411@*
M!T %<6)Q/+[D-SZ+*,H]K:M67N]%W_X'YA:VL=C;)#"BQ11*%1%& H'0 5)1
M17F'V6VB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNOMGB._M0X;2M(@P]W-Y@BE6*1D_=0M*GEFXGMT8@/7]BM4RF%%%%22%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 8WQ _Y%&[_P" ?^AK7FE>E_$#_D4;O_@'_H:U
MYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .^^%?_ "+TW_7PW_H*UTU<S\*_^1>F_P"O
MAO\ T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "OFSXU?\ )4-7_P"NB_\ H"U])U\V?&K_ )*AJ_\
MUT7_ - 6NS!?&_0^>XC_ -WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "N\^#WP>D\<7*WUZKQ:3$WT-R1_
M"OMZG\!ST/@]\'I/'%RM]>J\6DQ-]#<D?PK[>I_ <]/?+6UCL;9(846**)0J
M(HP% Z "N+$XGE]R&Y]%E&4>UM6K+W>B[_\  _,+6UCL;9(846**)0J(HP%
MZ "I***\P^RVT04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+X9\76S3VJWML;>YMWCE>&:"5.0)(IHY(V*LR$H2CNA5CZ17C7[ /[&^F_L
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M 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O\ X!_Z&M>:5Z7\0/\
MD4;O_@'_ *&M>:4%(****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#OOA7_ ,B]-_U\-_Z"M=-7
M,_"O_D7IO^OAO_05KIJ"'N%%%% @HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *^;/C5_R5#5_P#KHO\ Z M?2=?-GQJ_
MY*AJ_P#UT7_T!:[,%\;]#Y[B/_=X^OZ,Y:BBBO4/C HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N\^#WP>D\<7*WUZKQ:3$WT-R1_"
MOMZG\!ST/@]\'I/'%RM]>J\6DQ-]#<D?PK[>I_ <]/?+6UCL;9(846**)0J(
MHP% Z "N+$XGE]R&Y]%E&4>UM6K+W>B[_P# _,+6UCL;9(846**)0J(HP% Z
M "I***\P^RVT04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 8WQ _Y%&[_ . ?^AK7FE>E_$#_ )%&[_X!
M_P"AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH [[X5_P#(O3?]?#?^@K735S/PK_Y%
MZ;_KX;_T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\O\ \31_PS7X=_OZC_W^7_XFCZY3#_5_%^7WG@E%>]_\,U^'?[^H_P#?Y?\
MXFC_ (9K\._W]1_[_+_\31]<IA_J_B_+[SP2BO>_^&:_#O\ ?U'_ +_+_P#$
MT?\ #-?AW^_J/_?Y?_B:/KE,/]7\7Y?>>"45[W_PS7X=_OZC_P!_E_\ B:/^
M&:_#O]_4?^_R_P#Q-'URF'^K^+\OO/!**][_ .&:_#O]_4?^_P O_P 31_PS
M7X=_OZC_ -_E_P#B:/KE,/\ 5_%^7WG@E%>]_P##-?AW^_J/_?Y?_B:/^&:_
M#O\ ?U'_ +_+_P#$T?7*8?ZOXOR^\\$HKWO_ (9K\._W]1_[_+_\31_PS7X=
M_OZC_P!_E_\ B:/KE,/]7\7Y?>>"45[W_P ,U^'?[^H_]_E_^)H_X9K\._W]
M1_[_ "__ !-'URF'^K^+\OO/!**][_X9K\._W]1_[_+_ /$T?\,U^'?[^H_]
M_E_^)H^N4P_U?Q?E]YX)17O?_#-?AW^_J/\ W^7_ .)H_P"&:_#O]_4?^_R_
M_$T?7*8?ZOXOR^\\$HKWO_AFOP[_ ']1_P"_R_\ Q-'_  S7X=_OZC_W^7_X
MFCZY3#_5_%^7WG@E%>]_\,U^'?[^H_\ ?Y?_ (FC_AFOP[_?U'_O\O\ \31]
M<IA_J_B_+[SP2BO>_P#AFOP[_?U'_O\ +_\ $T?\,U^'?[^H_P#?Y?\ XFCZ
MY3#_ %?Q?E]YX)17O?\ PS7X=_OZC_W^7_XFC_AFOP[_ ']1_P"_R_\ Q-'U
MRF'^K^+\OO/!**][_P"&:_#O]_4?^_R__$T?\,U^'?[^H_\ ?Y?_ (FCZY3#
M_5_%^7WG@E%>]_\ #-?AW^_J/_?Y?_B:/^&:_#O]_4?^_P O_P 31]<IA_J_
MB_+[SP2BO>_^&:_#O]_4?^_R_P#Q-'_#-?AW^_J/_?Y?_B:/KE,/]7\7Y?>>
M"45[W_PS7X=_OZC_ -_E_P#B:/\ AFOP[_?U'_O\O_Q-'URF'^K^+\OO/!**
M][_X9K\._P!_4?\ O\O_ ,31_P ,U^'?[^H_]_E_^)H^N4P_U?Q?E]YX)17O
M?_#-?AW^_J/_ '^7_P")H_X9K\._W]1_[_+_ /$T?7*8?ZOXOR^\\$HKWO\
MX9K\._W]1_[_ "__ !-'_#-?AW^_J/\ W^7_ .)H^N4P_P!7\7Y?>>"45[W_
M ,,U^'?[^H_]_E_^)H_X9K\._P!_4?\ O\O_ ,31]<IA_J_B_+[SP2BO>_\
MAFOP[_?U'_O\O_Q-'_#-?AW^_J/_ '^7_P")H^N4P_U?Q?E]YX)17O?_  S7
MX=_OZC_W^7_XFC_AFOP[_?U'_O\ +_\ $T?7*8?ZOXOR^\\$HKWO_AFOP[_?
MU'_O\O\ \31_PS7X=_OZC_W^7_XFCZY3#_5_%^7WG@E%>]_\,U^'?[^H_P#?
MY?\ XFC_ (9K\._W]1_[_+_\31]<IA_J_B_+[SP2BO>_^&:_#O\ ?U'_ +_+
M_P#$T?\ #-?AW^_J/_?Y?_B:/KE,/]7\7Y?>>"45[W_PS7X=_OZC_P!_E_\
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M^7_XFCZY3#_5_%^7WG@E%>]_\,U^'?[^H_\ ?Y?_ (FC_AFOP[_?U'_O\O\
M\31]<IA_J_B_+[SP2BO>_P#AFOP[_?U'_O\ +_\ $T?\,U^'?[^H_P#?Y?\
MXFCZY3#_ %?Q?E]YX)17O?\ PS7X=_OZC_W^7_XFC_AFOP[_ ']1_P"_R_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O_@'_H:UYI7I
M?Q _Y%&[_P" ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\B]-_P!?#?\
MH*UTU<S\*_\ D7IO^OAO_05KIJ"'N%%%% @HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,;X@?\ (HW?_ /_ $-:\TKTOX@?\BC=_P# /_0UKS2@I!11104%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 =]\*_^1>F_P"OAO\ T%:Z:N9^%?\ R+TW_7PW_H*UTU!#W"BBB@04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &-\0/\ D4;O_@'_ *&M>:5Z7\0/^11N_P#@
M'_H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** .^^%?_(O3?]?#?^@K735S/PK_ .1>
MF_Z^&_\ 05KIJ"'N%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\BC=_\
M /\ T-:\TKTOX@?\BC=_\ _]#6O-*"D%%%%!04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!WWPK_Y%
MZ;_KX;_T%:Z:N9^%?_(O3?\ 7PW_ *"M=-00]PHHHH$%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!C?$#_D4;O_ (!_Z&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@H***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  '3_"N*HH]C3[(/[0Q7_/R7WL[7_AH+Q1_S^P_^ Z?X4?\ #07BC_G]A_\
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M  T%XH_Y_8?_  '3_"N*HH]C3[(/[0Q7_/R7WL[7_AH+Q1_S^P_^ Z?X4?\
M#07BC_G]A_\  =/\*XJBCV-/L@_M#%?\_)?>SM?^&@O%'_/[#_X#I_A1_P -
M!>*/^?V'_P !T_PKBJ*/8T^R#^T,5_S\E][.U_X:"\4?\_L/_@.G^%'_  T%
MXH_Y_8?_  '3_"N*HH]C3[(/[0Q7_/R7WL[7_AH+Q1_S^P_^ Z?X4?\ #07B
MC_G]A_\  =/\*XJBCV-/L@_M#%?\_)?>SM?^&@O%'_/[#_X#I_A1_P -!>*/
M^?V'_P !T_PKBJ*/8T^R#^T,5_S\E][.U_X:"\4?\_L/_@.G^%'_  T%XH_Y
M_8?_  '3_"N*HH]C3[(/[0Q7_/R7WL[7_AH+Q1_S^P_^ Z?X4?\ #07BC_G]
MA_\  =/\*XJBCV-/L@_M#%?\_)?>SM?^&@O%'_/[#_X#I_A1_P -!>*/^?V'
M_P !T_PKBJ*/8T^R#^T,5_S\E][.U_X:"\4?\_L/_@.G^%'_  T%XH_Y_8?_
M  '3_"N*HH]C3[(/[0Q7_/R7WL[7_AH+Q1_S^P_^ Z?X4?\ #07BC_G]A_\
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M+;WP5K4=[92;)$X93]V5>ZL.XK*KAHR7NZ,[\!G-6C4_?-RB_P"M#ZIHK"\
M^/K+X@:*+JU.V1,+/ Q^:%O0^H]#W_,5NUY333LS[:G4C4BIP=TPHHHI%A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!C?$#_ )%&[_X!_P"AK7FE>E_$#_D4;O\ X!_Z&M>:4%(****"
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#OOA7_R+TW_7PW_H*UTU<S\*_P#D7IO^OAO_ $%:Z:@A
M[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OFSXU?\E0U?_KHO_H"U])U\V?&K_DJ&K_\ 71?_ $!:[,%\;]#Y
M[B/_ '>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"3:U^J5OY3T/\ 5G-?^?$C]!**_/O_ (B0_@=_T*OQ6_\ !9I__P FT?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%
M?_(O3?\ 7PW_ *"M=-7,_"O_ )%Z;_KX;_T%:Z:@A[A1110(**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?\E0U
M?_KHO_H"U])U\V?&K_DJ&K_]=%_] 6NS!?&_0^>XC_W>/K^C.6HHHKU#XP**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T_"7BV
M]\%:U'>V4FR1.&4_=E7NK#N*^C/ /CZR^(&BBZM3MD3"SP,?FA;T/J/0]_S%
M?,%:?A+Q;>^"M:CO;*39(G#*?NRKW5AW%<]>@JBNMSU\KS26%ERRU@_ZNCZI
MHK"\ ^/K+X@:*+JU.V1,+/ Q^:%O0^H]#W_,5NUY#33LS[JG4C4BIP=TPHHH
MI%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M];+L8\-"FI*R=VWU/YHO^&#_ (X_]$9^*W_A):A_\:K]^OV;OA-!XI_X)^>
MO OC'2;R.VU'X>Z?H.N:7<^;:7"H^FQP7$#X*RQ/@NIP5=3GD$5['17GXC%R
MJI)JUCX?/.)ZV9PA&<%'E=]&S^:C]NO]E>^_8Q_:F\5> ;I;M[#3[C[3HMW<
M!B=0TV7Y[:7>8HUD8+^[D:-?+$\4R*3LKV#_ ((R?MUVW[%G[3SVFO'9X,^(
MHM='U:8RV\$>FS+-BUOY9)0,0P^=.)!YB*(YY)"':)$/Z=?\%F?V&8?VP_V6
M;S5M+L[V[\>_#NWN-4\/QVTDS&\C/EM=VGD1HYFDEBA'E*JAS-'$H=4:0-^
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M4445!Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 =]\*_\ D7IO^OAO_05KIJYGX5_\B]-_U\-_Z"M=-00]PHHHH$%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#KHO\ Z M=F"^-^A\]Q'_N
M\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;_9GV_RKW[9Y&?W7G^5]@\W;\^S[-OX\NOVOI""BBB@ HHHH **** "BBB@
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MRY^R?XF&B^-?C-X4M]86ZNK&XL=)$^NW.G7%LZI-#=1V$<[6LBNVW;.$)*N
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M@?\ (HW?_ /_ $-:\TH*04444%!1110 4444 %?S1?MX?\GQ?&7_ +'K6_\
MTX3U_2[7\T7[>'_)\7QE_P"QZUO_ -.$]>GEGQL_1/#O_>:W^%?F?07_  1W
M_P""D7@?_@GS_P +%_X3/2O%>I_\)=_9OV/^Q;:WF\O[-]KW^9YLT6,^>F,9
MZ-G'&?M?_B)#^!W_ $*OQ6_\%FG_ /R;7X]_#'X#^./C;]N_X0SP9XK\7?V9
MY?VS^Q=(N+_[)YF[9YGE(VS=L?&<9V-CH:ZO_A@_XX_]$9^*W_A):A_\:KLJ
MX:C.;E/?U/K,RX>RG$XF5?$RM-VO[UMDDM/0_5G_ (B0_@=_T*OQ6_\ !9I_
M_P FU^@E?S1?\,'_ !Q_Z(S\5O\ PDM0_P#C5?TNUYV,HTZ=O9GP'%F4X'!>
MR^I._-S7UOM:WYL****X3XX*_GX_X+=_\I0/B=_W"O\ TTV5?T#U_/Q_P6[_
M .4H'Q._[A7_ *:;*O0RW^*_3_(^Z\/O^1C/_ __ $J)ZO\ \&WG_)\7BK_L
M1;O_ -.&GU^V%?B?_P &WG_)\7BK_L1;O_TX:?7[85&8?QCEXY_Y&K_PH***
M*XCX\*_#+_@NG^PI<_LV_M(W'Q%TI?-\&_%._GO=L<-PW]DZF562YBFE<LA^
MT.TMQ$ RG'GHL:I &;]S:^6/^"SGQ)\$^ ?^">WCBS\;Q7MS%XKA&C:);VJ2
M%I=7*M<6;,R,H6.*6W$[[V"LL#+ARPC?IPE24*JMU/H.&,QK83,(.DK\SY6N
MZ?\ EN?S]V.M7FF6=];VUW=6]OJ<*VUY%%,R)>1++',L<@!PZ"6**0*V1OB1
MNJ@BUX*\':E\1?&FC>'=%MOMNM>(+^#2].MO-2+[3<SR+%%'O<JB[G=5RS #
M/) K,K[2_P""#GQ1\#_#3]O+38O%ECNU?Q)93:/X;U.>>V6TTJ]D&[YEE4.)
M9T0V\3Q2!MTYB\N07&Z+WJLW"#DD?MF9XJ6%PE3$TX\SBKV_KMU\C]??V OV
M3;3]BO\ 94\+>!8ULWU:U@^UZ[=V^UEOM2EPUPXD$432(K8BB:1 _DPPJV2M
M>RT45\S*3D[L_G>M6G5J2JU'>3=V%%>??M(_M3> _P!D;P-:^)/B'KO_  C^
MBWM\FFPW'V*XN]]P\<DBIM@C=AE(I#DC'R]<D9\3_P"'W?[+_P#T4[_RW-6_
M^1:N-*<E>*;.FAEN,KP]I1I2DNZBVOP1]6T5\I?\/N_V7_\ HIW_ );FK?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_\ D7IO^OAO_05KIJYG
MX5_\B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_
MR5#5_P#KHO\ Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*??\I*_VAO\ LIGB3_TZW-?V0U_&]_P4^_Y25_M#?]E,\2?^G6YIH:/Z//\
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MPT$S:?;O*);\6SS/-,#(PWRJK+"B(E6*L?TN#_@J!^S2PX_:'^!G_A>:5_\
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M^'OCZ'[-\:/!FE_;[V[MK799>*+!)(X3?J$&R"X626)9H?E0M(LD(V,\5O\
MI#4DA1110 5_*A_P<E_\II_C/_W _P#TQ:=7]5]?RH?\')?_ "FG^,__ ' _
M_3%IU-#1^J__  : ?\HU/''_ &4R_P#_ $U:37ZL5^4__!H!_P HU/''_93+
M_P#]-6DU^K%#W![GY]_\%6O^#?'X2_M]^"_$/B#P;HFA_#CXT7.Z\M/$%E$U
MM8ZQ<^9-,Z:E;Q?))]HDF<R7:QFY5A&Q:5(S _\ +<K;U!'0C-?W#>*?%.F>
M!O#&HZWK>HV&CZ-H]K+?7]_?7"6]K8V\2%Y)I9'(5(T169F8@  DG K^+/\
M:<^-/_#27[2?Q"^(ATS^Q3X]\3:EXC_L[[1]I^P?;+J2X\GS=J>9L\S;NV+N
MVYVC.*:&C^J[_@A[^T/XF_:G_P""57P=\9^,;K[?XCN=,N=,N[QI)99;_P"P
M7MQ81W$TDKN\D\L=LDDKEOGD=V 4$*/QP_X._P#_ )25^!_^R9V'_IUU:OU6
M_P"#;)MW_!%?X,?77!_Y7M1K\J?^#O\ _P"4E?@?_LF=A_Z==6H6X+<^Y/\
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MDK>3>0>8L<J[986V2IC#Q'!RO#L.Q_:[17S=_P $@-2^(&N_\$R/@KJGQ/\
M$O\ PE_C#6_#-OJLVK-*TTMU:7):>Q$TC(C23I9R6R2NP9FD1V+R$F1O9?CI
M\=/"/[,_PCU[QYX\UZQ\,^$O#-J;O4=1NV/EP)D*H"J"SR.[*B1H&>1W1$5F
M95,DG65Y1\2?V\?@=\&O&U[X:\7_ !F^%/A3Q'IOE_;-*UCQ;I]C>VGF1K(G
MF0RRJZ;HW1QD#*NI'!%?SH?\%8/^#A[XI_\ !0:_U7PEX/GOOAI\(?M5S%;Z
M=I]Q);ZMXALY(/(*:K-'(5D1U:9C:QXA'G[)#<&*.6OD7]GC]AOXQ_M9&U?X
M:_"_QUXSL;K5$T7^TM+T:>;3+:[;R_W<]YM^SV^U98V=I9$5$<,Q5>:JQ5C^
MMOPS_P %&?V>_&OB;3M%T;X[_!K5M9UBZBL;"PLO&NFSW-]<2N$CABC28L\C
MNRJJJ"22 !DU[+7\;G[2?_!-+X_?LA-K4GQ$^$7CKP[I?AWR/[0UHZ6]UHEO
MY_EB+_B8P;[1MS31I\LIQ(WEG#@J/1_^";W_  6F^-O_  39\2Z-:^'_ !%?
M>)/AM9W2O?\ @?5;CS=-N+??,\D=JSJ[6$C/<2R^9;[0TNQI4G5?+)8+'];E
M%>;?LA?M5^$OVW?V;O"GQ3\#2W\OAGQ=;//:K?6QM[JW>.5X9H)4.0'BFBEC
M8HS(2A*.Z%7/I-22%%%% 'FW[5?[(?PW_;=^$DO@;XI^%+'Q=X8ENH;Y;6>2
M6"2WN(B2DT,T+)-"X!92T;J2DDB$E'=3A_L%_L+>!_\ @G1^S?IOPQ\ K?RZ
M/875S?37^HBW.HZI<3RL[2W,D$42RNJ>7"K%,B*"),D(*]EHH *_GL_X/!_V
M;=-\!?M4?##XGV!L+>Y^(NA76E:C:V^GI#)-<:9)%B\FG4YFD>&^@@&Y<HEE
M&-S JJ?T)U_+S_P= _M':9^T#_P5=UW3])6QEM?AEH5CX.>]L]02\COIXVFO
M)\[0!%)#->RVSQ98J]JV2"2B-#1Z3_P: KG_ (*7>-SW'PROQ_Y5=)K^CVOP
M(_X,Z/V<-3U/X[?%GXNRF_M=&T708O!]L'T]_LNIW%W<17<VRYR%\RW2R@WQ
M!6.+Z)B4&T/^^]#W![A7FWQ@_;*^$'[//BB#1/'_ ,5?AMX'UJYM5OH=/\0>
M)K+3+J6W9W19ECFD5C&7CD4,!@E&&<@U^4W_  =1?M\?M#_LI_$#P!X0\ >*
M+_P!\-?&N@S7#ZKH<Z6NK:IJ5O>(UQ#]I5OM-O'!$;$@P^2)!>3(SS+E(_Q$
M^"_[,/Q(_:+74A\.OAWXY\>#1?*_M >&] NM5^P>;O\ *\T01OY>_P N3;NQ
MN\ML9VFBP6/ZZC_P4_\ V:5Z_M#_  ,_\+S2O_C]>J_#/XI>&?C3X)LO$W@[
MQ%H7BSPYJ7F?9-5T:_BO[*Z\N1HG\N:)F1]LB.AP3AD8'D&OY0OC%_P0;_:\
M^!GAF#5M:^!GBR]M;FZ6S1/#TMKXBN0[([@M!I\L\J1X1LR,@0$JI8%E!\:_
M9._;A^+/[#GC27Q!\)O'FN>#+Z["_:TM)%ELM1VQRQI]IM95>WN-@GE*>=&_
MELY9=K8-.P[']H%%?,'_  2"_P""B4/_  4Y_8DT/XC36=AI7B>VNIM$\3Z=
M8B;[+8ZE!M9O*,J@F.6&6WG50T@C%P(S([QNU?3]22%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M-\0/^11N_P#@'_H:UYI7I?Q _P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH
M*_FB_;P_Y/B^,O\ V/6M_P#IPGK^EVOYHOV\/^3XOC+_ -CUK?\ Z<)Z]/+/
MC9^B>'?^\UO\*_,_0/\ X-C/^:W?]P+_ -R5?JU7Y2_\&QG_ #6[_N!?^Y*O
MU:KGQW\>7R_(\+C+_D<5O^W?_28A1117(?,!1110 5_/Q_P6[_Y2@?$[_N%?
M^FFRK^@>OY^/^"W?_*4#XG?]PK_TTV5>AEO\5^G^1]UX??\ (QG_ ('_ .E1
M/5_^#;S_ )/B\5?]B+=_^G#3Z_;"OQ/_ .#;S_D^+Q5_V(MW_P"G#3Z_;"HS
M#^,<O'/_ "-7_A04445Q'QX5_.Y_P5(_;JN?V[_VF[S6;5O+\&^&A+I'AB".
M:X,<]JLS'[<T<H7RYKGY&8"-&5$@C;>8=[?>_P#P7V_X*&P?#_P%+\#_  EJ
M-E/K_B>#/BR:VO)5NM#LLQ216I$>%WW:EMZNYQ;Y#1%;F-Q^0.AZ'>^)]:L]
M-TRRN]1U+49TM;2TM86FGNIG8*D<<:@L[LQ "J"22 !FO7R^A9>UE\C]2X&R
M3V<'F5=;_#Z=7\]EY7[F]X$^"?B_XH>%_$^M>'/#6L:WI/@JR74M=N[.W,D>
MEV[.$$DA]/O,0,D)'+(1Y<4CI@Z'KE[X8UJSU+3+R[T[4M/G2ZM+NTF:&>UF
M1@R21R*0R.K $,I!! (.:_H _P""8O\ P3LTC]D3]D6;PUXFTVTU?Q%\0;=;
MOQE;:A9VLR9EMQ&VE-LWK-;0JTB89Y$=Y;AUVK+L7\B/^"I7["ES^PC^TU>:
M1:KYG@SQ-YNK^&9XX;@1V]JTK V+22EM\UM\BL1([,CP2-M,NQ>BCBXU*CA]
MQ[N4\44,?C:N$6WV7_,EO_FO(_8/_@E%^WE!^W9^S-;WVH.4\<>$O)TCQ+'+
M-;F6\G$*E=06.(+LAN<.P!C0+)'/&H98M[?3U?SI_P#!,7]MB_\ V(OVI]#U
MJ;4[RV\$:S<1Z?XKLT=O(N+-MR"X>-8Y&9[9G\]?+7S&"/$K*LSY_H@\.^(M
M/\7^'['5M)OK/5-+U2WCN[.\M)EFM[N&10\<L<BDJZ,I!# D$$$&O*Q=#V4]
M-F?FW%.2O+\8^1?NY:Q_5?+\K'P/_P '(?\ R8[X5_['JT_]-^H5^)]?U:45
MKA\;[*')RW._(N,/[.PJPWL>;5N_-;?RY6?REU^K7_!L9_S6[_N!?^Y*OU:H
MIU\?[2#AR_B:YSQK]?P<\)['EYK:\U]FGMRKMW"BBBO//A0K^:+]O#_D^+XR
M_P#8]:W_ .G">OZ7:_FB_;P_Y/B^,O\ V/6M_P#IPGKT\L^-GZ)X=_[S6_PK
M\S] _P#@V,_YK=_W O\ W)5^K5?E+_P;&?\ -;O^X%_[DJ_5JN?'?QY?+\CP
MN,O^1Q6_[=_])B%%%<C\=/CKX6_9J^%FI^-?&NIG1O#.C&$7EX+6:Y\GSIHX
M(_W<*/(<R2HO"G&<G !(Y%=Z(^:A&4Y*,5=LZZBLCP)\0-!^*/A6VUWPSK>D
M>(M$O2XM]0TN\CN[6<H[1OLEC)1MKHRG!X92#R#6O0)IIV9\1_\ !P+\+&^(
M/_!/*]U8:A]B'@;7]/UQH?(\S[>'9]/\K=N&S!OA)NPW^IVX^;<OX3U^Q7_!
MR)^T+9:!\#?!WPRL]5O8==\1:LNN7]I:72K&^FV\<L:I=1APY22YDC>(,A1G
MLI#D-$,_CK7NY<FJ6O<_:.!*=2.67GLY-KTT7YIG] W_  1!79_P2^^&6/75
M3_Y5KVOJZOF/_@C7X*U;P#_P30^%EEK5I]CN[BSN]3BC\U)-]K=WUS=6TF48
MCY[>:)\9RN_#!6! ^G*\>OK4DUW9^3YQ)2Q]>4=G.7_I3"BO.M'_ &M/AQKG
MQ]UCX6P^+M*C^(.A- MQH=RS6UU*9;8W:_9Q(%%SB >8_D%_+'W]M>BUFTUN
M<,Z<X64U:^OR>S"OYRO^"IWPL;X._P#!0WXM:2VH?VF;O7Y=<\[R/)V#4%74
M!%MW-GRA<^7NS\WE[L+G:/Z*?$'B&P\):!>ZKJM[::9I>F6\EW>7EW,L-O:0
MQJ7>21V(5$5026)  !)K^9/]J/XR']H;]I'QWXX%QK-Q;>*=>O-1LAJLF^[M
M[.29C;0/\[A?*@\N((K%46,*IVJ*]'+$^=OI8^_\/*=1XNK47PJ-GZMJWY,]
MP_X(BKN_X*@_##V.JD?^"F]K^@BOP)_X(4^"M6\5_P#!2_P3>Z;:?:;3PU9Z
MGJ>JR>:B?9;5K&:U63#,"_\ I%U;IA Q_>9QM5B/WVJ<R_BKT.7C^2>912Z0
M7YR"BBBO//APHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .^^%?_ "+TW_7PW_H*UTU<S\*_^1>F_P"OAO\ T%:Z:@A[
MA1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OFSXU?\ )4-7_P"NB_\ H"U])U\V?&K_ )*AJ_\ UT7_ - 6NS!?
M&_0^>XC_ -WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5_&]_P4^_Y25_M#?\ 93/$
MG_IUN:_LAK^-[_@I]_RDK_:&_P"RF>)/_3K<TT-']'G_  ;:?\H6/@Q_W'/_
M $^ZC7W+7PU_P;:?\H6/@Q_W'/\ T^ZC7W+2$%?@1_P=\?MM3^*OB]X%^ .D
MW=A+HWA:U3Q=KXM[J&>3^TYQ-#:P3($\RWD@M3)*!YG[U-3C8IA(V/[[U_*?
M_P ')2X_X+4?&CW.AG_RA:=30T)_P0*_X)C:+_P4V_;+N=)\:QZ\/AUX'TS^
MW=<^P02)%J<GGQ1V^F27:D?9O/W2OE3YKQ6LZQ[&_>Q?U1>%O"VF>!O#&G:)
MHFG6&CZ-H]K%8V%A8VZ6]K8V\2!(X8HT 5(T15554    # K\?/^#.#X*_V%
M^S;\9OB+_:?F_P#"4^);+PY_9WV?;]E_LVU-QYWF[CN\S^U=NW8-OV?.YM^%
M_9*A[@]SD_CE\#?"7[2WPDU[P)X[T&Q\3>$O$UJ;34=.NU/ESID,I#*0R2(Z
MJZ2(5>-T1T9656'\=G[;_P"R=K?[#/[6?COX3^()?M5_X,U-K2.[V1I_:-JZ
MK-:W>Q))!'Y]M)#-Y9=FC\W8QW*17]G]?S$?\'47P5_X59_P5KUK7/[3^W_\
M+)\-:5XC\C[-Y7]F^7$VE^3NW-YF?[-\W=A<>=MV_)N80(_4C_@U:_:OU/\
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M/M=U?^TO$?P:U-=+@21;F2XCT6Y0RV!EFE+(^V1+VWC2,@10VD"E%&UGQ/\
M@[__ .4:G@?_ +*98?\ IJU:O#/^#,$?-^TD?^Q8_P#<Q7N?_!W_ /\ *-3P
M/_V4RP_]-6K4=0ZGPW_P: ?\I*_''_9,[_\ ].NDU_1Y7\X?_!H!_P I*_''
M_9,[_P#].NDU_1Y0]P>X5_.'_P '?_\ RDK\#_\ 9,[#_P!.NK5_1Y7\X?\
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M67R8Y=UI?7"6-W'AU8#S+:XF3<!N7?N4JP##^I/_ (*??\HU/VAO^R9^)/\
MTU7-?RH_\$P?^4E?[//_ &4SPW_Z=;:FMAK8_LAKY]_;H_X)@?!W_@H]J'@>
M;XM:!?Z_'X!N;R>P@M]5N;&.X2ZA$<T$QA=6*%X[>4%65P]M& _EM+')]!5\
M:_\ !7+_ (+1^ /^"4'@O3(M0L?^$V^(WB'9-I7A&UOQ:2M:>9MDO+F;9)]G
M@&UU0F-FEE4JBE4FDBDD^N_"WA?3/ _AG3M%T73K'1]&T>UBL;"PL;=+>VLK
M>) D<,4: *D:(JJJJ    !@5?K^/?]M/_@K+\?OV]M5U<_$+XC:Y)X<U?"/X
M5TRX?3_#T4*7+7,,1LXV$<WE2%=LMQYLV(HMTKE%(W_@K_P0\_:S^/7]IC0O
M@1XZL/[)\KS_ /A([>/PUO\ ,W[?*_M%[?S\>6V[RMVS*[MN]<NP['T!_P '
M4'[*.F_L]?\ !2A?%&@:)?Z9HWQ7T*'Q#=SBS2'3I=76:6WO$MV2-5,A6.UN
M)@6>0RWK2,<3**^NO^#,_P")&MZG\./C[X0GO=_AS0]2T76;&S\F,>1=WD5[
M#<R[PN]M\=A:#:S%5\K*@%G+?BC\9/V7_B3^SA_9Q^(7PZ\<^ ?[:\W[!_PD
M?A^ZTK[?Y6SS/*\^-/,V>9'NVYV^8N<;A7[)_P#!F#_S<C_W+'_N8IO8;V/N
M3_@Y-8+_ ,$5_C/GUT,?^5[3J_EM^&>O:+X6^(_A_4_$GA__ (2SP[IVI6UU
MJFA_;Y+#^V;5)5::T^T1@O#YJ!D\Q 63?N'(K^UOXH_#31/C1\,_$7@[Q+9?
MVEX<\6:9<Z-JMIYTD/VJTN(FAFCWQLKINC=AN1@PSD$'FOY:_P#@L%_P1"\?
M_P#!,?XF:CJ6DV.N^,O@O=9NM,\5QV9E&E1M*D2VNJ-&NRWN%DEB19"$CN-Z
MM&%?S((1 C^I/X7?$O1/C1\,O#OC'PU>_P!I>'/%FEVVLZ5=^3)#]JM+B)9H
M9-DBJZ;HW4[74,,X(!XKE/VK/V0OAO\ MO?"27P-\4_"ECXN\,2W4-\MK/)+
M!);W$1)2:&>%DFAD +*6C=24DD0DH[J?Y,_V&/\ @I]\;/\ @G5XG6\^&'C6
M_P!.TB6Z%U?^'+T_:]#U0EX#)YMJYVK)(EO%$T\7EW C!5)4!K]N_P#@GC_P
M=6_"7]H8:9X;^-5A_P *A\83^5;?VL':Y\,ZA,WV>+=YV/-L=\LDS[9PT,,4
M.7NR32L*Q^I?A;PMIG@;PQIVB:)IUAH^C:/:Q6-A86-NEO:V-O$@2.&*- %2
M-$5555     P*_%'_@[Y_;GU/0;+P)^SOHS7]E:ZU:IXS\2S*7CCU" 336]C
M:ADE DC$T%S-+'+$0'BLG1LHP'[>U_*?_P ')*[?^"U'QH]SH9_\H.G4($7?
M^" 7_!*33?\ @J!^U-JG_"9_;U^&'PYM8-2\01V<Z12:K/-(5M-.+B19HDF$
M5R[RQ*2$MG0-$\L<B_U*>%O"^F>!_#.G:+HNG6.CZ-H]K%8V%A8VZ6]M96\2
M!(X8HT 5(T15554    # K^/O]C?_@J-\<?^"?WAO6=*^$/B^Q\'VWB*Y2[U
M.1/#>E7MU>NB[(P]Q<VTDQC0%]D>_8ADE95!D<M[)_Q$E_MI_P#19_\ RT="
M_P#D*FTQM,_JOK^97_@YF_X)G^$OV"?VJ/#'BCX>6%CH'@GXMVMY>1Z';RGR
M]*U*UDC^V+!#Y86"T=;JU>.,.VUS.JK%$L2#SK_B)+_;3_Z+/_Y:.A?_ "%7
ME/[8'_!6_P#:$_;V^&ECX/\ BQ\0/^$K\.Z;J<>L6UI_86FV/EW:12PK)OMK
M>-SB.>4;2Q7YLXR 0),$F?HY_P &>'[6.MVOQ/\ B=\"YX?M'AR]TMO'EE+O
MC3^SKN*6TL;E<"/?)]HCFM>6DVQ_8OE0F5V'[TU_.%_P: '_ (V6^-_^R97_
M /Z==)K^CVD]Q/<****0@HHHH ^8/^"OO_!1.'_@F+^Q)KGQ&ALK'5?%%S=0
MZ'X7TZ^$PM;[4I]S+YK1*2(XH8KBX92T8D%N8Q(CR(U?R3$^)?C7\2/^8[XO
M\8>+=3_Z:ZAJ>MW]S+_P*6>>65_]IW=^Y-?57_!;W_@IQ=_\%./VR[_6M/D\
MKX=^"_/T+P=;Q3W)BN[19W+:D\4P3RY[OY'8"*-ECCMXGWM#O;[F_P"#3S_@
MF-=Z_P".)_VH?%$?DZ5H?VW0O!EI+!<Q2W5V\:PW6I(^4BD@2*2XM%&)5:5[
MC/E/;*6K9%;(_6;_ ()=_L+:;_P3I_8D\%_#*U2QDUFPMOMWB2_M0C+JFKSX
M>ZE\P11-+&K8AA:1!(+>"!&)*5]!445))XU^W'^P7\-_^"B7PETWP3\4--O]
M3T'2==L_$$$=G?RV<@N+<LI4O&03'+#+/ XZ[)V*&.18Y$[GX&? SPC^S1\(
M]!\!^!-!L?#/A+PS:BTT[3K13Y<"9+,2S$L\CNS.\CEGD=W=V9F9CXU_P4[_
M ."G?@#_ ()<?L_R>+_%\G]IZ]J?F6WAGPS;3B.]\17:@$JI(/E01[D,TY4K
M$K* 'DDBBD_G"_X*!?\ !<WX_P#[?'C77?M7C37? _P_U'[7:6G@WP_J#V=C
M'87$:1/:W<D0C?4-\:?.;G<FZ2;RXX4D,8=AV/ZSJ_ C_@\(_91TWP?\7_A=
M\8M&T2_AN?&=K=Z!XEO[>S1;![BT$+V+32)&";N6&6Y0&61B\.GQJB@0-7YW
M_LZ?\$A?VF/VI_LK^"?@KXYN;"_TM-9LM2U*Q_L72[^T?RS')!>7IAMYMXE1
MD6.1F="64%58CAOVAOV%OC'^R:]U+\2/A;XY\&6=IJ;Z-_:>IZ+/#IMS=+YA
M\N"\V_9Y]PBD96BD=71"REEYIV'8_1__ (,\?B1K>E_MR_$WPA!>^7X<UWP*
MVL7]IY,9\^[L]0M(;:3>5WKLCO[L;58*WFY8$JA7^B&OYP_^#0#_ )25^./^
MR9W_ /Z==)K^CRD]Q/<****0@HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_(HW?\ P#_T-:\TKTOX
M@?\ (HW?_ /_ $-:\TH*04444%!1110 4444 %?S1?MX?\GQ?&7_ +'K6_\
MTX3U_2[7YH?'C_@W:_X7;\<?&?C/_A<']F?\)=KM]K7V/_A%/.^R?:;AYO*W
M_;%W[=^-VT9QG Z5W8&M"G)N;/L^#,VPN!KU)XJ7*FE;1OKY)GYH_LQ?MO?%
M#]C;^V_^%;^)_P#A'/\ A(_(_M'_ (EUI>?:/(\SRO\ 7Q2;=OG2?=QG=SG
MQZM_P^[_ &H/^BG?^6YI/_R+7U;_ ,0QG_5;O_+._P#NZC_B&,_ZK=_Y9W_W
M=7?+$863O*WW?\ ^SK9[PU6FZE7EE)]73;?WN)\I?\/N_P!J#_HIW_EN:3_\
MBT?\/N_VH/\ HIW_ );FD_\ R+7U;_Q#&?\ 5;O_ "SO_NZC_B&,_P"JW?\
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MG@+X/PV8)A \:7UU+%R"?M-E:I"XD]/MID#1]X-K_?%?K!7E_P"U9^QU\/\
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M( +KG</LS]BK_@A9\-?V3_'NA>,]8UG5_'_B_0?,DMVO8(K;28+GS-T-U%:
M.XFB0 *9)Y%#YD55<1F-O%T*<;0_ UJ<49-E]'DPEGVC%6^]VM^IE?\ !##_
M ()\:I^RE\)-6\;^.-%_LOQWXX\M+>UN50W>D:4H#I$X,8D@FFD)>6+>PVQ6
MH=4DC=5^\J**\6I4<Y.<C\CS#'5<9B)8FMO+^DOD%%%%0<84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO9\+?^"?7PDU6U\'Z_X4^)'Q?ENKG1[#PWI^IQWD6BWD)V32ZKY+[K=('.#
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MB\3^$+I;>Z-E<BXMITDB2:&:)Q@F.6&6*10RJX$@#HCAE']@>K_MF?!_P_\
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M6^$?%]REIKWC2;?HECX5>:010%XKZ*)I8U;Y[B1C$D,)#JT[!HE0C]+Z***
M"BBB@ K\B/\ @ZL_X*<7?[/_ ,%[#]GOPG)Y7B'XJ:8U_P")+Z.>YM[C2]%$
MX1(HB@5'^VR0W,,@,C 0PS(\1%PCK^D'[<O[6>B_L+_LD>//BQKT/VNR\&:8
MUU#9[Y(_[1NW98;2UWI'(8_.N9(8O,*,L?F;V&U2:_C[_:7_ &AO$O[67Q_\
M7?$GQA=?:O$?C/4YM3O-LDKQ6^]ODMX?-=W6"% D42%VV11QH#A130T=5^P3
M^Q1XN_X*"?M2>&/AEX1L[YY=8NHWU;4;>U%Q'X>TT2(MSJ$RL\:^7"CYVM(A
MD<QQ*3)(BG^P7X&? SPC^S1\)-!\">!-!L?#/A+PS;"TT[3K13Y<"9+,2Q)9
MY'=F=Y'+/([N[LS,S'\)O^#=O]L?]CS_ ()Q_!C6?&7Q$^*OV/XQ>/<VE_8S
M>$-0N/\ A&;"">41VT%S!:R[_M.([B4K*$;;;(8P]N7?](/^(DO]BS_HL_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH [[X5_\B]-_P!?#?\ H*UTU<S\*_\ D7IO^OAO_05KIJ"'
MN%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYP_\
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MIO\ P46_8D\%_$VU>PCUF^MOL/B2PM2BKI>KP )=1>6)96BC9L30K*YD-O/
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M;*V&'@#?\'?_ .TL%_Y$CX&#ZZ-JO_RQIV8[,_H]HKD_@+J_B[Q!\#/!E_\
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M3X8>)XQ=ZA]L\K^S-)U!#;S_ +HN%E\R]32UX1Y%QD;4\TTD)'V3_P $H_\
M@H7HO_!3']C3P_\ $33QY&O6VW1O%=DME):PZ?K44$+W4<(=Y-T#><DL3"1S
MY<J!R)%D1?I&OYEO^#6[]MBX_9I_X*)0^ +Z[L+;PE\:[7^QKQKRZAM8X-2M
MDFFTZ4.Z%GD9VFM$@5T$CZ@I^=DC4_TTT,&%%%%(04444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_
MR5#5_P#KHO\ Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11N_^ ?^AK7F
ME>E_$#_D4;O_ (!_Z&M>:4%(****"@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7$8D8+&C0S2?GA^R%H_@/7?VH_ $'Q2U2QTCX;+KMK/XIGNUOFCDTR.027,
M^Q1R7/F2Q*\2&-00\B$O&H,B_P!-/_$27^Q9_P!%G_\ +1UW_P"0J;\AOR/-
M=7_X-0/V5-2^$6E>&X?^%E6&LZ?=-<7'BNW\0(=7U-"92()HY(6LA&/,0 Q6
ML;X@CRY)D+_E1_P68_X( >+O^"8UBGCKPMJE]\0?A#>730S:D]F(K_PL\DS+
M;PWRH2KHZ-$BW:!$>;<C1P%X5E_:'_B)+_8L_P"BS_\ EHZ[_P#(5>;?MB?\
M%N?V&?VPOV5_B!\,-6^-%A#;>.-"NM*CNKSP#K5_'IMQ)&?L]X(&LU#R6\PC
MG3YE(>)"&4@,%J+4_,3_ (-E_P#@I#J7[)G[;NE_"_7-8O\ _A6WQ@NAI/V!
MI'>UT_79=B65XD:Q2-YDKHEF^TQJ1<1R2L5MDV_TTU_#4Z^8A![C%?W*T,&?
MPUD9%?KE_P $Q?\ @VF\;?MZ:1'\8/V@?&.N>&?#?C3R]>L8[&\@U+Q!XO@O
MK8W0U&2[=IDMM\D\+_OHY9I")PZ0G9(WY&U_<I38V?FC\0/^#4']E/QGX:\-
MV.G#XD^$[K0[7[/>ZCI7B!)+GQ$^R-?/NA=0SQ+)E&;%M' F9G^3 14_ O\
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M2S0R;)%5TW1NIVNH89P0#Q7YB_\ !W__ ,HU/ __ &4RP_\ 35JU?<O_  3
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MDOQ9\,]&T&PTGQUX8U33/(^T^(],\1R2:GJ_EQ-&_GI<K-:+YK$2/Y-O%AU
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M&-K]F\1>#=3FTN\ BE2&YV'Y+B'S41V@FC*2Q.47?%(C 885^R/_ !&?<?\
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MK;[#XDL+4HJZ7J\&$NHO+$LK11LV)H5D<R&WG@=@"]?S2_\ !>'X0Z9\#_\
M@KS\==$TF>_N;6[UY/$$CWCH\@N-3M(-3G4%54>6LUW(J#&0BH&9F!8_I9_P
M9G_$G6]4^'/Q]\(3WN_PYH>I:+K-C9^3&/(N[R*]AN9=X7>V^.PM!M9BJ^5E
M0"SEF]KC>USUC_@[_P#^4:G@?_LIEA_Z:M6K^=#3?$^HZ!IVIVUGJ-]8VFLV
MRV>I0P7#Q1W\"S13B*900)(Q-!#*%;(#PQMC<BD?T7_\'?\ _P HU/ __93+
M#_TU:M7Y:_\ !MO^RI!^U)_P5:\%2ZA#8W.C?#*WG\<WL%Q<S022/:-''9M"
M8OO21W]Q92E'949(I VX?NW%L"V/O+_@G_\ \&CGAR#P7H?B7]HGQ1KMUXBN
M/LE_/X.\/3Q6UEI^V1WELKR\ D>YWQ^2CFU,'EL)A'+*"DP]R\'_ /!K'\'/
MA%^V7\/OBIX'\;>.M"TKP9XG'BB?PU=&"_BFD@G2YL;:VN2JR06\4J /YPN9
M98L+YD;YE/Z?44KL5V<+^TU^T3X:_9*_9^\7_$KQA<_9?#O@S3)M3N]LD237
M.P?);P^:Z(T\TA2*)"Z[Y)$4'+"OX^?VSOVS_B!^WO\ '[5_B3\2M8_M/7M3
MQ%##"ICLM(M%+&*SM(B3Y5O'N;"Y+,S.[L\DCNW[>?\ !X3^TAJ?@3]EWX6_
M#"Q6^M[7XB:Y=ZMJ-U;Z@\,<T&F1PA;.: +B:-YKZ&8;FPCV49VL2&3\B_\
M@CMXQ^%/PM_X*'_#WQK\:/$%CX>\!^!+M_$$LEQ;ZC/)<7MNA:P6%+&*20R)
M>&WG(DVQ%+>0,6R(Y&AH_0#_ ()F_P#!J!<_&WX1Z?XV_:&\1^+/ CZ]:O-8
M^#]%AAMM8L$8Q&">]GN$E6*1D\[=:>1O0/$7D2020+]D_$#_ (-0?V4_&?AG
MPW8:</B3X3NM"M?L][J.E>($DN?$3[(U\^Z%U#/$LF49L6L<"9F?Y,!%3TK_
M (B2_P!BS_HL_P#Y:.N__(5'_$27^Q9_T6?_ ,M'7?\ Y"I:BU/P7_X*W_\
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M[QK;ZFQTVX8!64^8L-W*R'. X0E6 *E[H>Z/ZA?^"GW_ "C4_:&_[)GXD_\
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M/R/L_E?V;Y<3:7Y.[<WF9_LWS=V%QYVW;\FYOT?_ .#0 8_X)J>./^RFW_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@_\ -R/_ '+'_N8K]RJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QOB!_R*-W_P#_T-:\TK
MTOX@?\BC=_\  /\ T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@HHI""OXWO\ @I[_ ,I*_P!H;_LIOB3_ -.MS7]D-?R@?\'!_P"RM<?LI_\
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M/ __ &4RP_\ 35JU22?#?_!H!_RDK\<?]DSO_P#TZZ37W)_P=_\ _*-3P/\
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M&X2XMKVWEU*X>.:*1"5>-T965E)!!!!P:$"/ZO?^"8/_ "C4_9Y_[)GX;_\
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M-#)LD573=&ZG:ZAAG! /%.0Y&[1114DA1110!_#6.E?UZ_\ !%GQ'X1\4_\
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M_P"FK2:^&_\ @[__ .4E?@?_ +)G8?\ IUU:ON3_ (- /^4:GCC_ +*9?_\
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M/'VEZK>_9;_QIJFCZ-HT7DR/]LNTU""^:/*J0F+:RN7W.57]WMSN95/\\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?\E0U?_KHO_H"U])U\V?&K
M_DJ&K_\ 71?_ $!:[,%\;]#Y[B/_ '>/K^C.6HHHKU#XP**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M< X5&)X!H ]7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M QOB!_R*-W_P#_T-:\TKTOX@?\BC=_\  /\ T-:\TH*04444%!1110 4444
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MJ-O%.JH[1-)"S*'"NC%2<@.IQ@B@#IZ*** "BBB@ HKQ?]D3_@H3\(/V\/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$NQ\8?%CX?\ _"5^(M-TR/1[:[_MW4K'R[1)99ECV6UQ&AQ)/*=Q4M\V,X
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M_4RJ'A;PMIG@;PQIVBZ+IUCH^C:/:Q6-A86-NEO:V-O$@2.&*- %2-$5555
M    P*OU))_#77]RE?#7_$-I^Q9_T1C_ ,N[7?\ Y-K[EIMC;"OPU_X//O\
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M&GV$_$_XD74&I:_%:3/+'I-O#&1::<7$C0RR0F6Y=Y8E +W+(&E2*.1O2/\
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MKHOP[^'>B_\ "/>#O#WG_P!GZ?\ :Y[O[/YT\EQ+^]G=Y&S++(WS,<;L#
MP/VM/V&?A)^W3X*BT#XL> ]#\9V-KG['-=(T-]IVZ2*1_LUW$R7%OO:"(/Y4
MB>8J!7W+D4NHNI_/!^R1_P '1/[3?[.9L-/\5:EH?Q=\.6OV&V:#Q)9B/4HK
M2WRLJPWUOLD:>:,@-/=K=-O17(8F027OV^O^#G_XW?MC^!?%'@CPWH/A3X9>
M O%-M)IUY;6\/]K:O=6,]F]M=6DUW.!$8Y3*[AH;:&5,1J)/E9G_ $>\3?\
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MY)Z_N4KX:_XAM/V+/^B,?^7=KO\ \FU]RTFQ-GQK_P %HO\ @D9HO_!5_P"
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M8^7=I%+"LF^VEC<XCGE&TL5^;.,@$<-^Q_\ \$D/V>_V"?B7?>,/A/\ #_\
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M[!_PISP)_P +'_Z#O]IW?]B?\?&[_D&_Z_\ U'[O_C^_UG[S[O[JON7]H?\
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M6/A__P )7XBTW3(]'MKO^W=2L?+M$EEF6/9;7$:'$D\IW%2WS8S@ #N?V/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I40R.%4$L3@ #DFA$,
MCA5!+$X  Y)KW#X+_!<>'$CU758PVH$;H86'%L/4_P"W_+Z],JM54U=G;@<#
M4Q53DAMU?8/@O\%QX<2/5=5C#:@1NAA8<6P]3_M_R^O3TNBBO'G-S?-(^_PN
M%IX>FJ=-:!1114'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUY;:Q/"FF:1=I%,()!#?7;16TLBRY4QI(7RDGRXC?;U7_!&']@4_\%&OV_\
MPCX&OX/.\'Z43XB\7?/MSI-J\?F0_+-%+_I$LD%KOA8R1?:O-"D1M7];?A;P
MOIG@?PSIVBZ+IUCH^C:/:Q6-A86-NEO;65O$@2.&*- %2-$5555     P*J]
MBKV/XLO&_P ,?B5^R-\2M'_X23P[XY^&'C"R\C6]*_M/3[O1-3M]DK>3=P>8
ML<J[98FV2KT>(X.5X_=C_@W3_P""\6I_M/ZAH_[/GQBNK_5/B'%;2CPKXH=7
MGD\1P6\+S26U\PR1=Q0Q.ZW#<3I&PD(G4/<_5?\ P7]_8G\(_M>?\$V/B)JF
MMVEC!XF^%FA7WB_P[K;VIEN=->TA^TW,"%70^7=0P-"ZL60%HI2CO!'C^6#X
M9?$C6O@W\2?#WB_PU>_V;XC\*:G;:SI5YY,<WV2[MY5FAEV2*R/MD13M=2IQ
M@@CBC<-S^WBOY:O^"T/_  7)^('_  40^)7B[P/X=U[^RO@%;:FL.DZ181&+
M_A(XK663R=0O))(TN&\XE9A;.%CBV6^8VFA,S?TT_ 7XQ:9^T/\  WP9\0-%
M@O[71_'.A6/B&PAOD1+J&WN[=+B-951F42!9 &"LP!!PQ'-?!7[7/_!L3\ /
MVD/C_P"'/'GAVW_X5O!:ZGITOB+PMHUBD7A[7["W)\^WCMX&@>RGN(Q'&9X)
M BA&?R6E=I"D)'\]_P"RM_P3X^-G[;>HPP_"SX9^*_%UM+=2V)U.WLS#I%O<
M10B=X9K^79:PR",H0LDJDF2, $NH)^U3_P $^?C9^Q)J,T/Q3^&?BOPC;174
M5BNIW%F9M(N;B6$SI##?Q;[6:0QAR5CE8CRY 0"C@?V)_#3X7>&?@OX)LO#7
M@[P[H7A/PYIOF?9-*T:PBL+*U\R1I7\N&)51=TCNYP!EG8GDFE^*/PUT7XS_
M  S\1>#_ !+9?VEX<\6:9<Z-JMIYTD/VJTN(FAFCWQLKINC=AN1@PSD$'FG<
M=S^7G_@D+_P7?^(__!-#Q)H?A;5[F^\8_ V.ZF:_\+E8FN=,%PZM)<Z=,^&2
M1'5I!;LXMY#+/D1R3?:$_J4\+^*=,\<>&=.UK1=1L=8T;6+6*]L+^RN$N+:]
MMY4#QS12(2KQNC!E920000<&OXI/CK\']4_9Z^-WC'P#K<]A<ZUX'UR]\/ZA
M-8N[VLUQ:3O!(T3.J,8R\;%2RJ2",J#Q7]27_!NGXFU/Q;_P1F^"EUJVHW^J
M745MJEE'->7#SR);V^KWT$$(9B2(XH8XXT7HB1HJ@!0 ,&?;%?SV?\'9?QQ^
M.^@?M4:;X$U?7;[3?@=KNA0WGA_3=):YMK#6W22-KH:B2!'=7<-U#&ZQY=((
M7LW"I)-(S_T)UYM^TU^R%\-_VRO#.@:+\3_"ECXQT;PSKMOXDL+"]DE%L+Z!
M)$C>6-&59X]DTJM#,'B<.0Z,*E$H_DS_ &5/^"6/[0W[;-C#??#3X3^*]?T>
MYM9KNVUF>%--TB[2*802"&^NVBMI9%ERIC20OE)/EQ&^WSCXS?LQ?$G]G-=-
M_P"%B?#OQUX#_MKS?[/'B30+O2OM_E;/-\KSXT\S9YD>[;G;YBYQN%?VN5\W
M?\%;_P!BVU_;W_X)^_$7P -(_M?Q(=,EU;PHD9MH[B/6K5&ELQ%-< I#YKC[
M/(^4/DW,R[T#EA5RKGX^?\$/?^#C+QS\//BWX5^$OQ]\66&N_#G6;JZA7QMX
MGO;A]7T&>8;[<7%XQ<36GG!HR9P#"+H.UPD%N(Q_0I7\-=?V7?\ !.;Q-J?C
M3_@GM\"-8UK4;_6-9U;X=^'[V_O[ZX>XNKZXDTVW>2:61R6>1W)9F8DL223D
MTF)GLU?@/\5_VY_B/_P;[_\ !:?XIZ=KK7OC#X*_&?79?']YHR&))'M]2GD=
MK^Q3S6$5W;S)/;$2&,7:68WK&#;RP_OQ7YH?\'2W[$UO^TG_ ,$\9/B'8VE_
M<^+?@I=?VO:K9VLUU)/IMR\,.H1%$<*D:*L%V\[(YC2P<?(KR,! C] _@;\<
MO"7[2WPDT'QWX$UZQ\3>$O$ML+O3M1M&)CG3)5@5(#)(CJR/&X5XW1T=596
MZROYS_\ @U?_ ."F-Q^SY^TD_P  O$VH6%MX#^*5U+=Z.\T4,36/B+RHDC!N
M'D0^7=0P" 1XE9KA;18U3?*7_HPI,3"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[05K\5F\#>&!\1[.WFM8_$2V$:W[++'%"Q>0 &1Q#"D2R/EXXC)&C*DLBL7
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M:!XGTZWU;3+KRGB^TVL\2RQ2;'"NNY'4[64,,X(!XK:K\_O^#;G]J3_A??\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_G/_X.:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH QOB!_R*-W_P#_T-:\TKTOX@?\BC=_\  /\
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MP9#XD\3^&;KP3<M8WO@K7)FOM%1&G2ZDC%JS-$J3GY_M%J4=XYV>.8"7<5Z
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M7,-Q%XSTJ)+>;[3=*ZQV=\SR\Q!(S'IP5<*Y,\A^< ^7]9_\'!_[-,_[1_\
MP3*\6S6$5[<:K\.;F'QG:007$,,<B6RR1W;2F3[R1V4]W*%1E=GB0+N/R/\
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MO9/B/X\MKS3_  @D$*LEE.D:"2_E:1'BV6QGA<1,K&5V1-NPR21_8-?S&_\
M!=;]I>?]IG_@II\1)A+>G2O ]S_PAFF075O##):I8,T=PH,>=Z->F\E1G8N4
MF4';@(J0'DW@WX>_&?\ X*B_M0:L=)L]:^)?Q+\3^=JVHS/+%$?+C4 R222-
M'!;PH/+B0$I&N88D S&E?>6E_P#!J!\5I?A;J5W>_$[X?0>-8KE5T_28(;R;
M2[J#,>7EOC&LL3@&;"+:R ^6GSC>3']2?\&PW[(FC_#;]C*X^+=WI6BS>+/B
M-J-Y!9:K$7DO+?2+:5;<6C;P%BS=VUS(PBR)%^SEV8QHL?Z:TVP/Y0/V]/\
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MTWB3Q)IW@WP[?ZOJ]_9:5I.E6TEY>WMY.L%O9P1J7DEDD8A415!9F8@  DG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O\
MY%Z;_KX;_P!!6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O\
M]=%_] 6OI.OFSXU?\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %*B&1PJ@EB<  <DT(AD<*H)8G  ')->X?!?X+CPXD>JZK&&U C=#"PXMA
MZG_;_E]>F56JJ:NSMP.!J8JIR0VZOL'P7^"X\.)'JNJQAM0(W0PL.+8>I_V_
MY?7IZ7117CSFYOFD??X7"T\/35.FM HHHJ#H"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEM-:2,ASDHR$JI)4?HA_P9@M\W[20]O#'_N8JNA70_<NBBBI)"BBB@ HHHH
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M;[#XBTN>]M/MVIM;QVZR:M%;Q;&6UF:>/)\I$CE=XAN"*[_852!\_P#[5?\
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MV*Y\!^%--T'4'G152:=S/J(:(AB2GE7\*DL%.]9!C #-]L?\&H?P_P!'T_\
M8[^)'BN"TV>(-8\9G2+VZ\USYUM:6-M-;Q["=B['OKD[E4,WFX8D*H7\J/\
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MK6]O[F\M9,H2/GMYXGVD[EWX8*P('UI4@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M =]\*_\ D7IO^OAO_05KIJYGX5_\B]-_U\-_Z"M=-00]PHHHH$%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O\
MDJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#KHO\ Z M=F"^-^A\]Q'_N\?7]&<M1
M117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %*B&1PJ@EB<  <DT(AD<*H)8G  ')->X?!?X+CPXD>JZK&&U C=#
M"PXMAZG_ &_Y?7IE5JJFKL[<#@:F*J<D-NK[!\%_@N/#B1ZKJL8;4"-T,+#B
MV'J?]O\ E]>GI=%%>/.;F^:1]_A<+3P]-4Z:T"BBBH.@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1K=G0.%?8Z;T1MR+_0E_P;:?\H6/@Q_W'/\ T^ZC7\_?[2/_  11_:6_9O\
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MM\0[*]FL/#^D7&IW,4"Z;J:-,T<*,PC#21J6(P"ZC.2* /Q]_P"#;3_E-/\
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M*L'[$7[$?PS^%D<-C%=>$="A@U0V-S-<6MQJ4F9[^>)YL2&.6[EN)%!5<!P
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M?MNOZ;IQ\0:$L6E?VE>&]LO](6&UC&'$]PB2VH:/Y@MTX <$HWTW10!_'/\
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M;Z9 TDMU<2R7%S(S! SRNS.^%!/(4<-L#\C?^#JW]KNU\1>,O 7P4T?5?/\
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M*6Z\4Z+#-J0L[>:WMH-1CS#>PQI+EPD=U'/&I);(0$,X(8^M5^./_!I[^TM
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MN=_C'P[J4'B30+5[M+6#4;F%)8GMY'=2/GM[BX"9:-?.\DO(J!S7UI14@?R
M_L\?'CQ!^S)\;_"OQ"\*7/V?7O"6HQ:E:$R2I%<;#\\$OE.CM!*A:*1 PWQR
M.I.&-?L5IG_!V?X/E^%NI7=Y\&O$D'C6*Y5=/TJ'78)M+NH,QY>6^,2RQ. 9
ML(MK(#Y:?.-Y,?UG^V=_P0R_9\_;7\1-KVK>';WP7XHN;DW-]K/A&6+3KC4R
MS322?:(VCDMY7DDF+O,8O/8H@,NT;3X:?^#5/]GH_P#,Y?&;_P &VF__ "!5
M70'I?_!%G_@K-XC_ ."H+_%<>(O"6B^&/^$*U"SFTPZ=<RR[[*]^U>5!-O\
MOS1?96W3+L67S1B&+9\WG_\ P<,_\$KM1_;$^&-C\4_A[HM[K/Q.\$6RV5Y8
M6]TQ?6=%4SRM%!;[6$EU%-*9$5"C2)).N)I/(C'TU_P3N_X)=_#;_@F;X>\3
MV7@*X\3ZG<^+[F"?4M0UV]CN+B1(%=885$4442HAEF8$1[R9FW,P"!?HZEZ
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M\=Y8WUG.T%Q9SQL'CECD4AD=6 964@@@$'(K^POX;?$/1_B[\.] \6>'KO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '??"O_D7IO\ KX;_ -!6NFKF?A7_
M ,B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7S9\:O^2H:O_UT7_T!:^DZ^;/C5_R5#5_^
MNB_^@+79@OC?H?/<1_[O'U_1G+4445ZA\8%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %*B&1PJ@EB<  <DT(AD<*H)8G  ')-
M>X?!?X+CPXD>JZK&&U C=#"PXMAZG_;_ )?7IE5JJFKL[<#@:F*J<D-NK[!\
M%_@N/#B1ZKJL8;4"-T,+#BV'J?\ ;_E]>GI=%%>/.;F^:1]_A<+3P]-4Z:T"
MBBBH.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#\^_^#BO_@F+=_\ !0W]C:+6O"T?
MF?$7X1_;-=T>W6"YN9M9M&@S>:;#%"3F>?R+=XCY4C&2V2(>6LSN/Q]_X-E_
MVVK?]DO_ (*3:5X?UF[OHO#'QBMAX0E1+J86T.I231OIUP]O&CB:0S VJ,P4
M1#4)7+J@<-_4-7X#_P#!QG_P0=U+X?\ B3Q;^TE\([6^UCPWK%U<:YX]T'<]
MQ<Z+/*[2W&J6^<L]H[,SS1\FW):1?]'+"U:[#78_?BBOF'_@C1^U3XM_;6_X
M)H?"[XE>.YK&Z\6Z]:WL&HW-I;"VCO'M-0N;-9S&IVK)(ENKN$"IO=]B(N$7
MZ>I""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\T?\ @Z6_;9M_
MV;/^">,GP]L+N_MO%OQKNO[(M6M+J:UD@TVV>&;4)2Z(5>-U:"T>!G0R)?N?
MG5)%/Z75_-E^TQ^SC\;?^"]__!;WXG^%(38:?H/PMUR[\'W6OII^W3O"6A6.
MH744!DP=UQ=S.+B1(B^Z6627!AMXF,#0T4?^#9#_ ()C7?[77[6UM\7]?C\G
MX?\ P6U2VOXTE@N5_MO6@K2VD4$R%$'V618;F4%V(_T9&B9+@LO]+=>;?LA?
MLJ>$OV(?V;O"GPL\#17\7ACPC;/!:M?7)N;JX>25YIIY7. 9)9I99&"JJ N0
MB(@5!Z30P84444A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11N_P#@'_H:
MUYI7I?Q _P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH **** /R8_P"#D?\
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M!_P:.?\ -P7_ '+G_N5K]F*^9O\ @G5_P2J^'O\ P3*_X3#_ (0/6?&>K?\
M";?8OMW]OW=M/Y7V7[1Y?E>3;PXS]I?=NW9PN,8.?IFA@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^
M2H:O_P!=%_\ 0%KZ3KYL^-7_ "5#5_\ KHO_ * M=F"^-^A\]Q'_ +O'U_1G
M+4445ZA\8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4J(9'"J"6)P !R30B&1PJ@EB<  <DU[A\%_@N/#B1ZKJL8;4"-T,+#BV'J?]
MO^7UZ95:JIJ[.W X&IBJG)#;J^P?!?X+CPXD>JZK&&U C=#"PXMAZG_;_E]>
MGI=%%>/.;F^:1]_A<+3P]-4Z:T"BBBH.@**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *'AWPOIGA#3Y+32=.L=+M9;JXO7AM+=((WN+B9[BXF*J #)+-+
M)([=7>1V))8FK]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_ )%Z
M;_KX;_T%:Z:N9^%?_(O3?]?#?^@K734$/<****!!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\V?&K_ )*AJ_\ UT7_
M - 6OI.OFSXU?\E0U?\ ZZ+_ .@+79@OC?H?/<1_[O'U_1G+4445ZA\8%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2HAD<*H)8G  ')-"(9
M'"J"6)P !R37N'P7^"X\.)'JNJQAM0(W0PL.+8>I_P!O^7UZ95:JIJ[.W X&
MIBJG)#;J^P?!?X+CPXD>JZK&&U C=#"PXMAZG_;_ )?7IZ7117CSFYOFD??X
M7"T\/35.FM HHHJ#H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#&^('_ "*-W_P#_P!#6O-*]+^('_(H
MW?\ P#_T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_D7IO\ KX;_ -!6NFKF
M?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !43V4,K[FBC8GJ2H)-2T4 0_P!GV_\
MSPA_[X%']GV__/"'_O@5-11<5D0_V?;_ //"'_O@4?V?;_\ /"'_ +X%3447
M"R(?[/M_^>$/_? H_L^W_P">$/\ WP*FHHN%D0_V?;_\\(?^^!1_9]O_ ,\(
M?^^!4U%%PLB'^S[?_GA#_P!\"C^S[?\ YX0_]\"IJ*+A9$/]GV__ #PA_P"^
M!1_9]O\ \\(?^^!4U%%PLB'^S[?_ )X0_P#? H_L^W_YX0_]\"IJ*+A9$/\
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M!1_9]O\ \\(?^^!4U%%PLB'^S[?_ )X0_P#? H_L^W_YX0_]\"IJ*+A9$/\
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M!1_9]O\ \\(?^^!4U%%PLB'^S[?_ )X0_P#? H_L^W_YX0_]\"IJ*+A9$/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#&^('_(HW?_ /_0UKS2O2_B!_R*-W
M_P  _P#0UKS2@I!11104%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 =]\*_P#D7IO^OAO_ $%:Z:N9
M^%?_ "+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^
M11N_^ ?^AK7FE>E_$#_D4;O_ (!_Z&M>:4%(****"@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#OO
MA7_R+TW_ %\-_P"@K735S/PK_P"1>F_Z^&_]!6NFH(>X4444""BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH QOB!_P BC=_\ _\ 0UKS2O2_B!_R*-W_ , _]#6O-*"D
M%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!WWPK_Y%Z;_ *^&_P#05KIJYGX5_P#(O3?]?#?^
M@K734$/<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 8WQ _P"11N_^ ?\ H:UY
MI7I?Q _Y%&[_ . ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\B]-_U\-_
MZ"M=-7,_"O\ Y%Z;_KX;_P!!6NFH(>X4444""BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_3O\?\ @'UY17R'11]1_O?@'^LW_3O\?^ ?7E%?(=%'U'^]^ ?ZS?\ 3O\
M'_@'UY17R'11]1_O?@'^LW_3O\?^ ?7E%?(=%'U'^]^ ?ZS?]._Q_P" ?7E%
M?(=%'U'^]^ ?ZS?]._Q_X!]>45\AT4?4?[WX!_K-_P!._P ?^ ?7E%?(=%'U
M'^]^ ?ZS?]._Q_X!]>45\AT4?4?[WX!_K-_T[_'_ (!]>45\AT4?4?[WX!_K
M-_T[_'_@'UY17R'11]1_O?@'^LW_ $[_ !_X!]>45\AT4?4?[WX!_K-_T[_'
M_@'UY17R'11]1_O?@'^LW_3O\?\ @'UY17R'11]1_O?@'^LW_3O\?^ ?7E%?
M(=%'U'^]^ ?ZS?\ 3O\ '_@'UY17R'11]1_O?@'^LW_3O\?^ ?7E%?(=%'U'
M^]^ ?ZS?]._Q_P" ?7E%?(=%'U'^]^ ?ZS?]._Q_X!]>45\AT4?4?[WX!_K-
M_P!._P ?^ ?7E%?(=%'U'^]^ ?ZS?]._Q_X!]>45\AT4?4?[WX!_K-_T[_'_
M (!]>45\AT4?4?[WX!_K-_T[_'_@'UY17R'11]1_O?@'^LW_ $[_ !_X!]>4
M5\AT4?4?[WX!_K-_T[_'_@'UY17R'11]1_O?@'^LW_3O\?\ @'UY17R'11]1
M_O?@'^LW_3O\?^ ?7E%?(=%'U'^]^ ?ZS?\ 3O\ '_@'UY17R'11]1_O?@'^
MLW_3O\?^ ?7E%?(=%'U'^]^ ?ZS?]._Q_P" ?7E%?(=%'U'^]^ ?ZS?]._Q_
MX!]>45\AT4?4?[WX!_K-_P!._P ?^ ?7E%?(=%'U'^]^ ?ZS?]._Q_X!]>45
M\AT4?4?[WX!_K-_T[_'_ (!]>45\AT4?4?[WX!_K-_T[_'_@'UY17R'11]1_
MO?@'^LW_ $[_ !_X!]>45\AT4?4?[WX!_K-_T[_'_@'UY17R'11]1_O?@'^L
MW_3O\?\ @'UY17R'11]1_O?@'^LW_3O\?^ ?7E%?(=%'U'^]^ ?ZS?\ 3O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 8WQ _Y%&[_X!_Z&M>:5Z7\0/^11N_\ @'_H:UYI04@HHHH*"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .^^%?_(O3?\ 7PW_ *"M=-7,_"O_ )%Z;_KX;_T%:Z:@A[A1110(
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "OFSXU?\E0U?_KHO_H"U])U\V?&K_DJ&K_]=%_] 6NS!?&_0^>XC_W>/K^C
M.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .H^&'Q/NOAUJF1NFL)B//@SU_VE]&'Z]#[?1.AZY:
M^)-+BO+.59K>895A_(^A'I7R=74?##XGW7PZU3(W36$Q'GP9Z_[2^C#]>A]N
M3$8?G]Z.Y[N4YL\._95?@_+_ (!]*454T/7+7Q)I<5Y9RK-;S#*L/Y'T(]*M
MUY6VY]LI*2NM@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% &-\0/^11N_P#@'_H:UYI7I?Q _P"11N_^ ?\ H:UYI04@HHHH*"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .^^%?\ R+TW_7PW_H*UTU<S\*_^1>F_Z^&_]!6NFH(>X444
M4""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KYL^-7_)4-7_ .NB_P#H"U])U\V?&K_DJ&K_ /71?_0%KLP7QOT/GN(_
M]WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!C?$#_D4;O_ (!_Z&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@
MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH [[X5_\ (O3?]?#?^@K735S/PK_Y%Z;_ *^&_P#05KIJ
M"'N%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *^;/C5_P E0U?_ *Z+_P"@+7TG7S9\:O\ DJ&K_P#71?\ T!:[
M,%\;]#Y[B/\ W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ZCX8?$^Z^'6J
M9&Z:PF(\^#/7_:7T8?KT/M]$Z'KEKXDTN*\LY5FMYAE6'\CZ$>E?)U=1\,/B
M?=?#K5,C=-83$>?!GK_M+Z,/UZ'VY,1A^?WH[GNY3FSP[]E5^#\O^ ?2E%5-
M#URU\2:7%>6<JS6\PRK#^1]"/2K=>5MN?;*2DKK8****!A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 4444 %%%% !1110 45^4__!S?_P %)OC5_P $]?\ A27_  I_QG_PB/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH QOB!_R*-W_P#_T-:\TKTOX@
M?\BC=_\  /\ T-:\TH*04444%!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O\ Y%Z;_KX;_P!!
M6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O\ ]=%_] 6OI.OF
MSXU?\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^&O\
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M1J?M#?\ 9,_$G_IJN:7474_E1_X)@_\ *2O]GG_LIGAO_P!.MM7]D-?QO?\
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MU$E_=67C9;NYMK<N!))%"]C$LLBIDJC2QAB "Z [@[,=F?M[17QK_P $]/\
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MXP,EP^ H "@*B(BJB1H%2-$1$5555'T?_P $W?\ @BO\;?\ @I)XFT:Y\/\
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MW5JGEK+)&AQ).A.7'RAL9. :6Q2V/[!:*_*?_B+_ /V:O^A'^.7_ ()M*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WQ _P"11N_^ ?\
MH:UYI7I?Q _Y%&[_ . ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\B]-_
MU\-_Z"M=-7,_"O\ Y%Z;_KX;_P!!6NFH(>X4444""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7_)4-7_ZZ+_Z
MM?2=?-GQJ_Y*AJ__ %T7_P! 6NS!?&_0^>XC_P!WCZ_HSEJ***]0^,"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1\S['I6C:?+?WUUY<;2/Y<,2L[[8T=SM!PJ,3P#0D"1]Y_\ !KE\(-3^)?\
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M;AL$?#?_  9_C'_!-3QQ[_$V_P#_ $U:37ZL4NHNI_*!_P $[?\ @@W\>/\
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M*1Z?.T0C*96Y9#,1+$CQ-$?5OVD_^#.!@=:O_@_\91C]Q_9&A^,=+_ZYK/\
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M3F8"2: -/$EIE(8Q.UPI,US''Y?*LW]0U<+^U%\%O^&DOV9_B)\.QJ?]B_\
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M%Q*6VM;*^Y)'B@,?] GQ1_;S_9/^-'PR\1>#O$OQY^!NI>'/%FEW.C:K:?\
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MZW-?U7?\$P?^4:G[//\ V3/PW_Z:K:FQLX;_ (*;_P#!(#X:_P#!5S_A"?\
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MU;"U\)^-K6/QGH5A:A$&DV]W-.DEKY<<44<4<=U!<K#'&&"VX@!8MNQ^I/\
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MZ&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\ (O3?
M]?#?^@K735S/PK_Y%Z;_ *^&_P#05KIJ"'N%%%% @HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHKX:_XB2_V+/\ HL__ ):.N_\ R%0!]RT4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK+4[J*W5T1IFCAD9A&'DC4L1@%U&<D4 >DT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_Y*AJ__ %T7_P! 6OI.
MOFSXU?\ )4-7_P"NB_\ H"UV8+XWZ'SW$?\ N\?7]&<M1117J'Q@4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!U'PP^)]U\.M4R-TUA,1Y\&>O^TOHP_7H
M?;Z)T/7+7Q)I<5Y9RK-;S#*L/Y'T(]*^3JZCX8?$^Z^'6J9&Z:PF(\^#/7_:
M7T8?KT/MR8C#\_O1W/=RG-GAW[*K\'Y?\ ^E**J:'KEKXDTN*\LY5FMYAE6'
M\CZ$>E6Z\K;<^V4E)76P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_Z==6K^CROYP_\ @[__ .4E?@?_ +)G8?\ IUU:DA(^Y/\ @T _Y1J>./\
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M_:9\??LH?$JT\8_#7Q?KG@WQ%;;%%YI=T8OM,2RQS>1.GW)X&DBC+PRJ\3[
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MJ&E:[J]U#J<&Z)9(K@PP6LVV"7,B([$;WMYP!^[-?2'_ !" ?M*_]#Q\#?\
MP<ZK_P#*ZMK_ (-#OVL=%^$_[7/CSX4ZI#Y5]\7=+MKG1[S=(VZ[TI;N9K78
ML; >9;7-S+YCNBK]CV?,TJ@?T14VQMG\X?\ Q" ?M*_]#Q\#?_!SJO\ \KJ/
M^(0#]I7_ *'CX&_^#G5?_E=7]'E%*[%=GY,?\$(/^"$'Q>_X)??M>>(O'WC[
MQ'\-]7T;5_!]UX?AA\/ZA>W%RMQ)>V,ZLRS6D*^7LMI 2&)R5^4@DC]9Z**0
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH QOB!_R*-W_ , _]#6O-*]+^('_ "*-
MW_P#_P!#6O-*"D%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ;KU]KLGAKQAJWAG21<,/+TW3;*_N(;:UA10%2-%7)"@;G>21MTDCLW[E?\
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MRM?>(O*E20"X21SY=K#.8#'B)EN&NUD5_+B*+=BW9XW_ ,%6?^#@?XM?M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'/[,_M7[/)K.JW<[76IZ[-#$(UEN)F_X&XBC"0H\TICC3S&S[I2;$V?S2?\
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M*:]D^T7<UT_F-%'&AQ).X&$'RA<Y.2?5J0@K^&NO[E*_)?\ 8/\ ^#4;P/\
MLL?M(:9XY\?_ !!L?C'HNCVURL7A?4?!5O!IUY<2Q&%7NEGN+I9HXU>1U0(I
M$JPOO C*.T-'R+_P3^_X.QOB#\ O!.A>#OC+X2_X6GI6E_9+%/$UMJ36OB".
MT61Q-+<B0/'J$ZQ&,)EK9G,),LKO*TH]D^.7_!Y/I]MJ.OV7PU^!UY>6AM2F
MB:SXF\0+;2+<-",27.GV\4@,:3$C8EX#(B [XBV$]6_:H_X-$O@G\4;Z6_\
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M)51=TCB1!<M<M"T4+1R!T,C?H)2;$V%%%%(04444 ?SA_P#!W_\ \I*_ _\
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M8HX?/G?[\\[1Q1AII6>1]@+,QYKNJ38FS\-?^#S[_FV[_N9__</1_P &8/\
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M5U*3Q%=0O(BK!/:CRK:&.2([VQ-'<(Y*90!65_H__@UM_P""L/BW]I^R\3_
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MZYT;P-H5CX?L)KUT>YEM[2W2"-I6154R%(P6*JH))P .*\J_X*0?\$X/ _\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /XWO^"GW_*2O]H;_ +*9XD_].MS7
M]'G_  ;:?\H6/@Q_W'/_ $^ZC7\X?_!3[_E)7^T-_P!E,\2?^G6YKN?V;/\
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M7[1'B;X]?\$MHK#Q+=?;O^%;^)[SPEI-S))++</81VUI=PI*\CMGROMC0QA
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M[2WC[]DWXF6OC'X:^+M<\&>([78OVS3+DQ?:8EECF\B=/N3P-)%&7AE5XGV
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M#OP(\;?M!>)IM#^'_@WQ3XWUFVM6OIM/\/:1/J5S%;JZ(TS1P(S",/)&I8C
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M-P?\//?AE_PN#_AJS_A77_$U_M;_ (3'^W_[%_Y!-[Y/G_:OW/\ K_*V;_\
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M-\N,X)!^C_\ B)+_ &T_^BS_ /EHZ%_\A4VAM']5]%?RH?\ $27^VG_T6?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KYL^-7_)4-7_ .NB_P#H"U])U\V?&K_DJ&K_ /71
M?_0%KLP7QOT/GN(_]WCZ_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ZCX8?$^Z^'6J9&Z:PF(\^#/7_ &E]&'Z]#[?1.AZY
M:^)-+BO+.59K>895A_(^A'I7R=74?##XGW7PZU3(W36$Q'GP9Z_[2^C#]>A]
MN3$8?G]Z.Y[N4YL\._95?@_+_@'TI15?2=4AUO3(+NW8O!<H)(V((R#[&K%>
M4?;)IJZ"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\X?_  =__P#*2OP/
M_P!DSL/_ $ZZM7W)_P &@'_*-3QQ_P!E,O\ _P!-6DU1_P""[_\ P0@^+O\
MP5!_:[\.>/O /B/X<:1H^D>#[;P_-#X@U"]M[EIX[V^G9E6&TF4Q[;F, E@<
MAN, $_1__!"#_@G!XX_X)??LB>(_ /C[5?"FKZQJ_C"Y\00S>'[FXN+98)+*
MQ@56::&%A)NMI"0%(P5YR2!70KH?:]%%%22%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!C?$#_D4;O_ (!_Z&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@H**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH [[X5_\ (O3?]?#?^@K735S/PK_Y%Z;_ *^&_P#05KIJ"'N%%%%
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M_93+_P#]-6DU\-_\'?\ _P I*_ __9,[#_TZZM7W)_P: ?\ *-3QQ_V4R_\
M_35I-#V!['ZL5_#77]RE?PUT1")_<I1114DA1110 5_#5&OEH!Z#%?W*U_#4
MC;T!]1FJB5$_K9_X(+?![5/@;_P2%^!NBZO/87%U>Z')X@C>S=WC%OJ=W/J5
MNI+*I\Q8;N-7&,!U< L &/UY7R'_ ,$%?C#JGQR_X)"_ W6M7@L+>ZLM#E\/
MQI9HZ1FWTR[GTVW8AF8^8T-I&SG."[.0J@A1]>5)(5_$K\<O@]JG[/'QL\8>
M -;GL+K6O VN7OA_4)K%W>UFN+2=[>1HF=58QEXV*EE4D$94'BO[:J_B5^.?
MQAU3]H;XV^,?'^MP6%KK7CG7+WQ!J$-BCI:PW%W.\\BQ*[,PC#R,%#,Q  R2
M>:J)43^H3_@VR7;_ ,$5_@Q]=</_ )7M1K\-O^#DO_E-/\9_^X'_ .F+3J_<
MG_@VQ;?_ ,$5_@S]=<'_ )7M1K\-O^#DO_E-/\9_^X'_ .F+3J%N"W/W*_X-
MM/\ E"Q\&/\ N.?^GW4:^Y:^&O\ @VT_Y0L?!C_N.?\ I]U&ON6I)/@O_@YB
M\+:9X@_X(T?%*[O].L;VZT.ZT6^TV:XMTDDT^X;5[.W::%F!,<AAGFC++@[)
MI%SAF!_$3_@VT_Y33_!C_N.?^F+4:_<K_@Y+_P"4+'QG_P"X'_Z?=.K\-?\
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MO].T6]&HZ7<02!UFM9)KR58I&3S(68)DQ3RID!S7]%W_  ["_9J_Z-Y^!O\
MX0>E?_&*/^'87[-7_1O/P-_\(/2O_C%*Z%='\X?_  ;:_P#*:CX,?]QS_P!,
M6HU_5?7E/PV_80^!_P &O&MEXE\(?!KX4^%/$6F[_L>JZ/X2L+&]M=\;1OY<
MT42NFZ-W0X(RKL#P37JU#!G\;W_!3[_E)7^T-_V4SQ)_Z=;FOZKO^"8/_*-3
M]GG_ +)GX;_]-5M7\J/_  4^_P"4E?[0W_93/$G_ *=;FOZKO^"8/_*-3]GG
M_LF?AO\ ]-5M0P9[G1112$%%%% %#Q3X6TSQSX8U'1-;TZPUC1M8M9;&_L+Z
MW2XM;ZWE0I)#+&X*O&Z,RLK @@D$8-?RG?\ !9?_ ((T^+?^"5'Q:CG@>^\3
M?"+Q-=-'X:\2R1CS(GPS_P!GWVT!4NT16(8!4N$1I(PI6:&'^L"J'BGPMIGC
MGPQJ.BZUIUCK&C:Q:RV-_87UNEQ:WUO*A22&6-P5>-T9E96!!!((P::8TS^2
M3]@;_@L_^T!_P3F,%AX&\7_VIX/AW?\ %)>(T?4=$&?/;]U'O66U_>W#S-]E
MDA\R0*9/, VU^Y7[ W_!SK^S_P#M<B#2/'5S_P */\82;O\ 1_$=\CZ)/CSW
M_=:IM2)=L4*%OM26^9)ECC\X\GA?^"B'_!JG\)OVA_[3\2_!74/^%0^,)_-N
M?[)*-=>&=0F;[1+M\G/FV.^62%-T!:&&*'"6A)S7X-_MH?L7_$#]@;]H#5_A
MO\2-(_LS7=,Q-!/"3)9:O:,6$5Y:2D#S8)-K8. RLKHZI(CHKT8]&?V?5_.A
M_P '@WB;4[O_ (*$_#W1I=1OY=&L/AY;7MK8/<.;6VN)M2U%)IDCSM621+>W
M5V !801 DA%Q].?\&HO_  4YUKXS^#=7_9R\7R:[K>I^!=+DU[PSJ]Q/'+#:
MZ+'):VQTQL@2CR)9T:$DR#RY6C'E);Q*_P J_P#!W\^?^"EW@@>GPRL#_P"5
M75J%N"W/C?\ X)L?\%-/&'_!+CXFZ_XQ\!^%O VN^(]?TL:,UWXCAOI_L5H9
M4FECB2WNH$_>210%FD5V'D*$*!I _P!D_P#$7_\ M*_]"/\  W_P3:K_ /+&
ML_\ X-4? /@GXZ_M?_$;P!X^^&OPW\?Z+>^#O^$@BF\2^'K?5;K3;BTO;>!5
MMFF#+''*E_(90%RYA@^8!"&_=G_AV%^S5_T;S\#?_"#TK_XQ1H&A^&W_ !%_
M_M*_]"/\#?\ P3:K_P#+&O&OV\_^#A;XN_\ !1;]G#4OAEX_\"?!N/1[ZZMK
MZ"_T[1;T:CI=Q!('6:UDFO)5BD9/,A9@F3%/*F0'-?T7?\.POV:O^C>?@;_X
M0>E?_&*/^'87[-7_ $;S\#?_  @]*_\ C%*Z%='\X?\ P;:_\IJ/@Q_W'/\
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M?^([K3;G3+N\;P/82RWXL+ZYL([B9Y8W>2>6.V225RWSR.[ *"%%LMGYQ_\
M$7_^TK_T(_P-_P#!-JO_ ,L:/^(O_P#:5_Z$?X&_^";5?_EC7[D_\.POV:O^
MC>?@;_X0>E?_ !BC_AV%^S5_T;S\#?\ P@]*_P#C%3H3H?RH?\%"/V]_$O\
MP4A_: _X63XO\,^!O#7B.73(--O/^$7TZ6SBU+R2^RXN/-EE>6?RV2+>7_U<
M$*@ (*_<K_@S_P#^4:GCC_LIM_\ ^FK2:^Y?^'87[-7_ $;S\#?_  @]*_\
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M!_VA?^"@WC'1?'W@WPIXXT>V^'E[>PV'B#2+?4[:*==2TQ%F6.9&42!9)%#
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MC/P[=;V^R:G;"7[-*T4D/GP/]^"=8Y9 DT3)*F\E64\UW5%22?AE_P %#_\
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MBQ_[F*_<NOPT_P"#,%OF_:2'MX8_]S%?N70]P>X4444A!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7S9\:O^2H:O_P!=%_\ 0%KZ3KYL^-7_ "5#
M5_\ KHO_ * M=F"^-^A\]Q'_ +O'U_1G+4445ZA\8%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5Z;\%O@L=?:/5M6C(L0=T$##_CX_VC_L
M?S^G4^"WP6.OM'JVK1D6(.Z"!A_Q\?[1_P!C^?TZ^W*H10   !@ =JX,3B;>
MY ^FR?)^:U>NM.B[^;\@50B@   #  [4M%%><?7!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C?$
M#_D4;O\ X!_Z&M>:5Z7\0/\ D4;O_@'_ *&M>:4%(****"@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#OOA7_ ,B]-_U\-_Z"M=-7,_"O_D7IO^OAO_05KIJ"'N%%%% @HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOB6Y%IINFV:CS+A\%B2S$*B*JL[R.52-$=W955F'5?LF_L0_%C]N;QK+X?\
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M9Y6W2S-LB3J\IP,MS_8+^P:/$R_L-_!D>-/[=_X3'_A!=$_M[^V_-_M/[?\
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M&@1?:K_P7JBW<EINC3^T+5U:&[M=[QR"/S[:2:'S C-'YN]?F4&OZO/V%O\
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M67]F^'/"FF6VC:5:>=)-]EM+>)888]\C,[[8T4;G8L<9))YKPS_@F+_P3%\
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MI29GOYXGFQ(8Y;N6XD4%5P' "( %'LM22%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7S9\:O^2H:O\ ]=%_] 6OI.OFSXU?\E0U?_KHO_H"
MUV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5Z;\%O@L=?:/5M6C(L0=T$##_CX_VC_L?S^G4^"WP6.OM'JVK1
MD6(.Z"!A_P ?'^T?]C^?TZ^W*H10   !@ =JX,3B;>Y ^FR?)^:U>NM.B[^;
M\@50B@   #  [4M%%><?7!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMT9@%!9+=':.,L6FFG:5QI7/Z$_^"8__  6 ^&O_  5<'C;_ (5YH?CG1?\
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M.TW21/-;;Q\]O-Y3NBSPR!XI4#MLDC=2<J:[JD(**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#&^('_(HW?_  #_ -#6O-*]+^('_(HW?_ /_0UKS2@I!111
M04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 =]\*_^1>F_Z^&_]!6NFKF?A7_R+TW_ %\-_P"@K734
M$/<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNH$>1MTLL:_*IQNR< $CPS]FS_@MQ^S#^UY\:M%^'?P[^)O_  D/C'Q#Y_\
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M?_V;_BS_ ,%#_P!H"Z\/^!M%UWXC?$#7?M6MW\DMVIFFY\RXN[JZN'5$W2.
M99I!OEE1<EY%#?I;\/\ _@SJ^,&I>&?$DOBKXL?#;1M8M;7?X?M=*@O=3MM3
MN-DA\NZFDCMVM(]XA&^.*X.'<[,H%>K(JR/T!_9O_P"#H;]E/]H#Q,=)U+6O
M%GPQN9;JUL[*3QAI*PVU\\[LF?/M);B*".,A?,DN7A11(&W$*Y3] _"WBG3/
M''AG3M:T74;'6-&UBUBOK"_L;A+BVO;>5 \<T4B$J\;HRLK*2"""#@U_*#_P
M4(_X(4?M ?\ !-SP4/%?C+2-"\1^"4\B.[\1^%[Y[VQTV>:22-(;A)8XKB/E
M$'FM#Y.Z>%!(9'"5N?\ !$#_ (+ >)?^"8_[0-EI.I:C]I^#'C/5((_%FF71
ME>'2MY2)M7MEC1W6XAC +HB-]HCB$;+N6"2$MV"W8_JQKY3_ &D_^"W'[,/[
M(?QJUKX=_$3XF_\ "/>,?#WD?VAI_P#PCNK7?V?SH([B+][!:O&VZ*6-OE8X
MW8.""!]65_*A_P ')?\ RFG^,_\ W __ $Q:=20D?T/Z_P#\%=_V;_"G[,.@
M?&+5/BKH>F^ ?%?VC^Q+NZM[F&]UG[/=BSN/LU@T0O)O*G(#[(3L4AVPGS5\
M;+_P> ?LU$?\B-\<Q]=&TK_Y8U^-W[ O_!*[X_\ _!5@P0^!K/S?!_@_=HA\
M0^(]2>WT30=WGWOV2(X>5MTLKNT5K%)LDO5DD"";>?N;QS_P9P_$S3_AGHUU
MX:^,?@75O&4_D?VMI>IZ9=Z=IEEF)C-Y%['Y\L^R7:J;[6'>A+GRR/++LAV1
M]Y?LX?\ !T/^RE\?_$QTG4M:\6?#&YENK6TLI/&&D+#:WSSNR9\^TEN(H(XR
M%\R2Y>%%$@;<0KE/T#\+>*=,\<^&-.UK1=1L=8T;6+6*^L+^QN$N+6^MY4#Q
MS12(2KQNC*RLI((((.#7\=?[=W_!.CXM?\$X/B;;^&?BGX;_ +*.J?:)-&U2
MUG6ZTW78(93$TUO,O_ ',4@29$FA,D<?F*#]D_\ !OO_ ,%P=:_8;^)6B?!_
MX@7W]I?!?Q7J:6MM/>7<</\ P@MW<2@&[265E1+%I'+W$;,%3+SIA_-2X+=@
MMV/Z6J\V_:K_ &O?AO\ L1?"2;QS\4_%5CX1\,1745BMU/'+/)<7$I(2&&&%
M7FFD(#,5C1B$CD<@(C,/2:_C-_;S_;7\6_\ !07]J3Q/\3O%]W?/-K-S(NE:
M=<70N(_#VFB1VMM.A94C7RX4?&Y8T\QS)*P\R5V*2N)*Y^]'B;_@[J_9BT'Q
M-J-A:^&OC+K5K974MO#J-EHE@EMJ"(Y59XA->QRB-P RB2-'PPW(IRHW/A!_
MP=??LI_$KQ-/8:TWQ)^'MI#:M<+J7B#P\L]M.X=%$"KI\UU-YA#,P+1A,1ME
MP=JM^3/_  2Z_P"#>#XM_P#!23P9I?CR?5]"^'GPJU;SOLFOW3+J-[J7ER74
M#_9K&*0$^7<VPC?[1);_ "R!X_-P5KNOVTO^#5?]H']F_2M7UWP#>Z'\9?#F
MFXD2'24>Q\0/"MLTLTIL)-R-MD1HUBM[B>:4O$5CRS*CT'H?T/\ [.O[3GP_
M_:W^&=KXP^&OB_0_&?ARZV+]KTRY$OV:5HHYO(GCX>"=8Y8R\,JI*F\!E4\5
MX=^TE_P6Y_9@_9$^-6M?#OXA_$W_ (1[QCX=\C^T-/\ ^$=U:[^S^=!'<1?O
M8+5XVW131M\K'&[!P00/C3_@S[_9Z'@G]C7XC_$NXMM=M;WX@^)H],M_M4>R
MQO;#38/W5Q;90%\W-[?1.X=DW6P0!6C?/CG_  >+_LKW%OXJ^$OQNLX;^6TN
MK67P-K$KW,/V6TDC>6]L%2+B8R2B74B[@L@%M&#L)'F+J+J?L'^Q]^V]\+_V
M]_AK?^+_ (3>)_\ A*_#NF:I)HUS=_V;=V/EW:10S-'LN8HW.(YXCN"E?GQG
M(('J]?SV?\&B_P"VU;_#']I/QC\#M:N[_P"R_$ZU75O#B/=3/:P:G8Q2O<1)
M;JC1I)<6FZ1YV:,8TR*,[RT87^A.DQ,*^4OVDO\ @MU^S!^R+\:];^'?Q#^)
MO_"/>,?#I@&H:?\ \(YJUW]G\ZWCN(OWL%J\3;HIHV^5CC=@X(('T]XI\4Z9
MX&\,:CK>MZC8:/HVCVLM]?W]]<);VMC;Q(7DFED<A4C1%9F9B  "2<"OXP/V
MO?VC]3_:]_:B\?\ Q/U<7T-WXXUVZU9+6\U!]0DTV"20F"S$[!2\=O#Y<"?*
MH"1( J@!0UJ-:G]>_P"Q_P#MN_"_]O?X:WWB_P"$WB?_ (2OP[INIR:-<W?]
MG7=CY=VD4,S1[+F*-SB.>([@I7Y\9R"!ZO7R_P#\$;_V)+C_ ()_?\$[OA]\
M/M7L["U\7?9I-8\3FWM889&U*[<S213/$\BSR6Z-%:"?>WF):1D;5VHOU!2$
M%%%% !7SY^W5_P %1?@E_P $Z/#3W7Q-\:6-CK,EJ;JP\-6.+S7=4!2<Q^5:
MH=RQR/;RQ+/,8[<2 *TJ$UY5_P %RO\ @JWIO_!,#]EES8&_D^*'Q#M;[3?!
M:6\"-'8SQQHLFHS/+&\.RU,\+B)E8S.T:;=AEDB_E\^)7Q*\?_MD_'^]\0^(
M;W7/'GQ%\>ZG&KNL)N+W5;N4K%#!##&O_7.**&)0JJ(XXU"A5#2&D?T!C_@\
M _9J(_Y$?XYC_N#:5_\ +&O5/V3_ /@YF_9:_:F\:S:!=:]KOPKO>/LDWCRV
MMM-L;_\ =RR/B[BGFMX=BQ8/VB2+>TL:Q^8Q('YB_LV?\&C_ .T#\3FT6]^(
M?B7P+\+]*OO/_M&U-R^M:WIFSS%B_<0 6DOF,L9^6]&V.7)^=3%7E/\ P4 _
MX-O_ -H']A7P7KOC.&+0OB5\/]#^UW=WJGAZ9_MNF6$4B!+F\LI55TW1OYCB
MW:Y2%8IFDD"()&>@]#\_Z_N4K^&NO[E*)!(POB7\4?#/P7\$WOB7QCXBT+PG
MX<TWR_M>JZS?Q6%E:^9(L2>9-*RHNZ1T09(RSJ!R17YV_%[_ (.O_P!E/X;>
M)H+'16^)/Q"M)K5;AM2T#P\L%M Y=U,#+J$UK-Y@"JQ*QE,2+AR0RK\I_P#!
MXQ^SKXL/BOX2_%L:M>WO@1+6;P@^F/*!;:+J1>6[6=$,N6DO(5=7*1 *-+C#
MN=T2K\;_ +$W_!N3^TG^W#\([3QUI=AX4\#>&-8M8;[1+KQ=J,UH^NV\AD F
M@AMX9YECPBL&F2,2)-$\1D1MP5D*R/U+/_!X!^S4/^9'^.9_[@VE?_+&OJK]
M@+_@M+^S_P#\%&_L^G^"/%AT?QE/N_XI'Q(B:?K;8\]OW4>]HKK]U;O,WV66
M;RXRID\LG;7Y;_&+_@S9\<Z)X9@E^'_QO\)^)M8:Z5)[7Q#H%QH5M';['+2+
M-!+>,T@<1@(8E!#,=X*A6_*C]JG]D3XC_L3_ !8F\#?%3PG?>$?$T=K%>BTN
M9(IX[BWE!*2Q30L\,T9(92T;L \<B$AT90[(=D?VFT5^=O\ P;9_\%(M3_;Q
M_8EN- \9:S?ZY\2?A/=1Z5J]_?2/-<ZK8S^8]A=RR>4BF0K'-;MEY96-D9I6
MW3C/Z)5))^#'_!Q__P %;_V>_P!O;]A_PKX/^$_Q _X2OQ%IOCFTUBYM/["U
M*Q\NT2PU"%I-]S;QH<23Q#:&+?-G& 2/E3_@W _;<^&'[!/[<'BKQA\6/$W_
M  BGAW4O UWH]M=_V==WWF7;W^GS+'LMHI'&8X)3N*A?EQG) .[_ ,%?_P#@
MWX_X=2?LTZ'\1/\ A;?_  GO]L^)H/#G]G_\(M_9?D^;:W=QYWF_:YLX^R[=
MNT9WYW#&#X9_P2 _X)D?\/6_VEM<^'?_  FW_"!?V-X9G\1_VA_8_P#:GG>5
M=6EOY/E>?#C/VK=NW'&S&TYR*TL5I8_H#_XB2_V+/^BS_P#EHZ[_ /(5?5G[
M-G[2?@K]KSX*Z+\1/AWK/_"0^#O$/G_V?J'V.>T^T>3/);R_NIT21=LL4B_,
MHSMR,@@G\;O^(,'_ *N2_P#,??\ WRK]5_\ @FU^QA_P[U_8K\&?!_\ X23_
M (2[_A$?MW_$V_L_[!]K^TW]Q=_ZGS9=FW[1L^^V=F>,X"T%H>R>*?%.F>!O
M#&HZUK6HV.CZ-H]K+?7]_?7"6]K8V\2%Y)I9'(5(T169F8@  DG K\_/VC_^
M#H?]E+X >)ETG3=:\6_$ZYBNKJSO9/!^D+-:V+P.J9\^[EMHIXY"6\N2V>9&
M$9;< R%_*/\ @[M_9U\6?$O]BCP7X_T;5;T^&/AEKK/XBT590EM,M]Y5M;:@
MX:50\D$V+=%6.1\:G(P*(LF[\F_^">O_  0H^/\ _P %)/!1\6>#=)T+PYX(
M?[1':>(_%%\]G8ZE/#(D;PVZ11RW$F&9QYJP^3N@F0R"1"E"0)'ZZG_@[_\
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MHH H>%O"VF>!O#&G:+HNG6.CZ-H]K%8V%A8VZ6]K8V\2!(X8HT 5(T15554
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M&;?3+N#4KA055CYC0VDBH,8+L@+*"6'\DT@W1D>HQ5+8I;']RM87_"KO#/\
MPLS_ (37_A'="_X3+^S/[$_M[[!%_:?V#S?.^R?:=OF^1YO[SRMVS?\ -C/-
M;M%22%?*/_!<C_A"?^'2GQV_X6!_R O^$:?[+_Q\?\A;S8_[*_U'S_\ (2^Q
M]?W?_/3]WOKZNK\B?^#N/]M&T^&_[)GACX):5J^SQ%\2-3BU;6;&(6TW_$EL
MV+J)PQ,T/FWPMFB=$ D^PW*[P%9'$"/YX3TK^Y2OX^/^"3?[%MW^WQ^W[\.O
MA]_9']K^')-3BU3Q4DC7,5O'HMLZRWHEFMP7A\V,?9XWR@\ZX@7>A<,/[!ZJ
M14@K"\#?"[PS\,/[8_X1KP[H7A[_ (2+5)M;U7^S+"*T_M._FV^==S^6H\V>
M3:NZ5\NVT9)Q6[14DA7XV?\ !X__ ,(3_P ,V_!G[?\ \E'_ .$EO?[#_P"/
MC_D$_95_M+[O[C_7_P!E?ZS]Y_SS^7S:_9.OYI?^#JC]M&T_:0_X*!6/@'0M
M7_M+PY\&M,;29DC%M);QZU<.);\Q31%G?:B65O(DA!BFLYE"*=S.UN-;GE7_
M  ;:_P#*:CX,?]QS_P!,6HU_5?7\[O\ P:/_ +%MW\2_VN?$OQLU72-_ASX:
M:9+I>CWTK7,/_$ZO5$;& J!#-Y5B;I94=R8_MULVPEE=/Z(J'N#W"OQ>_P"#
MQG]G'3-0^"?PD^+T36%KK&D:[-X.NE33T^U:G!=V\MY!ON=P;R[=K*XV1%6&
M;Z1@4.X/^T-?(?\ P7J^#^J?''_@D)\<]%TB>PM[JRT./Q!(]X[I&;?3+N#4
MKA055CYC0VDBH,8+L@9E!+!(2/RV_P"#1W]OK_A77QN\3?L\:Y/MTKXA>;XC
M\,_N_P#5ZM;VX^UP_)"6/GV4"R;Y95CC_L[:JEY^?Z!:_BC_ &:OVA_$W[)G
MQ]\)?$GP==?9?$G@S4XM3L]TDJ0W)0_/;S>4Z.T$R%XI4#KOBD="<,:_L^^%
MOQ,T3XT_#+P[XQ\-7O\ :7ASQ9I=MK.E7?DR0_:K2XB6:&39(JNFZ-U.UU##
M." >*;&S>HHHI""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_(HW?_ /_0UK
MS2O2_B!_R*-W_P  _P#0UKS2@I!11104%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_P#D7IO^
MOAO_ $%:Z:N9^%?_ "+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5#Q1X7TSQQX9U
M'1=:TZQU?1M7M9;*_L+VW2XMKVWE0I)#+&X*O&Z,596!!!((P:OT4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %#P[X7TSPAI\E
MII.G6.EVLMU<7KPVEND$;W%Q,]Q<3%5 !DEFEDD=NKO([$DL35^BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSXU?\E0U?_KH
MO_H"U])U\V?&K_DJ&K_]=%_] 6NS!?&_0^>XC_W>/K^C.6HHHKU#XP**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KTWX+?!8Z^T>K:M&18@[H(&'_'Q_M'_ &/Y
M_3J?!;X+'7VCU;5HR+$'=! P_P"/C_:/^Q_/Z=?;E4(H    P .U<&)Q-O<@
M?39/D_-:O76G1=_-^0*H10   !@ =J6BBO./K@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"[;(XT0'"BOZZ/\ @I^,_P#!-/\ :'_[)EXD_P#35<U_&]0@1_63_P $*?\
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MEJ _\JND_P"%?T?5_.'_ ,&@'_*2OQQ_V3.__P#3KI-?T>4GN)[GY3_\'?\
M_P HU/ __93+#_TU:M7PW_P: ?\ *2OQQ_V3._\ _3KI-?<G_!W_ /\ *-3P
M/_V4RP_]-6K5\-_\&@'_ "DK\<?]DSO_ /TZZ31T#H?T>4444A%#Q1X7TSQQ
MX9U'1=:TZQU?1M7M9;*_L+VW2XMKVWE0I)#+&X*O&Z,596!!!((P:POC%\>O
M W[/'AJ#6OB!XS\)^!M'NKI;&"_\0ZO;Z9;37#([K"LD[JID*1R,%!R0C'&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_Y*AJ__
M %T7_P! 6OI.OFSXU?\ )4-7_P"NB_\ H"UV8+XWZ'SW$?\ N\?7]&<M1117
MJ'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>F_!;X+'7VCU;5HR+$'=! P_X^/]H_
M['\_IU/@M\%CK[1ZMJT9%B#N@@8?\?'^T?\ 8_G].OMRJ$4    8 ':N#$XF
MWN0/ILGR?FM7KK3HN_F_(%4(H    P .U+117G'UP4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '\]G_  >+?"#4]$_; ^$WCZ6>
MP;1O$W@Z7P_:0H[FZ2XTZ]EGG9UVA1&R:G;A"&))27*J I;QK_@UH_:'\,_
M3_@J=:V7B6Y^P_\ "Q_#%YX0TJYDDBBMX[^6XM+N%)7D=<>;]C:&,(&=YIH4
M"_/D?NS_ ,%??^"=L'_!3K]B37/AS#>6.E>*+:ZAUSPOJ-\9OLMCJ4&Y5\T1
M,"8Y89;B!F*R",7!D$;O&BU_*'\2?AOX_P#V-?C_ 'OA[Q#9:[X"^(O@+4T9
MT68V][I5W$5EAGAFC;_KG+%-$Q5E*2(Q5E8TM44M4?VMT5^$G[#'_!WS=>'?
M#2Z-^T1X$OM>N;*U"P^)?!D4*75^Z) BBYL9Y8X1(Y%Q*\T,T: M&B6RC+#Z
M[\<_\'4_[)GA+X9:-KUAJOCOQ/JNI^1]I\-Z9X<>/4](\R)I'\][EH;1O*8"
M-_)N)<NP*;TRX5F*S/T@HK^>O]LC_@[I^)7Q \2Z-%\$_!UA\/='T+77O;FY
MUV2+5[GQ38HV(+:>'RU6SCD3)F6&5Y02@BN4",TO[E_LA?M5^$OVWOV;O"OQ
M3\#2W\OACQ=;//:K?6QMKJW>.5X)X)4.0'BFBEC8JS(Q0E'="KE6%8^8_P#@
MY+_Y0L?&?_N!_P#I]TZOPU_X-M/^4T_P8_[CG_IBU&OW*_X.2_\ E"Q\9_\
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M=T P]D/9'Z)5_.'_ ,'?_P#RDK\#_P#9,[#_ -.NK5_1Y7\X?_!W_P#\I*_
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M'_!0.T_8O_;KNO#7BG7="\/?#CXIZ9)::WJ.LZE;:99:5=64,]S97<D\R_\
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MZM[_ .+VB>*=5BTM]3MK'PC%+KWV_'F!+=+FV5[2.=VC*A)IX]NY&<HC!Z_
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M+&_EH))6'EQNP_CZ^-WQO\6_M)?%C7?'7CO7K_Q/XM\2W)N]2U*\8&2X? 4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^
M2H:O_P!=%_\ 0%KZ3KYL^-7_ "5#5_\ KHO_ * M=F"^-^A\]Q'_ +O'U_1G
M+4445ZA\8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>F_!;X+'7VCU;5HR+$'=! P_X^/]H_
M['\_IU/@M\%CK[1ZMJT9%B#N@@8?\?'^T?\ 8_G].OMRJ$4    8 ':N#$XF
MWN0/ILGR?FM7KK3HN_F_(%4(H    P .U+117G'UP4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\P?\%$O^"0?P2_X*=6
M-G-\1M#O[;Q/I5K]AT[Q/HEU]CU:QM_.68P[F5X9HR0X"SQ2B,3S&,1O(SU]
M/T4 ?SO?$C_@SQ^.6E^-KV#PA\3?A1KOAR/R_LE_K#ZAI-[/F-2_F6T5O<I'
MB0NHQ.^Y55CM+%%PV_X- ?VEL<>-_@9^.LZK_P#*ZOZ/:*=V.[/QL_9(_P"#
M/[P#X0%AJGQI^(VN>,[Y/L-U+HGAN$:5IJ2IEKNTEN'\RXN8'.U%DB%G*$5F
M^5G'E_K/\#/@9X1_9H^$>@^!/ F@V/AGPEX9M1::=IUHI\N!,EF)9B6>1W9G
M>1RSR.[N[,S,QZRBD(^&O^#DO_E"Q\9_^X'_ .GW3J_G?_X))?L?>&OV]_\
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MDO[JRO\ 4KNYMK<N!))%"UE$LLBIN*HTL88@ N@.X?J1_P $]O\ @WR_9_\
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M/B:?Q'_:']C_ -E^3YMK:6_D^5Y\V<?9=V[<,[\;1C)^K*** "N&_:?^"_\
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MX7/PU_X@P?\ JY+_ ,Q]_P#?*C_B#!_ZN2_\Q]_]\J_<JBB["[/PU_X@P?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O_ )%Z;_KX;_T%
M:Z:N9^%?_(O3?]?#?^@K734$/<****!!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5\V?&K_ )*AJ_\ UT7_ - 6OI.O
MFSXU?\E0U?\ ZZ+_ .@+79@OC?H?/<1_[O'U_1G+4445ZA\8%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5Z;\%O@L=?:/5M6C(L0=T$##_ (^/]H_['\_IU/@M\%CK[1ZMJT9%B#N@
M@8?\?'^T?]C^?TZ^W*H10   !@ =JX,3B;>Y ^FR?)^:U>NM.B[^;\@50B@
M  #  [4M%%><?7!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH [[X5_P#(O3?]?#?^@K735S/PK_Y%Z;_KX;_T%:Z:
M@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OFSXU?\E0U?\ ZZ+_ .@+7TG7S9\:O^2H:O\ ]=%_] 6NS!?&
M_0^>XC_W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\ (HW?_ /_ $-:\TKT
MOX@?\BC=_P# /_0UKS2@I!11104%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 =]\*_^1>F_P"OAO\
MT%:Z:N9^%?\ R+TW_7PW_H*UTU!#W"BBB@04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS#_\71_PH?Q7_P! K_R9A_\ BZ^C:*/KM3L@_P!7,-_-+[U_D?.7_"A_%?\
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M;11]=J=D'^KF&_FE]Z_R/G+_ (4/XK_Z!7_DS#_\71_PH?Q7_P! K_R9A_\
MBZ^C:*/KM3L@_P!7,-_-+[U_D?.7_"A_%?\ T"O_ "9A_P#BZ/\ A0_BO_H%
M?^3,/_Q=?1M%'UVIV0?ZN8;^:7WK_(^<O^%#^*_^@5_Y,P__ !='_"A_%?\
MT"O_ "9A_P#BZ^C:*/KM3L@_U<PW\TOO7^1\Y?\ "A_%?_0*_P#)F'_XNC_A
M0_BO_H%?^3,/_P 77T;11]=J=D'^KF&_FE]Z_P CYR_X4/XK_P"@5_Y,P_\
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M*-W_ , _]#6O-*]+^('_ "*-W_P#_P!#6O-*"D%%%%!04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MWWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7PW_H*UTU!#W"BBB@04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% ',?&3Q)9>$?AOJ.H:C<+:V=OY7F2L"0NZ5%'0$]2!^->%
M?\-(>"?^@_;_ /?J3_XFO;_CGX0L_'OPLU32=0$C6EUY7F!&VM\LR.,'ZJ*^
M>/\ AD+P;_SQU#_P*/\ A04KFQ_PTAX)_P"@_;_]^I/_ (FC_AI#P3_T'[?_
M +]2?_$UC_\ #(7@W_GCJ'_@4?\ "C_AD+P;_P \=0_\"C_A0/4V/^&D/!/_
M $'[?_OU)_\ $T?\-(>"?^@_;_\ ?J3_ .)K'_X9"\&_\\=0_P# H_X4?\,A
M>#?^>.H?^!1_PH#4V/\ AI#P3_T'[?\ []2?_$T?\-(>"?\ H/V__?J3_P")
MK'_X9"\&_P#/'4/_  */^%'_  R%X-_YXZA_X%'_  H#4V/^&D/!/_0?M_\
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M?^@_;_\ ?J3_ .)K'_X9"\&_\\=0_P# H_X4?\,A>#?^>.H?^!1_PH#4V/\
MAI#P3_T'[?\ []2?_$T?\-(>"?\ H/V__?J3_P")K'_X9"\&_P#/'4/_  */
M^%'_  R%X-_YXZA_X%'_  H#4V/^&D/!/_0?M_\ OU)_\31_PTAX)_Z#]O\
M]^I/_B:Q_P#AD+P;_P \=0_\"C_A1_PR%X-_YXZA_P"!1_PH#4V/^&D/!/\
MT'[?_OU)_P#$T?\ #2'@G_H/V_\ WZD_^)K'_P"&0O!O_/'4/_ H_P"%'_#(
M7@W_ )XZA_X%'_"@-38_X:0\$_\ 0?M_^_4G_P 31_PTAX)_Z#]O_P!^I/\
MXFL?_AD+P;_SQU#_ ,"C_A1_PR%X-_YXZA_X%'_"@-38_P"&D/!/_0?M_P#O
MU)_\31_PTAX)_P"@_;_]^I/_ (FL?_AD+P;_ ,\=0_\  H_X4?\ #(7@W_GC
MJ'_@4?\ "@-38_X:0\$_]!^W_P"_4G_Q-'_#2'@G_H/V_P#WZD_^)K'_ .&0
MO!O_ #QU#_P*/^%'_#(7@W_GCJ'_ (%'_"@-38_X:0\$_P#0?M_^_4G_ ,31
M_P -(>"?^@_;_P#?J3_XFL?_ (9"\&_\\=0_\"C_ (4?\,A>#?\ GCJ'_@4?
M\* U-C_AI#P3_P!!^W_[]2?_ !-'_#2'@G_H/V__ 'ZD_P#B:Q_^&0O!O_/'
M4/\ P*/^%'_#(7@W_GCJ'_@4?\* U-C_ (:0\$_]!^W_ ._4G_Q-'_#2'@G_
M *#]O_WZD_\ B:Q_^&0O!O\ SQU#_P "C_A1_P ,A>#?^>.H?^!1_P * U-C
M_AI#P3_T'[?_ +]2?_$T?\-(>"?^@_;_ /?J3_XFL?\ X9"\&_\ /'4/_ H_
MX4?\,A>#?^>.H?\ @4?\* U-C_AI#P3_ -!^W_[]2?\ Q-'_  TAX)_Z#]O_
M -^I/_B:Q_\ AD+P;_SQU#_P*/\ A1_PR%X-_P">.H?^!1_PH#4V/^&D/!/_
M $'[?_OU)_\ $T?\-(>"?^@_;_\ ?J3_ .)K'_X9"\&_\\=0_P# H_X4?\,A
M>#?^>.H?^!1_PH#4V/\ AI#P3_T'[?\ []2?_$T?\-(>"?\ H/V__?J3_P")
MK'_X9"\&_P#/'4/_  */^%'_  R%X-_YXZA_X%'_  H#4V/^&D/!/_0?M_\
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M?^@_;_\ ?J3_ .)K'_X9"\&_\\=0_P# H_X4?\,A>#?^>.H?^!1_PH#4V/\
MAI#P3_T'[?\ []2?_$T?\-(>"?\ H/V__?J3_P")K'_X9"\&_P#/'4/_  */
M^%'_  R%X-_YXZA_X%'_  H#4V/^&D/!/_0?M_\ OU)_\31_PTAX)_Z#]O\
M]^I/_B:Q_P#AD+P;_P \=0_\"C_A1_PR%X-_YXZA_P"!1_PH#4V/^&D/!/\
MT'[?_OU)_P#$T?\ #2'@G_H/V_\ WZD_^)K'_P"&0O!O_/'4/_ H_P"%'_#(
M7@W_ )XZA_X%'_"@-38_X:0\$_\ 0?M_^_4G_P 31_PTAX)_Z#]O_P!^I/\
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MK'_X9"\&_P#/'4/_  */^%'_  R%X-_YXZA_X%'_  H#4V/^&D/!/_0?M_\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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MJW_@<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\
MALKX9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_
MX4 =%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@
M<?\ "C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX
M9_\ 0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =
M%_PV5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\
M"C_AWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\
M0UVG_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV
M5\,_^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_A
MWO\ #G_GWU;_ ,#C_A0!T7_#97PS_P"AKM/_  'F_P#B*/\ ALKX9_\ 0UVG
M_@/-_P#$5SO_  [W^'/_ #[ZM_X''_"C_AWO\.?^??5O_ X_X4 =%_PV5\,_
M^AKM/_ >;_XBC_ALKX9_]#7:?^ \W_Q%<[_P[W^'/_/OJW_@<?\ "C_AWO\
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M??5O_ X_X4?\.]_AS_S[ZM_X''_"@#HO^&R?AG_T-=I_WXF_^(H_X;)^&?\
MT-=I_P!^)O\ XBN=_P"'>_PY_P"??5O_  ./^%'_  [W^'/_ #[ZM_X''_"@
M#HO^&R?AG_T-=I_WXF_^(H_X;)^&?_0UVG_?B;_XBN=_X=[_  Y_Y]]6_P#
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MO\.?^??5O_ X_P"%'_#O?X<_\^^K?^!Q_P * .B_X;)^&?\ T-=I_P!^)O\
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M\^^K?^!Q_P * .B_X;)^&?\ T-=I_P!^)O\ XBC_ (;)^&?_ $-=I_WXF_\
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M]^)O_B*YW_AWO\.?^??5O_ X_P"%'_#O?X<_\^^K?^!Q_P * .B_X;)^&?\
MT-=I_P!^)O\ XBC_ (;)^&?_ $-=I_WXF_\ B*YW_AWO\.?^??5O_ X_X4?\
M.]_AS_S[ZM_X''_"@#HO^&R?AG_T-=I_WXF_^(H_X;)^&?\ T-=I_P!^)O\
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M(H_X;)^&?_0UVG_?B;_XBN=_X=[_  Y_Y]]6_P# X_X4?\.]_AS_ ,^^K?\
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M??5O_ X_X4?\.]_AS_S[ZM_X''_"@#HO^&R?AG_T-=I_WXF_^(H_X;)^&?\
MT-=I_P!^)O\ XBN=_P"'>_PY_P"??5O_  ./^%'_  [W^'/_ #[ZM_X''_"@
M#HO^&R?AG_T-=I_WXF_^(H_X;)^&?_0UVG_?B;_XBN=_X=[_  Y_Y]]6_P#
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MO\.?^??5O_ X_P"%'_#O?X<_\^^K?^!Q_P * .B_X;)^&?\ T-=I_P!^)O\
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M\^^K?^!Q_P * .B_X;)^&?\ T-=I_P!^)O\ XBC_ (;)^&?_ $-=I_WXF_\
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M]AO\H2OO8;W:1LGO\S&@#<HHHH **** "BBB@ HHHH **** ,;X@?\BC=_\
M /\ T-:\TKTOX@?\BC=_\ _]#6O-*"D%%%%!04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!WWPK_Y%
MZ;_KX;_T%:Z:N9^%?_(O3?\ 7PW_ *"M=-00]PHHHH$%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!C?$#_D4;O_ (!_Z&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@H***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\
MBC=_\ _]#6O-*]+^('_(HW?_  #_ -#6O-*"D%%%%!04444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!W
MWPK_ .1>F_Z^&_\ 05KIJYGX5_\ (O3?]?#?^@K734$/<****!!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\V?&K_D
MJ&K_ /71?_0%KZ3KYL^-7_)4-7_ZZ+_Z M=F"^-^A\]Q'_N\?7]&<M1117J'
MQ@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M&^('_(HW?_ /_0UKS2O2_B!_R*-W_P  _P#0UKS2@I!11104%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 =]\*_P#D7IO^OAO_ $%:Z:N9^%?_ "+TW_7PW_H*UTU!#W"BBB@04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-
MGQJ_Y*AJ_P#UT7_T!:^DZ^;/C5_R5#5_^NB_^@+79@OC?H?/<1_[O'U_1G+4
M445ZA\8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 =]\*_^1>F_P"OAO\ T%:Z:N9^%?\ R+TW_7PW_H*UTU!#W"BBB@04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2&X":UI>HW2O<:$T]QL@:!R%,UMNEBAV,6F0[&+2AW:+]JJ^;?\ @KYXQLO
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M2XE$\C&.)%:-E$1BE_:VN&O0E2ERR/C<XR;$9;6]C7Z[-;-!1116)Y(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '??"O\ Y%Z;_KX;_P!!6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH
M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7S9\:O^2H:O\ ]=%_] 6OI.OFSXU?\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]
M?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,;X@?\BC=_\ _]#6O-*]+^('_(HW?_  #_ -#6O-*"D%%%%!04
M444 %%%% !7\T7[>'_)\7QE_['K6_P#TX3U_2[7\T7[>'_)\7QE_['K6_P#T
MX3UZ>6?&S]$\._\ >:W^%?F1_"']K#7?@I^SO\4?A]HL'DI\5O[-@U'4TNY(
MIK:TM&N&DMT5",BX\\(Y9BIB$J%&\W<GEE)+*L,;.Y"JH+,2<  5]#_MJ?\
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M]4FD-Q%'%-&"+%%DB&WSOM?E2K'(RK)':W'WPC(W[[U\F?\ !&O]B[_AC_\
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M_P#A(?LNA^%-%GEFTKP]IS/]FB9F?9/<,QS<7*Q,(O,(50 _EQQ>;('Z1O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7PW_H*UTU
M!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?-GQJ_P"2H:O_ -=%_P#0%KZ3KYL^-7_)4-7_ .NB_P#H"UV8
M+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** ,;X@?\BC=_P# /_0UKS2O2_B!_P BC=_\ _\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_Y*AJ__ %T7_P!
M6OI.OFSXU?\ )4-7_P"NB_\ H"UV8+XWZ'SW$?\ N\?7]&<M1117J'Q@4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5O0]<NO#>J17E
MG*T-Q"<JP_D?4'TJI12WW*4G%W6Y])_##XGVOQ%TO(VPW\('GP9Z?[2^JG].
MA]^IKY.T/7+KPWJD5Y9RM#<0G*L/Y'U!]*^B/AA\3[7XBZ7D;8;^$#SX,]/]
MI?53^G0^_EXC#\GO1V/MLIS98A>RJ_'^?_!.IHHHKD/<"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M66XM+*&"1HF=48QEXV*EE4D$94'BFQL](HHHI""BBB@ HHHH **** "BBB@
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MSP5=W\BZ1K22B)97$?S+!=[(8METB%U\I%821%XG+!8_KXHKRC]BS]M/X?\
M[?G[/^D_$CX;ZO\ VEH>I9AN+>8".]T>[55,MG=Q GRIX]RY&2K*R.C/'(CM
MZO4DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !5#Q3XITSP/X9U'6M:U&QT?1M'M9;Z_O[ZX2
MWMK*WB0O)-+(Y"I&B*S,S$  $DX%7Z\W_;(^#^I_M"_LA?%7P!HLUA;:SXX\
M'ZOX?L)KYW2UBN+NRF@C:5D5V$8>12Q56( .%)XH ^"_^(M3]EK_ (63_8?]
MG?%?^R_[3^P?\)%_8-O_ &;Y/F^7]NV?:OM?D;?WFW[/YVSCRM_R5^EOA;Q3
MIGCGPSIVM:+J-CK&C:Q:Q7UA?V-PEQ;7UO*@>.:*1"5>-T965E)!!!!P:_D(
M_P"'0/[4O_"R?^$4_P"% ?%?^U/[4_LCSO\ A';C^S?/\WRMWV_;]D\C=S]H
M\WR=GS^9L^:OZOOV-_@_J?[/7[(7PJ\ :U-87.L^!_!^D>'[^:Q=WM9;BTLH
M8)&B9U1C&7C8J65201E0>*;&STBBBBD(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7_)4-7_ZZ+_Z M?2
M=?-GQJ_Y*AJ__71?_0%KLP7QOT/GN(_]WCZ_HSEJ***]0^,"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K>AZY=>&]4BO+.5H
M;B$Y5A_(^H/I52BEON4I.+NMSZ3^&'Q/M?B+I>1MAOX0//@ST_VE]5/Z=#[]
M37R=H>N77AO5(KRSE:&XA.58?R/J#Z5]$?##XGVOQ%TO(VPW\('GP9Z?[2^J
MG].A]_+Q&'Y/>CL?;93FRQ"]E5^/\_\ @G4T445R'N!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WQ _Y%&[_X!_Z&
MM>:5Z7\0/^11N_\ @'_H:UYI04@HHHH*"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** / OVU?\ @FM\+/V\K>UG\::9?6GB'3K<6EEX
M@TBY^S:C:P>:LIBRRO%*A(< 31R",32F/8SEJ_/WXV_\&U?C#3]>5_AQ\0O#
M6K:7<7%PS0^)89]/N+"'<OD()($G6Y?:6#OL@&4!"8?"?K_16]/$U*>D7H>U
MEW$.88)<E"I[O9ZK\=OD?B<?^#;SXY;>/%/PHS_V$]0_^0J]%^ '_!M1JUW=
M1W'Q5^(MC96\=Q*DFG>$H6N)+F#R?W;K>74:")Q*3N0VLH*)PP+Y3];**UEC
MZS5KGHUN-,UJ1Y>=+T2N<-^SQ^S5X'_91^'*>$_A]X>M?#FA+<RWC0122323
MSR'+R2RRLTLKX"J"[,0B(@PJ*H[FBBN-MMW9\M.<IR<YN[?5A11102%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!WWP
MK_Y%Z;_KX;_T%:Z:N9^%?_(O3?\ 7PW_ *"M=-00]PHHHH$%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7[(?P5UKXB?$36?^$>\'>'O(_M#4/L<]W]G\Z>.WB_=0(\C;I98U^53C=DX
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M2XM]Y@E*>;&GF*A9-RX-?A/^U5_P:+_&[X56,U_\+/&'A3XLVEO:PN;"=/\
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MQY_X)K_"2R\=>,$\)^*?"<MU]DO]1\*7ES>1Z$[%5A-V)K>%HTE9MB2!63>
MC,C21+(]!Z']0O[.O[3?P^_:V^&EMXP^&OB_0O&?AVYV+]KTRY$OV:5HHYO(
MG3[\$ZQRQEH9521-X#*IXKNJ_E._X-^/^"AX_P""?W_!0'1'US4_L'PZ^(X3
MPSXH,]SY5I9B1Q]DU"3?-% GV:<KOGEW>5;37FU=SU_5C2>@GH%%%%(04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O\ ]=%_] 6OI.OFSXU?
M\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,;X@?\BC=_\ _]#6O-*]+^
M('_(HW?_  #_ -#6O-*"D%%%%!04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!WWPK_ .1>F_Z^&_\
M05KIJYGX5_\ (O3?]?#?^@K734$/<****!!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?E/_P=_P#_ "C4\#_]E,L/_35JU?JQ7Y3_ /!W_P#\HU/ _P#V
M4RP_]-6K4 ?@Q^Q+^U_XF_8*_:=\,_%CP=9:%J/B/PI]J^QV^LP2S64GVBTF
MM7\Q(I(G.(YW(PX^8*3D9!_4GPY_P>3>.K7X1266K?!#PG>^/3:W"1ZQ9Z]<
M6ND+<,7^SR'3VBDF,: Q[T^V R%'(>+< GYI_P#!-K]B_P#X>%?MI^#/@_\
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M=_!+_@G3X:2U^&7@NQL=9DM1:W_B2^_TS7-4!2 2>;=.-RQR/;Q2-!#Y=N)
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MLK6(%G=W:*,,WF7$HBA5Y)"B8^K/V3_^#6#]I3]H;PSHGB#Q0WA3X3Z-J=U
M9K3Q#<S2:Y%8R)%(URME!&ZB0)(P%O<36\HDB9)!$,-56[E6[GVK_P %LO\
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MCHNM:=8ZQHVL6LMC?V%];I<6U];RH4DAEC<%7C=&965@002",&K]%(1_$/\
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M#57]I#4_A#_P5(L/!42W]UH_Q8T._P!(NK=-0>"UMY[2!]1AO'A *SR(MK/
MF=I07LI#8W(_]--?RH?\&VG/_!:?X,?]QS_TQ:C7]5]#!G\X?_!W_P#\I*_
M_P#V3.P_].NK5]R?\&@'_*-3QQ_V4R__ /35I-?#?_!W_P#\I*_ _P#V3.P_
M].NK5]R?\&@'_*-3QQ_V4R__ /35I-/H/H?JQ7\-=?W*5_#71$(G]RE8/Q1^
M)>B?!?X9>(O&/B6]_LWPYX3TNYUG5;OR9)OLMI;Q---)LC5G?;&C':BECC !
M/%;U>&?\%/QG_@FG^T/_ -DR\2?^FJYJ23^1?]I?]H?Q-^UE\?O%WQ)\877V
MKQ'XSU.;4[S;)*\-OO/R6\/FN[K!"@2*)"[;(XT0'"BOZD/^"%/_  3]T7]@
MK_@G]X,A_L+^SOB!X[TRU\0^,;N[TV2RU.2ZG0S16-PDC,Z?8HYOLXC^5=Z3
M2>6CS2 _R;5]R_\ $-I^VG_T1C_R[M"_^3:MEL_JOJAXI\+Z9XX\,ZCHNM:=
M8ZQHVL6LMC?V%];I<6U[;RH4DAEC<%7C=&965@002",&OY7_ /B&T_;3_P"B
M,?\ EW:%_P#)M'_$-I^VG_T1C_R[M"_^3:FQ-CY]_P""@W[*US^Q'^VO\2_A
M9-#?Q6WA#79[?3&OKF&XNKG37(FL)Y7A C,DMI);R, JX,A!1""@_IG_ .#?
M/XD:W\5/^".OP0U/7[W[??6NFWFC12^3'%LM+#4;NQM(L(J@^7;6\,>XC<VS
M<Q9B6/X-?\0VG[:?_1&/_+NT+_Y-K^@/_@B-^S;XU_9#_P""8/PR^'GQ$T7_
M (1[QCX>_M7^T-/^UP7?V?SM6O;B+][ [Q-NBEC;Y6.-V#@@@-C9_/Y_P<E_
M\II_C/\ ]P/_ -,6G5^Y7_!MI_RA8^#'_<<_]/NHU^&O_!R7_P II_C/_P!P
M/_TQ:=7[E?\ !MI_RA8^#'_<<_\ 3[J-#V!['W+7A?\ P4D_8LT7]OS]C+QQ
M\.-3TC0M3U;4=,N)O#-QJK21PZ/K2P2"RO!+&&EB\N5AO* EHFE1E=)'1O=*
M*DD_AK5MRY]:_KT_X(N_M(:G^UC_ ,$N/@SXUUH7YUBXT,Z1?W%]J#ZA=:C/
MIT\NG27DLS@,\EPUJ9VW9(,Q!9R-[?RP?MV?#/1/@M^V]\9/!WAFR_LWPYX3
M\<ZWHVE6?G23?9;2VOYX88]\C,[[8T4;G8L<9))YK^EK_@VTX_X(L?!C_N.?
M^GW4:IE,_EK^)GPXUKX.?$CQ#X0\2V7]F^(_"FIW.C:K9^='-]DN[>5H9HM\
M;,C[9$9=R,5.,@D<U_0__P &ZG_!9;P!\5_V2_!'P6^(WC?0O#_Q3\'D>&M$
MM=3F%I_PD6G1M;PZ<('\F*W,X$\=HELLDEQ+]D,I#;V([K_@MY_P0%T;_@I:
M8?'WP\N="\&?&BV\FVN[V_\ ,BTSQ/:+M0+>F)'=9X8P/*G5'8H@A<,GE/;_
M ,[_ .UA^Q#\6?V&_&L7A_XL> ]=\%W]UN^R27<:RV6H[8XI'^S743/;W&P3
MQ!_)D?RV<*VULBC<-S^T"BOY3_\ @G?_ ,' _P"T!_P3_P#[+T-=;_X6/\.K
M'RH/^$8\32O.+.V3[.GEV-WS-:[8(/*BCR]M%YCM]G=C7]#_ /P3#_X*>> /
M^"H_[/\ 'XO\(2?V7KVF>7;>)_#%S.)+WP[=L"0K$!?-@DVN8;@*%E56!"21
MRQ1JPK&[_P %+OV/O^&]_P!A3XD?":.^_LV_\5Z8ITVY:;R8H[^VFCN[/SG\
MN4B W,$(EVH7\HR;<-@C^27]D']I#4OV1/VH? 'Q/T@7TUUX(URUU=K6SU![
M"34H(Y 9[,SJ&*1W$/F0/\K I*X96!*G^TZOY3O^#B;]D#_AD+_@J9XX$%_]
MNTSXGY^(-CYDWFW%N-0N+C[3%+B.-5VWD5WY:KOQ#Y.YV??AH:/ZHO"WBG3/
M''AG3M:T74;'6-&UBUBOK"_L;A+BVO;>5 \<T4B$J\;HRLK*2"""#@U\,_\
M!R?^U3<?LO?\$I?&4&GRW]MK'Q.NH/ UG/;VT,\<<=VLDMXLPE/RQR6%O>0A
MT5G5YHRNT_O$Y/\ X-</VM_^&B?^"9=AX2U&_P#M7B+X0ZI/X=F6YUC[;>RZ
M>Y^TV,S1,-\$"I+):0H=R;=.8(P"F./\\/\ @[H_:IM_BM^V_P"#OA=82V%Q
M:_"70FFOF2VFCNK;4M3\J>6!W<B.2,6D&G2(8UP#/*&=B-D:ZBZGR+_P1/\
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M 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O\ X!_Z&M>:5Z7\0/\
MD4;O_@'_ *&M>:4%(****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#OOA7_ ,B]-_U\-_Z"M=-7
M,_"O_D7IO^OAO_05KIJ"'N%%%% @HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "ORG_X._\ _E&IX'_[*98?^FK5J_5BORG_ .#O_P#Y1J>!_P#LIEA_Z:M6
MH _*C_@VT_Y33_!C_N.?^F+4:_JOK^5#_@VT_P"4T_P8_P"XY_Z8M1K^J^FQ
ML****0@K^=[_ (/#OB1K>J?MQ_#'PA/>^9X<T+P*NL6-GY,8\B[O-0NX;F3>
M%WMOCL+0;68JOE94 LY;^B&OP7_X/#_V3]:M?B=\,?CG!-]H\.7NF+X#O8ML
M:?V?=Q2W=];-DR;Y//CFN^%CVQ_8OF<F5%#0T'_!G_\ L76OB;QS\1OCSK>D
M>>/#0C\*>%KR4VTL,5W,GG:C(J$&>*>.!K.-95**8[ZX3]YE@G[T5_-+_P &
MW_\ P6"\%_\ !.7QOXX\&_%?4==T[P!X[%O?VFIQ&>]LO#U_;),'9K*)'?\
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MMOAI:7=Y<ZGI7]I:8MW^[$EI!+9-+<2<NY222VB5DB);RV*H6QL_3VOY^O\
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MDUPV4BE4WIAE7= ,?HE28F?SA_\ !W__ ,I*_ __ &3.P_\ 3KJU?<G_  :
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M/Y4/^#DO_E-/\9_^X'_Z8M.K]RO^#;3_ )0L?!C_ +CG_I]U&OPU_P"#DO\
MY33_ !G_ .X'_P"F+3J^CO\ @C+_ ,'*'AO]@C]F#1_@[\3?A]KNI^'/"GVZ
M71]<\+R137TGVB[-S]GN+6XDB0XDGNCYZ3+\HA3R2=TIKH5T/Z(:X7]IO]HK
MPS^R3^S]XO\ B5XPN?LOAWP9IDNIW>V6))KG8/DMX?-=$:>:0I%$A==\LB*#
MEA7P5\0?^#K[]E/P9X9\-W^G'XD^+;K7;7[1>Z=I/A]([GPZ^R-O(NC=301-
M)EV7-K).F87^?!1G_*G_ (+,?\%__%O_  4XL%\"^%=+OOA_\(;2Z::;37O!
M+?\ BEXYF:WFOF0!41$6)UM$+HDVYVDF*0M$K"L?G>B^6@'H,5_6S_P05^$&
MI_ __@D)\#-&U:>PN+J^T.3Q#&]F[O&+?4[N?4K=2653YBPW<:N,8#JX#, &
M/\[_ /P18_X)O:G_ ,%)?VV_#GA^ZT>_N_AMX;NHM5\<7Z1L+:WL4W.MH\BR
MQ,DEX\9MT\M_-4/),JLL$F/ZW*;&PK!^)?PN\,_&CP3>^&O&/AW0O%GAS4O+
M^UZ5K-A%?V5UY<BRIYD,JLC;9$1QD'#(I'(%?A+\5O\ @ZS^)/P0_P""AOQ2
MBTW1O"?Q&^"=GKLNE:)I*7\2N+>S22V%Y8ZI;Q8:.\F5;MO.CN0$81Q,H_>'
MZ[^"W_!V-^S/X]^&>IZIXLM?'7@/Q'H^EQ7;:'/I7]H?VS=F)VEM+"XMV9'V
MR($62[%HK>;&QVCS/+5F*S/SA_X./_\ @C[X*_X)R>-_ _C+X3Z=KVG?#_QV
M+C3[O3)1<7MEX>O[9(2BK>RN[G[5&TLBPS,7#6MRRNR8CAY7_@V!^.'B[X=_
M\%9?!/A+1=>OK#PQ\0K;4K3Q'I:,&MM5CMM+O;NW+HP($D4T:LDBX=0TB!MD
MLBLG_!=[_@MOIW_!5O4?!WA_P7X=\5^%/ G@FYNKU5U;4E$FOSSPVRI-/90[
MH89+8I=1QMYTQ*7+D&/>Z5?_ .#6K]GGQ-\5O^"JWAWQGI=K_P 4[\+=,U#4
M]<O)8Y?*075E<6%O;I(J,@GDDN#(J.R;HK:Y923'M-="NA_3O7Y2_P#!VM^R
M!_PN3]AC0/BU;7_V>]^"^ID7%M+-MAN[#59K6TDVH(V+SK<I8E<O&@B-QG<V
MP5^K587Q1^&NB_&?X9^(O!_B6R_M+PYXLTRYT;5;3SI(?M5I<1-#-'OC973=
M&[#<C!AG((/-00?S2?\ !LQ_P4#M/V+_ -NNZ\->*==T+P]\./BGIDEIK>HZ
MSJ5MIEEI5U90SW-E=R3S+_U\6PC\R-6:^5B6:-%/Q3^U]^TAJ?[7G[4/C_XG
MZN+Z&Z\;ZY=:NMK>:@^H2:;!)(3!9B=@I>.WA\N!/E4!(D"JH 487QU^$&I?
ML_?&WQEX UN:PNM8\#Z[?>'M0FL7=[66XM+A[>5HF=58QEXV*EE4D8RH/%?5
MG_!O?^RM<?M5_P#!5KX9P&&_.C^ +K_A.=5GL[F&&2T33V22V8B4'?&]^;*)
MTC4N4F8C8 9$OS+\S^DO_@FA^Q]_PP/^PG\-_A-+??VE?^%-,8ZG<K-YT4E_
M<S27=YY+^7$3 +F>81;D#^4(]V6R3[I114$!17YO_P#!T9^TO\0/V8?^"=6@
MZA\._&&N^"=4\0^.K#1[W4-&NC:7KVGV._NC%'.F)8LRVL)+1,K,JLA)1W5O
MYF/#/B34?!7B/3M8T:_O=(U?1[J*]L+ZRG:WN;&XB</'-%(A#1R(ZJRLI!4@
M$$$4TKC2N?W#T5\P?\$9?VJ?%W[:W_!,_P"%WQ)\>36-UXMUVVO;?4;FSMA;
M1WCVFH7-FLYC4[5DD2W5W"!4WN^Q$7:B_3](04444 %?SA_\'?\ _P I*_ _
M_9,[#_TZZM7]'E?SA_\ !W__ ,I*_ __ &3.P_\ 3KJU-#1[E_P9@_\ -R/_
M '+'_N8K]RJ_DD_X)1?\%A_'/_!)GQ-XEE\*>&?"?BC1O'%UICZ_:ZLMPER]
MO9/<'R[6:.15@D=+J4;Y(I@IV'80I5OO/XE_\'EWB;5?!-[!X.^ NA:%XC?R
M_LE]K/BJ75K*#$BE_,MHK:V>3,8=1B=-K,K'<%*,VM1M:G[L^*?%.F>!O#.H
MZUK6HV.CZ-H]K+?7]_?7"6]M8V\2%Y)I9'(5(T169F8@  DG K^6S_@O]_P5
M;TS_ (*?_M2Z5_PAGV\?##X<VL^F^'Y+R!(I-5GFD#76HA#&LT23"*V1(I6)
M"6R.5B>62-?-_P!OK_@L]\?_ /@HTT]AXY\7'2O!\VW_ (I'PZCZ=HAQY#?O
M8][277[VW29?M4DWE2%C'Y8.VN5_X)X?\$T?BE_P4Z^+=[X3^&FGV"KH]K]L
MU?6]6EDM](T9"&\H3S)'(P>9T*1QHCNV';;LCE=!*P)6/JK_ (-;_P!B>?\
M:8_X*)P^/[ZTL+GPE\$[;^V;Q;RUANXY]2N$FATZ(([ADD5UFNTG5'$;Z>H^
M1GC<?M=_P7K^$&I_&_\ X)!_'/1M)GL+:ZL=#C\0R/>.Z1FWTR[@U*X4%58^
M8T-I(J#&"[("R@EAZM^P)^Q)X2_X)\?LL>%_AEX2M+!4TBUC?5]2M[4V\GB'
M4S&BW.H3*SR-OF9,A6D?RT$<2GRXT ]FI7U%?4_AJD3S(V7^\,5_:W^S)^T5
MX9_:V_9^\(?$KP?<_:O#OC/3(M3M-TL3S6V\?/;S>4[HL\,@>*5 [;)8W4G*
MFOYB/^"WW_!'WQ-_P3(_: OM6TS3OM7P8\9:G/)X4U.U$KQ:3O+RKI%RTCNZ
MSPQ@A'=V^T1Q&16WK-'#?_X)3_\ !P!\5/\ @F%X9_X0S^R[#XC_  P-U)=Q
M^']3O)+6YTIW24L+"[ <6Z23.DLD;PRH2CE%B>:21F]1O4_JBHK\W_@K_P '
M4_[)?Q3.I_VYJWCKX;?8/*\@^(_#DD_]I;]^[RO[.:[QLVKN\WR\^8NW=AMO
MS[^T=_P>,^"=/\-+%\(?A)XKU?6+JUND:Z\8W-OIEMIEQL46T@@M9+AKN/<7
M,B>;;G"*%?+ED5F*S/VBHK\PO^#<S_@L[K?_  4,\&>(?AS\5=9.K_&+PJ)M
M9AOHM'CLXM9T4R0IYCF " 3P3SB-E$<(:.2W*B5A.X_3VD(_C>_X*??\I*_V
MAO\ LIGB3_TZW-?U7?\ !,'_ )1J?L\_]DS\-_\ IJMJ_E1_X*??\I*_VAO^
MRF>)/_3K<U^H_P#P39_X.L?!/P _99\)_#KXL_#;Q7]J^'VA6'A_2]4\(&WO
M$U:"VC:!&F@NIH#;R+#';@E991*YE8+"-J570KH?NU7RC_P6^_:'\,_LX_\
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ML?!C_N.?^GW4:_#7_@Y+_P"4T_QG_P"X'_Z8M.K]RO\ @VT_Y0L?!C_N.?\
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M\5:!IMM+<:1;"Z,\L>HJ2Q%C&)@EMY2@6Y,]LD:PE2)OS^_X(U_'#Q=\"_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M QOB!_R*-W_P#_T-:\TKTOX@?\BC=_\  /\ T-:\TH*04444%!1110 4444
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M\-O&U[XI\12V\MX;:#PUJT*001@%Y99I;9(HD!*J&D=07=$!+.JG^;3]MO\
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M?Y'VW[+;23^5YFUMF[R]N[:V,YP<8KLZ\9_X*-_\H]/CQ_V3OQ!_Z;;B@#X
M_9R_X.A_^&@/VA? ?@/_ (4=_9/_  FWB+3] ^W?\)GY_P!B^U7,<'F^7]A7
M?M\S=MW+G&,C.:_66OY-?^"<G_*0OX#_ /91/#__ *<K>OZRJ; ****0!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>%_LP_\ !1+X;?M8_&;XE?#SP[>WMCXU
M^%FM7>D:MI&J1QPW%TEO.;=[VV"NXEM?.!3=D.A*>8D?F1[_ '2OP8_X. O@
MMJ__  3W_P""BO@[X[_"_6/^$2U+X@^?J\#:>4CELM7M/*BO9/*$2QF&XCN(
M&D$AE,\DUYYHV.%8 _>>BOG[_@F3^W=I'_!0_P#9)T+QY8CR-;M]ND^)[-;1
M[:*QU>*&)[F.$,S[H#YJ21D2.?+E0,1('1?H&@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH [[X5_P#(O3?]?#?^@K735S/PK_Y%Z;_KX;_T
M%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2+;VCV<$J2P"1YPB&*'R8DA3,QW/7[FT47"Y\4?\$'_^";WC?_@E[^R)XC\
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M7)?^8^_^^5'_ !!@_P#5R7_F/O\ [Y5^Y5%.['=GX:_\08/_ %<E_P"8^_\
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M%M_\(%_8WAF#PY_9_P#PBW]J>=Y5U=W'G>;]KAQG[5MV[3C9G<<X'N7_  2
M_P""9'_#J3]FG7/AW_PFW_">_P!L^)I_$?\ :']C_P!E^3YMK:6_D^5Y\V<?
M9=V[<,[\;1C)^K** "OB;_@K7_P0[^''_!5:PM];O=2OO!7Q0TRUMM.T[Q5
MLM]''8Q332M:36)FCAD1C<SL'4QRA_+/F,BF)_MFB@#^=#Q-_P &?/[0EIXF
MU&+1OB%\&K_1XKJ5+"ZO;[4K2YN;<.1')+"EE*L4C)M+(LL@4D@.X&X_T7T4
M4 4/%'A?3/''AG4=%UK3K'6-&UBUELK^PO;=+BVO;>5"DD,L;@J\;HQ5E8$$
M$@C!K\>_V^_^#1SP9\0!/KG[.WB?_A M4.W_ (ICQ)<7%]HLG^H3]U>8DN[?
M"K<2MY@NO,DD55\A!Q^R=% '\X0_X- /VEL?\CO\#/\ P<ZK_P#*ZNJ^#_\
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MR^\9ZG'X;T.6ZT?RIDL+-?,N)K:[8YD@N+F98G5 $$NEC<SLN(_Q@^-7Q?\
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M^RJ**DD**** "OSA_P""O_\ P;\?\/6_VEM#^(G_  MO_A O[&\,P>'/[/\
M^$6_M3SO*NKNX\[S?M<.,_:MNW:<;,[CG _1ZB@#\-?^(,'_ *N2_P#,??\
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M^T_^9?\ [6^W_;?L?_3S!Y>S[)_M;O,[;>3_ ((P?\$8/^'0_P#PLG_BY/\
MPL+_ (6%_9G_ #+_ /9/V#[%]L_Z>9_,W_:_]G;Y??=Q]RT4 %%%% 'X:_\
M$&#_ -7)?^8^_P#OE7[E444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M19 QLK8%!.B3*D;N\L2 LX1I'BDC5V[@?I+_ ,15G[/6/^1-^,W_ (*=-_\
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MOXOV=/B#K5[J,Z6^?A[/+:M,\<,$,LMSITLX8D1QPQA[<.F$2.:/S !;Q!6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '??"O\ Y%Z;_KX;_P!!6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;/C5_R5
M#5_^NB_^@+7TG7S9\:O^2H:O_P!=%_\ 0%KLP7QOT/GN(_\ =X^OZ,Y:BBBO
M4/C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I+6UD
MOKE(84>665@J(HR6)Z "BUM9+ZY2&%'EEE8*B*,EB>@ KWSX/?!Z/P/;+?7J
MK+JTJ_46P/\ "OOZG\!QUQK5E35V>AE^7U,54Y8Z);L/@]\'H_ ]LM]>JLNK
M2K]1; _PK[^I_ <=>\HHKQYS<WS2/OL/AX4*:ITU9(****DV"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMHLTVFB\MYKBVGU&3$-C#*D6'*274D$;$%<!R2R %@ ?@#_P<$?M+0?M(?\
M!3?Q@EC+97&E?#RWA\&6D\%O-#)(UJTDEVLHD^\\=]/>1!E549(D*[A\[_M]
M_P $=_V7/^&1O^"=7PV\-75C]AU_4M.'B#75ETK^S;P7M[_I#0W49RYGMT>*
MU+2?,5M4&$ "+^ /_!,;]E^Y_P""BW_!0_PIX:\5RZUKVFZOJ,^O^+[^5;B\
MENK6$-<7!NIUD62/[5(%MS<&0,LEVC LY56_J9JF 4445(!7R!_P6K_X)_\
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M/&WQ-U*7S+WX6:=;V^DVNUQMN=26ZB:YWK( =EO;W$7ENCJWVK=\K1*3C_\
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M9O\ X)R?\I"_@/\ ]E$\/_\ IRMZ_ID_X*-_\H]/CQ_V3OQ!_P"FVXK^9O\
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MX$\8?%W7;+0?!7@NY?79))X-0FDGO($+62Q+912.72Z,$Q#[8BD$@8MD1O\
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MO^#?0Y_X)#?"3_N,_P#IZOZI[ ?9E%%%2 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!WWPK_Y%Z;_ *^&_P#05KIJYGX5_P#(O3?]?#?^@K734$/<
M****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\V?&K_DJ&K_]=%_] 6OI.OFSXU?\E0U?_KHO_H"UV8+XWZ'SW$?^
M[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5):VLE]<I#"CRRRL%1%&2Q/0 46MK)?7*0PH\LLK!411DL3T %>^?![X/1^
M![9;Z]59=6E7ZBV!_A7W]3^ XZXUJRIJ[/0R_+ZF*J<L=$MV'P>^#T?@>V6^
MO5675I5^HM@?X5]_4_@..O>445X\YN;YI'WV'P\*%-4Z:LD%%%%2;!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV7YW]FW_ /9WG>;Y6[[;Y'V7R-W/G^;Y.WY]^SYJ^M*_C/K^GS_@A=_PD/\
MPZ@^#G_"3?VU_:/]G7?D_P!J>;Y_V+[?<_8MOF?-Y'V3R/)Q\OD^5L^3;3:
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M +/'[8VK?#O7&LK32?C';6]E;7LQ6,P:I:><]G$9'E15299[F(*$>1YY+55
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MOB1^VU\?M0U2YC\3?$CXC^,KF2[F2SLY+[4-0=(RS"."%2=D<,9VQQJ$CBB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH [[X5_P#(O3?]?#?^@K735S/PK_Y%
MZ;_KX;_T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OFSXU?\E0U?\ ZZ+_ .@+7TG7S9\:O^2H:O\
M]=%_] 6NS!?&_0^>XC_W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#&^('_(HW?_ /_0UKS2O2_B!_R*-W_P
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M_L5_!OXM^+[OQ!XJ^$OPS\3:_J&S[5J6K>%[&]O+G8BQIOEDB9VVHBJ,GA5
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M:YM+:34[!);G3TN%59C;3X\VV=@B?O(71P8T(8%5(]!HH ^,A_P;Y_LAJ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\V?&K_DJ&K_\ 71?_ $!:^DZ^;/C5_P E0U?_ *Z+_P"@+79@OC?H?/<1
M_P"[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %26MK)?
M7*0PH\LLK!411DL3T %%K:R7URD,*/++*P5$49+$] !7OGP>^#T?@>V6^O56
M75I5^HM@?X5]_4_@..N-:LJ:NST,OR^IBJG+'1+=A\'O@]'X'MEOKU5EU:5?
MJ+8'^%??U/X#CKWE%%>/.;F^:1]]A\/"A35.FK)!1114FP4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M??"O_D7IO^OAO_05KIJYGX5_\B]-_P!?#?\ H*UTU!#W"BBB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQJ_Y*
MAJ__ %T7_P! 6OI.OFSXU?\ )4-7_P"NB_\ H"UV8+XWZ'SW$?\ N\?7]&<M
M1117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %26MK)?7*0PH\LLK!411DL3
MT %%K:R7URD,*/++*P5$49+$] !7OGP>^#T?@>V6^O5675I5^HM@?X5]_4_@
M..N-:LJ:NST,OR^IBJG+'1+=A\'O@]'X'MEOKU5EU:5?J+8'^%??U/X#CKWE
M%%>/.;F^:1]]A\/"A35.FK)!1114FP4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8
MWQ _Y%&[_P" ?^AK7FE>E_$#_D4;O_@'_H:UYI04@HHHH*"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* .^^%?_ "+TW_7PW_H*UTU<S\*_^1>F_P"OAO\ T%:Z:@A[A1110(**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSX
MU?\ )4-7_P"NB_\ H"U])UY_XN_9_L_%WB.ZU&34+F%[I@Q144A< #^E=.&J
M1A*\CR,YPE7$45"DKN_Z,\#HKVK_ (9<L/\ H*7G_?M:/^&7+#_H*7G_ '[6
MN[ZW2[GS7]A8S^7\4>*T5[5_PRY8?]!2\_[]K1_PRY8?]!2\_P"_:T?6Z7</
M["QG\OXH\5HKVK_AERP_Z"EY_P!^UH_X9<L/^@I>?]^UH^MTNX?V%C/Y?Q1X
MK17M7_#+EA_T%+S_ +]K1_PRY8?]!2\_[]K1];I=P_L+&?R_BCQ6BO:O^&7+
M#_H*7G_?M:/^&7+#_H*7G_?M:/K=+N']A8S^7\4>*T5[5_PRY8?]!2\_[]K1
M_P ,N6'_ $%+S_OVM'UNEW#^PL9_+^*/%:*]J_X9<L/^@I>?]^UH_P"&7+#_
M *"EY_W[6CZW2[A_86,_E_%'BM%>U?\ #+EA_P!!2\_[]K1_PRY8?]!2\_[]
MK1];I=P_L+&?R_BCQ6BO:O\ AERP_P"@I>?]^UH_X9<L/^@I>?\ ?M:/K=+N
M']A8S^7\4>*T5[5_PRY8?]!2\_[]K1_PRY8?]!2\_P"_:T?6Z7</["QG\OXH
M\5HKVK_AERP_Z"EY_P!^UH_X9<L/^@I>?]^UH^MTNX?V%C/Y?Q1XK17M7_#+
MEA_T%+S_ +]K1_PRY8?]!2\_[]K1];I=P_L+&?R_BCQ6BO:O^&7+#_H*7G_?
MM:/^&7+#_H*7G_?M:/K=+N']A8S^7\4>*T5[5_PRY8?]!2\_[]K1_P ,N6'_
M $%+S_OVM'UNEW#^PL9_+^*/%:*]J_X9<L/^@I>?]^UH_P"&7+#_ *"EY_W[
M6CZW2[A_86,_E_%'BM%>U?\ #+EA_P!!2\_[]K1_PRY8?]!2\_[]K1];I=P_
ML+&?R_BCQ6BO:O\ AERP_P"@I>?]^UH_X9<L/^@I>?\ ?M:/K=+N']A8S^7\
M4>*T5[5_PRY8?]!2\_[]K1_PRY8?]!2\_P"_:T?6Z7</["QG\OXH\5HKVK_A
MERP_Z"EY_P!^UH_X9<L/^@I>?]^UH^MTNX?V%C/Y?Q1XK17M7_#+EA_T%+S_
M +]K1_PRY8?]!2\_[]K1];I=P_L+&?R_BCQ6BO:O^&7+#_H*7G_?M:/^&7+#
M_H*7G_?M:/K=+N']A8S^7\4>*T5[5_PRY8?]!2\_[]K1_P ,N6'_ $%+S_OV
MM'UNEW#^PL9_+^*/%:*]J_X9<L/^@I>?]^UH_P"&7+#_ *"EY_W[6CZW2[A_
M86,_E_%'BM%>U?\ #+EA_P!!2\_[]K1_PRY8?]!2\_[]K1];I=P_L+&?R_BC
MQ6BO:O\ AERP_P"@I>?]^UH_X9<L/^@I>?\ ?M:/K=+N']A8S^7\4>*T5[5_
MPRY8?]!2\_[]K1_PRY8?]!2\_P"_:T?6Z7</["QG\OXH\5HKVK_AERP_Z"EY
M_P!^UH_X9<L/^@I>?]^UH^MTNX?V%C/Y?Q1XK17M7_#+EA_T%+S_ +]K1_PR
MY8?]!2\_[]K1];I=P_L+&?R_BCQ6I+6UDOKE(84>665@J(HR6)Z "O9O^&7+
M#_H*7G_?M:Z+X>_!G3?A_>O=(\EY=L-J2R@?NAWV@=SZ_P#U\S+&4TM#2ED&
M)E-*HK+O<I_![X/1^![9;Z]59=6E7ZBV!_A7W]3^ XZ]Y117F3FYOFD?98?#
MPH4U3IJR04445)L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C?$#_D4;O_
M (!_Z&M>:5Z7\0/^11N_^ ?^AK7FE!2"BBB@H**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [[X5_\
M(O3?]?#?^@K735S/PK_Y%Z;_ *^&_P#05KIJ"'N%%%% @HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** ,;X@?\BC=_P# /_0UKS2NK_:2\37_ (.^"VLZCI=G_:%];^1Y
M5OL9_,W3QJ>%YX!)X]*^5/\ AIGQ]_T)O_DE<?XT%(^@**^?_P#AIGQ]_P!"
M;_Y)7'^-'_#3/C[_ *$W_P DKC_&@=SZ HKY_P#^&F?'W_0F_P#DE<?XT?\
M#3/C[_H3?_)*X_QH"Y] 45\__P##3/C[_H3?_)*X_P :/^&F?'W_ $)O_DE<
M?XT!<^@**^?_ /AIGQ]_T)O_ ))7'^-'_#3/C[_H3?\ R2N/\: N?0%%?/\
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MPTSX^_Z$W_R2N/\ &@+GT!17S_\ \-,^/O\ H3?_ "2N/\:/^&F?'W_0F_\
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M (:9\??]";_Y)7'^-'_#3/C[_H3?_)*X_P : N?0%%?/_P#PTSX^_P"A-_\
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MXT!<^@**^?\ _AIGQ]_T)O\ Y)7'^-'_  TSX^_Z$W_R2N/\: N?0%%?/_\
MPTSX^_Z$W_R2N/\ &C_AIGQ]_P!";_Y)7'^- 7/H"BOG_P#X:9\??]";_P"2
M5Q_C1_PTSX^_Z$W_ ,DKC_&@+GT!17S_ /\ #3/C[_H3?_)*X_QH_P"&F?'W
M_0F_^25Q_C0%SZ HKY__ .&F?'W_ $)O_DE<?XT?\-,^/O\ H3?_ "2N/\:
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MQ_C1_P -,^/O^A-_\DKC_&@+GT!17S__ ,-,^/O^A-_\DKC_ !H_X:9\??\
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M\: /K*BODW_AM/XK_P#1.O\ RF7G^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\
MAM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_ !H ^LJ*^3?^&T_BO_T3K_RF
M7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_BO\ ]$Z_\IEY_C1_PVG\5_\
MHG7_ )3+S_&@#ZRHKY-_X;3^*_\ T3K_ ,IEY_C1_P -I_%?_HG7_E,O/\:
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M_BO_ -$Z_P#*9>?XT?\ #:?Q7_Z)U_Y3+S_&@#ZRHKY-_P"&T_BO_P!$Z_\
M*9>?XT?\-I_%?_HG7_E,O/\ &@#ZRHKY-_X;3^*__1.O_*9>?XT?\-I_%?\
MZ)U_Y3+S_&@#ZRHKY-_X;3^*_P#T3K_RF7G^-'_#:?Q7_P"B=?\ E,O/\: /
MK*BODW_AM/XK_P#1.O\ RF7G^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\ AM/X
MK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_ !H ^LJ*^3?^&T_BO_T3K_RF7G^-
M'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_BO\ ]$Z_\IEY_C1_PVG\5_\ HG7_
M )3+S_&@#ZRHKY-_X;3^*_\ T3K_ ,IEY_C1_P -I_%?_HG7_E,O/\: /K*B
MODW_ (;3^*__ $3K_P IEY_C1_PVG\5_^B=?^4R\_P : /K*BODW_AM/XK_]
M$Z_\IEY_C1_PVG\5_P#HG7_E,O/\: /K*BODW_AM/XK_ /1.O_*9>?XT?\-I
M_%?_ *)U_P"4R\_QH ^LJ*^3?^&T_BO_ -$Z_P#*9>?XT?\ #:?Q7_Z)U_Y3
M+S_&@#ZRHKY-_P"&T_BO_P!$Z_\ *9>?XT?\-I_%?_HG7_E,O/\ &@#ZRHKY
M-_X;3^*__1.O_*9>?XT?\-I_%?\ Z)U_Y3+S_&@#ZRHKY-_X;3^*_P#T3K_R
MF7G^-'_#:?Q7_P"B=?\ E,O/\: /K*BODW_AM/XK_P#1.O\ RF7G^-'_  VG
M\5_^B=?^4R\_QH ^LJ*^3?\ AM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_
M !H ^LJ*^3?^&T_BO_T3K_RF7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_
MBO\ ]$Z_\IEY_C1_PVG\5_\ HG7_ )3+S_&@#ZRHKY-_X;3^*_\ T3K_ ,IE
MY_C1_P -I_%?_HG7_E,O/\: /K*BODW_ (;3^*__ $3K_P IEY_C1_PVG\5_
M^B=?^4R\_P : /K*BODW_AM/XK_]$Z_\IEY_C1_PVG\5_P#HG7_E,O/\: /K
M*BODW_AM/XK_ /1.O_*9>?XT?\-I_%?_ *)U_P"4R\_QH ^LJ*^3?^&T_BO_
M -$Z_P#*9>?XT?\ #:?Q7_Z)U_Y3+S_&@#ZRHKY-_P"&T_BO_P!$Z_\ *9>?
MXT?\-I_%?_HG7_E,O/\ &@#ZRHKY-_X;3^*__1.O_*9>?XT?\-I_%?\ Z)U_
MY3+S_&@#ZRHKY-_X;3^*_P#T3K_RF7G^-'_#:?Q7_P"B=?\ E,O/\: /K*BO
MDW_AM/XK_P#1.O\ RF7G^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\ AM/XK_\
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MB=?^4R\_QH ^LJ*^3?\ AM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_ !H
M^LJ*^3?^&T_BO_T3K_RF7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_BO\
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MO_*9>?XT?\-I_%?_ *)U_P"4R\_QH ^LJ*^3?^&T_BO_ -$Z_P#*9>?XT?\
M#:?Q7_Z)U_Y3+S_&@#ZRHKY-_P"&T_BO_P!$Z_\ *9>?XT?\-I_%?_HG7_E,
MO/\ &@#ZRHKY-_X;3^*__1.O_*9>?XT?\-I_%?\ Z)U_Y3+S_&@#ZRHKY-_X
M;3^*_P#T3K_RF7G^-'_#:?Q7_P"B=?\ E,O/\: /K*BODW_AM/XK_P#1.O\
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M\-I_%?\ Z)U_Y3+S_&@#ZRHKY-_X;3^*_P#T3K_RF7G^-'_#:?Q7_P"B=?\
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M7_Z)U_Y3+S_&@#ZRHKY-_P"&T_BO_P!$Z_\ *9>?XT?\-I_%?_HG7_E,O/\
M&@#ZRHKY-_X;3^*__1.O_*9>?XT?\-I_%?\ Z)U_Y3+S_&@#ZRHKY-_X;3^*
M_P#T3K_RF7G^-'_#:?Q7_P"B=?\ E,O/\: /K*BODW_AM/XK_P#1.O\ RF7G
M^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\ AM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z
M)U_Y3+S_ !H ^LJ*^3?^&T_BO_T3K_RF7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ
M*^3?^&T_BO\ ]$Z_\IEY_C1_PVG\5_\ HG7_ )3+S_&@#ZRHKY-_X;3^*_\
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M\: /K*BODW_AM/XK_P#1.O\ RF7G^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\
MAM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_ !H ^LJ*^3?^&T_BO_T3K_RF
M7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_BO\ ]$Z_\IEY_C1_PVG\5_\
MHG7_ )3+S_&@#ZRHKY-_X;3^*_\ T3K_ ,IEY_C1_P -I_%?_HG7_E,O/\:
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M_BO_ -$Z_P#*9>?XT?\ #:?Q7_Z)U_Y3+S_&@#ZRHKY-_P"&T_BO_P!$Z_\
M*9>?XT?\-I_%?_HG7_E,O/\ &@#ZRHKY-_X;3^*__1.O_*9>?XT?\-I_%?\
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MDW_AM/XK_P#1.O\ RF7G^-'_  VG\5_^B=?^4R\_QH ^LJ*^3?\ AM/XK_\
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MB=?^4R\_QH ^LJ*^3?\ AM/XK_\ 1.O_ "F7G^-'_#:?Q7_Z)U_Y3+S_ !H
M^LJ*^3?^&T_BO_T3K_RF7G^-'_#:?Q7_ .B=?^4R\_QH ^LJ*^3?^&T_BO\
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M?XT?\-I_%?\ Z)S_ .4V\_QH ^LJ*^3?^&T_BO\ ]$Y_\IMY_C1_PVG\5_\
MHG/_ )3;S_&@#ZRHKY-_X;3^*_\ T3G_ ,IMY_C1_P -I_%?_HG/_E-O/\:
M/K*BODW_ (;3^*__ $3G_P IMY_C1_PVG\5_^B<_^4V\_P : /K*BODW_AM/
MXK_]$Y_\IMY_C1_PVG\5_P#HG/\ Y3;S_&@#ZRHKY-_X;3^*_P#T3G_RFWG^
M-'_#:?Q7_P"B<_\ E-O/\: /K*BODW_AM/XK_P#1.?\ RFWG^-'_  VG\5_^
MB<_^4V\_QH ^LJ*^3?\ AM/XK_\ 1.?_ "FWG^-'_#:?Q7_Z)S_Y3;S_ !H
M^LJ*^3?^&T_BO_T3G_RFWG^-'_#:?Q7_ .B<_P#E-O/\: /K*BODW_AM/XK_
M /1.?_*;>?XT?\-I_%?_ *)S_P"4V\_QH ^LJ*^3?^&T_BO_ -$Y_P#*;>?X
MT?\ #:?Q7_Z)S_Y3;S_&@#ZRHKY-_P"&T_BO_P!$Y_\ *;>?XT?\-I_%?_HG
M/_E-O/\ &@#ZRHKY-_X;3^*__1.?_*;>?XT?\-I_%?\ Z)S_ .4V\_QH ^LJ
M*^3?^&T_BO\ ]$Y_\IMY_C1_PVG\5_\ HG/_ )3;S_&@#ZRHKY-_X;3^*_\
MT3G_ ,IMY_C1_P -I_%?_HG/_E-O/\: /K*BODW_ (;3^*__ $3G_P IMY_C
M1_PVG\5_^B<_^4V\_P : /K*BODW_AM/XK_]$Y_\IMY_C1_PVG\5_P#HG/\
MY3;S_&@#ZRHKY-_X;3^*_P#T3G_RFWG^-'_#:?Q7_P"B<_\ E-O/\: /K*BO
MDW_AM/XK_P#1.?\ RFWG^-'_  VG\5_^B<_^4V\_QH ^LJ*^3?\ AM/XK_\
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M\: /K*BODW_AM/XK_P#1.?\ RFWG^-'_  VG\5_^B<_^4V\_QH ^LJ*^3?\
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MVG\5_P#HG/\ Y3;S_&@#ZRHKY-_X;3^*_P#T3G_RFWG^-'_#:?Q7_P"B<_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** .^^%?_(O3?\ 7PW_ *"M
M=-7,_"O_ )%Z;_KX;_T%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&
M^('_ "*-W_P#_P!#6O-*]+^('_(HW?\ P#_T-:\TH*04444%!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '??"O_D7IO\ KX;_ -!6NFKF?A7_ ,B]-_U\-_Z"M=-00]PHHHH$%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!C?$#_ )%&[_X!_P"AK7FE>E_$#_D4;O\ X!_Z
M&M>:4%(****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#OOA7_R+TW_7PW_H*UTU<S\*_P#D7IO^
MOAO_ $%:Z:@A[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O(_B%\>]8\)^,K[3K>VTUX;9PJM)&Y8Y4'G#@=_
M2O7*^;/C5_R5#5_^NB_^@+75A(1E-J1XN>XBI1HQE2=G?]&;O_#3NO\ _/II
M'_?J3_XNC_AIW7_^?32/^_4G_P 77G-%>A]7I]CY7^U<7_S\9Z-_PT[K_P#S
MZ:1_WZD_^+H_X:=U_P#Y]-(_[]2?_%UYS11]7I]@_M7%_P#/QGHW_#3NO_\
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M_&>C?\-.Z_\ \^FD?]^I/_BZ/^&G=?\ ^?32/^_4G_Q=><T4?5Z?8/[5Q?\
MS\9Z-_PT[K__ #Z:1_WZD_\ BZ/^&G=?_P"?32/^_4G_ ,77G-%'U>GV#^U<
M7_S\9Z-_PT[K_P#SZ:1_WZD_^+KJ_A=\?1XJU/[#JZ6UI<2MBWDB!6-S_=.2
M<'TYYZ=>OAU .*F6&IM62-:.<8J$U)RNNS/KRBO*O@I\:_[2\K1]8E_TCA+:
MY<_ZWT1C_>]#W^O7U6O*J4Y0?+(^VPF+IXBG[2G_ ,,%%%%0=(4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-\0/^11N_\ @'_H
M:UYI7I?Q _Y%&[_X!_Z&M>:4%(****"@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#OOA7_P B]-_U
M\-_Z"M=-7,_"O_D7IO\ KX;_ -!6NFH(>X4444""BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7_ "5#5_\ KHO_
M * M?2=?-GQJ_P"2H:O_ -=%_P#0%KLP7QOT/GN(_P#=X^OZ,Y:BBBO4/C H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH  <5[/\%/C7_:7E:/K$O^D<);7+G_ %OHC'^]Z'O]>OC% .*RJTE4
M5F=F"QM3#5.>'S7<^O**\J^"GQK_ +2\K1]8E_TCA+:Y<_ZWT1C_ 'O0]_KU
M]5KQZE.4'RR/O\)BZ>(I^TI_\,%%%%0=(4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 8WQ _Y%&[_ . ?^AK7FE>E_$#_ )%&[_X!_P"A
MK7FE!2"BBB@H**** "BBB@ HHKYP\2_\%<?V=_!GQ0OO!VK_ !(M-+U_3-5?
M1;R.[TN_AM[2Z28PNLEPT @1%<'=*SB-0"Q8*,U482E\*N;T,+6K7]C!RMJ[
M)NWK8^CZ***DP"BBOF?QY_P6$_9S^&7CG6?#>M_$3[%K7A^^GTW4+?\ L'4Y
M/L]Q#(T<B;DMBK8=6&5)!QP2*J,)2^%7.C#X2OB&XT(.379-_D?3%%>4?LQ?
MMO?"_P#;)_MO_A6_B?\ X2/_ (1SR/[1_P")==V?V?S_ #/*_P!?%'NW>3)]
MW.-O.,C/J]*47%VD16HU*,W3JQ<9+HU9_<PHHHI&04444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 45R/QL^//@W]G'P)<>)?'/B32O#&BV^
MX?:+V8(;B18WE\F%.7FF*1R%8HU:1]I"J3Q7QSXT_P"#BOX"^%_%MWIUAIGQ
M&\2V5OL\K5=.TBWCM+O<BL=BW-Q#.-I8H=\2_,AQE<,=(4IS^%7.["99B\5K
MAZ;DO):?>?>E%?GT_P#P<B_ ]%X\)_%AO8:9I_\ \FU[-^R__P %A/@1^U3J
M6F:3IGBI_#/B?5LK!H?B2#^S[EI#<+!%"LV6M99I6>,QPQ3O(RO]W*N%J6'J
M15Y1-\1D>84(>TJT9)=['T_1116)Y04444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !117RU^VQ_P5N^'/[!WQ:L?!OB_0_'&HZEJ&D1:S%-H]G:S6
MXADFGA"DRW$;;PUNY(VXPR\DY J$)3=HHZ<+A*V)J>RH1<I=D?4M%>>?LJ?M
M*Z'^U]\!=#^(GANSU?3]%\0&Y%M!JD4<5TGD7,MLQ=8WD09>%B,.?E*YP<@>
MATFFG9F-2G*G-TYJS6C]4%%%%(@**** "BBB@ HHHH **** "BBB@ HHHH *
M*^.OVG?^"X?P7_9=^,>I>"+Z+Q9XIU710(]0G\/6MM<6EG<Y8/:M)+<19F3
MWA0RJ6V%MZNB_07[+W[4/@_]L#X.:=XW\$Z@;W2K[]W-!* EWIEPH!DM;B,$
M[)DW#(R58,KHS(Z.VDJ4XQYFM#NK9;BZ-&->K3:A+9M:'H=%%%9G"%%%% !1
M110 45SWQ;^)-C\&OA3XF\7ZG#=W&F^%-)NM8NXK55:>6&WA>9UC#,JERJ$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 =]\*_\ D7IO^OAO_05KIJYGX5_\B]-_
MU\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#K
MHO\ Z M=F"^-^A\]Q'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  #BO9_@I\:_
M[2\K1]8E_P!(X2VN7/\ K?1&/][T/?Z]?&* <5E5I*HK,[,%C:F&J<\/FNY]
M>45Y5\%/C7_:7E:/K$O^D<);7+G_ %OHC'^]Z'O]>OJM>/4IR@^61]_A,73Q
M%/VE/_A@HHHJ#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX8>&M;L_[/UGP]X2TK3+^U\U)?LUQ#9Q1R1[T+(VUU894D''!(YKY2\#?\%
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M&_\ 05KIJ"'N%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *^;/C5_R5#5_^NB_^@+7TG7S9\:O^2H:O_P!=%_\
M0%KLP7QOT/GN(_\ =X^OZ,Y:BBBO4/C HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ !Q7L_P %
M/C7_ &EY6CZQ+_I'"6URY_UOHC'^]Z'O]>OC% .*RJTE45F=F"QM3#5.>'S7
M<^O**\J^"GQK_M+RM'UB7_2.$MKES_K?1&/][T/?Z]?5:\>I3E!\LC[_  F+
MIXBG[2G_ ,,%%%%0=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ;J5G<V-_I\\EG>6=U"T,]K-&Q22*2-@&1U8,K*P!!!!&17]*O\ PWA\#O\
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MV%%%%9'FGPM_P<-?$>_\$_\ !/U-*M(;*6U\9^*+#1]0:=&9XH8UGOU:(A@
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M)9WEG=0M#/:S1L4DBDC8!D=6#*RL 0001D5_2K_PWA\#O^BR_"G_ ,*W3_\
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MT5=0LM'T+QY;);W%S=CPSJ!FFLUB56P8;A(99G<%MB6Z2LQ0C )0-\9@I=0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '??"O\ Y%Z;_KX;_P!!
M6NFKF?A7_P B]-_U\-_Z"M=-00]PHHHH$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7S9\:O^2H:O\ ]=%_] 6OI.OF
MSXU?\E0U?_KHO_H"UV8+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110  XKV?X*?&O^TO*T?6)?](X2VN7/^M]$8_WO0]_KU\8H!Q656DJ
MBLSLP6-J8:ISP^:[GUY17E7P4^-?]I>5H^L2_P"D<);7+G_6^B,?[WH>_P!>
MOJM>/4IR@^61]_A,73Q%/VE/_A@HHHJ#I"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5U/R!XCV>(/#]K(+>.*2ZB3R[U%<D32320+;.L8#J([*=_DPQ?[)_P""W?\
MRB_^)W_<*_\ 3M95Y+I>SQ*CYH_,)Y=]1S^GAUM[2+7HY)K_ "/Y^*_JTK^4
MNOZM*ZLT^S\_T/H_$;_F'_[?_P#;0K^?C_@MW_RE ^)W_<*_]--E7] ]?S\?
M\%N_^4H'Q._[A7_IILJQRW^*_3_(\OP^_P"1C/\ P/\ ]*B?5O\ P;&?\UN_
M[@7_ +DJ_5JORE_X-C/^:W?]P+_W)5^K598[^/+Y?D>9QE_R.*W_ &[_ .DQ
M.<^+GQ<\-_ ;X;:OXO\ %^L6F@^&]"@^T7M]<D[(ER%50 "SNS,J(B N[LJJ
M&9@#_-5^U'\4]-^.7[2OC[QGH^F'1]*\5>(+W5;6T;?YB1S3,X:0/++B5\[Y
M KF,2.XC"1A$7[,_X+G_ /!1W4/C?\7=0^$7A'5[RW\!^$)S9Z_$+5K9M8UB
M"9Q*CL6W2VT#(@12J*TRR2?O56WD7XI_9[^ _B']I_XU>'O 'A..RE\0^)KA
MH+07=P(((PD;S2R2/R0D<4<DC;0SD(0JNQ"GOP-'V</:SZ_D?;<'Y.L!AI9A
MBGRN2^Z.]WYO?T.7T6_BTO6;2YGL;74X+>9)9+.Z:58+M58$Q2&)XY C ;28
MW1\$[64X(_I$_8!_:8\*_M8?LI^%O%/A#2+/PSIL4']ER^'K>2%E\/2VV(C:
M!8L*D:J$:(%8R89(6,:;MH_"S_@H;^P%KW_!//XQV'AC5-77Q-IFLZ<NH:7K
MD6FRV,-Z VR:(HS.BS1.!N1)9,)+ Y*F4*+O_!-']OJ^_P""?7Q_;Q&UC>:U
MX6URV&F^(-+@N&C>:#>'2XA0LL37,)#>7YO!66:,-'YID6\325>FIP.KB++8
M9U@(XK!N[CK'S75>3_56/Z+**J:!K]CXKT*RU32[VTU+3-2@CNK2[M9EF@NH
M74,DD;J2KHRD$,"00015NO"/QAW6C/YHOV\/^3XOC+_V/6M_^G">OU9_X-O/
M^3'?%7_8]7?_ *;]/K\IOV\/^3XOC+_V/6M_^G">OU9_X-O/^3'?%7_8]7?_
M *;]/KV\9_NZ^1^P\5_\B*/_ &X>4?\ !SF1N^"/K_Q/O_<;7YL?L[:YX8\,
M?M ^!=2\;1V<O@S3_$.GW.OI=V9O+=]/2YC:Y$D 5S*AB#Y0*VX9&TYQ7ZW?
M\''7[/\ +X\_9B\*_$*TCO)IOAYJS6UX%N(H[>"QU#RXGF=&P[N+F&RC41G@
M3R$J0-R?B[-$)XF1ONN"I^AJ\"U*AR^IU<'RC7R6-&+U7,G\VW^3/ZMJ*\D_
M8;_:BTW]L#]F#PGXUL]2T>_U2\L((?$$.FJ\<6FZJL*&[MO+D)DCV2,2H<DF
M-HW#.KJ[>H:_K]CX4T*]U35+VTTW3--@>ZN[NZF6&"UA12SR2.Q"HBJ"2Q(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!WWPK_P"1>F_Z^&_]!6NFKF?A7_R+TW_7PW_H*UTU
M!#W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?-GQJ_P"2H:O_ -=%_P#0%KZ3KYL^-7_)4-7_ .NB_P#H"UV8
M+XWZ'SW$?^[Q]?T9RU%%%>H?&!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444  .*]
MG^"GQK_M+RM'UB7_ $CA+:Y<_P"M]$8_WO0]_KU\8H!Q656DJBLSLP6-J8:I
MSP^:[GUY17E7P4^-?]I>5H^L2_Z1PEM<N?\ 6^B,?[WH>_UZ^JUX]2G*#Y9'
MW^$Q=/$4_:4_^&"BBBH.D**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'XX_LR_#W]I;15L?'O@WP]XJBBMKBUMI=0LDDN;!+A568VT^/-MW8(GSQ,C
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MA3Q=_9GF?8_[:TBWO_LGF;?,\OS4;9NV)G&,[%ST%<I_PP?\#O\ HC/PI_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGCO0-"D\0G5=#G<Z3J=NEXD#K]GF9IK:1!<V@ \V<2$3,3#A$;]+Z0@HHHH
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M*Z[-X5U'4+0"--=>"VM9Q>F%5"P2.MTJNB?(7C9T$:NL4?VQ0 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL^-7_)4-7_ZZ+_Z
M M?2=?-GQJ_Y*AJ__71?_0%KLP7QOT/GN(_]WCZ_HSEJ***]0^,"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ****  '%>S_!3XU_VEY6CZQ+_I'"6URY_UOHC'
M^]Z'O]>OC% .*RJTE45F=F"QM3#5.>'S7<^O**\J^"GQK_M+RM'UB7_2.$MK
MES_K?1&/][T/?Z]?5:\>I3E!\LC[_"8NGB*?M*?_  P4445!TA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7;VZW1Q _:;F\@9'VR)*R>3!!A9BK^855Z\J;_@Y)_;48?\ ):"/<>$=!_\
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MJV@O-2U1$>%EGM;.=/)M8V*3IBX2=WBE1MMM*"J@'[[UX9_P4^_Y1J?M#?\
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M&GWES;2Z9;V[-=SJT$L061)IK!0'DRPF;"-M9D /O6BOQM_X(R_\%^/VB_\
M@I=^W9HOPZUKP1\*8/!\.F7VL^)+W1[*\MKW3K2&$I%+&9[YU;-[+9Q%5C=M
MLS'  9U_9*@ HHHH ***_-__ (*[_P#!Q5X _P""?&?!_P /$T+XJ?%.7[7;
MW=K;ZH&TSPE+%YL(^WO%N+SK<IAK)6CDV1R%Y(,Q>: ?I!17\KOB;_@Y?_;,
MU[Q-J-_:_%6RT6UO;J6XATZR\)Z0UMIZ.Y98(C-;23&- 0JF61WPHW.S98WO
MAO\ \'.W[8O@;QM9:KJ?Q!T/QE8VOF>;HVL^%M.BL;S=&R#S&LX;>X&TL''E
MS)\R+NW+N4NP[&)_P<E_\II_C/\ ]P/_ -,6G5^Y7_!MI_RA8^#'_<<_]/NH
MU_.%_P %)/VT#_P4*_;3\9_& ^&O^$0_X2[[%_Q*!J/]H?9/LUC;VG^O\J+?
MN^S[_P#5KC?CG&3_ $>_\&VG_*%CX,?]QS_T^ZC3>PWL?<M?DQ^WO_P:F^$_
MVN/VIO%'Q*\(_%:^^',7C2ZDU;5M(N/#YUM#J<TCR7-Q#*UW"T<<KMO,3!]C
MM)M98RD4?I/_  <#_P#!8#XE_P#!*3_A4G_"N]#\#:S_ ,)[_;']H?\ "1V=
MU<>3]C^P>5Y7D7$.,_:I-V[=G"XQ@Y_.'_B+_P#VE?\ H1_@;_X)M5_^6-)7
M$KG[=?\ !,S_ ()V>$O^"8?[+-A\-?"M[?:Q+)=/JVNZO=DJ^LZE)'%'+<"+
M<RP1[(8D2)"=J1+N:20O*_T%7SA_P20_; \2_M[?\$]_A_\ %CQA8Z'IOB+Q
M7_:/VNVT>&6&RC^SZE=6J>6LLDCC,<"$Y<_,6Q@8 [?]M3]M7X?_ + /[/VK
M?$CXD:M_9NAZ;B&WMX0LE]K%VRL8K*TB)'FSR;6P,A557D=DCC=U0CUBBOYP
M?VT?^#L+X[?%;QKJ]G\'(=#^%_@Z'5!+H][+I,.H>(+BT2-DV79N#-:#S&/F
ME8H0T9"1B:0*SR^''_@Y*_;4(_Y+1_Y:.A?_ "%3LQV9_5?17\]?[*/_  =\
M_%3P;XET2Q^,G@;PGXR\+V]K!9:AJ.@12:7KKN&B62_8-(]K-(8Q,QMTCMD>
M1UVR0HNT_P!"E(045R?QT^.GA']F?X1Z]X\\>:]8^&?"7AFU-WJ.HW;'RX$R
M%4!5!9Y'=E1(T#/([HB*S,JG\-/^"DG_  =E>+_$OB76/"G[-NG6/AK0+.Z:
M"'QQJMH+S4M41'A99[6SG3R;6-BDZ8N$G=XI4;;;2 JH!^^]%?RH#_@Y*_;4
M _Y+1_Y:.A?_ "%7HW[.'_!U7^U)\(O$S2^-;[PI\6-'NKJU>XM=7T:#3;FW
MMXW8S1VLU@D*QR2HV/,GBN A1"$QO5W9CLS^FFBOF[_@F'_P4[\ ?\%1_P!G
MZ+QAX0?^R]>TSR[;Q-X9N)Q)>^';M@2%8@+YL$FUS#.%"RJK A)$EBC^D:0@
MHK\4?^"M_P#P<?\ QP_8)_X*$?$#X3^#_"OPIU+P[X4_L[[)<ZQIE_->R?:-
M-M;I_,:*]C0XDG<#"#Y0N<G)/JLG_!S'HOP6_P""8?PK^*?Q T/0O$GQI^)G
MV^:U\$>';F33K=;2VU:[LC>RR2FY>V@\NV(4MYC33!E1=B2O"[#L?JS17\MG
MQ(_X.=OVQ?'/C:]U73/B#H?@VQNO+\K1M&\+:=+8V>V-4/EM>0W%P=Q4N=\S
M_,[;=J[5'V/_ ,&_O_!3#]L7_@HE^W;;Z?XO^(G_  D'PK\':9<ZGXLCE\,:
M=:0R^9#)!9VZ7%M9*5G:Y=)E0RQ[X[2X(+;"C%@L?N9117Y+_P#!5K_@Z*\)
M_LL>)?\ A"_@):^$_BSXE^RQW%YXE?4#=>&]+=GB=8(_L[ WSM"9-YBGC2%G
MB&^5UEAC0C]:**_E/3_@Y)_;44?\EH+>Y\(Z#_\ (5=S^SQ_P=*?M5_"CXF6
MNJ>,_$6A_%+PY\D5YH>IZ)9::'C\V-I'@N+*&*2*?RT=$>02Q+YI9H9"%P[,
M=F?*O_!3[_E)7^T-_P!E,\2?^G6YK^J[_@F#_P HU/V>?^R9^&__ $U6U?R+
M_M._&@_M(?M*?$+XB'3/[%/CWQ-J7B,Z?]I^T_8/MEU)<>3YNU/,V>9MW[%W
M8SM&<5_71_P3!_Y1J?L\_P#9,_#?_IJMJ&#/<Z**_-#_ (*P_P#!R9\./V$]
M0U;P-\-K>P^*/Q8TVZN=,U*V\Z6'2/"UPD.5:YF"8NI%F=$:VMW!!BN$DFMY
M$"LA'Z7T5_+9\2/^#G;]L7QSXVO=5TSX@:'X-L;KR_*T;1_"VG2V-GMC5#Y;
M7D-Q<'<RESOF?YG;;M7:HH^&?^#F#]LS0?$VG7]U\5++6K6RNHKB;3;WPII"
M6VH(CAF@E:&UCF$;@%6,<B/ACM=3A@[,=F?U0T5^/7_!-[_@[#\)_&WQ+HW@
MWX_>'+'X>:[JMTMI#XKTF4_\(WOD>8J;J.=S-8QJ!;1^9YEPA9WDD:WB4D?L
M+2$%%?%'_!=__@I!XX_X)??LB>'/'W@'2O"FKZQJ_C"V\/S0^(+:XN+98)+*
M^G9E6&:%A)NMHP"6(P6XR01\B?\ !)/_ (.4O&'[57Q?^(*?'J+X4^ OAUX"
M\#77BN[U?2K&^MY8I8KZPMDC/FW4_F;_ +656*.,R22-$J99@K '[)45_.?^
MW/\ \'9?QC^+OB5K'X&Z;8_"7PQ9W1>'4;VUMM7US4T5YU4RB='M8(Y(W@9H
M4CD=)(CBY=&(/AOAK_@XC_;F\;^)-/T;1?BO?ZMK&KW,=E86-CX)T2XNKV>1
M@D<,4:6)9Y'9@JJH))( !)IV8[,_JBHKD_@+I'B[P_\  SP98?$#5+'7/'EE
MH5C;^)-2LD"VVH:DENBW4\0$<8$;S"1E C088?(OW1UE(04444 %?R\_\'#W
M_!6*?_@H+^U+/X0\):K??\*@^&ES+I^GP1W\,]AXAU**2:.;64,.5>-T;R[<
MM))B%3(OE&YECK]O/^"]_P"VC=_L/_\ !,GQUK^B:O\ V+XQ\5>5X3\-W"BY
M65+J\)$TD,L!5H)XK)+R>*5G55E@C^\2$?\ G"_X)$?L[_\ #5'_  4R^"O@
MI[70;^QN_$]OJ6I66LQ>;8W^GV&Z_O+>2/8XD\VVMIHPC+L=G56*J2PI=REW
M/Z6?^"+/[ ?_  [D_P""?WA+P1J,'D^,M7+>(_%WS[MNJW21^9#\LTL7^CQ1
MP6NZ%A'+]E\T*#(U?5U%<G\>OC%IO[/'P-\9^/\ 6H+^ZT?P-H5]XAOX+%$>
MZF@M+=[B18E=D4R%8R%#,H)(RP'-22?D3_P=2_\ !5Z?X<^&D_9G\ ZK?V6N
M:_;1:AXXU'3[^$+%ILJ2JNC2*NZ9'N!Y<TH)B_T<PK^^BNI%7\-O@C\$O%G[
M2'Q9T'P+X%T&_P#$WBWQ-="STW3;-09+B3!8DEB%1$16=Y'*I&B.[LJJS"C\
M2_B-K7QB^)'B'Q=XDO?[2\1^*]3N=9U6\\F.'[7=W,K332[(U5$W2.S;44*,
MX  XK^DK_@V3_P"";FF?LH?L3:7\5-=T:P_X63\7[4:JM^\:/<Z=H4NQ[*S2
M199%\N942\?:(V)N(HY5+6R8K9%;(X;]A?\ X-,O@]\)?#*W_P =-3OOBQXF
MO+4+-IMC=7&D:'ICLD#,(FA=+JXDCD2=5F>2-'CE&;9'4,/LGPY_P19_92\+
M?"*3P1;? 7X<RZ-+:W%F;F\TP7FKA)RY<C4IBU\)!YC;)!/OB 01L@1<?3]%
M3<FY^6G[5'_!IC^SQ\7K":?X:ZIXL^$&L+:PV]M'!=/KND;UF+R3S07;FY>1
MXF,8"7<:+MC;82'$GLG_  0D_P""1MY_P2C^ /B:T\5:GH6N?$;QUJ:76LWN
MC27+64%I;JZ6=K&9MGF;/,N)3)Y,3%KHQD.L2.?N>B@ HHHH *_$'_@[Y_;H
MU/0;3P+^SOHS7]E::U:IXS\2SJ7CCU" 336]C:ADE DC$T%S-+'+$1OBLG1L
MHP'[7^*?%.F>!O#&HZWK>HV&CZ-H]K+?7]_?7"6]K8V\2%Y)I9'(5(T169F8
M@  DG K^-S_@H-^U1/\ ML_ML?$WXIS37TMMXOUV>YTP7UM#;75OIL>(;""5
M(<QB2*SBMXV(9B3&27=B7+0T8?[(7[1VI_LA?M1^ /B=I(OI;OP/KMKJSVMG
MJ#Z?)J4$<@,]F9U#%([B'S('^5@4E<,K E3_ &?^%O%.F>./#.G:UHNHV.L:
M-K%K%?6%_8W"7%M>V\J!XYHI$)5XW1E964D$$$'!K^/K_@I%^P=XC_X)X?'C
M1O!/B33+[2[O5?!^A^(/+O+^UO)//N+&,7ZA[<E!'%J4=_ @/.R!3ND#+(_[
MZ?\ !KC^UO\ \-$_\$R[#PGJ-_\ :O$7PBU2?P[,MSK'VV]EL'/VFQF:-AO@
M@5)9+2%#N3;IS!& 4QQMC9^D%%%%22?QO?\ !3[_ )25_M#?]E,\2?\ IUN:
M_57_ ((C_P#!O5\ /VO/V+_AE\;OB))X[\0ZGXA_M7^T/#G]L1VFB7'DWU[9
M1?ZB%+M=JQ1R?+<C,B\Y0E#^57_!3[_E)7^T-_V4SQ)_Z=;FOZ//^#;3_E"Q
M\&/^XY_Z?=1JNA70\V^,/_!J#^RG\3/%$%_HH^)/P\M8K5;=]-\/^($GM9W#
MNQG9M0ANIO,(95(60)B-<(#N9OS2_P""K?\ P;1?$#]A/P5XA^)'P\UO_A9?
MPPT3==WL)MFB\0:!:&28F6:) 8KB"")8?-N8RC9>1S;Q0QNZ_P!+=%*XKG\8
M'[%_[:'Q _8&^/\ I'Q(^&^K_P!F:[IF89X)E,EEJ]HQ4RV=W$"/-@DVKE<A
ME94=&21$=?ZR_P#@G#^WEX:_X*1_LD^'/BGX;MO[*.I^9::MHTE[%=7&A7\+
M;9K:5HS_ +LL9=4=X9H9#''YFT?SO_\ !Q__ ,$_M$_83_X* R3>"]"_L+X?
M_$G2X_$.EVEIILEMIFF76]H;VRMW+,C[9$2X,<>Q84OX8UC1%C+?0/\ P:$?
MM7ZGX/\ VJO'/P<OM;L(/"_C/0GU_3K"]O'6235[22%"ME&T@C,DMI).\P6-
MI'2PB;<$@;+>PWL?T)U^-G_!W'^P)_PL'X,^&/VB=#@SJ?@'RO#?B?\ >?ZS
M2KB<_8YOGF"CR+R9H]L4322?VCN9@D''[)UY/^W9^SM_PUM^QC\4?AK%:Z%=
M7_C/PQ?Z;IG]LQ[[&VU!X&^QW$GR.5\FY$,H=49T:-74;E%22?EK_P &KO\
MP5AN/B1X<?\ 9H\?ZK?WVNZ#;2ZAX'U+4+^$K-IL21*^C1JVV9Y(!YDT0!E_
MT<3+^YCM8U;]HJ_BC_9H_:'\2_LG_'SPC\2O!UU]E\1^#=3AU2S+22I#<;#\
M]O-Y3H[03(7BE0.N^*21"<,:_L_^%WQ+T7XS_#/P[XP\-7O]I>'/%FF6VLZ5
M=^3)#]JM+B)9H9-DBJZ;HW4[74,,X(!XIL;-VBBBD(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *^;/C5_P E0U?_ *Z+_P"@+7TG7S9\:O\ DJ&K_P#7
M1?\ T!:[,%\;]#Y[B/\ W>/K^C.6HHHKU#XP**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ****  '%>S_!3XU_VEY6CZQ+_I'"6URY_P!;Z(Q_O>A[_7KX
MQ0#BLJM)5%9G9@L;4PU3GA\UW/KRBO*O@I\:_P"TO*T?6)?](X2VN7/^M]$8
M_P![T/?Z]?5:\>I3E!\LC[_"8NGB*?M*?_#!1114'2%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M-\0/^11N_P#@'_H:UYI7I?Q _P"11N_^ ?\ H:UYI04@HHHH*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .^^%?\ R+TW_7PW_H*UTU<S\*_^1>F_Z^&_]!6NFH(>X4444""BBB@
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MMX!UW6O(_P")IX.OY=+^P^5Y8_T>RR^GQ[TCVO\ Z*=WF._$C>97AW_$7_\
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M_P %._\ @N'\&O\ @F3I,NG:M>_\)O\ $:3S(H/!^A7D#WMG*+83Q/J#%O\
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M!]"M=*DNK/PMI%A'J5Q'&/M%X85U)@DEQ-YD[_,Q+RN2S$EC7H5Z'W+\/_\
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M=+>3W$]Q=SZO&X,1 AU*29KV"/\ <IF.*=$(,@*D22;N6_X-M/\ E"Q\&/\
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MIL/^%0^,9_*MO[6#M<^&=0F/V>+=YV/-L=\LDS[9PT,,4.7NR33=QNYA7/\
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M (&\,VJZOXKUFVM7DDCM_,5([2"0HT*7=P=PC\TX"0SR!9?),3];_P ')?\
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M%:RW$:1;HUL()$MFM#+&SB"X6X)$K)))*N!5_P#;1_X-J?V9?VK-+U>\\/\
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M6TV?=0(T^[)*8W?^#0$?\;+?&Y_ZIE?C_P JNDTWL-['W+_P=_\ _*-3P/\
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M[M[BSL6DPK /FVO;E-KAE_>;L;E5AY5_P<DKM_X+4_&GW.AG_P H.G5]=?\
M!FS\'-,UOXZ?&_X@2SWZZSX8T+3?#UK"CH+62WU&XFN)F==NXR*^EVX0A@ '
MERK$J5KH5T/WVKXG_P"#BSQ/J?A+_@C-\:KK2=1O]+NI;;2[*2:SN'@D>WN-
M7L8+B$LI!,<L,DD;KT=)'4@AB#]L5\,_\')AQ_P18^,__<#_ /3[IU22?RO>
M'/#.I^-?$-AHVB:=?ZQK.K7$=E86%C;O<75]<2,$CABC0%GD=V5550220 ,F
MO[>/"WA;3/ WAC3M%T73K'1]&T>UBL;"PL;=+>UL;>) D<,4: *D:(JJJJ
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M !ST729[^XM;W7D\0R/>.CR"XU2U@U*X4%54>6LUW(J#&0BH"S$%C^A__!F
MN'_:3/J/"X_]/%4]BGL?N91114DA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7S9\:O\ DJ&K_P#71?\ T!:^DZ^;/C5_R5#5_P#KHO\ Z M=F"^-^A\]
MQ'_N\?7]&<M1117J'Q@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%%  #BO9_@I\:_[2\K1]8E_P!(X2VN7/\ K?1&/][T/?Z]?&*V? W@B]\>
M:VMI9K@##2S$?+"OJ?Z#O6-:$91]X[\OQ-:C63HZM].Y]1T56T?3SI.E6]L9
MY;DP1A#+*<O)@=2?6K->*?HBNUJ%%%% PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&^('_(HW?\ P#_T
M-:\TKTOX@?\ (HW?_ /_ $-:\TH*04444%!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?PUU_<I52*D?E/\ \'?_ /RC4\#_ /93+#_TU:M7PW_P: ?\I*_''_9,[_\
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M^#;3_E-/\&/^XY_Z8M1K]RO^#DO_ )0L?&?_ +@?_I]TZOPU_P"#;3_E-/\
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M_P"GW4:I[%/8^Y:_E0_X.2_^4T_QG_[@?_IBTZOZKZ_E0_X.2_\ E-/\9_\
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MV-S-<6MQJ<F9[^>)YL2&.6[EN)%!50 X 1  HIE,_FV_X.2_^4T_QG_[@?\
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M65E)!!!!P:_J]_X)@_\ *-3]GG_LF?AO_P!-5M38V?SA_P#!R4<_\%J/C/\
M]P/_ -,6G5ZK_P $!_\ @D%\#_\ @JY\./B*OCG6_BMHWC'P#J5H9/["O-/M
M],FL+R*3[/CSK>:4SB6UN]_W4"-!MR2^.X_X.X/V+;OX:?M<>&OC9I6D>7X<
M^)>F1:7K%[$US-_Q.K)3&IG+ PP^;8BV6)$<&3[#<ML!5G?QS_@VW_X*1:;^
MP7^VY/H7C'6+'0_AK\5[5-)UF_O9$AMM*O8?,>PO)9/*=@@>2:W;+Q1*+TS2
MMM@&*Z%=#]+?^(0#]FK_ *'CXY?^#G2O_E=1_P 0@'[-7_0\?'+_ ,'.E?\
MRNK]6**F[)NS\I_^(0#]FK_H>/CE_P"#G2O_ )75] _\$X/^"#_PB_X)??'+
M5/'_ (!\1_$C5]8U?0IO#\T/B#4+*XMEMY;BWG9E6&TA82;K:, EB,%OE)((
M^NM?^*/AGPIXVT#PUJGB+0M-\1^+/M/]AZ5=7\4-[K/V>,27'V:%F#S>4A#O
ML!V*06P#6[2$?E/_ ,'?_P#RC4\#_P#93+#_ --6K5\-_P#!H!_RDK\<?]DS
MO_\ TZZ37W)_P=__ /*-3P/_ -E,L/\ TU:M7PW_ ,&@'_*2OQQ_V3.__P#3
MKI-/H/H?T>4444A!1110 4444 ?RH?\ !R4<_P#!:CXS_P#<#_\ 3%IU?:W_
M  9D^*=,M/$_[0VBRZC8Q:SJ%KX?OK6P>X075S;P/J233)'G<T<;W%NKL!A3
M/$"077/S#_P=1?!?_A5G_!6S6M;_ +3^W_\ "R?#.D^)/(^S^5_9OEQ-I?D[
MMS>9G^S?-W87'G;=OR;F[C_@T!7/_!3'QL?3X8Z@/_*KI%5T*Z']']?-W_!8
M#]G?_AJC_@F/\:O!B6NO7]]<^&9]4TVST:+S;Z_O[ K?V=O''L<R>;<VT,91
M5WNKLJE6(8?2-%22?PUD;A7]E_\ P3S_ &JH/VW/V(_AE\4HYK&6[\7:%!/J
M@L;::WM;?4H\PW\$23$R".*[BN(U)9@0@(=P0Q_F(_X+2_\ !-W4_P#@FQ^V
MSXB\/VNC7]I\-O$=U+JO@>_>-S;7%@^UVLTD:65GDLVD%N_FOYK!(YF55GCS
MZO\ \&__ /P67@_X)C?%S5?"WCI;Z[^$7Q!N8'U*:&2::3PM>(&1=0BMP2KH
MZ,J7"HGG.D,#(7,"PRT]2GJ?U"T5R?P,^.?A']I?X1Z#X\\":]8^)O"7B:U%
MWINHVA.R=,E6!5@&21'5D>-PKQNCHZJRLHZRI)/#/^"GW_*-3]H;_LF?B3_T
MU7-?QO5_7/\ \%H/VF_A_P#L^_\ !.OXOZ=XS\7Z%X>U7QMX&UW1_#^G75R!
M>ZW=36;6R1VT S+-B6Z@#LBE8ED#R%$!8?R,52*1_<I7A?\ P4O_ &P3^P1^
MPG\2?BS%8_VE?^%-,4:9;-!YT,E_<S1VEGYR>9$3 +F>$R[7#^4)-N6P#[I7
MX+?\'@'[:-IXH\=?#GX#:)J_VC_A&/,\5^*;.(6TL,5W-'Y.G([@F>*>.W:\
MD:)@BF*^MW_>94I*)1^,7B?Q/J7C;Q)J&LZSJ-_J^L:O<R7M_?WUP]Q=7L\C
M%Y)I9')9Y'9BS,Q)))).37]'G_!//_@M!^Q)^Q%^Q'\,_A9'\8;&&Z\(Z%#!
MJAL?#7B2XM;C4I,SW\\3S60D,<MW+<2*"JX#@!$ "C\4O^"2_P#P31U+_@JK
M^U//\.+#Q78^"[;3-"N?$&HZI<63WLD5O%)# %A@#())&FN8 0TD8"&1MQ*A
M'_2W_B#!_P"KDO\ S'W_ -\JIV*=C[E_XB2_V+/^BS_^6CKO_P A5_-I_P %
M"&^'%S^VS\3+WX1:W8Z_\-M7UV?5= N+'0Y=%MK:WNL7'V.*TD56CCMFE:V7
MY5#" ,JJK!1^LW_$&#_U<E_YC[_[Y5\P_P#!6K_@W2U+_@F%^RU;_$ZQ^)5_
M\2K4:[;:3J-K;^#WT^/28)HYB+R:87<X6/SDAA&Y5!>YC&[)56%8%8^U?^#/
MW]K?_A+_ (!?$?X+:I?[[[P9J<?B30XKK6/-E>PO%\NXAMK1AF.""YA65V0E
M#+J@W*C-F3]DZ_D5_P"")_[6_P#PQ=_P4T^%GBR[O_L'AW4=4'AWQ TVL?V7
M9"POQ]F>:[D(*-!;/)%=E)/D+6B$LA D7^NJDQ,_C>_X*??\I*_VAO\ LIGB
M3_TZW-?T>?\ !MI_RA8^#'_<<_\ 3[J-?SA_\%/O^4E?[0W_ &4SQ)_Z=;FO
MZ//^#;3_ )0L?!C_ +CG_I]U&F]AO8^Y:**_*3_@L%_P<K> /V=/AIJ/@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH [[X5_\ (O3?]?#?^@K735S/PK_Y%Z;_ *^&_P#05KIJ"'N%
M%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY\_P""FO\ P3L\)_\
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MK'2-'TBUCLK"PLK=;>VLH(U"1PQ1H J1HJA550    ,"F,\W_;3_ &+/A_\
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M@KP]O^'/C;R&\5/8I&%T'6F;RFFEACB3RX+O]T_G,TA>[DG\QD::!9/Z(J*
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M3QA\&OA3XK\1:EL^UZKK'A*POKVZV1K&GF32Q,[;8T1!DG"JH' %)"1\X?\
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M7$30S1[XV5TW1NPW(P89R"#S6]12$?R+?\%@/^"8^M_\$N_VM=1\(^7KNH>
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ME@9D=H6DAC5C&6CC8J3@E%.,@4= Z'I%%%%(04444 %%%% 'XV?\'@/[(_\
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MUK4? 7B'3H=1\.:IJ3>;//M41W4$TJ00PF>.<,Q2,';#/;%CN?%?T_U^#/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y+_\')?_  15U/\ :_\
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MO$'B&^G:YO;C[5?37KV\6?D@@6255V0HF];> RF5XP]"!'#?\$>O^"8NB_\
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M=R)"@B?]9?\ @ZK_ .4>G@[_ +*)9?\ IMU.OC/_ (-5/^4A?C'_ +)W>_\
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M??B+4?"'["?QJU;2+^]TK5M+\!ZY=V5[9SM!<6<\>GSO'+'(I#(ZL RLI!!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME>5QPL>:6LW^'D@HHHKF/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP[\.?V@O'7A_PAJW]O\ A/0O$.H:=HFJ?:HKK^TK&&YDCMY_.B CDWQ*C;T
M5MV5 !%?T+?\%%_^"[7PE_9)^!CW_P //%?@OXK>/=:\RVT33=%UB'4;*TD
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M,0  23@5('Y_?\'.7Q7U+X=_\$S3I%C#92VWCSQ9IVA:@TZ,SPP(L^H!HB&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4?%GEZQ;Z=*?LXB^Q0-Y]S$DL#/)-*R%7Q):V[90J-WY.?\ $/I^UY_T2/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#OOA7_P B]-_U\-_Z"M=-7,_"O_D7
MIO\ KX;_ -!6NFH(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KYL^-7_ "5#5_\ KHO_ * M?2=?-GQJ_P"2
MH:O_ -=%_P#0%KLP7QOT/GN(_P#=X^OZ,Y:BBBO4/C HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MMGP/X'O?'NM+:6BX ^:65A\D*^I_H.])M)79<(2G)0@KMAX'\#WOCW6EM+1<
M ?-+*P^2%?4_T'>OHWP9X,LO VBI9628 YDD/WYF[L3_ )Q1X,\&67@;14LK
M), <R2'[\S=V)_SBM:O)KXAU'9;'W65Y7'"QYI:S?X>2"BBBN8]<**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!))/&&N(2FSS//:XC_8*B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** .^^%?\ R+TW_7PW_H*UTU<S\*_^1>F_Z^&_]!6NFH(>X4444""B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKYL^-7_)4-7_ .NB_P#H"U])U\V?&K_DJ&K_ /71?_0%KLP7QOT/GN(_]WCZ
M_HSEJ***]0^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHK9\#^![WQ[K2VEHN /FEE8?)"OJ?Z#O2;25V
M7"$IR4(*[8>!_ ][X]UI;2T7 'S2RL/DA7U/]!WKZ-\&>#++P-HJ65DF .9)
M#]^9N[$_YQ1X,\&67@;14LK), <R2'[\S=V)_P XK6KR:^(=1V6Q]UE>5QPL
M>:6LW^'D@HHHKF/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#&^('_(HW?_  #_ -#6O-*]+^('_(HW?_ /_0UKS2@I!11104%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 =]\*_^1>F_Z^&_]!6NFKF?A7_R+TW_ %\-_P"@K734$/<****!
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &-\0/^11N_^ ?^AK7FE>E_$#_D4;O_ (!_Z&M>:4%(****
M"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#OOA7_R+TW_ %\-_P"@K735S/PK_P"1>F_Z^&_]!6NF
MH(>X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K,O?!FCZE=//<:5IMQ-(<M)):HS-VY)&:TZ*:;6Q,HQDK25S'
M_P"%?:#_ - 32/\ P#C_ ,*/^%?:#_T!-(_\ X_\*V**?/+N1["E_*ON,?\
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M_P" <?\ A6Q11SR[A["E_*ON,?\ X5]H/_0$TC_P#C_PH_X5]H/_ $!-(_\
M ./_  K8HHYY=P]A2_E7W&/_ ,*^T'_H":1_X!Q_X4?\*^T'_H":1_X!Q_X5
ML44<\NX>PI?RK[C'_P"%?:#_ - 32/\ P#C_ ,*/^%?:#_T!-(_\ X_\*V**
M.>7</84OY5]QC_\ "OM!_P"@)I'_ (!Q_P"%'_"OM!_Z FD?^ <?^%;%%'/+
MN'L*7\J^XQ_^%?:#_P! 32/_  #C_P *O:7HEEH<3)96=K9HYW,L$2QACZD
M"K5%+F;W*C2A%WBD%%%%(L**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH QOB!_R*-W_ , _]#6O-*SO^"EG[34_['7[$_C3
MXCVVD1:[-X=^P[;&6X-NL_GW]M;G+A6(P)BW0YVX[U^4'_$3/KO_ $2/2?\
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M_P#XB9]=_P"B1Z3_ .%!)_\ &*/^(F?7?^B1Z3_X4$G_ ,8H^HUNP?ZEYO\
M\^O_ ":/^9^N%%?D?_Q$SZ[_ -$CTG_PH)/_ (Q1_P 1,^N_]$CTG_PH)/\
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M_$3/KO\ T2/2?_"@D_\ C%'U&MV#_4O-_P#GU_Y-'_,_7"BOR/\ ^(F?7?\
MHD>D_P#A02?_ !BC_B)GUW_HD>D_^%!)_P#&*/J-;L'^I>;_ //K_P FC_F?
MKA17Y'_\1,^N_P#1(])_\*"3_P",4?\ $3/KO_1(])_\*"3_ .,4?4:W8/\
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M_P#&*/J-;L'^I>;_ //K_P FC_F?KA17Y'_\1,^N_P#1(])_\*"3_P",4?\
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MH_XB9]=_Z)'I/_A02?\ QBCZC6[!_J7F_P#SZ_\ )H_YGZX45^1__$3/KO\
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M_P!$CTG_ ,*"3_XQ1]1K=@_U+S?_ )]?^31_S/UPHK\C_P#B)GUW_HD>D_\
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M,^N_]$CTG_PH)/\ XQ1_Q$SZ[_T2/2?_  H)/_C%'U&MV#_4O-_^?7_DT?\
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M_B+ \0?]$5T;_P *63_Y'H_XBP/$'_1%=&_\*63_ .1Z/J-;L'^I6<?\^O\
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M/^B*Z-_X4LG_ ,CT?4:W8/\ 4K./^?7_ )-'_,_:6BOQ:_XBP/$'_1%=&_\
M"ED_^1Z/^(L#Q!_T171O_"ED_P#D>CZC6[!_J5G'_/K_ ,FC_F?M+17XM?\
M$6!X@_Z(KHW_ (4LG_R/1_Q%@>(/^B*Z-_X4LG_R/1]1K=@_U*SC_GU_Y-'_
M #/VEHK\6O\ B+ \0?\ 1%=&_P#"ED_^1Z/^(L#Q!_T171O_  I9/_D>CZC6
M[!_J5G'_ #Z_\FC_ )G[2T5^+7_$6!X@_P"B*Z-_X4LG_P CT?\ $6!X@_Z(
MKHW_ (4LG_R/1]1K=@_U*SC_ )]?^31_S/VEHK\6O^(L#Q!_T171O_"ED_\
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M9Q_SZ_\ )H_YG[2T5^+7_$6!X@_Z(KHW_A2R?_(]'_$6!X@_Z(KHW_A2R?\
MR/1]1K=@_P!2LX_Y]?\ DT?\S]I:*_%K_B+ \0?]$5T;_P *63_Y'H_XBP/$
M'_1%=&_\*63_ .1Z/J-;L'^I6<?\^O\ R:/^9^TM%?BU_P 18'B#_HBNC?\
MA2R?_(]'_$6!X@_Z(KHW_A2R?_(]'U&MV#_4K./^?7_DT?\ ,_:6BOQ:_P"(
ML#Q!_P!$5T;_ ,*63_Y'H_XBP/$'_1%=&_\ "ED_^1Z/J-;L'^I6<?\ /K_R
M:/\ F?M+17XM?\18'B#_ *(KHW_A2R?_ "/1_P 18'B#_HBNC?\ A2R?_(]'
MU&MV#_4K./\ GU_Y-'_,_:6BOQ:_XBP/$'_1%=&_\*63_P"1Z/\ B+ \0?\
M1%=&_P#"ED_^1Z/J-;L'^I6<?\^O_)H_YG[2T5^+7_$6!X@_Z(KHW_A2R?\
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M (4LG_R/1_Q%@>(/^B*Z-_X4LG_R/1]1K=@_U*SC_GU_Y-'_ #/VEHK\6O\
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MC_GU_P"31_S/VEHK\6O^(L#Q!_T171O_  I9/_D>C_B+ \0?]$5T;_PI9/\
MY'H^HUNP?ZE9Q_SZ_P#)H_YG[2T5^+7_ !%@>(/^B*Z-_P"%+)_\CT?\18'B
M#_HBNC?^%+)_\CT?4:W8/]2LX_Y]?^31_P S]I:*_%K_ (BP/$'_ $171O\
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M?\18'B#_ *(KHW_A2R?_ "/1_P 18'B#_HBNC?\ A2R?_(]'U&MV#_4K./\
MGU_Y-'_,_:6BOQ:_XBP/$'_1%=&_\*63_P"1Z/\ B+ \0?\ 1%=&_P#"ED_^
M1Z/J-;L'^I6<?\^O_)H_YG[2T5^+7_$6!X@_Z(KHW_A2R?\ R/1_Q%@>(/\
MHBNC?^%+)_\ (]'U&MV#_4K./^?7_DT?\S]I:*_%K_B+ \0?]$5T;_PI9/\
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M_P"(L#Q!_P!$5T;_ ,*63_Y'H_XBP/$'_1%=&_\ "ED_^1Z/J-;L'^I6<?\
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M^9^TM%?BU_Q%@>(/^B*Z-_X4LG_R/1_Q%@>(/^B*Z-_X4LG_ ,CT?4:W8/\
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M\CT?4:W8/]2LX_Y]?^31_P S]I:*_%K_ (BP/$'_ $171O\ PI9/_D>C_B+
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M?\^O_)H_YG[2T5^+7_$6!X@_Z(KHW_A2R?\ R/1_Q%@>(/\ HBNC?^%+)_\
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M/_D>CZC6[!_J5G'_ #Z_\FC_ )G[2T5^+7_$6!X@_P"B*Z-_X4LG_P CT?\
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M^(L#Q!_T171O_"ED_P#D>C_B+ \0?]$5T;_PI9/_ )'H^HUNP?ZE9Q_SZ_\
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M<?\ /K_R:/\ F?M+17XM?\18'B#_ *(KHW_A2R?_ "/1_P 18'B#_HBNC?\
MA2R?_(]'U&MV#_4K./\ GU_Y-'_,_:6BOQ:_XBP/$'_1%=&_\*63_P"1Z/\
MB+ \0?\ 1%=&_P#"ED_^1Z/J-;L'^I6<?\^O_)H_YG[2T5^+7_$6!X@_Z(KH
MW_A2R?\ R/1_Q%@>(/\ HBNC?^%+)_\ (]'U&MV#_4K./^?7_DT?\S]I:*_%
MK_B+ \0?]$5T;_PI9/\ Y'H_XBP/$'_1%=&_\*63_P"1Z/J-;L'^I6<?\^O_
M ":/^9^TM%?BU_Q%@>(/^B*Z-_X4LG_R/1_Q%@>(/^B*Z-_X4LG_ ,CT?4:W
M8/\ 4K./^?7_ )-'_,_:6BOQ:_XBP/$'_1%=&_\ "ED_^1Z/^(L#Q!_T171O
M_"ED_P#D>CZC6[!_J5G'_/K_ ,FC_F?M+17XM?\ $6!X@_Z(KHW_ (4LG_R/
M1_Q%@>(/^B*Z-_X4LG_R/1]1K=@_U*SC_GU_Y-'_ #/VEHK\6O\ B+ \0?\
M1%=&_P#"ED_^1Z/^(L#Q!_T171O_  I9/_D>CZC6[!_J5G'_ #Z_\FC_ )G[
M2T5^+7_$6!X@_P"B*Z-_X4LG_P CT?\ $6!X@_Z(KHW_ (4LG_R/1]1K=@_U
M*SC_ )]?^31_S/VEHK\6O^(L#Q!_T171O_"ED_\ D>C_ (BP/$'_ $171O\
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M_B+ \0?]$5T;_P *63_Y'H^HUNP?ZE9Q_P ^O_)H_P"9^TM%?BU_Q%@>(/\
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M?_(]'_$6!X@_Z(KHW_A2R?\ R/1]1K=@_P!2LX_Y]?\ DT?\S]I:*_%K_B+
M\0?]$5T;_P *63_Y'H_XBP/$'_1%=&_\*63_ .1Z/J-;L'^I6<?\^O\ R:/^
M9^TM%?BU_P 18'B#_HBNC?\ A2R?_(]'_$6!X@_Z(KHW_A2R?_(]'U&MV#_4
MK./^?7_DT?\ ,_:6BOQ:_P"(L#Q!_P!$5T;_ ,*63_Y'H_XBP/$'_1%=&_\
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M_$6!X@_Z(KHW_A2R?_(]'_$6!X@_Z(KHW_A2R?\ R/1]1K=@_P!2LX_Y]?\
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MSC_GU_Y-'_,_:6BOQ:_XBP/$'_1%=&_\*63_ .1Z/^(L#Q!_T171O_"ED_\
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M_P!$5T;_ ,*63_Y'H_XBP/$'_1%=&_\ "ED_^1Z/J-;L'^I6<?\ /K_R:/\
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M_P *63_Y'H^HUNP?ZE9Q_P ^O_)H_P"9^TM%?BU_Q%@>(/\ HBNC?^%+)_\
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M8'B#_HBNC?\ A2R?_(]'_$6!X@_Z(KHW_A2R?_(]'U&MV#_4K./^?7_DT?\
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MM%NVZ>NKZ/R/::***P/%"BBB@ HHHH **** "BBB@#XY_P""_?\ RB1^+/\
MW!__ $\V-?S6U_8EJ&G6^K6;V]U!#<P28W12H'1L'(R#QU /X5F?\*Z\/_\
M0"T;_P  H_\ XFN[#8SV4>6US[/AWBU97AI8=TN:\F[WMT2[/L?R 45_7_\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
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M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
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M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
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M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
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M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
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M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
M^3?_ &I_(!17]?\ _P *Z\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q
M-']J+^7\0_XB1'_H'_\ )O\ [4_D HK^O_\ X5UX?_Z 6C?^ 4?_ ,31_P *
MZ\/_ /0"T;_P"C_^)H_M1?R_B'_$2(_] _\ Y-_]J?R 45_7_P#\*Z\/_P#0
M"T;_ , H_P#XFC_A77A__H!:-_X!1_\ Q-']J+^7\0_XB1'_ *!__)O_ +4_
MD HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\ T M&_P# */\ ^)H_M1?R
M_B'_ !$B/_0/_P"3?_:G\@%%?U__ /"NO#__ $ M&_\  */_ .)H_P"%=>'_
M /H!:-_X!1__ !-']J+^7\0_XB1'_H'_ /)O_M3^0"BOZ_\ _A77A_\ Z 6C
M?^ 4?_Q-'_"NO#__ $ M&_\  */_ .)H_M1?R_B'_$2(_P#0/_Y-_P#:G\@%
M%?U__P#"NO#_ /T M&_\ H__ (FC_A77A_\ Z 6C?^ 4?_Q-']J+^7\0_P"(
MD1_Z!_\ R;_[4_D HK^O_P#X5UX?_P"@%HW_ (!1_P#Q-'_"NO#_ /T M&_\
M H__ (FC^U%_+^(?\1(C_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ *
M/_XFC_A77A__ * 6C?\ @%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ_
M_P#A77A__H!:-_X!1_\ Q-'_  KKP_\ ] +1O_ */_XFC^U%_+^(?\1(C_T#
M_P#DW_VI_(!17]?_ /PKKP__ - +1O\ P"C_ /B:/^%=>'_^@%HW_@%'_P#$
MT?VHOY?Q#_B)$?\ H'_\F_\ M3^0"BOZ_P#_ (5UX?\ ^@%HW_@%'_\ $T?\
M*Z\/_P#0"T;_ , H_P#XFC^U%_+^(?\ $2(_] __ )-_]J?R 45_7_\ \*Z\
M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
MT M&_P# */\ ^)H_M1?R_B'_ !$B/_0/_P"3?_:G\@%%?U__ /"NO#__ $ M
M&_\  */_ .)H_P"%=>'_ /H!:-_X!1__ !-']J+^7\0_XB1'_H'_ /)O_M3^
M0"BOZ_\ _A77A_\ Z 6C?^ 4?_Q-'_"NO#__ $ M&_\  */_ .)H_M1?R_B'
M_$2(_P#0/_Y-_P#:G\@%%?U__P#"NO#_ /T M&_\ H__ (FC_A77A_\ Z 6C
M?^ 4?_Q-']J+^7\0_P"(D1_Z!_\ R;_[4_D HK^O_P#X5UX?_P"@%HW_ (!1
M_P#Q-'_"NO#_ /T M&_\ H__ (FC^U%_+^(?\1(C_P! _P#Y-_\ :G\@%%?U
M_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\ @%'_ /$T?VHOY?Q#_B)$
M?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\ Q-'_  KKP_\ ] +1O_ *
M/_XFC^U%_+^(?\1(C_T#_P#DW_VI_(!17]?_ /PKKP__ - +1O\ P"C_ /B:
M/^%=>'_^@%HW_@%'_P#$T?VHOY?Q#_B)$?\ H'_\F_\ M3^0"BOZ_P#_ (5U
MX?\ ^@%HW_@%'_\ $T?\*Z\/_P#0"T;_ , H_P#XFC^U%_+^(?\ $2(_] __
M )-_]J?R 45_7_\ \*Z\/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\
M$T?VHOY?Q#_B)$?^@?\ \F_^U/Y **_K_P#^%=>'_P#H!:-_X!1__$T?\*Z\
M/_\ 0"T;_P  H_\ XFC^U%_+^(?\1(C_ - __DW_ -J?R 45_7__ ,*Z\/\
M_0"T;_P"C_\ B:/^%=>'_P#H!:-_X!1__$T?VHOY?Q#_ (B1'_H'_P#)O_M3
M^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\ _0"T;_P"C_\ B:/[47\O
MXA_Q$B/_ $#_ /DW_P!J?R 45_7_ /\ "NO#_P#T M&_\ H__B:/^%=>'_\
MH!:-_P" 4?\ \31_:B_E_$/^(D1_Z!__ ";_ .U/Y **_K__ .%=>'_^@%HW
M_@%'_P#$T?\ "NO#_P#T M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?
MU_\ _"NO#_\ T M&_P# */\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1
M_P"@?_R;_P"U/Y **_K_ /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\
MP"C_ /B:/[47\OXA_P 1(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C
M_P#B:/\ A77A_P#Z 6C?^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_
M /X5UX?_ .@%HW_@%'_\31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\
MT#_^3?\ VI_(!17]?_\ PKKP_P#] +1O_ */_P")H_X5UX?_ .@%HW_@%'_\
M31_:B_E_$/\ B)$?^@?_ ,F_^U/Y **_K_\ ^%=>'_\ H!:-_P" 4?\ \31_
MPKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\ ^3?_ &I_(!17]?\ _P *
MZ\/_ /0"T;_P"C_^)H_X5UX?_P"@%HW_ (!1_P#Q-']J+^7\0_XB1'_H'_\
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M_P! _P#Y-_\ :G\@%%?U_P#_  KKP_\ ] +1O_ */_XFC_A77A__ * 6C?\
M@%'_ /$T?VHOY?Q#_B)$?^@?_P F_P#M3^0"BOZ__P#A77A__H!:-_X!1_\
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M?Q#_ (B1'_H'_P#)O_M3^0"BOZ__ /A77A__ * 6C?\ @%'_ /$T?\*Z\/\
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M'_\ H!:-_P" 4?\ \31_PKKP_P#] +1O_ */_P")H_M1?R_B'_$2(_\ 0/\
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M/_\ 0"T;_P  H_\ XFC_ (5UX?\ ^@%HW_@%'_\ $T?VHOY?Q#_B)$?^@?\
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M M&_\ H__B:/[47\OXA_Q$B/_0/_ .3?_:G\@%%?U_\ _"NO#_\ T M&_P#
M*/\ ^)H_X5UX?_Z 6C?^ 4?_ ,31_:B_E_$/^(D1_P"@?_R;_P"U/Y **_K_
M /\ A77A_P#Z 6C?^ 4?_P 31_PKKP__ - +1O\ P"C_ /B:/[47\OXA_P 1
M(C_T#_\ DW_VI_(!17]?_P#PKKP__P! +1O_  "C_P#B:/\ A77A_P#Z 6C?
M^ 4?_P 31_:B_E_$/^(D1_Z!_P#R;_[4_D HK^O_ /X5UX?_ .@%HW_@%'_\
M31_PKKP__P! +1O_  "C_P#B:/[47\OXA_Q$B/\ T#_^3?\ VI_(!17]?_\
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M\0_XB1'_ *!__)O_ +4_D HK^O\ _P"%=>'_ /H!:-_X!1__ !-'_"NO#_\
MT M&_P# */\ ^)H_M1?R_B'_ !$B/_0/_P"3?_:G\@%%?U__ /"NO#__ $ M
M&_\  */_ .)H_P"%=>'_ /H!:-_X!1__ !-']J+^7\0_XB1'_H'_ /)O_M3^
M0"OZ4O\ @@)_RB1^$W_<8_\ 3S?5]6_\*Z\/_P#0"T;_ , H_P#XFM/3].M]
M)LTM[6"&V@CSMBB0(BY.3@#CJ2?QKFQ.,]K'EM8\#B+BU9IAHX=4N6TD[WOT
M:[+N34445PGQ@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
:1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>elym-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-08T15:43:56.6486+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="elym-20210930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="elym-20210930.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" xlink:href="elym-20210930.xsd#StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments" xlink:href="elym-20210930.xsd#DisclosureInvestments" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccounts" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="elym-20210930.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders" xlink:href="elym-20210930.xsd#Role_DisclosureNetLossPerShareAttributableToCommonStockholders" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:href="elym-20210930.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables" xlink:href="elym-20210930.xsd#DisclosureInvestmentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccountsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables" xlink:href="elym-20210930.xsd#Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" xlink:href="elym-20210930.xsd#DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:href="elym-20210930.xsd#DisclosureInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:href="elym-20210930.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails" xlink:href="elym-20210930.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" xlink:href="elym-20210930.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ResearchAndDevelopmentExpenseRelatedParties" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_3"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="elym_ResearchAndDevelopmentExpenseRelatedParties" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAccretionReductionToRedemptionValue" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_19"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_20"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_21"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_22"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_TemporaryEquityAccretionReductionToRedemptionValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_19" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_21" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1PreferredStockMember" xlink:label="elym_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1PreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock" xlink:label="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInNonCurrentAssets" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAccretionReductionToRedemptionValue" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="elym_IncreaseDecreaseInNonCurrentAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="elym_TemporaryEquityAccretionReductionToRedemptionValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock" xlink:label="us-gaap_InvestmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDisclosureTextBlock" xlink:label="elym_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_TemporaryEquityDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReserveStockSplitPolicyPolicyTextBlock" xlink:label="elym_ReserveStockSplitPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_InitialPublicOfferingPolicyTextBlock" xlink:label="elym_InitialPublicOfferingPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_LiquidityPolicyTextBlock" xlink:label="elym_LiquidityPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RisksAndUncertaintiesPolicyTextBlock" xlink:label="elym_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="elym_ReserveStockSplitPolicyPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="elym_InitialPublicOfferingPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="elym_LiquidityPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="elym_RisksAndUncertaintiesPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:label="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:label="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member" xlink:label="us-gaap_FairValueInputsLevel12And3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairValueLevel1Level2AndLevel3TransferAmount" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwritingDiscount" xlink:label="elym_UnderwritingDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel12And3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_ProceedsFromIssuanceInitialPublicOfferingNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_FairValueLevel1Level2AndLevel3TransferAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_UnderwritingDiscount" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ShortTermMarketableSecuritiesMember" xlink:label="elym_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_LongTermMarketableSecuritiesMember" xlink:label="elym_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="elym_ShortTermMarketableSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="elym_LongTermMarketableSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentHoldingsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_InterestReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_SummaryOfInvestmentHoldingsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RecoverableResearchAndDevelopmentTaxCredits" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PrepaidResearchAndDevelopmentExpenses" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="elym_RecoverableResearchAndDevelopmentTaxCredits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="elym_PrepaidResearchAndDevelopmentExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedResearchAndDevelopmentExpenses" xlink:label="elym_AccruedResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="elym_AccruedResearchAndDevelopmentExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityIssuePrice" xlink:label="elym_TemporaryEquityIssuePrice"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityIssuePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesARedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesBRedeemableConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwrittenPublicOfferingMember" xlink:label="elym_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CumulativeDividendsReceive" xlink:label="elym_CumulativeDividendsReceive"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PercentageOfTemporaryEquitySharesOutstanding" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionDate" xlink:label="us-gaap_PreferredStockRedemptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="elym_UnderwrittenPublicOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesBRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesARedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_CumulativeDividendsReceive" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_PercentageOfTemporaryEquitySharesOutstanding" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockRedemptionDate" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1PreferredStockMember" xlink:label="elym_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1PreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1TrancheCallOptionMember" xlink:label="elym_SeriesA1TrancheCallOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDiscountRate" xlink:label="elym_TemporaryEquityDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDividendYield" xlink:label="elym_TemporaryEquityDividendYield"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedTerm" xlink:label="elym_TemporaryEquityExpectedTerm"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedVolatility" xlink:label="elym_TemporaryEquityExpectedVolatility"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityProbabilityOfMilestoneAchievement" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStrikePrice" xlink:label="elym_TemporaryEquityStrikePrice"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityFairValueOfEachTrancheFeature" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="elym_SeriesA1TrancheCallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityDiscountRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityDividendYield" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityExpectedTerm" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityExpectedVolatility" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityProbabilityOfMilestoneAchievement" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityStrikePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityFairValueOfEachTrancheFeature" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseAndRentalExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseExpirationDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandNineteenEquityIncentivePlanMember" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_StockOptionsMember" xlink:label="elym_StockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_EsppMember" xlink:label="elym_EsppMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExecutiveOfficerEarningContribution" xlink:label="elym_ExecutiveOfficerEarningContribution"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairMarketValueCommonStockPercentage" xlink:label="elym_FairMarketValueCommonStockPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_TwoThousandNineteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="elym_StockOptionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_TwoThousandTwentyOneEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_EsppMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="elym_ExecutiveOfficerEarningContribution" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="elym_FairMarketValueCommonStockPercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" xlink:label="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_PreferredStockConversionBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CommonStockOptionsMember" xlink:label="elym_CommonStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnvestedRestrictedStockAwardsMember" xlink:label="elym_UnvestedRestrictedStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="elym_CommonStockOptionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="elym_UnvestedRestrictedStockAwardsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>elym-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-08T15:43:57.7248+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_EsppMember" xlink:label="elym_EsppMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairMarketValueCommonStockPercentage" xlink:label="elym_FairMarketValueCommonStockPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_LongTermMarketableSecuritiesMember" xlink:label="elym_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ShortTermMarketableSecuritiesMember" xlink:label="elym_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReserveStockSplitPolicyPolicyTextBlock" xlink:label="elym_ReserveStockSplitPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock" xlink:label="us-gaap_InvestmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_StockOptionsMember" xlink:label="elym_StockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExecutiveOfficerEarningContribution" xlink:label="elym_ExecutiveOfficerEarningContribution"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock" xlink:label="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandNineteenEquityIncentivePlanMember" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1TrancheCallOptionMember" xlink:label="elym_SeriesA1TrancheCallOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1PreferredStockMember" xlink:label="elym_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionDate" xlink:label="us-gaap_PreferredStockRedemptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ResearchAndDevelopmentExpenseRelatedParties" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PercentageOfTemporaryEquitySharesOutstanding" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwrittenPublicOfferingMember" xlink:label="elym_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedResearchAndDevelopmentExpenses" xlink:label="elym_AccruedResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInNonCurrentAssets" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAccretionReductionToRedemptionValue" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnvestedRestrictedStockAwardsMember" xlink:label="elym_UnvestedRestrictedStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CommonStockOptionsMember" xlink:label="elym_CommonStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" xlink:label="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_InitialPublicOfferingPolicyTextBlock" xlink:label="elym_InitialPublicOfferingPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PrepaidResearchAndDevelopmentExpenses" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RecoverableResearchAndDevelopmentTaxCredits" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairValueLevel1Level2AndLevel3TransferAmount" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member" xlink:label="us-gaap_FairValueInputsLevel12And3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDisclosureTextBlock" xlink:label="elym_TemporaryEquityDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDiscountRate" xlink:label="elym_TemporaryEquityDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDividendYield" xlink:label="elym_TemporaryEquityDividendYield"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedTerm" xlink:label="elym_TemporaryEquityExpectedTerm"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedVolatility" xlink:label="elym_TemporaryEquityExpectedVolatility"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityProbabilityOfMilestoneAchievement" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStrikePrice" xlink:label="elym_TemporaryEquityStrikePrice"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityFairValueOfEachTrancheFeature" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwritingDiscount" xlink:label="elym_UnderwritingDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CumulativeDividendsReceive" xlink:label="elym_CumulativeDividendsReceive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:label="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:label="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RisksAndUncertaintiesPolicyTextBlock" xlink:label="elym_RisksAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_LiquidityPolicyTextBlock" xlink:label="elym_LiquidityPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityIssuePrice" xlink:label="elym_TemporaryEquityIssuePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current Including Related Party Transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued liabilities current including related party transactions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of premiums and accretion of discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairMarketValueCommonStockPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of fair market value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ESPP [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ESPP Member</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairMarketValueCommonStockPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of fair market value, common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairMarketValueCommonStockPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair market value, common stock percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value per share, 250000000 and 40,000,000 shares authorized; 26199262 and 3,418,751 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, $0.0001 par value, 10000000 and 12,909,389 shares authorized, 7140157 shares issued and outstanding with aggregate liquidation preference of $0 and $49,891 at September 30, 2021 and December 31, 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Continuous unrealized loss position, 12 months or longer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Continuous unrealized loss position, less than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-sale Securities, Gross Unrealized Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Gross Unrealized Loss, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-sale Securities, Amortized Cost Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Amortized Cost Basis, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock in initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock in initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash And Cash Equivalent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Bonds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Bond Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReserveStockSplitPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserve Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReserveStockSplitPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reserve Stock Split Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReserveStockSplitPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserve Stock Split Policy</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Procurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment In Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments consists of available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_StockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_StockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options[Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_StockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExecutiveOfficerEarningContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Executive Officer Earning Contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExecutiveOfficerEarningContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officer Earning Contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExecutiveOfficerEarningContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Executive Officer Earning Contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty one equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrealized Gain (Loss) on Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Income (Expense), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock to common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Redeemable Convertible Preferred Stock to Common Stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of redeemable convertible preferred stock to common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock sold in initial public offering, net issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock Sold in Initial Public Offering, Net Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock sold in initial public offering, net issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flow from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of premiums and accretion of discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Prepaid Expense, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options grants in period, weighted average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand nineteen equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease payments under non-cancelable operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Rent Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1TrancheCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 Tranche Call Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1TrancheCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A 1 tranche call option.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Indexed to Issuer's Equity, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Indexed to Issuer's Equity, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A - 1 Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A - 1 preferred stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A 1 Redeemable Convertible Preferred Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 Redeemable Convertible Preferred Tranche Liability [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A 1 redeemable convertible preferred tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of redeemable convertible preferred stock to redemption value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockRedemptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redemption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockRedemptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Redemption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred dividend, per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Amount of Preferred Dividends in Arrears</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, automatic conversion, sale of common stock, gross proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Automatic Conversion Sale Of Common Stock Gross Proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity automatic conversion sale of common stock gross proceeds.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, automatic conversion, sale of common stock, price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Automatic Conversion Sale Of Common Stock Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of redeemable convertible preferred stock tranche liability upon settlement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability), shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Government Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Investment Holdings [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Holdings [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-sale Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-sale Securities, Gross Unrealized Gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Gross Unrealized Gain, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Share New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period share new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency gain (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of redeemable convertible preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of redeemable convertible preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of redeemable convertible preferred stock tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development expense related parties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; deficit:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity automatic conversion sale of common stock price per share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock, price (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of outstanding shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Temporary Equity Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of temporary equity shares outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Temporary equity liquidation preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwritten public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B redeemable convertible preferred stock member .</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A1 Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A1 redeemable convertible preferred stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Athenen Acquisition Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Athenen Acquisition Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Athenen acquisition redeemable convertible preferred stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A redeemable convertible preferred stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued payroll</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Payroll Taxes, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Of Redeemable Convertible Preferred Stock To Redemption Value And Cumulative Preferred Stock Dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Long-term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Non Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in non current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Release of restricted stock awards, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Release of restricted stock awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of Series A and A-1 Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Accretion Reduction To Redemption Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity accretion (reduction) to redemption value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options and release of restricted stock awards, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserve stock split, conversion ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction, Amounts of Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Amounts of Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnvestedRestrictedStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested Restricted Stock Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnvestedRestrictedStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Awards [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnvestedRestrictedStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock awards member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CommonStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CommonStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CommonStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock options member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation, weighted average amortization period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested, weighted average grant date fair value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted, weighted average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested, weighted average grant date fair value per share, beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested, weighted average grant date fair value per share, ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate intrinsic value outstanding, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate intrinsic value outstanding, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contracted terms (in years), exercisable at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contracted terms (in years), vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contracted terms (in years) outstanding, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contracted terms (in years) outstanding, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term 3.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options cancelled and forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average exercise price outstanding, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average exercise price outstanding, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options exercisable, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options, vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of options outstanding, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of options outstanding, ending of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, number of shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, award vesting rights, percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share based payment award, purchase price of common stock, percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Stock Options And Release Of Restricted Stock Awards Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of stock options and release of restricted stock awards, shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options and release of restricted stock awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Stock Options And Release Of Restricted Stock Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of stock options and release of restricted stock awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of redeemable convertible preferred stock tranche liability upon settlement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Redeemable Convertible Preferred Stock Tranche Liability Upon Settlement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 5)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Related Parties, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, Redeemable Convertible Preferred Stock, and Stockholders&#8217; Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock tranche liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_InitialPublicOfferingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_InitialPublicOfferingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_InitialPublicOfferingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial Public Offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_AccruedResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid research and development expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recoverable research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recoverable Research And Development Tax Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recoverable research and development tax credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock Tranche Liability [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock Tranche Liability [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable convertible preferred stock tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value by Liability Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value by Liability Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value transfer amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Level1 Level2 And Level3 Transfer Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Level 1 Level 2 and Level 3 Transfer Amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares issued upon conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel12And3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock Tranche Liability Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable convertible preferred stock tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity disclosure text block.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certain Balance Sheet Accounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Organization and Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expenses, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Foreign currency gain from remeasurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable And Accrued Liabilities Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in accounts payable and accrued liabilities related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued liabilities, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity discount rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity dividend yield.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Dividend Yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity expected term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity expected volatility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Expected Volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity probability of milestone achievement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Probability Of Milestone Achievement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStrikePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity strike price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStrikePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Strike Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity fair value of each tranche feature.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Fair Value Of Each Tranche Feature</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value of redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityExpectedVolatility_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Probability of milestone achievement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStrikePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strike price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of each tranche feature</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_SeriesA1TrancheCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A 1 Tranche Call Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss and comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total other income (expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnderwritingDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_UnderwritingDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Redeemable convertible preferred stock accretion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issuance cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of redeemable convertible preferred stock and related tranche rights, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CumulativeDividendsReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative dividends receive.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CumulativeDividendsReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Dividends Receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_CumulativeDividendsReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage of cumulative dividends receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Foreign Currency Transaction Gain (Loss), before Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable and Accrued Liabilities, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic and Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance initial public offering net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Initial Public Offering Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from Issuance Initial Public Offering Net.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Share-based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Assumptions Used in Black-Scholes Model</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of the Rollforward Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure for rollforward of redeemable convertable preferred stock tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Valuation of the Redeemable Convertible Preferred Stock Tranche Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Valuation Of The Redeemable Convertible Preferred Stock Tranche Liability Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of information about valuation of redeemable convertible preferred stock tranche liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Uncertainties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks And Uncertainties Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risks and Uncertainties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_LiquidityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liquidity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Leases, Rent Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConversionBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Conversion Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConversionBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unit conversion ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityIssuePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity issue price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityIssuePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">temporary equity issue price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued during period shares new issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel12And3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Inputs Level 1, 2 and 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityIssuePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Issue Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity incorporation date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Temporary Equity, Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Liquidation Preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of options, cancelled and forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Temporary equity, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of shares, Unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of shares, Unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other income (expense):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income (expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts payable and accrued liabilities, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity estimated fair value of redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Estimated Fair Value Of Redeemable Convertible Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:to="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_EsppMember" xlink:to="elym_EsppMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="elym_TwoThousandTwentyOneEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_FairMarketValueCommonStockPercentage" xlink:to="elym_FairMarketValueCommonStockPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_LongTermMarketableSecuritiesMember" xlink:to="elym_LongTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ShortTermMarketableSecuritiesMember" xlink:to="elym_ShortTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateBondSecuritiesMember" xlink:to="us-gaap_CorporateBondSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ReserveStockSplitPolicyPolicyTextBlock" xlink:to="elym_ReserveStockSplitPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_StockOptionsMember" xlink:to="elym_StockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ExecutiveOfficerEarningContribution" xlink:to="elym_ExecutiveOfficerEarningContribution_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock" xlink:to="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" xlink:to="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TwoThousandNineteenEquityIncentivePlanMember" xlink:to="elym_TwoThousandNineteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesA1TrancheCallOptionMember" xlink:to="elym_SeriesA1TrancheCallOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesA1PreferredStockMember" xlink:to="elym_SeriesA1PreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionDate" xlink:to="us-gaap_PreferredStockRedemptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" xlink:to="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_SummaryOfInvestmentHoldingsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ResearchAndDevelopmentExpenseRelatedParties" xlink:to="elym_ResearchAndDevelopmentExpenseRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_PercentageOfTemporaryEquitySharesOutstanding" xlink:to="elym_PercentageOfTemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_UnderwrittenPublicOfferingMember" xlink:to="elym_UnderwrittenPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="elym_SeriesBRedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" xlink:to="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="elym_SeriesARedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_AccruedResearchAndDevelopmentExpenses" xlink:to="elym_AccruedResearchAndDevelopmentExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" xlink:to="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_IncreaseDecreaseInNonCurrentAssets" xlink:to="elym_IncreaseDecreaseInNonCurrentAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityAccretionReductionToRedemptionValue" xlink:to="elym_TemporaryEquityAccretionReductionToRedemptionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_UnvestedRestrictedStockAwardsMember" xlink:to="elym_UnvestedRestrictedStockAwardsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_CommonStockOptionsMember" xlink:to="elym_CommonStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" xlink:to="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_InitialPublicOfferingPolicyTextBlock" xlink:to="elym_InitialPublicOfferingPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_PrepaidResearchAndDevelopmentExpenses" xlink:to="elym_PrepaidResearchAndDevelopmentExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_RecoverableResearchAndDevelopmentTaxCredits" xlink:to="elym_RecoverableResearchAndDevelopmentTaxCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_FairValueLevel1Level2AndLevel3TransferAmount" xlink:to="elym_FairValueLevel1Level2AndLevel3TransferAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel12And3Member" xlink:to="us-gaap_FairValueInputsLevel12And3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityDisclosureTextBlock" xlink:to="elym_TemporaryEquityDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" xlink:to="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityDiscountRate" xlink:to="elym_TemporaryEquityDiscountRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityDividendYield" xlink:to="elym_TemporaryEquityDividendYield_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityExpectedTerm" xlink:to="elym_TemporaryEquityExpectedTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityExpectedVolatility" xlink:to="elym_TemporaryEquityExpectedVolatility_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityProbabilityOfMilestoneAchievement" xlink:to="elym_TemporaryEquityProbabilityOfMilestoneAchievement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityStrikePrice" xlink:to="elym_TemporaryEquityStrikePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityFairValueOfEachTrancheFeature" xlink:to="elym_TemporaryEquityFairValueOfEachTrancheFeature_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" xlink:to="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_UnderwritingDiscount" xlink:to="elym_UnderwritingDiscount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_CumulativeDividendsReceive" xlink:to="elym_CumulativeDividendsReceive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:to="elym_ProceedsFromIssuanceInitialPublicOfferingNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:to="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" xlink:to="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_RisksAndUncertaintiesPolicyTextBlock" xlink:to="elym_RisksAndUncertaintiesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_LiquidityPolicyTextBlock" xlink:to="elym_LiquidityPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConversionBasis" xlink:to="us-gaap_PreferredStockConversionBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="elym_TemporaryEquityIssuePrice" xlink:to="elym_TemporaryEquityIssuePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>elym-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-08T15:43:57.3218+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2" xlink:href="elym-20210930.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="elym-20210930.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" xlink:href="elym-20210930.xsd#Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="elym_ResearchAndDevelopmentExpenseRelatedParties" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" xlink:label="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ResearchAndDevelopmentExpenseRelatedParties" xlink:label="elym_ResearchAndDevelopmentExpenseRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="elym_IncreaseDecreaseInNonCurrentAssets" order="7" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" order="10" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" xlink:label="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInNonCurrentAssets" xlink:label="elym_IncreaseDecreaseInNonCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" xlink:label="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="elym_RecoverableResearchAndDevelopmentTaxCredits" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="elym_PrepaidResearchAndDevelopmentExpenses" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssets" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RecoverableResearchAndDevelopmentTaxCredits" xlink:label="elym_RecoverableResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PrepaidResearchAndDevelopmentExpenses" xlink:label="elym_PrepaidResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:to="elym_AccruedResearchAndDevelopmentExpenses" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" xlink:label="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_AccruedResearchAndDevelopmentExpenses" xlink:label="elym_AccruedResearchAndDevelopmentExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>elym-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-08T15:43:57.2159+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" xlink:href="elym-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" xlink:href="elym-20210930.xsd#StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" xlink:href="elym-20210930.xsd#DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:href="elym-20210930.xsd#DisclosureInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:href="elym-20210930.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" xlink:href="elym-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" xlink:href="elym-20210930.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" xlink:label="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" xlink:label="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAccretionReductionToRedemptionValue" xlink:label="elym_TemporaryEquityAccretionReductionToRedemptionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="elym_TemporaryEquityAccretionReductionToRedemptionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1PreferredStockMember" xlink:label="elym_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1PreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member" xlink:label="us-gaap_FairValueInputsLevel12And3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="elym_ProceedsFromIssuanceInitialPublicOfferingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairValueLevel1Level2AndLevel3TransferAmount" xlink:label="elym_FairValueLevel1Level2AndLevel3TransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwritingDiscount" xlink:label="elym_UnderwritingDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel12And3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_ProceedsFromIssuanceInitialPublicOfferingNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_FairValueLevel1Level2AndLevel3TransferAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="elym_UnderwritingDiscount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ShortTermMarketableSecuritiesMember" xlink:label="elym_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_LongTermMarketableSecuritiesMember" xlink:label="elym_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="elym_ShortTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateBondSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="elym_LongTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_InterestReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateBondSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityIssuePrice" xlink:label="elym_TemporaryEquityIssuePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityIssuePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesARedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnderwrittenPublicOfferingMember" xlink:label="elym_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="elym_SeriesARedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CumulativeDividendsReceive" xlink:label="elym_CumulativeDividendsReceive"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_RedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_RedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_PercentageOfTemporaryEquitySharesOutstanding" xlink:label="elym_PercentageOfTemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" xlink:label="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionDate" xlink:label="us-gaap_PreferredStockRedemptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="elym_UnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesARedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_CumulativeDividendsReceive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_RedeemableConvertiblePreferredStockTrancheLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_PercentageOfTemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockRedemptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" xlink:label="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" xlink:label="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1PreferredStockMember" xlink:label="elym_SeriesA1PreferredStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="elym_SeriesA1PreferredStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" xlink:label="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_SeriesA1TrancheCallOptionMember" xlink:label="elym_SeriesA1TrancheCallOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDiscountRate" xlink:label="elym_TemporaryEquityDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityDividendYield" xlink:label="elym_TemporaryEquityDividendYield"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedTerm" xlink:label="elym_TemporaryEquityExpectedTerm"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityExpectedVolatility" xlink:label="elym_TemporaryEquityExpectedVolatility"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityProbabilityOfMilestoneAchievement" xlink:label="elym_TemporaryEquityProbabilityOfMilestoneAchievement"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityStrikePrice" xlink:label="elym_TemporaryEquityStrikePrice"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TemporaryEquityFairValueOfEachTrancheFeature" xlink:label="elym_TemporaryEquityFairValueOfEachTrancheFeature"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="elym_SeriesA1TrancheCallOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityDiscountRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityDividendYield" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityExpectedTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityExpectedVolatility" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityProbabilityOfMilestoneAchievement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityStrikePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="elym_TemporaryEquityFairValueOfEachTrancheFeature" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandNineteenEquityIncentivePlanMember" xlink:label="elym_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_StockOptionsMember" xlink:label="elym_StockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="elym_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_EsppMember" xlink:label="elym_EsppMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_ExecutiveOfficerEarningContribution" xlink:label="elym_ExecutiveOfficerEarningContribution"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_FairMarketValueCommonStockPercentage" xlink:label="elym_FairMarketValueCommonStockPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_TwoThousandNineteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="elym_StockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_TwoThousandTwentyOneEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="elym_EsppMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="elym_ExecutiveOfficerEarningContribution" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="elym_FairMarketValueCommonStockPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_CommonStockOptionsMember" xlink:label="elym_CommonStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="elym-20210930.xsd#elym_UnvestedRestrictedStockAwardsMember" xlink:label="elym_UnvestedRestrictedStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="elym_CommonStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="elym_UnvestedRestrictedStockAwardsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>elym-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-08T15:43:56.3265+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://eliemtx.com/20210930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:elym="http://eliemtx.com/20210930" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elym-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elym-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elym-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elym-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" id="Role_StatementCondensedConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2" id="StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2">
        <link:definition>100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited">
        <link:definition>100050 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" id="StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical">
        <link:definition>100060 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows" id="Role_StatementCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies" id="Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Description of Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments" id="DisclosureInvestments">
        <link:definition>100090 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts" id="Role_DisclosureCertainBalanceSheetAccounts">
        <link:definition>100100 - Disclosure - Certain Balance Sheet Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" id="Role_DisclosureRedeemableConvertiblePreferredStock">
        <link:definition>100110 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability" id="Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability">
        <link:definition>100120 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100130 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100140 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders" id="Role_DisclosureNetLossPerShareAttributableToCommonStockholders">
        <link:definition>100150 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>100160 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100170 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100180 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables" id="DisclosureInvestmentsTables">
        <link:definition>100190 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables" id="Role_DisclosureCertainBalanceSheetAccountsTables">
        <link:definition>100200 - Disclosure - Certain Balance Sheet Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" id="Role_DisclosureRedeemableConvertiblePreferredStockTables">
        <link:definition>100210 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables" id="Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables">
        <link:definition>100220 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100230 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables" id="Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables">
        <link:definition>100240 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100250 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails" id="Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails">
        <link:definition>100260 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails" id="DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails">
        <link:definition>100270 - Disclosure - Investments - Investments consists of available-for-sale securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" id="DisclosureInvestmentsAdditionalInformationDetails">
        <link:definition>100280 - Disclosure - Investments (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" id="Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
        <link:definition>100290 - Disclosure - Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails" id="Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails">
        <link:definition>100300 - Disclosure - Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails">
        <link:definition>100310 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100320 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails">
        <link:definition>100330 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails">
        <link:definition>100340 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails">
        <link:definition>100350 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100360 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails">
        <link:definition>100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails" id="Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails">
        <link:definition>100390 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails" id="Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails">
        <link:definition>100400 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails" id="Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails">
        <link:definition>100410 - Disclosure - Stock-Based Compensation - Summary of Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails" id="DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>100420 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails" id="DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut" id="DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut">
        <link:definition>100440 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>100450 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" name="AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" name="AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_AccruedResearchAndDevelopmentExpenses" name="AccruedResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" name="ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock" name="ConversionOfRedeemableConvertiblePreferredStockToCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_CumulativeDividendsReceive" name="CumulativeDividendsReceive" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_ExecutiveOfficerEarningContribution" name="ExecutiveOfficerEarningContribution" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" name="ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" name="ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_FairMarketValueCommonStockPercentage" name="FairMarketValueCommonStockPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="elym_FairValueLevel1Level2AndLevel3TransferAmount" name="FairValueLevel1Level2AndLevel3TransferAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" name="IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_IncreaseDecreaseInNonCurrentAssets" name="IncreaseDecreaseInNonCurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_PercentageOfTemporaryEquitySharesOutstanding" name="PercentageOfTemporaryEquitySharesOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_PrepaidResearchAndDevelopmentExpenses" name="PrepaidResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_ProceedsFromIssuanceInitialPublicOfferingNet" name="ProceedsFromIssuanceInitialPublicOfferingNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" name="ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" name="ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_RecoverableResearchAndDevelopmentTaxCredits" name="RecoverableResearchAndDevelopmentTaxCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_RedeemableConvertiblePreferredStockTrancheLiability" name="RedeemableConvertiblePreferredStockTrancheLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_ResearchAndDevelopmentExpenseRelatedParties" name="ResearchAndDevelopmentExpenseRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_ReserveStockSplitPolicyPolicyTextBlock" name="ReserveStockSplitPolicyPolicyTextBlock" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityAccretionReductionToRedemptionValue" name="TemporaryEquityAccretionReductionToRedemptionValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" name="TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" name="TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityDiscountRate" name="TemporaryEquityDiscountRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityDividendYield" name="TemporaryEquityDividendYield" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" name="TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityExpectedTerm" name="TemporaryEquityExpectedTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityExpectedVolatility" name="TemporaryEquityExpectedVolatility" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityFairValueOfEachTrancheFeature" name="TemporaryEquityFairValueOfEachTrancheFeature" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityIssuePrice" name="TemporaryEquityIssuePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityProbabilityOfMilestoneAchievement" name="TemporaryEquityProbabilityOfMilestoneAchievement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" name="TemporaryEquityStockIssuedDuringPeriodShareNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityStrikePrice" name="TemporaryEquityStrikePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_UnderwritingDiscount" name="UnderwritingDiscount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="elym_CommonStockOptionsMember" name="CommonStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_EsppMember" name="EsppMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_LongTermMarketableSecuritiesMember" name="LongTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember" name="RedeemableConvertiblePreferredStockTrancheLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesA1PreferredStockMember" name="SeriesA1PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesA1RedeemableConvertiblePreferredStockMember" name="SeriesA1RedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" name="SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesA1TrancheCallOptionMember" name="SeriesA1TrancheCallOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" name="SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesARedeemableConvertiblePreferredStockMember" name="SeriesARedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_SeriesBRedeemableConvertiblePreferredStockMember" name="SeriesBRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_ShortTermMarketableSecuritiesMember" name="ShortTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_StockOptionsMember" name="StockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_TwoThousandNineteenEquityIncentivePlanMember" name="TwoThousandNineteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_TwoThousandTwentyOneEquityIncentivePlanMember" name="TwoThousandTwentyOneEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_UnvestedRestrictedStockAwardsMember" name="UnvestedRestrictedStockAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="elym_InitialPublicOfferingPolicyTextBlock" name="InitialPublicOfferingPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_LiquidityPolicyTextBlock" name="LiquidityPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_RisksAndUncertaintiesPolicyTextBlock" name="RisksAndUncertaintiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" name="ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" name="ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" name="RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="elym_TemporaryEquityDisclosureTextBlock" name="TemporaryEquityDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>elym-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:elym="http://eliemtx.com/20210930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="elym-20210930.xsd" xlink:type="simple"/>
    <context id="C_68f7e8b4-274f-4fe8-b269-524e2cacfad2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:EsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_c9f66eae-8887-4a36-997b-b20ccec6a003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_b6b57452-47f5-4388-a412-3f3ba1283020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_240f8cde-e329-49df-8877-bf46eeb51205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_471f6e68-ef76-445c-b86e-f172ff3b5785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_340d9bd0-d7ea-4047-a232-5b317397c002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_68582859-0096-46e8-8bb0-1a00b93cbdf0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_13f227b3-c2ea-418b-951c-f0a483067432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_4a8d8b13-384d-41d2-8000-99caf630a9b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_9f661c20-6f08-4391-8bc7-a8daecf3219b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_5b3c644e-edca-435e-b343-309e123a2ea3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_531646ff-7d69-4062-a71d-4de0f8f78fed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_645dc54a-5fc5-4131-a259-f5bbd15481e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_a08166e1-5c98-4297-81ec-f148b463fbeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_593e17e9-ffd0-4218-9443-cc138e4c41d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_b78178eb-00d0-406e-baa2-53b8b434c787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_347b031c-725b-474a-9a52-13972c241f68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_8f44875f-fa81-4c6f-a4d8-7bccd495c678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_ad6f985b-b398-416c-a97e-19ed5c2ba56c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_3d855745-343a-4c58-aacc-25642060cf47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_4a876d31-7de7-495b-a7b5-bba7c9a4a7d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_c86051eb-0d3e-4119-82d7-626225e4cc0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_e50b5ef4-1e50-483c-b6d3-4444344701f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_844e6091-3490-47b1-ba64-9d928eb8531d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_4d7d035a-64cf-46ac-a997-043054a67440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_49b12a98-c4f0-494b-bb47-7d43ab89b59f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_4ed1c900-e113-443f-a67b-a7be04e9fecf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_3c1f890e-2a01-4903-afa6-61704660b423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_55e83e5b-e1f0-4f60-8528-da2a67b8a332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_a0e75eaf-c8c0-4041-b14e-3d776b96ecb0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_308a931a-0338-4cef-80b1-90d2080e2ef4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_1335aefe-f684-4dfb-84f4-21a81a7b3905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0f1a829c-ed84-4c89-b645-95747568e8c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_93109258-498b-4c14-93fc-9952e94ea8f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_71ae99b8-6442-4275-bd07-b38f55d947bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_fa7a0150-db25-4f6d-8b6e-4487da4738f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_02ca6dff-2485-430e-84db-9a99d6227383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_c1ac6833-38fa-4679-a86b-de27670a06dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_50f80129-d404-4d29-a58a-3d06114b7d2a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_37af721e-0687-4647-a911-6481229378d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_54207afe-8ac8-4d70-9d88-5a5cc0805155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3316dedf-bc1e-41a0-9dd7-e5ff0ba3463b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_c979a217-c5e3-4cc3-a4c8-2ea6f9acc46d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_e16d4b2c-90c7-4cf7-89fb-de39e5cd2c7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_72d3a4a0-a7dd-4cce-b4cd-5ceeab4550af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_34d11ddd-adb9-490d-935d-6318e8747598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_7a07cf1a-9b36-4553-a382-4b7030b2b6fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_8793bdfe-da79-41be-90e0-59ecbd5154a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_ad1bea71-dec8-49f4-8388-dcc31f1a917a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_0950534c-0e42-47f2-9fff-61cb3af705cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_bae15c67-f4c8-4995-984c-a35ab4ed4694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_2019ec91-516c-4bf3-ac1b-fa77f62f2f90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="C_1a65d3f7-d7e5-4d07-9686-97499e60085d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5789f58a-2e10-4100-9e66-25c8a9b30a0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f078b167-0dbc-4247-867c-2c3caced4b04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_8b74eebe-7367-44f3-89a2-41a2ae3c4f6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_81c02b73-1cfc-43ff-81c8-ad3d786216a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">elym:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_66d4dd4a-39ec-4e58-a0db-4d2f02dce3b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:EsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_5ace5a9e-cd32-4d91-b90b-5a3b7e9a6f23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_3e8bd169-1cd0-4494-b634-7a499711cee0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_95fcdeb7-8d75-4866-b9b3-f9a0ef7464a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_1f934220-7227-455a-a222-d949fb36f763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0d1271c8-61fb-4654-8d3a-3c7dc98c3046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_4dd18ba3-1af3-403a-a4dd-75dd15b5568f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_969acfbd-1a24-44dd-a3fe-5aa7b81c5654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_90f3cb70-fc4d-4dc8-b871-9fbf79d9d423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_9a126cdb-371c-4e20-aaf9-f06be6c3406a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_438167c9-390f-440b-bc81-485d4089e8fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_61c4932e-fb1e-472e-b741-e5bb1f637f14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_2ead6c6d-1e36-4252-80e7-a03d15dab206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_d57b29e1-52ee-4b19-9fdc-0dcbcf61ce63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_8865c8f2-5fc8-47cb-be44-ea1ba848844c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_4a372294-5c08-4856-8ab5-1e655a909612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_31b8ed67-f03c-4547-8524-ec693e5089df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_049452a9-fc43-43c7-8a1c-3587620997bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_cea26e02-7880-4f1c-83d4-65fc62248c5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_ea28cdf2-fea4-428a-98b1-56bb6cc26c9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_b4227218-0fbb-4ded-b156-157f89ae7254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_9af81434-0b8f-4b94-835b-f7c9145d2966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_21615b53-9670-4e5e-9edd-186adb41d615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_b3f43bab-a6cb-4d81-a307-cb587d9e5ead">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_03e5d18b-f2bb-400c-bc23-acf4b46aceb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_3ed3a81a-7827-4cef-8afe-082b91627928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0791263e-f277-474d-b34a-5bf44a42eeb0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_aec7af12-734e-49d6-876e-4f51ec91a65e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_481e58e9-cf0c-4dd5-a802-7bc69141a9ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_d491de55-e878-46da-a26f-9d31bf0a5efa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_9ec6ede2-f478-478a-b73b-15c197d0267f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_46ca06ae-f957-4d6e-af82-97b092ac535d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_83a11aaf-7840-457e-9202-2ea0f69ba41f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_5ab82fd0-f468-46f6-9578-f2c09bf493a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_d49ac965-16d2-49f6-8496-6b6bd4de9295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_64c92ae1-3adc-4f1d-b3af-072fddc18c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_2aa7983d-2e71-4d10-bac5-a6414b081d2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_9991e520-51cf-427f-89de-e1753fed04a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_75286094-929a-4cd3-b751-e628bfe63388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_3e199be2-33a5-477c-a0da-56b294f88cd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_ddf6340c-4eb3-4c81-96c0-c3840a43b061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_2392a1b8-059d-420a-a61d-e8a43d080997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_f03dc908-cddc-420d-9f23-e55b22233be8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_e4be4acd-0552-45c9-9ae0-524e93aee408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_86547cb0-3862-4a95-981d-e7e9f18fd071">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_398fad3d-4870-4949-9d7c-6dfc42616d57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_e0d329b9-6c79-4719-a2f5-874661472d87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">elym:SeriesA1TrancheCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_cce22c4e-7230-4435-ad69-db554d6a00a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_5b84124c-9c47-43b4-84c4-b441d84b7611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_3a75adc8-6494-436d-8e73-ab1898a3f4a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_fcf7810e-cac0-4293-8256-a2a97feb91f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_dba68e91-f80f-4784-96e6-c91207909a6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_1a46cf12-25cf-4536-bbb3-735a35b5967e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_79e4fccb-c419-40b4-9864-4b8eeee9746d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_58902cc5-c0a4-4b35-962a-3a2dc5e8d973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0baa77a4-0ccf-4e25-9f89-25825a5dd5de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_3a9e7f57-d4e5-4367-8742-49198b69b770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_6c88688a-cb57-432a-9574-d7f050357c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_48b80c70-8600-4f46-a177-2157d5d486f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_e66b3150-0c6b-4578-9500-22dc6c115867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">elym:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_f32fa3fe-04ff-4f37-9cda-74b7fa643680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_c81c2950-d46e-4287-a0f4-4964fefc37bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_861dbad3-d53a-4204-a645-525cd720e7a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_921214ea-f1eb-402a-b0d4-e85238b44c06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_6cba2cd1-feca-4dac-af1b-4c2e02d95093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_73fac32b-1946-4425-9058-8304c2ddbf20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_35048792-ecdc-4ad5-96d7-88fe71e99d94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_3e5d32c4-3b28-4cb4-944a-cb5fad009173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_3b30f421-7970-424e-addd-c4971489194f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_ed02f132-4271-4596-83d9-8aea2fbffae7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_ba7c150f-8562-403b-bdbc-e0b6db0cec39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_48c9728b-916c-42b6-8e04-80f3aed9bdaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_87892d72-2788-4288-9f97-01316b8174e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">elym:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_9966861e-a257-4483-a647-6780eab777a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_b3e80fb2-f161-4a38-a1e3-c8d52f228cee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_573f20af-85b7-4cca-9a77-16dd39a823ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_31769d99-77c6-4ee7-9d41-eb3e0d4c18c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">elym:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_5ceab66a-25cf-4427-b629-b07de4d324b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">elym:UnvestedRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_c6f17551-2fcd-44a6-8f39-eb07919299f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_9e23dbd6-7d37-4dc5-857b-7212c0ea9084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_467945a5-3ec2-4005-a9d6-1240297ff054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">elym:RedeemableConvertiblePreferredStockTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_12bd7c9a-9686-44a2-803f-a81d4cdeccf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_91e85f77-84b1-41c9-939d-ce1d423da25a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_5f6cd6f8-2b85-43a3-8604-dcd98e7b76d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_26dc1ae5-daf7-4353-af46-9f523316d9d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_ac126da1-96bb-4ee7-9242-49c11ef12bd4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">elym:SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_db5a93dd-38e3-4ced-bd29-6d7309409a64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="U_USDollarShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0"
      id="F_cad6912b-f4dc-44a2-b287-0fa48d3726a3"
      unitRef="U_USD"
      xsi:nil="true"/>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards
      contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997"
      id="F_54b7083d-4cd2-4ee7-b111-7a31a0b56b00"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_f161b092-35d8-4378-b101-d067bf0d0c7b">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9a126cdb-371c-4e20-aaf9-f06be6c3406a"
      id="F_2455f9e5-7001-4416-b693-e07b21507683"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4a372294-5c08-4856-8ab5-1e655a909612"
      id="F_952dab32-e751-422e-a571-f065e2503d1d"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_cea26e02-7880-4f1c-83d4-65fc62248c5f"
      id="F_0caf0953-2fe3-4856-a0d2-4263052be7e7"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_85f6ec00-71a2-4fee-a7e6-4e208f9bedb2">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0"
      id="F_18b1fff5-aa6f-4693-afe4-8fed26a3316f"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_5789f58a-2e10-4100-9e66-25c8a9b30a0d"
      id="F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      id="F_bdf1698b-4c4f-4e4e-86e5-5c9d69711ce1"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6cba2cd1-feca-4dac-af1b-4c2e02d95093"
      id="F_f0adb4f9-e15c-4b6b-8040-c551c670f74b"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0"
      id="F_536e3532-29ed-4c37-90c2-0ddc3fddf513"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_4a8d8b13-384d-41d2-8000-99caf630a9b4"
      id="F_0004fd8e-d21f-4b53-971f-f43d8e0443dd"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_91b8529f-2f92-40c3-aca7-45631fc73d32">false</dei:AmendmentFlag>
    <us-gaap:PreferredStockRedemptionDate
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_48b04b20-61bc-4a16-8826-6dea6acb138e">2026-10-31</us-gaap:PreferredStockRedemptionDate>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6c88688a-cb57-432a-9574-d7f050357c95"
      id="F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_438167c9-390f-440b-bc81-485d4089e8fa"
      id="F_bb574e2b-e549-41d5-a114-d1eae627d3de"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_1f36fdf3-3b2c-43f0-b0ad-cd794e2c3a23">0001768446</dei:EntityCentralIndexKey>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_573f20af-85b7-4cca-9a77-16dd39a823ea"
      id="F_4ee89191-586d-4bd2-97cb-383860193695"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_48c9728b-916c-42b6-8e04-80f3aed9bdaa"
      id="F_caca09e3-072e-4355-8e2b-6979c157fdd0"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      id="F_34f12efc-296e-4e51-8096-c241fee45935"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997"
      id="F_b192cd7e-2aa4-4bde-a1f3-86421ba91240"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_34d11ddd-adb9-490d-935d-6318e8747598"
      id="F_8774bdeb-cb3d-48e2-a101-98fadcdf44be"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_fcf7810e-cac0-4293-8256-a2a97feb91f8"
      id="F_237ebc67-be1b-4813-8e0c-2b9924f70c1a"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_8af660b6-f65c-4046-b7c8-c16bce3ae9eb">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_fbafd745-a682-41a3-9cd4-7e3ad106437c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_6d7ac858-7673-46cc-9db2-2c34a96fbb1b">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_356c6a53-1721-4364-9043-390a0670a767">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_fdb55e41-d165-4e6d-ba34-8ccafba92fe6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_9ecbe7fa-f40e-4af9-8d92-ea449140a922">001-40708</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_1cae572d-dd5b-4433-b4eb-4df86881558d">ELIEM THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_f7353715-2f60-4746-93d4-4ad0b22212bc">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_161ef73f-3b05-4d7b-b1e0-0770771b7ddd">82-2273741</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_54daa2fd-1a62-4e4b-af49-1e8209dfb4fa">23515 NE Novelty Hill Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_6dc4911b-f70f-48d0-9208-9c6657c85e5c">Suite B221 #125</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_7ef6e600-aad9-4a99-afee-33faf8745637">Redmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_ee008c7d-9842-40ae-89a1-183683127aab">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_064de2cd-0128-4dd0-8b4f-522bf7c94830">98053</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_2efcf921-45af-4794-a7af-013fc8ea6cad">425</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_af9b1a65-9f20-4f70-9cdd-020d8274a774">276-2300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_aabe3c28-63f1-49e4-b166-ad47d6e81a70">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_dac1e5f9-2d98-426e-addf-3d38e554020b">ELYM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_57c1ac5f-b584-4931-a251-9637eeff5799">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_41b3b642-083b-4c8f-8a41-bfde9d30a696">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_2a6d0b0d-a897-4f9d-816f-dbeaa59ccb07">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_c436557d-37d0-4fcc-8e8b-cfa0b38c908d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_151309dd-93b3-4c57-acc5-667e75c7dcea">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_0d040d2e-302b-4a0d-9335-d73d67795daf">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_9131f262-e5d9-4fec-99c9-10df724c3541">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_365481ed-f40e-4993-9d0c-f45880d4eb48">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_2019ec91-516c-4bf3-ac1b-fa77f62f2f90"
      decimals="0"
      id="F_e378259f-4c8c-4608-9df4-1b3ea91daf20"
      unitRef="U_shares">26554316</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_dae021a7-a44f-4c1a-b95a-2598f788a7dd"
      unitRef="U_USD">62819000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_fa53f4bf-2f72-4dae-8e51-a1a4a81ce1b3"
      unitRef="U_USD">20487000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_2c16731a-1fc5-4600-8464-3157a16c31b3"
      unitRef="U_USD">83199000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_3a723eaf-97a4-4d5a-bc85-0b55153a5e89"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_7d26b063-3a06-4286-8970-4b312d260958"
      unitRef="U_USD">12614000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_0e2df3de-7ad7-494a-b374-d860d496ebab"
      unitRef="U_USD">1511000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_4eab7d42-14e7-438b-a366-a6d9d13c1637"
      unitRef="U_USD">158632000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_55c19dd3-8ee7-4bb6-a9af-2e93f940c33f"
      unitRef="U_USD">21998000</us-gaap:AssetsCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_3f6e64e4-60cb-43fa-8b6f-1d7e2f3a53e3"
      unitRef="U_USD">23619000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_8a55e454-2b3f-4ae3-8d4b-4958c4f09735"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_8efa8076-82b2-4669-a7d1-bbe9f7e36787"
      unitRef="U_USD">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_4ba55fd0-1bf5-47b0-ac0d-858a5729bea8"
      unitRef="U_USD">2633000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_52a317dd-14d0-4dcd-9725-d0cd876b036e"
      unitRef="U_USD">182251000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_62136ecc-2e4b-4de5-b721-59d2ce2f1fe1"
      unitRef="U_USD">24631000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_615e07d2-753e-4ef9-a349-a52c26dbd604"
      unitRef="U_USD">2579000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_2197cb6a-d396-4d4f-8da4-23ab41a9b185"
      unitRef="U_USD">1086000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_f8b895d2-5d90-401b-ace2-0d8c16d79e93"
      unitRef="U_USD">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_d1ad18dd-222d-4c06-9d7e-fcfe25afea14"
      unitRef="U_USD">207000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_913f4aca-a230-4c30-a3d9-780bd465f27a"
      unitRef="U_USD">2979000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_d0d7c083-cda9-4513-9563-2147b6673bd3"
      unitRef="U_USD">1219000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_caf6c7f3-4af7-4119-95ef-83918c8fd9ba"
      unitRef="U_USD">32000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_7e2d1c6f-157a-4506-88f0-5eea8a7fdc83"
      unitRef="U_USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <elym:RedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_166e0603-a048-4999-ba59-0f8d9f2f0072"
      unitRef="U_USD">0</elym:RedeemableConvertiblePreferredStockTrancheLiability>
    <elym:RedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_98c6346b-b1f3-4839-a917-7a0b924db5cd"
      unitRef="U_USD">551000</elym:RedeemableConvertiblePreferredStockTrancheLiability>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_a070d7a0-6702-4682-a48a-cdb5fb91f849"
      unitRef="U_USD">5590000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_2b7a166a-3ef8-41ea-a100-3ec091d2bb18"
      unitRef="U_USD">3063000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_7c0a11a4-ddc1-443d-9454-760f9cb89a99"
      unitRef="U_USD">5590000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_3b465d92-25b2-49de-8ac1-ef7a48db5872"
      unitRef="U_USD">3063000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="4"
      id="F_3663ea36-2eb8-4fd3-82ea-e79c03645c76"
      unitRef="U_USDollarShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="4"
      id="F_4d2e6215-cc1c-40f1-89bb-4a0aceb13864"
      unitRef="U_USDollarShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="0"
      id="F_63463708-15ea-465d-afdb-181869fb33fb"
      unitRef="U_shares">10000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_b17ee0fd-0de8-4356-a145-e06ccd89838a"
      unitRef="U_shares">12909389</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_86cf786b-7d24-4949-b5b0-3eab08e1fd05"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_3f60985d-e15f-4385-8360-444314d31d9b"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_89999fb9-14c6-4bb9-ba32-375b4d526a20"
      unitRef="U_shares">7140157</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_7c91c613-50fd-4913-bc94-b098958eeb93"
      unitRef="U_shares">7140157</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_d4671cc6-4602-43cd-bcd8-606cd6b11f05"
      unitRef="U_USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_7e1fefb5-7812-4aae-a7d2-bda8e8cd6b4d"
      unitRef="U_USD">49891000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_bf4be240-a051-43f9-adea-9b69f40f22c6"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_de650fb0-e03c-4f1a-b87f-be967f9eb96e"
      unitRef="U_USD">46551000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="4"
      id="F_fb4d4505-fd5f-452a-99d2-6aa0405c6374"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="4"
      id="F_657bcf5b-4c36-4e74-ac13-ae5d61a6fe86"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_7027728a-c77f-46f6-bf69-2c6f5a2c9143"
      unitRef="U_shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_b234835b-fffd-405e-80e5-8f902f36d53b"
      unitRef="U_shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="0"
      id="F_6132c1db-bfae-4ec4-aaaf-eaf068ee2b99"
      unitRef="U_shares">26199262</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="0"
      id="F_17b97c44-eedb-4f11-8353-570e404c4cbe"
      unitRef="U_shares">26199262</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="0"
      id="F_df3c512b-964a-4689-a70e-4ca3dc4bc19d"
      unitRef="U_shares">3418751</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="0"
      id="F_cfce7194-71f5-4237-a18c-0f15a63c74fa"
      unitRef="U_shares">3418751</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_5766b0b4-258f-40d8-8bff-21b2794a82cf"
      unitRef="U_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_2356fd64-ad9d-4d20-8ae2-5d933e7ade8d"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_bef672de-198b-4dc0-9238-2656d3b6ebea"
      unitRef="U_USD">241747000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_72e9da31-5ad3-457a-affa-764eda0d5ae3"
      unitRef="U_USD">3152000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_7b01ae11-03b6-44af-a8fb-6000b14ecff4"
      unitRef="U_USD">-18000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_7b87c502-4f9b-4707-9def-e1449db3937e"
      unitRef="U_USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_be8fa30d-7801-49e7-9e8b-00db1196fc9b"
      unitRef="U_USD">-65071000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_a0565cb9-1503-4af2-a134-d96a0747800d"
      unitRef="U_USD">-28136000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_dbf50086-a905-459c-9d1e-0e34d2a04f0a"
      unitRef="U_USD">176661000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_f3c382a8-cc5d-4986-8e3e-e7885a7e4717"
      unitRef="U_USD">-24983000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_0d6cdf81-875a-4761-a54f-c730cc2fe141"
      unitRef="U_USD">182251000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_462fbc64-3693-4c60-a3ec-0f8353a18b68"
      unitRef="U_USD">24631000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_fb73b728-df1f-4478-8a37-afeaf050c441"
      unitRef="U_USD">5704000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_268e989e-095b-4cb3-8457-6f50bee913bb"
      unitRef="U_USD">1930000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_89ab67d4-f132-4dd7-85a3-5256c7c9df4c"
      unitRef="U_USD">15455000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_40697878-1f5b-4165-86da-a4ad432cb136"
      unitRef="U_USD">4644000</us-gaap:ResearchAndDevelopmentExpense>
    <elym:ResearchAndDevelopmentExpenseRelatedParties
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_0c01ae15-bcae-49f1-a355-7ddedb142f07"
      unitRef="U_USD">285000</elym:ResearchAndDevelopmentExpenseRelatedParties>
    <elym:ResearchAndDevelopmentExpenseRelatedParties
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_8bfca85a-178e-4eec-9d53-fca7fd5e83d8"
      unitRef="U_USD">17000</elym:ResearchAndDevelopmentExpenseRelatedParties>
    <elym:ResearchAndDevelopmentExpenseRelatedParties
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_98af3a13-e6d6-4980-a756-04023c16f7ee"
      unitRef="U_USD">988000</elym:ResearchAndDevelopmentExpenseRelatedParties>
    <elym:ResearchAndDevelopmentExpenseRelatedParties
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_72366703-30a0-428a-b6a4-6e8e416a131b"
      unitRef="U_USD">286000</elym:ResearchAndDevelopmentExpenseRelatedParties>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_817241fa-b496-472a-b5c2-16cde7b8a58e"
      unitRef="U_USD">3394000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_a15fac6b-3fbc-48d8-bbb6-ebc26c84e2cb"
      unitRef="U_USD">312000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_749fa255-5192-43bc-94c5-f31052690f86"
      unitRef="U_USD">8526000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_a7bf4f1b-86a5-4616-9f7c-c7cd3939f1d8"
      unitRef="U_USD">888000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_89bcc640-0d17-4aa9-90fe-01fafc4274ca"
      unitRef="U_USD">9383000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_9f24eded-d203-46bb-bf68-8179d651fbd4"
      unitRef="U_USD">2259000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_5b5e110a-9d69-4dfd-8816-28c80ee5bdb7"
      unitRef="U_USD">24969000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_bc333a01-2732-4fd0-895c-bcf38681da65"
      unitRef="U_USD">5818000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_054f2109-e7b0-4380-b640-c6fa646ce2d0"
      unitRef="U_USD">-9383000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_58ca2e72-d1b6-42e7-b693-f7f0317e94df"
      unitRef="U_USD">-2259000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_e2354fe1-43b3-4c58-b0f1-230c3456235f"
      unitRef="U_USD">-24969000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_0d045293-026a-4184-8ca9-0cae99b79ef7"
      unitRef="U_USD">-5818000</us-gaap:OperatingIncomeLoss>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_b32a9be3-05e9-4e7a-a00e-18e27b0c06f9"
      unitRef="U_USD">0</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_1343524e-1809-4bd0-be32-49f2b0f95ffc"
      unitRef="U_USD">0</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_b2768036-4b04-48e6-91fc-fe2ff565ce1f"
      unitRef="U_USD">11718000</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_77ff43a5-5234-4a5a-8581-e924aa1b85fd"
      unitRef="U_USD">0</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_70224af5-b951-4f00-b887-a8793dcd0cb4"
      unitRef="U_USD">-252000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_98a844b7-55e0-4f9c-a3ea-d77cec91396f"
      unitRef="U_USD">1000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_1435eaf8-db75-4f2f-8ff4-959cde163afb"
      unitRef="U_USD">-268000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_661dcf38-a793-469e-be8a-02def9459804"
      unitRef="U_USD">13000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_bd5b367d-a5e3-42fd-8d03-7ca9506e2c0d"
      unitRef="U_USD">20000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_c93a9cb1-61a8-44a0-be74-06ab6bbaa727"
      unitRef="U_USD">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_ec1c8603-aab6-493f-aaae-89413643c99c"
      unitRef="U_USD">20000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_b0f56a96-4bc8-4f51-9b3f-47e0f990adb7"
      unitRef="U_USD">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_73b8d965-0b1a-4431-b936-0ada48f0a5af"
      unitRef="U_USD">-232000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_7747478f-0ec5-4be8-b6d4-ff783bcbe61c"
      unitRef="U_USD">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_9d749f19-7723-40b8-862e-94e90933b546"
      unitRef="U_USD">-11966000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_9d50649e-7edd-48da-9f5e-4cf59254ed98"
      unitRef="U_USD">13000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_6730250b-17b4-49f9-9770-ea0bbc12f09a"
      unitRef="U_USD">-9615000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_ed9eb14b-797f-4216-8aa8-169a65070791"
      unitRef="U_USD">-2258000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_f00e5d61-223a-4763-8980-dd532104e404"
      unitRef="U_USD">-36935000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_cc78b34f-7c46-4c8c-9415-1ce05349bb64"
      unitRef="U_USD">-5805000</us-gaap:NetIncomeLoss>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_bd36e077-5b14-4b8f-bfec-32e1954b0738"
      unitRef="U_USD">1322000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_9d74468d-0c99-46af-9648-d548aaedc87b"
      unitRef="U_USD">461000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_a1fe7b3a-000b-497d-a237-d26c224781b1"
      unitRef="U_USD">4548000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_527e1007-b924-445d-a2dd-f07433b5abcb"
      unitRef="U_USD">1352000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_46c6dc90-2ffd-4cac-b7f9-7f1b8a60c0a3"
      unitRef="U_USD">-10937000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_be57334e-df62-4fe2-a69d-8c1957c7e6d9"
      unitRef="U_USD">-2719000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_e814ba58-c513-4c85-b10e-31337d620b48"
      unitRef="U_USD">-41483000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_73ca978c-ccbf-407c-be96-49cec9515dab"
      unitRef="U_USD">-7157000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="2"
      id="F_d27a5ca6-b287-4956-b56b-215293d44897"
      unitRef="U_USDollarShare">-0.70</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="2"
      id="F_0bf3094c-761e-4421-90d9-8b308c92ec65"
      unitRef="U_USDollarShare">-1.46</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_1a1ed7d4-ee0b-4890-aabb-bcca4e0b8ab2"
      unitRef="U_USDollarShare">-5.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="2"
      id="F_983d2492-3a21-47d6-9084-f3d2feaeb820"
      unitRef="U_USDollarShare">-3.85</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="0"
      id="F_7bc21c95-1bd2-4df7-a912-b529fc7a2f37"
      unitRef="U_shares">15585611</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="0"
      id="F_f8944854-d547-4fc1-94ae-d5dea583a720"
      unitRef="U_shares">1863860</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="0"
      id="F_6308d4c0-fb19-47d4-8cad-78afab034e6f"
      unitRef="U_shares">7554300</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="0"
      id="F_8fa0a573-1ce8-4b20-9be9-e694a46587a1"
      unitRef="U_shares">1859713</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_84baf45c-b9b1-43f6-875a-e37132840f86"
      unitRef="U_USD">-9615000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_76cf9a98-e99d-448a-bb0e-9d25452f5212"
      unitRef="U_USD">-2258000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_2d64bf5e-378d-4be2-ad0b-d46fae04be22"
      unitRef="U_USD">-36935000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_b12ce037-d561-4906-9ee8-6151f2b5bfe3"
      unitRef="U_USD">-5805000</us-gaap:NetIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_89b86afa-47d8-4e14-9a50-24aa9767f627"
      unitRef="U_USD">-18000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_e4a83641-156f-4ab0-94d5-7d23bfb9df9f"
      unitRef="U_USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_4e1170a7-da4f-4e4f-b723-c92f9afec674"
      unitRef="U_USD">-18000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_1ec7d6c5-9ceb-4148-855a-92c2e9a2eb7f"
      unitRef="U_USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_45d3922f-65df-423d-9238-8e93fff3e06c"
      unitRef="U_USD">-9633000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_0beafbc8-347f-4593-8169-b4599940859e"
      unitRef="U_USD">-2258000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_020ed3ff-2ece-4140-b4bd-0be81b4ac606"
      unitRef="U_USD">-36953000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_ae1ca670-d0ca-4bb6-932c-87794d2aea9a"
      unitRef="U_USD">-5805000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_83a11aaf-7840-457e-9202-2ea0f69ba41f"
      decimals="0"
      id="F_f1ed930e-e64f-4064-8703-7f6a5ef62861"
      unitRef="U_shares">7140157</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_83a11aaf-7840-457e-9202-2ea0f69ba41f"
      decimals="-3"
      id="F_0c11858e-cb94-4382-ac94-b7724910eb09"
      unitRef="U_USD">46551000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70"
      decimals="0"
      id="F_472f1814-4ae6-47e8-b7a4-872e5a86006e"
      unitRef="U_shares">3418751</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_179d19c2-e60b-48f3-8a1b-0d2d01c01e70"
      decimals="-3"
      id="F_2a7cdd4d-85fa-4523-bc6c-83408054820f"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fa7a0150-db25-4f6d-8b6e-4487da4738f3"
      decimals="-3"
      id="F_bab8c789-55a4-4969-8a9f-fe10a5904d26"
      unitRef="U_USD">3152000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5ab82fd0-f468-46f6-9578-f2c09bf493a4"
      decimals="-3"
      id="F_c1a62508-0fec-4abe-9343-085c10db798c"
      unitRef="U_USD">-28136000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9af81434-0b8f-4b94-835b-f7c9145d2966"
      decimals="-3"
      id="F_71d34bb5-0988-4b65-b8e5-7e3e0994c6ec"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_4f2cf233-fb1f-427b-a3e0-61f709e66758"
      unitRef="U_USD">-24983000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_921214ea-f1eb-402a-b0d4-e85238b44c06"
      decimals="-3"
      id="F_585d275d-4c78-4916-a832-08ea52afeb05"
      unitRef="U_USD">22000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues
      contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5"
      decimals="0"
      id="F_45d64305-0714-44ad-9910-7a8cdd65a512"
      unitRef="U_shares">4358972</elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5"
      decimals="-3"
      id="F_519305b4-5a2c-4bf8-b305-6a7acb40dfee"
      unitRef="U_USD">33978000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement
      contextRef="C_3e199be2-33a5-477c-a0da-56b294f88cd5"
      decimals="-3"
      id="F_4debfd41-7ad2-49bc-bf73-b666cc348479"
      unitRef="U_USD">12269000</elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares
      contextRef="C_03e5d18b-f2bb-400c-bc23-acf4b46aceb7"
      decimals="0"
      id="F_e7222176-3180-48b7-b142-f951a24d7b4b"
      unitRef="U_shares">64047</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards
      contextRef="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c"
      decimals="-3"
      id="F_de0ca3f4-ac55-4c9a-9b57-c251ac17ffd8"
      unitRef="U_USD">105000</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards
      contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df"
      decimals="-3"
      id="F_a830d764-0ffe-4d2d-89e4-4d9308658e95"
      unitRef="U_USD">105000</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_fcf0feaa-4fe9-4f2d-8772-0458b5a7fe5c"
      decimals="-3"
      id="F_bd20b005-66a1-4822-937e-bcc514863d74"
      unitRef="U_USD">297000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df"
      decimals="-3"
      id="F_b739564d-43e3-4a1a-a18d-35046642d5e6"
      unitRef="U_USD">297000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_75286094-929a-4cd3-b751-e628bfe63388"
      decimals="-3"
      id="F_e8876a94-24e5-47e7-9262-51dffdabe1db"
      unitRef="U_USD">-18601000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_31b8ed67-f03c-4547-8524-ec693e5089df"
      decimals="-3"
      id="F_173e9f2b-df0c-4952-be3d-f18f5fb28130"
      unitRef="U_USD">-18601000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_35048792-ecdc-4ad5-96d7-88fe71e99d94"
      decimals="0"
      id="F_accb6df7-64e9-4e29-a4e6-1b28d776b90b"
      unitRef="U_shares">11499129</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_35048792-ecdc-4ad5-96d7-88fe71e99d94"
      decimals="-3"
      id="F_d4259240-714e-46e7-bed0-c196347d5dba"
      unitRef="U_USD">92798000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_c1ac6833-38fa-4679-a86b-de27670a06dd"
      decimals="0"
      id="F_1d176c33-1662-4da8-91b3-cf0ff18dba62"
      unitRef="U_shares">3482798</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c1ac6833-38fa-4679-a86b-de27670a06dd"
      decimals="-3"
      id="F_01c5a4e6-19d1-4f39-a970-65a4ca9ca51a"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_347b031c-725b-474a-9a52-13972c241f68"
      decimals="-3"
      id="F_e761520c-d75d-4a00-896d-d61b69eac2eb"
      unitRef="U_USD">3554000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3a9e7f57-d4e5-4367-8742-49198b69b770"
      decimals="-3"
      id="F_55d48b8e-f187-47ca-851e-cbb0051d6856"
      unitRef="U_USD">-46737000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_844e6091-3490-47b1-ba64-9d928eb8531d"
      decimals="-3"
      id="F_ce123a77-a5cc-41ec-a098-c39f0d757d27"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2aa7983d-2e71-4d10-bac5-a6414b081d2c"
      decimals="-3"
      id="F_42b374fd-100c-431e-9a1e-8d4af2e768a5"
      unitRef="U_USD">-43182000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_55e83e5b-e1f0-4f60-8528-da2a67b8a332"
      decimals="-3"
      id="F_78f4dd84-8f4f-4fc4-a230-fea863514593"
      unitRef="U_USD">39000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues
      contextRef="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e"
      decimals="0"
      id="F_cb069e1d-0257-4914-b4ba-7b1a55c579d0"
      unitRef="U_shares">3846150</elym:TemporaryEquityStockIssuedDuringPeriodShareNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_e0b094cc-14ff-4ae4-8a14-8141fe7cae8e"
      decimals="-3"
      id="F_66de4a8b-2844-4ee7-9c61-833b3fd1cce9"
      unitRef="U_USD">59961000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares
      contextRef="C_e16d4b2c-90c7-4cf7-89fb-de39e5cd2c7c"
      decimals="0"
      id="F_0d2af29f-3131-4087-83a6-11369c40c05f"
      unitRef="U_shares">7158</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards
      contextRef="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c"
      decimals="-3"
      id="F_d03603f0-4e37-4848-884c-27e090fc0a0d"
      unitRef="U_USD">6000</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards>
    <elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards
      contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432"
      decimals="-3"
      id="F_bec18e16-9bca-4ba7-b3ba-a1c09f102349"
      unitRef="U_USD">6000</elym:ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_f31bcf0f-a372-4773-8767-9ef4a26ed25c"
      decimals="-3"
      id="F_a8cea1ca-2ede-4724-abb5-f6c126b8f59b"
      unitRef="U_USD">1050000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432"
      decimals="-3"
      id="F_df18bb81-7273-4010-b521-1776f91dd217"
      unitRef="U_USD">1050000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_2392a1b8-059d-420a-a61d-e8a43d080997"
      decimals="-3"
      id="F_c10edba3-291c-4874-9642-d4243803f840"
      unitRef="U_USD">-8719000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_13f227b3-c2ea-418b-951c-f0a483067432"
      decimals="-3"
      id="F_be0d2950-f25f-42bd-b8d1-63b95d087f28"
      unitRef="U_USD">-8719000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_c9f66eae-8887-4a36-997b-b20ccec6a003"
      decimals="0"
      id="F_d46f1883-ff41-49de-908c-1ecc91fcf662"
      unitRef="U_shares">15345279</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_c9f66eae-8887-4a36-997b-b20ccec6a003"
      decimals="-3"
      id="F_921d60d2-faca-417a-958f-447c50a98cda"
      unitRef="U_USD">152759000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_73fac32b-1946-4425-9058-8304c2ddbf20"
      decimals="0"
      id="F_0eff54bb-0368-4d68-9194-cfeb0e3e26b3"
      unitRef="U_shares">3489956</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_73fac32b-1946-4425-9058-8304c2ddbf20"
      decimals="-3"
      id="F_c53cb4c2-02fb-4454-9f3b-9f1cfbb00486"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_37af721e-0687-4647-a911-6481229378d2"
      decimals="-3"
      id="F_e0c64ae0-bef7-42bd-ad7d-7635799850da"
      unitRef="U_USD">4610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_861dbad3-d53a-4204-a645-525cd720e7a8"
      decimals="-3"
      id="F_b1fa709b-1949-4dd9-9f0c-91c5a21acda6"
      unitRef="U_USD">-55456000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b3e80fb2-f161-4a38-a1e3-c8d52f228cee"
      decimals="-3"
      id="F_57b9e1fa-c0ae-418b-9ce3-acc976447961"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_dba68e91-f80f-4784-96e6-c91207909a6b"
      decimals="-3"
      id="F_d5d8ad00-a2e7-46b3-9b79-08179f3e95bd"
      unitRef="U_USD">-50845000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_26dc1ae5-daf7-4353-af46-9f523316d9d9"
      decimals="-3"
      id="F_cb1cd009-d972-4c5e-b92c-89b80aca2f59"
      unitRef="U_USD">8856000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5"
      decimals="0"
      id="F_e9b0e173-9616-4ef3-bfad-9516443663a2"
      unitRef="U_shares">7360000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5"
      decimals="-3"
      id="F_3e4b9242-639d-43ed-95ba-a736f4d4eef8"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3"
      decimals="-3"
      id="F_470a9ae4-77cd-425d-88a9-040f16fe0e34"
      unitRef="U_USD">83143000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_054f8225-7331-48c3-aa38-23a588c1b60e"
      unitRef="U_USD">83144000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_b6b57452-47f5-4388-a412-3f3ba1283020"
      decimals="0"
      id="F_4d538b42-512a-4e1f-9d5c-1afcaf6cc93b"
      unitRef="U_shares">-15345279</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_b6b57452-47f5-4388-a412-3f3ba1283020"
      decimals="-3"
      id="F_e7f78601-2905-4055-8fb8-d869eb501991"
      unitRef="U_USD">-152759000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5"
      decimals="0"
      id="F_07a4ff9d-ed2d-41d0-8cc3-fca7a6a04a07"
      unitRef="U_shares">15345279</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5"
      decimals="-3"
      id="F_831f4172-16f5-4e67-9836-c703500d807b"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3"
      decimals="-3"
      id="F_10f4170c-12bd-4c59-bfc6-73359b839308"
      unitRef="U_USD">152758000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_dfef0c35-a03d-4261-ac74-4ff7f52b2cc3"
      unitRef="U_USD">152759000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_93109258-498b-4c14-93fc-9952e94ea8f5"
      decimals="0"
      id="F_aca553be-409b-459f-961d-ea32f8a97cee"
      unitRef="U_shares">4027</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_48b80c70-8600-4f46-a177-2157d5d486f3"
      decimals="-3"
      id="F_b1f5bd35-5c48-40ed-9b37-50865ca790ad"
      unitRef="U_USD">1236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_056a98a0-7520-4fa7-a693-df2b34a079cd"
      unitRef="U_USD">1236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_ad1bea71-dec8-49f4-8388-dcc31f1a917a"
      decimals="-3"
      id="F_19b5b083-3377-42b1-904c-4539dd2a5238"
      unitRef="U_USD">-18000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_b38f3351-2ab0-468f-b1fa-cfd3ce001a72"
      unitRef="U_USD">-18000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="C_68582859-0096-46e8-8bb0-1a00b93cbdf0"
      decimals="-3"
      id="F_632c56b1-e7ba-458a-95df-156fc6e9c9c4"
      unitRef="U_USD">-9615000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_1afc5f6d-26dd-4071-945f-0317eea3b074"
      unitRef="U_USD">-9615000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"
      decimals="0"
      id="F_60dcca79-04e2-4075-a71d-4ead571942fb"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"
      decimals="-3"
      id="F_87a8e4be-56fb-4779-b613-fa1764ec6d96"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_e4be4acd-0552-45c9-9ae0-524e93aee408"
      decimals="0"
      id="F_ee7009ee-6027-482a-978d-8718f7b62fde"
      unitRef="U_shares">26199262</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_e4be4acd-0552-45c9-9ae0-524e93aee408"
      decimals="-3"
      id="F_0019dc60-618b-4eae-a149-a16203f5f11a"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_95fcdeb7-8d75-4866-b9b3-f9a0ef7464a7"
      decimals="-3"
      id="F_37252ea2-a738-47e3-aa8e-35a3a1d8714a"
      unitRef="U_USD">241747000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ed02f132-4271-4596-83d9-8aea2fbffae7"
      decimals="-3"
      id="F_fa042bbc-b43f-4962-b076-95dd7b30fbd9"
      unitRef="U_USD">-65071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4ed1c900-e113-443f-a67b-a7be04e9fecf"
      decimals="-3"
      id="F_d024aa46-9a88-4ba4-9d89-648c80540672"
      unitRef="U_USD">-18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_71f546b1-1678-47aa-946b-fce31d6ec97d"
      unitRef="U_USD">176661000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_79e4fccb-c419-40b4-9864-4b8eeee9746d"
      decimals="0"
      id="F_6f453f6c-199e-41e4-a8c7-1d3fe94e7168"
      unitRef="U_shares">3999133</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_79e4fccb-c419-40b4-9864-4b8eeee9746d"
      decimals="-3"
      id="F_d1b612ad-aa06-46db-a785-66335837c9c2"
      unitRef="U_USD">26174000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3"
      decimals="0"
      id="F_6ff5908b-fd38-4f5c-940f-db8071fd011c"
      unitRef="U_shares">1852797</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_2f96dffb-d4d7-40ca-8098-2a3ad552b5e3"
      decimals="-3"
      id="F_e0d494e7-b563-4664-adb9-2e1c18e465ab"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_471f6e68-ef76-445c-b86e-f172ff3b5785"
      decimals="-3"
      id="F_059a1a5b-0953-4617-949c-b722be7ad591"
      unitRef="U_USD">1905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3316dedf-bc1e-41a0-9dd7-e5ff0ba3463b"
      decimals="-3"
      id="F_8e195a7c-58cc-4854-bfd3-70e9147f4a10"
      unitRef="U_USD">-7468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8f44875f-fa81-4c6f-a4d8-7bccd495c678"
      decimals="-3"
      id="F_cf2c5514-25b3-4b1c-b498-2a097876a78e"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1335aefe-f684-4dfb-84f4-21a81a7b3905"
      decimals="-3"
      id="F_632cdc1b-b9e0-4a10-a614-8127495543cc"
      unitRef="U_USD">-5562000</us-gaap:StockholdersEquity>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_ad6f985b-b398-416c-a97e-19ed5c2ba56c"
      decimals="-3"
      id="F_a2ac5b8e-c93f-4755-b332-58591c17db04"
      unitRef="U_USD">439000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786"
      decimals="-3"
      id="F_c158145e-d079-4405-8445-1f6026f2ad7d"
      unitRef="U_USD">-439000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba"
      decimals="-3"
      id="F_d508e75e-cd97-40fe-bf2b-31981fb0c135"
      unitRef="U_USD">-439000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_aec7af12-734e-49d6-876e-4f51ec91a65e"
      decimals="-3"
      id="F_73943ac7-2953-4023-84e3-e914ca1ad58b"
      unitRef="U_USD">4170000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_67c90c7e-9101-40b3-8fa5-ba77a02a2786"
      decimals="-3"
      id="F_d678e60a-d00c-45cd-bd8b-5564b5f335fa"
      unitRef="U_USD">134000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba"
      decimals="-3"
      id="F_6004d698-5307-4fe5-a87c-ee7f62e187d1"
      unitRef="U_USD">134000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_8b74eebe-7367-44f3-89a2-41a2ae3c4f6a"
      decimals="-3"
      id="F_fc7d827a-ad09-4206-8276-9a496183dcef"
      unitRef="U_USD">-1916000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_ae7f7069-0f13-4041-b1ee-8a23f0f60bba"
      decimals="-3"
      id="F_b3a7a68e-7197-4d67-9043-cbc509616b01"
      unitRef="U_USD">-1916000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b4227218-0fbb-4ded-b156-157f89ae7254"
      decimals="0"
      id="F_0c48ff24-1acf-43e3-9f49-d4aa74698524"
      unitRef="U_shares">3999133</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b4227218-0fbb-4ded-b156-157f89ae7254"
      decimals="-3"
      id="F_a0f860ff-fc6d-4405-a130-e622e7d94c48"
      unitRef="U_USD">26613000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_3b30f421-7970-424e-addd-c4971489194f"
      decimals="0"
      id="F_c3521032-0bbe-493b-b88a-89f784a56321"
      unitRef="U_shares">1856967</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_3b30f421-7970-424e-addd-c4971489194f"
      decimals="-3"
      id="F_391f51b0-825a-413d-83c3-dd1bb1d9dead"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_240f8cde-e329-49df-8877-bf46eeb51205"
      decimals="-3"
      id="F_57aa8005-26ed-49ba-93b6-cb3bbf3040ed"
      unitRef="U_USD">1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f03dc908-cddc-420d-9f23-e55b22233be8"
      decimals="-3"
      id="F_bb691e91-d3f7-46cd-8dec-42eccf21a1b2"
      unitRef="U_USD">-9384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_12bd7c9a-9686-44a2-803f-a81d4cdeccf3"
      decimals="-3"
      id="F_1e4f388c-2bd3-4789-8dd6-901541f9e2ed"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7a07cf1a-9b36-4553-a382-4b7030b2b6fb"
      decimals="-3"
      id="F_c32d5f63-50a9-4bcb-be81-6f2829d0578d"
      unitRef="U_USD">-7783000</us-gaap:StockholdersEquity>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_9e23dbd6-7d37-4dc5-857b-7212c0ea9084"
      decimals="-3"
      id="F_e292481c-856d-4748-af10-c6b0c7031c34"
      unitRef="U_USD">452000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54"
      decimals="-3"
      id="F_40e31ad2-3340-4bef-ba57-3272d7994006"
      unitRef="U_USD">-452000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0"
      decimals="-3"
      id="F_b7d0bf2c-3ef3-49e9-8196-03c8bb2fbe7e"
      unitRef="U_USD">-452000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_58902cc5-c0a4-4b35-962a-3a2dc5e8d973"
      decimals="0"
      id="F_ba1e591f-2d4e-424a-bd98-21da4c5c0c4d"
      unitRef="U_shares">4174</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_7eb42679-4ad1-4b90-bf11-055a66cc2e54"
      decimals="-3"
      id="F_f5e85256-aec5-43fd-a280-ceaafac4f136"
      unitRef="U_USD">51000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0"
      decimals="-3"
      id="F_9afb7c15-3e90-47a1-8183-775ea9a99170"
      unitRef="U_USD">51000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_a0e75eaf-c8c0-4041-b14e-3d776b96ecb0"
      decimals="-3"
      id="F_334fade6-8b72-42e1-903e-e092cc4dc2f3"
      unitRef="U_USD">-1631000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_9e7218a3-2e50-4752-a4fe-e4983c2fa5e0"
      decimals="-3"
      id="F_8a9ee90a-4161-4b06-b073-b5063ea3c8a3"
      unitRef="U_USD">-1631000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0"
      decimals="0"
      id="F_4328d145-321a-414a-909c-0c0a04b16578"
      unitRef="U_shares">3999133</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_a0757e73-45f3-4c14-9ac8-1d1f527a98f0"
      decimals="-3"
      id="F_31b025cc-6d5a-406c-96d0-e6dfbb84c075"
      unitRef="U_USD">27065000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e"
      decimals="0"
      id="F_b83bb95a-1d03-4e5b-ba5c-76ff83af6706"
      unitRef="U_shares">1861141</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_57556a1f-00e7-45b7-9ce1-e4cf2e4c901e"
      decimals="-3"
      id="F_12727ca0-d44b-49ed-bf14-e3e4e11d90eb"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3a75adc8-6494-436d-8e73-ab1898a3f4a0"
      decimals="-3"
      id="F_1993bf86-ea8f-42ec-8882-49888984f1cf"
      unitRef="U_USD">1199000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3e8bd169-1cd0-4494-b634-7a499711cee0"
      decimals="-3"
      id="F_96e37903-0348-4a66-bcd9-ba6c5e550711"
      unitRef="U_USD">-11015000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ba7c150f-8562-403b-bdbc-e0b6db0cec39"
      decimals="-3"
      id="F_eae86503-666d-4eee-ac32-a77963e216b8"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0baa77a4-0ccf-4e25-9f89-25825a5dd5de"
      decimals="-3"
      id="F_133cd6c2-4db9-4e4b-9646-e7f71d072f0b"
      unitRef="U_USD">-9815000</us-gaap:StockholdersEquity>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_5b84124c-9c47-43b4-84c4-b441d84b7611"
      decimals="-3"
      id="F_f0f4f10c-40c2-4c3d-bf8d-c7e330728c62"
      unitRef="U_USD">461000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31"
      decimals="-3"
      id="F_d0231dc5-16f8-4909-a8c1-2178eaaa7ccb"
      unitRef="U_USD">-461000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_3086f857-2b5b-46a8-a43f-1e5614436d80"
      unitRef="U_USD">-461000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_f32fa3fe-04ff-4f37-9cda-74b7fa643680"
      decimals="0"
      id="F_43439bae-35b2-43d1-b431-8afe9485ac6a"
      unitRef="U_shares">4175</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_1e1d20bb-b2fb-4743-a953-a7954e8abc31"
      decimals="-3"
      id="F_aa1aa9f9-e3a1-4ea7-ac15-a5984ce9c799"
      unitRef="U_USD">49000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_ff45a56c-85c9-4df9-a551-9e310bdfdf61"
      unitRef="U_USD">49000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="C_969acfbd-1a24-44dd-a3fe-5aa7b81c5654"
      decimals="-3"
      id="F_ca300f30-83d4-4120-a650-3743056afc13"
      unitRef="U_USD">-2258000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_b030af62-cfc0-4723-adcc-803e521f1ecc"
      unitRef="U_USD">-2258000</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0791263e-f277-474d-b34a-5bf44a42eeb0"
      decimals="0"
      id="F_25dad995-2d74-452d-af31-241892f258f6"
      unitRef="U_shares">3999133</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0791263e-f277-474d-b34a-5bf44a42eeb0"
      decimals="-3"
      id="F_83645935-b520-4d15-8c8a-702b9ffdb3d2"
      unitRef="U_USD">27526000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744"
      decimals="0"
      id="F_f7374677-1331-4c62-911b-a39479e411d0"
      unitRef="U_shares">1865316</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0fa6a262-4a9c-4bb0-82f1-e36763ad5744"
      decimals="-3"
      id="F_2e8de6d4-9131-4bdc-93cc-985c02b803bd"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_02ca6dff-2485-430e-84db-9a99d6227383"
      decimals="-3"
      id="F_63730ace-6b25-4f2f-9c0e-3cb0d206b0bf"
      unitRef="U_USD">787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_71ae99b8-6442-4275-bd07-b38f55d947bb"
      decimals="-3"
      id="F_3fdf359b-722f-4c2b-8b87-7e2e200d0140"
      unitRef="U_USD">-13273000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8793bdfe-da79-41be-90e0-59ecbd5154a0"
      decimals="-3"
      id="F_b221799d-97c3-4ea7-aa2b-3b5d99d860f3"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86"
      decimals="-3"
      id="F_f5981060-6681-4cb8-b666-16bdd7a43174"
      unitRef="U_USD">-12485000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_d799ef09-b6f0-46a2-b388-da02c46f2c87"
      unitRef="U_USD">-36935000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_d45b6608-4704-4803-9909-2a3fed7122e2"
      unitRef="U_USD">-5805000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_2f0ecf08-644b-4985-a468-ddb4646adfbc"
      unitRef="U_USD">2583000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_49054650-cebc-4ff7-9488-1d4a783d6a4c"
      unitRef="U_USD">234000</us-gaap:ShareBasedCompensation>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_e29e8cc2-e232-4a1e-ba5d-1214ba0c03e1"
      unitRef="U_USD">11718000</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_44da2829-56f0-4295-9c5a-ce151de9c10e"
      unitRef="U_USD">0</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_27ce27a3-20ce-456a-8a6c-b55987b0b8a7"
      unitRef="U_USD">-83000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_ab2c2421-feb3-46d5-8110-3bfa17a681db"
      unitRef="U_USD">0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_0d074ebe-85d9-460e-8ec9-cf2068614c4c"
      unitRef="U_USD">245000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_03991848-8878-4db8-b76f-4820b63895c5"
      unitRef="U_USD">-59000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_af572de0-4054-4fd2-88e2-f6f96d924269"
      unitRef="U_USD">-11103000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_7a5cba05-0316-4266-b197-4ecf5ff5cf3b"
      unitRef="U_USD">2235000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <elym:IncreaseDecreaseInNonCurrentAssets
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_88d5088f-007f-4c1f-b8ca-1a9dfe7882a4"
      unitRef="U_USD">-2633000</elym:IncreaseDecreaseInNonCurrentAssets>
    <elym:IncreaseDecreaseInNonCurrentAssets
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_573643af-5ecb-41a6-8060-659061a98339"
      unitRef="U_USD">1361000</elym:IncreaseDecreaseInNonCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_ccb2b06d-ae56-4980-a4e7-a17c136db3b9"
      unitRef="U_USD">1494000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_3697c292-aba8-487f-89c0-1763e0931b14"
      unitRef="U_USD">82000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_b18ab015-328b-4a6d-8cc4-8e4d88e2b6a0"
      unitRef="U_USD">1760000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_8fbffc80-640b-4af0-a35a-545037e68ca1"
      unitRef="U_USD">611000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_b68d4462-fff2-43de-aa36-b2e6f447e998"
      unitRef="U_USD">-176000</elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty>
    <elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_ed408615-5d3a-4a0e-9549-5ef50d897245"
      unitRef="U_USD">-59000</elym:IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_fdef9457-64ee-45c1-9079-910a9514e138"
      unitRef="U_USD">-28188000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_a55aabe7-9b77-4df2-8e81-b6edb8f3bf5d"
      unitRef="U_USD">-8474000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_3ff1f8e4-b119-4427-98ef-d89e34dae13d"
      unitRef="U_USD">106919000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_2378196b-2172-4304-8230-69fc8755efaf"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_65cb912b-5665-473e-9037-1f6036a3210b"
      unitRef="U_USD">-106919000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_3507728f-bba1-4211-95ff-a34ed0b3f892"
      unitRef="U_USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_26eb5d61-6a23-40e9-84bb-5f7987d2851e"
      unitRef="U_USD">83144000</elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts>
    <elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_e778c4a5-e0de-4599-b522-75c60d605836"
      unitRef="U_USD">0</elym:ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_dbbe0bce-02ed-44a5-bfe3-c5d123cfac29"
      unitRef="U_USD">93939000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_83bd210d-7a6b-4c9b-9539-7808c254c5ac"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_64ca2aea-21b6-4c0c-883d-bdf579129288"
      unitRef="U_USD">111000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_d67f5394-3960-45b3-ac71-9d5f060bfc62"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_9d103fcf-9e5e-402e-9dfa-6c3da65367f7"
      unitRef="U_USD">177194000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_17160c6f-fc22-4a0b-ab0f-40b35d6e710c"
      unitRef="U_USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_6945243e-6099-4313-aa04-6724e37745b5"
      unitRef="U_USD">245000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_ae93c51d-52e4-4922-9639-cd3d749d217f"
      unitRef="U_USD">-59000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_6b4779dd-ae8e-4a87-b0d0-b1fdc3b1e35c"
      unitRef="U_USD">42332000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_73932ff9-c00d-4357-8baf-34d6025bf98d"
      unitRef="U_USD">-8533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_053ef5d6-2d56-4a16-b208-6ea65eed4d87"
      unitRef="U_USD">20487000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_1335aefe-f684-4dfb-84f4-21a81a7b3905"
      decimals="-3"
      id="F_be1d636c-5cf2-4349-897e-3dac8e8ddc34"
      unitRef="U_USD">21223000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_e86c91ed-a8fb-4b0d-9800-9cc95ac8ffa0"
      unitRef="U_USD">62819000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_a8c6115d-e38a-4dc3-b89f-6e63b07efe86"
      decimals="-3"
      id="F_0547441a-45cf-4556-b876-c3e94638de1f"
      unitRef="U_USD">12690000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_9dddffa9-7c8b-4710-a955-0799bdd247f8"
      unitRef="U_USD">152759000</elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock>
    <elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_f20ae5bd-74dd-4c8f-9463-73e44f7d7f39"
      unitRef="U_USD">0</elym:ConversionOfRedeemableConvertiblePreferredStockToCommonStock>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_f31013db-4243-4de4-85ea-99b9ee181ff1"
      unitRef="U_USD">0</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <elym:TemporaryEquityAccretionReductionToRedemptionValue
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_78db5932-60dd-4420-9067-b1db50d8e8da"
      unitRef="U_USD">1352000</elym:TemporaryEquityAccretionReductionToRedemptionValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_c50b406f-3e5b-4917-b9cf-d140449afd6c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;1.    Description of Organization and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Organization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Eliem Therapeutics, Inc. (the Company) is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Headquartered in Redmond, Washington, the Company was incorporated on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;October 18, 2018&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as a Delaware corporation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying interim condensed consolidated financial statements of the Company and its wholly owned subsidiaries have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated balance sheet as of September 30, 2021, and condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of cash flows, and condensed consolidated statements of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) for the three and nine months ended September 30, 2021 and 2020, are unaudited. The consolidated balance sheet as of December 31, 2020 was derived from the audited financial statements as of and for the year ended December 31, 2020, but does not include all disclosures required by U.S. GAAP. The unaudited interim condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair statement of the Company&#x2019;s financial position as of September 30, 2021, the condensed results of its operations as of the three and nine months ended September 30, 2021 and 2020, and its cash flows for the nine months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2021 and 2020 are also unaudited. The condensed results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; or any other period. These interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited financial statements included in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In July 2021, the Company's board of directors approved an amendment to the Company's certificate of incorporation to effect a reverse split of shares of the Company's common stock on a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1-for-2&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; basis, which was effected on July 29, 2021 (the Reverse Stock Split). The number of authorized shares and the par values of the common stock were not adjusted as a result of the Reverse Stock Split. In connection with the Reverse Stock Split, the number of authorized shares, outstanding shares, and the conversion ratio for the Company's redeemable convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. All references to common stock and options to purchase common stock share data, per share data, and related information contained in the condensed consolidated financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On August 12, 2021, the Company completed its initial public offering (IPO) of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,360,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock, including the underwriters' full exercise of their over-allotment option at the IPO price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12.50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. Gross proceeds from the IPO were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;92.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, and the net proceeds were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, after deducting underwriting discounts of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million of offering costs payable by the Company. At the closing of the IPO, all of the Company's then outstanding redeemable convertible preferred stock was automatically converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,345,279&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock. The related carrying value of the redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;152.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million was reclassified to common stock and additional paid-in capital.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;65.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million as of September 30, 2021 and expects to incur additional losses from operations in the future. The Company estimates the available cash, cash equivalents, and marketable securities as of September 30, 2021 will be sufficient to meet its projected operating requirements for at least the next twelve months from the filing date of these unaudited condensed consolidated financial statements. Therefore, based on management's updated evaluation of the Company's ability to continue as a going concern, management has concluded the factors that previously raised substantial doubt about the Company's ability to continue as a going concern no longer exist as of the issuance date of these unaudited condensed consolidated financial statements. The Company will need to obtain substantial additional funding to develop and commercialize the Company's clinical programs as currently contemplated. The Company expects to finance future cash needs through equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, but there are no assurances that the Company will be able to raise sufficient amounts of funding in the future on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;These condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to the valuation of assets acquired, accrual of research and development expenses, the valuation of stock-based awards, the valuation of common stock and redeemable convertible preferred stock, and the valuation of redeemable convertible preferred stock tranche liabilities. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and marketable securities. The Company&#x2019;s cash is held by two financial institutions in the United States (U.S.) and two financial institutions in the United Kingdom (U.K.). The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company&#x2019;s deposits held in the U.S. and U.K. may exceed the Federal Depository Insurance Corporation and Financial Services Compensation Scheme, respectively, insured limits. The Company has investments in money market funds, U.S. government debt securities, commercial paper, and corporate bonds with high-quality accredited financial institutions.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company&#x2019;s products and processes and clinical efficacy and safety of the Company&#x2019;s products under development, compliance with government regulations and the need to obtain additional financing to fund operations. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical studies, clinical trials, and regulatory approval, prior to commercialization. These efforts will require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be obtained or maintained, that any products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s product development efforts are successful, it is uncertain when, if ever, the Company will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees, consultants and other third parties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Moreover, the current COVID-19 pandemic, which is impacting worldwide economic activity, poses risk that the Company or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time which may delay the start-up and conduct of the Company&#x2019;s clinical trials, and negatively impact manufacturing and testing activities performed by third parties. Any significant delays may impact the use and sufficiency of the Company&#x2019;s existing cash reserves, and the Company may be required to raise additional capital earlier than it had previously planned. The Company may be unable to raise additional capital if and when needed, which may result in delays or suspension of its development plans. The extent to which the pandemic will impact the Company&#x2019;s business will depend on future developments that are highly uncertain and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the CODM). The Company&#x2019;s CODM is its chief executive officer who reviews financial information together with certain operating metrics principally to make decisions about how to allocate resources and to measure the Company&#x2019;s performance. Management has determined that the Company operates as a single operating and reportable segment. The Company&#x2019;s CODM evaluates financial information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is found in the interim condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company measures fair value based on a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In determining fair value, the Company utilizes quoted market prices, or valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; transfers into or out of Level 3 for any of the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s fair value measurements as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021 and December 31, 2020 was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:35.72%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.138%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.101%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;42,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;145,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Redeemable convertible preferred stock&lt;br/&gt;&#160;&#160;&#160;tranche liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The redeemable convertible preferred stock tranche liability was settled on March 9, 2021.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. As of September 30, 2021, the Company's cash equivalents consisted of money market funds. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; cash equivalents as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Costs that were directly related to the Company&#x2019;s IPO were deferred for expense recognition and capitalized and recorded within prepaid and other current assets on the accompanying condensed consolidated balance sheet. These costs consist of legal fees, accounting fees, and other applicable professional services. These deferred offering costs were reclassified to additional paid in capital upon the closing of the IPO. As of September 30, 2021, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; deferred offering costs capitalized.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities are classified as available-for-sale, primarily consisting of U.S. government debt securities, commercial paper, and corporate bonds, and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of stockholders' equity (deficit) in accumulated other comprehensive loss until realized. Realized gains and losses on the sale of these securities are recognized in other income, net. The cost of marketable securities sold is based on the specific identification method.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company periodically reviews its available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security rating or sector credit ratings, and other relevant market data.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There have been no other significant changes in the Company&#x2019;s accounting policies during the three and nine months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of consolidated financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The effective date of this update for nonpublic companies is for fiscal years beginning after December 15, 2021 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today&#x2019;s &#x201c;incurred loss&#x201d; approach with an &#x201c;expected loss&#x201d; model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard&#x2019;s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The effective date of this update for non-public companies is for fiscal years beginning after December 15, 2022 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_8c2c3cd5-5dda-47d3-911c-94dde0014d5e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Organization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Eliem Therapeutics, Inc. (the Company) is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Headquartered in Redmond, Washington, the Company was incorporated on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;October 18, 2018&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as a Delaware corporation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_51861616-7030-4a62-af1c-134d871fdba6">2018-10-18</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_23ab2df8-a0b4-4913-aec8-cb2de9fc62b4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying interim condensed consolidated financial statements of the Company and its wholly owned subsidiaries have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated balance sheet as of September 30, 2021, and condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of cash flows, and condensed consolidated statements of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) for the three and nine months ended September 30, 2021 and 2020, are unaudited. The consolidated balance sheet as of December 31, 2020 was derived from the audited financial statements as of and for the year ended December 31, 2020, but does not include all disclosures required by U.S. GAAP. The unaudited interim condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair statement of the Company&#x2019;s financial position as of September 30, 2021, the condensed results of its operations as of the three and nine months ended September 30, 2021 and 2020, and its cash flows for the nine months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2021 and 2020 are also unaudited. The condensed results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; or any other period. These interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited financial statements included in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.&lt;/span&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <elym:ReserveStockSplitPolicyPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_c433d299-e5f7-45f1-a038-8ab7b81e6af0">Reverse Stock SplitIn July 2021, the Company's board of directors approved an amendment to the Company's certificate of incorporation to effect a reverse split of shares of the Company's common stock on a 1-for-2 basis, which was effected on July 29, 2021 (the Reverse Stock Split). The number of authorized shares and the par values of the common stock were not adjusted as a result of the Reverse Stock Split. In connection with the Reverse Stock Split, the number of authorized shares, outstanding shares, and the conversion ratio for the Company's redeemable convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. All references to common stock and options to purchase common stock share data, per share data, and related information contained in the condensed consolidated financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split for all periods presented.</elym:ReserveStockSplitPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_d86db185-8ae9-4d32-a309-c4dc84783477">1-for-2</us-gaap:StockholdersEquityReverseStockSplit>
    <elym:InitialPublicOfferingPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_40a42246-d7aa-4ce5-bf43-b4f02f32ce10">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On August 12, 2021, the Company completed its initial public offering (IPO) of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,360,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock, including the underwriters' full exercise of their over-allotment option at the IPO price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12.50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. Gross proceeds from the IPO were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;92.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, and the net proceeds were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, after deducting underwriting discounts of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million of offering costs payable by the Company. At the closing of the IPO, all of the Company's then outstanding redeemable convertible preferred stock was automatically converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,345,279&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock. The related carrying value of the redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;152.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million was reclassified to common stock and additional paid-in capital.&lt;/span&gt;</elym:InitialPublicOfferingPolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928"
      decimals="INF"
      id="F_cb6de910-8135-43d1-aca3-1fbda3ee8dc6"
      unitRef="U_shares">7360000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47"
      decimals="2"
      id="F_f3175582-393b-4bf1-bb0a-53866206bc2d"
      unitRef="U_USDollarShare">12.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928"
      decimals="-5"
      id="F_8154f19c-921f-4df1-b6e0-de0fa373df78"
      unitRef="U_USD">92000000.0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <elym:ProceedsFromIssuanceInitialPublicOfferingNet
      contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928"
      decimals="-5"
      id="F_bd002069-5217-48b9-ae66-aa15fbc22afc"
      unitRef="U_USD">83100000</elym:ProceedsFromIssuanceInitialPublicOfferingNet>
    <elym:UnderwritingDiscount
      contextRef="C_3ed3a81a-7827-4cef-8afe-082b91627928"
      decimals="-5"
      id="F_f346235c-ebd2-4179-9dc7-b7008914a835"
      unitRef="U_USD">6400000</elym:UnderwritingDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47"
      decimals="-5"
      id="F_35ce06d8-7563-4247-9f2c-a4d76c88d69a"
      unitRef="U_USD">2500000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_a0c2cff0-d7ff-42e5-87bb-6073f68eaa47"
      decimals="INF"
      id="F_eb5ad079-d156-427f-8cc4-883e6133851d"
      unitRef="U_shares">15345279</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-5"
      id="F_787b1f16-3cf5-4289-bc99-ddd8de301493"
      unitRef="U_shares">152800000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <elym:LiquidityPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_928f8844-6538-4df6-a467-26af4889cddf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;65.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million as of September 30, 2021 and expects to incur additional losses from operations in the future. The Company estimates the available cash, cash equivalents, and marketable securities as of September 30, 2021 will be sufficient to meet its projected operating requirements for at least the next twelve months from the filing date of these unaudited condensed consolidated financial statements. Therefore, based on management's updated evaluation of the Company's ability to continue as a going concern, management has concluded the factors that previously raised substantial doubt about the Company's ability to continue as a going concern no longer exist as of the issuance date of these unaudited condensed consolidated financial statements. The Company will need to obtain substantial additional funding to develop and commercialize the Company's clinical programs as currently contemplated. The Company expects to finance future cash needs through equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, but there are no assurances that the Company will be able to raise sufficient amounts of funding in the future on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;These condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/p&gt;</elym:LiquidityPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-5"
      id="F_07f224ee-4d3d-4a5c-bd5d-b31de2111a26"
      unitRef="U_USD">-65100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:UseOfEstimates
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_6dc57576-c27d-4889-8159-522e5f9cfc7c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to the valuation of assets acquired, accrual of research and development expenses, the valuation of stock-based awards, the valuation of common stock and redeemable convertible preferred stock, and the valuation of redeemable convertible preferred stock tranche liabilities. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_4c1cc554-fefd-4849-ab73-9d0666207245">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and marketable securities. The Company&#x2019;s cash is held by two financial institutions in the United States (U.S.) and two financial institutions in the United Kingdom (U.K.). The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company&#x2019;s deposits held in the U.S. and U.K. may exceed the Federal Depository Insurance Corporation and Financial Services Compensation Scheme, respectively, insured limits. The Company has investments in money market funds, U.S. government debt securities, commercial paper, and corporate bonds with high-quality accredited financial institutions.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <elym:RisksAndUncertaintiesPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_24ef9726-6d02-48fd-915e-c7b53568c22d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company&#x2019;s products and processes and clinical efficacy and safety of the Company&#x2019;s products under development, compliance with government regulations and the need to obtain additional financing to fund operations. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical studies, clinical trials, and regulatory approval, prior to commercialization. These efforts will require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be obtained or maintained, that any products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s product development efforts are successful, it is uncertain when, if ever, the Company will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees, consultants and other third parties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Moreover, the current COVID-19 pandemic, which is impacting worldwide economic activity, poses risk that the Company or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time which may delay the start-up and conduct of the Company&#x2019;s clinical trials, and negatively impact manufacturing and testing activities performed by third parties. Any significant delays may impact the use and sufficiency of the Company&#x2019;s existing cash reserves, and the Company may be required to raise additional capital earlier than it had previously planned. The Company may be unable to raise additional capital if and when needed, which may result in delays or suspension of its development plans. The extent to which the pandemic will impact the Company&#x2019;s business will depend on future developments that are highly uncertain and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;</elym:RisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_58fbf6b7-0407-4345-a333-b58dcd8c95a7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the CODM). The Company&#x2019;s CODM is its chief executive officer who reviews financial information together with certain operating metrics principally to make decisions about how to allocate resources and to measure the Company&#x2019;s performance. Management has determined that the Company operates as a single operating and reportable segment. The Company&#x2019;s CODM evaluates financial information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is found in the interim condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_28034bc4-7407-41d6-a14c-c5dad45ed6e8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company measures fair value based on a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In determining fair value, the Company utilizes quoted market prices, or valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; transfers into or out of Level 3 for any of the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s fair value measurements as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021 and December 31, 2020 was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:35.72%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.138%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.101%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;42,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;145,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Redeemable convertible preferred stock&lt;br/&gt;&#160;&#160;&#160;tranche liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The redeemable convertible preferred stock tranche liability was settled on March 9, 2021.&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <elym:FairValueLevel1Level2AndLevel3TransferAmount
      contextRef="C_d49ac965-16d2-49f6-8496-6b6bd4de9295"
      decimals="-3"
      id="F_82a4a4fb-1226-419c-bc8e-9683cade0871"
      unitRef="U_USD">0</elym:FairValueLevel1Level2AndLevel3TransferAmount>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_732f07bf-a2a8-4601-a079-2d39f91b592d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s fair value measurements as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021 and December 31, 2020 was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:35.72%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.138%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.101%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
          &lt;td style="width:1.651%;"/&gt;
          &lt;td style="width:1.53%;"/&gt;
          &lt;td style="width:12.157%;"/&gt;
          &lt;td style="width:0.751%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;42,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;145,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Redeemable convertible preferred stock&lt;br/&gt;&#160;&#160;&#160;tranche liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9966861e-a257-4483-a647-6780eab777a6"
      decimals="-3"
      id="F_48489c7f-76f0-47cb-9e1a-bfe11f7e975e"
      unitRef="U_USD">38412000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_308a931a-0338-4cef-80b1-90d2080e2ef4"
      decimals="-3"
      id="F_e3e75d8b-ad0e-4d0a-9f03-67723966c9b5"
      unitRef="U_USD">38412000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_481e58e9-cf0c-4dd5-a802-7bc69141a9ed"
      decimals="-3"
      id="F_20665e38-f91c-446f-b245-25f77c03ebf4"
      unitRef="U_USD">3995000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_50f80129-d404-4d29-a58a-3d06114b7d2a"
      decimals="-3"
      id="F_2333b35c-ee5a-46eb-b029-a7643e90e6e8"
      unitRef="U_USD">102823000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_54207afe-8ac8-4d70-9d88-5a5cc0805155"
      decimals="-3"
      id="F_61963b1e-d4fc-4296-98b0-dad16ef6742e"
      unitRef="U_USD">102823000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c979a217-c5e3-4cc3-a4c8-2ea6f9acc46d"
      decimals="-3"
      id="F_5802c818-f8d9-435f-94d0-58d1c4877e4e"
      unitRef="U_USD">42407000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3c1f890e-2a01-4903-afa6-61704660b423"
      decimals="-3"
      id="F_45d32ba1-13af-4a1e-acf5-39758863b6b1"
      unitRef="U_USD">102823000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_9afe1ddb-21a6-47b1-b5f9-3802c35e5777"
      unitRef="U_USD">145230000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_9991e520-51cf-427f-89de-e1753fed04a5"
      decimals="-3"
      id="F_f451a23f-0eb2-431b-895b-40e4470ec377"
      unitRef="U_USD">551000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_467945a5-3ec2-4005-a9d6-1240297ff054"
      decimals="-3"
      id="F_95ead2ef-a58b-412f-a929-b0c15b7966d7"
      unitRef="U_USD">551000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_d57b29e1-52ee-4b19-9fdc-0dcbcf61ce63"
      decimals="-3"
      id="F_369393c1-aa71-44c9-8f66-aeac0e8d4895"
      unitRef="U_USD">551000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_cd1dfe02-2545-431d-930e-b6974c8cf2ab"
      unitRef="U_USD">551000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_933f940f-2e0e-49f2-a718-f28ea9bf75e2">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. As of September 30, 2021, the Company's cash equivalents consisted of money market funds. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; cash equivalents as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_4ceb0945-4456-4511-bd5e-3facd9483858"
      unitRef="U_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_a3bf8671-c5c4-4ae4-9a1d-c360179c2c46">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Costs that were directly related to the Company&#x2019;s IPO were deferred for expense recognition and capitalized and recorded within prepaid and other current assets on the accompanying condensed consolidated balance sheet. These costs consist of legal fees, accounting fees, and other applicable professional services. These deferred offering costs were reclassified to additional paid in capital upon the closing of the IPO. As of September 30, 2021, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; deferred offering costs capitalized.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_cea92f45-3c18-4602-bf75-88a3a2c2a722"
      unitRef="U_USD">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_7d8c605b-308e-48d0-8eef-cd2d3ae9a574">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities are classified as available-for-sale, primarily consisting of U.S. government debt securities, commercial paper, and corporate bonds, and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of stockholders' equity (deficit) in accumulated other comprehensive loss until realized. Realized gains and losses on the sale of these securities are recognized in other income, net. The cost of marketable securities sold is based on the specific identification method.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company periodically reviews its available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security rating or sector credit ratings, and other relevant market data.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There have been no other significant changes in the Company&#x2019;s accounting policies during the three and nine months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_aaeffccc-5133-4b99-88d2-82417ab730d6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of consolidated financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The effective date of this update for nonpublic companies is for fiscal years beginning after December 15, 2021 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today&#x2019;s &#x201c;incurred loss&#x201d; approach with an &#x201c;expected loss&#x201d; model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard&#x2019;s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The effective date of this update for non-public companies is for fiscal years beginning after December 15, 2022 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_61806b46-f8da-42b6-be2f-ee1cb2e8e45b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2.   Investments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments consists of available-for-sale securities as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.532%;"/&gt;
        &lt;td style="width:1.856%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.746%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.626%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.755%;"/&gt;
        &lt;td style="width:0.937%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.512%;"/&gt;
        &lt;td style="width:11.737%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term marketable securities:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19,633&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All the commercial paper, U.S. government debt securities, and corporate bonds designated as short-term marketable securities have a  contractual maturity date that is equal to or less than one year from the respective balance sheet date. Those that are designated as long-term marketable securities have a contractual maturity date that is more than one year from the respective balance sheet date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued interest receivable is excluded from the amortized cost and estimated fair value of the Company's marketable securities. Accrued interest receivable of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million is presented separately within the prepaid expenses and other current assets line items in the Company's unaudited condensed consolidated balance sheet as of September 30, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021, there were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million of corporate bonds in a continual unrealized loss position for less than 12 months. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; investments in a continual unrealized loss position for greater than twelve months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021, the Company did not intend, nor was the Company more likely than not to be required, to sell its available-for-sale investments before the recovery of the amortized cost basis, which may be maturity. Based on the Company's assessment, it concluded that none of the available-for-sale investments held as of September 30, 2021 were considered to be impaired, as such, no impairment loss was recorded for the three and nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_d91e99b7-943a-4ef4-970e-1127862d4416">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments consists of available-for-sale securities as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.532%;"/&gt;
        &lt;td style="width:1.856%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.746%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.626%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:11.755%;"/&gt;
        &lt;td style="width:0.937%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.512%;"/&gt;
        &lt;td style="width:11.737%;"/&gt;
        &lt;td style="width:0.733%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term marketable securities:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. government debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19,633&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost
      contextRef="C_0950534c-0e42-47f2-9fff-61cb3af705cc"
      decimals="-3"
      id="F_42a72ecf-c361-44f5-bbb3-0cacbe7bb6f2"
      unitRef="U_USD">83208000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="C_87892d72-2788-4288-9f97-01316b8174e3"
      decimals="-3"
      id="F_9edcfb88-78c4-43d5-bbcc-8dfa349dad60"
      unitRef="U_USD">9000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecurities
      contextRef="C_0950534c-0e42-47f2-9fff-61cb3af705cc"
      decimals="-3"
      id="F_89f73fdf-a83f-41a2-9b6c-7f20c1f4dd95"
      unitRef="U_USD">83199000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost
      contextRef="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8"
      decimals="-3"
      id="F_e4ca931c-ec7d-4dcd-a7d2-b7af056f04f5"
      unitRef="U_USD">83208000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="C_5b3c644e-edca-435e-b343-309e123a2ea3"
      decimals="-3"
      id="F_782fa5c1-524d-4077-af70-c617d7209245"
      unitRef="U_USD">9000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecurities
      contextRef="C_9bfdc1a7-d432-445d-9751-7c5f72c789d8"
      decimals="-3"
      id="F_016fe8bf-34de-48a5-8a29-9751471f3ed9"
      unitRef="U_USD">83199000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost
      contextRef="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc"
      decimals="-3"
      id="F_1fabd9aa-d2f0-428e-ba74-45a4c881a113"
      unitRef="U_USD">3995000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecurities
      contextRef="C_72c9c74b-0c44-4ca9-98d9-9a1b517410bc"
      decimals="-3"
      id="F_99b1eee1-b8d7-4e8d-96c3-71502f2ddcb0"
      unitRef="U_USD">3995000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost
      contextRef="C_340d9bd0-d7ea-4047-a232-5b317397c002"
      decimals="-3"
      id="F_0c71c671-e53e-4de1-926b-7bd09a51b948"
      unitRef="U_USD">19633000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="C_0d1271c8-61fb-4654-8d3a-3c7dc98c3046"
      decimals="-3"
      id="F_4c3bdbd2-c70c-4ff7-8cb7-1207a8ffe67d"
      unitRef="U_USD">9000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecurities
      contextRef="C_340d9bd0-d7ea-4047-a232-5b317397c002"
      decimals="-3"
      id="F_82a656d2-d966-4546-87a9-2e1de077a84f"
      unitRef="U_USD">19624000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost
      contextRef="C_86547cb0-3862-4a95-981d-e7e9f18fd071"
      decimals="-3"
      id="F_0fc3d966-bbff-4c47-8fc8-70038926d007"
      unitRef="U_USD">23628000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="C_2ead6c6d-1e36-4252-80e7-a03d15dab206"
      decimals="-3"
      id="F_4f099496-24e6-4bac-a37b-4aa1f46c994d"
      unitRef="U_USD">9000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecurities
      contextRef="C_86547cb0-3862-4a95-981d-e7e9f18fd071"
      decimals="-3"
      id="F_fe7b6361-dba8-464f-9849-e4ca2d882eb7"
      unitRef="U_USD">23619000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:InterestReceivable
      contextRef="C_ddf6340c-4eb3-4c81-96c0-c3840a43b061"
      decimals="-5"
      id="F_6593856c-4c5a-4eba-afc9-5a7757dd9110"
      unitRef="U_USD">300000</us-gaap:InterestReceivable>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_b3f43bab-a6cb-4d81-a307-cb587d9e5ead"
      decimals="-5"
      id="F_67923007-6722-4c15-bb50-f97369c1293b"
      unitRef="U_USD">45900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_58fe0e7e-b916-40d0-a7cd-ded52c0d0640"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_9636a912-4fcf-48c7-93d9-0481598e09f6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;3.    Certain Balance Sheet Accounts&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.614%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.458%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.449%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Recoverable research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,661&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accrued Expenses&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.614%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.458%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.449%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued payroll&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_68beea9e-c7c7-42e7-aaf3-d7ec6c813f9d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.614%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.458%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.449%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Recoverable research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,661&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <elym:RecoverableResearchAndDevelopmentTaxCredits
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_810d4d20-ac3b-421d-99d5-e38b04d24ffa"
      unitRef="U_USD">6943000</elym:RecoverableResearchAndDevelopmentTaxCredits>
    <elym:RecoverableResearchAndDevelopmentTaxCredits
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_6ae0975a-524d-44e1-b15c-87d05938ae89"
      unitRef="U_USD">0</elym:RecoverableResearchAndDevelopmentTaxCredits>
    <elym:PrepaidResearchAndDevelopmentExpenses
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_3db90650-7b05-46da-9892-9eaaa107e7f1"
      unitRef="U_USD">2661000</elym:PrepaidResearchAndDevelopmentExpenses>
    <elym:PrepaidResearchAndDevelopmentExpenses
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_7f38e564-d7b4-4124-8287-b9bc683ec8cb"
      unitRef="U_USD">1500000</elym:PrepaidResearchAndDevelopmentExpenses>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_a47e161a-ad71-49d4-9965-4144ebd74f68"
      unitRef="U_USD">1960000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_e39dbb23-3bf4-48bb-a0c2-2e8a600fa3d4"
      unitRef="U_USD">0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssets
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_21cbcc28-d21f-4cc7-b87d-0237ae7810e8"
      unitRef="U_USD">1050000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_d0b12c11-61e4-4500-83fa-49493e5fcfbb"
      unitRef="U_USD">11000</us-gaap:OtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_fb02e764-8013-4b3a-9822-70db95971aa2"
      unitRef="U_USD">12614000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_e7033503-9cae-4ddf-93df-f8a02114b885"
      unitRef="U_USD">1511000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_f024ba1a-6d02-4ab4-af36-dd3c7a5bc9e1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.614%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.458%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.716%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.449%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued payroll&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_15b16272-8d80-4879-b1fe-7a11a9c0b4b1"
      unitRef="U_USD">1443000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_db61ffd6-183a-4383-a080-8f0b07372d33"
      unitRef="U_USD">592000</us-gaap:AccruedPayrollTaxesCurrent>
    <elym:AccruedResearchAndDevelopmentExpenses
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_f23d3198-aa9d-425b-8d71-8e3d2eb0254a"
      unitRef="U_USD">1278000</elym:AccruedResearchAndDevelopmentExpenses>
    <elym:AccruedResearchAndDevelopmentExpenses
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_da4f6258-5583-4781-a917-a12935d5cfcb"
      unitRef="U_USD">627000</elym:AccruedResearchAndDevelopmentExpenses>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_c902e6e6-65e7-4a10-8853-f8da9344f864"
      unitRef="U_USD">290000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_db40dff2-0c20-448c-9a0a-1057e107f519"
      unitRef="U_USD">0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_7414acdd-dc57-4479-8b6d-7550b4d17bc0"
      unitRef="U_USD">3011000</elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions>
    <elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_fc72fc89-83d3-420f-afc3-d123bd3e9e86"
      unitRef="U_USD">1219000</elym:AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions>
    <elym:TemporaryEquityDisclosureTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_c9b9b1e3-a989-40c8-956a-391acb95c398">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;.    Redeemable Convertible Preferred Stock &lt;/span&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020, the Company&#x2019;s redeemable convertible preferred stock consisted of the following balance (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:28.541%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:7.151%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:0.751%;"/&gt;
        &lt;td style="width:11.594%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:0.751%;"/&gt;
        &lt;td style="width:13.45%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.062%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:11.873%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Issue&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares &lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares Issued and Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,717,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,717,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,074&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,569&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A  (Athenen Acquisition)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,692,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,923,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,977&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,069&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Ending balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,909,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,140,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;46,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In March 2021, Series A-1 preferred stockholders exercised their tranche rights in connection with milestone achievements related to Phase 1 clinical trial results of ETX-155. As a result, the Company issued an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,358,972&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series A-1 redeemable convertible preferred shares for gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. Upon exercise of the tranche rights, the Company reclassified the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million in preferred stock tranche liability to Series A-1 redeemable convertible preferred stock on the consolidated balance sheet.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In May 2021, the Company issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,846,150&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series B redeemable convertible preferred stock for gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;60.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon completion of the IPO on August 12, 2021, all of the Company&#x2019;s then outstanding redeemable convertible preferred stock was converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,345,279&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock. As of September 30, 2021, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; redeemable convertible preferred stock outstanding.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prior to conversion, the holders of the Series A, Series A-1, and Series B redeemable convertible preferred stock had various rights, preferences, privileges, and restrictions, with respect to voting, dividends, liquidation, and conversion.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In the event of any liquidation event, either voluntarily or involuntary, the holders of the Series B redeemable convertible preferred stock were entitled to receive, out of the assets of the Company before any payment shall be made or any assets distributed to the holders of Series A and A-1 redeemable convertible preferred stock, the Series B redeemable convertible preferred stock liquidation preference of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15.60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series B redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the Series B redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;After the payment to the holders of the Series B redeemable convertible preferred stock of the full preferential amount, the holders of the Series A and Series A-1 redeemable convertible preferred stock were entitled to receive, out of the assets of the Company, the applicable liquidation preference specified for each series of redeemable convertible preferred stock before any payment was made or any assets distributed to the holders of common stock. Liquidation preference was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for Series A and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.80&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for Series A-1, each adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series A and A-1 redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;After the payment to the holders of the redeemable convertible preferred stock of the full preferential amount specified above, any remaining assets of the Company would have been distributed pro rata among all holders of the preferred and common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A liquidation event required approval by the holders of at least a majority of the outstanding shares of redeemable convertible preferred stock and at least &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;70&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the then outstanding shares of Series B redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Optional Conversion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of redeemable convertible preferred stock was convertible into common stock at the stockholder&#x2019;s option. The converted shares would have been determined by dividing the original issue price for each series by the applicable conversion price for such series in effect at the date of conversion. The conversion price for each share of redeemable convertible preferred stock was initially equal to the original issuance price applicable to such share, with the exception of the Series A redeemable convertible preferred stock issued related to the Athenen Acquisition, which were convertible at any time after the date of issuance into common stock at the original issue price of the original Series A of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The conversion ratio was subject to appropriate adjustments for anti-dilution provisions, including stock splits, stock dividends, subdivisions, combinations, recapitalization events or similar events. Specific to the Series B convertible redeemable preferred stock, the conversion ratio was subject to specific anti-dilution provisions adjustments if there was common stock issued for consideration below the Series B issue price.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Automatic Conversion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of redeemable convertible preferred stock was convertible into common stock at initial conversion rates described under the Optional Conversion heading above, subject to adjustments based on certain antidilution provisions, including stock splits, stock dividends, subdivision, combinations, recapitalization or similar events, as provided by the Company&#x2019;s certificate of incorporation. Further, all shares of redeemable convertible preferred stock automatically would have converted into common stock upon the vote or written consent of the holders of a majority of the shares of redeemable convertible preferred stock or upon the closing of a firm-commitment underwritten public offering of the Company&#x2019;s common stock at a stock price of at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share and with gross aggregate proceeds to the Company of at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon completion of the IPO, the Company's redeemable convertible preferred stock was converted into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,345,279&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of shares of Series A, Series A-1, and Series B redeemable convertible preferred stock were entitled to receive cumulative dividends of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% per annum of the original issuance price on each share of redeemable convertible preferred stock. The dividends were payable in cash, out of the assets at the time legally available thereof, when, as and if declared by the Board of Directors, on an equal basis according to the number of shares of redeemable convertible preferred stock held by such holders, prior and in preference to the common stock. As of December 31, 2020, the Company had total dividends in arrears for the Series A redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.72&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.48&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share, respectively, and for Series A-1 redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.40&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.56&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. As of September 30, 2021, the Company had no dividends in arrears as all shares of redeemable convertible preferred stock converted to common stock upon the completion of the IPO.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Under certain circumstances, subsequent to the occurrence of a deemed liquidation event, defined as (1) a majority of the holders of the then outstanding redeemable convertible preferred stock and (2) at least 70% of the then outstanding shares of the Series B redeemable convertible preferred stock could have required the Company to redeem their shares at a price per share equal to the liquidation amount, to the extent that sufficient funds were available. Additionally, holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock initially had the option to redeem their shares beginning in October 2026. As a result, these shares were considered probable of becoming redeemable since redemption is solely dependent on the passage of time. As such, the Company adjusted the carrying value of the redeemable convertible preferred stock by accreting changes in the redemption value over the period from the date of issuance to the earliest redemption date of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_48b04b20-61bc-4a16-8826-6dea6acb138e;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;October 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. In October 2020, the Company amended the terms of their Certificate of Incorporation to remove the redemption option of their Series A and Series A-1 redeemable convertible preferred stock, as a result the Company ceased recording adjustments to the carrying value of its outstanding redeemable convertible preferred stock for accretion to redemption value. There was no change in value as a result of this modification. There was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; accretion to redemption value recorded for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Voting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of the Company&#x2019;s Series B redeemable convertible preferred stock, voting together as a class, were entitled to elect one (1) member of the Board of Directors (the Series B director). The holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock, voting together as a class, were entitled to elect two (2) members of the Board of Directors (the Series A directors). The holders of the shares of common stock and of any other class or series of voting stock (including the preferred stock), voting together as a class, were entitled to elect the balance of the Company&#x2019;s directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stockholder Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of the Company&#x2019;s redeemable convertible preferred stock had protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the redeemable convertible preferred stock, changes in the authorized number of shares, declaration or payment of dividends, repurchase of shares, changes in the size of the Board of directors, creation of a new class or series of stock, or taking any action that would cause a liquidation event.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Further, the holders of the Company's Series B redeemable convertible preferred stock had additional protective provisions that required Series B preferred stockholders representing 70% of the outstanding shares of the Series B redeemable convertible preferred stock to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series B redeemable convertible preferred stock, changes in the authorized number of shares of Series B redeemable convertible preferred stock, declaration or payment of dividends or distributions shares of capital stock other than the Series A, Series A-1, and Series B redeemable convertible preferred stock, sell shares of Common Stock to the public at price below $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in a firm-commitment underwritten public offering, or taking any action that would cause a liquidation event that would results in proceeds of less than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share of the Series B redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Additionally, the holders of the Company&#x2019;s Series A and Series A-1 redeemable convertible preferred stock had additional protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#x2019;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series A and Series A-1 redeemable convertible preferred stock and changes or reclassifications of any existing security of the Company that is pari passu with the Series A and/or Series A-1 redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;</elym:TemporaryEquityDisclosureTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_1247c153-9074-4001-805f-d1c409e9cc14">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020, the Company&#x2019;s redeemable convertible preferred stock consisted of the following balance (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:28.541%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:7.151%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:0.751%;"/&gt;
        &lt;td style="width:11.594%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:0.751%;"/&gt;
        &lt;td style="width:13.45%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.062%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
        &lt;td style="width:1.707%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:11.873%;"/&gt;
        &lt;td style="width:0.742%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Issue&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares &lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares Issued and Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,717,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,717,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,074&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,569&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A  (Athenen Acquisition)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,692,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,923,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,977&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,069&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Ending balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,909,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,140,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;46,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <elym:TemporaryEquityIssuePrice
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="INF"
      id="F_5a21ddd1-92d3-4356-8b08-234d82b8c96a"
      unitRef="U_USDollarShare">6.00</elym:TemporaryEquityIssuePrice>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="INF"
      id="F_3945cbd5-f61c-499a-b7e7-a90a82acb53c"
      unitRef="U_shares">2717084</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="INF"
      id="F_166d012e-8144-4bc6-bb2c-0ebcb1ee8bcb"
      unitRef="U_shares">2717082</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="INF"
      id="F_133588bb-9cd9-4d78-b2a9-ee8791391cfa"
      unitRef="U_shares">2717082</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="-3"
      id="F_65c455b8-56bc-40ab-a796-d2e284c26a6d"
      unitRef="U_USD">17074000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c"
      decimals="-3"
      id="F_f1faaa75-6212-454c-96d8-a42990d8d715"
      unitRef="U_USD">18569000</us-gaap:TemporaryEquityLiquidationPreference>
    <elym:TemporaryEquityIssuePrice
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="INF"
      id="F_7399ae2a-3c89-4ebd-b2a0-2236b1acb995"
      unitRef="U_USDollarShare">5.80</elym:TemporaryEquityIssuePrice>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="INF"
      id="F_aa6fb93d-0757-4acd-ac10-3fe5dc8ac1e6"
      unitRef="U_shares">2500000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="INF"
      id="F_730456b9-d551-4a71-ae8f-cb117061c43c"
      unitRef="U_shares">2500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="INF"
      id="F_db150609-ec19-454d-9b04-7b6330e65f04"
      unitRef="U_shares">2500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="-3"
      id="F_42288466-da81-4aaf-9279-e58b35bcfac6"
      unitRef="U_USD">14500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_3ed9bd1e-ed85-4618-9cdb-a3326f493b32"
      decimals="-3"
      id="F_f305a833-c957-4843-add9-098dc5880032"
      unitRef="U_USD">15253000</us-gaap:TemporaryEquityLiquidationPreference>
    <elym:TemporaryEquityIssuePrice
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="INF"
      id="F_3eb044d5-9a9b-4a0f-9337-bf3d584e0e9f"
      unitRef="U_USDollarShare">7.80</elym:TemporaryEquityIssuePrice>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="INF"
      id="F_10a48ed4-d490-451b-ac74-e7919fd25641"
      unitRef="U_shares">7692305</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="INF"
      id="F_3c2dedb4-65bf-47bf-a6c3-3e59a8424d48"
      unitRef="U_shares">1923075</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="INF"
      id="F_5cabd6e1-6522-4d7e-953b-926a759510c2"
      unitRef="U_shares">1923075</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="-3"
      id="F_0bc38816-bcba-458f-acc3-64c9df6ec9c5"
      unitRef="U_USD">14977000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_aaf531f9-5e07-42ae-99aa-cecc3bd4698c"
      decimals="-3"
      id="F_788f5044-c386-4b64-9eba-f8ea30901a04"
      unitRef="U_USD">16069000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_25989da9-e6f5-48ce-b5ea-f39c0826d768"
      unitRef="U_shares">12909389</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_3444ca1f-5f45-43c7-b6dd-68eb4eaf4249"
      unitRef="U_shares">7140157</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_3721d358-6190-4604-9caa-c9c628a7e7b2"
      unitRef="U_shares">7140157</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_6f92c29c-6760-4da8-b880-577ab6d92947"
      unitRef="U_USD">46551000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_cb3b4443-085e-4587-8590-db0b48d838e6"
      unitRef="U_USD">49891000</us-gaap:TemporaryEquityLiquidationPreference>
    <elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_9f661c20-6f08-4391-8bc7-a8daecf3219b"
      decimals="INF"
      id="F_6083e9e2-c187-485c-8359-637e6ee0de25"
      unitRef="U_shares">4358972</elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_9f661c20-6f08-4391-8bc7-a8daecf3219b"
      decimals="-5"
      id="F_75768dce-5c7e-4ad4-8815-0bddaf77d392"
      unitRef="U_USD">34000000.0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <elym:RedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_531646ff-7d69-4062-a71d-4de0f8f78fed"
      decimals="-5"
      id="F_70bbe2c6-61d6-4437-8f0e-bfb4885ea278"
      unitRef="U_USD">12300000</elym:RedeemableConvertiblePreferredStockTrancheLiability>
    <elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57"
      decimals="0"
      id="F_0e6c0a7e-6d9c-4a2c-af1f-bdfc99fda172"
      unitRef="U_shares">3846150</elym:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_5c9f7402-be6d-403c-81e9-58d6b24cfa57"
      decimals="-5"
      id="F_ad09d509-61df-4186-af20-0a6837d71dc2"
      unitRef="U_USD">60000000.0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5f6cd6f8-2b85-43a3-8604-dcd98e7b76d3"
      decimals="0"
      id="F_abd83a27-5a52-40a4-9c4c-f4f4757518b3"
      unitRef="U_shares">15345279</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"
      decimals="0"
      id="F_577c26f9-92f5-4f09-b86a-baf81e7713ac"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d"
      decimals="2"
      id="F_4f4cd689-1b53-40a5-9e84-b440c7eb61a6"
      unitRef="U_USDollarShare">15.60</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7"
      decimals="2"
      id="F_35670ab0-f442-4710-a2ee-59aa8e7898a5"
      unitRef="U_USDollarShare">6.00</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_531646ff-7d69-4062-a71d-4de0f8f78fed"
      decimals="2"
      id="F_121eb461-9772-4c3b-93bd-19c10f6ce956"
      unitRef="U_USDollarShare">7.80</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <elym:PercentageOfTemporaryEquitySharesOutstanding
      contextRef="C_4dd18ba3-1af3-403a-a4dd-75dd15b5568f"
      decimals="2"
      id="F_ad074abd-615a-40cf-a005-0dd6b22eb91b"
      unitRef="U_pure">0.70</elym:PercentageOfTemporaryEquitySharesOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_2832e224-7cc3-4a15-81d7-ea64dcb80ca7"
      decimals="2"
      id="F_ef93ac20-9d0a-471d-8d40-e83c93317ded"
      unitRef="U_USDollarShare">6.00</us-gaap:SaleOfStockPricePerShare>
    <elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare
      contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"
      decimals="2"
      id="F_3d936cc9-bb86-46a3-8cd8-92ed82afbe99"
      unitRef="U_USDollarShare">17.16</elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare>
    <elym:TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds
      contextRef="C_46ca06ae-f957-4d6e-af82-97b092ac535d"
      decimals="-5"
      id="F_182eb8ac-03d8-4e5f-a62b-c9066311d2a6"
      unitRef="U_USD">80000000.0</elym:TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c6f17551-2fcd-44a6-8f39-eb07919299f4"
      decimals="0"
      id="F_53a99917-f1de-4ce4-b1de-82a1ddb880d5"
      unitRef="U_shares">15345279</us-gaap:CommonStockSharesIssued>
    <elym:CumulativeDividendsReceive
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_4ff2cec3-cabc-41d0-9527-77d4cc31032e"
      unitRef="U_pure">0.08</elym:CumulativeDividendsReceive>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears
      contextRef="C_91e85f77-84b1-41c9-939d-ce1d423da25a"
      decimals="-5"
      id="F_3c3f8f00-be06-4ef2-9a4d-34ed384982f9"
      unitRef="U_USD">3800000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears
      contextRef="C_1a65d3f7-d7e5-4d07-9686-97499e60085d"
      decimals="-5"
      id="F_38ce9951-7b80-4639-900c-82d7dbc1e5cb"
      unitRef="U_USD">2500000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears
      contextRef="C_91e85f77-84b1-41c9-939d-ce1d423da25a"
      decimals="2"
      id="F_b6b79f22-8efc-42ba-8c89-6a9f6d1c0d69"
      unitRef="U_USDollarShare">0.72</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears
      contextRef="C_1a65d3f7-d7e5-4d07-9686-97499e60085d"
      decimals="2"
      id="F_be75b664-b6c4-42bb-aa42-c7190d77a4ce"
      unitRef="U_USDollarShare">0.48</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears
      contextRef="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc"
      decimals="-5"
      id="F_2b9300c2-e4a5-4d5c-b0ee-b05a7e24c00a"
      unitRef="U_USD">2500000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears
      contextRef="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215"
      decimals="-5"
      id="F_59d02ef7-3662-4b1e-998d-06b7104a3a4a"
      unitRef="U_USD">1100000</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears
      contextRef="C_836500f2-c3d2-49ab-8d43-8dba77beb0dc"
      decimals="2"
      id="F_2d93c679-2717-406c-bd34-e22abea428fb"
      unitRef="U_USDollarShare">0.40</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears
      contextRef="C_253e079d-2bf9-4ade-86b3-e3cee6d4d215"
      decimals="2"
      id="F_d924cd5c-d051-4d12-ae32-4ed5509d2ec8"
      unitRef="U_USDollarShare">0.56</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-6"
      id="F_d87d311c-061d-4207-a254-b337ecb95742"
      unitRef="U_USD">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare
      contextRef="C_81c02b73-1cfc-43ff-81c8-ad3d786216a0"
      decimals="2"
      id="F_3c437832-e0df-49bd-9e89-1e08a910a0d7"
      unitRef="U_USDollarShare">17.16</elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare>
    <elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare
      contextRef="C_aa03c3ec-b522-4ea9-9117-574b7f5fd52d"
      decimals="2"
      id="F_aed479a9-1b2b-466a-9576-9f56decf6860"
      unitRef="U_USDollarShare">17.16</elym:TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare>
    <elym:RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_d4da6288-b284-4398-9b13-3deff1b2ab91">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;. Redeemable Convertible Preferred Stock Tranche Liability &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The purchasers of Series A-1 redeemable convertible preferred stock also received tranche rights, which provided them the right to purchase additional shares of Series A-1 redeemable convertible preferred stock in an additional future tranche. This tranche was for the purchase of Series A-1 and was valued based upon the Company achieving certain future milestones and utilized a valuation model that reflected both potential outcomes of success or failure to meet the milestone.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon issuance in October 2020, the Series A-1 redeemable convertible preferred tranche liability was valued at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.86&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. There was no change in value from the date of issuance and December 31, 2020.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company estimated the fair value of the Series A-1 Tranche Rights using a probability-weighted present value model that considered the probability of triggering the Series A-1 Tranche Rights through achievement of the clinical development milestones specified in the Series A-1 Purchase Agreement. These estimates were based, in part, on subjective assumptions. Changes to these assumptions could have had a significant impact on the reported fair value of the Series A-1 Tranche Rights.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following reflects the significant quantitative inputs used in the valuation of the redeemable convertible preferred stock tranche liability:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.341%;"/&gt;
        &lt;td style="width:2.087%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:14.768%;"/&gt;
        &lt;td style="width:2.273%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1&lt;br/&gt;Tranche&lt;br/&gt;Call Option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated fair value of redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.94&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.25&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Probability of milestone achievement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Strike price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value of each tranche feature&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.86&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Series A-1 redeemable convertible preferred tranche liability was settled on March 9, 2021 with the achievement of milestones set forth in the Series A-1 stock purchase agreement. The fair value of the liability was remeasured prior to settlement, resulting in the Company recognizing a loss in the consolidated statement of operations and comprehensive loss of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Immediately thereafter, the balance of the redeemable convertible preferred stock tranche liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million was reclassified to Series A-1 redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A rollforward of the redeemable convertible preferred stock tranche liability is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.602%;"/&gt;
        &lt;td style="width:2.091%;"/&gt;
        &lt;td style="width:1.529%;"/&gt;
        &lt;td style="width:15.782%;"/&gt;
        &lt;td style="width:0.995%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Change in fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Settlement upon issuance of Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</elym:RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_3d855745-343a-4c58-aacc-25642060cf47"
      decimals="INF"
      id="F_f4ab2fd4-db9f-4aa4-bcee-03871a966a4a"
      unitRef="U_USDollarShare">0.86</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_847674c6-26af-4357-a444-abbc52f68a25">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following reflects the significant quantitative inputs used in the valuation of the redeemable convertible preferred stock tranche liability:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.341%;"/&gt;
        &lt;td style="width:2.087%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:14.768%;"/&gt;
        &lt;td style="width:2.273%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1&lt;br/&gt;Tranche&lt;br/&gt;Call Option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated fair value of redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.94&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.25&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Probability of milestone achievement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Strike price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value of each tranche feature&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.86&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;- $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock>
    <elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock
      contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f"
      decimals="INF"
      id="F_6d3071b1-7cb2-4fff-b8e3-ea5e6c4026fe"
      unitRef="U_USDollarShare">6.94</elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock>
    <elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock
      contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231"
      decimals="INF"
      id="F_e7d9f140-5c22-4ff9-9c67-0d2d60efd8e0"
      unitRef="U_USDollarShare">11.10</elym:TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock>
    <elym:TemporaryEquityDiscountRate
      contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87"
      decimals="INF"
      id="F_b8483321-2db0-4407-a1e1-4a01acbd23cf"
      unitRef="U_pure">0.0010</elym:TemporaryEquityDiscountRate>
    <elym:TemporaryEquityDividendYield
      contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87"
      decimals="INF"
      id="F_f1f26620-aa1f-4963-b4bc-9ffb48e72305"
      unitRef="U_pure">0</elym:TemporaryEquityDividendYield>
    <elym:TemporaryEquityExpectedTerm
      contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f"
      id="F_6ba53466-0460-4e57-b72d-1365d036e2a4">P0Y3M</elym:TemporaryEquityExpectedTerm>
    <elym:TemporaryEquityExpectedTerm
      contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231"
      id="F_dcf091cb-3c82-4dd6-b658-107529cb6615">P0Y5M12D</elym:TemporaryEquityExpectedTerm>
    <elym:TemporaryEquityProbabilityOfMilestoneAchievement
      contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f"
      decimals="INF"
      id="F_c1068024-5d7d-42d1-bd0d-b61b89ea54ea"
      unitRef="U_pure">0.80</elym:TemporaryEquityProbabilityOfMilestoneAchievement>
    <elym:TemporaryEquityProbabilityOfMilestoneAchievement
      contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231"
      decimals="INF"
      id="F_997c8782-f7f4-4d94-ba9a-5fe657969c93"
      unitRef="U_pure">1</elym:TemporaryEquityProbabilityOfMilestoneAchievement>
    <elym:TemporaryEquityStrikePrice
      contextRef="C_e0d329b9-6c79-4719-a2f5-874661472d87"
      decimals="INF"
      id="F_0de3d9f5-4b9a-4629-878a-289181eb8344"
      unitRef="U_USDollarShare">7.80</elym:TemporaryEquityStrikePrice>
    <elym:TemporaryEquityFairValueOfEachTrancheFeature
      contextRef="C_9ec6ede2-f478-478a-b73b-15c197d0267f"
      decimals="INF"
      id="F_c72bbd6c-8a1c-4d9d-baae-aeb78c31b09d"
      unitRef="U_USDollarShare">0.86</elym:TemporaryEquityFairValueOfEachTrancheFeature>
    <elym:TemporaryEquityFairValueOfEachTrancheFeature
      contextRef="C_7c9dfdcb-b90a-4cb9-b372-7db04f0be231"
      decimals="INF"
      id="F_e13db31d-0d42-4b68-8ced-9557a9f6f4e0"
      unitRef="U_USDollarShare">3.32</elym:TemporaryEquityFairValueOfEachTrancheFeature>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_ac126da1-96bb-4ee7-9242-49c11ef12bd4"
      decimals="-5"
      id="F_0072e6e8-5135-4109-93da-f0f6c794de38"
      unitRef="U_USD">11700000</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_e50b5ef4-1e50-483c-b6d3-4444344701f9"
      decimals="-5"
      id="F_85b64c88-6608-4765-af31-cbcbcc6d1894"
      unitRef="U_USD">12300000</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_9734d469-dbd4-4fe1-afdf-759cc1301443">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A rollforward of the redeemable convertible preferred stock tranche liability is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.602%;"/&gt;
        &lt;td style="width:2.091%;"/&gt;
        &lt;td style="width:1.529%;"/&gt;
        &lt;td style="width:15.782%;"/&gt;
        &lt;td style="width:0.995%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Change in fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Settlement upon issuance of Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</elym:ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock>
    <elym:RedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_3f1a09f0-2728-48e0-b979-71f53b6cac71"
      unitRef="U_USD">551000</elym:RedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_2b932264-68b6-4e75-a74b-9decdb75babe"
      unitRef="U_USD">11718000</elym:ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability>
    <elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_2c56e34d-3598-4925-87f2-18f95ecfe527"
      unitRef="U_USD">-12269000</elym:ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement>
    <elym:RedeemableConvertiblePreferredStockTrancheLiability
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_325359d3-ada9-4339-a599-313299e3048d"
      unitRef="U_USD">0</elym:RedeemableConvertiblePreferredStockTrancheLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_190cb0cc-2f3f-42bb-a7d5-6f309e4956b3">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;. Commitments and Contingencies&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company leases office space in the United Kingdom under non-cancelable operating leases. Total rent expense for the three months ended September 30, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. Total rent expense for the nine months ended September 30, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. As of September 30, 2021, future minimum lease payments under non-cancelable operating leases were &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; the terms of which expire on various dates through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;June 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Legal Proceedings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Indemnification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless, and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company intends to enter into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#x2019; and officers&#x2019; insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is immaterial.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-5"
      id="F_a48f3eb9-4e7b-4463-8635-bb94e557328a"
      unitRef="U_USD">100000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="0"
      id="F_ecf23442-b5bb-4b93-8edc-87c6242e9d28"
      unitRef="U_USD">13000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-5"
      id="F_d3c17df6-5af6-4a1a-bb2e-e84061c4ed03"
      unitRef="U_USD">100000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="0"
      id="F_7d9e4390-1b0a-4b08-b6b9-419fecac3928"
      unitRef="U_USD">38000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-5"
      id="F_dd2f2c0b-f1ff-43f2-9f6c-79af9c28eeb2"
      unitRef="U_USD">600000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_4ec47661-dca4-4511-afb2-b57f26f37db7">2023-06-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_e46c4580-be1c-4995-9890-a4aee560aec7">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;. Stock-Based Compensation&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;2019 Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In 2019, the Company adopted the 2019 Equity Incentive Plan (the 2019 Plan). The 2019 Plan provides for the Company to grant qualified stock options, non-qualified stock options, and restricted stock awards to employees, non-employee directors and consultants of the Company under terms and provisions established by the board of directors. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company&#x2019;s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;110&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the fair value of the Company&#x2019;s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; terms measured from the option grant date. While&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; no s&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;hares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;2021 Plan and ESPP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The compensation committee of the Company's board of directors adopted and the Company's stockholders approved the 2021 Equity Incentive Plan (2021 Plan) and the 2021 Employee Stock Purchase Plan (the ESPP ), which became effective immediately prior to the effectiveness of the Company's IPO. The 2021 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. The Company's employees, officers, directors and consultants are eligible to receive awards under the 2021 Plan. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021, the total number of shares authorized for issuance under the 2021 Plan was&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,558,790&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The ESPP allows employees, including executive officers, to contribute up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the fair market value of a share of common stock on the first day of the offering period, or (b) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the fair market value of a share of common stock on the last day of the offering period. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;255,879&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock reserved for future issuance under our ESPP plan and no shares purchased as of September 30, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Awards with vesting conditions under both plans typically include vesting &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% on the first anniversary of the grant date with the remainder vesting monthly over the following three years.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.145%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:10.121%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:10.046%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:12.904%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.857%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Options &lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Remaining &lt;br/&gt;Contract Terms&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic &lt;br/&gt;Values &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;435,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.19&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,386,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options cancelled and forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;59,466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested and expected to vest, September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options exercisable as of September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;206,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.39&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The aggregate intrinsic value disclosed in the above table is based on the difference between the exercise price of the stock option and the estimated fair value of the Company&#x2019;s common stock as of the respective period-end dates. The weighted-average grant date fair value of stock options granted during the nine months ended September 30, 2021, was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.71&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Black-Scholes option pricing model for employee and nonemployee stock options incorporates the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"&gt;&#xf0b7;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value of Common Stock &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014; Prior to the completion of the Company's IPO, the fair value of the Company's common stock was determined by using straight-line interpolation between the value of common stock derived from valuations performed by independent third party specialists, further described in Note 2 to the consolidated financial statements &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies &#x2013; Fair Value of Common Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. After the completion of the Company's IPO, the fair value of each share of common stock is based on the closing price of the Company's common stock on the date of grant as reported on the Nasdaq Global Market. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"&gt;&#xf0b7;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Volatility &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014; The expected stock price volatilities are estimated based on the historical and implied volatilities of comparable publicly traded companies as the Company does not have sufficient history of trading its common stock.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"&gt;&#xf0b7;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risk-free Interest Rate &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014; The risk-free interest rates are based on US Treasury yields in effect at the grant date for notes with comparable terms as the awards.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"&gt;&#xf0b7;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected Term &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014; The expected term represents the period that the Company&#x2019;s stock options are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term).&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"&gt;&#xf0b7;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividend Yield &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014; The expected dividend yield assumption is based on the Company&#x2019;s current expectations about its anticipated dividend policy. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of the Company&#x2019;s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;nine months ended September 30, 2021:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.865%;"/&gt;
        &lt;td style="width:2.083%;"/&gt;
        &lt;td style="width:21.052%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.80 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;- &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.94&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.13&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has restricted stock awards with service and performance conditions. Awards with a service condition vest &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% on the first anniversary of the grant date and monthly thereafter. Awards with a performance condition will vest upon the Company&#x2019;s initiation of a registrational clinical trial to study the efficacy of ETX-810. The probability of achieving performance conditions is assessed each reporting period. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021, this performance condition was assessed and deemed not probable, and the Company has recognized no stock-based compensation expense relating to these performance awards. The Company also granted restricted stock awards to employees and non-employees with service conditions that are subject to repurchase by the Company at the original purchase price in the event that the award recipient&#x2019;s employment or relationship is terminated prior to the shares vesting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The activity for restricted stock awards is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.939%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:17.551%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.523%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-Average &lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;66,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;297,724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"&gt;(1) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Includes &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; restricted stock awards granted in 2018 and still outstanding for the period ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, subject to only performance conditions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company&#x2019;s consolidated statements of operations and comprehensive loss (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.935%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.046%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.009%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.046%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.009%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.44%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021, there was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million of total unrecognized compensation cost related to unvested stock options and unvested restricted stock awards granted, which is expected to be recognized over a weighted average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.19&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2"
      id="F_623fd3d8-0390-4664-9810-a43827d23920">Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company&#x2019;s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than 110% of the fair value of the Company&#x2019;s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have 5-year terms measured from the option grant date. While no shares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2"
      decimals="2"
      id="F_7cfe926c-d353-483b-a3ac-39bd10dacd23"
      unitRef="U_pure">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_d90a6997-6437-4d46-94c8-bbaf9b146ca2"
      id="F_6a797a8b-d13b-453f-937d-590c2b3671e8">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_8865c8f2-5fc8-47cb-be44-ea1ba848844c"
      id="F_846b8296-bd8d-4042-994e-95df34a32b6d">The compensation committee of the Company's board of directors adopted and the Company's stockholders approved the 2021 Equity Incentive Plan (2021 Plan) and the 2021 Employee Stock Purchase Plan (the ESPP ), which became effective immediately prior to the effectiveness of the Company's IPO. The 2021 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. The Company's employees, officers, directors and consultants are eligible to receive awards under the 2021 Plan. As of September 30, 2021, the total number of shares authorized for issuance under the 2021 Plan was 2,558,790.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_31769d99-77c6-4ee7-9d41-eb3e0d4c18c0"
      decimals="0"
      id="F_9eddc988-acf4-4c8c-98b6-6135eb32eb62"
      unitRef="U_shares">2558790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_68f7e8b4-274f-4fe8-b269-524e2cacfad2"
      id="F_742db9b4-165b-4535-8007-13826b6ec831">The ESPP allows employees, including executive officers, to contribute up to 15% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) 85% of the fair market value of a share of common stock on the first day of the offering period, or (b) 85% of the fair market value of a share of common stock on the last day of the offering period. There were 255,879 shares of common stock reserved for future issuance under our ESPP plan and no shares purchased as of September 30, 2021.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <elym:ExecutiveOfficerEarningContribution
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_0b4fb47d-da2d-4083-82e2-c83d1e0eaba1"
      unitRef="U_pure">0.15</elym:ExecutiveOfficerEarningContribution>
    <elym:FairMarketValueCommonStockPercentage
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="2"
      id="F_e53100c3-f35e-4acb-8ad8-ed0d79c7a8da"
      unitRef="U_pure">0.85</elym:FairMarketValueCommonStockPercentage>
    <elym:FairMarketValueCommonStockPercentage
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="2"
      id="F_14329ebc-1f8e-49a6-ad87-4f47f1dace4e"
      unitRef="U_pure">0.85</elym:FairMarketValueCommonStockPercentage>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_66d4dd4a-39ec-4e58-a0db-4d2f02dce3b8"
      decimals="0"
      id="F_48c1ffa7-04ee-40e1-add3-b63f89797c34"
      unitRef="U_shares">255879</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_e66b3150-0c6b-4578-9500-22dc6c115867"
      decimals="2"
      id="F_842084b9-af53-4324-9c01-b7928da328d2"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_e7136ebf-e8c3-465e-a1d7-9886a0420b03">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.145%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:10.121%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:10.046%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:12.904%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.857%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Options &lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Remaining &lt;br/&gt;Contract Terms&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic &lt;br/&gt;Values &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;435,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.19&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,386,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options cancelled and forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;59,466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested and expected to vest, September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options exercisable as of September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;206,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.39&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="INF"
      id="F_50abde7e-9a0b-4b1a-8de7-d329d9c2ec1c"
      unitRef="U_shares">435342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="2"
      id="F_6278b7b2-5a90-426e-b081-70f7df72679c"
      unitRef="U_USDollarShare">0.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_c86051eb-0d3e-4119-82d7-626225e4cc0b"
      id="F_5d1fa068-715d-447c-af5c-5286ec187ee1">P9Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_b17ce63a-e30b-47a5-abd5-5402d3c12a39"
      decimals="-3"
      id="F_33196d6b-cb7d-41f2-a0bb-22417985284c"
      unitRef="U_USD">415000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="INF"
      id="F_9eb86d3f-3fca-48dd-9601-78c57d8dc9bb"
      unitRef="U_shares">2386990</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_0846cb41-4f9d-42e2-974c-def1431ef9f7"
      unitRef="U_USDollarShare">3.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="INF"
      id="F_fec9888b-96f1-42f3-aa5f-48fe9fe72ed3"
      unitRef="U_shares">25551</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_491817d8-e74a-4b9f-a7f1-de8746516251"
      unitRef="U_USDollarShare">1.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="INF"
      id="F_8718d58a-1ce9-4d09-82c8-0daa084563e2"
      unitRef="U_shares">59466</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_43645783-d4c5-4f10-a100-1ed30c807771"
      unitRef="U_USDollarShare">1.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_7ca971c4-f32d-424e-b1f5-a462cb232178"
      unitRef="U_USD">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_127c5bf3-b728-43f7-881b-ff35cd921af6"
      unitRef="U_shares">2737315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="2"
      id="F_a1049221-d439-4f2f-bba4-0dea2e909a61"
      unitRef="U_USDollarShare">2.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <elym:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_320c4237-cd19-4c2c-b9b5-b497c02a2c33">P9Y3M29D</elym:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_b6a36b12-e4fd-4699-b419-5f552e732209"
      unitRef="U_USD">41727000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_46a2b5ca-bf71-47ed-867b-702f7d8f77eb"
      unitRef="U_shares">2737315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="2"
      id="F_d23ea602-4296-4b11-9340-20e29592eb03"
      unitRef="U_USDollarShare">2.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_f70baa2f-b2c8-4bb9-926f-724243ec08c1">P9Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_130f7e75-2e53-4974-95de-390e95b8991c"
      unitRef="U_USD">41727000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="INF"
      id="F_5cd0f20e-fd02-42cf-b817-f172d6ded0b0"
      unitRef="U_shares">206339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="2"
      id="F_28ccde28-2245-455b-85fc-3b9b8172bdcd"
      unitRef="U_USDollarShare">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_a754aa92-faba-4b5c-bdb8-c14af6d3113b">P8Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-3"
      id="F_5a71dd9c-659d-4fbc-af60-68ba49885b90"
      unitRef="U_USD">3646000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_e66b3150-0c6b-4578-9500-22dc6c115867"
      decimals="2"
      id="F_725fb74b-b675-4bfa-aa7f-6f470b9f5d2f"
      unitRef="U_USDollarShare">6.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_faddb653-9e72-409f-9ff9-a9d6f23db76e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of the Company&#x2019;s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;nine months ended September 30, 2021:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.865%;"/&gt;
        &lt;td style="width:2.083%;"/&gt;
        &lt;td style="width:21.052%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.80 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;- &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.94&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.13&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_1f934220-7227-455a-a222-d949fb36f763"
      id="F_52656cc5-4cfa-4a72-a61d-be674e32c2ed">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d"
      id="F_24ce7552-1a80-4571-93ec-8cbd8737b36b">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_1f934220-7227-455a-a222-d949fb36f763"
      decimals="4"
      id="F_44b0c136-ba29-4b51-a268-0d27f14eb6af"
      unitRef="U_pure">0.7825</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_a0b8bfdd-288a-4b33-bf75-c433b5e9645d"
      decimals="4"
      id="F_b36a4f41-6b33-4889-8db4-ef7c393a3edf"
      unitRef="U_pure">0.7957</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="4"
      id="F_784db583-c8c4-498a-9e68-84f705835848"
      unitRef="U_pure">0.0094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="4"
      id="F_61cecf61-f91a-49c7-8707-4face6eef3b1"
      unitRef="U_pure">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="4"
      id="F_8ffb1b99-4bec-47aa-bf3d-b2d125fb3a1d"
      unitRef="U_pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"
      decimals="2"
      id="F_afbf309c-c1b4-4a5a-bca2-10dedd91afdf"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_0789c9c0-efa8-4426-a7a6-a487e3a41827">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The activity for restricted stock awards is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.939%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:17.551%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:1.735%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.523%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-Average &lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;66,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;297,724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"&gt;(1) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Includes &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; restricted stock awards granted in 2018 and still outstanding for the period ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, subject to only performance conditions.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4"
      decimals="INF"
      id="F_ca3a35ef-a845-423b-806e-1680fbe58312"
      unitRef="U_shares">66681</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_3067a383-1bbc-47dc-b6b2-b38a02771ef4"
      decimals="2"
      id="F_206c9caf-3e3a-45eb-92b8-22ac58b33b2d"
      unitRef="U_USDollarShare">1.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"
      decimals="INF"
      id="F_325f5bc1-1c75-4316-b838-41eef3bbdeb4"
      unitRef="U_shares">297724</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"
      decimals="2"
      id="F_b58c8079-9780-4e89-8377-daef67a468eb"
      unitRef="U_USDollarShare">8.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"
      decimals="INF"
      id="F_dff68bf3-5f47-4d50-823e-cecbc804de2c"
      unitRef="U_shares">15766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2b12b419-ce13-4577-a7ff-e9700e68e6ab"
      decimals="2"
      id="F_489cd2fa-aa4f-42d0-a53e-99381cf17f7f"
      unitRef="U_USDollarShare">1.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_1a46cf12-25cf-4536-bbb3-735a35b5967e"
      decimals="INF"
      id="F_ee753bd7-ca86-4051-bce4-f70049f368c8"
      unitRef="U_shares">348639</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_1a46cf12-25cf-4536-bbb3-735a35b5967e"
      decimals="2"
      id="F_be39a320-6d9b-4e7e-a4a5-82fd3e91a4ed"
      unitRef="U_USDollarShare">7.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_4d7d035a-64cf-46ac-a997-043054a67440"
      decimals="0"
      id="F_738e3f6d-a597-4cc1-b578-dc46e3ec241a"
      unitRef="U_shares">21750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_e1e24c30-132c-4d88-8a28-e23154065a6f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company&#x2019;s consolidated statements of operations and comprehensive loss (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.935%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.046%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.009%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.046%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.522%;"/&gt;
        &lt;td style="width:9.009%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_90f3cb70-fc4d-4dc8-b871-9fbf79d9d423"
      decimals="-3"
      id="F_3ab4052c-0afb-4b13-b2c8-931a4f837329"
      unitRef="U_USD">297000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_4a876d31-7de7-495b-a7b5-bba7c9a4a7d1"
      decimals="-3"
      id="F_f57dbeaa-a4d2-4095-acc2-67ad566b4807"
      unitRef="U_USD">45000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5ace5a9e-cd32-4d91-b90b-5a3b7e9a6f23"
      decimals="-3"
      id="F_6cf81ba3-a01c-4d28-8893-c55f2c3dd120"
      unitRef="U_USD">626000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_64c92ae1-3adc-4f1d-b3af-072fddc18c73"
      decimals="-3"
      id="F_b0f45842-3bc4-4ff8-8522-8154f03f34a7"
      unitRef="U_USD">220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ea28cdf2-fea4-428a-98b1-56bb6cc26c9a"
      decimals="-3"
      id="F_32345555-ee17-45bc-8b36-b4f9b778a158"
      unitRef="U_USD">939000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0f1a829c-ed84-4c89-b645-95747568e8c8"
      decimals="-3"
      id="F_87d09a7c-0ee3-49b8-9e46-24fec84b5238"
      unitRef="U_USD">4000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_49b12a98-c4f0-494b-bb47-7d43ab89b59f"
      decimals="-3"
      id="F_a613a50f-a6c5-4c02-b29b-45ad503025be"
      unitRef="U_USD">1957000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d491de55-e878-46da-a26f-9d31bf0a5efa"
      decimals="-3"
      id="F_7f0a193e-fbd7-444e-85ad-e8a84e9d3f32"
      unitRef="U_USD">14000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_5b2b88bd-d225-4f1e-a6be-81c9c248f4cb"
      unitRef="U_USD">1236000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_74c622ad-0a3c-417d-a654-bed6b1b21b61"
      unitRef="U_USD">49000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_b6e07b5c-7a40-4117-a037-c1e535b812b2"
      unitRef="U_USD">2583000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_9c3c6f1f-a2ed-400c-8b9d-0afe0bed923e"
      unitRef="U_USD">234000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_b78178eb-00d0-406e-baa2-53b8b434c787"
      decimals="-2"
      id="F_50e4b996-e42b-4df8-9afd-928059f3e2f7"
      unitRef="U_USD">13300</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_d8b1609c-eaa5-4a8f-8f10-4e9fd86ab6be">P3Y2M8D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_de4c04c1-29d0-4a89-8554-c07f8b162a6c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;8. Net Loss Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.679%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.185%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.138%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.007%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.138%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,615&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;36,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,805&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,322&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average common shares used in computed net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,585,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,863,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,554,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,859,713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All outstanding shares of redeemable convertible preferred stock were converted on a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1-for-1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; basis to shares of common stock on August 12, 2021, the date of the Company's IPO (see Note 1). &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The cumulative preferred stock dividend was therefore eliminated upon conversion of the redeemable convertible preferred stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following outstanding shares of potentially dilutive securities were excluded from the computation of the diluted net loss per share attributable to common stockholders for the periods presented because their effect would have been anti-dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.812%;"/&gt;
        &lt;td style="width:1.224%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:13.366%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:1.224%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:13.366%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three and Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;366,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted stock awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;117,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,999,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total potentially dilutive shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,085,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,483,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_8d278068-baee-4e35-bad4-e69f8ed6ba4e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.679%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.185%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.138%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.007%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.265%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:9.138%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,615&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;36,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,805&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,322&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,157&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average common shares used in computed net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,585,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,863,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,554,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,859,713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_2fb04a2a-a01e-40b8-9440-112590187eb9"
      unitRef="U_USD">-9615000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_a8f333d3-b156-41a2-ab47-401d2224151c"
      unitRef="U_USD">-2258000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_e9208b1a-6394-49d5-84fa-129392487132"
      unitRef="U_USD">-36935000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_60f66c9b-1a61-447e-8a45-2b453ad5542a"
      unitRef="U_USD">-5805000</us-gaap:NetIncomeLoss>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_8294a2c4-6be5-4b91-95d8-e1eede643ea7"
      unitRef="U_USD">1322000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_d1389b62-5770-4fb6-bdd9-c615dc3b0894"
      unitRef="U_USD">461000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_c103787b-2030-49c2-80bc-fc8bc6b6480f"
      unitRef="U_USD">4548000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_d1abae1d-6945-4949-b21c-654f2bc6fa57"
      unitRef="U_USD">1352000</elym:AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-3"
      id="F_33a1dae7-693d-42ca-82d6-4f809c10802f"
      unitRef="U_USD">-10937000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="-3"
      id="F_aafbbd0d-3700-4a26-89ef-7a7620b20bb0"
      unitRef="U_USD">-2719000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-3"
      id="F_9e3f3c8d-9678-4b2d-b774-93ca7d8f32ac"
      unitRef="U_USD">-41483000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-3"
      id="F_1ea8a822-b378-4df7-8bb2-7ff8371890a9"
      unitRef="U_USD">-7157000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="0"
      id="F_ebbdbef8-e22d-47bd-b090-17e5c30681be"
      unitRef="U_shares">15585611</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="0"
      id="F_ebdfbfb9-b372-4fad-adc8-ccf0e976b815"
      unitRef="U_shares">1863860</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="0"
      id="F_75f0f9ed-1fe2-4fa7-8a97-fe87a5616b1a"
      unitRef="U_shares">7554300</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="0"
      id="F_82858687-23fe-419f-92d8-ba2f5ccc7b6c"
      unitRef="U_shares">1859713</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="2"
      id="F_76e457ef-d43f-4f99-b444-737c8a10099e"
      unitRef="U_USDollarShare">-0.70</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="2"
      id="F_15649890-402e-419b-84a0-c89bbfbe4207"
      unitRef="U_USDollarShare">-1.46</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="2"
      id="F_0d825fe4-8e7e-4686-8874-d335deae8000"
      unitRef="U_USDollarShare">-5.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="2"
      id="F_0f191110-a742-4c2d-9f32-454f48b56528"
      unitRef="U_USDollarShare">-3.85</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_c9f28a47-051f-42d9-b600-212fdae2dd25">1-for-1</us-gaap:PreferredStockConversionBasis>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_6f8c5a36-4023-4265-8d35-a5f65e6cd6c0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following outstanding shares of potentially dilutive securities were excluded from the computation of the diluted net loss per share attributable to common stockholders for the periods presented because their effect would have been anti-dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.812%;"/&gt;
        &lt;td style="width:1.224%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:13.366%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:1.224%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:13.366%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three and Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,737,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;366,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted stock awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;117,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,999,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total potentially dilutive shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,085,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,483,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_72d3a4a0-a7dd-4cce-b4cd-5ceeab4550af"
      decimals="INF"
      id="F_1f1f2dec-f688-4178-9db4-3f7bd2396569"
      unitRef="U_shares">2737315</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_398fad3d-4870-4949-9d7c-6dfc42616d57"
      decimals="INF"
      id="F_a342d02d-db0a-44f2-b33b-3374aa20e22c"
      unitRef="U_shares">2737315</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_049452a9-fc43-43c7-8a1c-3587620997bc"
      decimals="INF"
      id="F_4f3f9216-a514-456a-9b6c-21ccc2e4e3e3"
      unitRef="U_shares">366501</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bae15c67-f4c8-4995-984c-a35ab4ed4694"
      decimals="INF"
      id="F_50f02997-8902-497d-b5fa-000dc8d62e37"
      unitRef="U_shares">366501</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3e5d32c4-3b28-4cb4-944a-cb5fad009173"
      decimals="INF"
      id="F_3387638f-6261-4d1f-92fc-cc71b29f6929"
      unitRef="U_shares">348639</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a08166e1-5c98-4297-81ec-f148b463fbeb"
      decimals="INF"
      id="F_071c8ba6-3e09-4a8e-b574-326a273678bc"
      unitRef="U_shares">348639</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_f078b167-0dbc-4247-867c-2c3caced4b04"
      decimals="INF"
      id="F_c5409ecc-244c-417d-b2e4-6bafe91e4d20"
      unitRef="U_shares">117556</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_5ceab66a-25cf-4427-b629-b07de4d324b5"
      decimals="INF"
      id="F_d849e403-2733-448b-b90b-690218a519d4"
      unitRef="U_shares">117556</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_593e17e9-ffd0-4218-9443-cc138e4c41d3"
      decimals="INF"
      id="F_06176804-6fec-4439-85e9-e7c9e34692e9"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_61c4932e-fb1e-472e-b741-e5bb1f637f14"
      decimals="INF"
      id="F_fc22df61-85c5-4b6f-a11e-96d7b760b9fe"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_cce22c4e-7230-4435-ad69-db554d6a00a1"
      decimals="INF"
      id="F_ebf79400-53b0-48f7-93be-256e14811a4a"
      unitRef="U_shares">3999133</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c81c2950-d46e-4287-a0f4-4964fefc37bd"
      decimals="INF"
      id="F_1970432c-e649-4908-9bf6-8f23e3cc5069"
      unitRef="U_shares">3999133</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="INF"
      id="F_3d4d6251-11e8-492a-af09-455ac1564b39"
      unitRef="U_shares">3085954</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="INF"
      id="F_4a848a18-b3ef-4278-81b0-aeb132f4c0a1"
      unitRef="U_shares">3085954</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="INF"
      id="F_71fcc4d3-5c53-4078-a1d6-3b13a9119c07"
      unitRef="U_shares">4483190</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="INF"
      id="F_f1df89b6-4820-4cea-9358-96a066d3d4db"
      unitRef="U_shares">4483190</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      id="F_cbea8402-e9cf-438b-8935-45f128724e0c">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;. Related Party Transactions&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Services Provided by Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has a services agreement with Carnot, LLC. Carnot, LLC was subsequently dissolved and the services agreement transitioned to its successor Carnot Pharma, LLC. The Company reimburses Carnot Pharma, LLC for research and development expenses incurred on its behalf. RA Capital Management, L.P. is the manager of the members of Carnot, LLC and Andrew Levin, a member of the Company's board of directors and former CEO, is the President of Carnot Pharma, LLC. Adam Rosenberg, a member of the Company's board of directors, is a Venture Partner at Carnot Pharma, LLC dba RA Ventures.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amounts invoiced and reimbursed for the three months ended September 30, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. Amounts invoiced and reimbursed for the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;nine months ended September 30, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_21615b53-9670-4e5e-9edd-186adb41d615"
      decimals="-5"
      id="F_9f12d996-ec24-45fd-a010-3edfcb26ea4f"
      unitRef="U_USD">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_c0709b5e-996e-460e-ad80-bae6d0aa8e3c"
      decimals="0"
      id="F_9550d910-731c-4c1b-a1fe-1bae52349072"
      unitRef="U_USD">17000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_db5a93dd-38e3-4ced-bd29-6d7309409a64"
      decimals="-5"
      id="F_6ce170ed-e823-4329-84a3-47b5a659484a"
      unitRef="U_USD">1000000.0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_645dc54a-5fc5-4131-a259-f5bbd15481e3"
      decimals="-5"
      id="F_5f471f41-82c1-4378-88a1-8997eb7d173e"
      unitRef="U_USD">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131730717368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ELIEM THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001768446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-2273741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">23515 NE Novelty Hill Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite B221 #125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redmond<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">276-2300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELYM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,554,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131731149832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 62,819<span></span>
</td>
<td class="nump">$ 20,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">83,199<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">12,614<span></span>
</td>
<td class="nump">1,511<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">158,632<span></span>
</td>
<td class="nump">21,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">23,619<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,633<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">182,251<span></span>
</td>
<td class="nump">24,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable, related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,979<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Accrued expenses, related party</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiability', window );">Redeemable convertible preferred stock tranche liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,590<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,590<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock, $0.0001 par value, 10000000 and 12,909,389 shares authorized, 7140157 shares issued and outstanding with aggregate liquidation preference of $0 and $49,891 at September 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value per share, 250000000 and 40,000,000 shares authorized; 26199262 and 3,418,751 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">241,747<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(65,071)<span></span>
</td>
<td class="num">(28,136)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="nump">176,661<span></span>
</td>
<td class="num">(24,983)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; deficit</a></td>
<td class="nump">$ 182,251<span></span>
</td>
<td class="nump">$ 24,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Convertible Preferred Stock Tranche Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726608680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary Equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">12,909,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary Equity, Liquidation Preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">26,199,262<span></span>
</td>
<td class="nump">3,418,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">26,199,262<span></span>
</td>
<td class="nump">3,418,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727661784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,704<span></span>
</td>
<td class="nump">$ 1,930<span></span>
</td>
<td class="nump">$ 15,455<span></span>
</td>
<td class="nump">$ 4,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ResearchAndDevelopmentExpenseRelatedParties', window );">Research and development, related party</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">8,526<span></span>
</td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">9,383<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">24,969<span></span>
</td>
<td class="nump">5,818<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(9,383)<span></span>
</td>
<td class="num">(2,259)<span></span>
</td>
<td class="num">(24,969)<span></span>
</td>
<td class="num">(5,818)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,718)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency gain (loss)</a></td>
<td class="num">(252)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other income, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(232)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(11,966)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,615)<span></span>
</td>
<td class="num">(2,258)<span></span>
</td>
<td class="num">(36,935)<span></span>
</td>
<td class="num">(5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends', window );">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</a></td>
<td class="num">(1,322)<span></span>
</td>
<td class="num">(461)<span></span>
</td>
<td class="num">(4,548)<span></span>
</td>
<td class="num">(1,352)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (10,937)<span></span>
</td>
<td class="num">$ (2,719)<span></span>
</td>
<td class="num">$ (41,483)<span></span>
</td>
<td class="num">$ (7,157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="num">$ (0.70)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (5.49)<span></span>
</td>
<td class="num">$ (3.85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted Average Number of Shares Outstanding, Basic and Diluted</a></td>
<td class="nump">15,585,611<span></span>
</td>
<td class="nump">1,863,860<span></span>
</td>
<td class="nump">7,554,300<span></span>
</td>
<td class="nump">1,859,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,615)<span></span>
</td>
<td class="num">$ (2,258)<span></span>
</td>
<td class="num">$ (36,935)<span></span>
</td>
<td class="num">$ (5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">$ (9,633)<span></span>
</td>
<td class="num">$ (2,258)<span></span>
</td>
<td class="num">$ (36,953)<span></span>
</td>
<td class="num">$ (5,805)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ResearchAndDevelopmentExpenseRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ResearchAndDevelopmentExpenseRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727009144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (5,562)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1,905<span></span>
</td>
<td class="num">$ (7,468)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,852,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Accretion of Series A and A-1 Preferred Stock</a></td>
<td class="num">(439)<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Release of restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(1,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="num">(7,783)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="num">(9,384)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,856,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(5,562)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
<td class="num">(7,468)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,852,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Accretion of Series A and A-1 Preferred Stock</a></td>
<td class="nump">1,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(5,805)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">(12,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="num">(13,273)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="num">(7,783)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="num">(9,384)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,856,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Accretion of Series A and A-1 Preferred Stock</a></td>
<td class="num">(452)<span></span>
</td>
<td class="nump">$ 452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Release of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(1,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="num">(9,815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="num">(11,015)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Accretion of Series A and A-1 Preferred Stock</a></td>
<td class="num">(461)<span></span>
</td>
<td class="nump">$ 461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(461)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Release of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(2,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="num">(12,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="num">(13,273)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 46,551<span></span>
</td>
<td class="nump">$ 46,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">7,140,157<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">$ (24,983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
<td class="num">(28,136)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,418,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues', window );">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,358,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement', window );">Reclassification of redeemable convertible preferred stock tranche liability upon settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards', window );">Exercise of stock options and release of restricted stock awards</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares', window );">Exercise of stock options and release of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(18,601)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,601)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="num">(43,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,554<span></span>
</td>
<td class="num">(46,737)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,482,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,499,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 46,551<span></span>
</td>
<td class="nump">$ 46,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">7,140,157<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">$ (24,983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
<td class="num">(28,136)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,418,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement', window );">Reclassification of redeemable convertible preferred stock tranche liability upon settlement</a></td>
<td class="num">(12,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Accretion of Series A and A-1 Preferred Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(36,935)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">176,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">241,747<span></span>
</td>
<td class="num">(65,071)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,199,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,499,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="num">$ (43,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,554<span></span>
</td>
<td class="num">(46,737)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,482,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues', window );">Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,846,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards', window );">Exercise of stock options and release of restricted stock awards</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares', window );">Exercise of stock options and release of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(8,719)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,719)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="num">(50,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">4,610<span></span>
</td>
<td class="num">(55,456)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,489,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,345,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds from issuance of common stock in initial public offering</a></td>
<td class="nump">83,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds from issuance of common stock in initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</a></td>
<td class="nump">152,759<span></span>
</td>
<td class="num">$ (152,759)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">152,758<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,345,279)<span></span>
</td>
<td class="nump">15,345,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Release of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(9,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">176,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 241,747<span></span>
</td>
<td class="num">$ (65,071)<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,199,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of stock options and release of restricted stock awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of stock options and release of restricted stock awards, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of redeemable convertible preferred stock tranche liability upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityAccretionReductionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity accretion (reduction) to redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityAccretionReductionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period share new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724333112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember', window );">Series A1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance cost</a></td>
<td class="nump">$ 8,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131730697752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (36,935)<span></span>
</td>
<td class="num">$ (5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,583<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="nump">11,718<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premiums and accretion of discounts</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency gain from remeasurement</a></td>
<td class="num">(245)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other assets</a></td>
<td class="nump">11,103<span></span>
</td>
<td class="num">(2,235)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_IncreaseDecreaseInNonCurrentAssets', window );">Long-term assets</a></td>
<td class="nump">2,633<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty', window );">Accounts payable and accrued liabilities, related party</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(28,188)<span></span>
</td>
<td class="num">(8,474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(106,919)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(106,919)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts', window );">Proceeds from issuance of common stock sold in initial public offering, net issuance costs</a></td>
<td class="nump">83,144<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="nump">93,939<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">177,194<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">245<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">42,332<span></span>
</td>
<td class="num">(8,533)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">20,487<span></span>
</td>
<td class="nump">21,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">62,819<span></span>
</td>
<td class="nump">12,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">152,759<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAccretionReductionToRedemptionValue', window );">Redeemable convertible preferred stock accretion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,352<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of redeemable convertible preferred stock to common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in accounts payable and accrued liabilities related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_IncreaseDecreaseInNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in non current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_IncreaseDecreaseInNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock sold in initial public offering, net issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityAccretionReductionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity accretion (reduction) to redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityAccretionReductionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131725852584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Description of Organization and Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1.    Description of Organization and Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc. (the Company) is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Headquartered in Redmond, Washington, the Company was incorporated on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">October 18, 2018</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Delaware corporation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying interim condensed consolidated financial statements of the Company and its wholly owned subsidiaries have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany transactions and balances have been eliminated in consolidation.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated balance sheet as of September 30, 2021, and condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of cash flows, and condensed consolidated statements of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) for the three and nine months ended September 30, 2021 and 2020, are unaudited. The consolidated balance sheet as of December 31, 2020 was derived from the audited financial statements as of and for the year ended December 31, 2020, but does not include all disclosures required by U.S. GAAP. The unaudited interim condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair statement of the Company&#8217;s financial position as of September 30, 2021, the condensed results of its operations as of the three and nine months ended September 30, 2021 and 2020, and its cash flows for the nine months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2021 and 2020 are also unaudited. The condensed results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other period. These interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited financial statements included in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reverse Stock Split</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2021, the Company's board of directors approved an amendment to the Company's certificate of incorporation to effect a reverse split of shares of the Company's common stock on a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1-for-2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> basis, which was effected on July 29, 2021 (the Reverse Stock Split). The number of authorized shares and the par values of the common stock were not adjusted as a result of the Reverse Stock Split. In connection with the Reverse Stock Split, the number of authorized shares, outstanding shares, and the conversion ratio for the Company's redeemable convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. All references to common stock and options to purchase common stock share data, per share data, and related information contained in the condensed consolidated financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split for all periods presented.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On August 12, 2021, the Company completed its initial public offering (IPO) of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,360,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, including the underwriters' full exercise of their over-allotment option at the IPO price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. Gross proceeds from the IPO were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, and the net proceeds were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, after deducting underwriting discounts of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of offering costs payable by the Company. At the closing of the IPO, all of the Company's then outstanding redeemable convertible preferred stock was automatically converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,345,279</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. The related carrying value of the redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">152.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million was reclassified to common stock and additional paid-in capital.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million as of September 30, 2021 and expects to incur additional losses from operations in the future. The Company estimates the available cash, cash equivalents, and marketable securities as of September 30, 2021 will be sufficient to meet its projected operating requirements for at least the next twelve months from the filing date of these unaudited condensed consolidated financial statements. Therefore, based on management's updated evaluation of the Company's ability to continue as a going concern, management has concluded the factors that previously raised substantial doubt about the Company's ability to continue as a going concern no longer exist as of the issuance date of these unaudited condensed consolidated financial statements. The Company will need to obtain substantial additional funding to develop and commercialize the Company's clinical programs as currently contemplated. The Company expects to finance future cash needs through equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, but there are no assurances that the Company will be able to raise sufficient amounts of funding in the future on acceptable terms, or at all.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to the valuation of assets acquired, accrual of research and development expenses, the valuation of stock-based awards, the valuation of common stock and redeemable convertible preferred stock, and the valuation of redeemable convertible preferred stock tranche liabilities. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and marketable securities. The Company&#8217;s cash is held by two financial institutions in the United States (U.S.) and two financial institutions in the United Kingdom (U.K.). The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company&#8217;s deposits held in the U.S. and U.K. may exceed the Federal Depository Insurance Corporation and Financial Services Compensation Scheme, respectively, insured limits. The Company has investments in money market funds, U.S. government debt securities, commercial paper, and corporate bonds with high-quality accredited financial institutions.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company&#8217;s products and processes and clinical efficacy and safety of the Company&#8217;s products under development, compliance with government regulations and the need to obtain additional financing to fund operations. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical studies, clinical trials, and regulatory approval, prior to commercialization. These efforts will require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be obtained or maintained, that any products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees, consultants and other third parties.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, the current COVID-19 pandemic, which is impacting worldwide economic activity, poses risk that the Company or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time which may delay the start-up and conduct of the Company&#8217;s clinical trials, and negatively impact manufacturing and testing activities performed by third parties. Any significant delays may impact the use and sufficiency of the Company&#8217;s existing cash reserves, and the Company may be required to raise additional capital earlier than it had previously planned. The Company may be unable to raise additional capital if and when needed, which may result in delays or suspension of its development plans. The extent to which the pandemic will impact the Company&#8217;s business will depend on future developments that are highly uncertain and cannot be predicted at this time.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the CODM). The Company&#8217;s CODM is its chief executive officer who reviews financial information together with certain operating metrics principally to make decisions about how to allocate resources and to measure the Company&#8217;s performance. Management has determined that the Company operates as a single operating and reportable segment. The Company&#8217;s CODM evaluates financial information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is found in the interim condensed consolidated financial statements.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company measures fair value based on a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In determining fair value, the Company utilizes quoted market prices, or valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers into or out of Level 3 for any of the periods presented.</span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s fair value measurements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021 and December 31, 2020 was as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:35.72%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.138%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.101%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets:</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,407</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">145,230</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liabilities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock<br/>&#160;&#160;&#160;tranche liability</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The redeemable convertible preferred stock tranche liability was settled on March 9, 2021.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. As of September 30, 2021, the Company's cash equivalents consisted of money market funds. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cash equivalents as of December 31, 2020.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs that were directly related to the Company&#8217;s IPO were deferred for expense recognition and capitalized and recorded within prepaid and other current assets on the accompanying condensed consolidated balance sheet. These costs consist of legal fees, accounting fees, and other applicable professional services. These deferred offering costs were reclassified to additional paid in capital upon the closing of the IPO. As of September 30, 2021, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> deferred offering costs capitalized.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments in Marketable Securities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities are classified as available-for-sale, primarily consisting of U.S. government debt securities, commercial paper, and corporate bonds, and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of stockholders' equity (deficit) in accumulated other comprehensive loss until realized. Realized gains and losses on the sale of these securities are recognized in other income, net. The cost of marketable securities sold is based on the specific identification method.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company periodically reviews its available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security rating or sector credit ratings, and other relevant market data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been no other significant changes in the Company&#8217;s accounting policies during the three and nine months ended September 30, 2021.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of consolidated financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The effective date of this update for nonpublic companies is for fiscal years beginning after December 15, 2021 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today&#8217;s &#8220;incurred loss&#8221; approach with an &#8220;expected loss&#8221; model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard&#8217;s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The effective date of this update for non-public companies is for fiscal years beginning after December 15, 2022 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726096344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2.   Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments consists of available-for-sale securities as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.532%;"/>
        <td style="width:1.856%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.746%;"/>
        <td style="width:0.733%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.626%;"/>
        <td style="width:0.733%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.755%;"/>
        <td style="width:0.937%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.512%;"/>
        <td style="width:11.737%;"/>
        <td style="width:0.733%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,208</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,199</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19,633</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total long-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,628</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,619</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All the commercial paper, U.S. government debt securities, and corporate bonds designated as short-term marketable securities have a  contractual maturity date that is equal to or less than one year from the respective balance sheet date. Those that are designated as long-term marketable securities have a contractual maturity date that is more than one year from the respective balance sheet date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued interest receivable is excluded from the amortized cost and estimated fair value of the Company's marketable securities. Accrued interest receivable of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million is presented separately within the prepaid expenses and other current assets line items in the Company's unaudited condensed consolidated balance sheet as of September 30, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, there were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of corporate bonds in a continual unrealized loss position for less than 12 months. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> investments in a continual unrealized loss position for greater than twelve months.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, the Company did not intend, nor was the Company more likely than not to be required, to sell its available-for-sale investments before the recovery of the amortized cost basis, which may be maturity. Based on the Company's assessment, it concluded that none of the available-for-sale investments held as of September 30, 2021 were considered to be impaired, as such, no impairment loss was recorded for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131725869480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Accounts<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Certain Balance Sheet Accounts</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3.    Certain Balance Sheet Accounts</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prepaid Expenses and Other Current Assets</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.458%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.449%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recoverable research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,943</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,661</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,960</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,050</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,511</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Expenses</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.458%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.449%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued payroll</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,443</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">592</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,278</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">627</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">290</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,011</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,219</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131725978840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityDisclosureTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.    Redeemable Convertible Preferred Stock </span><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the Company&#8217;s redeemable convertible preferred stock consisted of the following balance (in thousands, except share and per share amounts):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:28.541%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.521%;"/>
        <td style="width:7.151%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:0.751%;"/>
        <td style="width:11.594%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:0.751%;"/>
        <td style="width:13.45%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.062%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.53%;"/>
        <td style="width:11.873%;"/>
        <td style="width:0.742%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Issue<br/>Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares <br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares Issued and Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Liquidation<br/>Preference</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,717,084</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,717,082</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,074</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,569</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A  (Athenen Acquisition)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,253</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,692,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,923,075</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,977</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,069</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ending balance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,909,389</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,140,157</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46,551</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49,891</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, Series A-1 preferred stockholders exercised their tranche rights in connection with milestone achievements related to Phase 1 clinical trial results of ETX-155. As a result, the Company issued an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,358,972</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-1 redeemable convertible preferred shares for gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. Upon exercise of the tranche rights, the Company reclassified the $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million in preferred stock tranche liability to Series A-1 redeemable convertible preferred stock on the consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2021, the Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,846,150</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock for gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon completion of the IPO on August 12, 2021, all of the Company&#8217;s then outstanding redeemable convertible preferred stock was converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,345,279</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. As of September 30, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> redeemable convertible preferred stock outstanding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to conversion, the holders of the Series A, Series A-1, and Series B redeemable convertible preferred stock had various rights, preferences, privileges, and restrictions, with respect to voting, dividends, liquidation, and conversion.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of any liquidation event, either voluntarily or involuntary, the holders of the Series B redeemable convertible preferred stock were entitled to receive, out of the assets of the Company before any payment shall be made or any assets distributed to the holders of Series A and A-1 redeemable convertible preferred stock, the Series B redeemable convertible preferred stock liquidation preference of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series B redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the Series B redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the payment to the holders of the Series B redeemable convertible preferred stock of the full preferential amount, the holders of the Series A and Series A-1 redeemable convertible preferred stock were entitled to receive, out of the assets of the Company, the applicable liquidation preference specified for each series of redeemable convertible preferred stock before any payment was made or any assets distributed to the holders of common stock. Liquidation preference was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for Series A and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for Series A-1, each adjusted for any stock splits, combinations, and reorganizations, plus all unpaid cumulative dividends on each such share. If upon the liquidation event, the assets distributed among the holders of the Series A and A-1 redeemable convertible preferred stock were insufficient to permit the payment to such holders of the full liquidation preference for their shares, then the holders of shares of the redeemable convertible preferred stock shared ratably in any distribution of the assets available for distribution in proportion to their respective amounts, which otherwise would have been payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid the full preferential amount.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the payment to the holders of the redeemable convertible preferred stock of the full preferential amount specified above, any remaining assets of the Company would have been distributed pro rata among all holders of the preferred and common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A liquidation event required approval by the holders of at least a majority of the outstanding shares of redeemable convertible preferred stock and at least </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then outstanding shares of Series B redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Optional Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of redeemable convertible preferred stock was convertible into common stock at the stockholder&#8217;s option. The converted shares would have been determined by dividing the original issue price for each series by the applicable conversion price for such series in effect at the date of conversion. The conversion price for each share of redeemable convertible preferred stock was initially equal to the original issuance price applicable to such share, with the exception of the Series A redeemable convertible preferred stock issued related to the Athenen Acquisition, which were convertible at any time after the date of issuance into common stock at the original issue price of the original Series A of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The conversion ratio was subject to appropriate adjustments for anti-dilution provisions, including stock splits, stock dividends, subdivisions, combinations, recapitalization events or similar events. Specific to the Series B convertible redeemable preferred stock, the conversion ratio was subject to specific anti-dilution provisions adjustments if there was common stock issued for consideration below the Series B issue price.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Automatic Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of redeemable convertible preferred stock was convertible into common stock at initial conversion rates described under the Optional Conversion heading above, subject to adjustments based on certain antidilution provisions, including stock splits, stock dividends, subdivision, combinations, recapitalization or similar events, as provided by the Company&#8217;s certificate of incorporation. Further, all shares of redeemable convertible preferred stock automatically would have converted into common stock upon the vote or written consent of the holders of a majority of the shares of redeemable convertible preferred stock or upon the closing of a firm-commitment underwritten public offering of the Company&#8217;s common stock at a stock price of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share and with gross aggregate proceeds to the Company of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon completion of the IPO, the Company's redeemable convertible preferred stock was converted into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,345,279</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of Series A, Series A-1, and Series B redeemable convertible preferred stock were entitled to receive cumulative dividends of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% per annum of the original issuance price on each share of redeemable convertible preferred stock. The dividends were payable in cash, out of the assets at the time legally available thereof, when, as and if declared by the Board of Directors, on an equal basis according to the number of shares of redeemable convertible preferred stock held by such holders, prior and in preference to the common stock. As of December 31, 2020, the Company had total dividends in arrears for the Series A redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, or $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.72</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.48</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, respectively, and for Series A-1 redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, or $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.56</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. As of September 30, 2021, the Company had no dividends in arrears as all shares of redeemable convertible preferred stock converted to common stock upon the completion of the IPO.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Redemption</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under certain circumstances, subsequent to the occurrence of a deemed liquidation event, defined as (1) a majority of the holders of the then outstanding redeemable convertible preferred stock and (2) at least 70% of the then outstanding shares of the Series B redeemable convertible preferred stock could have required the Company to redeem their shares at a price per share equal to the liquidation amount, to the extent that sufficient funds were available. Additionally, holders of the Company&#8217;s Series A and Series A-1 redeemable convertible preferred stock initially had the option to redeem their shares beginning in October 2026. As a result, these shares were considered probable of becoming redeemable since redemption is solely dependent on the passage of time. As such, the Company adjusted the carrying value of the redeemable convertible preferred stock by accreting changes in the redemption value over the period from the date of issuance to the earliest redemption date of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_48b04b20-61bc-4a16-8826-6dea6acb138e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">October 2026</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In October 2020, the Company amended the terms of their Certificate of Incorporation to remove the redemption option of their Series A and Series A-1 redeemable convertible preferred stock, as a result the Company ceased recording adjustments to the carrying value of its outstanding redeemable convertible preferred stock for accretion to redemption value. There was no change in value as a result of this modification. There was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accretion to redemption value recorded for the nine months ended September 30, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of the Company&#8217;s Series B redeemable convertible preferred stock, voting together as a class, were entitled to elect one (1) member of the Board of Directors (the Series B director). The holders of the Company&#8217;s Series A and Series A-1 redeemable convertible preferred stock, voting together as a class, were entitled to elect two (2) members of the Board of Directors (the Series A directors). The holders of the shares of common stock and of any other class or series of voting stock (including the preferred stock), voting together as a class, were entitled to elect the balance of the Company&#8217;s directors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stockholder Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of the Company&#8217;s redeemable convertible preferred stock had protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#8217;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the redeemable convertible preferred stock, changes in the authorized number of shares, declaration or payment of dividends, repurchase of shares, changes in the size of the Board of directors, creation of a new class or series of stock, or taking any action that would cause a liquidation event.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the holders of the Company's Series B redeemable convertible preferred stock had additional protective provisions that required Series B preferred stockholders representing 70% of the outstanding shares of the Series B redeemable convertible preferred stock to consent to specific actions including the following: changes in the corporation&#8217;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series B redeemable convertible preferred stock, changes in the authorized number of shares of Series B redeemable convertible preferred stock, declaration or payment of dividends or distributions shares of capital stock other than the Series A, Series A-1, and Series B redeemable convertible preferred stock, sell shares of Common Stock to the public at price below $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in a firm-commitment underwritten public offering, or taking any action that would cause a liquidation event that would results in proceeds of less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share of the Series B redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the holders of the Company&#8217;s Series A and Series A-1 redeemable convertible preferred stock had additional protective provisions that required preferred stockholders representing a majority of the outstanding redeemable convertible preferred stock, voting as a single class (on an as-converted basis), to consent to specific actions including the following: changes in the corporation&#8217;s certificate of incorporation or bylaws that would affect, alter or change the preference or rights of the Series A and Series A-1 redeemable convertible preferred stock and changes or reclassifications of any existing security of the Company that is pari passu with the Series A and/or Series A-1 redeemable convertible preferred stock.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity disclosure text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726142088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock Tranche Liability<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock', window );">Redeemable Convertible Preferred Stock Tranche Liability</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Redeemable Convertible Preferred Stock Tranche Liability </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purchasers of Series A-1 redeemable convertible preferred stock also received tranche rights, which provided them the right to purchase additional shares of Series A-1 redeemable convertible preferred stock in an additional future tranche. This tranche was for the purchase of Series A-1 and was valued based upon the Company achieving certain future milestones and utilized a valuation model that reflected both potential outcomes of success or failure to meet the milestone.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon issuance in October 2020, the Series A-1 redeemable convertible preferred tranche liability was valued at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.86</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. There was no change in value from the date of issuance and December 31, 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company estimated the fair value of the Series A-1 Tranche Rights using a probability-weighted present value model that considered the probability of triggering the Series A-1 Tranche Rights through achievement of the clinical development milestones specified in the Series A-1 Purchase Agreement. These estimates were based, in part, on subjective assumptions. Changes to these assumptions could have had a significant impact on the reported fair value of the Series A-1 Tranche Rights.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following reflects the significant quantitative inputs used in the valuation of the redeemable convertible preferred stock tranche liability:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.341%;"/>
        <td style="width:2.087%;"/>
        <td style="width:1.531%;"/>
        <td style="width:14.768%;"/>
        <td style="width:2.273%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Series A-1<br/>Tranche<br/>Call Option</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Estimated fair value of redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.10</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.25</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.45</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">N/A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Probability of milestone achievement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Strike price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of each tranche feature</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.86</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.32</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Series A-1 redeemable convertible preferred tranche liability was settled on March 9, 2021 with the achievement of milestones set forth in the Series A-1 stock purchase agreement. The fair value of the liability was remeasured prior to settlement, resulting in the Company recognizing a loss in the consolidated statement of operations and comprehensive loss of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Immediately thereafter, the balance of the redeemable convertible preferred stock tranche liability of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million was reclassified to Series A-1 redeemable convertible preferred stock.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A rollforward of the redeemable convertible preferred stock tranche liability is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.602%;"/>
        <td style="width:2.091%;"/>
        <td style="width:1.529%;"/>
        <td style="width:15.782%;"/>
        <td style="width:0.995%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Settlement upon issuance of Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,269</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724685000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Commitments and Contingencies</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company leases office space in the United Kingdom under non-cancelable operating leases. Total rent expense for the three months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. Total rent expense for the nine months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. As of September 30, 2021, future minimum lease payments under non-cancelable operating leases were </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.6</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the terms of which expire on various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">June 30, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Proceedings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Indemnification</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless, and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company intends to enter into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#8217; and officers&#8217; insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is immaterial.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726081224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Stock-Based Compensation</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2019 Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2019, the Company adopted the 2019 Equity Incentive Plan (the 2019 Plan). The 2019 Plan provides for the Company to grant qualified stock options, non-qualified stock options, and restricted stock awards to employees, non-employee directors and consultants of the Company under terms and provisions established by the board of directors. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company&#8217;s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair value of the Company&#8217;s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> terms measured from the option grant date. While</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> no s</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2021 Plan and ESPP</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The compensation committee of the Company's board of directors adopted and the Company's stockholders approved the 2021 Equity Incentive Plan (2021 Plan) and the 2021 Employee Stock Purchase Plan (the ESPP ), which became effective immediately prior to the effectiveness of the Company's IPO. The 2021 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. The Company's employees, officers, directors and consultants are eligible to receive awards under the 2021 Plan. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021, the total number of shares authorized for issuance under the 2021 Plan was</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,558,790</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ESPP allows employees, including executive officers, to contribute up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair market value of a share of common stock on the first day of the offering period, or (b) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the fair market value of a share of common stock on the last day of the offering period. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">255,879</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock reserved for future issuance under our ESPP plan and no shares purchased as of September 30, 2021.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awards with vesting conditions under both plans typically include vesting </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% on the first anniversary of the grant date with the remainder vesting monthly over the following three years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.145%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:10.121%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:10.046%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:12.904%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.857%;"/>
        <td style="width:0.983%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Options <br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>Average <br/>Exercise <br/>Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted <br/>Average <br/>Remaining <br/>Contract Terms<br/>(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic <br/>Values <br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">435,342</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.19</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">415</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,386,990</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.11</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.86</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercised</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59,466</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and expected to vest, September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.74</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,727</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercisable as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">206,339</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.31</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.39</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,646</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The aggregate intrinsic value disclosed in the above table is based on the difference between the exercise price of the stock option and the estimated fair value of the Company&#8217;s common stock as of the respective period-end dates. The weighted-average grant date fair value of stock options granted during the nine months ended September 30, 2021, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.71</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Black-Scholes option pricing model for employee and nonemployee stock options incorporates the following assumptions:</span></p><div style="margin-left:3.333%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#61623;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value of Common Stock </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212; Prior to the completion of the Company's IPO, the fair value of the Company's common stock was determined by using straight-line interpolation between the value of common stock derived from valuations performed by independent third party specialists, further described in Note 2 to the consolidated financial statements </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies &#8211; Fair Value of Common Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. After the completion of the Company's IPO, the fair value of each share of common stock is based on the closing price of the Company's common stock on the date of grant as reported on the Nasdaq Global Market. </span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#61623;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Volatility </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212; The expected stock price volatilities are estimated based on the historical and implied volatilities of comparable publicly traded companies as the Company does not have sufficient history of trading its common stock.</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#61623;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk-free Interest Rate </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212; The risk-free interest rates are based on US Treasury yields in effect at the grant date for notes with comparable terms as the awards.</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#61623;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Term </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212; The expected term represents the period that the Company&#8217;s stock options are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term).</span></div></div><div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#61623;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Yield </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212; The expected dividend yield assumption is based on the Company&#8217;s current expectations about its anticipated dividend policy. </span></div></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the Company&#8217;s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.865%;"/>
        <td style="width:2.083%;"/>
        <td style="width:21.052%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.80 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.08</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has restricted stock awards with service and performance conditions. Awards with a service condition vest </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% on the first anniversary of the grant date and monthly thereafter. Awards with a performance condition will vest upon the Company&#8217;s initiation of a registrational clinical trial to study the efficacy of ETX-810. The probability of achieving performance conditions is assessed each reporting period. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021, this performance condition was assessed and deemed not probable, and the Company has recognized no stock-based compensation expense relating to these performance awards. The Company also granted restricted stock awards to employees and non-employees with service conditions that are subject to repurchase by the Company at the original purchase price in the event that the award recipient&#8217;s employment or relationship is terminated prior to the shares vesting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The activity for restricted stock awards is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.939%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:17.551%;"/>
        <td style="width:1.002%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.523%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted-Average <br/>Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">297,724</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.55</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,766</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,639</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.03</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Includes </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> restricted stock awards granted in 2018 and still outstanding for the period ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to only performance conditions.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company&#8217;s consolidated statements of operations and comprehensive loss (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.935%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.046%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.009%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.046%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.009%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">939</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,957</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,236</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,583</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.44%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, there was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of total unrecognized compensation cost related to unvested stock options and unvested restricted stock awards granted, which is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724665496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Net Loss Per Share Attributable to Common Stockholders</span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.679%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.185%;"/>
        <td style="width:0.993%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.138%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.007%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.138%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,615</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,258</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36,935</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,805</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,322</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">461</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,548</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,352</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,483</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,157</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average common shares used in computed net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,585,611</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,863,860</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,554,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,859,713</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.85</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All outstanding shares of redeemable convertible preferred stock were converted on a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1-for-1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> basis to shares of common stock on August 12, 2021, the date of the Company's IPO (see Note 1). </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The cumulative preferred stock dividend was therefore eliminated upon conversion of the redeemable convertible preferred stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following outstanding shares of potentially dilutive securities were excluded from the computation of the diluted net loss per share attributable to common stockholders for the periods presented because their effect would have been anti-dilutive:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.812%;"/>
        <td style="width:1.224%;"/>
        <td style="width:1.002%;"/>
        <td style="width:13.366%;"/>
        <td style="width:1.002%;"/>
        <td style="width:1.224%;"/>
        <td style="width:1.002%;"/>
        <td style="width:13.366%;"/>
        <td style="width:1.002%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three and Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">366,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock awards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,639</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117,556</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,999,133</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total potentially dilutive shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,085,954</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,483,190</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724612488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. Related Party Transactions</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Services Provided by Related Parties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has a services agreement with Carnot, LLC. Carnot, LLC was subsequently dissolved and the services agreement transitioned to its successor Carnot Pharma, LLC. The Company reimburses Carnot Pharma, LLC for research and development expenses incurred on its behalf. RA Capital Management, L.P. is the manager of the members of Carnot, LLC and Andrew Levin, a member of the Company's board of directors and former CEO, is the President of Carnot Pharma, LLC. Adam Rosenberg, a member of the Company's board of directors, is a Venture Partner at Carnot Pharma, LLC dba RA Ventures.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts invoiced and reimbursed for the three months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. Amounts invoiced and reimbursed for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131730648312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eliem Therapeutics, Inc. (the Company) is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Headquartered in Redmond, Washington, the Company was incorporated on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">October 18, 2018</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Delaware corporation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying interim condensed consolidated financial statements of the Company and its wholly owned subsidiaries have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany transactions and balances have been eliminated in consolidation.</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated balance sheet as of September 30, 2021, and condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of cash flows, and condensed consolidated statements of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) for the three and nine months ended September 30, 2021 and 2020, are unaudited. The consolidated balance sheet as of December 31, 2020 was derived from the audited financial statements as of and for the year ended December 31, 2020, but does not include all disclosures required by U.S. GAAP. The unaudited interim condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2020, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair statement of the Company&#8217;s financial position as of September 30, 2021, the condensed results of its operations as of the three and nine months ended September 30, 2021 and 2020, and its cash flows for the nine months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes related to the three and nine months ended September 30, 2021 and 2020 are also unaudited. The condensed results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other period. These interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited financial statements included in the Company's final prospectus dated August 9, 2021 and filed with the Securities and Exchange Commission, or SEC, on August 11, 2021 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ReserveStockSplitPolicyPolicyTextBlock', window );">Reserve Stock Split</a></td>
<td class="text">Reverse Stock SplitIn July 2021, the Company's board of directors approved an amendment to the Company's certificate of incorporation to effect a reverse split of shares of the Company's common stock on a 1-for-2 basis, which was effected on July 29, 2021 (the Reverse Stock Split). The number of authorized shares and the par values of the common stock were not adjusted as a result of the Reverse Stock Split. In connection with the Reverse Stock Split, the number of authorized shares, outstanding shares, and the conversion ratio for the Company's redeemable convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. All references to common stock and options to purchase common stock share data, per share data, and related information contained in the condensed consolidated financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_InitialPublicOfferingPolicyTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On August 12, 2021, the Company completed its initial public offering (IPO) of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,360,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, including the underwriters' full exercise of their over-allotment option at the IPO price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. Gross proceeds from the IPO were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, and the net proceeds were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, after deducting underwriting discounts of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million of offering costs payable by the Company. At the closing of the IPO, all of the Company's then outstanding redeemable convertible preferred stock was automatically converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,345,279</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. The related carrying value of the redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">152.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million was reclassified to common stock and additional paid-in capital.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_LiquidityPolicyTextBlock', window );">Liquidity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception, the Company has experienced recurring losses from operations and generated negative cash flows from operations. The Company has an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million as of September 30, 2021 and expects to incur additional losses from operations in the future. The Company estimates the available cash, cash equivalents, and marketable securities as of September 30, 2021 will be sufficient to meet its projected operating requirements for at least the next twelve months from the filing date of these unaudited condensed consolidated financial statements. Therefore, based on management's updated evaluation of the Company's ability to continue as a going concern, management has concluded the factors that previously raised substantial doubt about the Company's ability to continue as a going concern no longer exist as of the issuance date of these unaudited condensed consolidated financial statements. The Company will need to obtain substantial additional funding to develop and commercialize the Company's clinical programs as currently contemplated. The Company expects to finance future cash needs through equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, but there are no assurances that the Company will be able to raise sufficient amounts of funding in the future on acceptable terms, or at all.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to the valuation of assets acquired, accrual of research and development expenses, the valuation of stock-based awards, the valuation of common stock and redeemable convertible preferred stock, and the valuation of redeemable convertible preferred stock tranche liabilities. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and marketable securities. The Company&#8217;s cash is held by two financial institutions in the United States (U.S.) and two financial institutions in the United Kingdom (U.K.). The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. The Company&#8217;s deposits held in the U.S. and U.K. may exceed the Federal Depository Insurance Corporation and Financial Services Compensation Scheme, respectively, insured limits. The Company has investments in money market funds, U.S. government debt securities, commercial paper, and corporate bonds with high-quality accredited financial institutions.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RisksAndUncertaintiesPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, development by competitors of new technological innovations, protection of proprietary technology, dependence on key personnel, reliance on single-source vendors and collaborators, availability of raw materials, patentability of the Company&#8217;s products and processes and clinical efficacy and safety of the Company&#8217;s products under development, compliance with government regulations and the need to obtain additional financing to fund operations. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical studies, clinical trials, and regulatory approval, prior to commercialization. These efforts will require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be obtained or maintained, that any products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees, consultants and other third parties.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, the current COVID-19 pandemic, which is impacting worldwide economic activity, poses risk that the Company or its employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time which may delay the start-up and conduct of the Company&#8217;s clinical trials, and negatively impact manufacturing and testing activities performed by third parties. Any significant delays may impact the use and sufficiency of the Company&#8217;s existing cash reserves, and the Company may be required to raise additional capital earlier than it had previously planned. The Company may be unable to raise additional capital if and when needed, which may result in delays or suspension of its development plans. The extent to which the pandemic will impact the Company&#8217;s business will depend on future developments that are highly uncertain and cannot be predicted at this time.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the CODM). The Company&#8217;s CODM is its chief executive officer who reviews financial information together with certain operating metrics principally to make decisions about how to allocate resources and to measure the Company&#8217;s performance. Management has determined that the Company operates as a single operating and reportable segment. The Company&#8217;s CODM evaluates financial information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is found in the interim condensed consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company measures fair value based on a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In determining fair value, the Company utilizes quoted market prices, or valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers into or out of Level 3 for any of the periods presented.</span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s fair value measurements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021 and December 31, 2020 was as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:35.72%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.138%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.101%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets:</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,407</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">145,230</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liabilities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock<br/>&#160;&#160;&#160;tranche liability</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The redeemable convertible preferred stock tranche liability was settled on March 9, 2021.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash And Cash Equivalent</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. As of September 30, 2021, the Company's cash equivalents consisted of money market funds. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cash equivalents as of December 31, 2020.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs that were directly related to the Company&#8217;s IPO were deferred for expense recognition and capitalized and recorded within prepaid and other current assets on the accompanying condensed consolidated balance sheet. These costs consist of legal fees, accounting fees, and other applicable professional services. These deferred offering costs were reclassified to additional paid in capital upon the closing of the IPO. As of September 30, 2021, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> deferred offering costs capitalized.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investment In Marketable Securities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments in Marketable Securities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities are classified as available-for-sale, primarily consisting of U.S. government debt securities, commercial paper, and corporate bonds, and are reported at fair value. Unrealized holding gains and losses are reflected as a separate component of stockholders' equity (deficit) in accumulated other comprehensive loss until realized. Realized gains and losses on the sale of these securities are recognized in other income, net. The cost of marketable securities sold is based on the specific identification method.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company periodically reviews its available-for-sale securities to assess for credit impairment. Some of the factors considered in assessing impairment include the extent to which the fair value is less than the amortized cost basis, adverse conditions related to the security, an industry or geographic area, changes to security rating or sector credit ratings, and other relevant market data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been no other significant changes in the Company&#8217;s accounting policies during the three and nine months ended September 30, 2021.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Procurement</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (ROU) assets obtained in exchange for lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of consolidated financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The effective date of this update for nonpublic companies is for fiscal years beginning after December 15, 2021 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today&#8217;s &#8220;incurred loss&#8221; approach with an &#8220;expected loss&#8221; model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard&#8217;s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The effective date of this update for non-public companies is for fiscal years beginning after December 15, 2022 and interim periods therein. The Company estimates that adoption will not have a material impact on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_InitialPublicOfferingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_InitialPublicOfferingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ReserveStockSplitPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve Stock Split Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ReserveStockSplitPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risks and Uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727201736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s fair value measurements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021 and December 31, 2020 was as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:35.72%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.138%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.101%;"/>
          <td style="width:0.751%;"/>
          <td style="width:1.651%;"/>
          <td style="width:1.53%;"/>
          <td style="width:12.157%;"/>
          <td style="width:0.751%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assets:</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_952dab32-e751-422e-a571-f065e2503d1d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f0adb4f9-e15c-4b6b-8040-c551c670f74b;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,412</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0caf0953-2fe3-4856-a0d2-4263052be7e7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e9bd48b7-6d7a-4cc8-9de2-a250d0094e8e;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8774bdeb-cb3d-48e2-a101-98fadcdf44be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_237ebc67-be1b-4813-8e0c-2b9924f70c1a;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bb574e2b-e549-41d5-a114-d1eae627d3de;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,407</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102,823</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2455f9e5-7001-4416-b693-e07b21507683;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">145,230</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liabilities:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock<br/>&#160;&#160;&#160;tranche liability</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_bd8259ab-61f3-420b-96a9-0ba7b50ee4bc;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_caca09e3-072e-4355-8e2b-6979c157fdd0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4ee89191-586d-4bd2-97cb-383860193695;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0004fd8e-d21f-4b53-971f-f43d8e0443dd;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724658952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Investments consists of available-for-sale securities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments consists of available-for-sale securities as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.532%;"/>
        <td style="width:1.856%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.746%;"/>
        <td style="width:0.733%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.626%;"/>
        <td style="width:0.733%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.522%;"/>
        <td style="width:11.755%;"/>
        <td style="width:0.937%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.512%;"/>
        <td style="width:11.737%;"/>
        <td style="width:0.733%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,208</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,199</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. government debt securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19,633</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total long-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,628</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,619</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724552840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Summary of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.458%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.449%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recoverable research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,943</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,661</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,960</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,050</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,511</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.614%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.458%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.716%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.449%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued payroll</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,443</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">592</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,278</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">627</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">290</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,011</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,219</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131725921720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Redeemable Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the Company&#8217;s redeemable convertible preferred stock consisted of the following balance (in thousands, except share and per share amounts):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:28.541%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.521%;"/>
        <td style="width:7.151%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:0.751%;"/>
        <td style="width:11.594%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:0.751%;"/>
        <td style="width:13.45%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.062%;"/>
        <td style="width:0.742%;"/>
        <td style="width:1.707%;"/>
        <td style="width:1.53%;"/>
        <td style="width:11.873%;"/>
        <td style="width:0.742%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Issue<br/>Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares <br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Shares Issued and Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Liquidation<br/>Preference</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,717,084</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,717,082</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,074</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,569</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A  (Athenen Acquisition)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,253</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,692,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,923,075</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,977</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,069</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ending balance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,909,389</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,140,157</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46,551</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49,891</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724309288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock Tranche Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock', window );">Schedule of Valuation of the Redeemable Convertible Preferred Stock Tranche Liability</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following reflects the significant quantitative inputs used in the valuation of the redeemable convertible preferred stock tranche liability:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.341%;"/>
        <td style="width:2.087%;"/>
        <td style="width:1.531%;"/>
        <td style="width:14.768%;"/>
        <td style="width:2.273%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Series A-1<br/>Tranche<br/>Call Option</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Estimated fair value of redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.10</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.25</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.45</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">N/A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Probability of milestone achievement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Strike price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of each tranche feature</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.86</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;- $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.32</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock', window );">Schedule of the Rollforward Redeemable Convertible Preferred Stock Tranche Liability</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A rollforward of the redeemable convertible preferred stock tranche liability is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.602%;"/>
        <td style="width:2.091%;"/>
        <td style="width:1.529%;"/>
        <td style="width:15.782%;"/>
        <td style="width:0.995%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in fair value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Settlement upon issuance of Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,269</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for rollforward of redeemable convertable preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about valuation of redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727871704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.145%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:10.121%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:10.046%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:12.904%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.857%;"/>
        <td style="width:0.983%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Options <br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>Average <br/>Exercise <br/>Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted <br/>Average <br/>Remaining <br/>Contract Terms<br/>(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic <br/>Values <br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">435,342</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.19</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">415</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,386,990</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.11</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.86</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercised</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59,466</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Balance as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and expected to vest, September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.74</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.33</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,727</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options exercisable as of September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">206,339</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.31</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.39</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,646</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Assumptions Used in Black-Scholes Model</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the Company&#8217;s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.865%;"/>
        <td style="width:2.083%;"/>
        <td style="width:21.052%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.80 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">- </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.08</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% - </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Awards</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The activity for restricted stock awards is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.939%;"/>
        <td style="width:1.735%;"/>
        <td style="width:0.993%;"/>
        <td style="width:17.551%;"/>
        <td style="width:1.002%;"/>
        <td style="width:1.735%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.523%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted-Average <br/>Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">297,724</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.55</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,766</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,639</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.03</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Includes </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> restricted stock awards granted in 2018 and still outstanding for the period ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to only performance conditions.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Share-based Compensation Expense</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company&#8217;s consolidated statements of operations and comprehensive loss (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.935%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.046%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.009%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.046%;"/>
        <td style="width:0.974%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.522%;"/>
        <td style="width:9.009%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">939</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,957</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,236</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,583</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724393064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows the computation of basic and diluted net loss per share (in thousands, except share and per share data):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.679%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.185%;"/>
        <td style="width:0.993%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.138%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.007%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.265%;"/>
        <td style="width:1.528%;"/>
        <td style="width:9.138%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,615</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,258</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36,935</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,805</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,322</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">461</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,548</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,352</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,483</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,157</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average common shares used in computed net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,585,611</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,863,860</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,554,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,859,713</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.85</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following outstanding shares of potentially dilutive securities were excluded from the computation of the diluted net loss per share attributable to common stockholders for the periods presented because their effect would have been anti-dilutive:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.812%;"/>
        <td style="width:1.224%;"/>
        <td style="width:1.002%;"/>
        <td style="width:13.366%;"/>
        <td style="width:1.002%;"/>
        <td style="width:1.224%;"/>
        <td style="width:1.002%;"/>
        <td style="width:13.366%;"/>
        <td style="width:1.002%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three and Nine Months Ended September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,737,315</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">366,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock awards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,639</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117,556</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redeemable convertible preferred stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,999,133</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total potentially dilutive shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,085,954</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,483,190</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727385368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock, shares issued upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (65,071)<span></span>
</td>
<td class="num">$ (28,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Entity incorporation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 18,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Fair Value Inputs Level 1, 2 and 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_FairValueLevel1Level2AndLevel3TransferAmount', window );">Fair value transfer amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds from issuance of common stock in initial public offering, Shares</a></td>
<td class="nump">7,360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="nump">$ 12.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance initial public offering</a></td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ProceedsFromIssuanceInitialPublicOfferingNet', window );">Proceeds from issuance initial public offering net</a></td>
<td class="nump">$ 83,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock, shares issued upon conversion</a></td>
<td class="nump">15,345,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_UnderwritingDiscount', window );">Underwriting Discount</a></td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_FairValueLevel1Level2AndLevel3TransferAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Level 1 Level 2 and Level 3 Transfer Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_FairValueLevel1Level2AndLevel3TransferAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ProceedsFromIssuanceInitialPublicOfferingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance Initial Public Offering Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ProceedsFromIssuanceInitialPublicOfferingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_UnderwritingDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriting discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_UnderwritingDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131731283112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">$ 145,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">38,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">US Government Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">102,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember', window );">Redeemable Convertible Preferred Stock Tranche Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">42,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">38,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | US Government Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">3,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Redeemable Convertible Preferred Stock Tranche Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">102,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | US Government Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">102,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Redeemable Convertible Preferred Stock Tranche Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | US Government Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Redeemable Convertible Preferred Stock Tranche Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131730790088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Investments consists of available-for-sale securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=elym_ShortTermMarketableSecuritiesMember', window );">Short Term Marketable Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">$ 83,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Unrealized Loss</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">83,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=elym_LongTermMarketableSecuritiesMember', window );">Long Term Marketable Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">23,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Unrealized Loss</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">23,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">US Government Debt Securities [Member] | Long Term Marketable Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">3,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">3,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member] | Short Term Marketable Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">83,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Unrealized Loss</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">83,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member] | Long Term Marketable Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">19,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Unrealized Loss</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 19,624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=elym_ShortTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=elym_ShortTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=elym_LongTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=elym_LongTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131728318456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Additional Information) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Continuous unrealized loss position, 12 months or longer</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Continuous unrealized loss position, less than 12 months</a></td>
<td class="nump">45,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued interest receivable</a></td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131729287224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RecoverableResearchAndDevelopmentTaxCredits', window );">Recoverable research and development tax credits</a></td>
<td class="nump">$ 6,943<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_PrepaidResearchAndDevelopmentExpenses', window );">Prepaid research and development expenses</a></td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 12,614<span></span>
</td>
<td class="nump">$ 1,511<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_PrepaidResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_PrepaidResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RecoverableResearchAndDevelopmentTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recoverable research and development tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RecoverableResearchAndDevelopmentTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131728499080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">$ 1,443<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_AccruedResearchAndDevelopmentExpenses', window );">Accrued research and development expenses</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions', window );">Total accrued expenses</a></td>
<td class="nump">$ 3,011<span></span>
</td>
<td class="nump">$ 1,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued liabilities current including related party transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131813917000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">12,909,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 46,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary Equity, Liquidation Preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember', window );">Series A Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityIssuePrice', window );">Temporary Equity, Issue Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,717,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,717,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,717,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary Equity, Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember', window );">Series A Athenen Acquisition Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityIssuePrice', window );">Temporary Equity, Issue Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary Equity, Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember', window );">Series A1 Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityIssuePrice', window );">Temporary Equity, Issue Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,692,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,923,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,923,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary Equity, Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityIssuePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity issue price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityIssuePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727146440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock and related tranche rights, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,939<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_CumulativeDividendsReceive', window );">Percentage of cumulative dividends receive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiability', window );">Redeemable convertible preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,199,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,418,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionDate', window );">Redemption date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of redeemable convertible preferred stock to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=elym_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare', window );">Temporary equity, automatic conversion, sale of common stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember', window );">Series A1 Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares new issues</a></td>
<td class="nump">4,358,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock and related tranche rights, net of issuance costs</a></td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,923,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiability', window );">Redeemable convertible preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Dividends preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears', window );">Preferred dividend, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares new issues</a></td>
<td class="nump">3,846,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock and related tranche rights, net of issuance costs</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare', window );">Temporary equity, automatic conversion, sale of common stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_PercentageOfTemporaryEquitySharesOutstanding', window );">Percentage of outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember', window );">Series A Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,717,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Dividends preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears', window );">Preferred dividend, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">11,499,129<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="nump">7,140,157<span></span>
</td>
<td class="nump">15,345,279<span></span>
</td>
<td class="nump">15,345,279<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare', window );">Temporary equity, automatic conversion, sale of common stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds', window );">Temporary equity, automatic conversion, sale of common stock, gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,345,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_CumulativeDividendsReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative dividends receive.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_CumulativeDividendsReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_PercentageOfTemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of temporary equity shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_PercentageOfTemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Convertible Preferred Stock Tranche Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity automatic conversion sale of common stock gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity automatic conversion sale of common stock price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of cumulative preferred dividends in arrears.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAmountOfPreferredDividendsInArrears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of cumulative preferred dividends in arrears.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the preferred stock has been redeemed, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21564-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=elym_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=elym_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesARedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131818150456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,718<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember', window );">Series A 1 Redeemable Convertible Preferred Tranche Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember', window );">Series A - 1 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=elym_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131818495288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details) - Series A 1 Tranche Call Option [Member]<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityDividendYield', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityStrikePrice', window );">Strike price</a></td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=elym_SeriesA1TrancheCallOptionMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock', window );">Estimated fair value of redeemable convertible preferred stock</a></td>
<td class="nump">$ 6.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityExpectedTerm', window );">Expected term (years)</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityProbabilityOfMilestoneAchievement', window );">Probability of milestone achievement</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityFairValueOfEachTrancheFeature', window );">Fair value of each tranche feature</a></td>
<td class="nump">$ 0.86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=elym_SeriesA1TrancheCallOptionMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock', window );">Estimated fair value of redeemable convertible preferred stock</a></td>
<td class="nump">$ 11.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityExpectedTerm', window );">Expected term (years)</a></td>
<td class="text">5 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityProbabilityOfMilestoneAchievement', window );">Probability of milestone achievement</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_TemporaryEquityFairValueOfEachTrancheFeature', window );">Fair value of each tranche feature</a></td>
<td class="nump">$ 3.32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity discount rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityDividendYield">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity dividend yield.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityDividendYield</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity estimated fair value of redeemable convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity expected term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityFairValueOfEachTrancheFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity fair value of each tranche feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityFairValueOfEachTrancheFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityProbabilityOfMilestoneAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity probability of milestone achievement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityProbabilityOfMilestoneAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_TemporaryEquityStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity strike price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_TemporaryEquityStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=elym_SeriesA1TrancheCallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=elym_SeriesA1TrancheCallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724534440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiability', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability', window );">Change in fair value of redeemable convertible preferred stock tranche liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">11,718<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement', window );">Reclassification of redeemable convertible preferred stock tranche liability upon settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_RedeemableConvertiblePreferredStockTrancheLiability', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of redeemable convertible preferred stock tranche liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of redeemable convertible preferred stock tranche liability upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_RedeemableConvertiblePreferredStockTrancheLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Convertible Preferred Stock Tranche Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_RedeemableConvertiblePreferredStockTrancheLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131724629384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals', window );">Lease payments under non-cancelable operating leases</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractually required future rental payments receivable on noncancelable subleasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726342920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_ExecutiveOfficerEarningContribution', window );">Executive Officer Earning Contribution</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_FairMarketValueCommonStockPercentage', window );">Percentage of fair market value, common stock</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation, weighted average amortization period</a></td>
<td class="text">3 years 2 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, award vesting rights, percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Granted</a></td>
<td class="nump">297,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=elym_StockOptionsMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based payment award, award vesting rights, percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options grants in period, weighted average grant date fair value</a></td>
<td class="nump">$ 6.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=elym_TwoThousandNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share-based payment award, description</a></td>
<td class="text">Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company&#8217;s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than 110% of the fair value of the Company&#8217;s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have 5-year terms measured from the option grant date. While no shares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Share based payment award, purchase price of common stock, percent</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=elym_TwoThousandTwentyOneEquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share-based payment award, description</a></td>
<td class="text">The compensation committee of the Company's board of directors adopted and the Company's stockholders approved the 2021 Equity Incentive Plan (2021 Plan) and the 2021 Employee Stock Purchase Plan (the ESPP ), which became effective immediately prior to the effectiveness of the Company's IPO. The 2021 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. The Company's employees, officers, directors and consultants are eligible to receive awards under the 2021 Plan. As of September 30, 2021, the total number of shares authorized for issuance under the 2021 Plan was 2,558,790.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based payment award, number of shares authorized</a></td>
<td class="nump">2,558,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=elym_EsppMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share-based payment award, description</a></td>
<td class="text">The ESPP allows employees, including executive officers, to contribute up to 15% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) 85% of the fair market value of a share of common stock on the first day of the offering period, or (b) 85% of the fair market value of a share of common stock on the last day of the offering period. There were 255,879 shares of common stock reserved for future issuance under our ESPP plan and no shares purchased as of September 30, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">255,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_ExecutiveOfficerEarningContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Executive Officer Earning Contribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_ExecutiveOfficerEarningContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_FairMarketValueCommonStockPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair market value of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_FairMarketValueCommonStockPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=elym_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=elym_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=elym_TwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=elym_TwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=elym_TwoThousandTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=elym_TwoThousandTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=elym_EsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=elym_EsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131728109608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activities (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding, beginning of period</a></td>
<td class="nump">435,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options granted</a></td>
<td class="nump">2,386,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, cancelled and forfeited</a></td>
<td class="num">(25,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options exercised</a></td>
<td class="num">(59,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding, ending of period</a></td>
<td class="nump">2,737,315<span></span>
</td>
<td class="nump">435,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of options, vested and expected to vest</a></td>
<td class="nump">2,737,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options exercisable, end of period</a></td>
<td class="nump">206,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding, beginning of period</a></td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options granted</a></td>
<td class="nump">3.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options cancelled and forfeited</a></td>
<td class="nump">1.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options exercised</a></td>
<td class="nump">1.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding, end of period</a></td>
<td class="nump">2.74<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, options vested and expected to vest</a></td>
<td class="nump">2.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, options exercisable</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contracted terms (in years) outstanding, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 2 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3', window );">Weighted average remaining contracted terms (in years) outstanding, end of period</a></td>
<td class="text">9 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contracted terms (in years), vested and expected to vest</a></td>
<td class="text">9 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contracted terms (in years), exercisable at end of period</a></td>
<td class="text">8 years 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value outstanding, beginning of period</a></td>
<td class="nump">$ 415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value options exercised</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value outstanding, end of period</a></td>
<td class="nump">41,727<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value options vested and expected to vest</a></td>
<td class="nump">41,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value options exercisable</a></td>
<td class="nump">$ 3,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term 3.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131819725992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, Minimum</a></td>
<td class="nump">0.94%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, Maximum</a></td>
<td class="nump">1.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, Minimum</a></td>
<td class="nump">78.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, Maximum</a></td>
<td class="nump">79.57%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131730613992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Stock Awards (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested</a></td>
<td class="nump">66,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Granted</a></td>
<td class="nump">297,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of shares, Vested</a></td>
<td class="num">(15,766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested</a></td>
<td class="nump">348,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value per share, beginning balance</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value</a></td>
<td class="nump">8.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value per share</a></td>
<td class="nump">1.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value per share, ending balance</a></td>
<td class="nump">$ 7.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727786568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Share-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,236<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 2,583<span></span>
</td>
<td class="nump">$ 234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 939<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 1,957<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131725853832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,615)<span></span>
</td>
<td class="num">$ (2,258)<span></span>
</td>
<td class="num">$ (36,935)<span></span>
</td>
<td class="num">$ (5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends', window );">Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends</a></td>
<td class="num">(1,322)<span></span>
</td>
<td class="num">(461)<span></span>
</td>
<td class="num">(4,548)<span></span>
</td>
<td class="num">(1,352)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (10,937)<span></span>
</td>
<td class="num">$ (2,719)<span></span>
</td>
<td class="num">$ (41,483)<span></span>
</td>
<td class="num">$ (7,157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="nump">15,585,611<span></span>
</td>
<td class="nump">1,863,860<span></span>
</td>
<td class="nump">7,554,300<span></span>
</td>
<td class="nump">1,859,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="num">$ (0.70)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (5.49)<span></span>
</td>
<td class="num">$ (3.85)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elym_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727305176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Unit conversion ratio</a></td>
<td class="text">1-for-1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131727673816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Redeemable convertible preferred stock</a></td>
<td class="nump">3,085,954<span></span>
</td>
<td class="nump">4,483,190<span></span>
</td>
<td class="nump">3,085,954<span></span>
</td>
<td class="nump">4,483,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_CommonStockOptionsMember', window );">Common Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Redeemable convertible preferred stock</a></td>
<td class="nump">2,737,315<span></span>
</td>
<td class="nump">366,501<span></span>
</td>
<td class="nump">2,737,315<span></span>
</td>
<td class="nump">366,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_UnvestedRestrictedStockAwardsMember', window );">Unvested Restricted Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Redeemable convertible preferred stock</a></td>
<td class="nump">348,639<span></span>
</td>
<td class="nump">117,556<span></span>
</td>
<td class="nump">348,639<span></span>
</td>
<td class="nump">117,556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_CommonStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_CommonStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_UnvestedRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=elym_UnvestedRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140131726015320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related Party Transaction, Amounts of Transaction</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>59
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MF\S3</,^O0LZ. CH:KMK#:PAUD8:Q:>-%'\6N4)"$F:-[E66AIP(D#.10BF
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MH0#P?L.Y?+E1 [1'_/-_ 5!+ P04    " ![@&A3RGMY&WT+   S2P  &
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M$./Z0(L],U[842[1 \TJ9L)/LI1!\MZ"[\"'#TQJ;L:0MG=,PD>DC'%(2UI
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MY[;_-(&?^YBO<)7G?]56WOWY_I$J.M^Z=1A,%*QM+?_K3T$.V8 'IP<&S,*
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M5&.]:(UXHRO"56,H&@JU4+5EH]>LJS!W(D0<(A&U8:,<&4=O:L)#M"$Q#"G
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M\Y8T>22GWVSB^MHBSD_5"W("RMYJ<?O4DA.Z7HR3$&J37V4T-<'$J"Z/&G)
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M3?J*%^C[A2,["A^P0/HAK"?_ U!+ P04    " ![@&A3$<@"8]\$  !P#
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M\Q'\].HT'L:_'AYU+HPMC27]L#!D$IPFW7APVAY\#6-XPXO#\;CSQ7BAP+W
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MM'R ]I?&^-V$%;0?&;-O4$L#!!0    ( 'N :%-UAM]B_@(  #T'   9
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M@KJFE(;H>6/#7>*ZM]V\ 9%W:!AU:9.QA9[$ EV/Z1:6CF&?5H,YH&^80<Q
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M^UG5V/BY[>)VIG7G/=6'' ;:EP/VU]"V]CNEHYN\E+U?N6[\-I3N["WWKG,
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M(9A6<TS0HJ+H1X4!?N=XY%&W(/!:\9K.!=] "9P950-6X/E[Y<H10#()BS/
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MPW(C=0*'56RM965!!LR82B*0:S_O.J:V%!I69Y7B:%KED"AC5T"PQ#I;">7
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M-D_YXUJAU2EI ]:7.9H"_X4N:'Z:\N)_4$L#!!0    ( 'N :%.Y%+=;B00
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M^N9U MP_0OW$VS8:?V&]/"-Q6,N[31P"Y/O.6G^>!(+Q/X'57U!+ P04
M" ![@&A3,3NF.B :  "R40  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6S-7%N3V[:2?O>O8'E3&T^59CS2^)Y+E:_G>!.O79XXYV%K'R 2DA!3A$*0
M(T]^_?;7C1LE2A[/9JOVQ=9(!-!H].7K"_CCUK:?W4KKKOBRKAOWT]U5UVV>
MW;_ORI5>*W=F-[JA7Q:V7:N._FR7]]VFU:KB0>OZ_NS\_-']M3+-W9]_Y.\^
MM#__:/NN-HW^T!:N7Z]5>_U"UW;[T]WIW?#%1[-<=?CB_L\_;M127^KNT^9#
M2W_=C[-49JT;9VQ3M'KQT]WGTV<OIH\Q@)_XW>BMRSX7V,K<VL_XXVWUT]US
M4*1K77:80M%_5_JEKFO,1'3\Z2>]&]?$P/QSF/T-;YXV,U=.O[3UOTS5K7ZZ
M^^1N4>F%ZNONH]W^4_L-/<1\I:T=_UML_;/G=XNR=YU=^\%$P=HT\K_ZXAEQ
MDP$S/V#&=,M"3.4KU:F??VSMMFCQ-,V&#[Q5'DW$F0:G<MFU]*NA<=W/K[0K
M6[-A#ME%\;Y=JL;\I81C355<RFGAMTNS;,S"E*KIBN=E:?NF,\VR^&!K4QKM
MBGOAT\F/]SLB#0O<+ST9+X2,V0$RGA;O;-.M7/&ZJ70U''^?MA3W-0O[>C$[
M.N&EWIP5%^>38G8^FQZ9[R+RZ8+GNS@PW]B&_^OYW'4MR=5_'UG@05S@ 2_P
MX, ".>?'^'=T-'3WF=NH4O]TEY33Z?9*WQU,6;RNC5X7OZUTJS:Z[TSI)L7;
MICPK[G4K7;RTZXUJKD\*XPI5E#0]G7-]ZCK2S&)N;*?+56-KN[PN2GFT6%@2
M3UT5-'>EKTB]-V!.8^ECT?$RX!'9C:+1?6L;51?Z2VDZ-3>UZ:Z+RCC;5KIU
M16<+555$MBOZ9DV6J-&Z<H5IBG)% TU9;,B\3&2>C;LN5T9U[?6DT!M3:_J"
M)=5BT6Q6DECL;*-)O$%.S4^5NNGPN2$6V=X5[MIU>NW.BG^22?NS5VVG6]H4
MK?U15VO;5)/B7\JM:&N=)1(R7A5;!1I+VVYLJSKAQ/NRLW,B8_H$DC=]4BCP
M\Y6NU5:UN@@/TX&<%4>$YF$4FH='A>:%<H9W^@&'WG1);S^T1)K9U)I_?FD;
M1U);'92N_X-E(&MD=+VX0#9,0\PU:^("*7D#V2GC /IC81I%D]'AD-C1H=!"
M\10#S[&FH:^W*UO79)6V#0UT_=R9RJ@6 K=25R2Q6C<%*<)&^<.DA>#!('=;
MTZV8+J_.F[2%I6X@*#0Q_:XWG8S%^I\:@[\N01A9ND]GEV?%/YX__W!R5CRO
M:]E94 R2K\8I=CJ."9ZKFC8VH$W7AHRYZB)UB6]G^XP[P# _;R'N6S&S+D'V
M&B(8C-]$Y'Y\BB&GR=>+<#H_9DT\7,$%$]VU=60R;C1/21I3+,CANV]8G$Y*
M$^*8UU"3YDJWG<%GHF"AVY8?M^5GGH\_D01 S__]WY[,IH]_*/2?/4[W'GED
MLL[="5L>'%VW:K7F80V)=;$6/Z/A9T:XQ0_2!_H3"MLWJJ]P]'(J7V7_*UWZ
M^:8\WSE;":*3.$@2WMHUT^0G'1=YF0ETA"U<:]5ZBO<6F!3SOBLJ2^+5V X&
MJ>XK6H&DDFQA2:?6D](2=XD_X.+\NHC2*YN*>QQ1T%$"1U0,Y@#HB,P$>&3(
MJ!)*8%7+]ZN:IJ>Y_I9M*]AFKY[P/1[!K%5#/@M33H :@?Z8&:KZ@] 4+S4)
M-$*WZ#QUS?BF <JK:5#9MRU^&@QIB +G (4">0MEVK2!'4OEQ=)E>]U89\1P
M'M343F3,,Y_.C; E/PR;EVMG-(RWEVYO29.NQHU]TTPB0VF7I!LJ\\>FD<@!
M^_;R&*VJTQ!9%LZ:-8J P/]B3ZRPJG9V1&OW.9IQ\[:6HF7ZHV08$B/35 2<
M$&B$ PI+TM[FFA#0A@12)QE?]"2;0= A=+N2/BWH2;@5X2?@C)5]$?MNXU'=
MRO9U!6(0Q7GW\T??2)045797CH^:+&]UHKOT@[\7\2?1;ZW#Q@EP"67/^R6I
M5O$T.\(%8;DJK7\)-21]T>*+7G\I5ZI9\M1KXQ 43L"9R]<O)[ ^?L)I8-JF
M;UV/2(7X_K$G/_)@]N#>_.3>@Q.2#K+'NVL\+UF#IT\O+B8,VM9\[F='0-JC
M"-(>'45/'P6/$WB _[K<$/H=@V!?FX0\HAM,\K8I_J,GF4NF([%];E5;84,5
M&7W"I(2'U89.X8J-L.R.K997N32RA.-%E->Q""> "^F@I_5BP2:5I$<H<J %
MC[J5:O4N8L.,=&(T5MPW.XKI*8G_Z4P<QH3 G"E7["AE<O$GLK<@(1REC##A
M1%2\Z5EGX$#Z;F5;\Q< @Q $\>%(@)3L2M5]HG% V59[?1:S#T8YWB;T-XP8
MH>",PBBH4*-W-&CD63FF(\22+/<=*9;8@O!=V('@(DF(X$"B%4G,OB&* K-)
M'.A@03.=-3!OV+?K2^Q =?M,(LWK>?)^8YN<'IP_AHTM5.F23(VW^VG5('NC
M/ 6JYJDT(V=Z=$ '.YB-F&_ZC;2=S(/;(9;9QPYI KLY^!L3!+>3^RC:4D?!
M9C)EWV):$S!J===:R3CEG"52 R;!W%Z7#LL6'S#0BYA]G!D'8,<-T^-HF!X?
MM2EO*:C!#C[T\YJ"[/=$#7#/F'&ZU43%^V279Y-].\4!1JWY"-B)R"P;F<6&
M6>Z]_?#^!$QZ/+EX=#XY/S_/3$U^X!/OAS"H8V!+AGY+!I[8^KUX6OV%XC3C
M@G<F $<FL3TE%MM.4)RDPKSLT\J(#TM^_CO:Q=G#\R1*!*+)K[$BE9RQB/@>
MX]B>?%<\G9V=%VM3U^RQ@B8W%#'$8?[))Q=GT^S)18=TAJ[ZDG%JW S^ ))"
M_.J$KD=G#\) 7N&[@@B-WP#L!%Z6UM&@C;IF):98(#L.4CJO\032\+"72]K,
MA(5PS[+37\W 8'V#]2'39Z%S)<?;_FF)02R[J.6RU4OOA:8/)Q</'DYFCY\>
M.'KQ D&A2]6V'#BSN4]([$;$R4D_G)T]B1P$O>1&:T6X8V%$C_?,D:HJAO>0
M8&6J4P KM3&=JH_IZI.HJT^.JMBOAN(W6N!Z3#MO.+2X-(A7\0]+^5 95_"_
M7V!H8'*K+ Y"Y*^]=.^D""1C IXW."S@WCR@&(Z00\K7PSF79;_NY=Q\[.Z%
M^F%2AX,A$Q,AH)H= >VM;_.C.$"[-^Z+ONNAQSE=FN+"-:=Y.'*]4J86F:%]
M361WB*5)M"0P! 5KU7[6'3_F,MQZB.@M[0H W/4+;-CCL#72"#"$9!C^\#!(
M*&;-XOA=_ Q[A:ZHR:EVWIQ\H0];75_%L"7:(L+5;#*\*DG<E6+^;_!OS"?2
M%MOJ"9="&*>E@)LL0K^1X1J:IT)586@U0@*8E0@Y.%)1AEI+ZY-=A$%).-/$
M+"OX7H(,";X%U3),(16^,K9W9$A:99Q/"9)18G]2V7Y.J&Y.ANI6E! H)#&B
MV(-BM"_&=5GTS7 (.O5W<3<EER$BR(.#.#L')AEL*A/Q12_&EQ[TB?B0O5O#
MV:F:\.4N)/<)?HC:LE5KEE6H.Q$BUIB(VK!2[BA'4C790] A40Q)W%,<;?OE
M*J3D@O,A7:DTG83?/']1VIJTRX<7]#?J*9U>DOLGMV X:SHI" T@!XF,3-LB
M"/0)HYAD$/7C!^@[<HY=:^:]./)LA*3*,$+[X)VV[?I6DK,1\ Z.@+24U1K(
M#:*5ZZQ:1Q\<SF!@5SC8X42R3*';M>.@57%**@3QMT.8,?6&+:P%\HQMX*B*
M2>25';<+S\O!929SXGTHQ"DJ-JVMNQ1A.?K!+23UC9_I!%G#0A /D31=2!F(
MY9*D&Z&95E#9O*>3ULX=<YI/H]-\>M3S?9(I7P>+/N8[OVT&5@9A_<"ZW281
M,U*6B)G98.]=;@7A(]1GG7DHQATX_Q *00241!5$I&5$%<34ZT9("9]Q$;>%
MV-;7$Y3'>\Y^2KJJY"119:"[P9=8EZU]5ORBKW/J$E4A!RTC=I)[ \<0Y*>4
MY#2H*%N0P?4 IQ6%=4*W&#99B&P0L=A+Y& ^1F.GXII0<:O&'MI#;C<#A@F\
M#V:[(:I$4:BDL9E*[%A6F17L(XX</F*&^/2O:+*DW'LVCBNR>[9ELYYP7&8E
M@\L4L(J(U.T>ZMYJ6R!\#/0*;%I":W!"L)B5*2'-$*1OE)TCNCT]3YT+YT=U
M\R6L&*JYX2A>$KL)/7XT[O-H!\+MIRO>1 4V#7F77C18P(=%K<-P&$,>^H\0
MW(>#%7"1II;81>9N,;<O1B#07$L6V9?0O@EM#J0I9FUY I*0E:ZY]--M;6:,
ML!?3]0-(/%+I/!')O^G07T@8*SIT&OO+V<E0RF.=:JYK0SHM+"1.$(V1>4C@
M]PX2E;-IKJ]MB)Z]T\A^):&U1%@74L@)_9".-)\%0M=R "NS.<"N2G.1QO,K
M; M&&1S ?HCY0$&E]CCT#:D_^@E>R4C;7A=O&X\I:/J4.L4$28HN=7MEH$.@
M@*R9/'.)GBN-NA5GRSEYA*0&['55H&2\"Q-7W(-PI5WRJF3;V#!#1AB7D-3P
M%I9(=31L0AF')=F9Y.S:*+(=H6[K>QN*.;'>"6=79KDZ_9-.!UX+]EKO%@9R
MV3BJZEF3TO1X]IN.6"S0)R 7H&'0/:KEMYIIP-2A++9Q1#\8X=T(4N*JK:]]
MKXQ4[8V.2C%LGC%-17:WO<Y258)*H1-\P.PI)P.'-Y=,&2%<MM\H5>IM$6=E
MBV^:QEX%I$:HOM,1A2'C2LZ@0^TRD8(E-JAQ0%#IP<\D-'3P#HGL&B(H\!L_
MP;O4^M011J,OKFA0<",)OM,WDQ L2U %WZBV!0Q^2U(!LA0L9?;[6)V)J$7*
M2^;G%!D'\+Q:B%HT(+@JI1W$J86^P712]<G8.I'TH^R2)3M3D%8O^SK+<TB0
M/8C&\@@L1#0<%_5--4AZ?! 2R!93C% )R(ZAUAY9@MH]_"/6IYZ[;,'#V&A!
M>!)^(F5"]9?.=W!LD,/R+'0=_<J:'[[I_"D)(N+MPYI)V4C5D"J#<H,=1):I
M9<7IL/J1+:2(*=N-3Y/1TA6-@;F)@HC<?*O@<4N.J"3=$S:4':!0S96%9ND3
M%> X K@\SMN+DJ*D'.1IRM:4$$;DD;/4]<2#[DAZTKV=ZDQ<"<%"C2) +Q$X
M[;9+X::(%W(K"&R-+T>$9<@\19'V1+++0WI6Y#(U*NS+<WZ@!5/GYXS%P3AY
M("<=-NWZR@!UG!6OR0@4YJC&C8DE1]V)C1/O^*-=9;@YP<0HA>QTVX&>D&[D
MXB."6D:7845'(&G'/XH>BC4F8=#-E6EM$_HUT*-8[1A27V9FRY+E6X(!YG/E
M9**4XU>*H$C)#96^PW"L6Y+QV=MD,X9;,R[:XDX*:QQ,!XC@VS\0H=MKK7W[
M"B%M-<R"="O35JAR"AQ\9UMM(QN]Q2E>OO_][:O3Z5-ZCM9;FS(D 8@(0^1(
ML6%KV[K:&HKA-*UEU\C' (^0W9Z@CP4]&T!=>RD'DJE]6KE'EAV$ZS>DL+KU
M9L;SD"ANT+$):#5G,W7%-2YA-$)J7P,)N8% 3&@PI9,EQZH7J"!I7RMCAV#6
MVF\/<U<$ *7B0<?:=J=]2)3Q H<\R*B!#-ENM'PPUQ )]PB4^C;DH3HM'489
ML40:XGUIP]HYK^?$OMQ6,K7"%+\$U[1<D$V?ABH/NCY.5G*Z!T& [PK.JLGA
MS#S;8X=83'7MFVB&.H9E#3Q'8K;*LZ^;6I'5WLD9^OG[9IA(&YG=2/\7!YWP
MMC![Z?A\)=XT@346MPO<QE\1\&J2FQV0XPT".PW&<S*A- 2("HAMR9B\R\DH
M=_R@Z"J D4_S94N&% Q]"YS,#CX8-Y8UX@]'/^ :XF<D*K HJ1^D]2A<GB6X
M/#L*<B_UDHD9Q<<W&UJ\CZ4'%[["K@R,E!3!.">_)G,5.CC9P!+:(Z" \^6$
MNW#;2<),<_ZI);<YB!92]1W=Y['@ LW.Z@B^6%FNC%YDA9%*EP;G?XK46.N[
MV=^_>G<R'N'A)[9UR%/P5/H+Q4&^8XM4BN;8KE"FO\(%D -T=G:IV79)K.D/
M.!&UUF0L2A=ZB]EWANQ=(-AY#JWH=%'RK&M;BFL3H.V!)^I""@'@N+,5@P)D
M0Q9_6#"I-#+.#"7V[73PBYP5%H"?T9_0E,\RL 0<X6C*7HTSC-M^=KIGG8'5
M<P?I(L'*2/(T2"4ZVBK_[6%Q6EC <1^+W2)+>U0AT^61Z<51K7J#5M'?N1C]
M3DX3DX^JYVTF(B[&/'R><R>\C\L0;&*X6]77PQON:PKE7<DAAG!UV-3,(+K3
M2]^D))G5"%%J&#YH_A]])>>PFX81KF]Z!&!.[XJS:3.R2!C>)!H9$RU8>)6(
MB X=@-*0P2*]3:V,I986:X$#G%B6SDGXP6YT$,KTG)9&PSYRE2IR[SKP(VHP
MPW&+ZE]U1>Z9% W71T*:Q2/]N.Q@'N1K<2>E'MP-( JZ+2HY?@X& EB*K:FL
MOL[.N.)4Z^_1'C+(-'^BG6V7M=E9K]%]LU9?S#I4 7LI:=@Y\ "KMS\@3BT2
MUME]LF_VGMUQ\+*LR]>-Y6$E;;6G'6 #&=P6,=9U\.L<4Y*P_N7+[;FL^!-(
M'H"LZLI6C-0%T<O"D.%L906EK]%_\*SXE05T6K"QFOWP?F_/W+.F$(*$'JU)
M\6=O.XZ$&'V;<'/0GY,@3G&##/E%];(SYVI7=^#\A*)9H.BMD'$O('@2E=WE
M4V>MW\T)JZ4VG=QW0G]G+<B[27^EG0YD<Y?0U$@L)9OAXACJ2!YJU1[8YSYW
M($7[LR1^W63*,%?$4MR6R>L$#EX$#G[:E\XT#O&&%,$(/=#\';Q<BX2 5[H0
MU7A0'(9E,-R7K7+SN3C&S[=-=+Q#P1S&?(0X:I9ZSZM@!)AE7"2^&M-T)O%O
M5^>P20^2*<!S7,12Z$W#W0E_JX/OU7'C&8$\A:1%GH(W#:,J\,6Y$&*G_8>D
MC.^SC5;72<L7[1AHB(:$ UZ$QO=TD6_8 CD*1W+;E[3O2#,.^#1^;2=9DN(>
M&R.R^/2T.WEV9W^>.\'6! T/VW@A'O6.^.AG=UXB&I-88%C<>7;GW5[JOOBN
MN'@R>3"=T0<O\(-/\N.==V,5H6=WOI+V+RXF3Y\^C+.%__G;.R]W<O_AU^GY
M;/)D=K'[]YW?;)>LX7?%@]GDP?EC=-+YYW.JI^CENSB_L\?VKS+QUZ1JS^Y\
MO%GI=9QS#Q].Y5]/>6Z"OC+"]QK>JNXKUT:)25TM_O$=YQQ]F_M1M)EN$D^/
M7R5F"7M.$L8?7D<)&\6;-YA*[4\U+)@DXP!P[@/?FML.!]6IT*;MP2%Y_B5?
M#R&X'D22E1W7<'P;&\PK(N_8SA9;O;GE2F[5[&H2AQ5'KEAEC5 [(^/M-<X?
M[9?2=HW8WO@#UP"/'FRZ[3L]?@_W59"MV&']$OV\H^=ZJYG\OP*3L<4(*':Z
M.':M;FQXKL+$'+U+IP;'(<O&Q#JHS_=P2"&AIH]3(!;&]S:9*LL1AO1E<+H"
M#;_YDFQJN7+IK+E322]1Q^&,978WV'\1R5!(7Y9*%-TN--]#0KSH<[5A_LB%
MG<9K9M%N)_%.XW"1&H=3I+7?DOT5&<]D]! QV2D<%<]TSVEZ_([2VZCJ0$&9
M3TKWK$9%]::S,C8<G;88=8 2OB9>JRR[Q#>04#"89'T7V;50XNS?4S27+Q6?
M>VC(Z@:PZ%,C777T"^XT8_6E,K[PZ/N793S?' D7DV).+2;A8@>4OQK]_?ZE
M:#-LN/;*M7?/NX#\UT6@ZZSX&"C<HRQ4*U2=-<#NG('7_[\DC D70VE9C7NU
M7;BE*:HXWDM-"ETA*1#C2EYTHTO@])B5+/- <1BD"GSTUPU"=H_QZIY(Y.MV
MU@-:-F@>[B)5;%I)B5W2+H):A@ZKX ]EOS*>NT/CN*Q';CPWO1BD0M@%<G3(
M9F^-,N=?;.F(9_X6G:KD^A#LH)'*]8[1]MM"LU\3.Q'@89<:7<";%<H\=.83
M7P3CW8=!A<_#(7[C&X41^_/W S-)ZVHD28+KQ)6KX#E3!RN9)GD\#[?"RL.+
MI.D6:O;>AO :EDI2 'C\VV[P'K5ZZ1+5]/CEIX^ZU#MOQ&EM>2S%=W2^\5>Y
MC"[26!07Q#*2P7VCYVV/NN_L?/I(@,Z;YY<ON$D=5VXO/Q7_:<_XUU,"Y82M
M%13XWF]V0P?_Y,'L9))+3"T_RZ4*OK\G(1NZCAO?>\'NMPW(EN22!22]=<8A
M[I9D;3BB' N@!(NW)IW:Q2FBTWL?WW\ZB3Y^GB[BQ=S?@O$@:,GQNAW)7:(
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M<$V<7]_3A(?C"Q7RA]>V0@^;]%:%.PY!VCP!'I%PW6TK_<P16\1)25MC7G9
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M#+4SH/-2*7O:N ##;W'U'U!+ P04    " ![@&A3E!C;*]<"  #9!@  &0
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MF6J05@;JO!Q>D48:A>4RI7\/&!= ^TNM<6>X O7?;/(#4$L#!!0    ( 'N
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M+S?T&8':&=#S7"F[W[@$[8?)]%]02P,$%     @ >X!H4TB>_.MC!0  ]0P
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M6L+B1HC'<!$#<'"8.)_E2N8(1V4)^(%/&U8@ 4*0I-T*W.C5\\0(2TYV9XH
M7@AN8^E)S3"$(1"_]&&APT%%@"4D[$5>E@?Z!QW72PD@AX1]1T3Q #1(&!J'
M%P\_I*$2X 8)&Y =>6S<90E AC0U* 2 05JV*&2'1SD]Y6]D%!A#PB9E1T:/
MZ*H4.$2;.A4***$M.Y6PWN$ H  IN@=2K]/\?W9B6ON2%'8YD3BFP!T:MCKQ
M. X+';$:P#.ZYTM4M1HD*I/ )AKV-!&5#:2A83MS>&6_=C4AOTB!4[372GT
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MGVR:7S/1HK+]8R$T=B,[S/!_ =(8X/>E$'HW,2VI^P/%_P%02P,$%     @
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M M.!*L9J%?-SJ"U!&((Z_,5^YPAE?ES)1FM^'\&@1*#,:R:JJDX[ %7[L]8
M8'>,ISV#H%(/-N>>.P@WB.T91@,+U2$#H[0?.X<9&"76V*RH%>DB^T$/PKR<
M6Q#HB(>;"CJ%+69Y7U\S3SL"8E-GYKFD)_)*HK%9HW^)K'^.N^)-;<OJ6]Q*
MO[%9P)^9UM_@KF!CCU#+=7H8*<7&^R7[9^7$NJEVU#"0[(D:40I.S J^*R/
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M?5Y0G4B^+E\D/W )P2\/5\P/F2@,X/Z"<[DY*1IH/O(X_1]02P,$%     @
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M;]9C,:QXF9J/<O,35 9-2%\D4VU_V<;-G5[V6%1J([-*&!%D(G?__+ERQ([
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M:*+=X(JD-EVN<?HN=F $X_'H (Q9 V/V.AA]MK'LB\/\"13M*,^D,N(/A[(
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M8 H@GR\I%;N-,E#.N(,_4$L#!!0    ( 'N :%-OCV//QP,  ,\+   9
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M!ECO0.=;8_!H^ ##.Y3_!5!+ P04    " ![@&A3WZ7:&7H#  ")#0  &0
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MRE8)?,L0I^9_HA:_<"G)!@39)H$ LE!*L%VI@ET*1'&RY%F&+=TJ'CXF/(U
M2/([V:)DHQ(M>$P6N6(12TO=<[*%L!1,,9!D_1RF9001B07/-$^!K)4^$/23
MGG]9@0I8*G_%&*1&R:FIL! Z'3-LDKZKDW;>2)J2>YZK! /,,;HS^-5EO'\!
M;V(#VBXX+UVX<RX2;J&X(=3ZC3B68Y^)9SD<;IU+Y_]Y7_^T]Z-BT%:2M.*C
M;_!=5=.GOIJ^QF0=B)SE^ZZ:OG]!8O)902;_N1"6VX;E5F&Y;X3U !'@1UI+
M,^3Y$PC%]!@_SS$(@6%)+=-S8JQYO8I7?[B?YM2:>+[G3LVG;I-/[5QW0FW?
M.K9;#>1;7^<[*H37%L*[6(CNOY)\+70')/E^#]D.Q*5"CUK^T4?J_[@-:_Q.
M_1^?],$9TS&UO5[_3^WH:.19=J_] ^G65^F.RC!IRS"Y6(9OF+I4F.X#/@0+
M];"6PN(0B&B0$OS6E_^1E&!;KYNF]4Y::(B/NN).1M3O:>&,G6V//6_4$\-
MOO5UON-2=,X/]M!2+#NEV+2EJ,4Q0!6V\^K3^5"Z>-VY;/I>NJ G_;'ZDC@U
MH;[OVY3V-7&5:SV JRZ!V3E:9B#VU9E>8G9EKNHMO5UM[PV+ZK3<6[^S;Y?V
MF?65OF=41]E7^OJ2<A^(/<.M)84875DW8XQ6U.?^>J)X41UL=USA,;D:)GA7
M J$-\'W,N7J9: ?M[6O^'U!+ P04    " ![@&A305$;36$"  #(!@  &0
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ME'K7-%?8=BN_*UX=/KD>/A>?_P902P,$%     @ >X!H4[@VQ-RI 0  +AL
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M;W!S+V%P<"YX;6Q02P$"% ,4    " ![@&A35# Y0NX    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " ![@&A3
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( 'N :%,FU(!<? 4  +\6   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " ![@&A3
MOU:\9(X%   R%0  &               @(&_#0  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ >X!H4P>ZU.T6 P  )0H  !@
M     ("!@Q,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M 'N :%/I<2S<WP4  .X7   8              " @<\6  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " ![@&A3RGMY&WT+   S2P  &
M            @('D'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ >X!H4U6@7#^L @  :0<  !@              ("!ER@  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( 'N :%.I9,^R+@8  +\7
M   8              " @7DK  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " ![@&A3N+Q<K3P9   42P  &               @('=,0
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ >X!H4Q'( F/?
M!   < P  !@              ("!3TL  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( 'N :%-UAM]B_@(  #T'   9              "
M@610  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ >X!H
M4_E4XJ:^#0  <S8  !D              ("!F5,  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " ![@&A3MY0?HL\%  #C#@  &0
M        @(&.80  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( 'N :%-V("'HAP4  (8-   9              " @91G  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ >X!H4]').X:Z#   IB(
M !D              ("!4FT  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " ![@&A3N12W6XD$   E"P  &0              @(%#>@
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( 'N :%/8'MF
M60,  !4(   9              " @0-_  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ >X!H4S$[ICH@&@  LE$  !D
M ("!DX(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " ![
M@&A3NIX:/#\#   B!P  &0              @('JG   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( 'N :%.4&-LKUP(  -D&   9
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M970R,RYX;6Q02P$"% ,4    " ![@&A3[4)TH%8$  "<"@  &0
M    @(&'LP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M 'N :%- HZ_:4 0  %8.   9              " @12X  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ >X!H4T-S[1%7!0  Q"$  !D
M             ("!F[P  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " ![@&A37;9&F)8#   C#P  &0              @($IP@  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( 'N :%/*Z!&BG0(
M -L&   9              " @?;%  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ >X!H4S!!U4V^ @  <@<  !D              ("!
MRL@  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " ![@&A3
MI/S<V8L"  "-!@  &0              @(&_RP  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( 'N :%-;V\R=-00  #H4   9
M      " @8'.  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ >X!H4\&'F>;*!@  \"$  !D              ("![=(  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " ![@&A3W4UEK&(#  !B#
M&0              @('NV0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( 'N :%-"*]A)C ,  $0,   9              " @8?=  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ >X!H4T^7GY<0
M P  %@D  !D              ("!2N$  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    " ![@&A3/B8,<L0"   0"   &0
M@(&1Y   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( 'N
M:%/OM-T4>@<  )L;   9              " @8SG  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ >X!H4PC<<?2P!   ?10  !D
M         ("!/>\  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
M    " ![@&A3+,+=8P,#   R"@  &0              @($D]   >&PO=V]R
M:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( 'N :%.9DF[G2 ,  !(+
M   9              " @5[W  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL
M4$L! A0#%     @ >X!H4Y*?Y08I P  [PH  !D              ("!W?H
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " ![@&A3;X]C
MS\<#  #/"P  &0              @($]_@  >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;%!+ 0(4 Q0    ( 'N :%/#-3ED( (  ),$   9
M  " @3L" 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M>X!H4]^EVAEZ P  B0T  !D              ("!D@0! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    " ![@&A305$;36$"  #(!@  &0
M            @(%#" $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( 'N :%.F']7R$ ,  #(1   -              "  =L* 0!X;"]S
M='EL97,N>&UL4$L! A0#%     @ >X!H4Y>*NQS     $P(   L
M     ( !%@X! %]R96QS+RYR96QS4$L! A0#%     @ >X!H4YI@MR2G P
MLAX   \              ( !_PX! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( 'N :%.X-L3<J0$  "X;   :              "  =,2 0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( 'N :%-3V2LIL@$  %,;
M   3              "  ;04 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   U #4 :@X  )<6 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>176</ContextCount>
  <ElementCount>310</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>41</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100070 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Description of Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Description of Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Certain Balance Sheet Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts</Role>
      <ShortName>Certain Balance Sheet Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability</Role>
      <ShortName>Redeemable Convertible Preferred Stock Tranche Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Description of Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Description of Organization and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Certain Balance Sheet Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables</Role>
      <ShortName>Certain Balance Sheet Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock Tranche Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails</Role>
      <ShortName>Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Investments - Investments consists of available-for-sale securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails</Role>
      <ShortName>Investments - Investments consists of available-for-sale securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Investments (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Investments (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails</Role>
      <ShortName>Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Stock-Based Compensation - Summary of Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="elym-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="elym-20210930.htm">elym-20210930.htm</File>
    <File>elym-20210930.xsd</File>
    <File>elym-20210930_cal.xml</File>
    <File>elym-20210930_def.xml</File>
    <File>elym-20210930_lab.xml</File>
    <File>elym-20210930_pre.xml</File>
    <File>elym-ex31_1.htm</File>
    <File>elym-ex31_2.htm</File>
    <File>elym-ex32_1.htm</File>
    <File>elym-ex32_2.htm</File>
    <File>elym-ex3_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img155835445_0.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "elym-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 15,
   "contextCount": 176,
   "dts": {
    "calculationLink": {
     "local": [
      "elym-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "elym-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "elym-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "elym-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "elym-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "elym-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 362,
   "entityCount": 1,
   "hidden": {
    "http://eliemtx.com/20210930": 1,
    "http://fasb.org/us-gaap/2021-01-31": 19,
    "http://xbrl.sec.gov/dei/2021": 4,
    "total": 24
   },
   "keyCustom": 44,
   "keyStandard": 266,
   "memberCustom": 17,
   "memberStandard": 20,
   "nsprefix": "elym",
   "nsuri": "http://eliemtx.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Certain Balance Sheet Accounts",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts",
     "shortName": "Certain Balance Sheet Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability",
     "shortName": "Redeemable Convertible Preferred Stock Tranche Liability",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Commitments and Contingencies",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Stock-Based Compensation",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Related Party Transactions",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Policies)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Description of Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Description of Organization and Summary of Significant Accounting Policies (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Description of Organization and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Investments (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Certain Balance Sheet Accounts (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables",
     "shortName": "Certain Balance Sheet Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables",
     "shortName": "Redeemable Convertible Preferred Stock Tranche Liability (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Description of Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails",
     "shortName": "Description of Organization and Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_9bfdc1a7-d432-445d-9751-7c5f72c789d8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Investments - Investments consists of available-for-sale securities (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails",
     "shortName": "Investments - Investments consists of available-for-sale securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_9bfdc1a7-d432-445d-9751-7c5f72c789d8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Investments (Additional Information) (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
     "shortName": "Investments (Additional Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "elym:RecoverableResearchAndDevelopmentTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
     "shortName": "Certain Balance Sheet Accounts - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "elym:RecoverableResearchAndDevelopmentTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedPayrollTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails",
     "shortName": "Certain Balance Sheet Accounts - Summary of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedPayrollTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Schedule of Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_5fcdbd70-a54c-43ab-8ec7-a8a0f5025d8c",
      "decimals": "INF",
      "lang": null,
      "name": "elym:TemporaryEquityIssuePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "2",
      "lang": null,
      "name": "elym:CumulativeDividendsReceive",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b78178eb-00d0-406e-baa2-53b8b434c787",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
     "shortName": "Redeemable Convertible Preferred Stock Tranche Liability - Additional Information - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_3d855745-343a-4c58-aacc-25642060cf47",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_e0d329b9-6c79-4719-a2f5-874661472d87",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "elym:TemporaryEquityDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
     "shortName": "Redeemable Convertible Preferred Stock Tranche Liability - Schedule of Valuation of The Redeemable Convertible Preferred Stock Tranche Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "elym:ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_e0d329b9-6c79-4719-a2f5-874661472d87",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "elym:TemporaryEquityDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b17ce63a-e30b-47a5-abd5-5402d3c12a39",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "elym:RedeemableConvertiblePreferredStockTrancheLiability",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
     "shortName": "Redeemable Convertible Preferred Stock Tranche Liability - Schedule of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "elym:ExecutiveOfficerEarningContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "elym:ExecutiveOfficerEarningContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_b17ce63a-e30b-47a5-abd5-5402d3c12a39",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activities (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails",
     "shortName": "Stock-Based Compensation - Summary of Assumptions Used in Black-Scholes Model (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_4d7d035a-64cf-46ac-a997-043054a67440",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Awards (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails",
     "shortName": "Stock-Based Compensation - Summary of Restricted Stock Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_3067a383-1bbc-47dc-b6b2-b38a02771ef4",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Stock-Based Compensation - Summary of Share-based Compensation Expense (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Summary of Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockConversionBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockConversionBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_21615b53-9670-4e5e-9edd-186adb41d615",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_79e4fccb-c419-40b4-9864-4b8eeee9746d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_ad6f985b-b398-416c-a97e-19ed5c2ba56c",
      "decimals": "-3",
      "lang": null,
      "name": "elym:TemporaryEquityAccretionReductionToRedemptionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_921214ea-f1eb-402a-b0d4-e85238b44c06",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical)",
     "role": "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Deficit (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_921214ea-f1eb-402a-b0d4-e85238b44c06",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Description of Organization and Summary of Significant Accounting Policies",
     "role": "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Description of Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Investments",
     "role": "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "elym-20210930.htm",
      "contextRef": "C_db5a93dd-38e3-4ced-bd29-6d7309409a64",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 41,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Entity incorporation date"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "elym_AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends.",
        "label": "Accretion Of Redeemable Convertible Preferred Stock To Redemption Value And Cumulative Preferred Stock Dividends",
        "negatedLabel": "Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends"
       }
      }
     },
     "localname": "AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAndCumulativePreferredStockDividends",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued liabilities current including related party transactions.",
        "label": "Accrued Liabilities Current Including Related Party Transactions",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_AccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses.",
        "label": "Accrued Research And Development Expenses",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of redeemable convertible preferred stock tranche liability.",
        "label": "Change In Fair Value Of Redeemable Convertible Preferred Stock Tranche Liability",
        "negatedLabel": "Change in fair value of redeemable convertible preferred stock tranche liability",
        "terseLabel": "Change in fair value of redeemable convertible preferred stock tranche liability"
       }
      }
     },
     "localname": "ChangeInFairValueOfRedeemableConvertiblePreferredStockTrancheLiability",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_CommonStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock options member.",
        "label": "Common Stock Options [Member]",
        "terseLabel": "Common Stock Options"
       }
      }
     },
     "localname": "CommonStockOptionsMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_ConversionOfRedeemableConvertiblePreferredStockToCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of redeemable convertible preferred stock to common stock",
        "label": "Conversion of Redeemable Convertible Preferred Stock to Common Stock.",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock"
       }
      }
     },
     "localname": "ConversionOfRedeemableConvertiblePreferredStockToCommonStock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_CumulativeDividendsReceive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative dividends receive.",
        "label": "Cumulative Dividends Receive",
        "verboseLabel": "Percentage of cumulative dividends receive"
       }
      }
     },
     "localname": "CumulativeDividendsReceive",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_EsppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Member",
        "label": "ESPP [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EsppMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_ExecutiveOfficerEarningContribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Officer Earning Contribution",
        "label": "Executive Officer Earning Contribution",
        "terseLabel": "Executive Officer Earning Contribution"
       }
      }
     },
     "localname": "ExecutiveOfficerEarningContribution",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of stock options and release of restricted stock awards.",
        "label": "Exercise Of Stock Options And Release Of Restricted Stock Awards",
        "terseLabel": "Exercise of stock options and release of restricted stock awards"
       }
      }
     },
     "localname": "ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwards",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of stock options and release of restricted stock awards, shares.",
        "label": "Exercise Of Stock Options And Release Of Restricted Stock Awards Shares",
        "terseLabel": "Exercise of stock options and release of restricted stock awards, shares"
       }
      }
     },
     "localname": "ExerciseOfStockOptionsAndReleaseOfRestrictedStockAwardsShares",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "elym_FairMarketValueCommonStockPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair market value of common stock",
        "label": "Fair market value, common stock percentage",
        "terseLabel": "Percentage of fair market value, common stock"
       }
      }
     },
     "localname": "FairMarketValueCommonStockPercentage",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_FairValueLevel1Level2AndLevel3TransferAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Level 1 Level 2 and Level 3 Transfer Amount.",
        "label": "Fair Value Level1 Level2 And Level3 Transfer Amount",
        "terseLabel": "Fair value transfer amount"
       }
      }
     },
     "localname": "FairValueLevel1Level2AndLevel3TransferAmount",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in accounts payable and accrued liabilities related party.",
        "label": "Increase Decrease In Accounts Payable And Accrued Liabilities Related Party",
        "negatedLabel": "Accounts payable and accrued liabilities, related party",
        "terseLabel": "Accounts payable and accrued liabilities, related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_IncreaseDecreaseInNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in non current assets.",
        "label": "Increase Decrease In Non Current Assets",
        "negatedLabel": "Long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInNonCurrentAssets",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_InitialPublicOfferingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering.",
        "label": "Initial Public Offering Policy [Text Block]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingPolicyTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_LiquidityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity.",
        "label": "Liquidity Policy [Text Block]",
        "terseLabel": "Liquidity"
       }
      }
     },
     "localname": "LiquidityPolicyTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_LongTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Marketable Securities [Member]",
        "label": "Long Term Marketable Securities [Member]",
        "terseLabel": "Long Term Marketable Securities [Member]"
       }
      }
     },
     "localname": "LongTermMarketableSecuritiesMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_PercentageOfTemporaryEquitySharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of temporary equity shares outstanding.",
        "label": "Percentage Of Temporary Equity Shares Outstanding",
        "terseLabel": "Percentage of outstanding shares"
       }
      }
     },
     "localname": "PercentageOfTemporaryEquitySharesOutstanding",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_PrepaidResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid research and development expenses.",
        "label": "Prepaid Research And Development Expenses",
        "terseLabel": "Prepaid research and development expenses"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentExpenses",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ProceedsFromIssuanceInitialPublicOfferingNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Issuance Initial Public Offering Net.",
        "label": "Proceeds From Issuance Initial Public Offering Net",
        "terseLabel": "Proceeds from issuance initial public offering net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOfferingNet",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock sold in initial public offering, net issuance costs.",
        "label": "Proceeds from Issuance of Common Stock Sold in Initial Public Offering, Net Issuance Costs",
        "terseLabel": "Proceeds from issuance of common stock sold in initial public offering, net issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockSoldInInitialPublicOfferingNetIssuanceCosts",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of redeemable convertible preferred stock tranche liability upon settlement.",
        "label": "Reclassification Of Redeemable Convertible Preferred Stock Tranche Liability Upon Settlement",
        "terseLabel": "Reclassification of redeemable convertible preferred stock tranche liability upon settlement"
       }
      }
     },
     "localname": "ReclassificationOfRedeemableConvertiblePreferredStockTrancheLiabilityUponSettlement",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_RecoverableResearchAndDevelopmentTaxCredits": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recoverable research and development tax credits.",
        "label": "Recoverable Research And Development Tax Credits",
        "terseLabel": "Recoverable research and development tax credits"
       }
      }
     },
     "localname": "RecoverableResearchAndDevelopmentTaxCredits",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_RedeemableConvertiblePreferredStockTrancheLiability": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Tranche Liability",
        "label": "Redeemable Convertible Preferred Stock Tranche Liability",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Redeemable convertible preferred stock tranche liability"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockTrancheLiability",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable convertible preferred stock tranche liability.",
        "label": "Redeemable Convertible Preferred Stock Tranche Liability Disclosure [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock Tranche Liability"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockTrancheLiabilityDisclosureTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_RedeemableConvertiblePreferredStockTrancheLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable convertible preferred stock tranche liability.",
        "label": "Redeemable Convertible Preferred Stock Tranche Liability [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock Tranche Liability [Member]"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockTrancheLiabilityMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_ResearchAndDevelopmentExpenseRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expense related parties.",
        "label": "Research And Development Expense Related Parties",
        "terseLabel": "Research and development, related party"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseRelatedParties",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_ReserveStockSplitPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve Stock Split Policy",
        "label": "Reserve Stock Split Policy [Policy Text Block]",
        "terseLabel": "Reserve Stock Split"
       }
      }
     },
     "localname": "ReserveStockSplitPolicyPolicyTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "elym_RisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and Uncertainties.",
        "label": "Risks And Uncertainties Policy [Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for rollforward of redeemable convertable preferred stock tranche liability.",
        "label": "Schedule Of The Rollforward Redeemable Convertible Preferred Stock Tranche Liability Table [Text Block]",
        "terseLabel": "Schedule of the Rollforward Redeemable Convertible Preferred Stock Tranche Liability"
       }
      }
     },
     "localname": "ScheduleOfTheRollforwardRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about valuation of redeemable convertible preferred stock tranche liability.",
        "label": "Schedule Of Valuation Of The Redeemable Convertible Preferred Stock Tranche Liability Table [Text Block]",
        "terseLabel": "Schedule of Valuation of the Redeemable Convertible Preferred Stock Tranche Liability"
       }
      }
     },
     "localname": "ScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityTableTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_SeriesA1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A - 1 preferred stock member.",
        "label": "Series A1 Preferred Stock [Member]",
        "terseLabel": "Series A - 1 Preferred Stock"
       }
      }
     },
     "localname": "SeriesA1PreferredStockMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesA1RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A1 redeemable convertible preferred stock member.",
        "label": "Series A1 Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series A1 Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesA1RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A 1 redeemable convertible preferred tranche liability.",
        "label": "Series A1 Redeemable Convertible Preferred Tranche Liability [Member]",
        "terseLabel": "Series A 1 Redeemable Convertible Preferred Tranche Liability"
       }
      }
     },
     "localname": "SeriesA1RedeemableConvertiblePreferredTrancheLiabilityMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesA1TrancheCallOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A 1 tranche call option.",
        "label": "Series A1 Tranche Call Option [Member]",
        "terseLabel": "Series A 1 Tranche Call Option [Member]"
       }
      }
     },
     "localname": "SeriesA1TrancheCallOptionMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Athenen acquisition redeemable convertible preferred stock member.",
        "label": "Series A Athenen Acquisition Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Athenen Acquisition Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAAthenenAcquisitionRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesARedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A redeemable convertible preferred stock member.",
        "label": "Series A Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesARedeemableConvertiblePreferredStockMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SeriesBRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B redeemable convertible preferred stock member .",
        "label": "Series B Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term 3.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3",
        "terseLabel": "Weighted average remaining contracted terms (in years) outstanding, end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "elym_ShortTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Marketable Securities [Member]",
        "label": "Short Term Marketable Securities [Member]",
        "terseLabel": "Short Term Marketable Securities [Member]"
       }
      }
     },
     "localname": "ShortTermMarketableSecuritiesMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options.",
        "label": "Stock Options[Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_TemporaryEquityAccretionReductionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity accretion (reduction) to redemption value.",
        "label": "Temporary Equity Accretion Reduction To Redemption Value",
        "terseLabel": "Accretion of Series A and A-1 Preferred Stock",
        "verboseLabel": "Redeemable convertible preferred stock accretion"
       }
      }
     },
     "localname": "TemporaryEquityAccretionReductionToRedemptionValue",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity automatic conversion sale of common stock gross proceeds.",
        "label": "Temporary Equity Automatic Conversion Sale Of Common Stock Gross Proceeds",
        "terseLabel": "Temporary equity, automatic conversion, sale of common stock, gross proceeds"
       }
      }
     },
     "localname": "TemporaryEquityAutomaticConversionSaleOfCommonStockGrossProceeds",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity automatic conversion sale of common stock price per share.",
        "label": "Temporary Equity Automatic Conversion Sale Of Common Stock Per Share",
        "terseLabel": "Temporary equity, automatic conversion, sale of common stock, price per share"
       }
      }
     },
     "localname": "TemporaryEquityAutomaticConversionSaleOfCommonStockPerShare",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elym_TemporaryEquityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity disclosure text block.",
        "label": "Temporary Equity Disclosure [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureTextBlock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elym_TemporaryEquityDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity discount rate.",
        "label": "Temporary Equity Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "TemporaryEquityDiscountRate",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_TemporaryEquityDividendYield": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity dividend yield.",
        "label": "Temporary Equity Dividend Yield",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "TemporaryEquityDividendYield",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity estimated fair value of redeemable convertible preferred stock.",
        "label": "Temporary Equity Estimated Fair Value Of Redeemable Convertible Preferred Stock",
        "terseLabel": "Estimated fair value of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityEstimatedFairValueOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elym_TemporaryEquityExpectedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity expected term.",
        "label": "Temporary Equity Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "TemporaryEquityExpectedTerm",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "elym_TemporaryEquityExpectedVolatility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity expected volatility.",
        "label": "Temporary Equity Expected Volatility",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "TemporaryEquityExpectedVolatility",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_TemporaryEquityFairValueOfEachTrancheFeature": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity fair value of each tranche feature.",
        "label": "Temporary Equity Fair Value Of Each Tranche Feature",
        "terseLabel": "Fair value of each tranche feature"
       }
      }
     },
     "localname": "TemporaryEquityFairValueOfEachTrancheFeature",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elym_TemporaryEquityIssuePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity issue price.",
        "label": "temporary equity issue price",
        "terseLabel": "Temporary Equity, Issue Price"
       }
      }
     },
     "localname": "TemporaryEquityIssuePrice",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elym_TemporaryEquityProbabilityOfMilestoneAchievement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity probability of milestone achievement.",
        "label": "Temporary Equity Probability Of Milestone Achievement",
        "terseLabel": "Probability of milestone achievement"
       }
      }
     },
     "localname": "TemporaryEquityProbabilityOfMilestoneAchievement",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elym_TemporaryEquityStockIssuedDuringPeriodShareNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period share new issues.",
        "label": "Temporary Equity Stock Issued During Period Share New Issues",
        "terseLabel": "Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability), shares"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodShareNewIssues",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "elym_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period shares new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Stock issued during period shares new issues"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "elym_TemporaryEquityStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity strike price",
        "label": "Temporary Equity Strike Price",
        "terseLabel": "Strike price"
       }
      }
     },
     "localname": "TemporaryEquityStrikePrice",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elym_TwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand nineteen equity incentive plan.",
        "label": "Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_TwoThousandTwentyOneEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty one equity incentive plan.",
        "label": "Two Thousand Twenty One Equity Incentive Plan [Member]",
        "terseLabel": "2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyOneEquityIncentivePlanMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_UnderwritingDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discount.",
        "label": "Underwriting Discount"
       }
      }
     },
     "localname": "UnderwritingDiscount",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elym_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten public offering.",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten Public Offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elym_UnvestedRestrictedStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested restricted stock awards member.",
        "label": "Unvested Restricted Stock Awards [Member]",
        "terseLabel": "Unvested Restricted Stock Awards"
       }
      }
     },
     "localname": "UnvestedRestrictedStockAwardsMember",
     "nsuri": "http://eliemtx.com/20210930",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r178",
      "r189",
      "r209",
      "r210",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r339",
      "r363",
      "r364",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r178",
      "r189",
      "r209",
      "r210",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r339",
      "r363",
      "r364",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r178",
      "r189",
      "r200",
      "r209",
      "r210",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r339",
      "r363",
      "r364",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r178",
      "r189",
      "r200",
      "r209",
      "r210",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r339",
      "r363",
      "r364",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of trade and related party payables and accrued expenses.",
        "label": "Accounts Payable and Accrued Liabilities, Fair Value Disclosure",
        "terseLabel": "Accrued expenses, related party",
        "totalLabel": "Accounts Payable and Accrued Liabilities, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r307"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r30",
      "r74",
      "r301",
      "r302"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Related Parties, Current",
        "terseLabel": "Accounts payable, related party"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premiums and accretion of discounts",
        "terseLabel": "Amortization of premiums and accretion of discounts"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r10",
      "r33"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Accrued payroll"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r43",
      "r44",
      "r45",
      "r356",
      "r369",
      "r370"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r42",
      "r45",
      "r51",
      "r52",
      "r53",
      "r76",
      "r77",
      "r78",
      "r262",
      "r365",
      "r366",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r242",
      "r243",
      "r244",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r211",
      "r213",
      "r248",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r194",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Stock issuance cost"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r213",
      "r239",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Redeemable convertible preferred stock"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r73",
      "r116",
      "r124",
      "r128",
      "r143",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r257",
      "r263",
      "r282",
      "r305",
      "r307",
      "r344",
      "r355"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r40",
      "r73",
      "r143",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r257",
      "r263",
      "r282",
      "r305",
      "r307"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.",
        "label": "Available-for-sale Securities",
        "terseLabel": "Estimated Fair Value",
        "totalLabel": "Available-for-sale Securities, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.",
        "label": "Available-for-sale Securities, Amortized Cost Basis",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Available-for-sale Securities, Amortized Cost Basis, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.",
        "label": "Available-for-sale Securities, Gross Unrealized Gain",
        "terseLabel": "Unrealized Gain",
        "totalLabel": "Available-for-sale Securities, Gross Unrealized Gain, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedGains",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.",
        "label": "Available-for-sale Securities, Gross Unrealized Loss",
        "terseLabel": "Unrealized Loss",
        "totalLabel": "Available-for-sale Securities, Gross Unrealized Loss, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r214",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r27",
      "r68"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r13",
      "r69",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash And Cash Equivalent"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r63",
      "r68",
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r63",
      "r287"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents",
        "totalLabel": "Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r72",
      "r73",
      "r90",
      "r91",
      "r92",
      "r95",
      "r97",
      "r103",
      "r104",
      "r105",
      "r143",
      "r167",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177",
      "r187",
      "r188",
      "r190",
      "r191",
      "r282",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r35",
      "r165",
      "r346",
      "r359"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 5)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r166",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r76",
      "r77",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r307"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value per share, 250000000 and 40,000,000 shares authorized; 26199262 and 3,418,751 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r50",
      "r57",
      "r255",
      "r256",
      "r266",
      "r349",
      "r362"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r109",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r71",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r16",
      "r17",
      "r192",
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Convertible preferred stock, shares issued upon conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bonds [Member]"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r137",
      "r153",
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Continuous unrealized loss position, 12 months or longer"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r137",
      "r153",
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Continuous unrealized loss position, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Investments consists of available-for-sale securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r39",
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders, basic and diluted",
        "totalLabel": "Earnings Per Share, Basic and Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation, weighted average amortization period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r51",
      "r52",
      "r53",
      "r76",
      "r77",
      "r78",
      "r80",
      "r85",
      "r87",
      "r102",
      "r146",
      "r194",
      "r198",
      "r242",
      "r243",
      "r244",
      "r252",
      "r253",
      "r274",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r365",
      "r366",
      "r367",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r179",
      "r182",
      "r183",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r277",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Fair Value Inputs Level 1, 2 and 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r179",
      "r201",
      "r202",
      "r207",
      "r208",
      "r277",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r179",
      "r182",
      "r183",
      "r201",
      "r202",
      "r207",
      "r208",
      "r277",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r179",
      "r182",
      "r183",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r277",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r179",
      "r182",
      "r183",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r135",
      "r136",
      "r139",
      "r140",
      "r141",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r154",
      "r155",
      "r156",
      "r181",
      "r193",
      "r272",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "Foreign currency gain from remeasurement",
        "totalLabel": "Foreign Currency Transaction Gain (Loss), before Tax, Total"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign currency gain (loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r371",
      "r381",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r138",
      "r142",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Rent expense",
        "totalLabel": "Operating Leases, Rent Expense, Total"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r73",
      "r125",
      "r143",
      "r167",
      "r168",
      "r169",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r258",
      "r263",
      "r264",
      "r282",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r73",
      "r143",
      "r282",
      "r307",
      "r345",
      "r358"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock, and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Redeemable Convertible Preferred Stock, and Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r73",
      "r143",
      "r167",
      "r168",
      "r169",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r258",
      "r263",
      "r264",
      "r282",
      "r305",
      "r306",
      "r307"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r4",
      "r32"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term marketable securities",
        "totalLabel": "Marketable Securities, Current, Total"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable securities",
        "totalLabel": "Marketable Securities, Noncurrent, Total"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Investment In Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r106",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flow from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r63",
      "r64",
      "r67"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r46",
      "r49",
      "r53",
      "r55",
      "r67",
      "r73",
      "r79",
      "r81",
      "r82",
      "r83",
      "r84",
      "r86",
      "r87",
      "r93",
      "r116",
      "r123",
      "r126",
      "r127",
      "r129",
      "r143",
      "r167",
      "r168",
      "r169",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r275",
      "r282",
      "r347",
      "r360"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      },
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r88",
      "r89",
      "r94",
      "r97",
      "r116",
      "r123",
      "r126",
      "r127",
      "r129"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss attributable to common stockholders",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Procurement"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r116",
      "r123",
      "r126",
      "r127",
      "r129"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractually required future rental payments receivable on noncancelable subleasing arrangements.",
        "label": "Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals",
        "terseLabel": "Lease payments under non-cancelable operating leases"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r184",
      "r270",
      "r271",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r2",
      "r75",
      "r115",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Description of Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r33"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "elym_AccruedLiabilitiesCurrentIncludingRelatedPartyTransactions",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r14",
      "r343",
      "r354"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other assets",
        "totalLabel": "Other Assets, Total"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long term assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r50",
      "r51",
      "r52",
      "r54",
      "r56",
      "r194",
      "r288",
      "r293",
      "r294",
      "r348",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other income (expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities",
        "terseLabel": "Purchase of marketable securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r214",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of cumulative preferred dividends in arrears.",
        "label": "Preferred Stock, Amount of Preferred Dividends in Arrears",
        "terseLabel": "Dividends preferred stock"
       }
      }
     },
     "localname": "PreferredStockAmountOfPreferredDividendsInArrears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockConversionBasis": {
     "auth_ref": [
      "r17",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.",
        "label": "Preferred Stock, Conversion Basis",
        "terseLabel": "Unit conversion ratio"
       }
      }
     },
     "localname": "PreferredStockConversionBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of cumulative preferred dividends in arrears.",
        "label": "Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears",
        "terseLabel": "Preferred dividend, per share"
       }
      }
     },
     "localname": "PreferredStockPerShareAmountsOfPreferredDividendsInArrears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockRedemptionDate": {
     "auth_ref": [
      "r186",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the preferred stock has been redeemed, in YYYY-MM-DD format.",
        "label": "Preferred Stock, Redemption Date",
        "terseLabel": "Redemption date"
       }
      }
     },
     "localname": "PreferredStockRedemptionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r25",
      "r26"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r157",
      "r158"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses",
        "totalLabel": "Prepaid Expense, Current, Total"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance initial public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs",
        "verboseLabel": "Proceeds from issuance of redeemable convertible preferred stock and related tranche rights, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r46",
      "r49",
      "r53",
      "r62",
      "r73",
      "r79",
      "r86",
      "r87",
      "r116",
      "r123",
      "r126",
      "r127",
      "r129",
      "r143",
      "r167",
      "r168",
      "r169",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r254",
      "r260",
      "r261",
      "r265",
      "r266",
      "r275",
      "r282",
      "r350"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss and comprehensive loss",
        "verboseLabel": "Net loss and comprehensive loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r299",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related Party Transaction, Amounts of Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r300",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r251",
      "r340",
      "r393"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r198",
      "r245",
      "r307",
      "r357",
      "r368",
      "r370"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r76",
      "r77",
      "r78",
      "r80",
      "r85",
      "r87",
      "r146",
      "r242",
      "r243",
      "r244",
      "r252",
      "r253",
      "r274",
      "r365",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Summary of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareAttribut"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Share-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureNetLossPerShareAttributableToCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r214",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r220",
      "r229",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activities"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Assumptions Used in Black-Scholes Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "auth_ref": [
      "r212",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description",
        "terseLabel": "Share-based payment award, description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of shares, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of shares, Unvested",
        "periodStartLabel": "Number of shares, Unvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, weighted average grant date fair value per share, ending balance",
        "periodStartLabel": "Unvested, weighted average grant date fair value per share, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of shares, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, weighted average grant date fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Share-based payment award, number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of options exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of options, cancelled and forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options grants in period, weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate intrinsic value outstanding, end of period",
        "periodStartLabel": "Aggregate intrinsic value outstanding, beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r222",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of options outstanding, ending of period",
        "periodStartLabel": "Number of options outstanding, beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price outstanding, end of period",
        "periodStartLabel": "Weighted average exercise price outstanding, beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value options vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of options, vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r212",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options cancelled and forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Share-based payment award, award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r236",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contracted terms (in years), exercisable at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contracted terms (in years) outstanding, beginning of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contracted terms (in years), vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Share based payment award, purchase price of common stock, percent",
        "verboseLabel": "Fair value of share of common stock"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r72",
      "r73",
      "r90",
      "r91",
      "r92",
      "r95",
      "r97",
      "r103",
      "r104",
      "r105",
      "r143",
      "r167",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177",
      "r187",
      "r188",
      "r190",
      "r191",
      "r194",
      "r282",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r38",
      "r51",
      "r52",
      "r53",
      "r76",
      "r77",
      "r78",
      "r80",
      "r85",
      "r87",
      "r102",
      "r146",
      "r194",
      "r198",
      "r242",
      "r243",
      "r244",
      "r252",
      "r253",
      "r274",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r365",
      "r366",
      "r367",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r102",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r37",
      "r180",
      "r194",
      "r195",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r194",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Proceeds from issuance of common stock in initial public offering, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r194",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Release of restricted stock awards, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r194",
      "r198",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r38",
      "r194",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r194",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Proceeds from issuance of common stock in initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r17",
      "r18",
      "r194",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Release of restricted stock awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r73",
      "r131",
      "r143",
      "r282",
      "r307"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 deficit:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Reserve stock split, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r295",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r295",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r295",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Certain Balance Sheet Accounts"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureCertainBalanceSheetAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "terseLabel": "Accretion of redeemable convertible preferred stock to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r12",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r167",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable convertible preferred stock, $0.0001 par value, 10000000 and 12,909,389 shares authorized, 7140157 shares issued and outstanding with aggregate liquidation preference of $0 and $49,891 at September 30, 2021 and December 31, 2020, respectively",
        "verboseLabel": "Temporary Equity, Carrying Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityScheduleOfValuationOfTheRedeemableConvertiblePreferredStockTrancheLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Temporary Equity, Liquidation Preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference Per Share",
        "verboseLabel": "Temporary equity liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r12",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary Equity, par value",
        "verboseLabel": "Temporary equity, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTrancheLiabilityAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary Equity, Shares Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary Equity, Shares Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Temporary Equity, Shares Outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfConvertiblePreferredStockDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Series A-1 Preferred Stock Issuance (net of issuance costs and tranche liability)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholderSDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r12",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r135",
      "r136",
      "r139",
      "r140",
      "r141",
      "r181",
      "r193",
      "r272",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "US Government Debt Securities [Member]"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureInvestmentsInvestmentsConsistsOfAvailableforsaleSecuritiesDetails",
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized loss on investments",
        "totalLabel": "Unrealized Gain (Loss) on Investments, Total"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r107",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/Role_DisclosureDescriptionOfOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://eliemtx.com/20210930/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://eliemtx.com/20210930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r394": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r395": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r396": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r397": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r398": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r399": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r401": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r402": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r403": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r404": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r405": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r406": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r407": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0000950170-21-003448-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-21-003448-xbrl.zip
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MB.4 )5$F$.,I I<IE^GFTFM+<AB'!DP\)E&M^_K*E>^3\?)3M09,?B4,/"+
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M=WN3@!#!$ER7 (&4@8? +6+@(N9SN4$Q0(-RV4+"-/C(7+&;,?=V/.^2&GX
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M7.1#YCP!SFZ]1B20)*BR1J?R+6FQG'W0@!"CJ3_*#??M1!)3N3FR17V!A95
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MI;<%;\_'4L'^ 8-]1?4'%\M?*SC>1 5L&-S=7\UM!:L'MU:J#E:O@XI7M4?
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MXQ[&2@[M*++*24B6I-*F??F:O;A5]<>=V8MC%H) ESK;B/ 74#CXBR[1A[^
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M?&EJZZX7CGT#]65B\+F-W<EPA+GR-Q01BM@',W6BB(^VY^?;S8>Z!^F9D_1
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M,0OZ129$[< 5N$X)5V21R"*Q%8 K<)T<KJ!N4#>V G %KI/#%=0-ZL96 *[
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MM"-Q6VMV5]..FBJK)012M?CV+Y')62N(*>VB#K86G8Z1=AQGV O3R#KF1!=
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M1T_JH3_RR>6QT=DF/[L\-'I2G[T[,CJ\X^QP8/33FU[_6[3_VR77'5P,"NH
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MFD(U*7D9KTW=,E%;I04I6S4IZ1P%Q07)*F/@PDGVB4LV/E5;^IL>/*F/?I.
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MI_'2?^$]]EOG]?U\' !X+Q_'>OO%GZ/=EQ \(CSN2SOK?C^/-E^*Q?VNGAO
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M#!<E_W"Q6VU>/"V[U39?7FGZ[-TYT^%M9^,ITU]WVV&XU06G:LGM2>>E@RJ
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M0M<?(O;0=>@Z]A:",+<@0%PZP![B G'!WD(0YA8$B$L'V$-<("[86PC"W((
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MAR!Z]+><P4N[N=5M$(8T_UPU;7C4;!BCGUR@3SL/.:)NML*7]*JN_4>7OK*
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M\\<Y$-TC .U]6-=^('$0=?+.P0^>&KZNFK:)0'FON1MD![ CVPXU3%E;W0)
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M7!K%+#'K,KJ!='OY=4HY@S<+EU?JGT &/,V'(=H%T"A_6Q!B'5)OE_*,KER
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MU#6-=]!AY'4'Y766:UDPHI'5N4'<:(-D;BA2N70XS1SF;H?7%<H9362.#&?
MZWAJ4)&G!.4Z=3G5N2B,.*KRA4>: Y'?15U$741\C_@^*GP?CUH/M+TA>LLI
M><M8X3!J]40PBV 6P>Q9%$;D@CJ9:H)2RB&6QGF._"H'TAG)34YQ0?E.+)TJ
MIC/.+;)&2\19:I%BG"&&"TLHD]3*(RN,B)1D;#/S 34149F1P(Q$!>.93Y'
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M!1&R)(YG&C[<J8N@5II,9P81R^ [-*5(8)LCB9DAJ9&*XB.KBXB49&PS,Q[
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MA8G>S78[ OH_8F"B&.&^E)3+^-*'B,:[198.(#B@/S;EY^2T*XR>Z"=L"#R
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M-RK0WCE>\8C5W]:O]2*.K7U03,?\3.6PCBX^AZ3C&'G)K&*,5"XZ4![NXOL
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MR;G2WFN#+VUD)K3>C?67TQ.!9GYJJ^'?_O#%&4CRTUE'X_SJ^*HMP%]/8],
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M&6>?'6>S!V>()/K#8E[_R[>-%?).M"=+*2^-/BR-_\CKX>7M);#SS*E0(FZ
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M&E>BDF/JF"54,_70;O8W[O?8UGZ/W;K?*TN2HWQRE,]@YJ$_QN+MNK_RU<E
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M+P]>!:VDJ0Q%I8[E*FG,/\*2H J'RH6*BDKU#5Y7OMS.B;LZ[DKG7-=[M,6
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M[&;+6&PED\Z>34'FF\_*-[VO2F9<A:R6 G%<$F2LYR@ =>0J,"'M3C,+HKD
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M+;3_=FY'Y%#)W7V:Q,DQ_+HH_CIKF@(D6B21%F\68.3-,NT5HOT&LW0.@)$
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M#:=^SYTYY,R< GK?X3JJO=_"J[;<8?!D!#Q\SM.NKOT=4GYOUL[AN^9ZJ$!
M'.AX?3'#?&!_&O2G@)P0!\>N-YUX0^'L'"@Z) K\521XZ<YGGA?KKSE/E4$H
M]:-489*I\OK+7'3G,BU%]+:X[8C_GVLI1P:L(@33E&!M4MQP"54E]OOO^KFM
M[U#1DK?SZ&]+S\,4SGU&&F<>QA&=RP(&&\(POXC\0H;PV.<\PQNI(A:LMX1
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M;Y+<&[VOE3XNM0#H'?M-FF>5B<7X?)YC,IA>.GSI.=.6V,I42[E&7=QO,YD
MB(@\,9F 4F'J?FC6'76%Q0V2W.;RTV;;ZYKD_+JU:HE3O],(:,@5@ /^EV&:
M_@4,2B=D8)O SC^$+O('MJ1)),4INN-=574&HX<17O:W=J9IG52RP6B=68B<
MJ=/_-CD1^V?SG<G4"X*JC%$SA3E!@=QN\QHW,>J:1AHI*S.FOXRDSKNK3CG4
M24?0"JJ\69UKK(_)GM*Y),W@-;DVN4!Z+IAPI#?_V@E*C6$/=9Z,^+;@> 8$
MQ[E)P*J'MC%"*LO2.FWVLEY,)(0X<.>^O;Q<"=V6:.RX$EK" %$@(E7BBM.
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MB$!V48]S,2\3#O*[9GRURK,+Z+818*!!]=_#!7E,<DQR_#!RO-H4=:Y,Q84
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M@RNCX&M 4@GSA;9TBF,=8?5KE=T@095?SA1/X'G\)LC24O\40'^Q+)11/%6
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MA^T[GKBZ?6*GJ13*8%?^W':8HFD&\3<>>KE?O1M_]^P#[K+O*1CX]("%O\_
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M.V5BW_>$]'E4:/YEY>#S$)?-P* +58M^1O%1?V5*'TC>53W[32(W.?,BDRJ
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M#PUZ%WH4AQ/^#E! 0%F(/Z2%VVQ!V8+.W()2+R]F_L0!$?+S5MO0AL#[6$*
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M#F8T3TJ))9"9''.I7Y!=Y-/H/*16#2BL_8'2%[)WDI*)B-*0J =D\BAU$Y$
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M!9S\0H1Y+LD<LY]U;N11B#:J[9P6Y<X?>W2_FA<9G?JP!Q4MGCPX%+_;-/2
M2_:8>.'V&_D2&P# 6/@O)T=$9X/LBCTK\YGX-@O'CH\/>R6=@3TAXC(OAE*I
M=\A.V*43?GZX."69EPYJ.7( 3;Y8!]";_:[8EG#[;$9G_<QG=51]/U[;WA>3
M;1O5SZI?UM#.C*V)J7K$T%+#8M7P$<U0Z >(73[VH:L>'%:@3VI84S/<8<3+
MT%R%)!+N:!G"<$Z*8H8H):^ 1(:"E# Q(EW?2XM!:H-JQ.(8BKC\UI+]G=L
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MD_@#RA!%Q?U\6 J=EV'^V2?-;XOJQGGM04N[*P? ;=N]L3[KK;2TLYW9>.5
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MZ-4%?X,70>2=LC-ZW74@@57NN&L.K"NI6V#5P3@+G$02-P D.@HZ@<$%IH>
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M!^'9!E1VD0# #2'?A!54ZZ\H%V@F/&*_2&='HR7RE& A_ ^X%V#6FV;SQ;,
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M%C2U;JZ;;HOG)4HVT-L*R05]%9ITCT83X/Z9=+ P%4M&&"#R6?_+)E*CB]L
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MN&-67V7=#H]].Y"X('C<RTU40C]^=',-IM4Q7Q?[Y2QV[OF3ENL@ PF.][J
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MV6D#"VZT7P3R#"-Z=2Q/K(.SYZ4P0!E[M9RKY?Q K<=Y# 3B*(+/!$; NQE
MI9>EEN'D7I9UAN$9E(UAU]4X3W/#X_TGA6-ZMTFN"N8T@<%D71UH,][:< ,O
MM*RHI\!I](PJIW9L\V?P\E^5[01J;Q3DO.X[!'-_LOOSJ]=/XJ%!&&UR2-81
ME%-!/YWQG_P!!*):R?/$_="4.Z(P85[Y.-+@,#.+_G8J>^V_5 ^0K5I*.6/
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MA%\CYPZZ%.JEY]B",\EXP0B^8STN]=T8_P@[\Z#PP/@9=#;IB%Y&G^UM!YV
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M"I1G/0:9YN)YVU]A%3>^#BT,"$9+&C34D* &3<X']5M$F$^7RIT,A''OO*^
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M5N81CT6 L^X:I^W;)KE\[BTAAC*.OL9HE\EG(X;,"[+O:USTL3N6FE&YTP-
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MH?8QKS:O_"*"T&W6:T/"#O61^#KCEXV%85E*T:NOG(\'^\"1CBN76G?H5;H
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MYL'1+8E([N6!C.(/' ]PO/FCO*4>"6J&-@08,>X#_HS'6N\:!STU4?X&C_
M*D*6W J:B+V;W;BR(H$5?R5\SHKT%<S-H,J1^NJ($>E+<,BE**.0&FQ1CNX'
MH@A9_-V)@2#=- YU):J.+6P;>$3;C/=:F8$M5D4T-<X@\0AX5^30>,4B%J]8
M FIADTIXEG@L^FAQ?_(G[NKZJC!H*_NU)QD$C@#P+$5/P!TB$&\'1?6F";^
M:?8OL!)8G'6(-'38^-. UA@VC[7=ING G]Z8=&,$RUM0N\H(A%*CG2!X]AW
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MA0QP6^Y!.1AFJ[1-\=HW_2L#L-\37IN*Q<Q?Z^Q2\FH-%G@9@3VP>CDX&/5
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MW%Z=A[5S\<-9>3:D%N?Z]02FQ _;.]U=:S_SK;?G9;'YKQ(>"A;[RYNZ];_
M(P).C*D9 $%+:63"S-X-V/@@_/VA906@ LI&"9YRTZ  "WP6#(H_8H#W'*DA
MP4!Q;8E0FHHAP0 NXB*/XN=#])2&9".!$-JC@JW -=2P6RJH>7N\XW*:^;5I
M+F=5T6YP=KXLUY^T@:LIJ,TM^W"0D E4($"8&7WV4F$W@1>3 #;I^47T*@T4
MO@_>2@TW H2<N!35#<Y"+.HY4$*;XC<8WL 7CQ!63BV7":-J4]+'_N##JL1=
M8=(UO"Z Y(-JA!; $WD@1C9#!0("!"E_5['<$D1WHB+@[BOR7(XM_G7"E(=T
MF/_[MO=1A\S<)6;651-1 ?-SJL]!P&A(1<-$I.K*"*(.OJV",-C__>Y8!W+&
M,G-A7I$'Q$YQ\QLX1)B)2"N%,544E/D7<B$7M)+7@/ CNPH_*C+^>BKA"'+2
M?VH4/6BM4EE9@"=0B8U]"[3)M)L,?8ANJX@F6U5S8BB?H@KMQIE?00[/QHV,
M>.RP+ "=.CWFYOT!D)%GP\-:ANB/7>1+P=(%0MHR^Y,@]$M-W=D,IB' IAO7
M@[$M'8PWU/CW_,1YF.ER4<2_'!OY76V^L>T.),V=B:9(!)W[<O[JO9W#UGMD
MG_ZQV'SZ[-DSBJIXSNZY!HGGX?-5>(2KR!!'//2QY0H*B[]$.#_J6P]LZ</D
MKI36^T&:@*X9'"6R88T$[3^,W-_5!T0DS30 <<V5?>.=GE&4T>'-D'56R':M
M$GW$/DT8J/2+.!T4_!*0 ('.>]=SEWPY"/8@R)A'"H-GY7(7UH3X-+=P:]?*
MBTYA[4)L+91E_D,@N?2"?6KP)XNS) ;XFL-MP@3[L126TSUB2!(])*B8(30*
MVY,(&U2R: Y=6M RTH*TT(8" )S!+>\12C"ID2DC,P/O41'Z%7$:A=,\(E/V
M(0[9*VWQ"RC3VG3WQVU!1K37].EY#QQ:$(DH(G\[=2+D(>=/@%V1*BR6B &C
M5\T>BGB[A'DG$ QX+0=_@LQ<B_/NA"1,K/=C6QS*I6]J\<<T"V7=H(Q[-=.Q
MM\&0F>',5* 9(D("W*9!E4WM,$XLO8J8(9_?A#F!<#^SFH.2.>0KB];JWV'[
M(AB_/MSV9[VDA_M_^%RF)U9]7$J;S3W8](C]I0=T.<[9FN:Z'-^5&H%FXO8/
M7N11,F;62V334',7]"XG9)+AOD'CF?>PH7>3&:<#3%E:0_S(!S>.34)YQ*A:
MT>C-W,Y,BE7[X(X29(J1%!I!)-G9V9%W<H2.)4IQ6^.TC;C][>-#OUC7EWU-
M'#)';TO+%A$D"L>!!OV<?N=YT4"*0GIGE6H"RH$.)5@\F&\G%G#P?06C&A[)
M'R1N0"F+^4V&3M]%Z("V!$#1:74NSV71H0,+&0Q!W !>-O8(-Z-XH:']M]CD
MFO:X3&-K. %2'HLH6(B^+"V\8E@Y9I5YN]UQULWDOTQ-Y9)S8RN]XH6B7<^T
M=:HIYMQOU*E[3T\IXLGXB,"<P2G B#H?O5PK?5HEZJN6ACS:(=I[!AMD93Y\
MY,_\N'P5=?[CY,^DO.\A?J0ZT0)!/YXP]RIJ"7R.F>&(?8^D"!0M:ZG[M/PB
MY2>IL@PI.QE!-[0("%'/SE\G*+@_],"D[L](!-KO75:U8^(>:KP:@/F#TPP*
M78'9/$X]!'G0\SJZ:YX,>0(96?_P,SPB,]'HK1RIIY: @?KZ!*FX/#S,DR2/
MJ&4L3''XMU]-+D@ PGH"0I<C6,6D;4S:RK0-*&H+S+:J^PM1N#8OGH:1DHR[
M]-!,TC@3R:CPTIU:<%BY+ZL<T*D*]36#8)V&?)N^?#(1N2YB5SRX;LN?C[D/
MA#W@G+$^RQM@=F6H%KKPW,9UDJIBO.F0/@7+-BY'K7M/[3' 2Y+#[0ZE*-C;
M/[-PN?<4=#Z8%1QS6G^?VIVP7A RGE.(W"T*'7DYZ@G^L[]&."(5IL\"C! I
M]-VI;+@U"S576?:MZP_:8>DGDWF;DC[XV3O0F:^#L;34#]SFN3UMKNM;>9*H
MH12CIP@)'^&WE7J ENA*.OC3H*E_7*&I_QP>TIKLNAP',H@>6IH,BX'-BA2W
MW%J,W>:*R'I*W"QS88A[V'4,WXO%*4F2B2_<#Y*?I^P;%,>$C^<\J5&17$=&
MG/H/Y"T%?R/#(VXKTS.1H;N;3H%4F+?6=HZXU<;2$T?N4T0FA/5;)G=@K,=L
M1K -O@=WTF"GHAG)DH$;D6=["X,L!?QK7?VR9]HE)6H^6RW/KYRHX8(\95>R
M8#[;HIS5<%GN^&2Z5+U:H!X"HO@+6MZ_17_B41V8K]FN<A0N&-VFWCL8,Z-Z
M9^VG -YO&NIS=BT6X_>.2]FP!*&N4=95P=1D_ESUX5B*]%/AA=#ML?GTV>;D
M2B$B@R8#18X@U@9"'33F R(Q+)SD:O-_RA[HB*77&(YV.1J%*H@Z,!&UX!_1
MCB-$EZ8;U<=8):!Y*WCF0:8G!&E9"9F%$K\TO4)<OK.9+!K*#?+('3'71+3.
ML^O8:-L?<ZUD:]%R2$>*-24 M%:G(9ST.-WUSOXY2/NEUB1DP 2&%5$!CD E
MR[TFO;N>FI(II($O&!M2_']RH;Y,G6F:&IC7-YT]0G[2Y @N"[I/;[I^1"#H
M*$GIA:F/LA#^];U 2C5L +(L?"*N'C$-FBYEH1@RC3'H5D ^B*%.V@\;W"[T
M!BL7,>RE1;Y<T2W+M8>9A]^> _.'U7_YP ?!5TY 0M.1B8Y'Z)D  HN)K3;K
M!Y)[/X@+_\U7+PRA&F((;X$8;:EF7>2D2 R04HVV\S-7"[V;B@@&ORK8>:Y+
MP:"_ZJ?KS6ND+'II3",,G5VR-_#5[Y$6B1[KQ0Z-W?,__N'S(@="_$LY[FZ>
M_EB^\S.U>2&<X=),/W\6Z3H\]SCG'D-V/F@##$V98>KF@#7N4UHZJ\\\ @(1
M:B.CDXS'/]!T)-$B?YKPP4QG$T,%Y=P#;Q3?O$GLED.4VJ1'4/H >\<&N.\"
M(3A^.TW<PV/ 4IL?,LB-!?QC?^GN' ;_HX);6TS!^P7<:ME?+L3,@)CC[X5&
M$%^<N05K.A'/*J'?2@'?^NG9PSI#? IU)A'65=V/K.10 D,V!"*]H_("IA#D
M'=01?L>]@V-C<%@1J;SS<XWLS4KFZ?1 /MZ45-]9G+!"KPK9!:KXUJWE-Z]<
M68$1G'U4E:#/@]!C6(Y< I;# !"D<".K. %4B)+%04?-M=?C3< <RL1HZ0+Y
M981L$*[D9^!J\UV+8N*!R!W2_>D25;&M$:&V17H+@B31GVEVNS&\?UR[6W?R
M)G'S_'/KN(H5%!N!;(C8&R>,?+QO1B*4IU%5WG:!UM7!^0]77/G$_F"&M)H_
M! IF_H!8&7Z4LSFJA=TN:E-0=S'I&;,6A^QDT[3Y":[]X'@I*M<R3/%<XU'\
M(_$ISY'J*P ,'3Z'+K1T0Z=*L)*$DU,HP'8SR:NA\^NCS[B#TNDG[S(9FBF;
M$3'I"G)XW,_\J#PMYI/&(!K9E[O=;NH7E(U'H& P]7"A3@!:QP.CK&<G)3)?
M HP<G1GHW)7TKE3%B:C;A2HYR#_#+YMR:G<WG#J6G4@A.///4C 60>8PMUL.
M;KXM9YK$_P0HH34E>Z$IV9=^^5Y3:Y@D7LH[7HCY_G!3/ IE=9+>EBUED/XV
MH7O1\/[UB/C(1\1W6V:/7*",Y/CO"+;3WWJBY)"?SVD8^Q.)H,)J18"YDC 7
M&#1P%(+>8,N:#&%CV*QD>>=]\9 7@"X?MZLIK^KWP4O_]1[#""R>,H4BZK0:
MJ [IOR0J8%#"J\=)JZ\9LD'#_&A2B_@%(J P\U$(EZ'M%L/MBLI?U"V'SP@W
MBY2R0.!KL%UU=\Z?N&VZM=FMQ%QF"&U,D=*]JP=A$>3TH=)*1.$>S@DD.WZ8
MCA#P^&D$85O(_O83-H.V"NR3(+L<Z.5 ?.A_QCBC$ A3$/[(M0R;7':@RX>.
M4NX\C-E%H)L3GU\E<)A[5*\7ZK1R!7^X3RJ2'/HS1]&N$'+_RK"!GP1/=5WV
ME<"IYM.=+'>:UP+R"G>N 0VPW"53R;/)3,= J7?)Q%^02;Y<$,IO#_KUNV<K
M]&MU"G[Q9?4]67_5$ 3\J,T1\P&F8BH9 0;,WP/!W3#U^%ABYQ.IU$6>.3[4
M(X[!GH@.0Z<Y-A4;Y:H7 \G6<Q,T\\&%A)])B%O!VX,;BY!H?(5J#9\^>_Z9
MIK\S>>Y]W0_<9"A4M,)&$-B/_9D_;."?([-*!:<'$<@D$[?$O!S=!A@$3(.[
M;:]>O(>?$"Q8VB<*]8O_<>7-Z>D/!SC,7AR@3%MNOFU)/>$%]$)WF<_![UU;
M(JS:3\X/[C@R:<6SY\^+3!OVV)<M1>5<Z>!'$NDT?38BGM3^B *SZ3_U98:I
MF]TG/X><]\O/(\J!MN:UDCN!"4I4(\VTQ.-K>?!"H3:.9*:I=Y)U="%QV$XX
MU4#-:5FYV*>F!DVB*D*.A/*4WUI]V(5<BE;=8/[Z3(%'FBM$U+<4#5G;RC%,
MVX/?D;RS@V"K$'^C?RZU%W4:U1I@35R9+ZATX#_-[)'C")+0HQ67M= .'R7@
M]9^6%8;71)]JM(8C!>$ 4'B8&C&3K.9$*^G-T;.1U]R<C(00^/$VHF#=.O-D
M%&-L9-RAQ)'=>]QGJKHGVHT*K("R$#J;=4BU<+*717CCSH^R;TZ9S>//P:>X
M>100D[+1U2.)]D+CLP\:_)XHQ\"\R7P%F5O3SD-,$->"(^!FK/ICJV[SS0*!
M&;CP$/V @7C,1U6!H"95,OZG:O.]L*CADMV[7R9;&>> C*)()K2O,$DC;;Y^
M%R B#PW++6/BQ+Q!3;+J?,SOL%PM9T,!^#WH5DIT,*.C'10F6$@RD("&/(60
MA*8J W:D:>$,&0 !V]&B+8R+W;83F;HLHSKQY>S#-7;ZV#!7K$T#Y#%!K +@
MQWL#@"1UM'+;";P80K/Z92S[A[:#X;[%3W2L.!P=(^0SI<Z=;22&CH2RKF(?
M#+X50X<"[6X=DH+#2,S:MQPP '@4<9K&\4(H4#;%IWB3WB$\@@!+J;(R-R[2
MGML[%_E3=E:6QHMNJQ!UI";)NLPYLU3VIR5S)-"HR"P9\$LFB&#?3GT&00M=
MSDY:K<='MAY_[5JSAEG*T-0,@I1 N?7+K6O%VVS*XS!CILLR9%( 9]C(()$-
MN"+(AB.H&&LKA\/4JE5AO)9_T&'7UULP+6 '$"DY% 25YQWDAZ 6S=R$&J2]
M(4"5">C0ID:J+8 "44VZT5T))$V8&\&8&VEX.9J!9]SA;YEM'.L5T$(W,9V=
M&4:)Y(:XO?U<^+_1Q@:V?R+MQ/@E&(L$' 0UDL$"_$+Y(9 XP).;%P9C"Z^H
M[GWTV-'5EEZ733+D7EC!UR/M!HK32 M8"5=%JCV&.W'F2G%R,3WIMV?E[O'J
M35-N ;<*OQ W27Q#,^SE7L=[.A4R*!3$>YCV0LR^X[T86470]QQ<7?%271\1
M$S X[.+CJ]4R/[*@Z4U$#$%LF:1-DM%/]L&^N]94)F,E?XK0,Z&ESNOJ8!)E
M&G?<EFQWP-8D/PR_V)Q9DE)+1-^0IF$N9P&MF^9CHTLFR\NB*TJ2"-C_80OR
MDDHS4B%T2-C#*-"^% :;[ HY)(BP"-)K"QUR_N\B)YDE=;+,S#]QDRYLT1!>
MV!L'Z,.<VHF0#<)]Q)B*W*6-Q#F?S]NZ,SQ5>$IG43RUH13>.C0;E,\?.ZP!
M(>P2R8Z$HZ 0EX$D$DI @::ZX68\5"VY5YTL1WRS\/KL"1]R^7[= OB%J8,Y
MD4^P5*#Q?EBF'S.WN42_M .&,)I:HPW82&+4;5>=KC9_]<YL#Z$K@G!LS)T)
MXL^1?%/+X(P\'(% BEBI75,9QY3/&-XHRUZ8MO*(H&:0&J"87 :);)FDX05%
M(Y7O*HC;OZG=K>%1#?3GG 8/? H*]B]W\IJ"8D$Y)B0,3%B--1\J2-H[&%^Q
M=\>FW,VHJ3@/T/@7W;+P//CL85M'G!):8*A-4T(T TS&-9\'S43J Q-_[ U_
M&*N,R#C:!E;9P"9A1AB-OJ2B2D!46?\6=C'1O$:4BZS["XF.J<4BY9V;,\K)
M\"R%;FATJ:5-*66?U8_8$B2!XBBR''N'#3VLR\9*=EW?NE/@(<$0T3*,312
M0C6(V':5]#4>)%S.#A2AY5-UCM)VB<LVY7\57MOLG8E.-B@T2<PT<_5\P,6G
M0)?L($8'EG#V$*V;GS(@]S(321K9DM@6P/" A'=!_UB!]89QUIO2H6M;URA5
MH'<4Z=3F"'^H#?><Z=@QR[&FXWAW PZKU!+CIT!H/9T2AFG96'LL^F8YW90)
M\#Z*T R^+HP :XUKP6R%V?V*,+OG*\QNC8Y^\64U3R&P1FJ&2-YZ&EO$.'=M
M@(+/6+SXB.-.3?1Z";!ET<TQBHE.#,"!C1$U9/#M[B-ME9'V3L,GO)R!:-LF
M:78V"<?/#MV^1D^":D4H-.P?$SL_A0<@%@$6+% Q$YGL5=''']U\#V' 1!?;
M)D3E/.F:2CJWYYIS6:>O9SR2&4#CV!]BD<G8<[I/52ZF,5WP7[BR9@4_T&F7
MT#*GT6.C6Z/_@N&V/!D]]B9Z;HP0E"HM4D10/V&.RQ+GV<I6@4RR[=TH@B-/
MQ&T=UAK1MRBQV# =CH*^D:MC#RTV,VXG/ZB6:(MO_#;$%FPJUR&YQ,",_@/M
M(D E,:W$;4V-B@XH56 EEDI2ROK(YQX#E_F#UO3R>KMC5)*(,0=4X+!T7^NT
MJ;\LBRQ)3KA<:L(M:?:<3R>RQYWS%2MW\+L2(6M1]*9*HSJ?,)ZI-5LD#C?N
MI[ZF("D"6%H&/Y"'K:&/V@2\008G"7_G7((:]QF*!!-;*M_B*8STP<XL^,,
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MLB<2D4/'H 0;#_7U(45"FX.0MKB?>#A[^YJ++65S&NCT)K9="'-4 %:ZT6D
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MOA;WFQ\?BXH:))W?P.I7'[&HP5EEM2G>$OEX(/(.@J%#WI\#2NDP> VN"<)
M19@#?LZ0I!M. P 1"FMT]SZT,W;5WJZG;(!0W1BI3W^M7")Z\Q5]T89O9DWP
MK!K!,\C=15:UY%B" SI6'@Z39&=G3K9CM:5XEBG2\%<<#,67B9R1]NE]'_/-
M/1=%3Y!Q]E89CH2RQ &MP%T?TRE93*0:]2N03O(O-3A__+"\Z?@@0N%2>GX,
MV\-0]?K XSJP^-AEGUH7Z@S^!MO5/E_;U5:GZ5>ITYJ:JVE[U5"^FTFA&/!W
MHJ=R[.L6SJ"&52U!-5"%5M!FW_JK2R;"M==@CN%@JP>!W0=E34Y,&;"Z3;&
M: P<@DV-]2 \!XTK WJ55=E7DN+!9"8F,'Y%",=/V?JYMW1!!\RZPQ]'Z=K[
M7:([@@RN]? V=$X^@AV_[\NIFAJ^;;+S235'-O[I:O,JV >B<S%*05Q&0L/
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M5U$)1-3FAQ%YF<<(9:(B)O8$P#Y=9 C)NZU>6=B>MV][7F,A6U"J2_8RJ-L
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MV<1]@M!8M)48[6@HWV^G2EF(-F[?HO=!A@SY-ZV6W"HA7 89,5 71-P&3VV
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MEQ](7H[.%)8OA)CUT7P12*8BI[TD'I&:J+@ZL.:]+&!&'8D?^H+0G3PBJ??
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M3VN.UQ-S:AQVC]G6\(MX\K(6+2M 6.G.(0A(A." (A?BCDH81F3GH*R<+UG
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M<!J/=_:&=QI[9(37.(V?P/ <'E[W-(;7^-S3^&CZ\'#/:=P]<^"_&.V&#$)
M#=U(%8[T1SI:Q$R?)NJ:1L.3R2UHH5^4*5-"V7\QD6H5"\T:[XZTJFP#)7[7
M:"Z+PK)5A7:2:J+LB?>:%^?,M>#TB8F[P'\RHL-@1* E9'9F@O<D8>E=VNXT
MIEY8G_+%@N_OJ?MPSE@ ?OM+][".\<%6S:*7"$A9-QG:B(11A'3#^_2Z'QJP
M18\/9ZT/\0.9VQW?F^^[%]+L^.\YQQ91%I<I"67/4\(TZSOCRNW&">&T<[U(
M:Q9F;K',=5G5??R_1_7-ES$OPXRS8#C336I:#3S2"%$M,%W5/?.%O!J$%^(1
M2YF.+;<&6,6L<]JYZ((:<&U_?)$+%PV.!)-[1><I5E^IGQH_39*_/?+DTBAL
M!1IYWHJ%T-9Y+;Z97FJ2+<0E!N.'/6*%$/*BC::3A)KX$9!/4V/ P9VW1DQ2
MYH_:2B4.@6?HV#S!8A(MDMKL*MT(@1DR8E#SET<W*%I4/"^5*9/LJ U?,,(U
MT70E_ [U<0A6JRJH&=S2IE$QMTZ1RC'4Z4*G\+4[A1^&3N&[5K'[8\N_'=#
M> 8P+)KO[-2^RTU@^53B2HS,/OC.X5E/##ECW90U%W#O=>+)QT^?'&(\2<U
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MJ05&7;[*?!,TOIO-J$'8)6:V'!EA;U7EDAY_95TITO::R0S*26)["?:KY11
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MG5KG-V7#1]$S#H@UPZVU[LHX/)'CBC*4'VZF]Y \E_%8XN__!5!+ P04
M" ![@&A3O _#"C<*  " ?0  %0   &5L>6TM,C R,3 Y,S!?8V%L+GAM;.U=
MW7/B.!)_W[_"Q[[LUAT!DIG;26HS6X1,IJC*A!1DKO;M2K%%4(TLL9*=P/[U
MUY+Y,%@VPH'(3MU+/DRWW+]6?ZDMB]__F(74>\9"$LXN&YV3=L/#S.<!84^7
MC>^C9G?4Z_<;?WS^Z?=_-)O>]4W_SKO#+U[7C\@SOB;2IUS& GN_C+[]ZOUY
M-;SU;@G[\8@D]JZY'X>815[3FT31]*+5>GEY.0G&A$E.XPAN*$]\'K:\9G,Q
M?$]@I*Y[URC"WL5I^[33['2:[4\/G8\7'\XN/OYV<G;:^?3/=ONBW4ZQ\>E<
MD*=)Y/WB_^HI+K@W8YC2N7=#&&(^0=0;+6_Z+Z_/_!.O2ZDW5%S2&V*)Q3,.
M3I(Q*2"XH$L8,TDNI#_!(;KEOA;OLI'",WL4](2+I]9INWW66G'E4JC_FDNR
MIKK4[)PVSSHG,QDT/)@-)O6]+6ZR))]EZ%_.-'7G_/R\I3]=D4IB(H1A.ZT_
MO]V.-,XFS% $6L.-SS]Y7J(.P2D>XK&G?G\?]E>#8$IP&,WT1"K-M\_/VJT(
MS3CCX;REJ%M#^/'?4013JJRAQUF F<0!_ %V0 *X'EPAJNXWFF <29!5WW(B
M\/BR@>D\;"Y'5DKZN>QXT7R*+QN2A%.*&ZV#0"N68O6I'(P'4RRT\<@N Z)P
M*O $&,");KF4I[LP'_Q&%5;&6^GBB*JP,-&TG#TD)S>4OQS"] O'/1;4=2+H
M81$APM(.V/5]'H,\HS@,D9@/QO<"3Q$)OLRF2GHU-X-H@D4O%@+D[DH)3GN-
M81AJIY"CW[T::H,+(L8KP8^GH>(;Y2G#1]2/J78W50)L4.-9A,%6@^482@5'
M32%*+(-@7>%OR(6$OQ0)_MR0*IMV%Q0MJ?2D1FL2D&?)/Q8\O&S$LOF$T!1D
MY?Z/":<!5%9?_HI)-%^ICZ^I("2%G&G:_R :0T+G C@N&U"%O6!5FT!)UO!B
M"6+QJ;HEHHG*76)+7,2$)_EDX4GU '-+T".A)"+8B"CU<5UA08"SL\8-5=0!
MY):Y&?P+\I_*_/!+P7Y&5.7%;M1#0LQAA5,CIS,9HL$!%Z'\'LW1(\7OWF15
M "61KG9TA<<BF%58OZ9-N%-ET/FQ]!L2/R#QPBR.L!\+K9<[SORM*:T!N@)[
M-8'<-MI*(RSEED-,5<5RCT3M\-JY93<(2"+Q/53:?=9#4Q(AFBIWZH'6>G95
MN5Q0*IQ6&61^"-+KHN1C0^2I-"A+._7].(RU,R9KP'2+H,]@0:(;!7<X&HP?
MT*P>T,ODT0<<3KF Q5]"LJR/NJ$*6]TH$N0QUF'Z@4/4JHT5[,P_F[V 92O
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M"KF)/13HA*3^8XT#=4_/?>R[R5)FOSK8JZES:GB2<3@>9M0VV_GY\HU]1(W
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M;<?-[A%=U<1/Z ;$+[Z+,D:I*A4_9S&9HGW1VF.- 2HRQEA\ZQ8EX^G$>1.
MHM35&&-W.)[Z/$PG(#_78(/(=91NB#?)=;![,(@Q-<>_'IS047DR^A<6>T3>
MUX,$\^6S^#*.$O267&;:]=<#@I[SVOPB$[Y2$<<4QZ$TNK6D-1:&E 9SNOCH
MX?/^]>#T8) 22D \SY9R'0R.=S"8.@%!E9D4E4<(.!:%I?*,%\52P#._6<JB
ME?N5DQLJ"D5E)W56?(TX%%!$JFT*60PJCX\@7 (> Z6]L1<('=@BTEC8AH#8
MC3A9R[0X;)[GN$+ "B82DE(WP6[8R#4IU J*]XM>_G<5)5@G1('7'R8 32R
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M]\J3/DO;E%^2^5P\G[E?[9NLR[>YC[.K</A=P;HG:&=\N.>1Z(RX3=G<+DQ
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MC+E11#<_W=:41(;W-7L4FQ9Q<$_6 QH;TI"RO$]W6#'_JBMVF0H][F?#R+M
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M>O (G6R/T$:YW+^^S>L?_:8GS&F$%>&7#03+@H():8QI>@@EBU?9D8]QD$!
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M#S;Z-F%5G>AMPC,:F47V'VL#98T@T0IBS>CCM)@V_34*N-*S #S-@*<">,2
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MC!I3A[X#Y)/M,/8FU"8F/C:YM4XMFN&3*=^"C64G]JF7)&1)?.FYWR<@7^5
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MTC><S[<:E6VXT;<F]MH$<W8<'/E*5(TH9QY PT7""/U1#KGVO@BY=FRHJ .
ME(ADP[M&#2)W#+Q3*VR+DPO<HT4A6V>'[\C24C^GZ#CK5,_UE!MS!4<R='.N
M8C%Z&S,BAH:N2(QOTSF*P0XKRJG!M.?&,*;KIYS)^)5:W"B1-FLP,M6N&EK8
M^#-B->AF]K+/SEU;GJNW9E<PU&L@M\S(G<)XYM/Z%=W1(FZX9D,%^KPMG5G$
MT>+NC*J:XW\79XU^J[.\,>7F>O&*8Y\D6;31!6\20N/+EP$PM*E?Q2?B'FO0
MUB8;SF.MHDBTS<=^[,*CE/9M4GDD/-T51>0;(I>.%*)$"(OQ5<@@A GQ^2 Z
M&<%I165)?;@$LQ+MVZ9XS)"LS9#"'+QU2O9,S;9V'YZZ2$\;1/H3&PLX8*,3
MW')@2#Q$\)%RFSI_>HJYT499Y(-6Z(PD(KF<9-Y(.6*?.5M\X&+)&,QA^'C*
M(-=W&.(R8Y%U:T.'Q;P'3Z_X&<LYEP"YF1KZF2=Y/RITN8915RK@]8]3EX<U
M3M\@N.UCPC8 4+:?V3\C!!#("2).<8+3YB@8J"OL@Q7S\ -S#8<9X^C1,31U
M U"<XOA<QS$X>*/UGA@2S%'?#\9ON/,TM#M(NIQX7!N=KZ,M.[DOELIG RU.
M\H2[.Z00G2'9%"A]RN='B9@Z!W8>IB0@= MFY??8W\;<QOCBU:?;  >7<;0&
ME6PK3BJ+97:CGT7]%NP.Z_@^7@=O3 #95;S2-BH:1UGKPO9=:1^&1?ZHDD=$
MST:-LT*Z'L/0H%-8EU5A+73"FNBUWY;$QAU94P0E_1**<Y+V0F&,V/OR&*8W
MY#-EUFX %>T'R'P8_M&1U2+Q2X0-=SR&0[PI[WSR?F'DITI)U7'V=:^5DJ#I
M(386A,JX4G-JYY<TQ@.HZ7<"""0Q_&39L,S/#,6I, 6I?=,2:"8X< [<LT]W
M>@)##ZT-8ODJY-"ASAA_-_97.-A"TK6!,AG^[BPY :5V-$W8^(NP5?'1BN2B
M'I+KJQ:;EMS%>D.C'<X\W?0/)#>15)2$[L73-:O?@WO:393^#:?21^TW'&01
M>6+%;6WOAZ>R?AWGQ$L>A#/T@LG3BK^ L&,]Y&[SUA$[WO\F$YAQ3KY6$6K>
M[IH"SDEE6#[5<9]#QA+:X=SWD#$URT+$@%_B)"Z)QN2KZGU&1B;W6_K*!'/P
M>!/MM8P[XW=/E$8^7)?J!2DC,0X*0ESDN==X0F?Q.8\-8=\>-Q[*\A,.V?)/
MYV$P#]8DY*'T8 .6#0\ZG4K:PC"J1#W#-8GQ?$MHU8&6]$K,6$U<U0G B5B5
MA=<5C%0V*(>?7640S,*R+R-])%AH!XP)#JP->(8>.-WIF0%'QI9^,7UH/-2:
M21B=7(5L">/75@D/3OZP\L*2G=-5*%2]OTKU>BZTZT\0H!2" UYZ)!YLW22:
MTNCP3SP.:@!V3TO6D#1YRK.?_T.L!LWTI'6L @6)^/4I U,8\0D\$.8F\TS/
M,"$)"G%4/)0D ES.&OAU]AT'DDPR)3BU_G/B']*T/Q,$GJ]C)N0GM]&[K1XK
M(GNAVW]_F*'':IR)?PB[+:3%$%'C4CB,?\C9ZEJ40WG+BU!9E7*^3ZJ:TC&*
MO+QG.R_RZI9\C"+/I_+-=HAYNXVE1W!L]"Y,M0H:>OM5-G":P/Z_:\PD38.&
M_\,MO,/@EC4_DH$'4#5MI>X 9EJ%.X6Y1\[]4 ,-%SK)%1>Y\1:WZBX-=^ 7
MBA\=?%P*F39#A4_>T?@N9@ZO^0[.7Z.F=%/$D@,7MV*#0C(P4',VU1N'HQF)
MRDP:)MGZ?4'+(%2G;W$U$"V-VX<X)J[BQ-]36.QP_U6)R<!\+>T=T\[3<0((
M5&Y%[C"H3 S-613R6"A;CS[@>#W(P.NOU6NG.&L%'+9X,[ ?LV82](ZM>SOL
MQ<FWLVQ;X9Y=7CKI<'5;N.8V'A&VH7:[E'..%-81\.YN/S3HJT<R]NU$?CA:
MD4]]9GA[TT79R7IVTL?IYX5M9<]M^9K6;ZR.<^[6-7TG_&![D!O6>HY%K.K8
M[AC:IW)H:T9V[GZH<+S/L/[AZ^V BB>D(N&2J;-77F.2HMA&=@3WP,VOCI2Q
M7G^>KD\7Z B>*.T'@_Z6(]TU:?2=['KG-B;^H#NYVLJ27<&A#9">5:_F@)>O
M3F"3'Y/RT(.<77?EW7V5;WW<VCO_'(U<K;Z3N#OV&]\:FUX"K(]U%YY/K$IM
MCY&<#'I).=Y1>QG%2TS2;>S0N/7!)I!2N6 L!8=.CV+#4C0QCA66W\9(;K40
MGWX0/PF;_*]28";&:P^#>6>&:O^'QS&E7G_<[ABLMF\]715A\>"]EP"/[]G;
M\5/#D1P,^E]"'&:4JVX_@@(,,\U%S-$,P<$B,7T#8]H6V?R%@(&A9O/QV$%9
M6;TF,3Y V_+;J]%>LE6XOWO'CT)\(3<D"[K6-:,:M#F0DUIRNCOW-.=B!T2H
M/?JZ*\3R.>U3'"6#? +J4\W^4=6\! P,H_J)E'/FKA@';WGU$V9],+V),^40
M\12GQP[A2!_HKT$RI@^'SNKK@K'%4N@4\VVZBF((3C<HX*HBG9+QPPR%^8CC
M!A()\O(6W[!PQAM=Q8P5/*'Y5/([Q$B'G1$(SVIVH&K5<U#AO!EWC2&'BF*\
M(51P,HUB>8BT^#]PJF2+YQU<JT$X8Q^,L)Z&A8)N'D3".NM9M(EBWN@,QI-L
M]HU+:;SQ)>P-)5OH3@KRUF5!WC*B*T_>*R^62@X%R?;@,8>T8VXCV\TNZY=@
M4ICG6<A'W]<@L?'&7\::N'8'H:IY./*1Z*"Z<8X3/R9<?S2TR 5%"V\A^[$<
M-/E#RV)92;;"VD6R8?BR*>V/:/TM2*1BK#Q62FC'<F7;S))]W)(8:<8<MQ!&
MGB2F)L<=]JF7)&1)?)G;HTCX>%;D>[S-TCURB4#F2W^%KXGW2"A)=U\V;%_&
M:4KYSC,LVV29'2&1/ADH42J80C3C"FTWH.7D?+U="=(&X?&YE0M/80;EW,@9
M)_E!.4,(.$+W!H77G#)\_IAP=Y01,X6C><IFU>,VY9)((TCM"BK+SUE;!N,8
M/>#U)HJ]>"=8.?/B> ?Q?'A>!I6OATAP=2#NO)T\.WK6E,P!,6N0@CGHH!23
ME%NXL046G*08-SCTR?Y*1S5;GR3+ET]?)8S>W40I1K__]BA@43VB$DUS0++I
M?DA_0(0?V1\B00<MB#G)L13U]<1LGFWC0R9U7;Z^(#2YG \$4!<W6Y $*8,Q
MXWR?Y^=F)UY8XR"GB>_'6QPH;.0A:<])XM,HV<;# GB)!K(T- QE+-.';R!]
M^-%CI3E,D?E<-B=2NDCLI4XN(N2BHE6C8JB 'FW&>96N/080+2/S"-BG9<ZM
M+AYW8AHS'6F\_A!3:",:L+52C *L85F8(4D=2?+3]YN!GG*=]\;.,"[[^I0_
M]/164O#KJLZ?C@%#B\XSR5%3:9BI ^.=K-6^*8'K=[TPX\J"RL[_^N<_?CSY
MP[^A<[PD/IEF?(XJD7I/"X-E<=LP15_/DP2G(QS;/$['-3ZS%6T2YD8_HDTC
MTX&;!:<QP1;!%H.-1P*9$I'-0AX"?V3);T0CN:[+9V/$8^U/U2DF<"KK[NV;
M1$C+X+*\F8!-9$J8;)B68(RIQ(A>,:B_C,*Y?E689"?+<T NEI<D]$*?>/0V
M2GA^[,%O 5EZR6B)<N(HHVX4GGP=VOLM:-C[V6%O98;07T&2<]:9VT=*_,62
M\0#^11'[8_> 7]-3RI@9E@F5TT>B 92U<$1H:"L0)*BCGX$^X@V8&J@FP%7>
MP!M &HPUQ^9<PB $PB9VO'%WZB4D@26%S>0D \@WK5N&R"<;BA-A%*:T?QPP
MY8 LD9SEXU#^-#H<,U0W'CBG+9:+#1:FQ(/>#!?QDQ>2WPSWQ'">I?P%(1A#
M!2G#RT" R2\78<I3:S')L4V1/.-S+_5&4%X%7:00AFQZGCFM;FPPU#H.V<0=
MWD0QO V#:K,=9J4FP&2J7DX9"=+N@Z'6<=RO,*5@@>N%@_0V"8&30Y*>JWQ3
M.RQ?$HKC,Z;./T7Q&++F]%!&T%G.Z>1,RWET21+?HW_#7GP1!I#Z=(RSL""*
M@"IB9'E*5;=14!L N$8.CZ"XOT5A!(76W*B4/[Z#9=)VO:4>[%+ELN?DF00X
M'&S4FG.XCYEFQ$L*1F7>)&[#E?-:JQ)D[!HX*2A;$H8@V/0J#/#K?^(Q5AA)
M$7&2B-%TF'TZ->>J+9WTZCDLEYYR%5SVP>'D9DB$-IDA?D_L+HYZ5(%6-*=Y
M3(%3T]G#QT%6! 1HQ74AP@$8!W7'SNU>[*_8*GF.GS&--K"NR>OG(6,P(\P7
M-85T=K5M;"#F>P:38RNZ,59],,Z)5:2!@C1[H3!XL:,\/ RZ%.!/#*:?308P
M2U4^33V&\I$C7V#&'3FZ]ZO.87-, &D96S[YY_K)?U38*M.^=_\9=%6*(.HE
MMV#3 7WP7L^8UDB&K0E*,\U84^\5^:*MXT-+ZT ;!RYK!9T=*]#*"-ZW9PWN
M7^?RA).]@9Q%R;!1FQ%D)S'Y=.0#2<<1T KS^;O7F5GFS7D#J 9A2S"$?S:;
MK-:(K7_Q4 ZSXR8*E_D'-BW]V[&.;-LXC;WIB#AH#4)#!TUBTY$#$THK6]$5
MQCYC#Q@)%B%;DK<QS'A6@(VS./N3/[!>DQ!?I7@]:&%41"!8X5N<.DTS;M B
M1#D_O)3*$1)OOC\#4XAS]5:E1ZN"FV62\YHD%ZF2\VQ([E!CF\]X:(3H@SVL
M?Q9M'[TPZ#_DH-<V#S/%,JAUYLM*^VK"Y^N7,'I,</P, *["S38%[9GI (Q/
MP'>ZRZ5U!D$'SB-()CG20OVX4X8')_\5R:2V_&K$@7X6M*?8@JJHYJ]DT(8\
M?<^.@8!JF6>J%*,U12_PX99<PT'UA^%[%J>#?C"X]!H H-%+!-$9LHOGXU@=
M\O&X '1VB"T\)V-UR,EQ >CLD$GQ##B[/, .Z]*ICS/T%H6F&3(M)SEC<N":
M>J&*\3D@EB80!=\T0$E/F.HL8AD-'AS"\B251)''J1XAL+JZ*!H1/SZ*<<_;
M05E#,AS4$8*M'+&JH-%)OO%X&6Q4PVW6WT!_PA2!-H61 T16$P63@4%8SYK/
ME5E0341XFR(6GI^W>M0BH'7T-8=S&;G^2D%_-@'ZVSCR,0Z2RSA:0]M@Q*+U
MK!GVDBX:04O6"N]@: 81Z5ZS$>XUD3%G*.-@J0YGU@*:S.FK%&M9CEP>[_D6
MQ_RSP0&4\^DI8G-OV!K%I^T18*$E&)GYE@B'S6B*"6@I:]D-?N%?'9P?B=_,
MR;5#D,^S&XD69HBU(4J83'6T?4Q(0+QX=^_1+&#M]1BO(@5E!*2+$+W3O&^,
M"XQ6,<T$J&A:4-J#'&@^INX[3F92T9GTXD.>1GBLROS#OQ <@SG%;M1[X)RJ
M.(G,?S)I#YK'Q-IQ?1&\NZ(P*9Y-1W$<58-C[9#:T%%"HUVH2L_.DWB--J$=
M^*S> G&*Y_0++P9C[R3;K4<9C#<X1==1DA3[=2U L&JK+>,F'0%(V6<9/07?
M-&.P"F3@V-/AF&#,%5.7YU[)DXS(J<!-M&HY1I)11B8?;^]/:QE:W@Q857NN
M9IA1DM!,,UQ[8U<S] Q=4#NA3S#"6^)XC[SO6XKO;18@[8%M>@6@%^:!@[<_
M9 ?C"XVNTAYF]_.F!$*'R6*Z66)11N[;1U4R=8RV7%0S<TRZ0C2"FG#V'PVT
M/AUF?GZ.CZLR]PI\6. +"GPIP'N$1@S.M/OM9B,2"WE4^OK>KS!."ZCC'"3.
MV(#T2)CY$R/>",KB9!\GOORZLVBB@D]I92*E2\4HCPT*$P.7SS*X[":F!'*"
MPX(:0*P4'8UIF6H8."6(91Y]4M4\P^">/(4\25>8RI&8A=HC(PU[)<DG#R&F
ML"Y"<6_7:YC]<$->,(,*;E#&SM<K3SGX5#9GY8!^,N"?$@&P%&2TX%;=/KCX
MVV4^T9RMRVIH[%@=E"F.\5ZRNJ31RTT4^NS7JU FV&9#0_8&^QV"M7%KJG$]
MQDJKL+*+0IIEQ@M:,KX0"9=1O.9#Q*!;V=1BR,[" !/:G2'9,LJ;YJ,];QP5
MK4_MC@9,PG^@4#U[%";E79YH$[[@^3_5#Y22 P0#.?B80!1B,S7=*?_2X]E0
MRY\I%1P5BG@/OPK]&#*7GF/QD_U-MQ#!Y>+57\%=WAU; R^62SQH>(T@Q9E\
MP$<9Q^A=QO.W\*XJV489WP@81X)S@P\%G/YBJ4IK$0[JEQP*FV&;*/'HISC:
M;L"CGLTX?DVUQ<'@\*2"<5CER@(#,ZNQ.JSHE P*XEA$9!T%C1(BU6!D5YP"
MB[=Q!,'(@M/=EP2SX:]968=$#X(G.;Z$;F0[X/RSS!=0+V_D&('2 B/O[5L%
MXSMHA6V4WVJWBVEMV/@K2!;R:CQ#O72%$6Y* WU$"*D.7&Z=QZ->%X_&4^/J
M<;4Y.EY;=V#[S]A1TEID:JV4A*NKTT"U]H!5:A)-MD$ <@L<?1_:"L!LF9+T
M;?;R""#[]6[>T"1[4%V)KN?3')C-D ?LFR1QL DPLM,TJCL,34VRT(GAJ1D<
MCR/MY.@P.KNHE)AR2F#EI%4)#Z78&]V/ EV(G^#..5?K&C-QF0XE.3*\7IU7
MR<W%3F:\D2E!YNOQF;<A;)<:18_AQ]:DLKD5@6ZFR3UJ#FM[IQ8[G&QFFJA0
M48S)4RB"J?NJ?>XGCX1@BWJ*EZS,@_<Z;(K*AF1F/'^'GN 5D.NK8+J>6[ ?
M%]2*8X#$F#6A6B4C: 2]@V:^G:%'WA+$<C3L6,2-(U43PN%&H,)"T)_$"%0Y
M%*M^4N.%),^<AR:*2:Z/IRG7\3$B7[6'NI[ *^43#MDZ1AG >; F(8$5#'((
MC(91-L AEIN8$"7?;V^B,-^GV*(>K3.0 S<($5M:I8X$>?1.-O#M)'O#7]EB
MMF(K^!Q"M#[AFRT(=;'D4V:Q39/4XZ'A(=2!SZ^SZ38]8&XJ?9NU^-X33:*0
MM\GOYH1;8U2T*T[":<27(M8R"MD1DH+W1.ZUB;R*]X0O)G^B>$^PQ1@ B+"S
M H*QA'X=*CY,FMK13'6?&:IQ9"VS\50[ ?"X!)J3&RHYVKP9T=0R(69*6: J
M95[E_,='B5<_O3,=1@AI [R8BK<]O93:SL)-LIB5A3&=11YP=W= 0J$^IGA
M&['%&)OJVQ'QR%FO-9GD..[,I4BJP1")@OY&,-U[9^CN%T$<[8#Z9!TS %%S
MST@DG.HT0$"5@'?>!QROQ^X9+&DCMGZL)^J8(7B:^B6CB8#HM#!^BB#WUB'9
MIWMWSG/>Q,1==#BVSHXJ2$\#Z3:.'J4;Q&+YF5#,5,L0S_T58:>O]0%I3;MZ
M;U,T"&KQ.FN2[<1YFQ-UY^C8FWI7:0CB8N1-(:6M:2#?L^/$KYC'5!F[8Q-.
M6L2=<1Y,4T\)DB+HS#0@\H 7B^4%FP+22^H2\VS-8_=1D3\"YAYF[>7>4$O1
MXD13;U3439VIQ/U@LP[:R?WD9$L3;1M)2M9PH%!0&[ J*>6+S)JL='F_E)KN
M'Q%*K@GJ\>8(E.@R[^H1P'U%LS3&5"49O=MA+TZ^/19%3 OD^=B5KXJI8*>B
MY?P^77Z]F5K!&'67:H@7V[ /CP\PB=-?/I.0K+?KX8\8DI#I3!OW. :[NQ,I
M^3./T@6W;AV.0)!&<W22*P5 '@GZ$SS!L/FY)"F\IPZP.,O>5>2S;&'@?AO%
M'$<U_!(XU$1ARNA0\2[#9,+6!1=A,NWD,2J%EN*/(SRU=[1F*LL*APD\F\''
M+@*HFC]:8;_]I>] FX@'!1G_71HK$3D<I1V3 6U@A%ZIQ"LS(WZ^?'T) QR_
MQ"05SC/^" &J59+YQ;ZI0]L8_,O%JL1W1NL-F/+WB*+<^]@UXR_ K'A>U5#&
M39VN ^]N6,3H"K;<XN<A GFM^7YX4)KV\@+>,SJ+E_%AV+#HL6I8I(0*.]W5
M@I/-7[PXN&5$5^Q#KLJ6/%YN,6MN_\E1EE!9*Q0& .#UJ[SY&Q0*UX=.R[-A
M4)A9J6&=UH(5F=>MYL'?MXF(IO40S8. 0 =[]-8CP54HS1.5>,_9"C$DXZS2
M).A91:,(6H6W>-GN#*G!H&>%WX_A#+53RJ1F=%=>TM[ NE^>N4-7?JX59E8'
MV4DP!ENB9-I-X6R[WE)NC);=3"5WV,?L[X%Z2T$X?_8&HQ-.VI3Z,AX8.<<5
M$#E%)$F.CR' Y)>+,(4<<U4K4L5Z[5!W:TX8Z8Q)D4+=^9ZIS$.Q#8/E'6R<
M+6/.J*>9.&*->>;M-@.<"-#\V2,4V'B(E%$I>>"6E&/=9J"\J8:PT3.>2LL_
M6N#ZZX$WW-.ZD[==P!W&WD-ZM-O,V[BQ?L6X4GAU[/^FH("JVMS.I*M(:AS+
M2,X@"I:.<-%%[*&INFO,77XC<M>D7IQ*N'JW$:4)MISB)Q*&(D<ACX]W3%@O
MPJ _T@MA@&\<)K]\%0D8APQ5X5 AZ$S@X@/Q+7&0Y0A@<U[H43@XQTOBDT$K
M2$8=Y2D(WBD-(-G"MT>(LC[E>F.=<.*9PEU,O]ZHIYJ$!OTFU9%]B/.DL6%^
M:%#NB:.4'R_PYM#CE@4 MP;GDKG_VK+%",=T=X<W43S(FB0CB7*:2!!U&@&U
MPOP]9#?F5DHBD-V-MQYF^"+I%9'Q@**[O-/IV683"S:3^]WZ,:)#9"T)(4')
M06;I='QF'7CR\?&!I,,"T7 "<"EW\O'=X[<H(^TFXW1BGAL.[%IOR-PFK8AW
M.^:)7MQ7U+UH9ZHU==&T<3V]FOALJ+.V KV>!$W>*,IPH+P!\Y<T?9[EM _6
M=V#4GY 4W^/X6>3=98KX'?:CIY <_&A?&ARW5V?R!-UV49+['C.UEK]B(H4)
M8P)4U02N:A,AE-$TG8+H)*K.4 Q576<B]J\CGXW6513*^ I#1,]I(4X,"6IN
M\DRG9?<,S'/8##N+@D%[,-!!0 @!)?=XI=.Q*9X_V7++RB2W;,GRZ'^3S5 !
MRT=527:&!&'$*!\%%.H*"I[G8A'S2)KA,*>!*AA.&K%]*B/N/IR&;K&!!*;F
M(GZ(7@:%X:HBX1.> 0&Z3H-HZ(F)^9<_KDF(/X[9#?(7!(31PTOD.)2&SK"+
MXL18ARS"*2;X$"A].L0PB@?O]2I@RB]/A02J[W"=5,)AE%&9M%&5;U0XU#X2
M,"N)P=P<VN,[UQE<.\2[D52N$GUE;Y2M&%=<1L5'G8)V2>@(1SL)!HA-,-P.
MYYG:8/?BM3BLBUN<$41]\:I> 0BR;H.@=OE?X_B)A$^?XN@E7<%%FQ<.<RN7
M."1=) @C2=EY*-0VBONU1^GI-F%ZPS O/PF!TT,906<YIY,RG1M)9,\*GXM0
MUL5;PU\(CB$N[^X\6GODT'.3\H*0$^1W[3?SG]#/@K3)4.$9FM-='=@U!!N>
MOY)! ZT-X+'AZM5G0-A@CUW=+H8[^C,B$WB<'<PJG9++>X_BQ9+;HL!;_&*I
MV"@=-K5+=@J>>"XUG)QJ?!!4P_\$"]+]]C$A ?'BG0)IZ!HT52>,Q;M>]H87
MEH+[12S<GS_C= 7)1R'-+,8*IM-=O7!6[&%H>IZ"-%K$6=@RP0K*&D%<-(M,
M-*=,)]#5RHO_S+EZH\*C-;E%37*;H?*8>BP)+II0<-PF4>>9>@5/Y!Z]W3Y2
MXB^62W;&"9]N\-"P3SI75"*:0AO>%I.*: R<2X\0,*U@O2PE4)2M(-$,RMI!
M-T>)M6)IVI TL@6S ??:?"GP5SC8PG2?L^,*SSY GK$TE"(XN7B%>$0X +F<
M\2P'' 6$TRJ;]4!Z>IZ=_M %03("TUUE!16\H(P9(3F%'9YTN&8,)-<#!*PA
MSIO)-3479(?!$^=I3&GULH*R) O5V@GLBBZCN/ #RP)S%)9(R9PRUN0(TSN,
M\6@&I[M;QMLP299W\?6:[RG+DJV4VF[F1/:52RT;?UT69=R(C&W8T**EL:>7
MQ%V>7IPK%5_8JIOPT# RJ^?.R*@J6I6Z#&_2X&V093'T'28UN0 CLRS#ZL[Z
MR%%C!W$&17#!!.Y31,PAMGV+ $N)D8&CT$<R%2T3A.?_^IZQR^HEZ',48)-N
MNU:EHMGNM&,*.,G"\DAF9BAGIR1%VT-*G86J\(RN/ZID)LE?/#WRODN.:'3B
M-4;$0LUE\K#"=Q&ERRB&@7N L]N(@T296ND*(X6OGDGL)W,*=$9^U55IL40/
M(XD.B<'X\U<T&JLI#[S'+?5B'AI3N*APKX18$:XV*I>GB\J51>+*DH,9RS-3
M2#/?=81@79G;Q6:83717)[=E 6HF=R&[;*8?T>RV+,[NV0V1\4(VM=="Q-YC
MM$UY$,U\N/8,P3?%9,_TFTKL53-SMM\P.Q*0<E[5<KS8T<?[.&J:.=!)STQY
MG32)"FX>K.X2MZ=?ZJ0#X%S.''X?)GTSR6_L1!OCC4<")ADEX$_A)#OV()#-
MY8. RT;$")+AN&2LH+<C"3E"LF9%K-P94EJ>96*9*>(0[2O^RI,.E]P:1QFO
MTKPJ6(1W\#(1R_S3R>BKOV*XHYIT'3E:.0X*<+/28I"UA[C3JVR1/V=86BA6
M7OR$D]N($G\W2A?G,R!_X3,<-GI<*+5Y+*B"DR'013_+G]/.3V6"B/9'[##]
M/#Q"4+6II^*QTX'W^ D:%^[M;"Z,WGFR 9-JE@D(M,0]RHE/VTLB%!=)?DV8
M.O E].&6A82P3H_80YP^W_%++1P1&JH"F5>!Y#UVG%U5#9.F[RV#)VUV\H6(
MX,)["IH_8]L.2>&W0:$45+*@;@FR".@>!1BJPP&$9BH4.\OZEP3L8&0&TT'&
ML(P2MW'):+G*,]6S:V&]OB;_LR4!Y*8<;XW.:3K.,ZVP.^':.Q:$RGJ;DS6X
MPF;1G\ZQ^'D5UJ^'A@2ARJ-+O<M:^!;,&+0QR@S'ZKJ&UMD.>0<2IB,$B5]D
M2?D0)YV 20M3V*:*.'[!SI!^RM8M&: 1,C$OPC,O6<%_<,/Z[%'0?PM#&_B"
M2T#]0"F99Z \)\DF2CSZ*8ZV&VZ_F$#B21*R3I.PHW#0P!#<\P4S"S!YQWVC
M(=52LIKQ?Y'"6\E@B'\)FDCULU*%(J%FA@=Q0-(XLH"$"DSF \4/Z: A$A]-
MK(8%I%V2U#ML,^M1)36"\<"!VEB!2F3]X1',V[*8E</L3QC"W!3P(H1Y?]A3
MQ3"W;VC?=,]\D+4]9'^!8.B*M7TU4;$FX8_)J/B=[]K#'5%MO\>6\0@6$M8A
M_'K\8 ^<$O,S5) 5U^Y' J=T: S9Z=<O</!M?;)G<@.I7XJU^5&L4^@=6]%X
M?M'$8(KF"K S+XYWC(GY&O9)=;H_1+?>(9F)>B ]>G3%IB2WFJF!C9Z>IXQC
MFJ$XD7M5TQY9]Z>J;X#FP/\50R)1',S9@N8]R;A(TK):Z=>!D;7EAI UAF1K
M,GI2;GJ?5%).525CZ'ZE,JAYBEN>Q7FH05INCX2%/1(XW()M&2-MREAT-"RR
MR](6#-- 4-(.GV_A45M$>Q(#Y@:_\*]&2D+,AF; VT!B89*+#PKQB_A^"A.)
MJY!IPPF/S7+RD<VY'X9KE\J[K*"..'ET,D,?^03[P6!\D7''92EO1,7@3^3+
M!JW9R.ALW03%"!T7C5P4!>F)\<RWZ2J*P7C*"*:"_/$H*[V &<V/W!!3\ARN
M9I>ECT8-*WG.;TZ7Y8^/"9TFX!M1Z:& M7'$QX%R9NCZV,Q:%'O 9$#%"Q.7
ML#B0XX$!V^O(E"90T<;QIHYK.[8:NTB<%ESMM&<^TVKVDI8911^X.A8O<A.8
MV&M]6Q5WT].=WFM:>KY>1O$2DW0+JLF^(5=_%*A#_ 19.65G%6>U*/."]J';
M*&5:,^B02]&BR1U]<$>J;S7\"8:!R?H4&^_3RO+(UOI%S$,V!WQ=SJX=QEK]
ML5PC-U[,G9Y,/D$<.EJSL%])&O.C<\)M\Q]67BC'\2=&(MU_"&LVCV( )S+M
M,Z=M<KR:$\M-)"*3!8=%LJYO,W7I?)$M'*-X?N*<C[WP99+YZ6CE,LJP*39P
M&X.&0V(X\H4;3@9K+'>$^2/#[OD#-6CA($0X8?1.;@S?_LD6J$/5%8Y"I8JN
M)"1)V."M^KB(-/NVMHL,Z<:=-B-:O\<[S+.:LVU^#U59NP3E]B,;Q>'1DT9N
M5#5RBT6;L.<;,ZFLJ#&916J0WV NECT.$V-?KN.,#;2$VTZN\/3W\)[H/GXB
M65']<3DW'@Y4#\#%*-[@\]@O"<6+_8QC]FL'T[+$]SY8G&_2]X)_61UL1*0T
MZW-,^K3FIGCJG%-"/R=YCT6#2?'.^'YR 2AY@&/,]8$U..[\)FUYN+TAK!%L
M*6+]MB;;=2*BUW)%0,4_C))E^!6+Q7F:W6WQP:R#V5[#$AP^!B^2S48\N]2&
M9_&597E7HOG5V6TM:%.Z#R_1PRK:)FRO?'AA/;];A#A3D,&OA3QC""'9T %[
MU;;<1_(( #FB?<9BC#][\:^8WR@71G>Z/NM5T68?PC8E>.*353'C9"<[Z ;O
M"=>ZKD\ERSVF!$!@.K(O=AY=#VD+6F;^!J>PIO+4H@$.3G<0/?(J%'L$O&OD
M00!UB/K7=F"G85O@81M.9T7;X(I)T8RC4L8RRWN_HNDP'?849P_T.7Y,BZ5X
M_NP1"MQ!V&:/'QC PX1M4U]"=C#EL4[ <NPV$IG13CY^9B56R2*^CL(G_;X]
M;@M'+:YKG"1P69:!&E]<U18LB^LJ3#$[O:9WV,=LG6(X=)#KI6SK.R*83_8(
ME 44D@<XL5LV*ZK]:]L^Z54&5S'L/L5L3)5'F/: MP\!9\'*TZF()[4?S%)5
MRP 5+YU&?J])B*]2O-;VYEX$;"KML!,\X'BM.TPTG+:ZJ]@$=+]BPVA/1#WJ
M6%_\LSN=!];.F9?B)[#(X[= S:MG=RVG8$&NL&X8>6XRB]HMW# N<0S[T3V.
MGXG/U-+%\I*$7N@3CRJ/>L!QHO]*I*73*KXCTK<L*@UC3=W<4-1I+?6A20_K
M4<V%:PUXLX[QBBE7Y!F+5S_0+]BY?[%\\%X;;SDZZMG>OMO<$ H'0\BPDS^@
MM%^^#:/HICCDA=MXTNA'T$UA5%Q4]AX#9><6Y^#QKCD$7;FB[7.'[V_76_[2
MU[0*-2M#O2O;ONW3WDC6XH)4OA?AAOK?</:C9UL4TNH?GT:@"#5K\;TJ6 ;S
MY?Y3Q%;#$/2:LG;0C*>KCF5(GZ,0[\29Z7(;!BU ]"6=>2[5SP']IWU>5?>G
M9WNFZ9]!&C3UYM*V-PA^(9C;ZQ3APC-30^W&T%7)55![@;%Y)\,F!CO%8JYB
MW&\HT<<QKEW+]*MF_8'U15K\@<X41R'[U1<AVCM1'DK#]K*ON25KUC^:2[M_
MLF_MM7WJNW//UH9(4\P9QI.V)5Q3S.H=M)+5L.G*N5;$M@90&!#($&GB8"L7
MX8 -Z\LMN*AEF<H[K!#Z$;%JT??*)B_8ABV62^+C6$:4@6=A;ED ILO5;NM1
MQ[:VT'W,[;KAVY.$@[M1NYU6>PT'X9SMA^7,"2!L>!1C1:_U* 7LKW[5(9X-
M[[*A$8P3F.P1I=Q/1EA;-*R%0TC:OJW([0T^>22$'EJ$'2;J'54<?NZ +FG1
M+GI6=7@(MX#K4<V%GEMH7=,8IXT=UEC#ILZAOH[T">(0*1I531D90LSV8!T2
M^;KI2FI8*.TC%89XIJD[/4K'*#4BO(BS/KKT]N; LKCM!\O7=8%]KFRNB[=Q
MY&,<)!#V.CL;POMQOE[=1Y0['C %UZ.WVT=*_"QQ'NB1L@I/H5=;)\<D;E^I
M[NF0T;;G[T_%]@JI])42P:_C"J(6[,\5*^B6\YRVH.TK!0A7T6:@5RI@VP#B
MT'@<^9O)G V8M;B9@]19ES'&N54]6Y0_>Z]DO5UK;2@F:OO-BYB$]D0LVGY+
M(H;%!-2#GR+*R$ PN"G'<6OK7X&8)QK+K:V[(.;';J"/^P %>_V31K$::<T%
M,0X(,U@.SU:))L^_A/"MN11&';*'L>""P \928ML\.#8)PG<RES! U&8$)_C
M&G?<=K;F@A@/&33G./%CLJF^Q(U)]UA%<]WJ?3:8JB.Q0&X8/RG&X4&A0#HK
MVSX3,D9NO#5N]@,JEW"$W:9#H/J][5F5>U]VSH2D:2HT>O:,1MRRD'BB4J;>
MD")RNW9;TI6S_2*4/>V(9*O"I$2JNEF8G/,M+GU^OV4B9Z5%RE?M"!Z!K M]
M6LUKV]BIV@2X1[@7MNGMYP2N.!E0-FPG.X.IC5JU0V-:-D[F)S(6_)E'J= 5
MFXS2VLM;G_7 RE48X%=V'HOXO6Z<B-T=+A^;]]%^-1V'U[3O]JGGPB#49>%L
M'(&-*3LM@VA_9J_F7.@ >0@QVY[OY9!,>53*APC B&50K(K!W[?"\$<W9@\@
M8UO[+0W(@LOSAGVEK;Q34+)$!B*J5K)8YE]GNUAR!?LA]F*]VG\P-:?$(!@>
MB+X'$:L'Z\JLVZ9LWTN)7]@1@>-"Z66<QQ[*WL_KA^V!!(],&-G@'D,.I?PA
MUMRR?.HE"5D27X83/B"OT)<-0X33E.+J8F^J#8=&35M( *VW_<%$;)L -$:Q
MTMH#-)9V%D8ER!I8, \+T\8IV#Y1;]=K-LP@(5]FAOV7B()%6$?TLA[UG'$,
MRSAKO+!K*&H9@$RD=K_".+V.Q.+8?()M+NT@C*:3:E-9V_:@[9G$M<::[55L
MQ]R*8DR>0F$\YJOY$#+'C#NY2.FP]:]M_<*D9.#?Y&:D*6:9\4\X9"Q1R$,3
MK$E(P,027J9:[FL[JM@/I,'.-CX8(Y]#KNIH ZMM"YS6"JX,JSSH;)MK4%-A
MZ]LCC'6>KY#?6+?Z3FN+6O62X1;P5^%^B7>JIX::WCT.6=N!-!KGC9(#AVA.
M'7O4=<W:6\G3K1O!;>5=@U+D4N^%I)+9W0D@3:E0.P"U9E!UYD9;FP:[QQ5V
M<_IL9Z#UFDM==5R$U.P,TE+<12#MBT-'%;< [;-([)-JV:)M19%]#L(RPY*V
MBFB0O[5JS2PZZMB^'^H%PCFV[W#*3J(XR$[A2KR2<[PD/M'JN=VU;%].!@'/
M.^+16X\$5Z&,H-/@ =Z_EG.#K.TTTES:-@S^@B,TF9CXK0M:4UFK'K9Y.K7%
M<A_%8._*;NU#6KULC\VHM;[-_OP2LBGR$I,TQ6'99;G!ZJ2K@B4P29S^(IW!
MZHS7OK3)I##X;&!2_=(BDW=PPZ%G4?G*-H/5!X+2%T?RO*N/%7\X%=>6S9;G
MP::R]@WT3GO<Y[4:Y?4G8!]LEP%A'SO+8X([3U<XQ"'/?BLR] W&/X"D P(9
M#-]UL T+SNGN#&R*I(;=^.[?7<OV2Q//%]R4VU[[W-1:P_;Y5?!UZ^U8#?K@
MO;9":2YM<V9)KEK?2NH;?J]:ML^O6D<7[>E56]+VX,H-P1,P$H<:A.)2"-&'
M2!?4*'^A[1<:R40[ED078/++19A") C\Q"T&PA0<-%78364LLGP>^3SWVR5)
M?(\*7?F2?994^6XLZ SS?V/+00_6\V(.,"[$>,%6L(IC0V,ABTS/&3,!ER/U
MGJK,EKYT0++@B]4D4/C.(HMGD&1(MRK6OK2]-^/^-N0U5Z(P.!,7_A $H%0V
M=]/0[NR&VW0SHN">V^;^5&RK0YF]TV()C%_2Z*458%MYFY.B'G;U)@I+Z=%K
M8[J[BDNZ7L/[ECY8SAT6!WDLLN9BL5&!&O<4DGQ6=NI]!MJT/MQ;[B"+ ++"
MBPW<V[DW0^,#W=Z4W(3/>V8,].V$W+H].3A#Z"%T;/=['Y,GUUXP\ZWFNM5'
MIU;*NE7& ;>1>U>V;0:I7"$V>^O42[DRI%3.FMQT&@M;'V!E YZVT:0K:5VK
MT2H5+0F+VRK8G@>%>5%;-MY*(=N.7GS? MTM"MGP;IZ_VH*N3.$*<XU)6ELK
MN *F.<I:J80K[,K%< ]KMAX5'3)XR*\[V'Z\];416;JL'7J0L)ST#X*D9N9Y
M,G0JCX3&X[C!/4]=C4^$CEC#/HB:[4$],)3O3PP9#AC6/$1R!!\I>O3\Z2G&
M3VP&E,/1]G]SFH 9VYU06Q7N,(0,49(>-QY#VZO9!K9]3/#_;&'[>6;_-"L)
MVH)N,=\>7*ZQL'L@&E4%?5'K^G[NDZAZH>>AI93/](> WM5MGPS"E 00.8 \
M*_%$+EXA>Q,.(&L1+(K;5 ;0J08?$(BT)X@Q"!^W<%KO4,:B;=<._)GO?5I%
MH]$4O+..W22)^;FQ/8EV4T$GAVQ[J.^N.DY"ZCU33G=Z HT)I<PU9WM7SJ.'
M#\38(S[Y&"W8OK)9;VBTP]G;FOZ8<!/)]4PL8 ^1\'_+OX?$?3=1^C><RE>Y
MWYA:(,V%8N6A3AO^?%H.WJJXU35Z4BFK#=M>0RF%H%<XT*-K"9?3KZ;;48V:
M3X"]*EH_B[28]K8]1'16<RM04'<DNM8*;H)ITC):BMO6$@Z]#LMRW; YQ T+
M$^XQ\+#RPM)%F9T<8&,S]V8[R6:BMK&9>[.=E&LCCO5/?[[>;->4UQ&;:]B;
M%7%Y%;"Y KU9$><3^6;;^'@R5>.N"[DQTUJ1FCP,NA/NF6C'==%UO*QF3]SY
M?./';O,ONGW:/7+1*J_3YN79V)@+0APGZVU%X;G#,/T8WK,HY(8V6X^.GS3Z
M<#:.7/ -)A>.],=XW!UY-RGSOB?BCR;ZXP VK$;8F!SN#[7730L\N##6A^L,
MFMF=:1,\')]!=:6KZ2,7<+>9W=1R'\:1Z]W1>-QH4I)'%_^H'!R[N"^C>(D)
M9'^V)_ ]>3AVD;?>-IN7=O_F71=T_^/AU$OX&UFK^RL(!N[SFAHY<J%U[^[F
M9-FW;=LB;O/'5ZU?LLFDOZS?FXIMV -[5[.-FAA$FF:.7'#E';$Y4,+XS1RY
MX"99M)Q;G0[%([A?+,4*U)X89?1&7!#:(1<_;*<BL8A5W[ZBC4'\6(7$_X&=
MG,V1.U WDR*[P:@":VOH6(5WNXW]E2<U\FI"<\ VJ@0[6SM"3^+:->^!=!P(
M $%$O"P(<A>%,,IQZ#=D!&\I[DY:)QWCRM?N,-H25MG%J-#<X9+-:SB6@I5W
M+7YU;I%V3A*?1LE6GYKE0%+V!= _P+?#L;U5T9?3A;;CZ:SG%K3^8-Q@OSY4
MV@*2-)=V!X8V4UY/4*UU;0^T6CC.\C=.L-<V_-4"EIF]C?'&(X'TI&&]+C(C
M=$'H4<VE7F@-5*\K:/M8480[NB2AQ]0[C]Y&(K%*SS!)C?7LIMT>GGS\R#*-
M7X%#*NN%4J*XVXC]L7O K^DIK:2C[%W)^KDE3!A#,J-?,YX^Y6U'[O;@7GFQ
ME$&V&SQKZZ6LIZ.X"E,,4YH\XW,O]33K=5=9ZQ D'W=X$\5PE(45K)[FH:VL
M=0CW*TRY^[07[O2,JR6LLWM)*([/V#[Q%,4-_):*V$RG(#J\2.[1D$ZCJ9QU
M69]A, ND5V& 7_\3-TB[4LB)7%J-&K;RM=4DO$+_W#.]5*]:=O4C'Y*$B!.^
MCLD'[_6,:3E$DXU@C[J6A]BYU-4RQ0;"36@'F[:@.^?KGK=M3E^JM3/7\[*@
MI:9E>#EG8LEB$T)A^S/V@-5@$=Y!4!\88:S 313&V9^G7D*2Z[;(9Z,V<&1'
MLX9@8@=3<F6LM/<@[[(O8?28X/@94%Z%FVV:9;@C_&APNLNA\=COS8Z2QAMU
M1:A5[IIBB;16< 4,EWYR#7OK#\U!:UJ*.PCDXWY /CH+Y&0_("=N 1FPCS1&
MLAN-N,T-JE@I>:^)00A0^+3B06C9#E./X;IW9?L7:_I-4QA7"=O2+QN(T@8%
M$Z*/VGL &>M/$9&/<9! /$5@CZD(6'L1JG^0Z%G9]LV^(GUNC9,%B=1>YS<5
MM@UB^YB0@'CQ[MZCF;U-JYK<7L.5M5?=%6!UV'-O5^NX DFN[MQ@*/_P+P3'
M<#^PZZ&7]B%@/::@-D!Y4IQ&6U\F]JCN*-"V8WI7'=N!4JNQ<MMZJK&P8R#:
M^J.IK.T[N7RP<_-0)2DG'S[\YJUF^YVT]M9 DL<B$-78MG4F#J-H72MMM#OM
MN<SN1^$8X+9U]EX$CNS>KZ/#1R3K5L+7?CW?6<FA-&5]>K*[BO73R&9#N8+J
MT5./PLGO?H5Q6G#:OD_M4]\R5)4]N6TH7+:-RGXU;;\]QT]>2'Z3,>@5>R&(
M!<C8A"Z"/Q7KMMSB35U6P^">/(5D27PO3*6Q<69 13I&P]0\V#:3K''6:BO9
M6-KV?NTEJTL:O=RPHNS7*QYS4]QDRFYBOX/Q$[_R[+F%#Z1IVZH-IX#@-HZ>
M28"#T]V7!,+I:EC7@>]?V\%;PY*'6]_;PE(E)T'UT*GZ@^U![&@&<-LLWI^*
MF["EV>F!\U93VWZ*B1B\,L^Q^'D5UEVV= #[U',1FNKPU!N76LDY4&4?$!'X
MNA\R74WGX.531J:+;UMD^M>V_2X0Q9BII<)@UE<OA#]Y)+R.DN04+R-(6?:J
M?17H7]WV40+&%-/<HJP?1(Z:S&&II2_[U;0,KQ+?JQ1_0PE= B_W/EB!0O(Z
M?<R/PRC9]:CI6"FU_LSJ.TCMCF,X2<<N=8#WNXJE?%=9IR" ]A(&?R.8!MT8
ME,(.@<C#G>%XW85!+>L@A)\B-M+U[GB=-1R"P[3B1WG9O%A^)I2=YZ,0S_T5
MP<_\ J<+72<!A\#>IS'YM1YLLJ.H0P!R:P/(J.JOY'/!)>9^>%V06BL[!/(B
M2<D:=A&%X3W/^2.2M7_ML23I=4,DO.);IW7+_75*NUG/ QR_0$+C\"E3!FJ#
M2U?(]J,/CID&=EH>OLWF6BW%;5_ !W_?)N*A^"&:!P'WU??H+3L?7X7R\*@$
M%<TN\!I]IH;0LYJK?KO>4IZN-M/GF'[M8_9W;3@V%[7O\%E<(0OC3>4(I>+H
M5\/^3:18IV#-G3][A,+F\1 I+,OP,/QTV' =N0\)B_UW'OD\@=M_;=EQ#L=T
M)]S,JYW64,PBXS(A/=.\_17$ 82$:56N=64LLLRT,1C>][OU8T2KO):^=$"N
M)Q\?'TA*&V6:?>_ V.7W<438E+4-WFHYBZQ#KFAZNV*GJ'HL7]WW-J,10 2L
M&'MG45"/0*!\9WT38KL^VT>26[:E>_2_R4;'<'-)5]CG5A6+F+]DA7X[@$I9
M5R# J%C$#]%+V,I]4<P5QN6/:Q+BCZVLJP4=9/ZD+_.VDM,5/#UXKU=,E4VY
MQ1 LS?KUL+6P=1"@Z\5P#P$\\4EY!F?%>->\!+56L0X((N&T=43QO756+UZ+
M;;T>M;RMG'W6USA^8CK?ISAZ25>MH92T1:T#N%][E)YN$[:2) W!JTI%;+\"
M%S[V=9<N[LK6PSN_I:;MM_S;1?--4/ZE[0NLP@\23F.+I?*8WI)7N[.6;5@Z
M1\^FT=18V!D0BUC<IW_&Z2H*A DHQ@JWI[MZX:Q8HS_^F/3M1N'JZ71]@^N7
MROM4MCT>_!4.MM G<[:6!V "09ZQO  @.+EX]>DVP % @2UIFYF([^7=.'XK
MSHBMRF'%FH0/Y)ZRV8N4,P)0_?W@JOTRBFNNCVHVQ3EE[,ONU6?EX1?VI[M;
MZH7[B&]"1IP1OI[O2C*0+VSI242Z&6$BN]M'K*,TX:# U"0R:E854/R$5PQ;
MN=?BL\/D=7@+#HI+[?Q2$IK1AE0W59L*0<']PPK?190NHQ@Z]@!OT&91F6W)
M#?'EHU_@,RB^D5MRRV.W>[ZU5G!FA>ECC;K/VK(_/=O1&.0(Y,J&M&* !(/2
MDZ"<@*)G0(*A-%VYQ.D1.;)5#@<1<F4\L$WR"2<]\@^TUW"E+Y5H2X+#'LAZ
M5[:]G.&GM1J^OS? 7A6MQM @R:\0YN,+*Q:G'@EA"G7E^.A3R;97-12!X/3\
M,,/X%?'#X3==/[44MPSD"V1_S&QBM5>1Y1(V!],U89I( ,;F'0.HJ:!U(UY5
M6RRB2_+]0R?ZU@H.F6IS@\E>]O1%2>LO4Z7G5<B)L5B6/NKQ**NI9=L .S.C
MUF5Z:"Q4,/WOWQ<\7[/?_OQ/V2?L'XB^]>?_'U!+ P04    " ![@&A3R*<4
MC>PT   B+@0 %0   &5L>6TM,C R,3 Y,S!?<')E+GAM;.U]W7>D.)+O^_X5
MOK4ONV=O=96K9GJZ^DS/GO17K<]U.;W^Z-VY+W4PR$ZV2,@18#O[KU])0":0
M2$@@(2%XF"FW+8G03Q&A4$0H]-=_?UL'1R\ QGX4_O;N^*>/[XY Z$:>'S[_
M]N[A[OWB[O3R\MV__^V?_OI_WK\_.KNXO#ZZ!J]'"S?Q7\"9'[M!%*<0'/W+
MW;=_/?KOD]NKHRL__/'HQ.#H+'+3-0B3H_='JR39_/KAP^OKZT_>DQ_&49 F
MZ(/Q3VZT_G#T_GT^_"D$#O[]T9F3@*-?/WW\=/S^^/C]QU_NC__\ZY\^__KG
MGW_Z^4^__/QO'S_^^O%CJ5NTV4+_>94<_8O[KT>X%_IV&((@V!Y=^*$3NKX3
M'-T5'_V_1Y>A^]/1(@B.;G&O^.@6Q "^ .^G;,P S>#7H)C&6^S_&KLKL':N
M(I>0]]N[TGS>'F'P4P2?/WSZ^/'SAUTO:@O\7^^+9N_QK]X??WK_^?BGM]A[
M=X16(XS)MSD^4C1_.VC_^IFT/O[RY<L'\M==T]AO:HB&/?[PW]^N[L@\WZ,5
M2A!JX-W?_NGH*(,#1@&X!4]'^-^'V\O=("#PP3IY(PN)D?_XY?/'#XGS%H71
M>OL!M_YPB_[O>\$,Q;^+T#L/$S_97H9/$5P37!&1Y%LK")Y^>P>"[?I],21&
MYY^%!TJV&_#;N]A?;P+P[H.\R=PEB#_QQT^CT -A##ST V)JWT._]TZ< (-W
MMP(@B;GFU&$\ Z9VXT#4;@42WW4"V?-L'%S!I-DD[?X:+Y^6&P )=\6(Y4ZC
M]0:"%>J U.!5%+>NL^SOZ%G_,IVWP -(63P& +5 .TCBHQ]OT/0!A+AEY/Y
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M/T$#8 -!C(Q6TN4*_2)OCF>H-.T?_1I_H?[Y*KG@+0$A6FUR-:&@.(C<2J,
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MI]5M+-.FGC&=I+FW#:;Q#/L_:9[6?1]1#J>$^$>'A"/6.*O&R;@8<77L)T@
MX8OO@FRBR)2*GD.?)A>#?=;("@7[)YL:0>'JJFUB-S!Z\A/&]<Q2@S&Z KX?
M?QFA-^#[IX_&G):'"[1\_W1LS*QE^3&_?_JD/7S?&F:M!/ ; IJ67WRAAT/E
MO'\E%;=-9GDD#DP,0X\5I*PDNS6' BUG,F8 E%+#K_"[6@X-/8>B>J^6.Z9I
M.5Y"H<_J<U?5P.)4<*K$41L!:=9=4\%'9-^CUQ65>OO.N&V.6W^WQ(\MO\DI
M('.'UJCEV'"S$"UN;_D%1 '>*6FLJ8#"5-*,-_"D F.<6N:$9YCG$8Q#AW_3
MXD\"F<J[$D)&$5_D=RJO2C1"UR.!92HO2M!Q4Y(R8_FE0@Y8.V?A3.7]">G0
M%4D_EE\R%+#:N+<-6V\7]L+J( -)S?U!2]#B36DJ0+3U)"Z!Y010G.;1M'/*
M50';M$\8'5.W"O"F><;HF_Q5H#?-D\9PV6,%SM,\>H@EE1583?.LT92G5B R
M'QX.<]UVX$@]+62.S?/0D*)4'9V^.*MNYQ57D)0S,GPZY>?M\%,0[1TW?HVI
M?SNX%$1AJG"9]_"F<#6;N%[-)F.[%3HQN!BD? E&4=IFV+HPE LOR I#!]'%
M,4?EA_;V^LLAS)4>M%9ZL*!:TR@+'W$=Q_8'7OS_3N@BI1M3WY;L-:2^U2/J
MZ42@C@VKQ]CK"1F7J,NQY=C[PHC1.;F&0=0C-=!F6$RZG6,8-/W=E=3]T?(<
M;[Z[%<R=5456KF'\U27AU$(\^)B%?D%)JI,C&-ZW<1L)E>L]=>+511"][K72
M*%P3%7V)8S.AZP>@4KW_/L)SNX$1?NC .]D^(!0NP]W[)0LW\5](D+OE^*WD
M4WJO<Y_48UZTHT=S8VW$(\0ASLLZ ]F_)8SS/;)E+04&,&B2:$O;($.@>'&'
MA-RX)]C86>?;RTVB<N&'R)P1D<H. TES2:*/N@!X\07:> I+#"?0[+:4.W1P
MN@PO<;@8V7#I8^"[RR>T;2"ZL-Y@.#?DCV_:4F>O=4I8:M9 ^DJ1.-O"B'?1
ML1F";P[\ 4@$JK7$%%]?T]93?$/M,-!<6H;IC,MM./P<!?IQ+QBAUZ /S_S8
M#:(XA0=OE]5]=WV'E:9PRWF*7.]@E71EDX+M-9Y^QW_):N</'1UV,4V3-"CT
MWCN"/!X\M*R07&3OWB:+. ;-6SE'K[DT8!_MW& H<4@T79EW'$^>JI/TB'R#
MTI,SLLX:WQDG+M81HO2/_ X9WG=PL@^^MH-(7_OI.JZ\"-]\J.\VF&&<3M_F
M^/L9=,Y%BT+ 1X8P(Y6@O9^V*;6_AGX"GE ;>J%%D1'TO8.#SIHN,BG.WURB
M4VZ1D;$,\8Z,_X?WC1<GP/*RSU+'?R#WZLJ_*+5$BQJD..$,2> FBIW@*XS2
M#7G[,,9/K/EA"KS\A!"%-*DV@##3C*H&2[VW1\6X238<'7N?/0U3C!"Q6;$)
MTZ?'U56A25S3Q/@9^H/OWP)2HN'&@<UVBH11M9[$.ZN:[*+)X?1S!516:IFB
M8YS;!R1BG&"KP&Z&8M?R^\_: \$J0X0'5S0:(FJ6)V6(Q^+*H/$&N:2":.+;
M]-T#8KMT1;GA*,O9MGM4JG*3CR_,,U7N%=2@#?<B;64_6:&:G?#W"XU8CC9/
MQ*3,B%W8V7((Y4BX&EO,\E*K<K8JD6";$D C9 J: 6@WDY4[^B<5/1-W>^F;
M5Y_*.C)Y%.V5CY$I8B]ITV*J"7O3O_N=IR0$EBW?E%1[5:0&P>>UD.+AZAIY
MEWJCPL0-4:6R:3JG65^$K]^6Q\3=<@AENV,/<C$LQT_..5=D%2P'=*C-22CG
M1FK=?Q-W)%%-:D#&C.V/,<@Q$D32>Y0 :HX;1XZJ%DDELAQ0!;;#0;J2Y4(N
MU;4HGD4UE4=9.'>UH=.PE,!OCGX8%'XU+^48]ZK5H)A^_UG-0SFFECP5P+1?
M/&.()W0&+1RRG^09B%WH;S)7WQ(^.V'N^,/U3M/UVH';Y=,=.GF1]YS")-^T
M<)WZ*/#=4H[R2"J*'-#?5A>$WD%;'FAYG?857[)%NRGAOWS*&1Q7E2J*P908
M'"TQ:V7OT6J=!/1;1X.3H5OSM#-/I6;^X*LT1)+*4'IJ#T##-;]QZ)H2X:T%
M:PY;:KR84A#3I@":6NJ640;HU>-LPR1MDI_:/G\*('ZH^<0)<-SI;@5 H4I&
M)E3E&>2GX_TLV^2,L[.^V@_I9I,]>>D$95I+1+;)I- 0NH55;#$KUS&$D+)8
ML 7*((Q#P&O98MQU;-K[J2K!L?\433AY>^F61V[L:;E]C5!,6_IH13MF:90D
MC1W6@%-B)8T\/JF6!:G%DH\3M_S\G!'BNKOX3 ["\7G$&!/AKR$G-(;6YRQ:
MR6PSL 4'T2W\G9:W7D-;!#2+99XH/FI5Y7&(^WXV)/FT]!XJ.7Z1Z\'[%U.+
M&[ M\M]S4&T*@9ONDS+=;1JB[ZBZ588<%BGKD-XX6ZQ4K@&Y$WT#($&@^IIE
M*3T\?Z9G7-KFW($AVB[VLV/K$6IS?470:A2UR3Z]O6ZI;EN*2KXH?=862V(Y
MV:J48#PRD:/-HD7T6KMI$T$:9?PFN\@(NL64=_G*XBJ$D,4"W#^994YJT5?T
MT4F(?=A:_K.AH4:/0BFO@V"Y;?<?,+I(=(K& +YD)]:[3> GV9?8)(KTE%A>
MLJ%@%0>=7/VD47GE_R/U/:0L.2BCMM7&I@\QDI?S./'7:)^@R56MD4Z9<I&R
MS63[UH]_G*)MR$_P3W21HO:0)U%H-.P!>T#?(KD42;%?M,@33S^-#Q4_X[/V
M+=C@.]^% /%I,KZ^^LIT%V4%O@$'6P>85I'I\??76A 4.V5;,L;K5Q\(^319
MZC.D/D=>;JV>HM/J<YM8<G;2-IFF*H/,-6-TT%C#^[5D94)DM*=( :[WS,*W
M1L+#Z#Z_B>4(-QF]EI>:$P.(;6#;7OF%"RHA>]_V<@3\B/&=.RR_T"J %_T$
M9/FU5#&%53]JJ;CF.%IPF$<[%5<71X>4P%%SB%N)QN,E>([-,?MEQDSL@)SC
M]F7&K?>IN[!99_N>Y^!>H#5M$Y_',U @-6W3OKO[H<!/J:D_VL#H/6:Z.2RJ
MT8M=J@J4[]?>,KS%:@ ?7$^<V&]-3.PVUK@$OR->-F5%-%Z='Z, C_0"_1EX
M3/;[\^+%\0,,_D4$[Y I2!:B/30A,(1N >6\<B\&BTT"R7\7?XQ2:O6-_-WY
M!*>HYS7^_#\ +N""W[%#]A-YPBY['(0_(['WL/H2!MP5\-( +)]XZA=R*;M>
M0^I6?MU+&/1G+<LCA3VJ0_1BTB&BB@;?5Q_A%F32+74U4^)2I.P^NL59Z!HZ
M)PP66XD=[N#/HJNDP,1^-\&.A;QFW_VJ\PHQTT75?4P!'IBN* B>(OCJ0$\Q
M'K(_-BI]J)H1+3<E^V MG<DMMB^;*R2,<5^:ZR0T'OKWM_3+])-E7VZRBXI9
M*6T^BU7"P$:!DB_9 FN*,NT[?8U.\VGVT*FH;T3*1XP"JRH!1?8$F=%#Z".^
MQQ.4RDZB7S$ KC+Y6#]@=_D!)T"(WZK(E$5 Z"*F03,(1,N<;&\")Q0$=4A:
M=%L,\HN@R%"BEIMIPX#>1TE;?N-@>*X75OR6WV!0N0*#[B5#W)P81\FF,1Y_
M1E^X:<_U==IPZH]+'JH,4B11@C:0V&@&3'\1)KZ'B?-?2EFCYV_XH3/@X=>H
ML4"GQ5LDH@6O%'Q(MPH6J935F<TLM^2Z82B/5RWVL?5/YEUXGI]!<!D^17!-
M>I^!Q/&#D6U3=^ECC#@&31GGD*%IXVT7T0DN$["F%3IIZ:1/9V,Z+M'9 WAG
M*;F-FCUGB%D[O@:OY$_42?%UUC8Y*Y*Q]YRSA%DDX1M(5O@949P!"4")GTZV
MAXV+9F0O:&5."9\P *@2O8LW7T@D27M]4]@3<NVL<1QH7UGO+%H[?DB;2WM'
M?6][W2R_@?4C@!3:]W_7?^'A9+O[\3]\ )'ML=I>@1<0,/B(L[/^R96N7,:'
ME#+Y2VP,_5.]#)'%%A/PCS\A&^4SDP-;N^E3"&0KS;;8&^B[H# [:7J VE[;
M%&Y@Y +@Q=B2QH3A],K&.AB4*?'WEY9LPOW):U"W),3[ZZQYUYQ+4&:BAPUY
M2!0UC/V(IAVZC*37XLV]9)G]<@LP4:4Z-BQSMZ6GQHK%^'X'\(KS*3)ETW6:
M)3 #="BCSHJCHS3!VE^4(RJ6_#_6L^2'S\1F0=RS6&,CO$FPA/IKK9!7NH2_
M2$X="+<(6T(Z38;8G;1?1BE4%O&^M]PPJ;:5QCT/Z-@/7[%_)GS&K@D:ES2V
MZPE@#-R?GJ.7#Q[P,^S0#X1$0A[ZC^_GZ-R(ST)N!'':%[&\D1 MGRJ_JM$K
MT%&W=XW/[5'QL7'Z%BQW2PH6E9%ZW+<<6A6^D>;%.' I3 99BC.E A.'V\)V
MO+@]-Y47P?>N$<OQ$?.PM%6,8K@OIH*CB#.G$4ZJB\1R!#O8,70GC.6I6:KW
M5UZM,,,LWXPIL;SEZ6WB$B_@LYRQ"TLWF,0\IY87.A;GNTXN6<M+(7?T.[1Y
M>%742 Y&"AB/[]CR2LF">D[,D6UYU>0.>J[%0VYYR61QP"A>>,M+) L*97-\
M0$GMX[%I>I$ Q2#ECT>;Q[I/'&YTQ8PRHW4WDZSN%]['F(5,48/K*(35NJ:,
M_$)YX^O/++(Z0XRC?NU#&#WB9W_P<A 7(OIS%+JH%^'ND^VN!,5IX,0Q7U:9
MLN]*?-M4N 1'8\I9S\'TLT@=:#ZV;^ACV .&C'DP.FA,]V&__-#\6V869*\A
M]3/F1+-;Q1-;C5FQ'M; @9&KP.*XTG\[)Z-^-QGN0G7M_>8[.;U>2XU"L,T>
M1KE(0X^M5RF-]<M?22E\$E8CGW1/X^'N:X1LIQ KZVJ9=^9<6KN9)^RB0JXS
MI3SS(X"3")VG^1:$W4?;5$K[A;C^Y>QLE H0OR*C_78,&^9.:Z/=IR?=%],C
MW\+6%*#!_!VEIY([NP^FLA8LQT+7QY8Z+I[ED+<[0*K!X3Z>!A50FA%\49.)
M.36IE^D#*(/+<7*>"L1SQK6.IP#[FV^6XRK#@UUYIY;BDYG #J3XJ-!DEUF>
MD:UD<_]48TE;P9,MV>V>/A6 VB/CW0PEFU&5S:$M?D_+[P@HW8=8AU45N)K!
MH,K%GM>]/176E;G/UV]26@^>4OM3C@18?M5(L[ZPJ_)ZXUOVI1]/HQ#!E<3+
MI]V#XD\1C-'.M-_Z1YD'S'A4O5ZSL:&EQA)%Y3-!XR/OE&GP]#2AG'J-L#W)
M!S);+UDF-(:^U <J<8MU!!/\0C6^\4)+A.#LK:\"ZDY:[M&W3M$YX1FIR.SB
M ;LT:GM'>2]LKA!6]P"N,Q\:QK,E@X.[F[X'C?.+>'A#O /PQ7?19K=\NO!#
M)W1]7(H<Z:Z4J#$,<-S\)V;NJ-1/S,E4:D2.D=S=T%!?6LXA9[#2ZRFMI6F$
MJRA\%E<('+T,W&>^PBB.'Y!%[ 1XO\!/[0CO-DUCS*EX Z[:5Z1#>R];-HB!
MDQ6>F/93*>,\4;W<S&&_VQO&ZV3G5USXO-:SY1%E?C-[_^(VC]%K.6PJC.1.
MX3M; :;;HI5:D!S<:Z\2;#%]RT#)Y5=[(15PBU4<[[25L!>I#AL'S]G(\C2/
MCOS5I WMS310:-PU'EDMYSG5M@I?(H>MZ':4:$$>MS=K8SAASST=EB<8*,1S
M A%K>UY<W4_J/Z+ PQ4J64%=6FMM+KT3)\!U<.]6 +_AGCUNS_#K4YL;$$P9
M55[ KJ#;(4<<:(UZW)RGJ\;U0(H&D74+7."_,$7AH.$<BS4]%FM1Y$970%.A
MXF8R(*.#QO<WP<;QO?.W#0AC@$5CF:P /$TA-K^R?$$F;PD,8&@*V&F$[^^E
M45H[+M]$,;&0KD <WZ^<\/C3-]1R17_>3NI'1@I60?\28A\8E6LD?T3W4:3%
M!"T?.NCFWA0\J,Q(+Q5%>Y$1,4*K4!W:>);'R<QP[MF*[AQADPYIV\&^;5>8
M)D)T 14Q5>W%3,#4:(O5VAA0Z[B?RCXA6!X*$F!"OA6Q..JCA2,/CV%#!(,T
M/=MQ"B!^H:J\F^1E>>(=^CR;QRBC'^59WX+L5:X=,FT.><[.$M])<'&R'V;D
M6X0JOCV-5N(,7XN.-B3IPWD[1=SG)W4OBW!W:33GG-/\P8*?FJCEZVB(YR\7
M!"XG7]%6&^E$=#.9I1!<;F$(PH7*R:@2P;NYI^Z-34SQE&J="J@ RP_='2'D
MU$B6VZ#BX+5H/LO39;KC55&WEI?*D,55%&VOY#7>*'&"<5CAZ!<P!3LK?#:X
MI1G<LNX79@MTXVS1$@=H*P8ME@JC@S0+//^&N 7.UU&S&9O16*J@PP:\I9-L
MT \_<1FZ08K]%SG_WC@PV9*8 .)<)+*LE>@RVGAW!)8PS99MDV7+*>FS9<NT
MU.@:939Q&5S72=4I,8?-,.@X7B79I^!3FXS2QKM#E)%JCZ2F=?YT-B,WD=Y>
M7YYHB1)F5F)#0WU9P&"-<S#@%A=S3;8GVS)QK*Q^CHZF3(K[F;#V?J9,Z:HE
M7Y[:7)JU6OO"91RG2 _Y;IU?6AK+*Y<&(([:<:A01NTTT3%D4[] UD0(PH6+
M8,K"BC+FTV=44QC^;N5@@R)-5O@F./#X^/Z@EUG3(7(@-)6\AVR^.Y;!9@*#
MF+4,RS2)$R?$9J?(6I2[25Z0$PGK(3"&*<MQZD"XQ=60U]B)N4@2Z#^FI)C#
M?73C,%PTXN.8,N4K'_WC$:L\6QH0'FRA0EUUGPA;#?E*!G"#R6RYGX;?X*[D
M=-%1G19>=%N^DC#- ?*T<#LX,.Q\,0Q#WG*(Z ?V?3TZX5.%Y9AU4U]T9K3<
ML<S/8KV.?I:CR*/+N,^-,U9<1TS;(Q?\DBER.+8<M-[,53EJ6Y[8Q,UA(J=]
MRS'KP6 \S@,5R6!HO1XC"_"C>")RR/YLX2T6#K&SIV;7L-')V=UL2U3;_EBJ
M'3'ON_0Q!O](<=;6"VA]98?66A_Y#LYI(4!>.VOT8RGIAZFN.#I*4U\/2(/#
M5[0'(EU^DSX&OKM\0MH&&1UT;=7:QQ0Q.+ 5=*<4D#7-3J-G*0;L!L$6>=E!
MXAJ\DC\UYKYV&TBKZ/J>C^@M,7.+\#:W-TG[L*66VMZ4*3!+L#6WE45Z#),2
MV>B_ZB2C7WV_=<+G)@U?_=OP)#7B5O_KH&1]\T-_G:ZIA%7_KO'N:N0"X,47
MZ$"'-1+.JUT^<1BY%![M/MZPJ^.\L5>G\O>IY5F,.]G-NJ0=21/JNF[B_:5Q
MW&FZ3@,G\5_ F?_B>R#TXJP27F.^)Z.UQ,H6K2#@HX"[ L4U@VT3J5V&,442
M&EUVR+@EK-XCB6@WA+R2'@"ZV#GVC ]H8N(LWM^$0RS)H&A9"FIS52>J19I$
MV(7I9JP>HT7/:#B-UFOT,Z&DF>;>P^F<$WFLH["')$VL.J;&XN0[BCARBFFM
M=19L*7O;2>B&E([*?KO;/2[#!?IO!]*.Q.+C&#+E0CXRDN/^<Q<:T! 0\!Z\
M)K&D,R>A:4MF%U-V9'RQ$6"J[J,]A;\[00H6WO^D63$ZOHV9:R3=X4:E212V
MIM#-&=)SQJ\YJ9G4N)&]!7WY8TT[+=8>^;$7KJZ9Y+SQ&\O%LC6Z4Y%&#M:<
M %[,4!)#>]DKC(TA'XS$0>#%4O:@!)@*"&I!'OL8@#//HV5KM_^% Y$,R!XA
M-Q6W"(S()&V3LVJXSO++%"I3N&W%3-4%5UOQ4GD+<2+W4%IXK&8[30L;Y@;(
M?4?'5K#8PM<A7J_B?HZ1AI6 >XER^IVO,K4F2RC!R @S4_%]<KGEOD?(5)VR
M8V;PNJ7)*+DD9[*8TOE.+-$GQ^WGF>$8N4,Y2'^9,$C]DYER$'^90>R;/94C
M^67"2+8F7Q4N"ZG^U=%M"#V2O H ;77Z=(=/+&&LP-'6\WMW'.LY9P524SZ.
M]DIJ*P!4>GHPMU)$_31E3^4(??>$U4S@QH%+2.(-'F%BL0L3U-YSD8FQ%">9
MRTB,H]Q'KR(R=7W<MYX,93SILQ*M@J/XVM\*Q\TNPPO'AT3=<:5'\-R[DS3R
MB,TJ^CZD(CO'J-/CG (_%PE7B-=\96#H^SNTW=9R_.9JV*K8;4Z=8Z8,2#++
MAL!S/"Z;_=N*&%-"S_+I?M5EJ-G1H^"J_WF<^&ML+HNQ?=/I0]+(^AZR)L)Y
MB=CE#6V^$8D[P3B;3$OI1ZZNQDZ,Z1WB[&R*<V7V& U3('8N7C>J"H0M#K)\
MJSUU@B"3]W8?&:W+% K=-8@9#AS?'A;::&VNCJ8L</UW'^PM8R91Y?;*K(VW
M#7"127 /X)K'A"@W5TW3[Q%.&*:Y5ML[J:+O!D:/N06\?/KF!R!.HA LT)$'
MO("&VB?=QE!7<!CZ/[@?,2ZW5D51R1P]=]Q5KL<N@).D7!6ZV/U'<]R5=0ZP
MW!LE<B@H^Z-X;6[+X>OFS.,#?5K0S?YWXXL9F 3"5$M:=/-Y'+C*J0<B2V&;
M*Q1(O@D]$6RX[<OJ&7E:(,D*84XYX9S#QS&CU.Y$F2^(<_MSYIN[77U)@[QO
M.4+D*KZP^9IN!^_:(/=VQYA<@3,JHB!XBN"K [V))E>8F%@_JA=5K$A8[[=:
M+K;4_2??S5.5.I#SL(G".Y @ :)%9U1\Q@*._?[9M&V+[73M711&JA=IDU6"
M3AR8&&D"<& YIA3,40&K1*]-Z[RM1A4@E:?D2)XI@_/0TV_7XH(>/KG/'B]"
M#R&3^$C(0Q?[V:VYS\V8)+=5*C:&MMS$*^#$ !%XBY<CP(Z3,*;E6#:WU9@(
M"Z"#425TQ1<I/E3F@<$;9TN@/TM!Y?=W*1)BU#J; CT!N/_(>E<4+8X/G:)V
MQS%K0>M-=6OJ3L)7]KQ36-K26)\TV*2(D^6VFAS>/!#.(6PO3?8"L9-.T*01
M6FLLB=ER66,JD/OHA_.#$)]]"*.<;/=M<CE:8+<>^3^2_Q1Z-X$3XM=LF'<W
ME'Q*XPO/2$I\'*7A><VYJ:V^<C)M"T%;AP._N>@*MP\\/E#.0.Q"GV@YV;"4
MA];WD">/;/>62EJV]&MTOXK2V F]:\0C"0!A=@"^#'$16O\%X"_3[X<(]=<.
M,>-.7Z6)/B'9A7BZ*W/6+3AYXVN#:&\ZD!*K.])O08 3VD^C.(D)X8\EPN.6
MPWC/0;6!L=^XZ9Q=;:-7_S^V*^G'.K_=I-!=H5^22'J]-K%[&',9X(/R;N3A
M4;.4TYAQ">^PE8H-X/X5S6V[#$'7'8!C &ETG\>;#9VHTE_'Q_#D_WY')BTZ
M.][ZSZLDWI>$E\WKS&^-#[K]R3E[*54V7 ?CC\^<ODZQ6.0&0+Q(DU4$_3\
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MC91E>W^\?"K]3FQNC2/HEFK>Y:M*M0!"6D,,^1_P_^&K '_[7U!+ P04
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MN]-L$[P._?[EI_[YX*IQ\>67P7\JX-O-9OO;1)#V]\@Z_P_8<Z4S+E\*_%F
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M-A,VQ0F:"<1.0>IW@JJI!*<YQ68)B^;+,-3\?:O\[;Q)_@(;B1P90F1;,")
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M0@8(KZ*^7LR:9T"O3<$,JDRA;OYM=Z+*)>=G@;:8X+I5N WYE$;(J&"13C<
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M?O<(3?L)-)VW:YWA!WE7_M+ZSJ#KDF\&<*O;]<K_"-G2^PK/:C8P7LQ0J;4
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MD_+Y:QX5"9D,NE!QE1=EGWTQ8873_<!Q[P2K9D)9=G\C\,*[I<U)0M "EV$
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MN%0+1:8FHJ98<<NH50*2A$8;T3,ME'QX$GP)Y2%89*,8O_6(DPYCV]3IBDQ
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MNI7;>,K>5@O -UK=LS0\%K8FJ=' H<_Z0+(HJLL]4&"C0<N6%17PF4*,*[4
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M\M/EVFI1N&!K59#.RJJH#7$A3#4F#-G@D %M".1 -H*,L#%Z@L3 G+&^+O/
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M13JE6 _9;[W3U9O:Q:?8&<=]H[;T>)51#VS'M^M/+6;FO1>R-7>D5RC7;<W
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M!XX3SGI+=1R91V?94HZO<&O/VW3*VW32^_18S99%^PY:=P;GTZ0J-6U["'7
M3&8**7"IP:&D$ K2(V ;'I/C[=P(]C]LVZ9L*^J-:27J90'@V27I'4P8J8)[
M5$05)\3D6UN30/H&TQ-5-<R8=VS8/5VX"U^+A=RZ\89?(E/2(4[N49:1_XR<
M4+DP2&[9V!)4;3BM^71*L$BGLGKAYJ5MD(?<58S97;+VRV 8"4.%HL)@:GW*
M6__M"#2IHJS21/0$AS&N"R0R-]W9F/[8W<]&",RH/C<-(H>GWK!9%>1:&"ZS
M_I:*QW=G9/*EIEZ*IZQH/M9Z,YM(9Q7\SUE:C<32'*6:D!^3CD/XW\2/^;58
M19G^']IUX_9>IAJ;F@VX21APXSC"-V8_/H)@(NZ[+F%0U_E&2 A' AK78UMS
MKE-!+AY3_122<;,H!:I<J&5=LET"VLZ\%+&N[SZKN"9VO%^Q1@BM'D9H9_G0
M%60](O-/J8J=D!H=>.#QD?P&)I-.B-LV=Q@G^]O##X@.T2UY1NU@T*3QTIZ8
MAVTV;1\FG';NM4=&$6/M7\:E;2>Q.QV"4_7003;)J=F.(0*%\B 55;LH\..I
M.]'@JKDDX,#*'QP O]#BHV49L@9<?2&$W6"J7I:E)H/3KPPS)EPN+[2_,&Z#
MU\&$JQ>/4G2U)K!LEZ&U*^QGG3)%G3)II?+Q$,5&JQR8@'O<-I':"),$=5V$
M304!S%M2<[7'8$DD=Q[BMZ _'F0*(8YT=D$:%/FVT!$[5LR#C@6GB.ALQIW[
MVQD?4'L>0\XA>=9;M8ROD<@YN[C"T,[.J$&+$J.&..'GIFE428/\QA6$-Z4$
MN?BJC N]\"<X;'Q5.[">&4E$#3F)NH,[Q5BZV3_J9+61ME8]:@8[/9\PZZXR
M!/ZN"G]Y&Q]A@P&AS893JVAQG!4(GD6JR[6$"[#*.HE<[9./,C5OM,]VZ^S-
M /'NB'\MN%9N?-4);%!QUU(939F7ML58Z(V1.F"Y& E%=;)FK*L'+.K" 9W"
M8GZU+C@KZB5=",QMZ9(Y@J/E ^E]ON*Q.11_OPKDG<)6N$W*JM"Q_0CXL&+?
MPBE[7#Z$YFF2[V"4 ]5CDZB@-3?V7BI<%E5H:J:8DI<>PX5[=B:I*K]Q1"V'
M]59E9I'B-"\](H5MGJ:\Q%PF37]R@2DN?2J4A!ZYY)Y[99FR:I1LMAFM#V Z
MZ:W<G)>IB.LM(CPL,54S)(H]MH9[;,RHX=LHIZ=/9MCP^.&O,VQXA@W/L.&C
M?M,$G8/%,%?C1? /KI 7.Y0+JJA%IJWV.80N,7;' =]YT'E@U2J$*GZQE$E"
M]B#/Q&-9HEF2Z@BM%'3$K3EY@@]N5HV\RVMO(M&UM"T>PVIMRI>+J"30S%&T
MX8WT--U/K)98_O2RWL(T8P,*7O-=!,($AE7"MD@?Q]&V?!!9FT>OO_WBWOA8
M)Q*^8E'P_ZZ?,!G\J'L;O)4%TTE(S6G:T1WX;IHV&D<X[B9'XA=7Z_T15"BJ
M*PY_3^>(C'%:QX[8Q4B%%QV2BG^_+U1?>,F&:#F2,X"V/]0*Z\*SQWR.NH:Q
M)41(9>XLK1.Z;!&;C0F)4JMMCKFV6]'A&QT'M^E*UZ@Z\-F@]X9\W%Z)(^/0
M%#@\%.'"1)$+7A(>K:=JH1/(D:(%#HC!7:;JWP"E8#2J:'#Y.%#U#.29E(98
M3%=#_(:YW0E93&.<PRFH YL*H:33<@E>\F$E +=&*Y;-(,'@*R36SP)7'P:#
M.$)B$:_]O,3'A+YQZIG.;!:)$Q*)\71%XAO3!M+;TE,XXCU=>6'NQ;C [+)\
M5]078VO;(8=[V/<1COO6W FU^^-8;;X81_125W"*X]E!GYZL2:8K:_X9Q>!>
M:35;8 _: K/+;% /AQ!22TV.8XOH]<Z$\BSB)B#BU'1%W.^"3)XK11ZXD,,6
MQL8&E:8<N/*FWPLAIIK=-#PTM1!-:J9"=]V(/?9&2BYM=%FB9RC6ZW BV *Q
MA;:S<-M01"T1/C(]N<E%&U27C-'BJ@T-9F$^AAMVT.44"UQJJB\E O6+X#)&
M24QQ4X.4[+Y>8J,6,6D!L;J24<$0I(TQ,I8;1OJVF2^SS'V?A_QQ\SP.7R[K
M"ADMF4&U"_MW;Z!*"IT)A-VOSV30X]4ZYV@K17-Q'%C=X8%=N72@RDFI27TC
MZ4***NR,6@Q-N8'MWTP+["W0%=5TM&>2 ,/V1Z=#XWRCW$=S=2<!\.S^A %+
MY8.,%@ZD?*;%,-:9^KPE[2G<[8XJEG,I_F1)$R4N3W:M>Z*8"CQP '56Z=3?
M\_ YN/8X&C=C%+<F?*<-2<.]R+K.FXR",:T'V4Z"*JK687>&-ODN2N< RJ0T
M_G+*&I\VW+BUU:SM;S=_7N6$K6B@F)D'9:<Z>E5H 4H5:JD*%*?<3PX)(YFL
M.TDTM\;P5 ]'G)URC741UYN2M&HYV,E5$H0@PC#R57M/-)%HDH9*VI0U<W'N
M9;._-;8#,7<=/?5@"F/D'%&:R_+'<U[_C$7Y-S.=5M1HRASBL5L!@MGV%2!7
MCIV6X#4%B44#FWV@L-MGA3(QA;QP95GR>_;"$+.DR04R]8,4&*AD)+;?%L%S
MD*J ?:\3RO*Y<K!>@'[G^KL--3M-/0,F-+UHX5.1A"@OO. &T0]68/ULU^#:
M-WB/P L&'_3Q!H,"*ZK[VI<5MVZ3?GO\<R+NME2$4F]VJ@(T[$((?,=GJ#+L
MQE(VD4[=(_T_(%L1-:%=UD7E16:L2VM-G*4MUSUE^6:!.F&!.F&)^D&@>G\:
MB=K")MY$HI)T.T6$SM6HMZI&?3I7HXZ_JG*N1IVK4>=JU(=8C6H= ##]/:N?
MS&@&[QN%>QH%VB&V*4DI';"+_3FZ-^OHFCFAV2H?E54^8;/<F.-XQ-XY][/1
M&*$,WH&KN=T04].XK7;$/G!_^L,<B28K@FXZ\B";?/<R)&-\D/G=YQ&&[;&$
M>Q!=8$,(SI>/FS.HS PV'L'<,\+X0Y1 'DT14G WR9SC*&/:9<JATWLXI]XA
M-VJ,6)B.(IN8=Q1%0I?$B ]#&5XUN)&NFZ^>9=.89--NNJ+I%]OS=FJQ@U\:
MW7J;KKRCJD,1A&"<T^,$KI<20["(JNM&<<W@:%P3#245KS.8M=7^3J.<H6E(
MR)/=U[V8VWX_^Y9_Y3>&[B4"LY+K_=("VI"EDZ7O/RX^7-"00D=5B,6Q\N>E
M+N!=W)*;K]KF()56BAN1Z\1O1+XNE.ITQDXD*M,8RBQ$)RM$)RQ#_Q4A?A(W
M(\NDZ4C.*-NWR[J'(Z=7^)E)0P >A*V&33 L'UW$K%@J19]FDJ@ W5L04N)#
M;/%G;%['!?I<L%Y96 H!)AL 1;ZX;+S&0!W59S3(2END#A^;$[Z'ODG0L0L%
MYSKS)L;G&R6-@Y\:V>I0'*T5J@M%5?N-MVOFK@8O?%FGKL^?90M5";,NMI^;
M>L):)O3HDH4&&]1C>J_S*R1"]][/TCNAFZ[P,OPSQLE#)[BC,MB!!$N83C.O
M5VN4Z^LHX3RB&;30#SC:;\1V<LB=5MVDT&(B=J8>AI4V^CKX=YT7]09?Y[>7
MT4N;7CRPB4*QU]NH7IQS\S1$\"::F1J06!9C%HV,'T.X;:/$*WNP'2::+Z2_
MF-\.'X&+X-(@@?E9S<H7E3BJ"9/64*+Z"=ZUB1*8>O(\[#;465VYOG0W(\&>
M 5=?%7"UGJZN^[]\1/%<_C.?F_7>=CIGH,!MUWC&7MTN]WZ4ED(@,-@<;85&
M%Z)DB&-)*DW$ B.:2(5^=M4DMBY4&@G;->[B3<9O(H[O0A-_-,.?/PC5QK<O
MR%*3L)TQ"JS>!%_[<;76CC5<?<8.$7V\3\+23<5":(.BY2:%60.F[@UXH$(W
MQF-!!0P)ZI)4>;<0J<HK\,O[/J-JM'@9K*F5YBFR2.'H)@J,H:;Y:AHB]AE^
M)I"!J)##95OF#NZ(R_T!NE_"940#_.T92+LVNNN0<6W@(<8JI*^HUA%WEA'.
MUXT0:-W<2INE_;BD_:3%_:6T\3SN[D=56_;JTG5\0#GFA#MJ .N=.B:6#H=Q
MM%QJ&#5EB;GG8Y\([!SJT!#H1?"W)26"*KY_<:C\)#R9;$D8Z&;O:4+>TTB.
MX4W,_4NV<(S^D%3+[$(]Y-K!6V)<FY(J) -*HH-6 .9%LP<S)J^B3RH[.5YX
M*%EOPK_\1+-U(Q=WTQRD9$3 H<R:M+BAIX>V+T]4*GE%2 :R[:%##L-I# E"
M>V!NYYAJ2;UTAN)M7ARMI[?RD='+^^"1KEG-@M/[$79Y0E9PT\C0O BQ5UY#
MX^:UU+O(>XSWG:<]JW7#8"IL))#!T:.5[PQ^.J.59[3RUYZW&:W\==#*?R+G
M?EK@@PF[%#\I:7WX)M]L55;.W&-?+BDSTND[TFB6FY5ZN\'$.77!4>28>7'%
MKJ?6I;MC?;FQKW;',X"7N<:./2;SFFH-4K6B!( AM-IB%'P!IG.U;W:%;71!
M!8NWS.W@"&L']^9I?9B.^]Z&&DD,N91L:*'T9E$7I3(]8]5G7 "%H?*X1B88
M!TI<6H *1<\C"<V9"'1>#/5<&"C.[KIY_A0<"&3#1U\I1&*4K?$O+9"0>_%2
M9*WS19VL3P*K(Z3+1Q'B@Q 5+,BNJ-$M4\RA+R>.CMWO!*XN:M[P<+9PVZ@F
M8HAR "9KXB,L#'H;VPTSBCR"(TI+C-,IQ&B8WEI1"%)MMFF^1Y?53TK(HB.(
MA%#C_GFC#X$IG..*4XHK_C%=(^"-.4,S$<X,QQC/B9UM^-.VG:N@?.,BC.,^
MR1^'H<)@L^6:L)M!SX>APO9P$#[9Z]$(,@-D>QX:MAL\V&AX)S?(12(MKO&3
M+$N/MQ2?@9^J/JLB)F,@97 !4<"635OQP",=)1_8&L9PK$[O8!/:D=@.:-R;
M2X'MV-/PAG,#F(S]S*835<5A&%J:PC.3,:45 EV]@G$@RL&Z%+*$WDS8CR9S
MSGZRQNR$+=S+@S-]+K:\Q/*C)-]:##DB7C?P^4RVRROIMQ=K9#T(%DN=Y<\\
MX 4M?JKB%@]L ^9R;I#?Z3YHMV/#KCLR/66]<*F41I<SLMOI*Z*4!GZF\;OL
MIT3F&V@ 6U@$1K?O.7O3LR*SPIFPPIFPQOF53HXS&Z>K;L(NV"NT*HCDEBL5
MYF_U8A\'](2D^+HW\Z,/$J9UT'[7TG)>,I#IQG$<GF*!05-.D'[O/&[S22#@
MXD(OW !]Y59X/Y5!C%!!RF VY#O(6Y3[(,-!]*L=JB4>#E'<-E5!4PE@#"73
MRO9;ZM/_S=Z/L_R;L/R;L #$#L'3%'HA&BB&C1I/I)@R&X(["(HCKRMDCR9C
M9)B4FDIZU]*FL"210"T<%B4;4F5P%IV3G;,X9WFE2PO3?O8=TSCX17XZ0Y%2
M,DVEDG\3PM:"CCWQUPA2%@%C!B-NBP"F&LA.)5TE(A]Z\7%MA>A:;]L/DK"C
M=+VPCQ38M*D:]OH)4!\!:M  <C'#)AJ-G@*VU41CK <:4/  AWPC;[),@U^.
ML I7=YO1N_-A9LT&7D"M)YIA5=.#@J0]JX5N[X306<R%6T:1U;VKUYB3@Q]M
MZ88&6GM@V#6%I<JXPMWM#_\S0JK>8_^$Z?K()U@8P ^('=<WPLQ5+_S)QR!E
M&)7/+"E[:+Z8GLL%?^[!4K5@ZV;-I$3^(RN[.^E+Y6M,&L+6-39')I60S8^@
M/;;+V;4P6'DNUS3<(>W7>)PC!KS+A[3.HDQO\AI='^>?LW%S-%"/<B9N8]G-
M3/%:R)S0L ZNR:SP)ZSP)URC/Q56$Z\J:]"QZ/07'F:6[C/ 1>VT/!O/L=G6
M15E'F;2[\%7^"Y>!,SRJ=.0K^@Y+OU*Z5&?$8,5N1<! FEGJ_IM>!H>YJ,A?
M2FZ,/+5$UBOX1HIO29&#$6GM!V4=KN?<-JUJ36&F<+3*/)HH!Q#5=&&I<OS9
M[O&-6HRS[,<UZ6G:;-QVEGIKL?IF15[B./S\).@-]CIMSUU4:-@ +TO8P>GC
M.-J6]YHE&O<113M$-S/<[86IM[G;JKEG$Y3=JX\Q&,U WEL!>9_/0-[Q U)G
M(.\,Y)T2D'>F'3Y5_AIUUP:TL5'5;$EFL[*F+GO%V"K'OX-=0X^7&1UE!#R=
M#? B&"3+:@99ACBRCG1V'0%#ED]#.@&*K$XYG=TU!\D*FHF0TN;++3B04B$N
M_^];V9TZ99ML3P8"FUU?H,,):XNKS92W)LM,5&@C?AB#Z2F;ID:L V&E Y7<
M'L^E>W9ST#-\\4N&:NX:OOAINL&9MYS$A UX$OG\V&,X& H_D46?Q+(E.^ C
MB3_JA+M7IUTEU4"D#&<#.")_TC#,>_V\,D>')+L<PSZ$;RLT1H_+,@?E6?FU
MM-)*VN6MH[3,#SP/+W2I;?X3YX]M6?#@*%TRH1,BF9L^3TI@I=,56#^K* G>
MPR[:*MI*=I>.6S"-'G[]< 0[EHID-K:GO:WB-4T4I^&T)HPETF$GO8\BH*(J
M=H;F2C*DAQYW]E__\?G9DZ?QJ_'N![X81_125R ^X^D>/)[LY-4Y:^7!KW!>
M*CE[QA+(=ZJ;VNG=4UV 6%/Q6IB8 JF\2'6Y9O_*E;X=:0/Z!1Y]31MOUN43
MT.6;Z>KR7XM5E.G_F>NF'[SZ1@H\D*0=0)"GD4^63Z&AVXP:UV,J%T-8E,YU
M&77$5)4"C.&7'% !>/'R\$6GOV>H1=L9#=U\^7GC<_KO:#WX-]9-,*B>1YD/
M<!>U[M[D987-0#1<^T_T'0\^K@O+\F)L//,8IHN["V>;.F&8C.DY3V$=;#KB
MI'Z]I[$2_X#X1H0+AM(6QL,4RCBY;N6R1!@XXBGL+:Y/BRTVMK:<_9-\"?^!
M,=5)CD7QHD?E[SQ*VLZM<9KO(/ 6MF:Q;[\N=[R1Y 0WNK:.E1PQ:<W'<+(W
MY<M%5"I2"KU*][;Y9;J?XJEHK+RLMS!5R#/V9<$-(U/*CUY_]\65\%@G$KYB
M4?#_KJ]Q!C_J_DP./O03*M:>C?#1G?>N$1Y-V B7$Q&\M;&0Z1R.,4[HV&WQ
MCS9MT%O8+)8+\P&9Y+U 0$\)EQTT?EL&;-@H2VA:H_(@S]9SS_U)9U%&. )C
M(IMLS$>LGJ@+A(H>J@5)F>"(P/C^$+H&HTF:N+_85TBYH(O'V%FETO$55051
MIJ9=1^@"-[9#7Z+4ABN<MX6F@HTBR%2,30>+_>&/*:EW$A< 2#4%S RQ4E$%
M@?^!LMYNI >&<!%@NUF\6^Q=?!NFO\BV=NEW?ECO7I*L.#Y#>@$0A(!0(%C5
M@5 #>-]:+S39V<3>@\FEVQ.+TY254>J6T,*N'5U0>SH&C\/"-"Y8F%:4'GKF
MI"BRX$3N@B!KIIR])5+UVQFI.G[$Y8Q4G9&J4T*JSN[9:-RSQ73=LX\J UN3
M[!>'U9I>%&.,4SL7Q'[10SQ3SIVV[?ZFP&>(TK&'";!]KO6+A!,'?3^#.*RD
M!IV=X2.<.K8''!(AUS&ZM2U>-Z["Q)[%!-C';L9PGZUAM^VHRCS/E)",(2C]
MO>_!60X.B0HLD-U,E<S#4+5H']BC-!0-@J! $H>OY<:91"#&)AS,_4"@Q:(Z
M^M.&]+6-R,1,@_:PA."$I: //._=OF.7CQ\/G+P;H<D%!)!8-,+ ?7V2P/;J
M.PUU#I+A,,"A!6Z@7O V26_P[8>^78I;8KI(V8N&Y1#/@,>O1%-4;Y%%O"1^
M&)X8N928R8L\/30I+:[,%>O=GC@LE=_TO2GT^4%[WMK@"CT41!0NAF-H_FU>
M:A.7'#P6'QM\JT1C, P=&5C,+/=@']UKN->DI1$MF\QQ9G7<$[SVDS!7B7^G
M7#O\-<>/D0 ?_PQU$;-Z'95Z?1#ZU1[3*6C4MDP9K0X-C^ (KRF0?>TJ=;9M
MV[WGSD'+OX>N>D!BSUKZ5EK:.UR]VW>\NNM,TJ6#F7H!D@[M,7RK^UR<-T3%
MTGZ(-C9E?( SL>D/$QS4(W_,6S!6KN/XX55IOOJP87%^@FZ>5?-T5?.$^?"<
M9FX!7L:NGR_;>'%!G]2&[4,D%!UE^Y$M,'H?R6=DXE_MJ^'/B#M2!EWMHGP-
M>+N$]\YJQ^ W]'Z44PM%?!N-2-^0&+D(.E\]"LE^0+ ?D^OY<=E^<HU#>U9F
M<?L@Q>V#D+:N!*2)Y[._'[O\;92^& %"5$*GL54<3M'P\[ ?3,'/BV+$8.[R
MRO"+>KW:3<[#X."H.7JPR/-/?89UJVI'7H4\5(9=BEL-HA1$/6#EI<2;\N7)
M'WB:L\< S;X.B$+IC@J"A]8_=B.R+2>LD=@-(JUFU,Q!$$?E!QQ7%Z@MLOQ0
M=5J%X&!I^'A]Q7 H!GC[]Q,-.GWMR25A1+M]BEWC'G&*7>-!F?&Q1)?;-YQ[
M-#!FW.BM<*/?S;C1\>,?9]SHC!N=$FYT9C@]5?[>D7M\U_;.[ A/UQ%^$!G!
M@2*Z*?B_0_5_?.H^*;4ESEKFMZ6>HI^0@Y?20,8[C>(8/J?J<52I(5& T+N\
M7JV-U[M%"BBN]/(=93B>J-/@C-O^7_BXI1W;</-8? _)+'8BT1G%RRI%.:AV
M@]1KUUB*B&OEI@:FKI/. ___4$^B3L:.?))D;[SO98W4QC11,#"D8NXM#3PX
MI@<08[U[IWD8!M2=SV$8D*UFO3$,R#WA5!A0C^3Y..2S-][@48D7+6_>C>)4
MYWUHKDYQY8>^8U;M$U;M#T*WNW,P4+4^=BU_7?1+]P /H5]Z!)5#OSBU/8Q^
M"6<SHUE>T+(R[F'IOJJUTMY LWTRNJ"^6Z(;!_7=(TZQ!+R=V1/4/VW'Y)M-
MGJ681(CY\\S>_I-LE9GJ:D*UU/&$K21&&PJ\\))K[*K]N.VAT5=1C]R>_-@O
M]JAC=Z?3I\&C"LZ71&=>> K"KRZ5)O"M"LN"F9^PWVF%2M\V@\=K;;OW@.$&
M<Y^?*8F^9+JB[W<'K9Y9(QZTO+OT)!0*N8)6OMGN;F_Z^SGXU6E-\\0P'785
M3ZJ<.6AO-JU'L4X]C-ZE89\NO&H!Z]"KY1*+0N"!1%@(KU2F91^)=!F;H7@N
MN6H_%VO:3$?)31*]FJ THKZ .'O:\M<9QCJ=$4TV5_^K'<=C5>\ D8_ &Z3I
M3>T>W]-FS[W-^/,\3IZK*,8N@U&;F[O[<@;T.E)!:ND8?5)( &A'Q//;.[6H
MS/*ZPCJE/^K$ZZ],<;2RT>:Q'8BH*8K!B+L,=A3X;=8AYI<Q*?Q-HJBS4ORJ
M2E%-62EN\EV4CEN>S_KPR^K#A3+D,6S_.SX;HQ_#0&FRZ4E$Y865?!3O#0_%
M2X4=IA=9+"DKJF'$Y@MF4-2QWND@\CH"0B+3[F3654N1@S!I51P,V\Y=!1Z$
MJ'WT^L7<56#:']6"^LT@ZYN K%_,(.OQ@X5GD/4,LIX2R'HV@+Z(BL-@-N=#
M7ZYU MOHKDVB>S.([LU&D! 8^ "_+H,W$C-1P?NLK(J:(1^761+\,Z?PW*]4
MQVJ "K]>9> (_'7/R787;QFW1P8>;=\ [W,$<X1IM&[/@VJNY YW/G"X1W]4
MY^#3G22?*6.@0;C#1L;<!E-:*3 -X !P_GFCJG7.0&T'G\$_\+_S8N]GG0VQ
M5=AI8^FR'2&&[)GG2X7T&/RCRA(8E K@TH5:1^FRG_AK;W_&A)'9P)0>SV/Z
M-U<>Y/+@0T_S?U9!AH11)LB6ZHVN!/K'CR.#"5X)_S39@_+@XT/X1DR*8 X(
MJ:EM)L56YW?:"S6;!X6NLY-R)[B0B4>Z:YL566C.[E,4KXT:O([G+TKF+@WP
MKC%ZCVKFYBSD\5K%GX0*K@!OIL3_7/$.B[)/I=OPB2)N-F[Y!']F=*>DJ>"4
M);H7CLM4#91F0SPMXW8/-X/"G<#[R.N$Z^<5CY&&=K$GEO,;"<"IX^S%*:[L
MO&\.H,@[251N.6;E[!&F=W>[#Y;N:TQFQ02+5<FDBV1E.;D\28::' 5G9.&%
M\#TU#IKR#LLH+D$^I@1&/:L:)4!;_*2JZI5N+,XL<%H2#7"%@8T2N4L"DLWN
M7'_;VQ0$'!,>6'?_GK=P U96SKOXUK40KAL +#NN":$!#FY=5*<&O[Q2V.'
M)I:BS!@+"%)S_R;<&FW;S3;-]TKYV'E"K_$3"C.@BC $J $[.\9FP23;3X=A
M94@Z6:]O4Y6L%!E!1C;3[Z7F0:,M0#O8]&W8UO""DO:^^56T05G=WF*S'S=&
M/V["79@D^I+W1%\,@>"$HB^S2W=+BY28QSQ"KV;M$)F38&"HLJ*26=-WU&Z0
MDL5A)7?0-L+&"RJUV\F7I40E5I4J789&](E_!^=,<UDN"=L(OA6$<NC,5&1O
M2]B;83;M_#/>0, &;#XC%;;@?^8>AHX=Q"1LH>8\-60L5+P"GI.G-L@QC(P(
M._4T2VE:*\\5W\TR<GYA+*$M&F[R><YHB0>A;AZ]_GY&2TPCX_%A':&?@:D,
ME*/C%O>^NIRS!:,[]@\J6_"3*=-NI@U<S_,Y6_"@34O,%I0L' _%'@LEK4+8
M^XB]_4$VCKVPSKR_)=):T(^!^Z9;X?UT@#KWHK$?R1BM&L,FV]@5 ]C!^%P$
M8]XD(]\C48D%*#%VC2PI[&?K*+QUP75XG[7ZMK1B@A?!NYTJ]@$3*-N5,T:Z
M?_.!#3>OY(U7TOE;Z EB+P)PJ3C6YD^QEVIPE-*4,>N1$1)VJZX:+40/]+P)
MY55[#&_0D^O-PI 9T+5I5)*_6BK,JE!UCSGL5WX*1/91=_MP21'Z7JEMR6.#
MPY2FH1N\+S:]6$VP&X3.^RQ (]6OOPVY-&VI;,4MR; 5G(LBPL81.3&/R/11
M*PD,'KH0NLOF6882,!)BN)B2>:U5<*'06,%($N%]8:J%DT:T4"#[Y [_T1J/
M=%FCPZUM_)]_XTXW-=61V#O*@&4 O[Q2Q;5&($U[$Q$1](ZYVFI*UNV$8Z@_
MYV4U&[-_&F/V,LC@)U_.(6.6;SLZTY!EG1;Y:U.E!^Z5H"4)5+F])W(*SU<K
M3[&2C$]A'X9H[*2*(2:) NF8[ZG)N$%Q;*)/$O"/,F38TDFT,^ !D*)+S&DU
MHZ.@*$&MB!:-F[886U:L,(9?SYQ)[;RK9)ZIA0.V'<\2;CZWQ=IFGRT(I\&6
M 1^;?(Z-H@8O;!QV>&2'GR0N #W,M6E#(HW4F8X11F8)?Q2M"D598]0HFPQ$
MWR!OF:%#*U$Q&D(TF@Y)%5(/D<ZJ!TBY5($:S;.DAP.-4H;R4)](JC0C@ENC
M583Y>=Z'N+*\[G,ISZU*>;Z?2WG&7Y(RE_+,I3Q3*N7Y2J[(!/LEB&NYB;"A
MLBBXMO)LIH;SCC5S39-J]BZGY%U.F-OOH\0]9J_R=E[ES&!^RS7^JFV1QW%^
M;YC],B>8R4^H#Z47;#9>]*',&&DVHM(E1QZ1I4S'+:ZZ:18IE"R$2'+0?0R>
MPQXL,@4^88WTS3:$'G+C>Q/<QDBT'=!P=L2+)X!'*K!6\LZ9[AM>(0CQ@QXV
M@UV#5'\RX7DW+_-YG?1YG?:![3V&9!4R4KQ9N^6S;A-T&^- &YO"Q%]YN]OO
M[6IX5S,Z&AN,^5%:2GF)J8,"@D#E8)%J:2ABDR2GR9?3WM_(AC7&+_A,B68A
M#Q^<_[5>Z,J%+=_^[<W/L[$\)6-YPFRP/^G/&*G^G97LVSD9,YO-7WN-9[/Y
MAD?C?28]4"A!T5>YUZPJ;V@F'WHBY+=<P  _8^V H464ENI=S2Q56,D?>5UD
M&V&^9=MZH#:-B-?U9S!HQ<9/R%)F\ESO5QYKK:2Z''9!*!/Q#F&0-3"V)4LV
M_JU[EBYAC/FV.E0UQYB7@7$T^LZT"T"%69<, UB%+'CQ!'Y7!%2\1[_ ECM)
MM"\-!L1'87"FBR?X(G@_V+.^S/'KL$"S,;PEA=MXA<VGG[#&!U8UY"%YBT!]
M1Z1=THW?;?:3_[V687G@F^W6Q=41VXTXF"N9BUN-R,U&<TS23(])F7F9V$'L
M+A[S-/ T-KI*?=%IHFV1Y>TMC5-PM'W3H8%<7Q8,2@+[\48(I3D[R8NZQ/6S
M0"\X!H'>;%2"?9'2O1QN,RWX5WNV.W3<IA>-^?55A.3>X9=\I[^@\ :LR;H(
M+NVL68>@[:#(-'^)243QLC?=)7S1VMQOKT8- .&+<4PO=0462 RJRD"/PV -
M_N%.%>&8OP"L3JM2#^HQA%JT3QG5N?'280V_V5 9L4L4">$T++;/=@41A";L
MNP](QPX[[?D/9]'Y;%U.VKJ<S4L.P% KAF ;[7T^#)@2+,-,/!(7!*OJA2U+
M )&85_XMW&_ P(X&7Z@^JR+6@AF6>W1F<YL&9 ;FV0KL3UA,$$BEO%-]YM][
M!0U2>4OGU? 0++T&0& )+FMDCW%="X>E!H62HV2'<B#\6J;P08.76D7 "QM&
M+9FP6V(O-RPB_+V'#)1KFB&&V8$Y2F2FKV5=-":D9PWH\\OV=!4*[#V9,(06
MSL&X*07C)MV% N'Y"LF%/G@'8>2FT=@#<J,VCH=R)ZUB()29JPP9P9CF*4Y!
MVNVDX8XD$CE[6;@]U,A["I>3P_ERLL-3QT;_2OC#NBFEU)7@G:'7@E1B'0N<
MQ.8846@C.+>BP(A5YX*>S7U:# O*I?%(S:)7#(3$%DWM*M]YM5;T8\YI%(L*
MIJ23^HR)6(\.3APP&Y$25L"H'* $Q%=39WM4%Z .KJ)B+H^9E!I83E<-7"8,
M[(_2X#=I/.F% L<NS]ZC.2N5"54NEJ7/Z&D[ TM7S5)5:.J!!RR@"L.\>9 U
MT4LN$Y3?YR&C7F9X$?<_JU.AM@/96*?"N^-7$B1*;5!FJ$2C<P'[*U:%C<]1
M48DKIPO-HZB2S@2!.BB-=C)YKA>X5;W 7^9Z@?'CWN=Z@;E>8*X7>(CU GUT
M 3H#+\2F3FJ.PK2(1CID(%[NM"_>S>BG4*SV/GK=H]P6SH+@*LJ!T!L\.]=8
M_$?*'+L M@KFRX:>%R/, %/9"/"*,MG<($W?K$[%;&E4-*D.&NU9FV_%YW[C
MQ[U<R;[__IFJ[D&X+8]>_V6FJIL&5=VO))%\SM?EY'KMS/1UXQ4%#XJ^KL%:
MUSXYTSDF8YS:L8=_D!09V19*[&&S@$W.G00L0;+K>M"D2NZ8EWPYY1M[[*JS
M&"RV@JE"+$+BQ7EH2),<5=:=, CW$P@SYQX%R_U0=52:47E,7(-8K1G,<S]@
M'NX(9.ULW+/>EO6R%NT-N_=RT+">F*9A9T>6E-MT.&L_9,8Q?!LUYBA+3:T,
MNNQC(6=RJ@+4A$+2QH2BFP'K8QS5MBZ0VH7\)\YLWWSPAFFLS<*V]+AL2MO#
MA(*L%1P]DQEO/!N^-\^N/Q8Y%A1EW6P+395S7F>3+D7<TN^R0VQPDD>*<\0_
ME.C7@9R(!%Z9WVB!P^["NE5!\AT$?Y:13CQ2RZ; ^5BH"*EGN$=&%ER62-*(
M"^?]I;?]T&W%!W>>1Y?3S2BGO3BXWD=ZUYS57HH](M'S(N^.2X\WA4KHZFM-
M\D$B/@N %.^9/@ ?E[DEU<W%#T^BYO.QN]<Z-WG?1WMO)/Z#!%QD4DSA]4]#
MAK(3_D@P:+/D3:QZ.]@AA%?<&$[>S*G>O%ZM?5(J6C\>?V5(!$]8 /=E=>GM
MI'644-IU>):[NWN.63P(1^71ZQ_FF,4T8A9O#:)CY/;8')D8\X%_4)&)MRI.
M(Y>VG^ )&>.LCCTH89?9:\X:;=&!'2SU/R%5=4V:=<>$+[9=0GOQD#%_X3:H
MN6D+;@<&/4"3K)FUA A$Q)[66;MM@/^97_Z;9DS<E.3VA"FCS3D(?E>E*G9J
MW/)FEM>WF[^_LHL^4" 4LAMJ0[T*@;P:^9YJ>RWW>^[K7KZ+=&I[B5K,LX"0
MZPW'8#:'VC9W&M[:#N[1@HI(5'\K]U)D-?,W%[R1I=T*_I/0 E@@2,U2=8;-
M6K70*N-@U;]KD&G_@X$M#ZLM?RP4:(9"N@UO(IV9&!BU2Q4=T1]HYP?X@2?7
M757^>;R+M5?[1<$ I*>N8R)E%E)JVPBQ;Q 6N=&/UMCD";)#8^0%]KLNUSY
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M9'HJ/9F^?&NV>X[.(PAQHHP84^M.X2R-19%'2;HW0@#;D'B!741]JGZ*'39
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M5^M\X_I#B8SE)DV4V\;" ZP_0(P4:0U7CDOT3<3UQ@H$QB(5N@;J']KT?%M
M+HNHAID@:BF]B;!IEE:N!9772JODGFY<K8;<#=?&W,^B<4RB<<*M0OY.^YP.
M'9N*8Q>+[ZMFOP_N50IVBVL,1!4YG0,L<F!A441D!QGYACDR[&(*4FNKJ<=$
MOI1;X$B#"YUGJM'W3YXOQN?0(]%FS!23TR&@L5G@VO,\JA#C)3GAT?04(WIG
M'W/",F3"(L2YF+]YJ+E_H1)^DV\V=6;8NW09_"/C/H-CES+_6BMB8S-2@_K7
M=WU1TQ^LU>C3D,A=IT$0WB1^9U^K2'%Z?5PBF3EQ>X9KF>&P12_BVT+&8Y2G
M->2I_4PQB0JOP1DVLJVYU)3XD\RH5N2X8O@/FU;:BE1!!\9[[OH9P!1Q9UC#
MB8OWXSP>&!S[R8XO4X)X/D/= B&<GU3&?8]2UPK3/= :@Z?/G^\U6Z4B[>TP
M?BFLGZ5M]"QOPTI*HLHCPYQV";74PV=@8^C*Z2G37I$&W].44(LCS\3\LC!L
M1)(K(,7'WJ9R =G.WN/N1O0*[P9;SXH-K<R7"/TH-7TEG,JRYQB$_!WR!S2I
M770&'LD3738;N8*JQM66>R0$[*U+><K"S%INPEINPC&$_LQ2\&$=%4P,$%RR
M"SMVW?:N)_7B$84V&UHS,8*<6#[APR7NOI0YINN\.&M/6WN]=/'<*"AA@D&U
M'LD!(=0.'E4H;B_*<0;-['\J,_SK^W9PH61D/E(?R#TFA."+=5T:6?[!5-BC
M+/>4! O])HJ.?L<?8H2K']; 7L#TNGSQ!VH3+RYKV_*Z29,.\2]<A_@UD^W.
M4/E;0>6?SU#Y\4.^9ZC\#)6?H?)'S<T)0N4]'6E"=%U72!K$:IHK(7,"!<Q!
M>S$/,HE?7@I%D]//Y-;N<G;0NQ8 06$ZML500P5_%N\3(S0#XQ\"4/;1ZZ=?
MGM1NK#,Y<6"\ZX,S;H=NQL:/^L@_*&S\='I#X:GX4+-C;>!*EBT%*]TK#.=6
M:Q^]]>V+L_6YB4YTHQN'8AKA0!\YC!RHSUL,+*1[3.8A=2.'"*(DWR)+.$XI
MOE0Z67F1D9Z^3AP/QSN9MM*LA_> 1I.$/N3'8-,[L9?\4+/ME$?!YDWTA\3V
MI<65 YYD]6:!V<BE0V-,LRWIV,'B'SOQJ[3,_4@4LX/><(.]&O6QYHN;W"8&
MO1D&:_CP'8*SQ_P)CUX+]VN3FA;#K+N\LC@AKP: .&<9>%4@(%1J>AF"U7.\
MAW'T DL]+LLX[Q0;:='8;CTR8KG4,!$4N1WZABI(%:)%7[QX_.R;Y__YM47#
M373?R+>53#HL  :%60@(K$7^A*VQ'N=U1?RU>!&%RYT4B+9XJ(8WEI_,HW5>
MJ4P55"PA<#@J>Q"'W0/ER9BJ?,5-*8C'1MQVVMESV?>#,'7!N_WR;+1CG<F)
M>[<_YUC$\#$/?A5R\'%+M]G)'?7)?U!.+A^-:HI'8XS3.?9(P1% 1$\U:MLP
M0JANBD[6)L\4PN*H0F%51R#@D025P+J+5/J(40,P@]JEMX$%I*6AL^D^ZBI)
M#Y=P2&8$Z]MTPH0_8=#L5^$]TCY,>CM$7AG%8(5(\]E7 HVT-6*V>X^).W3"
M"N)/I#D2 +I905 @?7B42?UQ@_F(NO[$!K<AI$6=< AZPST/EF*4YN,7TB\!
MBS\$(VBIE*CH@Z^I,^SK5DA9B_R;BPCA*Z1\.BH/QU X;J*\M>AG[8V"+5C4
M*RZQL^;XD E^@2C]-2YLLU2QA\8)=. ^Y%>Q[U]6A9:VYN0<T(MDTO;<D*.0
M?_=0 E>$R(-_B1OIH(:('JRK04K>D>2"1P]#^7:&H8P?3C'#4*8#0_GQFT6>
M[%__KQ^_65>;]/7_#U!+ P04    " ![@&A3-M/K,U10"P#.5A, $@   &EM
M9S$U-3@S-30T-5\P+FIP9^R]!U13W]OG>Q 41(HT45I$4#HH51"(#1%0$:6W
MJ(A(D]X$B8* = $!I45!!*1$I$H+34 0D2XU";V34$(@[1[^\[[OO//[_=;<
MF7MGW;GKWD2_9[DDY3SG\^RG['UVH/VA88"C^M?TK@$,# S /? /0!L#K@ '
M&!CV__[;@_$@X_[C$!,3XT'F0\S,^V(Y?.0P"PLK"S,S*SLKZQ$V\,%\F(.3
MG8UC_]_[;[+_\OU7@7_96)A9V/ZG'[1&@(N%]8=0+R/#*>  %P,C%P.M%8
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M$XM;ILQ5$<WF_&?_8<X2WTF $B4<R!\Y,3#*&SFPE;YENKULB'58.KZ^XX3
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MSLBP",ND 3@79)-Y,(3:R-\@XR:W'O1L2C =>?;,D%6@BV7[">CW2+'J^S3
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M^93DG>^<3_D]O3.?9$6W\&_@-<TUO<9)I=-[.AE3+UK3IO*B./TS+Z;33I*
ML3(>N((.=F.<2D?8B4X;C3P;9(2?3)AEYU2 -)BAZ+)C7-R+'QK#?@_13&*+
MC,ZO#X:YOP#W/X^@"V9@D"K2FT, $QB*KK$!HB"1AP">CQ&6 Z$Z>2J1&WF
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M"@?_>I@_/'K.XJ\TVE\$_ I!;^!Y_TT8]Y\<;[3^$_FZ"?:3+'_Z$#!GSTE
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M'&(8ID"C7QR]"7$OK"5C!%K)K2QX@_,'#'0IR0<F>A) X>=&L*01_ SK):S
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M7>D1PX/=T^0!/.L?#SW(052S-5*7R-E0K43S$GL4F]>)!E< 9=5?I@6L'IT
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M[*ZT;$\QK_@2"%K'-5<(G$>'2LI+G=/[U?_:79RCHK2XY-W3RHI8+0[6RP"
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MK*S>7*\_9U0XV;HJG=XW3&4N--&2.\>=6,3R]C'#^95OH/I9K!9PC+<=B#5
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M'E$:HH2CL7R>@8.WF'.Q*[8%2?.FF4WQO=O3=[L<+[J2]U0U_>UH&14&<BA
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M"C2YDMPB!"M<ED->EQA>OJY1>,[C^1F PU')2\TJ@AHU?,DG$%LI L$K[2<
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MK#R10H#+7\@,!'[JN]>2''"]:8RSL746<R> ,P7]6:DZ7>NCO]@/D^[#'53
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M@!BS>H0)H?7GEZMYUC>"\]=%&</2#8\EKI-[$M\R<:B#B\V;HSMO*<U]_0W
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M_T9-^$GK^S?I)DHNTI-5PR3]_2[X$99B&WS_:,8A/M[(K7QG!+F"_'8 <H
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M;Z#>]E85E-+H]-T(2!"Q.)YJUO8;R'8+GDM=#@XE/Z4_5F9=)5H+_*A'XX6
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M&P8N9U]-S)I>\1<6*2,BPU??=^OF8J/2MU:[V&>23IA]8O'Y*?KXSDFYU^D
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MZY'LVS$MC7[4+6$C8Z^]Q%\OCCY'ZIT",<1PQL9).!;J&D2J5[&F0L:O:>_
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MTNN/0+P02#L)' 19\%"C3!^!!OCA"J-C,\<91"WO/S.(*8=U"JBB?]6-]0?
M5;#$?7A'&L!VJADI- "W$:6\SSLH^$<:T:SN'VG$!R.R9&&COQE0Y=C1A8@@
M X]'-_4=L/>1  BJ&8[K^>M<X;4#S;\'SR]M$>=U_9NA^PZ0.43LSA:)FX?X
MB#")UR<'.6V1SN9U?7*H$\$)H$.=9;E@!5,%^>45'NU/WEVP>I_J:3&?8.A4
M;>8HL9.)0"CG!<@.#PT<3\8>Z)$IM%CT4K"U58S3X(\?E24._B-E"%$$'Q/0
MKF,"F@:G-OSA;MFYC#BA]\9]YGE2S<+F8=SX=$^6I:J;B^@[7:KP*XDWKN&^
M*YS_ZDZM&"AR"## P%OP8<Z*#8#,G:)@=2-J[BI4XP1R>S)6*^CV"[^5OVN]
MZ@SZA0N;*B(]&"8U_0W!?5_"+JB;FBN%HSI'@^&S0/E)F1XHC2Y0U :16"-(
MB!>4!0@B*4B.TC6"(F$=)NV9WRREHO'":"/V^Z6@IMO2JU+T*I>.0.()_S,.
MG"%* .?TS XAAQW:LJ1(,7_3H@ =+D (0_\U17M8EN\!B1!,  A+#QB+[B9=
M^+M\%%H9SD"2K27TX1P;*0R#)A?U<+8H^PQ3:?)PXIQU, W^UQQ:!0A)"."[
M@XZYT#ABI>L1BNXX#?[[ND\,A;86&S%M8ZB^67;N$[M;%8_4I@WD8?MUBU*;
MKA!]"\:] YTKC^7ALO,U]A7[5_M^CV*,&M(NXKT)"K,H*H+[+]/?Z:R#<X,;
M%^A-]&Z+3Q>VB;;EV/+OH4#  QJ.U86X*#0KQ*OF:Q/Z37)1BAINY-C9L<P3
M<<+CYY2Z<E:++HE%!T<Z^#QS7*TBR0$_,$_Y<ET648<DB4UF\O63"%X<?A^[
M;;NY,2>_C#J\T,?[,7U:F1-9FONEKU/>&U1TD'!3MNRM$_J6(RIO< EN#5,A
MA!:2C'&%&7.0BPZCAYNU>=W.$BY;MO99/SQ:36($7X'602!7$<X(D=_X?O!/
MQD@K%O8\?B_XB6,/@:VH5Q;$HD)A)H6_*5RXA(JQO0*IB8V!T8<Q[M>GDUOG
M%W,3V9\%_TR+7OUEPZQG7<YLWRA6F2>'1F8;W>Z;0T8K*YJG(5IY!8<COBSW
M#DELT5X",=3R;=P#>3:B/J&^(# )2*Q6'R.P+AJ4ZQK/XWL^^YQKZH[S>6OV
M^/2\88>9HZN/8SA(7E"$,W #F0 ^Y" G0)ZYA$"*H*_G?];Q^#S2_3E'1;Z"
M1:4A8&UQ@^;*UA[IK]+R^N^\ LTUS_-IC#OTQ<[1BS79#.(?QBA!&Z#5Q%+B
MQF?2&NDFL!^RE,$9YI=A6R_[@N#7 FG":66A?!KQ09$?-A?"ZW?YGT2K<8]6
MPCNA6&WPY"W\&0(0.]'A?D9-/'[LN[?:>[.<,AW];!:J,D/VY%@+SGN+6IM<
M8(QTG31^FF",4!DR.E7"&6=H;TR(5..==[SS.%.'N[BJ1!_P,),-4("_ =;:
M^ %VB_B8I(A[P^?HD]$49ZSSV9532Z%C)GTALU.BGQ7]TA'71*'O?LV*>.5^
MFFL*=CNS]C:E^Q(\:R<?*[&_=OC;%6N>TBLL,)IZ!-*PFR_[SV8*&15$4T[5
M09,/O3D GYI20:X^ F4V UY[/AU=%$%16(L7(4(EA@X0@#TL\5%^ >]ZG*4R
M)M_^W]91/RS[T] ARL>&K@08^J0+M-/@;UQQ5S>%'?F1\):RH4;2W1:C_((6
M)\1LU!+%?9"S\,R\J=^&EH)$P>0 )Z8N45[57W)\M,U4\=2/UEO1LC(Q!)F)
M 1[-JVC"EH>'+</6LPJL:Z :>+W:LA+:H@TO@6D04F=G@M+/U>+ ;V5[1)K\
MSJ25;)A&9[Y,'"DG+A@/PJ+O%"Z_U(OO>')K-#6&(%2Q?OC(FR2A&S36BECP
M&"PY\!U>'L@SI1W"*Y\3[9%^("O\J.'&E^ERHY'IZ-ZIF ]HVS["C7T,0_T,
M4T.^(P =8F$:->77<)..)?>KW"LI?"Y, #?S3$AC\$2A7X@^&5A_6EX>(N+O
M^-+X2P0_=>R5R&NYT2#@'RJU[@JBX1G"5C?DIMF4 YA#$>P3 1E>N5B7)W+Q
M%4C+YMW^;OW6*SJ8-O$)HJ&_ZDR4G>=7TD5LP%()K/-WU1$H3&V\X+)+DF.+
MP]<.(067O2A6VIB$U[/$FWOI.270;#N%@L?+'#W[B>&PJ;A=Y:AC]1Y$P]V7
M,V,S>.WA&HEOT"-02Q,ARN9&0N;D9$]Y@/*$JG4ZX=W=2P:B1=\7.KNB62*.
M0 JR([ 7A,6YF8E;<SH9<T<@;L?1:3X<;VY#H8OS!^<7KBP&MQ_?EJ=^=2T:
MQ-(Q6A;<1!0RRSE<IEO0$FGR5[C5:]I14,L6!_D7XOIW8Y%J8-ZXQ6U23*=/
M'T5-]IB[7A'<?DI\1!FI4R27*(O,^#2U'6Z,H+*G.GM.U^%9_:SMV ,GKJA'
M2(+8N3\Z/^O6 M_X$G%X*LY0;?/E\\;W+#<U^\WXX<>EQR60"L$P107<W#+&
M&96K-!.LJ&KCD?W[1@63]<KHSYB;CX,4WR1>EBZFEU.K!)ETP>?^&(;YQUR#
M"MB?<PV247F'^JASDA%19H59<R3OX"PUZ:5O!7TL@FM>:-T:RC,$IG2&04R9
M'=&@!Y=<27R8?T$[3S7WQ4/0C*_CZ?F/#$9I,?-0\6-@!$4#P*@%203"TTI*
M:YTW.1EBBV2EC"*X9'1!!$%=MD/\#_'F'2YKUJ+L[OANPJTKJJ<_8-(EJ:[3
M!OA):;XW6X\9+D[ISTKHSS,8O^;FA,9FQ W!S')7#\^D95JL^@6/)&4<?&OL
M=0SU]P?+!FDM7K[UR!]D]IPK[-12;=XL&XEI#1]"6&:,;T)2*[K(U@U[5M8-
M]J:Z"#V[/2[6EQ@SF/9UODYDOX1"LP4L@@]!EWB2X-6[.JA5@8/&1 I)U.CF
MU/-_:)<R6^\OLBE_$/\*J<!.O_7*<8US9]76T.M;3'"WHLI"?,C)N I?SYWB
M"J39GM<8Y<5+!.$R=./UK/^DMI4NX2GBJ7]69Y)7Q8TZH8&,'^6QU-8O)[UK
M+8Q/4B]<N ZMF_D^^A;F.0\=%ZFOF+GX,DU-%7>XTCAH68&.EE_VS^;!^':V
M;9^02UJ*JG%Z_^1$BU\+2QN4Y5J.!S\LQ+/9)W+@>O051O-JF32RK,O=G4$*
M_1/"(X9H!";M'"JV?+G!DK\8K78NSBHU(..STFOIUIG'IA18WJ$N$)%?7=)
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M;YS*EY8>8Q0T6+Y$IM5?8]57'$']]JN[.XK   ZB&!E>5MVC"2"3ETE&$V^
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M+3M 4IO=N+^F/BIC]KZFJ+8\H'A2,_1:)[PVYNSG.70>9 P]WT09G"E&-,V
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M@M:4K74X'KD[G1&@>#QRM[:G>8";__J71%O!GR#=6<MC[<>.G\^PRZ2+)9B
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M /03B7,'(+Q2X@%(M.< =.86Y2=D2Y1TV A='_#N[=M[\QA($$6$D)N;+,4
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MWPL,,@#WNE][R_DCHD'3,]EB@L/:J8%SYP6FXM0WR95L >_4F*I]JD4SO?+
MONY-Y<NL[Z[J?9?L3D#L6T$0RQN!E%, J3R!P+>M=.-%^@#6W-BIJP+)3963
M(JD7MG'7S:)3W!GK:EAN:'><F*A(:"Y>>=0PL8^&OCX X9Y!2*PS;3M3%1R9
M>*^F2=XA%=UI ZX12[GMSJ!2:\9+:Y,3$K>?BSM:7I%69PUV.24;@0_#-.0H
MU5/:FMWB>87OM4JWCB5TM:],W5C/]MHHWNO L\X81/A)W0NMM<!VL\(^F3A/
M;_L:^0PR=BO&OY]_NS>T;$;B=K"7L2!Y?Y'6$8@G0;AOWEUY89B;<,>;A>JB
M8,7TDMB&TS3 >;GA<#SW(C\=#A6B8I:3>./)E1HZR0BK+K:J:]>E:.8>@AJ$
M<$[[ )\(N$#YJH1:.48$9[W%QH=!> @E>^6%+I,7$^SZAC^UL>=XGK7E?7+J
MM 6\+49,)LAVT3;[;*^;5>D6OWSK@YQ')8WJF1?E/I7OSM750T-W3B!XM\D1
M9AM4>,$&8Y(\(10%>S$;/K[ '=F:+,8V4C4=GVX;D?(\.R*I2=R[W9M?X<WF
M3?,03S@Z6&'O??D"I+1RU0S/N7,;'[VSVX3D7+9A[8>ZICR=([=@[C28PLS/
M9AG6A5BP^XL*V">M X3IL!2=!5BH6O5*XS#9:^C &V^:;B.-ZP=<G">?2+"?
M'(X/F/D@_*2OZ'KB?9['?>X["< ;&Y+@Y'BYO4*X-FX>BBZ.J$S,7TA Y2[V
M7:!(R0LKRZ91?^0)W, Y]<3?="8JJAJ@FQ^?I3.!<6]&RY5'5*/2HOOF_(+]
MF@!+O<*=E>[T$>Z#(]<GQ9T.;.&F9KEBZ#-N^0C)7TCG^J1F:!GY1L4@&S;4
MY.U7FCYEZ9BD7^C,-QN_FI%_A=--Y^-,G(*1AN!%ZM-NZB?1L>"3)&F\5#.4
M[0#T@(!H&IVK*?P5O4)6:K3*+WA#K_TNS.J-@,?2-=0B0*B<<*XM?U%1XG3P
M:Q6/[@,0G59T)GM-T#>IQZ@K<2U/AX4>GTV[&L5LOMS>=B=;OS?8)GB69!]W
M__*]>+>H+@/SR7TOZWJB8P',GL3+2F1;A):A5M0+"%T\YK;XX,9AL$5)[;2E
ME7!#3:5[65R:Z2+;L\WF6O].9%<W05ZTY?0"&&=8J#^H;>+KVN"U<R>0]+12
MWAV#^'K?EF"VDDAB&VN63SM[&%^#NU75Q9Y_8T"UM!/6Y<;P=E27P7;)1I-J
M/(SB!+SH^J@-8GASIPP';G[_(&X.<LHQ5&[\C+]=6L_ QZI(F;NN3X3BS41Y
M0KK9B\[<A+U4YR-)T0__>,OZ.GR]8].LLI-BOQT$C4?@3-<)$L&MZ,.LJN"7
M& -FF/MTQ<?ICLA+?:9]H@,>'2.2HXHF<7KK?%C!AT^R0*_O,5#%G0+W2]'
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M*_1K,"X+H'U(MI69,J)$0B6"O^[I]6E[SIB,C>H#T)C7>["G'%G.;!I-XC/
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M!K1<.=3Y]Q[/>Q0EV.2#DQ[/94^;.Z 3M_T*^-2 ER1(KH*XX,[W_#S*^+K
MS-FMD*?@<L%<N+K\?2O<*78YR?-"Q,-816Y9:?X$;JEV)#5JM*<^VGP53+D\
MN6](K.@XUAY!]+R2S2>%7L_:#J;U[$> 'PFM "9MFE2\R$A43K;W_LM"Z:^/
M3^DC97630,:95?E'W,8P$.Q"@[L33@X%#X-H/_-DG8T+E^]QU9D"A]^4]WY8
M)I;/?5'MM&HE*89T#WNC&%O=D3H?ZKNA,;P_P 0:R%Z_5;2^,K5"SWG35CPK
M?VJ]153K]D(\Z)<[B:OOI%%Z</Y[21KJ0F&VZDV":;5Z?4@X$U[3L_PC WE
M_&HY><-OGP/=FPF^61+620@)3;*2$'^B8.B^E51T#&!N!2XL,8=*X&@I]$F%
MSO1G$KL6,('Z8RE/A7O.9@Q^?/WJ;-W+57Y?3#P),[Z_A@M#:43AQE&FX0T<
M:#%O_Z_@3'WX7TT1EB[R1E\UIEJ2GGT.Y0X^Q2-VF$NNABTDP#F SX&\Z[=>
MI83LPRX33&["B<#6(_6H&;.Y']+&2_0UTZI7:;AK#M^Z2GZY\[FNXHF58#_T
M5-_O!^^POCF)C:-S:\5&>Y685>AJK^\1-:X_-TJZD=B!Q!HINT*F>H20;TA
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M^Q)*>!F%RM&L'GEVNE>RU*UESKN-6.QO9%]0Q'CBE/$@Y"Z%#[S;QGNE-R>
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M<"/P)SV;"+[/0R=X\?[UDCNVRY"!Q^7,J)G&=XV-H#F?JJ[#>=-I.]=]8/%
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M\"A[.,!UJ9/)LU\4T8:8$D8S=PQ\A_WT741<)0P3A7N)S'A\I7<>.:YW<B4
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MD$4!D^]3U"I(YB\1>KE ^JTZT_-P2TU?WIC?S]O=2;I7.I7-A-J\=R@A%"4
MC4>%V(I2QXGAD8J'(*95_!6&QOX=QB+7&QR,L,L7S;"W@[4]OFVC<Q4@@.PH
M 8;K4@R>P1.V(Z+."!1SWJD]XG+H_IO+P>%O+H=+?^)R:'JP$=8HZVO7;JM&
M H<I9 3<'J)<QRE6NS@WC^#L4;?)U]XTETLF+I1'O ]])@CR"&:D.FA*'[4R
M(IV0L6G2M4$-I(!6?&^0:/R=TTZ:#[<O#BA'PNX9@'/\P,V'(*PA7JZ).</
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M3YT\;^C\6-ZTN5W2ZM6+:6+;<#(?P-C ?Q\#?$@"MH#.G(M::R;OB*(0G>W
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M9%$L:W;V[L4QD6>K+?")>22)C55XI'VE7*%.AS%Q0W@^Z?8;_<X-8AFE;SD
MET?ADIK=:#L$3?#<!R1P&YS85=N+@^NQS38WSZ<+K+V6?EH>_ !O^2GFU,,:
MWLEC%U6.'["?9[Q7".IL.<'^1@LI['^QV@]7_'30:+#DUS-%9L:$Q9%5K%D4
MW,DH1#1B];J9&2B8[3HH:K^$%N_R"#9NN/E!'OSN)Y>L^$XVK&;:Z D[P5X7
MR@ 2*X/RKTV%D\$;:I>HPJ:+\4,%4M:V\.* 0K$LPF"="A*0S%LW=2.?#!H/
M.D?41.6/.5N)KM:V)WRY;0MG5IGJ-AL]%GG>L7DN0;_DA_+,JWD(2//B(:CY
M+X TB^+SNV]X"&)(QM@5^QE5C2:NC[+W5!H^]GYHIA-'"2BFK5W81SR8?;5Z
M?[&FH-.AOK$Q(S=SH8_/X;'>[+%UD-#))^;YO(T&ELY] _)C_M',_+RI+_23
M!P*WAZC?$"?GBL7PR&!/%/ORU9']S.@2*ZU .Q^ZL#@\WYG+RB)#[+8G:29U
M[R",PDY^$=25%I8T)_,<S(!LEEN$FPE?>/<Y^I;OG-MEO>K+^2]S$=\L?8^5
M,05#48;C*"J3%VEF5X/X]J>F,$)KV%,&W.UD;)B,Q5)'Z!_K\\[5Q&G%>XAF
MO'SR/M.O8*:BFG(F<2Z%@/R8FT0"XS7KT$Y,$Q,&,5IV]E=<S5A%N5<$GW/9
MG]3/E^J=?#*:(EB;[> ELO4,>LSN,S[IMNFG3QF#H^F_*M$+ <(:^%BE06V2
M4I;#H\]M1196-OJLE10CO3,^_5)O$B5UZ3Z[TYU\R.MP@LY$_%/#BQV3-#/_
MT#-&=QQ6^BC\H\2D>B/R8V"BG>UC<;T8+L2QQM8,_\N3X<4AZ,'L>^2WAL*]
M(,S;^-<S%3JMX)=/*0!/A^8E(FP7G;([LR[DO&1 =DBIZ]I23[$A^S1.C;?O
M=AC;I/PI:*1'--TNUE%#H1PH0A'='F5MV@5ZV,X)2V1&#P20R&O+!7"TA3\.
M-.#5PZ+F6O>\D[L%SA$(J/6?J';Q>U1%G->%GJ&4ZLMW%>*E!TI]?!YWKQOH
MB6[J*0KY-*N7&JT']G($?[QQAKM?+["S@P"F\#>1[['J-QV"3@>!9R83/7(-
M,L4'./2BN</NOK$Y+T$NB*LB-#7!PY1/B9(=*(*Q9!/(*\R7,M^KAC6ZE>@H
MU>"5T%M-]M8,'HJ#!;/)]V]=NFH@"]:(Q\6OCY*-?+=VKP-IF9< +_0/'(9=
MQ^7"NUIK1]F;-R]>S=*YK/Z,[=B" 5.P_#7%<K(9=1)VAI;:$7STAAK%?0L,
MS]@LW].H#!$0L%:HTGG8>]RZ@S]!E^\QH]JU7E )W\-T-$$5P@-[?<%8Q8+<
M,6ZC5^SF66>%;?#YY:=QQL@V<B]\)X7,0WD$K3BU'D\<;4]P(>M$(J[:!7H6
M3 0_4&!<D@T@)/I2I/!]@,H:3G1:Z2"XPI#36D< &DPQ<M/H*FW2AT?D5+O4
M/[_3Y]8AZ#" X4*PDY\A[ %[G+4&<PN2FWH10-X:',K)1>4"N?L#(^/ZW.?.
MQ]V+8N;PI4LP](_'@PFII!#\Z.N2"C 7P@Q(Q+LP 1]K!KW<.&VGL0^>>7G.
MG$FXK#1J^NAMTSV=\_6UOHPW/J4Y+(ZQG4*'=MSD8HKJ3R(X5.Z2XQ71ZX__
M&P143/)UL!KQ+OWE8<AFTA.84IX6+Z9$I:7C1QHX;+V'H#3:]2]XJ/@U4F^=
M7#2LPK 5$H]Z> AZO=9A>XF4MVN8N@LA$)R7C,B0U/+N3<J22WI]Q50UWUC-
MLE1L,7%[2M699:=,NM:"A44^T<>CL;$8,T0.H+*2#CXIQ(]O49F@GV2KGR>;
M:2H/RB)D99^\$77ON=*F<"Q20]C:=PY"T*T\$#(G]<%,*%!:H)H(&D*QU)^#
M?UR!\2@^'5S'GV[9/5!J,<JXQP)R^!JL9W#J>>OV=LD=6R93^SYN1,<9]]AG
M'1RERD[9A*<Y0>F*3_H&H(#RVBXC$(#?"#,D]9+;1FR92$'1S](LJFMB?D"B
M>=WDK=JCMYC?)K>\_*:=W3@4[Q_$-_HAZ.=,I6$K#-O2EE],T2*%5>.G;IPV
MFYPQ?/=L*)3E2_/7N-/>^><5[^G^^+%83ZUU'\HQ$"SST0P/+^L$6/A;\)(O
M*O?D+@Q3J/-!S<@F0>AL8RTLA"*439$$"/EZ3FQII>..MK+O%"+.?;<@;.C^
ML'E_$O6+0-<]4?%]IE080N)&X:>X)^X/H(MV-%1W+\DT'+%"7/G(QQ*777A<
M]30<V$)K :SD!PB#@Y0-RB$H?%J=I/-Z2R)35^'@AB[!5?"SS4 32M( 1%X-
M6M[FZH+)W4<,3<6G]7YE2SZ?A0Y.$4':4ZYN5LW\?[00&O$4GNK=BL'B5@^*
M5>I?/BDMM;>*#T&!BOG08GO?<BJS#]G$=Z!75TY3'NZ>G<7R3/I9D:#G\L\;
M,0UJ[/NC<KLNMFO[OR%J-,>P=8GJ&[A)@SV&RRF[)4 YL0]W]=O&Z0<(RQ%/
M#;$F_]#7NU:O_=.#JXD_!*3?B-Z4NU+&?5QY.+7\)2M2?.:TM*?+E8[:J>IP
MMQ(O*'ABIH\[U<^#)TEQJN![,Y\--#3U>$)#Y/D<X!7I2BN*&W$+BXFJOUX,
MI)MYLE?^*@R4(;2(BX9>UNT>.Y%Y97)$R)_W@5RIP:\]S8VPKRX+1NE)!@Y2
M?C)0&/3;?@B5805.'$;.?K!E&*)* NG:Q(ZP>C71M(K+SEDN.0OK4K58L;]P
MYX[?T6^\^>6W@&KMZ/9"GK/2?L/KJV:)+5XN[L&ZN:$M'9*9-Z78&#0_8>*P
M.\AQ\NXRT$26^AQ/<[RML#. <[?K(>AZ,"F[M$NHK;'GXK*/ _!WS6D63X@7
M3,&RI94B87ZEH/2,LY6>59]K@QDF!%K$+_6[H(IF +^I(U5O&$;Q@[1,CW(U
MJR[HZ<_$!SYM<H#4(8@@1XJ_'2 #GP-'#6 -A!2JHO6FK[SG='S+H5$>XS'P
M]1!4[KRG\P,-OL),'C[G9HG<%/LE1N$"4YGV9@W'Z'"[^;D6J_[>#22S7P/7
MLQTO0=2M;FMSP'M>^QE)G*OB-G\CP3R5\KN>E!?C!8T(NC1,6V6;'Y_A_ OS
MV-"#H9=N-5^3NA-TW4%=5SC<U8:9T_/E7)^D.0E;YCS^]:LM=>Q]@MY\@K/J
MMON88[^5:U!("T5-1RIW"*:P4'? \\0?O)Y'UEJ#EID3>'#@""S#S&? T$B_
MB?'AITW.OS(G2\VP9<T#VA;'KSW7.6N^PTP^&S26>?+@:Q"S$U69*/RYNC;P
M)Z./DX1IPX KZ#>AQ.[$^MN@'(O3WRWY+ Y!8HHC""& - <;WVB#E_@*M-&R
MX=>5]EC6WJ3 "X6W/X2-7QR@R]41_Y:_?)U+N4BRJ*1:Y6MZV+DT+9.0A7PA
MSN51AWW(J#T797 ,V12 A&LH#3^*QT]V%WZ[#/CH)F&XX?<-\7">=@S1&HQ-
MZ<":MF7LM<N=OL[565;G5%65]NS#U5//DH_>JC"]T7EFCCI(-Z^E-NJTR(&O
M"*PI_X=QJ/]!=N<>M>405.46#7TX@^74!T)PW%'ZZ29P:S+?C]/.5:XF76X7
M54!)9J< &_8OWOCZ:IM1MWKC$EMG_XR%D:Q\YRL-PU-30\4*>\9JW'ZBWA=2
MQR,O1(HFZ!4DK6^*L>E!B@[N<[9(*]KW"%C^7D;2,H$O>90S&)P#Y0QS4[[?
M[)2K5& 00XNSIF#C(^Z<O*ICT'.'(&L(=,UN,B.2A2G^ QSX-;"CG\%I7-U0
M]C5S8'/ -)-Q]DV'-(<$2TF1BMF)XPSS[+#;?Q? =04-SC JZ'H>B,R!(W.K
M7E)0V'RWPN^-$[_FDHAJ++,L('FIKOQD-7+\!E2Q _ QS@0D"Z9R C6=U Z^
M4U'P3""+!&^!G$#P>.'E>'U#=(CMH7;QFH<@XSI]1Q'I&Y\GYUF[=4%>HB^/
M7<2\MS&F,O>0+9UWVR6"9"8+WL<T?7"Z=_5@._D#M7(KI5T.>ZH#5B';6(N*
MJX?A#7EFM'O[]0M7+T\=H/Q.)LNOWW)VUS0!(3[8@4PZCFAC'X41-\XL4?O_
M40:O,W4((EIA )G7L*KA$,1EP&FWT"WLW@/1_; L];LL5)%D)5;>S3'ZN"E>
MJ="'?*DF;^JNH7N9Q-'WD\0'XZ4-!R]WEX4=#V[!C:"B V=2]XW_H_/V&N71
M(>C)[MXAR,#*/FAO=)./6'Y$KTCO&^QBW:0I19(+V;&.]JY(WKLYM#3XZT)H
MJLTGIW/VCT/?\N8K=TIT'*_;^$/9B+H!DZE#;^JF^LVFG7)!N];F3U%E9D[;
M8$ <1<D&S^4=_"6#I/VB.==<DL^_P("18T,RTX-XA.>N#,1>[;^P)]SQ#Y'A
M5Y0CD>'0#\B5SFE,H1550UT-KW&SB7JV=+@B?:U'SG3@ETA=64-%ZH>O%6E*
M8,'2[]F75;^P\.F>?7D=;?:',N2Y-IS-TS2''QY0%M,>R>8<E<^;A<Y'M.Y_
MT_!<HT".%JWK:-$R@N#F^O\B)65-P4K6*0;QQO!^>V6)AT1/XH"/AUD-F9'V
M;]QIVW9_)0A,]$XD%LY5Y5S(5G7NL/_H6_MPX&SX.;OJ!I$+WN[<R+H*\!77
M09&@5E]DJQ4RVM/:1?]V8_G0]MI8:]6>6:+TS][73X[(FQB6K_^+Y$U<B :]
M+6-O3375656+J+A&I@>Q!RG$F<Z)P+[.CIT\+:3"+I1H.X,=-*AF[R Y/S6:
MAK&M<%0?;(]D4RN3:,A49H9@-*>O<K8>:"IN3HBY]*6T[(O'8-9UILO;ZSIK
M#S#CE0'HM7G$!N5F=\=OW!YM$=]"/\&P=?B^%NCK&;KZZQXD!\N?VZB3J]R<
MX\[LJZY,,RVBS\JNO66I[_UNP3!G]K07I$C)0EPK[:_H$U[SGA9JK!FB0-V0
MZE;V"ZVV)J/>A2(,]IY4[B=,MW=%HU+PIUK[.!"6)$YGJB2)OAKO8OE3>[2V
M>+NZFN5#PID?(E<><OCVO;#P6G[DWMBF5C=);N3'52=INYJJO"^>KSA '(+H
M5L& 2 ZZQ93V;%[YBA@#A7@7@19A?N)Z@O//'P6Q52DI7TK6'#.-7[]FO"3[
MFZUE_MGJ&FPP.>/SQ.KNZ2DK0];ARF;&\VD\8,$"/Y8BY;/[450U^/ AR&%C
M(FONU'K))VCX(8@=88PKO%1W0,_<GM A[<--5DC_.(7"CV<:JJ?%V+(.(_H=
MP)S$G >]!:U&^4X7X!JU.U94%NH71_1BP025>8ELA;TF HLV,/7G(4['$7ZG
MW[CK,7,&,XL^!%5@VC4DUBO1,9I2^D[*G@-8&3'?7O>[GV[I[O9>ZK@]]W<!
MS\7_K8#G*XIH @6D9EY!'X+#L;FI=ODKV+TVZSH]^K<?6A$D)PE>/;02^\*M
M[+ Q2]MKV7+>L,6M]LQ+0]1S0(<9B;[2Y^+'(GA*HC//WOUCC8MX\\MZY[[1
M27?K?=LPD77-;JA)<,KV>YH475?'[?#XN9Y8@M[GM?Z61UE:3C7[8#"1(%B2
M;H083-[8MGECI,4U%'CZJ#;T3\/\3S(O_R%^?724*O[V'T>IZC/F&:E(1O]#
M4"HQB!91OM="YF#[=^)+/W^*(H';F_^K=D <\I_I>X_:4_[YP'&B"_GZ /G]
M(+&E[S>/(<7M$*0709OS,LKW_SE-?06RJ019=A(313WGVS)G5NPBN(+S. 0Q
M[ ;;F-87UF2!O>2_=]9>ZV]G4"\>>CE*L)^:].9.Z+L2@0]EB5OZ])E/E,JU
MN41AA\UF8+YA@(MNS77*?P5FM?+?!Q)6[W[@RP32D\1&GQERT"T'-PA0F3CG
MZE!AR"^H=B'O3N]*S&"]4,$/)]68=PY*9=(&] S?G^>]C5-!I[?>'2JBSOTF
M:[3U0=+N[J5(;AMT4:@.6W3D.Y2G7P\^(1WC!7U7%TI2*=8T&/&Y6JY6UR[Y
MJ2]>_?V)&Y]!RL>.SID5SYCWY]@_"2+??N_49!SVPQ(1M[=K"="B&//H;@J
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MO90&LB\V'OU^+6TR#@KQ@)BT6287D9KHAD=%^O>DVUYW\3AG+21\_G:'8N^
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M$&3]-VW11P!6\I65Y*[9OC!-SLI,T7->4H77/\.^VGU=7 S<G,UT%W"<!8%
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MV&,?]XX_V[&XIF)3?>G5Q6.BA,<F\PNZHI!6VJR@1(\E@AQQH\UC"DBT^8E
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M\,8,00F11#,]FNL+?DV[ER'-)SIJ0K$3-C)+80B=K ZV$-5>X2MNV09GP[M
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M!1?36J<G/XJA]?+R(.D# :_Y18I[J"V2DU"2LE]C: &R7@+N^?!+98D?18+
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M[I/7EZ?=@\;]O<HS-.HHR74\F'K8"&9B\]E=!U\UD8E\52VOAX=ERTJCV/2
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M:S;NE*M86^@4-'\\VDVF.JP@R5HR.U!D#VJWY?<!%7<:(#H\C29S;!)7>F@
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M%:J1$,&!BJ,!V[X?T3-ENZ1/!@N2OLEN2CT-6%^S!5F?GZ\['H7>@A3Y^-*
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M."Z[&R^\RS*?--,VTZ%+B/]Q5IU181X?_0S*\ZKA879R;K7&R]ECGWW/9=*
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M<2%6F,Q6[OPV+E4O>-K<_(TLW)P&'$-2^S#K0N1=MSB71P/:>=,G42152V(
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M[B+O?:\4)ZGH2U17AYNDC%,R[VN5C=SG3KQT,/W6S>]GAG7+,#X@CSBTV7(
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MS)U$8!YB+]ML8K5#1[8VK&1*]FJK2F&+P ^X2F0$T9<\3&PBBK#X55D-$O3
M\F[OZL&V\>]CDZG4#.Z+W[CW9QQTN5[TX9Q0XHSU Z[<_U#\"OD(7MW.DG&C
M(H;AC)=TXV;43M;!!B!!/%PMMS?0UWFRA<L@WOOB!_KH2+.PP_E>8^&29F61
MT7G% <\F,Z51"&=U P?P$41*/KZL*[H%SS.,]%QIO[UQH2[7*:P[Q]NR721E
M).;.ZV[9CR]NI\)&4TJF$D_1]W)]N?S/ZD4XCB:#=*87).,>F[!.XS.;L&^'
M[KQ=#-@@O(@]^&]L,$%,%0!BU!F0(7G1O0E+2X1VUH?+B_ZDZ9](0Q&KW?_O
MQ@&#+1;'Z,H.P%&F ,N-'AVUC"O'&%(MMOK<;4L-^M:N,^RWN*"4(:EMPD&L
MERK["]IVRL7"?GHKK[]D1^ H%'72]*3.8B/-IQ&4!RK9>52R*#!MT//3T0(P
M_.&)'?#RQVT[:MR@:Q@X)OUF-%["8V]X%\Y,<_$:J?&O@T-F(&C6!."X<A.2
M9MY-,F"I]&!ED9AS=.UDWSV@G,?@KCC?G/H>0ZV*G8N^1][>B3),[H@T$)#8
MM>1J]ZX;Y(; U?80&IXE6DA5([Z>==B^%E[O2)E_]6SH!_>T3BE)_OLE+SV=
MZ\<&75/W/9*[?D+/ZJ!YPY64>Z%!_^94"=%(NO&$<QS-A8I_4']MPI&\0-Z%
MMCA?,Q@(;333ADXOE+"Y9J:<3="(U!%2K-TD3+@5YM>#C(73)7&0/J:ZLM-!
M$=D:B%'A&/A4-@1VN*\@2;BKJ_[3[*2%!EO\%&;<F'0'M:ZW@%TANC:(8\QZ
ML$=91VG+\7I:T+:F=HMYI9$^0TOR48!4K+;?_ODCU]B2S)Q 7:>S?)1[G-J6
M_^J0YGKYI"TKE1\)UJJ#]RI_9/U]4L!"(P;U97U);A,6E$28^>P0>X!P$7C_
M?X%E_-_KWW$1#(&C]*?U2H>\,C++9Q/]]T0_\K8 .Q=)]7.Q,8WFMS[,-%_W
MOOCJ]:6[>"?#0]U"M1JUQ_B*\O?=GSF=;QN!^=<R".;_KL]&_=V*+!WW4)!+
MQD+4(EOZIU.TI:%H,NE_NMKOOZQJD(7"-5H0IQ1P%3KLQ]U"N-G![\0RJ7^0
M%6#.#^^99DE#%N. W3]EPZ^I8CCQ71*N0TR?#S<:L FSJ$T([30Y_4<4?X1(
MJ81+A29&(5;"\VU_7D-&X6AH@05D\;S44#,^Z81B<LG<79NLO(]4"Y%Q Y>4
M=H,$-<SB\3'8ZJ7/:4LKVJDQ<;<<\S^L'$A]GE,(V79M_<-S&>1&1*(^+(UW
M>P_F:(D7=F_E4\'6_G2I".&1SR4C54\&-#MOW3NPM[[&??L9\,O02O@F;!L<
MXFA/(""WK9==M:B%$_86'R3SZ7G<N(T4:^>[="7.<SW$YV=UHJ& 0OU[MZIS
M\R@M4KNTWCWX7#0UOQ7^RRF2'H.1F5#]PRG27>9=J\7ZY11)$%X/,/@$F9C;
MQY3XX@7V?FG,K.0TW^C!2P1:Q.!IM@2QF6J:G:$/;?5LKQ[BY;O:$Q]/UJ?%
M%!P];__ 2V_Q3.#V,PEQ$FUGCV(WH)5 4/*S8=#+.H+=*VABZS*[@."=[58=
MI7?$]UCB6HNM]Y9#N>%3CNTU?$/;S[44/>-*,7GQ:%T<>$J'.P"M=+D6?76Z
MZC(C_0'+NF!T_D3Q]*,]")^ZMZDO,YR27[_P2QZN>A$I^1[F#ZUF)9GFOM4-
M(H'[9O34<#_H9ILP+CRNJQHW"AGSMW>922#_5W;<3^)7/,B=2AT[VGK7J(ZZ
M+ &,7*ZG.U?GSKT\HI8IWZJZ^,7HF:9NT:*OO&>>XN444VN&X%1^,_YO4P1R
M7@4* $>Y0#]C<"J)_<EVR1J'P-$\;1>U:)LPRG0+,1XK0/>(^Z'.CXYK)].2
M"-&J6KK)/NQ*%0WR&=JIY8C@3^EIC?OXOYO6/[;9.85[=L["_V03,9T G-"9
MW%5 /PKR_)P8$P-Y)8JQLIYWC:-_#%4;VRM5I_1H*7K%'>%7RGIUX=DKRU(7
MZ5N2F6N9( \TZNW7 4=('EH LU?>#8<&;@0F29]\;?8<.-2[H37P,_UQ1^EQ
MBZ?/*L;XZI:R>-0?S[TP/6>P"?NHTT*.^16%DMU'Q\6@<!7UAA/%%Z;M!U!Z
M3SA!J)9BS=Z%!&OAVXE=E2('/L.VQGIZ<IS#X8>EU9FF J>I 9P4B34$ +%G
MT+* @F,>3(-O> \4S@@ .LL,<8A&7.T&%(>B;J-VY[&KXS !M\&C0RIJX<][
M\^NB1&*'.M$O4@[*588-NR>>:O73HTF4C&+8T,K=TR8#BH3[[T#%KQ!##RMV
M2+<,U-_S1^Q& <N)W7C@H$<[*1)S.L"+.,H]>/6%3.9V7*.IWI%B]/TBWWJ%
MR3@/FGM=Z"W+':FH($UUT:$G*ZU[+-L#MY>;RT>&C<1\L!KQ9]L"CJTG/!(Q
M1_)][BKF7"OR)+46V0Z*,W2X_7U"48>X$CUSSUA/WG9S<Y/??9IK1Q0?\;\C
MM^!6*DMKZ%=LU99*8,E"5$U[;!,6@ "I\VN'."DDJ\OK5<O,IYNP-0%3/X6W
MN,8GB-5;B#45W-+U=^V@P)90(LT<N36$9?X&OGYNH+"9^+=))Z_)-*OEKTQ0
MFLP0 9)I&;K+"Q 1%)V-8V?>Z@L^8HSSU0RZ@PU8OY6\I29,4*U??4I\)*IQ
MZZCL] H1DK&"_HIY!' 0WBCMY-(T+D+/3B8 [18T-I@\8:X5*'/B._GBTQMN
M'O=!FQ3-MUYRJ@_+VJ5%K]99_#R["=O5Q,X@SHQC=T!0C"L/1X\%3[ LJ G&
MC0W[^V_[^EQHZ-4*5?SN*,WDG0^JKBG+UCXHK]%&T3")+RHJVF*U<Z\@LH_
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MYK5MKL=3356:K_)(UKA#.[<[\1@[$X=X\#>[9X$=0Z1\AW1'->,-L:('8U9
MQDC3-:O>U"<#-=1HXPQ*LWRU8/.KPB<1_A*Q,6J1!8\_[C90:Q7_<>'A'\E%
MRA-)_]%5A#&=8P'U)CC-?WIA9$)@6&AU4K8@=(+(XSE?,@Z@SO=H.9U0'-)B
MSCL>4)<W<PSQ>HE4]_W$/6TF[R^?\N(#/?H,61J="0KH]!5CS%^UYF"[Q:LW
M](*L\B('EA/2>K]_'STN^%'EH,NA5CG%W@]E'T12MKZ5CBN7><H,X>2Y[(6F
MI$-/N C(0->'TG1;G:5[T@:RI0D"Z##RE=J4R;O;$YYE*VO:=4AR^ROOMC9J
MDB@#B[ =^,KE9MQ($%7>^3A@/U$(%T=?=RRXX3"W<RK,+.3! P&^+Y\*-#5@
MUF$?8L^92M^S[(D5G-7D1 IM/\%IE@A >;E1'5!4C?P=(5C9R20(SU41_?KJ
MU9^3V.4V#=6K:6*9/AIG^:ZF[\M/V[<W[)ID\J0KX3-<&-?X?2,P/Z92H@(U
M/,'8A!G'SEU^4_N.7D:Z,CH2O?^X0J2*FUVN*\E>S/ZWE%-!6_U5Q! H3T*K
M "1BM&!<U$\+:?O3$"._=_=[-+5]57\X- ==HFJSP6?4JE?GY>N;<OZ#X 4/
M\]>?FOTO)FPX,GEQC9;8G9!A-JS73D?PU7NYA!8;>ZL16%JA8'3)[%7Y'1;:
M Y^_)^J\C57,AFN,?CA75&(HQ@L_;6F(X?BO=2 -\YX3UPRSPC4);\)XA<_2
M/Y=OPKB71S9AT#=U3WGEVQ5L.P.ET[6ZM*\-.R [5E<>]?FPQI:?;J(K2BSA
M9I#7DA8-\AA3\3%20Y'%&&O*HC35NKB80<1-[BRJ8/J$!/?.LI8U=)]:NR2H
M*GA)G;EOM,ODL[X!NPA!6;:((//4^^Q*I^'?GYANK=NYRGCGOL2NUW$=3E2R
M*%>I6ADU[>Q(FCZ[8_"![ZIU\V^-+C])L:S3-#)+]LAK=%_+76S""VQG.JFM
MM/!*N]NU:VZ3^=G?-R:,N/<<,<JP]T@>#GO]2B$&]ILY-@;7"$%NRALX_Z^B
MIPB(.[=\80440=\AT$IQ6L(;JRSZZ>%+V9E=JQCF W]\I7&UWP*U/)XOC1>>
MA*==Q@$Z2HPG].C%2;IR*Y&__H@+7;K)67\(A;'U?>4X+X5-8ZB'!JBLV)OS
MC[7X?C_SZ?()/]/=;>LV'K&( 1RPUX,E7-=*IIDG?3V&-FL/2M- 5[<Z+(P?
MZK_-/"-OSCU=57G/7C(UMGN_ZNOR6LS];ZYG][_H5.J&&#A$@!<&-F%G$.WJ
M+&$O)*N4\$7]:Q+C/6UH<9%Y&.TQT1Z^$-BET]R@S+0=5JU\<#V*@2@?Z_(&
MK[?*/S@JO\MH#RLO(/RA;$[_3V_EQ\ R/=R<G=W !72VD_K%ATX@[O]0)N]&
M-KO&KFDT>OFM?BA5+BMX6.1ZP/VBJ>3> "2>^-NOUI;#JXQ(@$HAPV8:=@$?
M?8O0DTYE-';$4.V%C+0>BZ";#XUZRY#E.YM->$5M]FZ]!UEB;%H/,@U?C6#)
M>-$L&#?HRIYP/DVSY012:U9/%+C4P60JG;VGW+TG3+D]UJ;FH9Z_Z)$S@RO&
MAV^_5;B#QW>S9#'^[0M_R45\_"L7L0>)Q]$LEH'CXA2NQ;Y)7][&(/,2EB8=
MK&.8F9D?;1&4LYL+6FF;6O15O^YN-+)_YY=1U?+SO4VE;4Z??#:X34XC_PRC
M#1B\XAR604>P1#I!WH\T"Y [[Y6WK,2 &JK>AWZ&-*"8U.1PB,5HLW-+&1T?
M.[Q2G',]>6GKI[>7W\:>]IMYCP_GXKS?)DSQKR]8U/KK!2&P0[M@ 1Q/HI 7
MA^E'FW$"E6.\3H#CY"9,:/TAZ6S!E<:@%TY.ZW57R\, D3O9GAV/A49:BA6O
MVP0=X<:9<++27J%S6J4\[K..OIIW&,QQR?4D&1955Z^M57.C?-U00N(I7JZW
M1.4,K#Y].@43NK =AGQ!5-B$>>,!W7(*OFED_8:^&/IH*TY,S7?I^5E<@!)+
MKM:\J^Z,T[<H4Y>4F0\I(O'M"KE7D^6X]ME^HC=S N)_.Y"*/V?Z";(TB"5C
M#P'DA(&*!-Z)'?@2EA1=+._)>*AE[R:LF?YI2%GD""_05+N4,&B4-C&^\SKW
M :^;K[LWG*@HD=GLX[2VK.*9C(2HTAP?L5*D'?+KJ$)K\<_Z5W_ZQ7I24Q\_
M/+UMC]09]1Y#[*5-&*=DH]R64[*QAT@SS\.MM-WC0)<G",H+),V6'(:DG?>1
M/H:5\TE?TU<:\,6.Y:.19RN9[L6AJ&D51=^BCWQ'PJY$9=M%A'%'N!LGI! U
M.0SXV#3#%Q[=H@XR+*^6,M,-,9 FV 89V[#Z.3S-9GD7FFF?2558:TZ -Z9K
MV]A4+Q8U%/H6=6M\6CV3(FTGZGK?:BSK=$#<VQ@>GJ4YB$AU ZHZ"YS(U;8I
M':F@!)8CNW3R@/9TD[ZT07]@9?=#<D/2W58?9F'$4^R BK[KM7CL-6G/K7-S
MRG3>%C(MN"'+9\+72%6:@7Y'[,FI3551(V#\JM)UM*D?$DVOF4G:')343C-,
M.Y7[4.;]J">")8M]CR&67T4@'W B.&ZZ1X;Q-8]M.Y"<WE7I#!PTCOC,4$2C
MK"KX@1[/)$XDTZ44LXJU]1CL_A"2,F',L;Z+8:^X,GG(=>7C"-*F=[<M;0@Y
MFH?C#[0\I+1VT%#D<LJ?N9('.>T&_J-:\EZHO2&&R-3$-2+!G6 ?HE3I <*3
MU_<.="]"H'Y?H+\+X>.$F479Z*SX[@=/SGR4-BDWW6]QX[ICT.,/?G()IQ\_
M:6_$5T##E:/ MV+.U_:"TIC]0_I[T7Y]&.3(W>Q:S:W!ASKW+X>1%X9V7?4<
MU#%^W*J^S%-QP#:ET85Q(99UA@8I#%2^$SK]0IP].UO]AF:PV@LS9J&ZM.I8
M5V7-3?F4 \YM"FF&YJV6>?%'8.*G@@3Z\5]U0)Z3M$<@CR%M<+H%SZMGS'YY
MFU#>7C2K<U.K)/^YN>89P]@)L4W8_6=I&K2ZYL.)QBLCV\/::__(BSR,^U4Q
M22!N(U*>5(G=9!D-J2_56[PFL>LNT!JB?1A=#AODSW8._T TCW'$D"MS=C!;
ML?]Z#]$C;H0MJUQ@U32WUM;I%1#@M^?!MS21TM3KR8^\7.U=>4RWC/*WO+%C
MOWM!%-&7AA9J"I0>T/-UXXH#M\QGP*/AGYANC(2)MY6.,T>D1586\RJK3(_N
M-3R>I5UXE+_UC,XL:D$5,OF&@!ST*48C76%IT/,2&)4RKVJ)M(&U#=FZO'L/
M)?5&;'4SCHU/',A 8SH#]ATJJQ&Q4PG=;BA*-V:)A(.\1%H<R!U*;SY'$TBJ
MA^B0[:!6* ]\]UF=Z!],Y3BW,+.X!Z+V+^LB(S*+<^6WRVT/_K@7%DHPY&1N
M;.,0JH=H.,@33D-8T]?NW2:(SDKI)Y=T4=>?T[=7OGO7:2'SKGZAXTV7QA/&
M:-L6E5UG_>]Q;^RXQW. T('[E\#^"]=<JXAM!XY38JC"U8P$%)18^Q"T4DW$
MGGD$+9M-9") P4Y=QR2E!9S[*H:L/[''8]%R<:3NV(W)K7OA-I;(_;A&/02E
M$KX31\G%2@+)Q6B'H5;G73T-H@XDLL\:>#BVTZ*JNCI+#?]Y5:XFU>98;Z]-
M<NX!D:O?XB>_69":P5T_ '-:8=N;61PW:VL)QO%-$L)GT&]YI/F.^9.)VTR-
M3I1JR^_UK\#;AWT]H\A:5PY#@,_I%:$%SBG0GY3*3] SSI\A*2W4A!;Y2%5^
MNF,C)N9\(G@)52)_-;E9Q"LO+5CFR:'7878/8?)#BS\A>!H)CB-HEMT11$[Q
M6AHH#^1/(!:Z%RTJC'.\;!YJ#>:7=/$9&<6.BT(@<E_:F8<Y7;M3#%;%$6GC
MBA"2[OHQCQ3V/N()*=G614:"3'_!M<"0R<"*VIKJ70:WS'CL.DI-/E:4J91M
ME[^WM&/"3@4[WH-\X"SYQZT$8:\>'P1T9U2"0K\I+M!M,K"NIJI:;5N*(>_7
MEK(/!6]?:Y9&[?UM9A=U0Q=:;TA;A!$Q0M!GUM?QL[1I1V(EW2C5&U4)YYU/
MP[L,+/BROD>ZDXIH79+[N'V"W01CJ$(2XX;G5,3TG[V(76>"/*<A4=U+0T"<
MA8)-G5R&>SDK#_P(13I%-].:J1"TC$O--@N)&7CJGB$JN%CU4$CB]]3);0^W
M_. 776<R#^(:.Y#E^8NVKX$N(?4] *\933S*@^Y,* 1*VCZ/=RB;E/@6UU<P
M3_:O?-3M#.)I%VIS,-*U5>LH7L4M"D!;\P' ]9XLK%9!C"+OK.Q^H+^G@BS.
M&,\O2=BZF%)4I@:H@ETWO^](<+D=?-X*2RL\$QD,K:XKM+KJG"Z3$!,8BJF8
MJ<1#3*#9*&5.GEA;1B\;&QUQ3/_-='_D L?;-VHM9=>\>\MMKIML66B:[D"J
M$\N-:[Q0I+X/""A!DH"<<Y4ZI*3(GYW(TCF&-AAPIMS7!NT>_S"BLK[L00LM
MA@^U/P_"\Q8]AE=99D .%1\&<K^CJ\=C#)^C+9HS4.F,=[;VQ-BFCJ%/R=<M
M-+SL+8-,9L+EW;).?8N%C4.8@<B!#-64_%^00110_^>0P;"K[M0OR)#V!V10
M_0,R7/I$)P/Q?W7S+/Z%J,:P'^$XF'X3)HKQU4ZE>[R7FF[2Y?9GG'3ONX@2
MLE>32R4O*HM6V K>2MX??+B[)D^W/N],^T^/?V_N8:]@G3.*Z<*ZVK\)\R ,
M"T_D)U78J?@%)FT%$+;T[1$ZKY9]55OS'O>UE;W6*(VON'K8QNKTL;VKSLG(
M-#+- 0&H049)_3X)WDX<SK&A3;>$),F, _JKS;,XK_QA_12E_A\W:4>22P:1
MJH:C(=VIR95OI"&-D8PHMV")2$]Z+%9"@JG+QD\!^?2CK5CUJO2)ZDA"U%/_
MH&^SVFN"2,>_]NI.^TNO[E'\'$B,0WR=G-R1R3R)'<+QL$*+3X<&Y #P-BF+
M!^K4,L.0IU<KWD4%BRG<L=80C8_DZ^"6D]_EL]8'[M^$<9*CC($I3G,=Y4U8
MFM;YE]@BVZA_D07S%@4H&K/$ME()+%$4*(P";._"$V^C@%,-C9QL$FZ9K&)B
M%J.[8MW9-ME?VY]AK^,W$E]R]%'B-,@3RLG]83\G+CP%'FW"S&VU3IK.X0XA
M:.?AZZ;(A55.>ZQFW$9@%6$ABG-DQ-\GV]C^@$.3(L?Q:>IS@XW9"H-ZTM >
M78Z#"U7HOBPE]FH6-+2_G+45K-=WU;%=2GQQ*N6<]DC[31O'H%BD0HU(A\=,
MJBC@B:.L_I-3DU"#H#PATI#$<"3M$D*ZG9*E,>1$4V]!+KQ=CHHI>:*7964I
MZ?.J@OE@E)W_@607(Q=EG*2AXFB%.F@?^XF9':O\A_M*)/P]IWOK\OT-VZ3Z
MT#PTP;;G9^@=^#^YTE27E/[.E79&<!TRS]L7H1GGQH2R\W&H=SX30TU.8NWM
M&SI)B\6R*UU:RB?5IIM72?8C]NLH1L&D?8IUI*MQ_#?A_2?V&@1CBSC=PB 8
M111"4#+QW-A]\TB1UL3D"52,K<V!ACUAGB7?>BAO=+Q3S /XDGCKVV:?R+N%
M[3<R2[^3J&;[C]:<060)XR"E2,$!AP3>LVW;Q[?TUMOF>FX8U>E$?X]N$1MD
MK*GJW6&LEA]JUNQP&0F0V/;F.'\;3&'^VKS+C-2!U[('Z!>>4G!\<R<&*U]]
MG=G03O)1762S%YL<1^P=6R*_9=COB33I$2D_NANV[=%]$\,-Y15'1@$TC#HL
M#T:5F-9,18:Q;.G7OX_/B>BL:>":='.OC%0HC)NXIAWWBX_99_+I%LF(6^CP
M+5&];IE-V(/NMYNP1[Z;L$_AF[!QTAV7<L2M&<)'U+ CN&L1.$@WNQC5/)$/
M_2(M^_O$G*LXHQ?79)CKZ%BTK]<T-_9824327G2+OX/)EB.E-R59Q'YB%%ZD
M_B@]IU';68$6]*!"70P=8+6J__'US! =.>P4?$O38JI+6$-[6/ +Y7>-PWKA
M)D8_?P7';+O)-"L!2!#N<]H0D+?^(,#1S'.0)<B9VUC0AT?!!48<1Z\4K3B.
M7BCJU/SR*LFWXM[#EF\$"?E[ L\\"=WD83-PEQ4["^']SK;-,QD]_=X!>:_^
M*"+V9RBR]8[V'8:E@V& K^]4_O!2?IKIN.-;FV-I&KU'2#5WK%$0%_3$ 7K&
M[_5W $\#\UC:@&$)YC1MZB5 K/IY\K8G_$:J6W)0(XKA$WU8TT<ZI^/ZH[5(
M!Q'ECQ!343#$[D-[<'QG)?7F^89%8+=XE91FNJ4">R ](6WI.VGTK9"IB+J+
M4.?^EQ.O>MLD[O$^TXV>66,)EX,\3!HGUG\M6* YZQ8XU"IE7=#0CU$O<6 G
MV996KV:(9GJ7<XYR4RB>>FRD%&'B$BQZX(W=!C96F6L"R='&XA#"B,&X0-JX
M";NG#T.LG*OM8MF(V32XQ@D%/SK7$5=K;" IIS+')7]QQT_1=57F9<CHC1&W
MZXN1.Z_1"(U89: T !7((\U\BJ#*]*KYDGY;EM<PVU-M9/ PU_VXK]RV&(GC
M/-D>B1#K\QC%??Q+!:+O+WYSV_:;Q0(T=UQW,4I X:17!2%.'S:D+_C5+*ET
M7CLC')WRT7]/R2;,RZ[XQ=NXQS'"'Z-"NPZ.31T20Q0B^/4/ !Z3QO^'(_-\
M_WIDWL,$$A7G+1 &Z8A>1+EQBT6TBQ78N@F+6&L^D1Z-J-#O9N#?A)8-.N)T
M.T:SW;N/WAF;KY,8/9JQ5+BZQAB%-D@2R 4V(BHV83$-PD!S$U&T4ET0?6F!
MZ%/3\Z.3NRB7:9BK8SI545U:TQ+P[/CIU1UM1MPP3K;*@^NX&TC 'O$522-4
M_$)R;Z!- &GJ"UGLI]_6&Y C5<%DGQ5M<!7NL5KE/X5:5]ZP9Z>#O!#[UL%V
MP7>!,EEF3!]PMSK?;,,>\ L3,=Q 9NC:%;.6E0/60UCO1H*J1B?]VWQ6H_^1
M2MDH-1_UH_Z"Y]OW_@G/N4-IB'/_%'(H::8"UVCLRG>M'=T*[UKF/I6;\SQ@
MC)AP\UTX1P\S^09M*3R<9F\1#N%2<E3#2;IQI%I@-_=7EH9@]X06/;!>*HCA
MFYML=LA9[Z-FVL1O>VL^:D19E-<$&A[X'!'J:(@U  ?AM*#\)E0D5BO:##"G
MR 1,C$4$,YW+@[#CTF4WVH7SAU,<O?SDIZ:,5Y^'^QAHK[^F1J?J0+SXU"3#
M=QN3=:8=G#PXG/B)W?FBX2H'1T&2B&S@ *D;A%] :@3]+X"4XI^XTU/A+^*O
M/+OQ7Y/2\;]E6?]_N?ZW-.L_7Y;U'-=H2*1D(2K@"9 J>4:6J2P6IUBTF2.-
M!\!]\VM5X@QGGOX25<+51U9OT=]C#2(*V^8:_W0;@@3/Y[_I:T,*&(>50*=3
MNEE".E3U*-8UZF) 4_;^/ER5_E">CYC0UW'2\B#JFX6&I+53D-',Y%XW>Q-*
M+%,16L(2BTG\^^Z=8.\F;.?/Y=_0RZ=+Z3H1]>8W?+5D3BQ:I)]PU7C8<5;^
MP5Q)RC[;A!X927OK:'M#&.XP9"PN)0':TY,Z"RZ37EJ(J%K].GH2=;#TM:EO
MK@R7!=Z2OB,=GB:?$,AK!VG>DE=*$9KGK_%-C+U,%*9Y-)*39+78>(R%?@UM
M$]:&/4@S*@_T'CSJ+2L[,-WG][+:P]C3P4[&KLWYV->"8PHBDWMM&4.&UATU
MK'/HD&9G+?9+K.I'K]Q9\" 0/MDMZG0%J2=V9W6.U%!Z\^SHE?/69[LT([@5
M[C0>V]5",\=VXQHA<$X94D4UD85^+#_ 5^[(>JZ-SYV8-*=M"_*?@WO7V3N=
M]4Z2G;]3;6V0?#76U :E9= J*A^&'"4=O&++P^DH%MY-_#Y"7/+8A(V>Q$[]
M??G)C&/8*"N6G;T)N[8)BT-6IH>Q7 @L39ILW62FP);0.*;?22FMVG=53-<4
M8]0423GT16C;0>X5E]#8^.Y*(Q^NBYS*+@A?ZIG3TN9;9+5IY*BI 3@H!-]A
M%AKH<7TC0L.(P*C[K2,*_:WJ ?R(3N&IIXVGDX81_[S<2C=QFLY/&Z'B'X!'
MT(.=S?H"-+!Z@B XY^SQ]4>65)/C_#Q!33N5]?8ZIPY8-^L9U3*&(L6&H'H8
M C(:)0[D2%!AEBR(\);1/>.+,&W]G$G9N339KS]PIZRV\"\3E/HO)V@51UIE
M6-/2%^N8.D AU2/Q6D-ZLZQ:E8E:1MNWD=&1^ENY7[J%X^_1S46L#KBY*L!N
MWU;)[SV0*[>^@UU/I#S$07B9DM6@T$^EMX<3*A%\LW>JAE* ]F9&M<ZXU$'=
M!P^UJ#';-+B3'KMDN82.F%BE&"TSNEF2;#JB!4\;E3U&NTK?Q2E>]J=I@=7L
M"/4I\)/.)@S5>XV)'%X+=L:E,HDZ?FR\FG\KSD#DTMLE44 40E<68#M"'.>)
M! [HA%<28"QE(&DR07:$.I7Z> B$T[J6\GU%Y@N\_;Y4/&SKD.>5OW'Y]WMS
M_F'*:X.Q9Q":1,J@P'W9/X\[.]*#":60_SSN+"2$/_J!9MP?IYWU";K;?3=T
MD?3\=O']U<?7?@]'YE58GH*WK7%RK5-_Y5I/<7*M"Z&-H,S<]R+6-^$-H6V9
MT[;R*I#.-,$UW=N$10;15MOU3X)MT'_&,<^"@ET[YB\S!3+9J5/!#0:HJ>65
M;R-UTE7:1\.199I6@@ DECL>@Y_@0ILP]TT8@(2V:ZF^+ 3=D2,(&H0Y(3%N
M,N:<E..W0JS$D)6[$_2ZLEU#JJ;]?G[64&88Q1[8NHH#>8,V8=MV]! I>6UP
M6=;)FB_UDO070Q^KZMX15_?WZ5EXUEU4G8V1&42[P&NS++^^V'E%(]@"Q5H&
M!Y&EXJU)7UW:>M"XB>[[@=W;R6-+3/ETS[)A;UV76&.F5O]YQIKT-CK7BBM.
M]7=EWQNQX)<#^?ZCX $6/].<90(@:9WV-&14PUZ W-S 3Q?'LXN?S68L#KQ\
M^CJ8KG(TF-'S-A:IH6!'OIOUX?F%4ZV!R#(\2Y@\:;M8'<J'X&F0! I;&2EC
MYM<#=7TLE$RJW\8*ZC9KL?)4KSTTNAB98BW_40*6?A%7?NC@:!!"%T<9(P,*
MA%8$H.C1")=JA\3JCH83&IRVZ"_&',P?-PWRI58GCD5TRWT[XS>ED6NUSO,Q
M;J=)]M7+QAL*G"Z?OZJ0-#F],A;DZ,V3.BS1SHFA&#TXS6>B.I:E6X!S84,
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MSLH=K(&X"<>=C%8MZM"+4_T#])0E7_'6XG>Y9Q)>7_CP1Z+JVUOG#&DJR.$
M)E]&*Q$7AYG()&W5>.9ECA_0>&8_28I<0BTM%8N1Y]?)IIIC[$V4E"#1X;2T
M:,E$(\E!6A9RF)O)!YL%=^<Q=###JIOU_Z^R+V%;4("L,E-$8@.V[P<KANE&
M"P,%4$PI$C6*%0E*(:B1=\,H& ]\->3 '.ESM[T9!ANPFN'A>+6$21S5.X^9
MBYOH8'4@OK>]'%RTWFST/VKS9Z._[MQGP.LG6XT'^).MYKQ=G.BVYRSK0;9@
M),=I3)-JO2^"LO8'\W<J=T2]]51@HP8QY^F L,$SW_PQ>\]U__2L,PE-')V)
M-O8=JK)!DLY>:,!F2A ,/YHOR=S%>HR8(& $@)86.^ER&I8<%QFFE%L;2MZ
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M7=K?<Z3Y[TURT!@-_B!S[>;(4XFXM1OOOR\Q>0VGW!;PC.W0=$2@10.W,U&
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M8[R&=7L"-/K6XOA]G[<FU0B>7@[_^+L10 +WL&][)Q/3,K !\_#F)LLP%?'
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M:ZPMOHK!':V@:"PW=Z=>T.1E?:E"$?_UH?0#"1\BQ@-%[RDC4]@-@O\CCB[
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M;PRW[\0<Q_]S2GQ=QC]5!DXR-V#M73H\$(#N;&'CYTIVBF04_PMLAC[%[CV
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MBHMXT&&OF>0C$0M\ZF>SK8\]U_</ND\\60*H9=$M0^'[F'8 *9CK8;66P#%
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M%_44,&V_G98AD^2/4O]NNJHZN!![-<G]H^73W@?ZP7LXURX?Y('.Y(!/O=<
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M;*5>&D9KS^$JZ>5+1IF'D6[4DU/,CI$5[^ZIGKJS 'WO>."8Y +\4Q*#\RT
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MFQ",I>V8Z\FR-<-85PSOV89$$J\E'-Q,OG6S.V2AKR*H>/SST>H6H>D+'VZ
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MRDOFZ]R4K+,G+\U2LJAZ-$YR[AV-DE5B .;@%]L9&"ZS8U#I65UC7<@M89E
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M')VHIKZATB-5><?96\I@:MF<^/,"V?SOA19R6;GLKX56[\N7K&(/##E-9-=
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MZ=JUWZ%QD9 ,X7K:C >+Z_F1FG=C/_;4$&[RVQ3*=JO-Q-AD>^A<NI5@J-[
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MF]ELTU[<R1714CX&Z99*I[[]NZ(PG9*,E$Q_X;_#T/(@:;+!@"8S^0R!)R8
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MI^37[KOC?ON[]V)V)BWH%Y4D%@&<G26^HD'"/$ )727KD"1K*-%E ##I>\&
M!M$B&4U21T^2W.NDEX0H:J /GE:;>K_+JV>/^K"R6P7^R+?HF7QS,&4H6#-T
MPT>WG@\E 5(S\\/#624HKI&!94T1*R&!!./<2;DG15G73%3T6N::)OJY(E:_
M#NSFX;]AF^L(B3AH.%D$6PPB)#![,JT=^)D!/7\V:-3GT:DV%ILYQRM38N^^
MKW(YB0?WP3U4R2!0;RD"X0V($ #G_HEITBPTT@M=[7L!>_A;'B5_,K#Y+>IJ
M0??DPF6"/E&O[I9:-X?EO4#-2R^'*<(W6D(?(FMX6NQ)^D&?,>R:)V*-2%P
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MLJ+*!'Z8G*QS\SY?=4D2,/\M&2>=<+E/T-ER6!&0K5MMPO?C?%:U" V=S1*
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MG3AT]^H'U.P&%MF>Z3$SVHY@ ]!MZNCQ9G%\69Y[B8MZUK7'@0E_#(@@_LV
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M^/H]7X[/U*=A>=3C?: 7_W_8>^^PIK9M;W@I*@(BO2M1BB)U2Q&I41$!D:9
M1(18* ("*B*=*$B1(@(* DJD"=(B71")=*1*D2H$@J#TA!(6)%GY%OO<^WSG
M[+OO_<YYW_>[YSSOY8_?/RMKS:PUYAACCC;'%"1YBT#G\KJQHE"K[8Z>0)G
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M/?$=H7ST4]Y>]<.8QYK(F_#:<<+7-C%KI-G)T=&)M=[=:9\S]\F,Z%/FNJ:
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M.A&/_I*E:,$LW]QJ(%\TV\L C#9# H-0/PFT V$,X(C&!)HJ6H!<)>2@S@F
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M!^)0VM_(6<XO3=X1C[U[FS_BMM0UT%63ILN+VD'^?1<O.A)#,N4 #V&CM7E
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MK_>?69M\C5#W&#N9H\%]Z&=SJBCI:1X]A/C)J[XJ]'7Z+-HY88"J3G%Q$J_
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MF99,V$%W8Y)CV&WE -&ZMO,]]_-NS<_GYX]?EIL?CSZCQWLWAS4\=V=N#@
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MUO?2^PZ,V-(CCL(^F\Z7)RN5>;<^>%Q+W -<>87(B@9Q$ ?L!VQ? UGE*E_
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M6H-3'JSW?[X3H'@'KRQ35Z,YESSQO2K.7X'$4_U<WJX__%S!#0P.(!9B17X
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M^$E_,9;*"-967#B:*99MM'-\W1L4A.0XTW<+5@<)[MT?W* ]Z1\#^R]JA2<
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M[/W!1N\0-!4>1=GS@[+/>(Z3M 6S#34P??OF@Q?R0W7TU)Q<V^-AYZ")HI+
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M(?K-K9.Z6CB-9QU+A?_T^E3," ?W0.O)L_:&RPIPX_82K5'JZE6DO0[C%J4
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MJW?%]@IUH8^>Z%3*DN.Y:13O3MAD<YY#WZNA5*O3#C.TE]M&MV#2>D'4^VH
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M&>"GLZX!IG3-YFS1D4;CT-F#[JUGQ>*3\653D1)GY]K$%T73DM:"93ZD#[Q
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M)^?PKL%.Z$3IX$R]+NW5CY.TV#N#%XT_X>D^$'S(G+5ABRJ#$FBVFJ 4]RR
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MHTY>JOOKV5['%E^?%^C&D>N5\5FHQ7817Z. ZV'ZXL'7>Q:3&$R@(1-5CHJ
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M/+*,'C-6?[5S1G8L_;LFF@_K <;'@9E@;:ND<O\&XD?QB_QY_U6U#<3[G,S
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MSUSWUH):7I@4%1UR799047;P[U)<B_%9W6-8_M.Y!]?COQ!*MX2!Q!@SO>X
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MSSS:KS1XFC55,9&9ILH0:*-I4'<VO3NQ)OJKDNS:Z%]T3[90)[A"@%^V,%'
M6/O$^.V6@\]&UVY5GY"Q&0,24</"- \832S@J'+S#1L(OKK]Q:!ZLU_MUR&/
MY%S5<L/2=A[<-F;[A+O4$YD>]6;Z+BNG+D[/K<-MM%I'N'9N9TF!/6"@X*]^
M4/?Z3'3=M6*W"QZ?W?W]@R4IOP:RE3%82W_V$\F5'X2,[=6ZMNI&\!<J'DHX
ML8<?W6G] .[XWZ(J\IJ(87>['RWH'0/GIDP&L1N(\N[\4:/\.9_ 'B6S;^C1
M[!2_KY;;=5,M.K UWK=L1IFAA(F,#80$8:*,6!XY7D&,_&6J \T:3,9%.$K3
MSV=Y7TFFGBB,\U6\/D=VNN<;V6]<%Q8G=\1R.L;&2N\V2*:&6#!?!!\)Z&@;
M[A?2&NZ.U>P@[D$WN<0F]UQV&-5=5CJ[T"G-LY]#Y-G]'3:9GNNTOUH(@ RQ
M4KN!J4T+9!;7'PS89I"Y/F]$045K8GB^FMZ=754_Z7Y/@[>\,/*UB^)>)<M+
M?.<%=BNN#_W52VEI837_1O_3U.5A;>\UL7;W*K#:?]5$L2B!_^KOJCR<A7LN
M&/TCFQR 6TD,S<'5 W"C_9\;%0-'@,V>*QO/ZKG.+:!^SA>8GS(:_9?8A:QM
M[W^%K-CONSMOPHRQ)WP*]PBXSAKXYFE$"@?,.Y90VL*4BBLX38K,?R95EM\K
M4EOLY5>\?]HG->^Q1LRCZ,/^UPRN(P?& 'CIE1$7#*BNM%**:[3O4ECPMD&L
M[[4))/Q!;AAD&5995Q*\$LZ0:7:*02^#N@2JEYV#HL34R1=K:@A#9A!'#OT4
MU&*U9XBA 99-ON,TK*Q(ZQTQRG3I_QEU.ME)-X8[IK?#6R!&Q>9#?/C:M[42
MZ3#OR]Z7H88ZB\D,]??C(OV^19X72WI^>DL.V,_3Z?./JBI+JB(XVS5*CW+$
MOU145]^#8$M\@/ZXQ! >A#ANOX3OE2G@5>MMWV#NV40:?/"3L*#,0U[Y4.)Q
M*W"YW2>_S>U]4'KW&)]3>!K5[GVO%V:T946X96F$<W*&O)TUN8K$7@+CIS(D
M!WY@7I10>2*6?$W<;@A*"%V+#70X_4 F7G_+$XFPFZ9!2);3#;S&)+#F\-<7
M8 JYIV@5CB]>NW;=3,W^\@CYBG<WEQN?V!C:[;\GG\%?F"ZSBSUF]>UM<?/D
M-W9MPT2*:_@"KF@,:P9F4#^YUW>3.I25ZW9>$_I*I!LNVGJK%MM+F5*9F4>\
MC[C1VFG$I(:(?M9YTTXCJ!U%Z4%1SL'%4N@'#>E!%6Z4,.?A/34PC!K!7'MS
MF^8Y:V5Y;.*!N<WB=Y]JK1\?'4Y<E 'N8KE!,9+J4!Y)+F3";*N;EIX()27,
M.S0W(\_N ._[5*7F$ME,(S_70/&R#XN+"YV=;84Y009!9E/;:/N8A;Z$KZZT
M,HI\2QQ/"VNN:X>'I[]L[FP?W?#+EQ<UY>/4#](KY.PTY"%IC> ;O\2>BD+-
MT [&+4H*69F2>))*?* YC^0/,&D>>+ETOM][[]KMW+-O#KY7.Q-;&"<6&C F
M(6&9]!0X1J38X4%MZQ9"25Z$K@%5?N)3?-!DW,-#PQV%Z.&B][B+E%.*^%2!
M2/+,Y6&%H!\ZX0&3L>CR*P:T" **X,HS3)^,6PB?="Y@'((S;22#UU?S2]%T
MK[M.]!-[#S.O!0KGJRW+Q5GF2_3JGL\1$F>?+'".WL/!B6)3S5*L232VJFA.
M2_0?U2PKM?ZL9KG&DGA; AK.76%1$Z$1_[MM89BE13UA4*W?K9XW-B"W4OAP
M]/$NNGV[-%O"Y-6;(U)^56$]+C&.:CN3H"]HBB7/L!CM:TE:VZ1U"TYP?OAX
M5Z%6BHX&OUQJMD.VA<B4NLVPDE7OAU+2HS@1;#:@)6WZKHW!?P]B+Z%601PF
MDPZ2\TV01#V%V.19FV.R@1#WJ!RW2L?L6$LP5K8<$H4,[@5>72:O;D^Y^I%2
M$'C_[/NDN JX ,!)84@>XD<-\T^JML:8-W664 Q3D>%WC&^4 UK"A'?'%N4J
M:YT?SSP<YN5_N?6[\H4;+E;-N"I">3<YD$*D:5$&'A1ASU,MXT)^ OR>E9#8
M&\*[6 LO3)ZQI$;R:2L;Z2&NPKYSYC+L)CJ19D.<M$N4E 5]NG: !<GUP4M"
M5),>;V6 LMWZMU&'R[H)=7UFBK]M7>Y2*CUD<&G[A].G.4*H91 /)\6H!2G$
M. $Z%+1,%(P0'NEQ?KZ1!_ /#1EK^.DD37\[-'HR\&"9#"\YW'3Y7 3RV<K'
MU\M[K#1KA1:8711"Y)UN\0#7\P/E#H9M-CT5439X+]6%8K[)8=KX)1[QGC./
M"EIG&Y*>/CG))BZZ@AGIAGCQH!,>SJN4U T$!FB$@YI=I9I9RPR?!CR"0NAZ
M0'E0RB?F(&X:L\SH3@P>&[U.>((;:J+5@5GT_0&_P<"!2S=HDK!MK,O7,_!.
MVODL&:'AQ)%CNEOG$-B"5_VUT.*=.U)&YMG'MM5NBLJ?#-:$1M*>]F$MP)1)
M@O"(B:_@\@]_X3 )J>%)A7.[-+1XO2K"3HK<M#OR%*=VRECE6^WNMECK7_9O
M>4"ME.,$4BI@!AJP]KS8F7#^.0$^8#F+@TEY'G<KDFLGND.$WM;T,ZQE7T31
MK323)CT=E+/-$S_U&AS4N*_K1Q?)YAJ_K Y<<A2B5*9.8+C<A^4B\FS<UK7B
M/ 5C0D-C:NR'OXXT/Y .4_B\_4R/H.7O5LPO0E"19@_2JA[=X8G)Y*FG0DE
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M+^>TAPWQV:,M]YP YYNT52V+U@:6-5.8,>_#TM(G)Q$A\>B!-@9?"L111=E
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M$Y!@R']Q6L;7J_Q('K33_/Y#S'<\N>JV9G%+S/T5Y6*5:RL2/=8+]_2N)YV
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MM8H'UZK"7(P>2BP%ZC[_(//!2C .!S^#%3BC^SN*,S,UGY7/_]#PY,3M&7)
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M'.6<(AGDE8N^8_'S/3CAA^!LH<'IUF7U_=@YRES'@VR,T6!"[YBGVNC*=3M
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MJ-W6K[0QFFX!&=H]=56'%EUNOM]_1'7U 9,?XH%N4@_B6Z%H-*+GE"RQ7?&
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MFPR\4J@A2]=6C'"QCZ?M35B2JSRO,]E3\033(R :T[W.((>3"F+Q+BN"/24
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MHLT&%(8/><)**Y6@A_KV1(DF!??4W_16H/ ]CPX::]\B_V7CGW#6A/&RNMN
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MUS!7SCK]0ZA"(W:N5, XX7V_0DG9(^$DEW!TZU5HN27LHQ'PF15*E#8A*>J
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M*'&D.TDS!!ND2>+GOXE2(B_GE2_=M2R[)O(]>?BMJ/[ON!XOQ9TJ&=^W[3$
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M2/XI->_[[*>$MQ QY$7H6&[\NF;\?0R@.\^:-.C,2B-\&^H]4P)C *!G>KD
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M+4R)!P84,._2WO\;^4DI97L"HG!"[]:++^4'?7+V/5)(W'?UZ+;2]US88P@
M!(2+_2T8<-.[M@'\QV2R\_,@[<Z2-</4EH3T!XK5@J6,*J/:FYO;IY27/#QG
M3R6T"-_<FGLSZN7+9Q (Y*JEV!_7$?5_L(XV8(#&LV]";O"'8<K]J:ET)7QX
MUG:R&+4WF56YPOGI@7L>HZZ+,!> TW?%_PK1#64QZ<LO_G0+Q-)X^3,/]J_^
MR#]?T^>'Q2\847D!>R(F%DHV6;DW+4F)#_=5$47Z7 !<B.C*>=N>AU94*P>'
M3%>Y@$==Q?%5^D82'+Q11K*6*W2M;537#GI&1V,O79:UQ1C]XV7\Y#SG1^8.
M.CM9<W&%F+8&#V?RD#'W*P*+\G%9+2WC!K@T3_46.?E?O.()?^,5K^WZ)5?)
MSPLEG^4?RS."EG<T@D'SM@R88;4KO0&4:8?HJHR,<_DHZ: 39)5[YRKGT#=!
MVS_^S'8>COA6O>Z 2) ,R-!^J['\GG"D++:]KG8?!"M!QM*%,JB!9,5(M247
M?4" [&XXM!;]!.NA4APDDC\Q.68NQ!%GG6NL)Y^SS]E9-F0+AQS+L__?V+Z8
M5K"9F15@KP>XRYN;3[B?'URSUVGN(*+;3(M*W)N]Q[NYHT7A^U>*=7IW>4?(
M5Z<3]?>].&_7[<46]W6?^=@F!- HH/97,(I@,VDH<?+W:2QU19PNMPF)NFA9
M_=C.X*!E0LH)ITAA(_\$*NP >XJ^9:*I5LS*OO<$8W23$?IO[1@85CO&GEZJ
MQ9!V78.235R74E$L-U.4P/?._5?)_5&M%K6^2/E53?ZF>):)1^@<!>$0'W[F
M];AF,[_D3:D<(*UP?II_Z&#;VGR^VW!J=2%?2J73#%M&UZ,:P\2C33++4P\%
M*\(.3(G4PO)JFX T<G4+3#)(*)"($0=\3E-<PM555$"X5U[0AG;VF^M\79#&
M^[*3YJ3O_>A69^YM=H3%!1/B U:EA=H+$A4)2(!1Z-=RO@1.TB3ILHRL( N=
MZAG^4!A?/5^)O6UES'AX.%W5.=_>S.M]W(>*1^W%CBJ[/"X]%8SR?J34?_.7
MJ&G]!(@'/<D/J&$_\2#S%Q[T_!T>M/P+/+@W"D)N 7%7(R/=VH>F_;NXN8#G
MTQ%#NLS@0SSJU6=6=GQQ$")_RO@4G'2FKUBN]'7EJH(KO#MLSR6S?JV:1@F7
MZP%[JU_\76*U/F?6?!%*UB*IQ&*#3&?!H /C#K*:/6G:3;M15(PT-<<UU(Y)
MMF<Y];>^ISGJZR;>>O'L%OO=!N$M<U ^_%7"??SV>H3S+((S2 *P()H+NF:Q
M*@&AS2>"8[\7I$GI,Z_TZ;_*R/'7"SGZJI%L!G[P/,?C(!/& ]1VNC.E826R
M'DYV(1I%T4T*U]$>0Y7QG/,_1D905]P% Y),A;268@6VFS1GWV\4F9<1(^,R
M9N+Y7,</11=8STOJ)+A+)X>&)M=.3-CH2CYDB<V(R!N<?_D2C&;;V>%@5/G(
M/!*TG:RYQ$]\H0:' JK-J.-]2UXI&SS\.^=%-S(K-+GCHH]VG#@:N=5$+FR;
MK!;O3/I7E@NS"+S'<C<A/;_?GKYL0CA0K"W&G_QN0P5<BNU(\\9Q]:$!N-DU
MXA(+!*43$P3R;\X87-QM3+K0ZO30XND6<(_Y>U;S\[5Q'$%_>&VCP@#PM?W^
MZ6LOK)WG"-.D"VY"J*Y>>#"HM'PG_S+",6UEHJ=JX[3X *ON_]>]EY(4#X^4
M;W5E677D5B->BV?<"=D'7OXJ^K?Z\G]3@%+ZM (H(9;R7&ELH%/#<'( C0:G
MR;<ZGDTU(1>U*^>^2;*M,8QZU\;7Q*7Y^/.2X-Y=ZQH#&AV<EQCR\%X7^JY8
M<'^<35V:WX2PJWS .T.W C=H%O&-/RQ;S/K7OM;(F LN6(T'-TS8OX_I9G/U
M1"C)U<6<QG@D?Q+HZI;2,VI"D\]@ <4J%@^-"N-UT$GR9S.82Y_L1#'RY7>$
M8V7&N;[K6<*U*8+S>^=[GR:T9FO*>)2E;CTBC_U.(2) <+>=W)Z9?3/=+RP^
MYR:US'K4VGHBKZ$DMMY8\-CU6,BE6('+ER^!ALC+O6[*Y'P+.NZK ?1,,NSU
M ' C^'1'JXPVQ:Q_8?K L&?)A6,?GQH62F?6/;;)ZI]$?*,/)*Y>,195T>HR
MQ^Z[VOPWD9;_UM5[AHXZ^NWYH4W(U^Q-R!<>N,E(#T82__&%VR;D>Q]ZC?W5
M.[%V!G_6+.P'<H,9,_<B.^H[?\S_-/OEO\=_<7Q?"<&PPX;<)5L=XCT]2-_\
MH9VHO?%_\;N&N_7T<XJ+IS:*,8KC#7Y?\)8@W WX//1[7/^_9IRGF$?Y]FX#
M7"S^1L82:(/ KJR\$IP>[YI64%'H[_QXP#"B^-V[4Q#!<^S7@FX#GW]Q\S60
M\-)?AW]Q\\5.Y[R8*OLV<S;TO/#67OFZ PHW)3[ZZQO<<+Y(QZ*;[/$S982=
ML)E"M&!/R?<.JE$S@<\M]2(2WD*E?AIX%].]K[H>;W["8@]0Y1?[Y'@<;)HS
M67OL;*Q2K!(&AP,3N ?1,$<8%Y!AT>^%4Q\S]<N;,G512W&0'EKQS"3=CKG^
M)JR/F'Y4=T+A7">)M[A+MXC ]U,Y9/3K;$%L<06?*@D5[AZ,_A1PX>L)AYP<
MZ_S.<;U/]M-V;0@QSE.K"O;O+EL=[.)?#:?M0S?)X\' /H%N4D6F$E.;8P/A
MY$7DMTK3C&C[O5VTHZ82-+61Q!;I]V]E$Z!O7;Z-G0K.2]5Y2[O,4M F5"(6
M:QPUGO.'%./V?AD>+ITT#YQQKQJ<UDQTY+SO,26'2S%8EXZQ7(Z*$\>)FL5U
MWC%0 8ZK,"^:4S#,&?3&]8&B'TI,OHI-R..#0>*;D#>?F1@_2>;%H=-QQZ21
MV(66?_B;3"-59PZ+@;EA@0,=BTLTH055ZZ S0"71GL>FLC;L_6?#JN3O9@X]
M<P][)=+;^YQKHC2B>1600X<I]+$$322!OLOB!=V9/$(74FK5D0649^W]6R0Q
M8>JF)ZU:_26%RYM>=F>W7SFG/'>?MRS@=F7%M]KZ4W83DU[!+)F?=/28)E4&
M**=Y _UP?OI>LDP-2>FK&=X]L5\]JOO<U*[7BN->>?L1B'K=?>8:^JL2W*\^
M->8^2H3E88!(5:I2!ST%3:_P(S!/8R\SDM S6%@Y>JF%%!"D2NZ=?17Y"AEW
M$F>9[._IESM-N''<"78C[-L^A\].MXQ7/H9_&](-?IX*"Y61!JW# N\VA2 *
M9RG41!/?QQ?GE;0U Q=66O=4!LC($64%]813')PFA)]KZD*2M3MBPG@H1DO7
M:/Q!-HQP;5>Q<.9!)+\]V?G[,.KMGDEWY92<JF.YZ'+[5H=ITM4L6>;9^+GR
M4,^2A'.==UBUV2@5=!,60[;:A(C2@RFP")UM= =*\H\H]=$EC"WY1DG)5.1W
MJ4&K&PVEB9]<@[X6G/^JO;]LZGK<BF_(OFQ]QO-"A74Q)C>>YDB7(X<OVM-T
MD1R60"&99$J9Q/.K=RN0YPB1'L^'L@)C]SJRR0WE"J;M$32TN#-';VO4"D4?
M@9'/881=<9PLC9$@KI\^:]RW%A]QEWV)P5C\BO!T9KN;7/=;54_A;U4]>- Z
M9^H)Y-/\T?A=:-?X.'0%+FD6%B[*9'O](8>R;=1^0:RP2%RM1Y0M4]_]9E]
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M8A6.3N+_@ISP'*F&CD"WE.)=X1N:F#@XH+N IU__R\]3]0S$># M(U':*H6
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MK@9UAT-.-'&X'99C/%K=-KL99T16[#P )58*Z-^RD\]ZV%CP70*SOKD^8#4
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M09=P%G()$28T)T9'QT#V<AOX%#YC^BQP9AO>X;UP8.2Z+3"'"A+;@9.$G4S
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M>2'>6?5;%9>FJ[L]/]_L)6RM0#_VHLR/)G@;XB;\[BLZ]V$J(G&\D)1*GX\
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MKB(WW-<G+"&JYDX]V@G=G3_,!$@T&GJ*R %+V*-Z+78F/\J:%=M]E+239/+
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M[J+N%^(A#%B$+D /B^>7O)OWJ:-RRM3/[Q>K]>G80^K+?UA[X,XLBJR)[UN
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M^JL6UV.LBUI7B[^OJE+#IVN-KO8^<N? S'?BEMVJ;I%V8UJV(Z;2(3NG7>3
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M=-=6D=!4#JS]/G>UZ_7 S]6G[7Q]]?)N1QG&>)(C/^TO4TEI:KZA7(OQX<"
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M?2W[ZAI&X:V(:??N>W0C1F1P6 FTB@,8[B='F%--D4MKY&.&V)VLRWTRS-;
MK\2[J-NOOW^X%;7K].9<=H6YW_5GTE+;KZ?+[SLH,K1.+CZMP$" 0C:0Y3I
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M3FFX]Z.!V#XPDLI.QLT202$58 9%FP/Y+Y0"EN>'<$L:87L!H]7/!$O3]+(
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M,5"U[/@%@P25GE%N1PM-/W9<[;'1V]%K0IAS['S,5 .^&DK/F<)"/G@1EF-
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M8,5?*0OU1\H240G4*1RSDWHW+=!]1^.5/M>UA#H3^XM[;-).20.:F#*>;1A
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MCSZJ $_*^^W%:\?&6;';-JFD+ 9;$ G)$";0!+.F]$+I>?0DB@I_^PP"L<0
MTNC)!]+SDJKOSO90X<GUB,-I]2@T'K  IE:!&-',:)+IE.]]R8?-3+'@=$R$
M<J[7/6_Q#HSG[@:.V'JWV"3+&F6.Q',&81?V:WV $'5X*P\(H;2I+#TELLQ(
M.*+B#80K[+(\"[KS-CY]&UD73KEC4'8C6U^WJF5#F$6G31G6M5)@)U"E9PF!
MH9'@]W!2.XYDB8@*YJLHH;*&>W-? *-;%_?&TU-OJ%/)E"=A_0?/[5?*-$'O
MZEP5*K\MR'8,^T-J"[9GC;%MAF)%XTN:?A.&VC.L)S$.W[E08C-NQN43GU=@
MY)'==7Y#HOF-LV]LE'#:V]'3L7K,FK0.A#/*7YWG$49L:;HD;$$L+9#SS;EU
MM: "HKA,T\"09/,C(]YX2^6IPJ0[^W3>2B"?0=SB!;RRDW8(4Z'2AGRXF;,%
M2W6<#5)&\+HEV"]*7))[;2.>NF_<]FA;TF>[[39X@^TV^)AOXGO%&'NGF(+Q
MKM!%3M$T2*O=ME2?5!*NE9>S"+$4;$5Q*0J>FP$FGW"KI+G4V=U>$9W=A=IX
M5<54/R&0S-&>3&DE%,+#\\!;H+S2/-*0^\8G@D/'S5L52*X)I2^)':52W0=6
M%']_H^-\4$V?E?>E:O4<A@A033R0E00B8G8+%B7ZMBELL6/SZW!Q575ZR *?
M>XG)H:,VD:-R?L3IU2GSY%/&CW=?V!F_J$(Y0W^HJT,ZS& OG$:.K;1I.\?.
MQ>E*,.#DRT6Q] ';!2OATA-#MG*CV8L'UH6%SV?[.[.\D.\0O&P6XK@1#;U,
ME3_T]*\$[T39GA42%O;-/%9&HN;,Z'0H_=1D]-1<$WRR$<W]^4WX\;VOSY7L
M-O])1K8:2_J=? X\!]#('<''W#$5B+>$/8&G^J[A*OMH]UY:@V$M8E_.UH5-
M+D\H2]E<%GEB+'1JO\)1E@/'#O0=3 BEG@KN!#BV8![C6S"NSS13$)@V%W\_
M14U;_A$ZHOYMQ;'2_Z6;LT4<1\.M;'ZQL#-D?5F"ZOXT;5PD1J!!C637K-4D
M2XZ/J%!A!^^9K3)&"A:UR-8VMAN)BB9S9@KRLM_%]SG%E+\^D(#$X$AV.%!E
M$KI1EGZWP%TDRO@9,J8C&B,[M]P%4:C4WTCM6>C;(Z\.&[G/Q<3+[_:Z%B=[
M-_^K3.=:(_0:(N'[F2TZN(J=#HM6F2? 1K+8U;64?OP1UR&5= TU>UVAE#X%
M_]M&=?XL^R3;15/EHU[TE[P!;%H9' !5O626$@Z*_+-A>V.3:;*[PA!E^H$\
M?.B.V]<D!!:^;3K:3T--1UL6+4@<(%\N+I_S&,;*U/N7ZNO&HJ,U!H;N)G3*
M=BC4#M\0)]DQN*]NBRN94^\9_A)7<CA-AD=*8JBFP?1)*\K=B5F7H8FY#?\U
MX5M+FH0G6[";!%"6T($%#]>0"#1EGMUP5HB?(2G8I<?> =SZ1,!E-7 %_)G)
M]*L1)G3XDI\=4%</+H/F?9J$[.!R@PY5_]OJ@M:JV["6GD1C94E N&;5"+]R
M=M)O"?,>[R7MQ@M+8"4/#YJPU= ;L:W(_ZCO>+@F<QKY$?Y+>EY.@82@)^GP
MT+47AOYPDMYVGCY'XV&65K<R*ZLKV7C7#_^U"FT]E2:@12D,H1RB1S3)TBQ3
M4/MO-4B][-%+42G*K:VL&?S2)K3OW..$0W%VM>C9&R*G]IIXP6I K;]6":ZK
M@">.NC+8L&0,8PK8#!IX'1#RF6%%,Y^)->UHDA[\AW"1[9S=.)6Z&%Y3VYAI
MN-U16_YNZ<.'#R;2B>?- #LXR<@</ P/PTT] TKSPKSLS+D!Q\#39,TTYWQP
M>6'.KWBEV-L2YH[&^Y6%<;I+IQRQ4'6\_/EM?;=B&: (+YUOGE"C1-"+]80"
M$<-YVP(B,_3#K2-KUG4R@YKKOB7C[_K4"H\\EGZ4[WR-3<3B.):HF2'&04N%
M)E Y<#U(:V9D*2 W\%Z)G1B"/_!P75BG1=I#(]F\;(?/1CO;K,_VFTIKW6TA
M*Q@GO+KJ\$RM+HKNAGV*F*H@L'KUQF%(Y\SC;96+3M(KBU(?*=/TQ<;JI,-F
M37=95%O86/NC-;(]9D6.?-PE=^C1JXNT1F@JJ&_!W%5 )\3X^K1PFTTE%C3R
MPNWUR_RT:!L_RABA!,F[4O6RJ$6):K?*4J:#SZIRC_UVW )1ILT0??<.NVQ1
M8&#,$%W<S(0&?Q=Q/5:+H@U-_YM^YE>=2VO)KAUB*$#48YW$<A>]?-UJ@'@V
M\])=_SNV9<=BNQ_5U-0?:;]JM=J*_)S#M?^B@>#V0?#N8&A--4\AJL*JLQ81
M>X-WN:4WU>>ZV\:E'HZB6;KR=8K'58M=W="^JQ,RATM2ROD2R[]#:+X:>#YK
M*;SL#,A!D/7N.2(TAL% MW5MZ%I=>Y^;<0L@IA[!2;]]0TSE$*HF<A-FT'J,
MV>GP$*7SE3-C!U-0U^_!Y=#7JGD[FJ5K,D3LR3IVK3Y][[#[I39+2-40Y]D%
MNI[O\[+7WF[(MGYS4U$1W;_=D,U^X)CA?7G#B *(N\!@>W8'ZP'-S^"[ 8@V
M$&((O$ %C0">"S1UGNY=6BDG4E4HZ/R:M8:)3M\T>F'UK>;JI8W/XR1<V:6C
MUY'O,;0#W$P+9*;-33A(R/DFA+Q66C>DI)%V8RT[U7N"@4$%^<K:/XU7G9MQ
MQ>\=(E2>><V!>-/U5T7-ESL1=__L(05-D67<N L0ABM/#0G>XU;M _< 4^_B
M.R-F35\[S'%K=EAGX@]7.[GSZ40W&"<5&M[+-0[Q<]])1T")'0]T">EQ 9_O
M;<',ZV*#+9EZ5JT,3;NID"W8I:Y?RUM</W_-E[8OC\%.9!JWFB"F7HB:AP1:
M^X*'6].=.Z-TC=S%EU)219.S>03DT/ROCDDX]_24O0^+;4@Z9L)W*@Q7N 7C
M]+-CBJFJ$_G/#KS9%E.-ZFAIZ9C8%E,]E= JX+8SVRVJX!<SLB*/4X6W8*T0
MTFDW@7(-&?K];H8],'T0BLK>=.AR9DT]%*8L\'AGZAPP8(]K9UJWBT'@L1#Z
MLSLW0PQ1L$F#'G=(#3.YXQ4)>W6/40W\4/I41$21]W':R5F1)?4Q./7,L'5$
M>6-#LIU3L'Y+U2NC>"\,NCKF'<N%E^ NAJ;5%LP*"F:I9M=I)B!3CV\/V#-5
M2. &6UL)5491-)W\FU2'Y#?6?HF;78M.T9+^C[O>Q%:=-1)AY2HP.GCQ6ND"
MAH1"$GEF/$/AI,N>>T$UT[K><#TY]_2PM&*;;NDF2TX[A6AJP*-8^PN]!U+F
M-'RMQ@5[6E[O,6NEF/XR2E<,_&64CO%:H$'9, 3 75>)@^\!IHH!=EV369X0
MI&"#W/2$#M61^'MQZ;0"54S!?E.)YCYGIG@N\E?US *K-,>VO!!3M)43_H=F
M:]Z$-E,.M04 M>Q:-EUC$%-0^MBMI('6[KQ4&;5HV10G5N^5J5Y3W:]R2VF.
MX^T#:4N# Q$3%V<-603WX KQS+GY'P] %YJ2^#D8T&.:^DH #Q\. ZZMC*N=
M'0Z&^WDR>)F^&@)>M=['E0YEJI3:>I1\[ [R=-])(YW*5WKRDFUUJ/CYC4/[
M#(1_D)'Q ,D/!X5:.WH"@X]V*B7@YW"@VLQ&PTD4AS:GC=)/,3EE65?[^IBH
M3?N:,_MA$E<+^7+.LH'C#&Y->D&Q'@_0?/8G3]A 3S >T2'.$>!455T5.LOH
M'^@W'?>?2XA(D#*]/'B![3W7.N_R&9C?%LP']V?_'&;V$_-@RK.]_D-(_YB'
M!ET"^',S<,9GSWO@A,]H=N9]IQ&*# 16:NFA%2O,O3&#*6R89K>C<N5U-&6%
M#XE_Y#RDX4]:MXADN:A>6GACO^TE/DZ_@X;2.8#BWVC/+H5%LCQL&*>TTK.]
M"*-4BC7X@(RX(L2'!Z7.U TY5C8,\K6</#=SO'=LJ>W#?NE4?O_;A[O:&E[O
M+#UDGCW2BB#=O0;16Q8KL'<+=AM!U_L^)(WI=FWGB;3M[8!',"3)X9&>0$6@
M_DS1^7F;(:SN4V:_5UN1>O]2[&5AK[B>2H$C'V&[HAA5P%020/H-QPXT'X5&
M5Z32@K^"N<'0&D:CBVGH8@.YFB2;P4> =G;/ 33%V.:+J1_EX"69M, Q%U_&
M.;W]0 LTA3E56@FDT"W8+:#%D9Z'IH?2H^>@S$3']2#+Z:E=]'G,W-+85QJ5
M0IP7I!C1;F(96"AA*J=7V4%KF(P97Z-(,QNWI2C69*-6%2&\=9D'I4PO(?^J
M;4:D[LG\B ET)=ME!TT"I]ZY-Q'2^M*_!=8>@,^-_]OJA9/+<)M-2%J=QTVS
M^-@'9)5FY@;(FC@I/$97)A\*'PC+/A4BQ#3N=[.0SV&6ZK1])'$Y *@@'$<S
M8VY+5XIB8YW[&$,S"!%0N"53:7#I!\K$00R];NM,G^V4L!]FNV!V2+&G[,A8
M6DE.(4FK'4XZC\%G=3!DF-!DRIRXJW!1M'$PM7I]O8EC:%G9TS4A^KUZF:Y,
MII&+XH>V1!/I+R,_$50VF@H!>FM]H,843A3TQ;8J\9\=J1"_U<IX>4'_GKLW
M6GX+ACN08(R;O")NH*D)P $NFN<6C*-WQBB<9D*/?^D7SN"EGQNW8'2-*.F-
MY'H$_U9X>&SYY;NU:TFWWO-+W57CBAFA(*FRC&$'5GIETYYOF0C2GDK'0K?-
MQC=\O2Q6*>O"MAIM5>2K&K$SS=(0>3!1OV$<S?=HG85_VQ'R(9,?-1T,[L'Q
M:\"%&;V30B--!P/E!\N]Z;%YR[AAFI+4N03ZX]-)=P+V..\Y(64C;=Q_6D\7
MJ^?Y466,0$DEKR]AR,H#'0CN0/MB/ZVV*_4"#NZ^AO^)#+=8V#PEB*PR[;O=
MH[3>ZG",M/RK1PF)_U'DTK+=HV20K/O.^8KAN*143$B8@=1CA=]Q7% $@F[,
M5^1TKI\C)8G4,4TM1()F#6J>O;3Z]GFD^\86#)OV->43M+(ER['C!$Z_O-_(
MG6%>1)3!X$WO6#'KRJC-%D;'M+(2%OWU%+E'(.)<PZV8-V^R'[(=G!I,!)1P
MI'NL8=Y*K Q.-;+% O4\KJQRN*C";D(;%>T;=_+,9W>AVR(O76 F^]-%7BG6
MBDTGW'MR32\?>GC&P"W,+IHTV:I-)213WI,==+4B)_=DEKY I;I,=LW;U>Q-
M <94[D@7#+QO<G/HQQ\?G;.C?+3>M7D:>OKI$/91]3-E<.23TFX5V;:V(H1I
M&AY]H&=;O COQ_OE6S!7 GIW9M_$TT)8[ZWE?L/]ZI]Z:-V,H2U8*6L[9M3S
MGVW=NPD3RU2IB8ZR,0\=QR@CJL;GWRCK8BQDUE6G/YH:BOKLLJBGWHCO@IY^
MX.%9SWU^J:;0T\\%X]LQKHS/0^B;DF'K-E1=%P6@XD.!A*>\ZD6MI%(3S@?(
M;E<:/XZQ=P_(9 \L#$;WIQ$[*&O'DQ8ZNT(8O/'\Y]:B=9RHVOX^6OYJMNB'
M//)'5BE]_G$$5Q<-ZB+T*\70;7X,5-IVBO:\$-(J!TQ[2O@%#XL]=VVIJTC(
M>-J7>'1=,_%0^]"K#W,J6A['#W$E&,R?%;=MJ8S',CT_?XF$>_C!(?X0SDBO
M]/@E!_ZGXIQ\-M#S[WR<%39:F7[IB*\RP<>W8&6N$-G)LY?%975YWFGLG2UD
M< 10.1< :'V/.W9@N)2'&?92Y^NHKN$JRR'E'G5G-P)L&EH%3!6C,'5IKT[O
MKWGH97'&:@5+$YVFV@&M3+E0U25=F==(>F$;DJW2A*:C^GD1CFY,:>[%WW1Q
M&_5\N-O$J2)T[Y?QO*.&.WZ[ [K2Q#NI$+-J>0NJ3<?C#^N':.?=/^L@1D;T
M,LK/U3RCQWEF7LMZU_ \:US 3!J#UTE[>+JS&4.ZV4DL]Z3* ,TF/[ \BU:^
M9#_'6>X2TJ/2G,$6O/@YDRRT]C1QUHC?V&7/D,C#B+"7"JF7]HHPY5!SL/&(
M_17_=X* [_Y=$#"&AP\,;\=5]';TZ%^N-UT1]%N9V5NK]/F[\PW11>O!E5N<
M)5&3++#WBOW/2]ON.[<4_!"DLS&[R A5K#0YW*CC*= 4?9T238@53=,25FVM
M$[/CED?9U?K4))P[/Z)R0UA.<G]HAT]5*_(9@G0S?@F"+]S0>]F]HY+<5,J:
M-K7R< ^A+16II]=74%Y-N8J0[NNJ21%1KMZ=J$;AD3=H:Y5<YJRE[P2:U1&.
MLU26X!: NXG?-(B> TR;'8O+NUON_^D]<$\]U3?3=.,./ZPV\[K0%YZO;.O.
M9>:S\S1Q,O5F[PPVNFDWN"M[8M0TR\]V2-<>&QWPVC6)>OZ.NF;);P]TN_T/
M5:J>8WVJ.S@X>^.I\2B#.O++/I8+:/;04P_8UG.& #S3F>$'$M1$,=@SIN'C
MLY0\,B)*[]#W;785S&<[-FGR\NJYP$8[B[I$9.D;TH:S:X5!99V_E/++9Z?>
ME+7UOV2D%X*;]/@MV#2T4J9MD4 +%);#H'\_TJ&>-Z\"6G ,/.,#%4@6VH*I
M+2'KUVA8J1,;%'__6?3OU?]*KVCNK$TL=MZ7L;<3^F; #0<M!3=S]D 74G X
M/34GT%+XRJ2LJ;CFV;)XV]"4B][2S3&F)Y<L2E=;#OF49-YP\I>YOI;ZK\M]
MU3L:R$9O@*Z!Y#[]"J0VXRI'XM0#4#F-8:UMHD81WCIN>9>];%).)#PQ%C(1
M."JR8]25Y=-CZ2 (S._Q8WQBR Y H  ;B6-G#,W[:5TAM?I5C)M*%U%TJ$P1
M')+R%DQ.]ULQ66[4GM&-7MLAP?.#$_D 04*Q+MTC^U)^A^XA!&RU(:^WX"(E
M6/N6FR0<QO2!&1ZNR>\I_9\U<W*U6\K,1/,?O_F'P1R6X&%^A[FAG"VUFL'8
MVT6OT,"-42F:I/!6@&MA<SD\GV8_N/QJ<%GQBD;8FD'% X.O3\KF>\RU[>KU
MI/8G'I\WNA9C8=YF#LJR+AV#8GNS 0*-V1UXK,+TVX^@,XO$)BE<Y=Z]J=FG
MP^LR/O">*S5^3WUM>VFUIXTDM4^B:8194Y@*)UFLL,"185=V;<'DZRI]$217
MGF8DD8!WG86W(8D(!0:O)Y>MWSVJSA*U:8B>XTV)U^GYK+D!C-GY+.DT]3WO
M+N>VDZPR6NY\V_L@DX^>KL?GIL="D@WYP[G(UAWO_0JCS/+>1>9IBK_XV/,O
M=WNEZNO+U=0DRJ+D31#I2%#':#HW<LH<E+</R\^Q"4JA=F3N&?!^[H+4-M$;
M\TD53E&0%8GXS<[&3G:0 U<_$?OA W *]Q?OAC HY:YLP2 4"]'4I;11X/O(
M%6PMXL\_5_#-2O_GC?]MIY1&:%UY^[E:C."FGC:)UI4.8%?07LB(]*#E+(W&
M^O<2F%W6'D<5!U0?2L7TJ!_;<W/GFF%M]VMUX"_#[N^- W;I2E%-:5(C#>RS
MC7LZVR;YR!JE%8->BY5Z5[\_[M*7XTJ4*J@S#G70.NOE['QEUV>)>?)/*$MM
MTG/5":.SE!'0E:QC0Z+'1_X 6%$E2.3HU=&<18VF<R:*O T)6/R,H3MZ[/F9
MJP:<2:'8)<OIO'8XLR3&+#4R$#ZCQ-F>>6"PH;?,HTZ#9D6Q<K@:R[]Q[^P'
MB$-Z'3_,%<-S<&2-!XIS-M!L"0Y68KR5T"3O;9P6Y[$'HTFVX]Y?,1%O7MIE
M]$B.=Z>[FIUC:_)C]!Y0=JKGC7:Q%!.*_'+4:#5O"4/UI-G0PQK0*A%Z_."*
M/<F>/DRH['27['9^38RS'B!JEA6.?[YI\U5NWI!A=\(9/ZJ^+C%/,9C%A$Z*
M@"^9D89=)=Q+A1=HT2G0+_J.Q/OPVF_!7)"M]>_K0SY8?C67F!N7OSYRIUE$
MHQ$9CR29K8 Z/"V 6*!9%J@UNQZN&"R!JBOJQ^O/-,I:;L'8)C<D;N0NG_C<
MXRCZ  U/F[MZR-5?&N7W)('*:6%"JX264A>\*IE A%[2;@WR^0?NA?3Z9@);
M+TWR=X,&TWL"%^T-0O+KV^7&Y^G5/0]R8@6=HCX2Q%H4JONV8"3W3AI_?"OB
M0(/GS$H<XSB)0/F X-'0,=-JOGNU5R#EV$*+9N;"=-'&O9,5GDZ?ZA^(5G9K
MAZ7(^ ''(188 BU('!["#9X0#5R\A_P43Q,ED'Q_ Z&)QQ)!*JZ\?G+[1&@"
MV::=>%5[^T0([V9]ZL(5Q.'SH1$W.@.,?:\5%'DIO-R4NJI"U*+J^*$H571,
M Y(TTB%$<">MQ/QX7]'=6'IVS<X3+M.FYZ&M2'K'9_TLZV:B^C755_4%T**,
M1,;AV#008RNS0$S#KB+SZTS-8?LF$ITVK+R"4FK/:65N,Q:4QC3<O%26+R5R
MP0^[P,/@;F>>?&3AIA(Q>PV&*^F5Q7ZPSZ"6)=,I5VM4K_,0TRDW4K9'TY1G
M4IDXMC'Z3AK[%@>JP"&B/86D"1)F,Z.S>X%[J #LX0BG@$ZCQU<]4DH\K#@X
M"N*57.H3+C@>$MSA<K"4'L)$1WL04^F93'B4 3"KH67SERQ'(3CUE_7[$?IA
M: C,W<-4>O5/3&3ZYNBD&X%%"8TEWI1EE[KJL9[YN\TY1[_GML>%)A>N-<\F
MZD00Q4UVE&;]W3YST/M?NAX:S-9S9U7FMYG9FHGO>KE9:B!P*?%_8X,10DQG
M>$!9+V9$'K\U8$S6Q !W2*W-*7FVY)N/335*:N.?5)781<Q>2[QJ%E,,/B^:
MKG?[8A7#"S#VFMCC2+;QL1+S^HB-TP.%/P(87%.@ CV4JDES :/I>1#;;;&<
ML5/9"[@&83S'@'*T6>?SN66=AEZB?;T/-\[UXQPAM#C4"W&-IO173S4Q3DZQ
M_^BI)E]0<!\&V_' ZMNK["2F='[(@R91-PS3;:]D"R;VHW%G]Y*0EFU.;KFB
M@U?B<CUN@.A9_*6[G'?NZN??J*?Q]937EW<8K2#^8A7(//C\B]]]\-<_2RI>
MHL@M!38S8S!C7(VF07_6(/:KT\:*V6FCN]UI<Y39:4/YNTZ;U1$&&S0E6"A]
MP%0VAG2!^W!SDZ(.C7^Z1W6V74*J(HYB:AI[KI\U2J JLF]_O.K<W)A3J^&D
MR=/LR(/Z2.._VY\,U/JO[A::O]B$CZ:&-BCE^HFUBOI$OG(?%F7VB+8[7K_N
M>"N%4J5)/OA'M8;!Y<L78##847DZ(/_/C02W+5AL\A9L:'4+]G7 \L;-(.94
M9(4F93.BPJ;I $0[HTC#X12 UW;A#AC0H3;J7H:@A+XIY74-\)>O>D<+#T6?
MC9?XKC?N*?*8[:4^N9,F.D+5!S.FC6B"=JU-7/W+Y=.]4;8N+W-1*7??JSQI
M&>Z:84Q.2UE=4NN4J8VU'Z*TW[M=L"/I]BHN$L&%F'I!$&D0#)C&[?<+H+PC
M(\.]E3"H_LIH'CZDC?W-!"=S59'+"57O(F8/3B<;?^%85P&UJ!0^<)KDRN"8
M)R6U91X%-<AV+9GB [@JO9&"10D^7&E9)>$5@2D"V_8Z(]OK=*+JQQ=W3^5]
M"N(9,0=/J# NE/[C+*9PPQ\4(45;TE\T:8):;[45*4+XWCB-<3B/^QI2)^>-
ME; O[WA;?YG"T1C=*.N"TEW'+:"()?;7[4T-:":C$4Q;J3V(Y1-,5RG#T!*E
M^.\C%"?Z\P8-JC2CMVD?B)JB>I;[^3:G.VD[O_1[95+LPY,YXRG'*^J?K:)8
MS.O[7JI4Q-%^" H'_R@0 H[!2=[PCGC0%DFZTN-Z%@+'K#0%@.N[GM@:HX^Y
M%^6?H)D_C\8W.2 J&HIJ;V[H5 =2K:!L,M6+Y?+P!4@7>B.T/]AZT^HTPEOK
M,Q0*?U3?0Z'OZ.7DZ>YK>(HO,TY9YXHZ;WU:#O;HIA\K[0 $B.7R_MAZ.^8^
MM*Y"$X%FJY;4%NQN)V-.OD[P$[WK%1-_)2) %9X.;K59IH[R;'%U=C. 1KEB
M#X=_,6T[^_BSNT^)>U()QP?=JO1^0_UG3YP4"TPN_IB+A5;/% 3W9QG<CB$S
M5YY!\UI/LK_!%R +[2]J.$F)7CRI>RY=\&?BAV+[@^Q.Z8_Z0]FK^BX/\+*'
MSV$[S6-$,41.<G6''F)XJJ1R./!.L0/XD"$FX%49-K,\O2QCG3SVU%#"D$/D
MZ?T]UIFHS5%Z*.!BQF<.2O>V0 O*08X$4)23BVBJI7VTB]-S54GG,CXT##SQ
MN/@A8>-NNVYBSVUGSQ2DIM$-_42/*@7'C67F:]V">10"8_<8'-53KW^ROU'R
M B)3!D A2D"T>UZB%A1*RZW/&GU--*4&'(FN*Y,W/83.6H^D"S-;P %W!.B$
M  _/MZ]$W%X$2'$+37!2SVB?-[R4CEW:K/A."=)9-Y"^TO-E>''M9<RM[NE=
MO+3H0#.2423@%(_7;],3U>X<#70FM;:-:-L,>>G4WJ#JO<R;4#><&;YI)$],
M$>]KXNT0F#8W'^,!3X@Q.,X ;@ H@UT:@[ */BC\'+B.$5P@C 4?I)HUI@T0
MI_C=UC;<"N]]G40JTZFZM17-3ZNW8(424^L(6>;.$Y05BSJ)E50430VTX=+J
MQX/U]@\)EII:1\>OCG\OG4-MS/@_B#$1S/;E.R+?]O0MVY=0!+/OO0_#^A,1
M!I"L<,(HK;514Q291[]?5S\WI[[>9'>#3V1N\E/5^V7^^,"EG2EBHFKU,LE!
M5@QN87IR$4.!\5GB*)@%<(>V8UO,V*^76M6FZQ2B32^M78OR.KOSA)308X]C
M-0DE7&1!0ZG 8*:Z42I-JT\=$X6 T9"[4WKY4)M7*K,(]AO]<+W^+CNYHJQ1
MNQM+21?J=9+UM3+"I.5W!QD-;JXPN$^#S?DT:.$^M%2.!G8_TL3P!#H6^ %F
M 5[>B0'^0@0+EZ?E^_K]\8\6.$+%A(Y5'TIKJO^;SK/@D] -9R"$?_3PS&([
M>6#=NZDHO<.?O'KWV7Z,"!O6"=*>\9.U0H\_BMG,W@VS8#.YVW4FC/[H;ZYD
M;O$[IN,G<#>9IC&R+G=>_S'SN!'3HT(3A]@WA!E/*G=26:F<5"O&/K06@\]\
M:0NF0(3CX6X-8Y0>C!:&HE+J^&&#ABF?_3*&- ::GQYFG#?]=1(^/T\[P$Z6
M.@L604 T$IPM (/7B13-S9S<>,6FWQ+0]24#18JW9EL+DKY^'O\MXSY^7$O.
M^5#\MQ6:"(8T;M?/.$ +(C^BV.EJ%7O8*L<Z^O]JG\2ZU$;_J7W2%N)%PXAM
M!F68QV10N=; ]\(KV*YX4'. 86E.<F3,8C9O#*)^(O^ZN\6TI/N[N+G0%'4D
M7UH!?$NOVX)-0] H;!*$J#Z;.468=@A'>K8(C")&,ZTHKA1@?)ZJ-1:(F?"7
MN-*KTKVAB1[O4*!*@EEDE;.@"JFWS>$866F%XAFN>SCWZJ)V$2'I5[E?;KI9
M0J$.,78_T4#QSGWV&5R$WTAW#,_IJ-?)_)LES%'QT-S_W9Z8G$<3FX<>#0C-
M=Q8O\%"NW\/N)>$16_1RN8"#U]V5"MS@K94BF2ZU'7-V5_5E^WV5Z6\$'URD
MV)L<_HJAB8]-QYI#I."A(WACH?4\KK&R3T_2?;WNR3!E1?KWH'IKCPM_D#Y=
MWK";W$S2=P31"_QG?9Z,CU2CL28"Y7^Q]^;A4/[_O_BTRI;L134)J6QE+60J
MV4)"]IB0=3"5;!FFE'T+(;R9+%FR3/;=9!=)9!U99H2RSI!Q:Q;GGGI_SF=Y
M?[[G=Z[K=\YUOK_?^?YQNURX;_>\7L_E\7B^GHMJ0:D:1AFQ'4!K:JA6^K+@
MVBGYT_??G);ADO;T&9^!?GG]7W58_S^_ J#+ \@2\<;5+L_0\;'R/<F)=7$3
MHS6S?WA!69JY=&>CDIJ;S*-T(YI#O\81X$@3X."C@+F28A^E]QRGRS1Y0JX9
M/7[U$&*^7Z:^YJ1ZNFCO&R\I_1\V:J!SX &MTP+T]O_IZJ7_KU_\ZQAFJSW6
M7:11!EL=TZ;1I R\NE24:2?@2 8(O)X]6!^9_DAU'F^<5NZO2;] E0KP6>FT
MOMC=-?SB)DL/FJ0?!XBQM,$!<2CMU#2I=+/_Z!*,E$E_2M5@\*CV6L=)+*-=
MUQNQ)Z>..J\8>TXV7+CMP (S^T_PT?\S7P[,6=7Q6FN,73N0K!+_UX_@[5S;
M?)Z@W$-_"HVFW31F.YT=_)]M8-C_#==!ZC_E47O!V'8@7VW3&<W".Y K5M\+
M1%;![=O]JUGB_X8+E@H'5!9F]Z>2E1EL34HQ=OMHRF@N->AKP-<XX)EFK/]D
M_M!PUMGVRJ ;.6P)+3=^//=X9X8L1\_TH9_^S(PB&<ZFQ,UEME3">9;2X&$E
M=MJ_,Z0OM2\OU3 SI&L.:/!<UTNZR5<SITT3>,JL(.]BL%60UZR&9][6-)23
M8];"!J0&!I5J/@M3_WL%N?S?*LB;,21W:%L@[[L="$D;"5FL-T@91S:ZOEE2
MZ:R0S1"EEZ]>T@K8E\C1?DJZN"31;1]\<K5SWDGQ4VG89_".F_WC9EP37A11
M()54K>/NV$#V"5$3LFRN2YL:F3:.X[4PE&Q+W7O?I@,I"BD^<)7M@K@A>91$
M):I7D'"W,;<^R0:U!/CFN0FI)6R?[VT>9'Q$"->2%M_Y)X_R:M=R]N(>)-TY
MC$8JTEZ!@+D55E[5M5P(HE$K(!422G-AP$!H]VSA>N;Z_)'<!H,KF7K)N]7<
M8V0[EG423M][GJ7:PG/A";-A#!#4,PJM<J;Q(PDOCAML#]!V@0B']6/)I8P/
MY]Z['O_CO70%]VG5V8 -!_9<M]NYJUKO."+H\-%9..T(E2J&;A4A\1)AG24F
MAN.!LY=NP#B_/9C\QKCUWLZIV;%]9-3=2TQ04%[J1L%NUH=E=1DIW(P>8WOG
M=6;D&@/ "FD@9 TNI@4,>/LOR\BLH1P"B'L#E'UC/#:5&(,UQI:WF&G*UV</
M'RS=<VY7W(\KX/NNH1[4 LS#X%! [W[!THC*:@4A'8'CF(KR>::;)Y[TY=,X
M_D/\KO)K;P6NL>R:/'[Q<%EB #-##P_E_&&X&UPKDV)OZ;.]RS4,>9),:@E"
M;GL0-B$S2%SON-MVGC4*(7D7_\1\*Z"L+C5N'$9RVH%TQJWTCU?,*K?AEOLE
M&=QH7DN_.*K&BC#SV,7-@X:1=)F8VX$X>DXVKFZ0JWP<T\>0#J112C(]BYDB
M @)]WW;,X<G HO8@^:&YH36E]Y)M'HVT9-)VZ>K;JT].1K!7=\]>8V&3_ G"
MRF!^= OL!WQ,EL%*G:F%O<55-)_P6].O(G-%>Z[^&)?ROBB3KZ'@8\XJ*I\_
MEI.^3(0E^>:6^[MLZ'"M3U+U@OJ/GZ(GJL/\&@@UT=)!O438?C<OUY1T^Z23
M=6-!>N&H(6V74U<3VN<$40]$GX3RTZ^@6Z1Q,^68 VC$#F3<@5!(YNJ(8[-$
M6396EY,H=3F(GR')<46+CQ:[^(RKFO+F>,4_?#C.Z_G:NH^U2LP\8C\'U0G'
MB9[96-NN7J.F[D"VN.!OIBM!%SQ!":(_G[!Z2H1VK.T&T*:DM7AZ3C:G@<QF
M QK6>Q[=7L^YY5'G%,.PB!7U6#C SC6/8;##0+&X/P(ZA:(=2.6^Y.PT9YKH
M],%&?DHZ_,!W>>TC33IYY[='S1_(>*DQ],4ZB^TC'*[9+(NEW7T6]TGVGS.5
MT9<P).>N%?$\@)U2 &!(K71WC]6@D]_,ZDLSO.\7B,D9W,_3E7$GA(0ZQ1.:
M,[VJRB,<1?#O*B1^2&A\.?Z_),GYAR_MJ"!IVAH /\U>;V ZSR^H=V5KI-XC
MDQE]O>]>^7;(0[;T:V_YT[D)ZP_4*U\FE J<1 P_PD@N++0<DRXHQ41V!_)C
M.'=TT3 2)9OG-]NF\KL(LS.FV*K7 6T7Z)DB,%J]GJ4KDJR\SU99R_%W<:0+
M,P5:A':1Z&'88BOR=N2A@=8.1'OD87KXVN^&*XN=Q%]%F,_D=&+YDUX$Y^X^
MJ(E&'O_5E"..@UFW63"V] ]-.:QM)_[2E ,[BV6P25,/ .D,5AS5R@^$NQ&E
MZ"IKW?72RB8GU3,>'IL3K"DH92.II_1O7P\,GC3@&(B ]DJA;^!F0M&D!X+!
M.Q!GKG'0RP"R9'+5!#L7.[**M .)OA,9:'S:_;Q"H4?@8>=:N'CPE5TUL=?6
MIPY_N%>\7]O=G?X=&XR>F</&GD,)@@JC@;I:);3)>%(,S*_=('U\,>(AIQNT
M/MEU:;C0+ZSW:++ 5A:MM>![LYSN<\E'AK&PF=H=2+EYVW3H(^4H68:JW_%9
MO5%47,65/ .9_,*.A6N#^1@[]P2;";M;81O9AM*DN*IN$]H:NL49/5/R<YK&
M_Y027#XTJ@<:UP#"='#S9U<"YRF76>6R#GGM!1N;[KH/&]N'$H7*(L5CN'W?
M)K@F7-79-B'DMP4B9V7;T5R 1IL9'&\K2K9][9'CJA3T\![]S2K1-/3P5G=/
M1+VV4=W8Z8^Z>](84XCM<I!H6J-G,E0P*^)4APYRCFG-V^-[ 47O)H>AA_EU
M<5;#>34OK;L\EYNOOW>Q4JT.[!.[(47"-/%TT4]]:L&TV?Q+Y.-7HO6OAB@@
MW_>^]"M#R6P1E-^_I2@I_35%*>=O*4JP-V=I > +O<7-I-=C.L%/SS@*T&<F
MA78@IJ/-QZV:$XFU'J+^N2H"=VMC284I[,=R^Y1V(#*G[%-*Q*++K'F$A-1R
M&!QCP.P^;"3C DJI:13;-[R9ETKT@%[S25TQ%?%?J6+//7RN2T3^>P$M[+F4
M'\=)59C/$E!.C]^!N*$%&.W3E>@0]3-^0HC#*",">UYMI>!(ZSS^88)$L(NC
M1K!#\A''F,CR6AZ>V%C^KA^65.;(W\_H<FP'+-0'GQ_C30\@(,-#N[$*!GH:
MS4.4]W-:@VJ" C=[$J[,JV8W!I\1[I'Z]$HR^1,>IH/8OODGRU?8@?Q)\_.D
M57#>.#<<<,&:8DQ_L>QD&21N2;LR8C8BW*V W7-V*<XG0=]>Q#,^)%(GW58K
MUOK%O<@#QK;G=B!],!H?"Z5[&#;S"E8M&,.0=?NI&!962K/S9L]+=9;L.Y;4
M*$"VFNB\ZWY$[%#+\6VE5[Y3+:)[3X9STT_]96;52S3)SQ>4)CUZG?H1O^8
M6=FVM+4GYMIO&S=RU ,G,[-\%3\$[$':Q$_CCWW(LNYK33!M963^ZV/,83.-
M.)+^1!QP!KFLY_T:@!N6U0%9,T59)7ZZ\\G"3G5!/(OOON@*\^F%/[BZ%B%$
M9-<0BXQ/$#3RAIT$[?,@.O80BIF6\F))G0?W>Q"FWS\.PG3YYT&887\.PD0
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M'<AE,S[R=;)JG#T[Y8VC_/(;FCCX>N\9%UJ\B=@G.Q#.XLTELK>#:R&0;C'
MG:=GIIO)CF#//WSH_8ES;CI_I$0KI+*)"S/JZ5FXF>_8<7."<YMJADF+%:.)
MK->NC3)[="H]:]HU/7<]UV4J(&K,7F=F@YL[\[Q4U'RHQ>W]71NOJ;<90PQI
M>C7:90?"3S,F?QB1 S =6WKW?:1*0IHJ68_J[CW7_E1,F^^\IE"RTP/1?9-?
M*KA/Z/Q<8'!& ,@28('!SD^BF@P6-P\[S$PJ6XYXIZ*^?5[VB<LWM"^W>RG8
MUS=7[G&YCSHYAB]N^RGR;T+*S,:W^YD9/6IH0B;Z;L,.)$9=;) 6=QAEBU?
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MBD+8-ZX8&.D>UW(2R820F4JT;)9U:19G3 [.#?UHDFR+URM<]%4]J6LV9>$
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M2\^_BR8$)TM>(TG0^)6H^L/(H%[T+&P/,Y%4,%&47KXB([66IO;F^<OJ\KK
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M+*#7_TP=Y+@\3PMV(,YT[(J2L@!FB5;HXT$%L>NF1\;+V8N[QP2Z*)J:0?J
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M@)J4:S@X>*/S/F:[S 7TIF;O5W7-\M91=\_0TK:I#=R!%#Z\R1+-S/"$.>K
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M,AA1>U[)_]XW*G_<MOP;RK_H;<L?\OO*'^"M?P"V_B'_M$ 74>.3A.^FJ&:
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M8B]A+M^W*EA\U32%.CH19U9N*_/AIQ3Q79OE1$YH.B?+X0[NN_& 9T4?TS7
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M2705KJG2F-"AK'D0X=KHZ;I'\7 S_?.!N/$N4)G DG"=4&>)M;IS$/S?L )
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MRD&D'^ @DOVJ.(CW)4"C%K[0E2T4QZHJ)4.FKRLL40( 59XXC(:B49#U4=@
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MFO$"6!(+F?J[DY$![2YA1Z-FN(PP!? Y\-)Y,8H,(]*%,?,Y'(0^O"UJ.[?
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M4!,_QOTQO9W2."A98BE76W-]I$1YPK>DXF3Y.UM?F2?]-EKQV-]_?OR!A&W
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MR$;8&NQR%U(J\#+OYBV:)KDRS%R*)._V\$CP76P_7'PX(/4<=.5DEDV.IZP
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MDZ];?V=E:0B#V-K'Q2E4_A']%F+@++[7)MXT<JVHF2-?I;Y3J.I.L=$M$];
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M8B-J8\F3\6)O]3[8+#K=F$5'R(X$9 0UE?!YOY.Z3<Z:_^9"SV\#G('>8Q\
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M,4VO(?/# O6WKFK("0+?@MS8B QN#?(=*07>T?T5#^ OHR$!V"'=0XH),N>
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M:?YG\^.2!9SY_>O![N2*\8];_ZE^ _WM."X2&B713N)!?_S(/4Y!((KL S3
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MLA,)>JI,^!%"U#8R!.IKT+0:W%&PJP6@O4>5H<AJ@Y@*0NDFHN'@;&0:54]
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MG7.#&R4?:<O]JWB11A^ISOW?RA2;0J//OG>@*OE4K5\K$_[HH^ 1/_0PF+\
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M#W;#89+$U&;!W)>=S2Z#2:183+ ZK'.\V'GP]@8R98JJ9*VR*U@?(=?Q4>?
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M:]1;)\=P'%15CM#6[BY2C\S^1NM1CYX8+DNDC47*[EGWC6A2Y FX:AO(\5!
MS^I:W)I'E"5_0R4J%KT-*T,WQ$H/UK!-UNYL;1KCI2H6E?;=6BB3/=$K\21L
M^S']V#??)/D#1GFZ$Q.M_)Z8\C!JH#$TQ0NUQ$.7 I/-WE,<[@/4O ])ZN6#
M/ L9XB4Z?6+3-_=](%Y.M<V2U/>YN-5Y-<59Z7V\Y(8>Q(EFQN*4H"Z <ADM
MY.F@#5I2I3YLG!IL;!\^B&&<F4@;/4:T'C;M%7.TEHNYTF9Q0NC@"0FA2<3@
M2C[?LF8H[B!L:# \I!APL<@]F>^UY">Y'FPB8*3^B]YSW--(?&:%[F]4M+K<
MLXFXG)(UY'M3])F>EMX-4X*ZRJ/3S(+,1W%=)%!C&TT*Q-.W0XW080K0',?2
MN3U$5C1LU;C37)9+BWFYGN)&$\'*R]+=G<^D''CBI2 Z_?G(&=3S*R:GD9_"
M&>?<?S&9"FTBVJM93*9$*&\N,[WU!FM_Z 0!8BNCYD%[^#<1>PPA/MCD4!-*
M+ X[NC_=%I*E"2"=Z<8T#)PV(,UT"/Y#T_2THI)GSJYK5Z/.HEC%2$-<H.Q@
M2R$H5\A0(H%VXARLDR'>E47E13R8]A7-+%PD$1W\&7<ZE3H);M$K2Y\AE?MQ
M_2R"T1A@O !-T2$A@'I+AF".P2LTT+"/*MHX[-A38^_YF]*TK;'*K23_(RMQ
M2]QBG]LXHKHO-,>'U'2W,R#< (IR1IF83+M +3UIWM7 #"+O2)S!?7P+[OTT
MVR2@H>D4B?=I%B0>(+KLUN[FL"6>T*J=?YFWT0F_N"\XNHD(=\3U/ <^UF!]
MX='D,M]$3/(O L6%#%$2W0+J3Z8\U18F,5#=Q'G/$VOH_<M?LDH#)GA#!HH/
MU0:0?'2+=;PD!:^R(Q+XH,*YS G?B3A08H7!4PI_<6E(-*"R#"/,)0BVDP_V
MN@S@/GK2@E4NTJ5-ERHJ1E.N-558GDAG$(YJ%8XTF5<PN_X@^N!G0$"]-VH\
M H86ZTN!,#0_!:91]TV0&I5!?:P8&;E8N,@\!_$JRO8NB5]Z[()17LZM,K#D
M;99D?%*ID#H0 CP_>7#;=]@-?6!&0')0/>K=)B*J!DEU:D11H@*B3:F=8T5>
M[LPL]^ 9FU-A^#T?ZXC6W-?T940-=_[T?<AM/,?_CY0J"D6!_2F#]QSM ;.6
MX,VU!VR<0,&)(GB!H9D#BO3J559#H[W7L=6EA#Y9-YK=B.XL3Q?/"%]AY\,I
M;I3GJ^=<_R^M5MR,[H]5'ZA3P<%W%<8B)ZJ5EY1Y @H_$,?B7MH$=C?2\JJC
MV2;"3JT>RUR.[_.^O4<EX?0, =_U5>_W8,8!C2!WUCB2C1\0ANK$*+FQMXR<
MS'\/9JP&DG6*D6J:5+6KUW]VD,#!3#-V IT SU<'%*CQ^ JS"B=ESW %-8*<
M,%3)U:_*$3\4;=;(Y52A\C*>80-W^9U62K1&3D+2M.+(=1]*L7XO5&JBKT==
M95&^E?G7DR)Q+G$?NF)M_",8<F^\R_M*,>SS*L$)RV-VV;2*I.YB]2%N5=]S
M$F:ASE>/>+ZG[&+P6M+:F+6 FP%JX@!XDVI=8_ V\)A'G3P8[1F4V[S_H&,Y
M;U<0]L7,:M91:%Y9'7-8:KJE?C=RP _V-O@P!T5X[NK9UJ,HQC"T$$,UD2C/
M<-VNBW=R'I:O(X?N2(N;<I6Y&\R$?6>,?E]\G]8V*FT1*/"1%J?Q/7R"L"A%
M=X;:T,C%&H-Q^#IH,:U3D\#6^83@./-NAE1P()]92Z?H3U\=OJ3U(\?'PG?J
MRT5^11[3.+")L+]E<J-R J"8;B*&@II(Y<F+<E2I"> ^ YY3NUTC&.@<Q?R,
MG*[#9V]W[B_T5#E_+D+)5*/\R5TPRK_#YV$+J8.PQ"*/.<3, ZZA][%S&HX/
M1F--O&[Z^6%<7H':W34ZGG<>G2S$1Y]>'6X]X.?6W'>C>BONM$D_D/_IX'L[
M2 .8^(HN+4!-C6F?@#WK+A8M3M3Z)N(K&N+L9F9O(JX7\N9YBO,2P#,3FIXO
M=D!%DX;"I?1'_./?=Y3=#ZW,,#Y\[99"T7!EZ)<1*0[+-3T=0?8,$[H KAD/
M>^K?4$.;" /P)H6D#W5^^3'2>?/F45Z'!<'K;V1JJI]LF>F2[?_XP=S\O([^
MY'FT92;L$_E0XWE(BL<+,&X2S<TXSTS#E"KN-3KG]P/V_!BSQ=L.-V)=D^GJ
M4[R/?A;OMM"T-I>(R7X428XTE6:D4C48O'&T9Q1\9)F8[ (-"[8K#B3[*3[K
M<AFGTX== T:RA HD(B=2CYT9EK[4-LGQ]M,9U->7K,_?L@"PDIHKK*1&#,6U
MQ2.7E=,02<4$AH@G_3S#D1 %(^KD4&VNN04_M=I/=J.RE7G;K<ZU:JG38KVR
M8Z8=A;G\][VR%G7<LAW?X\)GI^0#;,'M_88O(7SHVHE%=<O657;7<+ZP N\T
M> [J52:-]8PJ3KI;\_-5ZO<5F5\V.'[Y>$'Q'RQ$C"C8A."(X8@AYD)[.*D:
M$^MAVOM .8C7.#1#L%?TRGNWFG,NN<%9-JG65V]J:6C<C-1*<R.O/M-Y0G=I
MV^N?B.Y @V&]M-Y-1.9_B$V4,2V[+TU6,EX!3>KX<CR3)XY17:H,&65!$J5,
MV/'./02F1U\ JUZ ^0_8(O_RN\)OKC0>T"L?*\P,AS@#4$U)Z*$Z24KNO5(C
MI'GI]ZRTQ8K;-.YSJD&3UW2')8^,/+PR>2"^\TX9/!0XUF+A+<)XZ#N@WNSZ
M+;0PJ&)31!EL7N&T:<UN5,_7:M3O_T$Z,:7^/:)'-TP_U3T[UFK2:WCL!/]]
M/6GD/32<<<+93QFR847$ 03,F7CH\"C)*A!W/54O7$DM3X DTJ957:V6-.:P
M?UNQ+K$^\=VG#\!OO]XBWA-),48/8VA$L/9E*YD0ABKEBF:8J>59$3TRCA?W
M21@&!3PH^:D(O+X>)E1_+-$R\4S@D>?5=P$]:#M+$.+='*DD/':8K!R[J$:(
M%JD+517GK^A^F=I[CK*<DU!=KS6HO,_0?W_(<:E'HLX\K6I?KB08R[IM(C"O
MX*CV<R>5B\&+IU4PTR$%:1X&-]CI1 8X1H;'ACUP(MU*:T*+RPB#B50B],&
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MSX1&#)).O"B.G99I"#/,_G!@%\X,VNNTB0AYZPF\Z_K R371U0AP;R*N8HW
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MDG!76YIJ9U,7[@GDQ^V8?Y1NKZ9J6OPR#*]P4,FD1R9%TL#BVZSO5M4(_PL
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M.WL5RXR,7<T\2G=H&9'4?3/$7WSDE_J,*F:<JU'V3_;:\5_;:XTGM,>,%8A
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M=NFO=I2K )?JS'T?0HP:YH/8NWKNG;9X&XB>M BG0%MX_J_"0$UQQ1/M@?:
M$T,8J.;OPD!L)?DAS"=F1R. 9AW$;#J:%9@MPK+<;90C2K;0SO@$Y@3DN]=?
M2IS\OGLZJ<FM63ZQJ^EFUV/QN(&!1[H3XO%2Q@S,>=?"F<*)G/UXSA>*KRFK
MNDV++T_0[!E*+:":-NDQ]:DF%=FLAB4T:AX7QOW L(_5NYOO;'!MU]M]D_ 8
M[,.C>K9_B3^89"Q^3TN(FD6'N2;\#LA*@QP(H^V[$"#3<2_764SSN4V^8BCO
M'<!5-)5],$FZMU6VT?C-0?-C%J2WR# LP5]OI12OQ.Z&9FU2^G;*WUB?Z!RU
MYOE#Z8ANK:0"LLV5^V1U05?MOKOE$[D&;)6$95*F=+?31IM/N@':$6C& @2K
M3#0H4]MB>[T%I6DCA(S%<93>"M:=$Q")0/!8O95692[]+<* \[,IWD0S)>"%
MH[34D?9="60/0!&ZVX"=K88?>!=?IT=C]A6DE<B<.OWG([":OOP.T@6S&2 ]
M'0+IA:62C&3QO_FGZ L_.$ -"AW64?TS!:7V>PH*I0,9)A;)I6(<AB-8 B&"
M15%*J&9[W]>V2P.&7[H5EQNH6M\[!C5%RX6=/K3)U,458[UYKEFBEAF"?="G
ME]!AU7R4HVD=U[\1<%/+<#;/%\0/SWFW3S8?BW:IT/$?$M#[<.PA'U]2F*Z%
M<\3)AH0UW,XSZC,&_6G]A3:(YM 2@?8+X &T')CS4&\#H+CD0E:?I'7Z\G0F
M+ZX"2D!:[<..R>>KO[2SWK*!3RSPA/]5N0']#\H-5_X[Y0;/X204"FCN1T#?
M<B_0+*P97/"]%NN$)1:^REN:4+&[DD#JK1H^T>2R\?KB[8F>A>TS9M29J36G
MZQ0"H^KH#S3;!#N[GC!99$3D?36+',?IN@M-9AU<T'2>L_HM/\EUFYUMA*26
MDV3J\+3Y7-]@I_SYWS*Z!][T<4#.WPN (LZJU<_<L_.>"&H5$+G]OR+:IF,%
MY53)?RNQ:;%E^V?E#+0;P.PSQ$82=OPKK<<Y@A%W/"[N!QQ53!@-D7]Z !#<
M_6<(\V>6^-_\6XN+]?!B[K^BR=_1V)F?J9Q_@&/4[C^Q5"P?1(TA:LBTA7B,
M)9@E)/RJB#D7WCZ]_L0KZ'S"G35B:5,A;L+\NZ$L^I1]0_1-ASV?W]^!G:+*
M,2;!\6W3854Y$,IJF8<0CJKMH274XH .CS@:PH6&\#>1%*$=LEB0T\\QE:UM
M:!8(%>O,8?>Y9'PLAJ(UR]5JCHFR-?D3&:YJ>@]?9N8_U#"Y^&06]@MF,1M;
M\7/!\Z[_7'#GGUW)9LKI^#CHVX^CVCWH,!5'FK#2:"1M9G0(6^FU$D"H)&D1
MN@=1_$$(0E&(@E-U=65]\N6AO(AE4T-'QT?3-QT^UB=J8]>E_!XX/I0W+-=*
MAE;K)KH3\\3:>66=<+H#.*+Z4FFMRFN?B\6,"#:BG7.ML+:J-C":5^*ACC+W
MDW"V'A8Q>2;5$8L.+.&><UN<%]Z"PCDZCRK"DW%OD+:N-;]J5NR<ZFT:))M4
ME3<D'"YA2O>XKQ+X:*IA6\9\SR.F#1=8#,*)AUJ*ZL4>P.(S@3M>D<!A+,2.
M:[#X/82.3'S_*D<E-7.5#G.HCL%]W*A%I&%[IVL#/3ZJ'[N#?9H 2F'>3P(3
M-J05$#&K08485=NN>C3%OM#*_:Q'QH=%XT*AEQ^("BQ'Q5W=)/T2+S\;.+XM
M;=M*5GZ=:(I(2 #EI%9L_,C[:#@T)PH.. *._@_.787<Z"NAF[U>DK$/5A6>
MQK@_8A3&D@+@BIK+ :.!O\D'=](.?8#,"4&'1>"IX9 A)C!GN=O603R%<LK/
M>UY?<A2HRFG"QM@76D_;UE!74<0Q6UM.S<#Y6#.C"GV).XB[C$D7C'.@QJ;C
MH"&QZ:,0<]F+MVGO)]HPWNH398.74DG-IO+\E^[S;XFNISSP%&7RW]=+D99R
MD2*J=* @MMO\_.>[?V5JQ\9M/QTS\E7MLSLPL&"8WO39)2H1Z7:(>.NBPV_=
MA=P/K)IK?V-_A#X=2..0!A&OEI'[:0=!FLP*GPYAY.UK_U^_\_GQF=YTXR7<
M/-_5\/#99Y7>1U_>G&BT-#\00TL FF6@'663,)9'8QDGI.'+<MBI994Y+@;W
M2R;M;K9Z2V07/%P/#(8E<2Y4W9^^>27JQINQZ,VW.Y.MP.P"YG$-0RQY]BGN
M2%E$*(!QUSK8,-1HE%^:T;=AJ6EQO]G7QU1L4^]X>/LWX*2R*-_31PYLE</9
M18M*%$%.8L=\,U"+C@]BU7IG7^0R<X80."V9>>]3?D93D8,WJTV45>2S03WW
M^R_?QI\.R7:H2#SB2&V$=C<:<@,(%R^R)./@:<CL W *0=!>CX,3<H#94L2>
MK?Z5_E6O&C!;Z7  W&5#$[MJ^660LCIIHV4QJ3E=MT-YUY#V$$_5^(.WRYSR
M\@9G_MI.*OU47SH7R\7HP$"#OYQNU<.7U1+@LVJU.?Y-2+YO7@YSZWR6'WAS
M"JTM;[;7&++*\/E<[Y>_:F[U6\7Y>!.6YY76W5)?<!0>;=*K4-(H=-F1059@
MBH-"W,<$S#+F8(*WJX=JE5^&1ZY$UI/%,PG/*@S<O?;5W2H*Q':%?H$\/GAZ
MDP1YBS XZ0R82)1='+6K:@)#YUQ^U&E]YDMS"+ O;"87Q]Y]H929.;F4U5KA
M6<.\M\H+_;X_!+%?TX9L$&3YJ9%UUHBQ76@*1(6NJB&?255AI];9<HEGX9=T
MS/T2>_)=XM=Z7O<ARI7&G$F& X ]<ESL/<#R@Z5IE)'2];C3./XSI:LRZA<H
M;,"&"NY+-ER(=$KH&\/*/KY!YB8+E^OPX)&$&V:,]L@/U-Q(3"O\: *EX.9P
M$G",APJ1X.::2 1!)R$4OGT,NE=K><B><, &3KB #-U%OU\'Q:7>?^ SSVY9
M_$[63FX[]2ZSH4-A2^/MEIRO1 JC>KRC[-2C[[.\L%.%U[4:_UJ-_!]][%3.
M6U!2V)&T>B7:H^H?64'CQ&+:Y0@,'68+A8CSUBO-05Z?=M8@#NJ7@%GZ:!TC
MC;D&OO]_097%_V\>!9>4?S';7_X+[+!!SI$N_(VC;;.P,Y+O6F>QS??Q;0EF
MGQW87W+6\UO>OWO.F ST+@_)5INI/GPX>T_UE-D9D5J+,2U6"I_P,?TM6_.3
M$X^%<L(C>5N'Z;!:2M.[<XHQ<IW/IW J"=@6O"O^VVN?D<<ZW#>._T<%C/Z/
M>P05D2%DU>R)N ,?YY@WKR:LSTFUX4"]1@?\NAA9VQAR6G[F#61$UGX_3A2)
MU2*N5D?>8Z.\8^78D?/;B/%*4C+!8C6 8*$#1A/6(9P:%MD\([))AU5N<93W
MNY(2) ,4%JC#2TF*X[<344X"DXE/+YPX_H';Y/R!_^2#IYMB#V[->HW/MYYT
MMT,0T>&:['G3M@I/^&@G/J_^Z'4M$S@^PI/D9Z;,':][Z+"^[B_O5;_""=!U
MCA?!-^[18?L0A,9!+$B%!69!GW6<\5D38JVGEY$<%&<\XM@2J=;(094.BZP.
M#+XZ(11^Z6%X_N/Q2Q ]C4E^>OSJ21W?W_Y2(>,_&LT8LP:OQ(4T&KU<JN_O
M] JUOEJ>-VWH -@'SMNJL68*13W/?]HKU"<@KF=:4K)G_Q%='5B@ L\BCHDQ
M'C\,7J4>_75 <P_1 H^-5RVV,6_*:&VE258,K^746EQRS?C%\0YG9)*JO.X>
M7X%NGF\JO_]C.]4Y+U"Z?V5[%L/E=E:QDHB;'4DN<=DV'<.-V8&C1B&+'7-2
MC).-S8,&G,/%<K ;(<Q=^81^"K<[*9"(B:Y:Y=,%UPGNYB.^L2]+[LK+-[H7
M]GL'WY<+B^?/,XC5C%]Y_?I%DC[,\1-3Y=_J@>QXL80;\/&<3GB5WOO6'\2U
M%#JL<]D/7[NZ0%"?5XI;:3R-YWB".Z1I,6=DW$<63LX#&XR;FAHVYEV1O1$R
M_]"L\(+#XG_:=?W?6Q1G%TPH(KT" 6+G7$*"I@!>B<MJ>484=/+V<IYS=[?\
MXO*C>_$H=U3?#1VQ4+;7RT+E<?..]TH.?6)Z,<!8Z9N=[4!<$QO(CE]2!8Z!
M#:W";(.>GN8?A:;]S$*OUJ8^M/"-=DQ/,4R)&_N+[$U?DRB$4[9IW5I\1!Y:
MFC<1-6B8I;9H:)4]=.&SE\+T_.T2AVPA\Y@;XL<K=/N>G#2+.O&):4S%HL,(
M(E(':5WZB"^EZ-:6^@$Z;/+L;B;>N*/_(,6?\&,7^YAB@T\0^&8^JN"LNA;^
M^L++R?:SKS4N#5[LRVFI/V7Z8-^K#N87A[/_5HE)!,:Y:(>X"*$DB!V'A=)X
MC&.Q>%GHI:7-\>LT"8L:A!-9+_,+9#I]I]:FOQAN>\<USHMI#?QE:Q.C()H6
MBG6$HK;J789:3RD=MG%<@R;*2GW:3_G<3ZFNQM"T7W!42F,2&C4@F+].30HR
MF9-C5YR<H^;[G4WI>_CFW4SHZ_')O*[F&]V:-<7<^BQ"^8DIW(Z5,!;,*YIP
MD#YAO;V?:<(_LB6#%#L7O.\:CF1K;- 40_KXU:'*J\)R/+&F7OFYL("^9NAY
MH1M_O:<6L;0N-.$:.@Q>&TD1AQ->!T%DFL6"(MHR]AU-E'U73E::T,1)T;3L
M$QZNBR(;GGM\%1 @_3]8N8Q1IA8C[B(CX>7PUEX$#\68R$<1.WLPYV5ALI<O
M%>T;N'BST;2G?*4V7D] WTDC)GSG_O.G'/WSM,-L/Y<6^[>E=<$\2: <$R"+
M*/WMMQA#D!U:;$MJ%L+5JU(JK$D)5 Z<G#;PB35"F#:<U<H+]J'9=>&K&SF-
M%3=%92O$Y$[)YE>\@<$O_-U]*#&FC35?1!U!,88A)-!A+2-$/XHHEO!;;'(!
MA'5?D\BK2.>-QG60%&'4$ 0VD4XW/)F=G_CK1IQ'X/.:A*&WS=!AX<'0XG\-
M1>#/T6$Y[F3/23*2:CR!F!\"LFA%VUB_M:#I,R\.?_QID7)/"%ZKQPG;<^IM
MYRQ:M(2)7T-5<3Q+=GZDU-@B]X>CUO%97WI$TCX^/M8MW"U@4BL]T<<]^_P:
MD_//D!FPW:PT482GPU8%YA""2S0VHFIV=7'0V9$"R+ZC5E+/B-0-8L3NZ%K$
MZYA+6XF;I5R([C/=_U!Z[(?@_W@E^__JL=[$0X=UO5.G!JG30JJ'+$X3,#2=
M;]AE//8'3UE&"*-:[]J)_[1'Q7SE8&C6,X[>0#BM.RN2EN7K1DN0^\HQN8_&
M(D(^1YO!'5T)LB<Z0(M.D4")#OET_0ATQZY.7^[LK3)P2G<8][@O>,Q L^B^
M*4[M]".8B\O/Z:W_/.4_ M4.&9D1)@1+,$:"!@B\,7B:Q@D'#9MZJ9!+X0HD
MTV'5U,R/&\#\=]>''N1+6&]/O\WG;(%9DI(_):&(& IO+(U%(!>R60L:;&Q,
M[Q5#68\HU(QPK2?$%ZLD"?$DW8=GN?H)?CUI_.4B6TRA98:*[TRN_AVR; R,
M)DT3#U(GTF$K7D3:=NO,B8I1S0-$OO?6S^\N50H%3LNNB5:T:I[6Q6U]M"R,
MCJFH>J#;;F5)72!+0?]O"%=5M$+$EW*UTJ2$N<'R/->T:RQE%!T/9?>DL8Y$
MW9'>P/U1A1<3R_GXCDQ==DS)UI9N&?TA1;9"M0(L",^$ SHO@BP)DI'S&D(W
MJ4DV^2X8G]5!'3%JQIJD86SP(G/HCJG4LY<\M8HZ*%0118!*5I6FPQ*_SN<%
M^V;)T6$IGRW6S,AH(=H DN"WW0$<SRQ&1F /4U@)I)9UPT#C*C?3?LSW5#^/
M18[J9J7=<W43@LJ)O1ZRZT]29TK?!.6158'F6RC$-RSA.H*9XC.\==Q[;K1-
M*$&JU=3E_+L*,+[%Y$M9"ON[#%G%;\<,N>^W=)/>)?,7!$-NP5[S-!UV,(;6
M]RM'=-4R&7.4XC12>K<LMR[3Z-W(RM'):Y?N?=A?RO[$FWEJ;XE#(ISM8?WS
MD^0T$J,5,""(DQI5(I* ]VI5.N2ONR9D57+UU8$B=/&43>_)+'P&[?;V=5U'
MYHO=<GL6.F![N/<N*2;<^><ZUM$U,W_G5<9H[0D06H@#AQ@JO30^IK\*LZTB
MQQ%$=>P;LM1$$%J#=NY.+&J]LGU[V\&9O[LOUX1QL/7/AZ+4'@P;-98A$XX\
M ,QF8PE)0 N:X$P111#2@M,8*F_;VW28.UD]BQ$1AP=7)DG1J,6I]:^_\&^?
MY3_)0!\[U_ZM6>AE7TG)T"*(T?H0U5\[2MTA8&\<@20\!3O;M/1($=!W8N$M
M94!TYM4YZC"?@>"<=!XR1??AER])QF]I']"5SB%81T1(O5(K-O)7)8K8S&'"
M-IJ*+J*6!6(K=X:Z[RNM._LE5LI7J/=U"KTY"=N#NX#3#O^SG(XL@G %OF.
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ML6;?P+@K[^L;A@%^TNP+%_ZFIQ<?A1NM#<<Z(5C\ =+YH2:FZ7:@S/]H;_.
MOZ +INRRK9N@FQ6KI)73(]U+"<PBV2>>E\O5/C&A)B/LL6'H-]B0@D]:7""'
M-L$I;D1K7.&U2NU$_+A$HM:0G]RY]HZ.[&O9=Q,6BE-LBQ_;80S*U0 !7"UV
MQ7@.!TI]73682XC04JIL,O )3!>Z/.RIH-.($AFZ$E\S$2:+$=WQ%G5VZZ+9
M1(O>%H\;1A4S4L3^.OV1%'6\$=.\1<OR](/%GL^K6S@^?V_3<$7,-"?EU9"A
M?UZ8_I=+XJP^T:F) ]P>CU#-M!'D&UR+\61>\[TE!*\F4X[_QYY1O[&%^KC<
MIJ%: ^X$DGM=NJ+"=A4GTT:^\:EK<IXW8R@T.,&9#EL99J(DP(_U4SM\,#2+
MZ_7?-<J*^N#5?A1ASCDZC-_?W6:@Z3!%\0W!J6_T^N28?QIR..*53ZJ3A/Y7
M&YYHD8@5+K87FK4G<W0O)N^KQ\IJB5".@'D (;5SWBO&!\XS#1IV[JZN/A=6
M&DXUR!O94M%RZG:=2@T0F+B^>(:ZW/J )^O%,ZD?*61)" A4(BM&5S#SKM7D
M+"8[L"BP<UR$N/"AIL#!GOS6(;@F\0)[X^3(3725GF)'C%I"[RV#W752"?4I
M2H@&1306"8)Z.^*0)=C0>M16.ZAFJ%O^J,W4)0.#G&Q>@YRG>Y>LU4U-#8XD
MQ7\W#.]_CP95.VF'O'-IW8@JX6*"=\<#]\Z+8/^K;R--\+J8 *F*@:W2_KUR
M$X\>4BL_A$C6734K+0U[U)DN0DM8WM2;5:((OB-KT?KA0A2!^56A#J2 YU;"
MON54K1-O(LCF0\(3[K&&8=FJ*:;-_#DN[V^5Y(?<N["(-7QUZC0(0O&(,;#O
M7#4&E/1;39GCB!2,#<Z[]$RM'&\STAC_W4-/)S4@:<0J1CS06=BP4_;9IX!R
M_6O\?9XSD%?87P_%[4B: D2A* (%X.%@^$4PDE!LL-G4_<)6]EMMO5>ZQ/ Z
MR7TI3SP@35W+@9JKD9!Z,G''2@$YB%RU((L$J5-KFXX:SGK%H'C*B7X1$O41
M.Q[.J9;BM7512<G:FO+)%V=Y30?JDY+TPW[SN[Y#G?,"52Q(MT<;C5Y"<3=M
M7C'6/=!7H>VL1VKM+=+$KQJIEJ*N)?G/.AZ%7Y>/_R(]M?*@'5>W/D6]_+<1
M<J+ [!<E4(142[9500LW<8XQU!#(VD-'1]M0 E653V[Z9X^PMRNN]D@'8'*?
M1/5Y6A5&2)O*:\I W.PQL(_VBW\ER0.L?@&NOZ]?W8YHM,)GY@04?C=_LO^I
MUJ&G%P[8J>LZ^D\IZ\<O?>_I*R*[8:*QG@F@^C+)@]I(N3(C,J*I"LPB>:>F
MA8JIWLW>VH4WO[=G!XB3KQASUPQVBU=6)6AHDR*D'_56>2B<*D3="#H,K?$[
MVCE_)9-/MXBCCYN$P'F=H5*=IGS2TZFEW::R91:=YU/R%9,Z8H8U>BRN;^*^
M1_/+6G1@9U^@"1#<@*#1)*99<#U4-.TBZ$X@WR3;EBZFX9>0JQG9:/DHTXD-
MDKES<'E.W(?Z2?%>^5[QN_%BR"$<8RPPR:V3L1OI,()W ;!1W_2<&D*'S4;"
M*[$4KH:V7>=H"@_>G6K3F6%;^B$?)4L\_&)[(KY[*DV.?]R=+>3TE^@3(>H;
MM3(.B_JVD*?\DHU]>QET9ZALQR)^BFPS=#0]@GLA+\488WH@%[)%71<LP8P.
M>Z2FQOD=("0$Z1*,)SP;Q5Y_$(]H=WRN]]7:MN-M']?.D5#15ZF2<<?]7B8)
M8%-QT7!V"D 6H@#O"-M1\M7]>X)T"+Q%0F?E.V:V+S=$E?SCF/?28XGEYN:(
MB84 O54G,CM%G%JOR</[F.CP/@/^9,7#FV3@F9C[[A_]U#-1C@7][-LOS*?>
M<DNRH/N=5R#RP&0,\9/*SH@J8P[PN?_UN8ZX0MOSD@U$GJKN,D,'01TA&X65
MHZ+IAW3;;M[4OB^39![ EL=JETS6 9IQ. '*0\]2E"!%@Z#4.LGZ3F%5:^"5
MH1;VM=5T[3.MT?W8)=*\BTN/GD)5<9.RS:\US:2+$&'!59HF[ BCSJJ/6C&P
MLT7C_T9R^5<H-J^3W*"%?D\!AH#90A0G^.W5][-?VS%1ZL+&$?F?'@<Z$8^'
MY77;R@H%JMRP'?PE57H^/'DU4/+493)D$E9;\X@*#(6K=S9A1<>>#6"%F/'U
M%O5[$Q]N^^HK:%+MYF:LPM;91C?YZC-.G[C(:V#)H7@2QOPB4%52\@_=Z#)T
MF#T<E.YOAY@/4UM#PM$@>:(4R8)4-#X_HE+\DG?YRJA]A(EH^WU6X/TG0P&#
M1,G?]$0#GAA_[Z0(!]-A:M-TF#>"AE_N0<R.&H^YXZ56!V:Q$Z<O@.6SYS@Z
M'IIC"7'!\>[Y+IBJU4$W4\1XV9QC7>W,K2A$BFA S&.;!U^N+VF%KTK1.'C
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MZ> S2>&0&'W8G9O\\;S>::G(VT^F!<RN_VM3+\$%U"' "_D2X-!!^1)8,,$
M:]"%D $@)ZBE6A84_>BD^;I?5OP!UR^7-<5_#3&4_Q##_A>/Z;N&:,XYU,L
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MNXL%<P4\(&++3U32ZUA@P2"P=Z&A)TXZ8C8"6OJK@90F[X7N^XE17^KAXYL
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M)=V+A6KY4[:^#K3S!WYP22+M[^M,P_U1=(XQF12B=V=%P'Z-_.FB\1'$B6>
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M:P\2=A?5#_^%@!T ",\&T>1VE!#P=YCQG ^"&+V_CK30TM _9U#,>Q <RP>
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M;PO:-Z,JN9;_O8=GI^;FU<\63WYMD,_YT+W8Z0L86L_8:COJ(/C1^3/BPYX
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MJF U,1DXA)JR5R+<GIQ."DV<@[%I]KAM59S:+<YV\3YV24Q.HR-@+6_X1*?
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M@Q^6[(@HLKNM*[P9'!N\+>A95K:1N,;5IR!LVL%G=+@+YZ]/L64(X].>-:B
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ML2@EE HEIN!,(JFZ^0B*5%(VN:IEE[3BZ"F^\Z!=5MTS1OCKOI:"8U]4J&E
MZV>T&WQ7+2L63M9>1E/O-?W1Z03N0F.A8*9;#&=%&LYQ/H/S-IS&3?]QY\6E
M.%F*D*S=K@K5;=%8[FI4G?X5 7&Y'A:)6^/IT,%^Y%F*-M <A#J& IT1P2P(
M/H'M\* EYE6ENOM"!8P?#DRX7JSLVKI35A^!O_%9I;Q9M,'0_OPD[KBNKF%.
MU/ICN@UZ]ET6 5&]9D11H1H.5V:_6T$+5Z"/NC_L!\T/%GJO=E1%=B<W&4?M
M7;FF^=VGKG.Q5TKRA?TC>(7!6M=3Z+#:BP:S/YT8_2K?+ZO^Z<38'GP7<'CP
MIQ/CVX#%R"N2]FIZ%A8WM9F./O#H@7FBI[9P+M1C6)P\-@HE17[?::!;F39G
M/,CM.F5)9&]SL CIF$BU\<>>DVF[*\Y=T$/L8(^;6YG=Z$0(TC&9TEFWR<"<
M(D^ N'5=I8= )2>G^]!2M9EM>7:%O-R10@?%$_=OO>&.]'YYBK 1BO2@7*/>
M3A@R'**:$4%_(U-7TY3 KA[XVQ-N52.ZKB E\VXQ[3)3@OK#!\(1RVZ;<:_@
ML0!?)6R2?<X_NB&X2/NN9R%YSJZ)R$%5/5MGT^[M[RW95L!=KWZHM:M91_GH
MV63I-'HR;'8L;J+3C$'F9/HPX"MOA=7U(:K;-Q&?^UFF!4UT.WBM<+SA_VZ8
M?.%=6>R"9$NH4<XDVY,-1A,NIH^@ =AIG:0Z$4O"&CPH5]S 97Q./6]<C<%9
MU+M2=4I.QPK<C72*HVO< <XFVZU7N]X)H'ZT'@W8@[R7$6)NB91-)/\F1EVC
M9="9 S!XYLJ#M-&X64\V2IL:P>J]YO H*7G#6ZRMN"OW<NG+=ZG:$DY/%G,2
M=PXQRI44,.33EFN,6C.UMKP]B$RU"L4?Q$$AR"/5!)=5R3F,,.8M=FD2$ZMQ
MAV28?UNN6Z0D=WSJLGR?3&>OZUQ=[?"-;OZ%MO"^:]J6.P/\H8J.T+<EJYT,
M+5699@H7J@TX3#^NSQ%M:<_U[=VS6ZIJRK=MOKO?= [:P0>6BL;:UGI)W#!_
M< (2#C$UN9?96?8'G_ZCR]+_B\&//0J;-ZW?@SP!?GK8N]FG$ _0=8709!9Z
M:.7B*YZ0R%-OW_Y+N[S>#?)%#Y)+%MYR]2D.&N%WUA[C0VBU]@CZ5GVTTQ.1
MMZQUZ^:UG^.!)^QT[@J&8_8'LMYDGJ=IEVC1"M N:S!2(2T-Z4/X8:9J:DON
MU:T=$J^M_VS[\]?.C/*\7;C51_\0A(+CSJNP" .GDV<@#([R,S>Z(M!2":[K
M^R5!-9+_%("[0PXR(^Q!,DAQBA18;XROHKK7T*(+^.\4Z.7LZF$*H_3HE1T8
M+9DNMX(E7%><VH.TVHN.XAH'*Q$O9F0]H-S6$Q\JUWI:>4K<\B<[:Z,5Q2]Y
MW3M\XO!G)]^3Y^F?3W]FHSJ"%_S)D#EJ<)@#D9!-9P<Z) U&E3#":VXWG294
MOKJA[>OF?>)@3F-%]'V*2=9"<L))05RQA-Q[Q/EPP/EG#@MQB> Q)QT!QMB-
M2$'I&"1?D7T T$87KN5[C'KGWHI4#,DYJFVI9^'XZ('IP(2 M=6S73Z*)GC)
M@3W("?H)83%,9R:4X-(6HX3Y2@GNKO:$6@W[!\9 -]Y*C6I&#\0E#RT:$%!^
M2I8K*8P(Q?2&S$%Y"+=SS[Q D,^B2JJI#EW2T,_IV?7[6$SH9#.6B#]:K<C=
MSO=*(<'1^#5[9:HM0ZSNV2WP_M["YA^2OZ+JJE+W(%V\EI>0Z<05^I$"<O6<
M7FTU.7A6D3G@>,>*L0="W339T\>TH@YQ)CA7 /"&3 HJE?8BQ-8OVSZN:MXI
M)Z;/J8'?UY4S8A<;@_0HF@EXUD87K55['/K.KQ6)>?(6 KFE>^-C^!,Q,1F9
M3Q\/;">VH@D>:JM+[P,B6T@_VN#'?P=YJ+_^D6Y2/RJ7/+/#^^R<$O_]N5?B
M3\RC'XK/9A3F,04[493!*5+6VD_OW";"D5ID."Y#R**J-GD=:U$3\UO^YL#"
M<^V3H9M+'VHB!#7R8R18M[HW%["2WT3 M)!Y#=4+/PH#UW;<UF)02XSLO-WR
MN"0<::D6+E=8(@*K$+I00=,4#Q2WD&=?C]1U_< JPR,:[['52S_RC,&;]4)-
MIBFV"@4IBF%P1]Y<&>-NK;)-G[XJZY'O]SG^V:6J)4>^4]$26UNU?H+T)[+S
MF' L0<=DP@./:9,/:K<_28:3:$%MDS$=1?G30(MA03LIO2#"QMIQ/.5J5.UT
M+._EZ%G(^0_!EZB+?UL8)PS9"'613,&O?W!HZFW>?>AZ42/EHF7J,:Q=QE8O
MXM%W?8WCA/#I&\?/+NM(FI=*KSL%IJSF44Y0S]/"Z2*,_K5A80!.X)NOL.%O
MCRCX&GL!5FD)'RF5&-R6<+Y'^^@DOV+O&\>$8-5$2$DJ;+846O:#JH*A'BO
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MO'+8P#U(FU96&93&#:/6^9;0KV7317\QBLU^QN]!%H:*@$TG];<PQ28EH'D
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MDF)"_D$J8(CO_K3!M!WZG=[H<GFX^!>_RK1Q5"\^R(J-?[WU]1@*<[;(>ML
M(_DF>E- H&6(E@:;Q7).I) >-$7N JQ8I-Z(Y[I3)CM:8+KXW0DW"3%Q=AN]
M>.N>J*V+J7?\+8.;R_++U^HN>0,5EE_@G*AA^ $-<\)VNQ\(MKXA;?.,\NP\
M8Z63L0$[TE']^KJ9TJQR7N95AH)G!$SA?9Q_?I,=F8LC2VUWGM:0QG=U9&<O
M:SEUAC7H(%B--%$C!@=?<2-K$Q^RWI&S475:F OXD+A;5NPP!VO.8J=_VX.P
M^Z(/!HSIEA,Y7U!U[WOZLK._];N6>OB0DVC\2$B=P?.+%V4+9$^=O,;9"ANG
MT(\\(:<0A'">):$H4;)2+[YU277 9FFW+VTXS3Y?1C11:M.,M^5[TQ!WQ'Z]
M/4B=O/C5=?NF&'(CH](/J35P/6,/<HBO!2X0\,IPD8:F &95 UK],9GPI/DH
MC)J?XW1][U2E-]I[:BGK*)B@EDQ4=]B?:1C^-:V#]W^^6NP7^%@OJ6BJU\6M
MDO=Z1WU5ID]-OD^3Q4Y&Z8N6:&=&[$"[5$$W+U!=H,:VU_8@\VR/]^W0< #Y
M?-!<<CW%)4 (SQ=3.9UYB+#^_LB[6=![VS86I\I'#T@VSHANC:SG'A)T18UI
M1)T@RU:R7J5'4 UQC>H=]L+H094@=GE+PQ'/G/+&LH:G+M4-(;JG)6[J?2G(
M/BW3\R6$E>G.& 9;^H/*C9A56U4)]O@4(/1E-(OP:LI69Q]1I$AV^6+V11T)
MQ7,/KUZ=TBB0:W*M-##=GBT>,8=GY^^C=@#--NC9A,Q3#.D!Y W#=T%8+J0\
MD;=5.JSA\D^-+NQ!>FM@Q4&C#^;W^"&)[Y7?WBQKY\P%H;(&;!8/BX"72K>L
M0/<')+8FPWF0HN^F- 25[)9ONNWFODZ-ZZGFLY6RK(RPN!1?H3O69VYM<3Y!
ME':8G-CZV#^Z01W(<2<=MRE._#1EZ!+D%+@?@PADBKQID!/SU%+OIGG24R;N
M0\TEF(W(+,)]E]5>(DO;#?N?<WC.I_+WJJR$3+[]7LB<<3F\ZNS<%+EH-W_F
M)M/3LX(X[>_6V!H1XSE%LKHX[G=<:Z/4CU8L*]+A4T 90IIB8CSLJ^[!<1%S
M]IA:HE^(F_24PHC=Z #BIM6J^%WJ BT'-EL%;H4U22*B%76FD8BFBI4'*-X0
MK'J:2_;[;KTT:3?V\F2@ZH7X=;6\- &O3*<I'V_^_:?ME7??8 GN6:N_]*FQ
M@$#GD,40;&=_TP=:'&PV$=B'OEN_8F?V9>9@^1[D>>[D)#]G^&\WN.F(P*"
M:&!VPDV+B05KIRW=3Y?CT ?]/GU*V[<*.J,&WX]44[(R#GK,0P3:0,@LPLL?
MQY@U?MM@%XH1#)PU=*SX'^Q]9UB3V[;N9T4$1) B-4I1$ &5IH!$1)J(""JA
M1Z6#@$K70!2E*E4! 272+4!$FK1$NE*D]Q((@B(M 0R!)%_NQ]IUK;WV><Y^
M[K[+?<_AQYOUJ"LS<\XQYQCO.\N8CV^+>X0_S7 _<T(K_N('>A0T!M\S@2D"
M>MX6<M^7_W3[1J21"2C3F( G#"2^DOU _R7/%>3:JTW4UUU> S7TS7<;_JYE
M:[0F&3$@WK<<H',,?SUJU-3>R?&<NL+6N''>,+_&5(/Z_9>&UJ!RN>Q0<"80
M?))"H%Y*/0JUAPF =PF#/H1^)C!#@62>EJCO6C0&5 >9P*<5]!V;=74T$MB
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M\6)<K[I*KK65:^K)=M^3]9\?JN=W#KLDK#:?S"A4:(4=&$Z(17<TLYE6</C
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M3/!P8#59_FQ7ROE>+FS"FOD#[D_L>UI56X\D^+MU"MBAC\S'Z1Y'EF?\:^.
ME]KV.TFODO!CZ7C266PH?GTA6FN]WKTHQ\SU!UDIA+?0"+4>TIQBO)D%'5.^
M6K8^"TA2GAMZ5.(9>V\3B>6WV;!P#NL[?.CJ0SC1]53H^/$C3. !ISDY-8\)
ML);VXT88>%\W>#P%6>0?B'CLL4N!DCA2X7/C?<.NP*2T?W?.ATUT)H"N=L8I
M4$/!G9%0=#,GK7Q8 +!#A^F\+TOO>[UM/PMY;>=F,2;@,MI<0FB+VGM.1CB'
M.[TQ1_V;S\<>FA(- .M%H98$!8+-Y2RU2,YAM#/:T3_1(C67<M/2* ]Y=BCK
M?>P%=(7@=D>[$"E;.9H*#^,Y>GU.OUNIQPC[T6I &!.(^$J42_-_Z9K\8W;N
MIC]\T,.^TDF\[=/6_9.7![CS?P3MV1\[P6G3<0X*QYD_VVW^5V )(&%![6G\
MS#A^F3<_N0P3C%Z4-V0"2 XF\"+/JWOW"A0+[_UL#;F!/QBH ?(;\&P(E@E8
M\S.!4Q9KYW'7J3U,0%(+\J3Y#Z&Q(>MS!:?R#;7"Q00J&ON6'66U>1 O45?^
M W*Y_'\'D_2_YKEH_YM2LQG_IZ]AQ5N\3JY0NW%<\.GK9S%#;V;_Z0-;J8G:
MO!.?W3V2=0GC-XI(RSVJKJ?2(P[MNON7,\T;^&G8'!J*DL_VTS):O\J0ZU5A
M[IXO;R-DX!6D\OY]TOP_O%&#[?@WK[]HU>+XN]3WYWSZ\R,YI0A^+$=6N:;0
ML-6Y%?X]O!<VQ9EGQ>FZYR^J<1OL07S[Z:KVOP-VCU_EZ,<:_":'_\YU>7/A
M9T_X_X782+"U@7_$1H*M/P@;2;4V\+\-_]K[/1OXP["Q([R!WP'OG@$MF7FG
MC&NWXUX\-NDXM9L). XQ@;8=Z(5[NI0 /)T4"E)YE7BL3,_ !Z#0LU0#HXT9
M,S >3$!]/Q/ ;3/4YF<3@\W2T*OCG R2%-A6R@12H5((F[/3'P;'<OZE#![T
M7\N]:*Q=\S&4ID$ _;28 &HGO'"."7Q] %_Y\.IE^KB=UM^5#OOK;U[J-K[Q
M;O_?%1_]E]\\Y"+UWOR?UOMP&/JOQ6?\[3>3(^3X-EJTT:*-%FVT:*-%&RWZ
M7]6B,R5'Q#?O#]M]:X=FO8$V#^>5_X"5V0UL8(L0D84>H8(F<3(X7%ME.L%]
MZ(\9ODP @!1+;V5G4(RQ-@_/SV;,_QOA2]C)!+[8I( X(2:@:3'])HF*@&3^
M,N$'B;"VL\]0D_,&9+[=_P%+WAO8P 8VL('_'C9%_GWRM?AI]*]2LVGJ2:5'
M[/RW'O#=P'\+:@N_/A/6TT+_U5;NB]#WD/5V_.SE_@UL8 ,;V,!_'QM;I/^A
MV-@BW< &-K"!_W&P1?WZTN)MY*\N-5XP@3174-!_P%GJ_VW81?O5D61/^*\7
MFE_NGX?,M_EGJ_$-_-'X[8EDRPM9<Y*NJ8'VT6M92A<35GQ&&SN]$!^]$(AN
M=!555'ZME0F<9P(P*DO?$^BOC7_ %@(W@87H+GPCN.G').^B"$^ +HUP%YU+
M6%X@,X&[ ?[:J%!MF#&X,@:;46&HT=%C,!MCY/X.W?4"63;*VRAOH[R-\O[[
MY7G#V#4.CJ!4>XZI&%X]*HH2F $[UXXP;L.<$UBSO%J=R!*22H(Q[Q;N@*&=
M3RX;<EH5DP\D\DX^>Z-467NH=A5V^N2AD1MS9<L19\_.7$F/D-K['[ [L($-
M_#NPL<OTGXF-7:8-_ YDIMHBD8N7E-!KW_!KF_LZO7^=-JYP&QFO]?5]-&-4
M Y]QPD4JO4IKXF?KR#],KV:,A];1L*$6V3K3N0?$V^Z?1 \B=6!8K;GE\Z'Y
M%M3'!A&+GR\GCUZ-OTJ/3A.-7_3^I[S _9P.##,:];7BR53;+D8\\O[B.@V1
MUK[4_J,9R>U\T\:\J="RY5@N/'99O#.O+[[DZY"TM$Q>$%2+JS_[#ND&-O!O
MP+^>6VP#?PP6<+_:^D(H_"IC49#H.&2]=>/\["/#&_@#\=M%.:1^7RM&$/_E
MI0L3^-&!7MZ6W\+?P.!,)<)7_-; 1Y,OTR-^<#[ZV23WCX1J= ALSSQ.Q"5)
M*/OMTV@-]A],P#E@;V 59VF'JFB9*]%03J;YA*FK?\CET$6-![<1GWJZ44>H
M&&_2S*6/(TH/ZOQ)CEB:P;?:']\"RH[N#43?5DN=OYBBKD:Y',C9#&Y:SN*]
MJ-4GB]+/JO=W/-3J<:3I+:C;'GVVU,9T"',],S._!*K%O>#_@,WT#6S@_P;_
MRB/!&_C#L 7WZYL?5FV_.3.SXTXP9+V@_P"IMH$_$/^0J3#@X#_D&:HX@A1:
MUK@3Q@1&)F;6%!+2(V2Z-8[\;*;[1^.[QEZ443G5^[6=>W+--76J0A\C:_GJ
MVK(&X<RWVY/8<,7WV,.3YGE3 J:PCVM<T\B#"&-2+3&@KS;OHKA7[QZNK]6I
M^#GY#,Z^-,J7NJNKC&_S=\K.7R<M#%RFPN6I+/]T;\'?TCW@75Q<>3]4B>T_
M^SS&_WS8"#"!;0<81?#Q47P!\A%X!%VCQ 18T70Q^%4F$*Y+":6@!\$NM(<S
MB&]*=" 4>3 !TX&!*(683?->B/$73.!^6S1#R .T@X$4$R90YTCXX89?C4'3
MALZW^#C.7^:E5I'0(*<4Z7PQT9E(9@(?%GC]7'4L3?W<*T\2V0)N?3>(_,:G
M'.27VV,K92=9EZMY66C'M>:U;31N)E!MBW=$4Z6VISEFTC6H]^VAFKGUY*JP
MU K6R6>[?%]@?ZS.U2C%ZBTAS8YS+O*/.Y+R<,[>P90W.N=;>F4.99X:GX<2
M8(2"QZBUM;[X 9P8*>=><97MV8I%VY394A_*GM9?WA@>$I,>_'YI8BM7/7"[
MF)?>%5@#)]W@G_,DIU#&J$IC3( ;90%VDA8BZ)[I3FMY.72Q-46X2]%[?)!
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M%)C+C!M@;]T7-^Y^X8ECA',F+07<&< $I+H9:?C9).IC)F"(4**/HZM+FBM
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M.M!RCG7JN0WY9B6UZT[$H6"A9FB/G90-*HU-O!;*3VT)J!B4TEES28'Q*6?
MC10YL.+_$G4>PU6K+?@P%='O$=5+]TQE&8B)I;=$E#!#]WCL\9K1B4A)U==?
M3</CFDI$9<,*M#4K1$/>*U7*>+@-L4R8=%\.+#^&(0?1JJET#JQKUBU^'KR!
M&"]%4@_#(29P'"X$M'JS2]QI</*=AJ0^^VT^==>=1V9/S&XS!Z[8)MQ(]0[-
M3U%)YS\JW&_2WSF$&R<!C#W-M4P8>I"@=B]X:1L[>QS7[F^GV63A'4ICI]DT
MI!_=Y_M\N4?6Y6K:>RFQ#,)@-S/5*IX'_H.?9D5?8:>!>A$Z-*F[3;:TZ?&
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M+/V/=^ CA6%6"\7,[2P$&X?P7D"2<>V):DQ;\R^5^F_:E:W"\T>?NTM.%A3
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M1306X"CP(\:;:! Q!GQM[DC6G5Y&XY/3O-#BT.L$0Z? MJ=[0>)6QO+\C"*
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M,#LX=8\/+,5Q6R4GV@]/@^\QW%;) _X7II'[@);MS?M],)"=&W^$V1!<KBK
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M8GB)-;#ODCX['1BG19X7LI1#)$+PK899:E-1&!:<S./:).;LLJ;4G7AU[[=
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M6%^PCKI?Y!(Z<4_1)8H8B^? _MJ<GLMS5O!G0C:5#)>,""<75C*\J(VM@'!
MA59 ^6+M#H?3:>T.)YONEVZBYW?7Q1Q4-":*6UU+.N8%.^^PCOCO<= A.HK;
M8Z59*E2DO1."2D"'MF3$T=KZAMI7M9]K<@P0PL3C*8UZ']WV9TPY*3VZZMJF
MTOA4)%;E4?$L:OX)4RA"F1W=)&5PEXIY>PM^5[."1G]??JJP^<O-]YIQ].S7
M$(\ST%N^M^():+F^\'?=ZBQ@/O#W<TS7"FDD4.@B&X.X@DQ2T*'1:R?@#S((
M74GZ1-(V9)M7J4^)O\1JB(A)@MB;N_L>Z-W;??D23$9YY<BFR. _2WQ=-9HT
MW10!_PQX8^^ 0O_6M"IR:T\;7?Q"PYL/+YU="D1KRN)?>&I(:YX[*W8")N_@
M8&TUB6#MX&9([_Y"1; ?]8BP]7T'J*1?(5YU#5H7.\V8 V,;S>HS0_Z8>'HM
M% YNO4M%'*.*)-<B)6=E35,JVBA\EZGLWC=O>NQWO&G?6O;97.<Q?>2=]5;A
M(RNWS98QOYK*;KM+EF*),2=B2B>68(QDBBFVS'==8@R>!=_FN]UA>\^FS.W<
MH<T^ OR&+I8;-"T% E/Y(GD_KL(9NT,6''CG+9BB$7:,8N7!;:,,JR.YD9I(
M%[L@O\"2]_<U=Z;O4C27K[].[&S7N2V?.K,AD+4$MI.H08@%-:;*[. M[?OZ
M+O 'IM(QWZ52M:5J/G_O=XDK2*4<")8,W)]Z2OV4RL?7HF&!FP['G\(58I,
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M;R#E,PMZ.&U9\^]272,7;91$M6*$ZH[+QY=?.C#"6,DYLI<C>J0$%$+MX!-
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M+66#0KF5NS!XY3=GD(L!Y).027BR$3ZJ3982&Q<P(@ DW@!G:(ZE9<BAL)"
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M66"XM;N-=4HN)*=MW#]=J;[I0:'UB3C2R677#P+W?*4/!.\;*AR\LHXAC..
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MIE>\]>NG3L]=3S\WODZ0NG&IY9$8M@IQRPS4UFE'E.'I?'Q-S&.0=9FU MR
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M=.G%H+=%RTI3,_I1]@F7GSA+7E +->K>U0/PYG"W+H7]%##*!?2)9 _YCXO
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MCA ]^GK%72/+(TE?@Q^?*)VI>\>\CY]>PN^GWQ["W\[0;G50)/_ZE=]H>IH
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M57O_*:*S4^UMQSK,]-VI]OX;H9;J7SQ7^!=1S.-H*/2&>0+3!7J_]:$U4)7
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MM^7@YT1XI>V-BWT]$N"8O;;!DK;T?N&.H^O('OGE#S0VNBVKXV4;YH.#/H(
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M#^@Z>L^POZ;LZVG]4'Y./.GGH7=]S>K"VC?:SI[8O^?^TUT[59VY</+O7&)
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M(Z!K<3D8HV]SWNYR]91%9=5+4MZ5M7-:2OV6I^ B?\0>E.JL6T,QV5D]B<=
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MJ\UUU[_4'U>:P$) S=%-)U"QF:VDE'"Y;VE=UNWXP]*V H&2/53!O^G@4K+
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M&6>]!1C6)?F%W'PA6%%!&4_<]\<288FB8Q'\DI$W99MYVI[+B>W+?Y2[,M.
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M]S\D(-C,SXCY!\>]Z)8E#G7(UHLTTA0_X[ S_$V<-%.CVQ.UU?LRM?W[RK?
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MJ:6/K1%8+[8QPA#:.L9ZA2*;XS[@A$%/NVR_X"O@"XIW\U#*(DJ%8:C7\67
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MKN<]ORH)"R?<37+.:/(_:A[BN"]9YZZ3S\YW'Z>GISY_;GC[\C'^+_M1A&\
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M93;3"> !A2G"&UQ_2EYW."3D8JU4"?IZCN@[7T^Y6E#D&R\W+,*OIRZ]+T&
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M_[=#+#X95ADD[H86)=K,/*KDHPW&+<8]+#<==E^E*EVEV*I[L$I5>LE+[?7
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MA?NXFL[+.GOT/<\@\>R?C'B"(8;^O^L WW_>')/LI?YQ[\SG@X$F)R>G@2;
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MO=<\@_-D0:F#B5?PG(J56VIB==)IEN:[Z:KQ\?'M]M)]CU1^;A657V&^[_%
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MWNZP\>D\W.2X?3!W]V"&E.&MGH+<'_D<9Z+=^^91P]K48\YX/H(*KHYH95%
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M0]E!1F7'5%$J*RC[4G?X1'P,8F)WK,SV5,NRA057D*/*U]9W<T?/-[]"&-*
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MT_HE!1X_^74EPGS@P]9VM@J\=G:GWG;IC"M(3WA)2LCNEU_G-43<L%P/AX(
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M!"<V;,S_#\DP_E8P$Q=_">;D?R"8S5TL/.#&0M'>LU[7 52DI="7"?J,?<U
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ML^"MP6(UPP3//J5SA.L)67$^!^\RH&#:><#-Y4J"YOV.O*B5?#J!%8.\L8H
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MEPF4.*WW:%,*KHFPC6XS.MEZ J^D^#U6RN ^?U75(U7^,/Z/<=(.OY\_(OH
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MW7OG3SZW/'G%UAEQK;RN(NRGB-U'Z7B9!+&.ICFMY"<=DS=MW5B/H0]! FX
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M/OZH>G?X.6ICJG64.D&[MV]L2>N*2OP.E9RYC9^ZS%R)%:OQO:4QP8A<N2G
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M-^ET +QK,55/R+-6BVCW :/B%N5H^<031CK*[:W'/ ;T;<NU5X[)*L1YSB#
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MBD\5+0:\O^$Z!P@32QY;(SL(:1V: $%X%H;14HZU^JCQ:$P<:=#BH5SMZ[L
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M=)8WVS3;27V3@X.HI/()\[6;>\\Y\>^+2S"U*0"5VUR3JTK\#8TM4EZZ=D<
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MF$KT:P]M5FHXR^>@8I0>J/A=[YRDAECY+44KI014:R"HWD=!TE#L'=RJ[K@
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M@8D"K7K/_>42_ S7T>?KFU:U/?9Z.=/=NI3OO]3=F4Y<F3ZT2T0(1[!L:58
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M.WX;MT,+0)#N&G9574\P"(QC\U0WU?&]=G&?MR7YUU_:?#&9;.*;0W ZD')
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MY0=OO+^+(W,]5(%J+JLS(,X12\OT.THZ4JOS!@F5?!4*O87"%2?/'KTPA;K
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MU-7L14 O\\)PP%$+1VBZ5^'M_(1=224#6[?V0BQ2C<J4Z?N^,B"LLJ!%FLK
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M!@&S^;5/3Z(LS'5V<=_RV/Q5J^,;1.6'M\(JOW7 .*D<)!-F-*P%=G@1?G-
MKRO-"*%:-,$[^S L[EM7W5NGA.FC8EWJ.4):IO,,R%G^HX@,$I3.GD*10T@
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M:[%4]-"P+RJ\;B1T_76G#?YR^5N[DLL5/D8"GGEY,KN2U?4"+W(M.32XDNO
M&8N@BM(>X B@MHTLGEX#]' $:8HI&4Z]L.:+'2*C9#XP((EN3N.U_0_7'#7?
M?MBO!:?O201G6X$!B8Y#]K0A](+(B7':+.LE#197+E$D!)">)F3C3G**X$9N
M9,/[=VI]?%_B3O7:8E7_#D')/T>6(([2BNA0:B -/044$3"\UM<19][6UC<(
M?9V][3Y,TO&4*)\PEAJS4(L5=W.>^,!WD]W55Y64WF8*G.XA.P-ATX=D?T0!
M]V?>67NG!7Y6.<-ZLS:R1^.IM>_+FO3@?8>2!"]J$&(G!$BN9 NFW??PC1[!
M5:*:T2NEH2UW5W/ILI^UU!W)GE;RQZ*./YZPLS.J]!+OKMUQ[.DY%ZN3!5>.
M(#.HX"K>-_G!?K"F#D"3/*T^MXYYT/),B#491Q)'%1+3;)WGFK(^A*/NYJE]
M4IX3GFTZMWR/S QH$N](+8_.*!RR<:]/B&[%[[6^OK:AZFUY/L)6T^15KWKI
MR]Z-[+9SG$GJO4O/Y*W"OOTGX=,6$T*4H9KX$<Q>QLT@/HRB&C,@>YT3'U$%
MIMF37F(+TL0OOBW_?*'GQ'MRN[NQ> MO1?>CD$=Z 8D',L)8_DO0RV*9[8>R
M'C] 8T#8^%%-UZEZQ+QV-30+DC>XT(;8_JXP)&A29>C.Y[3N=?Q=73]75^_
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MD&NXE9]?73+8W2]H>#/'2!"^.G==83B56O]?PU^4#3IG.?C"A8LBXKB'Y#O
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MBRG-))?AXQ>):2C)^:<K+J)R$ROO97$OT+]3(R^8UG'Z*&Z4BQ[WC6XS-L*
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MVT@UKY!<&_5%]CBBI&Z?74/5@?9")S>V]17*">07U &< SPF/4<&<)P&ER"
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M!)7A:EI3$[D^:UH=LS5EM(8.;CR6O#F4_2&)6TTL9DY\4VMSGD-P10/P=Z
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MD& &FM4B*O3$(9;T*$"'9!SVE4S /@W_'Y4R?MOVSXSI>_YCQH]KMNBYOE.
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M8/!W)?=O5@3<AFS%LH_/]^PAK]B1-BXC5T:&7#L+KAOXEZE/'(G*"\];$Z<
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M9(Q]#@" \KHS)L8&%F-)QMPWCS2$Y[<9)42;3)SEDT3!0R"8>]!/\ @D:T7
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MF4$2 \758+M'0LF"/LUD=N8[G:W;XL44H Q:K&25$]_64^MC>%W0O&U?3_<
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MWMX'J?):G!7/-[DCVNQA>S"31R[CK$[?PX=K,/Q)#4XS\>]/-+@60%4I:X=
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M0F[*TT3'-=G/R0XDO7P"U;X+B9&"(5,I+?Y,DMAK4D0&M7VET/W0R]@\Q*^
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M[):8CT$-4<X=*D416#;0P7Q%?#&/1 I:J?!FAY_R_Z2^0!(MWXXX3Z '/'(
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M',^GOPHXNI">\H>/5^.G&0=NP31'=[[9^WEZ=#:*/EVDFG83/-&9E9A03M<
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MN[/5W27JDL#A 7_7/MQ_3CHT3H^#1G%"G&MBM"LAE\"GOD.K9HMX'@\[B7/
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M&'R;@GY:K[@*U+A;GW_2.-EHHY9]$-D?)>7J55WP[L.96PZ!^W&92;Q VSG
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M=KQ>49JG!F_ZTSY-ZJ5!KVR>*;@5_K5MWSY 'T=>3)J6A7BQ].-(<GX()U.
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M-F)8KB.P4;F&K';OJ$IPPH!3^:!B^OQ[%B/1%/^S4V>>%]7ONFM^?5/\=]6
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M2T>\93M\K?JN5/T1N0]V?>RN!XRQ(Y8H*)1DY3=:O4IA9V!#I.@P+2.*4;B
M1=(54H&AKVM-DL';.XD?#=3?\V@FB-)TT$F2 0W=[[J$U>H%ZZ$U*-(=U+*%
M'Y/9-9-+5PNUWS.LJ[Q8VB);U5;9*T?Q_8,\9:9S_ A?3H2_VJ"4WGF9-1^]
M,T';D*,P_ 1ZS Y'R0;'7D(]9*HGSYD&):15 EKO:FK?IK#+!&O$:&L\;M7U
MDL;6EK_(+L^6,=_S!78'4/_%Q V-H:8"'*!;X$@%^%E&0 M*L D2:VF^A?(,
M"G.PIWEO2>"\A\7OR27=#*1E:&I_8:2?ZF_L0T_@J&H=%*L:JC[XCLE#NK*]
MW(\04)$?8WDQLU.S'O$TS8MW%?"AGA/,(:N+[#EV7H:\<NNT<<_SZ^C!NE]=
MD0[O^N6:T'3?OS$.X$82[2.C+X#SX(J*@O,00QD!&5S41BCOY(5O/WD'7=I!
MEN)WF+R#&U>%(*Q17*VE\&@L?BECS KU"$>Z?$J;>($/7HTFA^N%S:SX*CF!
M+ZJR\GM,%Y'-Y9*,<?^0_]RAT_JG6E.O/C#7!=UF+1,8SV-+K9??ZH;_/YU,
M/';ZFC)93CZ;];U'WN>!<YW09R S'T1#9G]",OX3BC&6'8LGH@7GTX^!7]A-
M1]3WJXMSFP_+%Q]O-RE:X0_J)^*,RVMJ'Y?'L<2:"L9J_3"*'GQP)9(Q]MN3
MWBQ9C-(2?ZMN+-S"_.-\YQD,Z,#_:TU3N:XL_3*IMPG-,D5-:I>4^MP@1^C1
M[&96C^#:G-P0L\9E><EJ1?GU.?YGXHY_>G7+X"!T-ZK)&'P.-!1>DQ3Q(T,T
M*&261M!L3;LUOXKY<?\HM-JKKK@5S9.L/IR^4N!Z9']>0$/B3&[M7;?UU$=4
M,QH2M%/[8)X\5#F5]&U(AR,O,$A":J.():3IQNPLKDU.VIB&0C7V7:VQ]?)E
M_5GC?4:S.^JP)0691#3G?/H)TJ?LK$6[@!A,MC>E? P^ZCB1VU:UW)!O;NP6
MW60=W1=97GH@],P^M17MC \8NH ^P%%/-@/8H\A^9D-TN0*<]Q07(BGI*LER
MDAZ5@S Y'.%V(^-X4V#YOFH'*1'X$:''L2)/MB%%N(<9^^G2M/-TF<_(0+SI
MO8[6*7ZR8FG]0)6XX:&3 [(V0@>.&\<4H<6?!$U*2%@FO$ )P_F_*XHTX_BJ
M&*HM(0? D*6BI>Y.[DU$+B+C6EP+S7U(UBUL=6F-G[29+T2OD8T/&?B 63 #
MN,N990_R]'T=)6]_SE.J."R!-Y!KY,<BN-%LJ1VOD?[@!\R1NX<K7RHO+U]O
M..A%F.<G\\EHBMEH^;1 BEJZO8IE7$]V&NI9FAR%O<R@'D4M%?O1!%%-^B$*
M=+72L.8)(Q)0M^Y)&0Y4O=KA\7HRR]'FO6OJ1K3,G1I>Z42%P$+ZRK%E&HC!
M]R2'3(KYM6%&-RRHHB'#&B&'J&8!ZI14CA<QIF;&[VKC[KPXDI"3:.P[DRSK
M%BU]MK9<U...VJF'2R&5EPV03+4OYL%DW#R69(H9C6_5FDFO</$B*[=2^N=U
M64OO"BQ;3#4.!K=&9R4X:JL]OPI+2;<0C!1V\YK^&(=2W(940]L552E/&26Z
M1^BG^ZYAJ_H:;A,9]JT:O#@IV4&-C<"*JX;E!:J'G\L\.&9UC>V$\TG,? ;
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M:(IL_*+C_MI4HR$=A\+V3XF!3P^%$;7/:T!4FS23JN]&&?8*%GXU$341Q_\
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ME-:;*73(B"2]1CR]HV;\H>Q#00SG8:Z/)C?>TL?!N=2$X:/@XC!\#B#;M](
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MK*#^_KL=BTD3A/"P1B[JT>Z6$!X2)9Q@MG>^'NC,]:3PV8S9K8* 06E?PN5
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MXI7'XR J$// PYM6J5JJE'=4#V+$#VY$6Z,P-=Q+O=#^=3*1AVO\#&)7DJ%
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M%L^HH<;,F;X=4%H5,W%+W(8LB8P(\WTQE2E9E5GKN!YW;J;QKL3H;I;#A%2
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M1>4X"E@AUK?_V3/'0(F>\<-9S]'1*'PEG&0\*0)P8$D[.\S0%DR)$*)F:,A
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M6IH8Y&#F&NUL??Y<Z+VUO"VF[]9-FZ+VII$!PK@R>4 <NC5W$P-N[R8O&\:
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M+]1""8<3_N!3;9Z9)J;4%!M0N@V:L $?(FL/MK<_83F?#:P=AX8P KBS#.$
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MG^LVR)._D7#OE(E(GN+'-9O5Y!AZ^+XLJC\D]IDI@REJ8LJ@%U6C40Y0$QO
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M(H@@\M\D/.S^_P-02P$"% ,4    " ![@&A35'.=R-/\ @ VY"P $0
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>-#5?,"YJ<&=02P4&      P # #Z @   JX/

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
